{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Gerando arquivo para NER-NestedClinBr\n",
    "Deixar sempre o arquivo de test para fazer o teste completo (com o pipeline todo)\n",
    "1o. -> passar pelo modelo de NER normal (binario), pegar possiveis entidades\n",
    "2o. -> combinacao de palavras, modelo de span\n",
    "\n",
    "Descontinuas: treinar duplicando as frases, tirando os termos do meio.. na hora da predicao: se duas entidades estão mito proximas (ou no mesmo chunk), tirar o espaço e ver se são (ou tentar achar uma regra, ex sempre q tem tratamento e uma anotmia perto, usar uma janela.. ex duas palavras de distancia)...\n",
    "\n",
    "Para tese: testar tbm sem as descontinuas.. pra pode comparar com outros metodos...\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "import re\n",
    "import pickle\n",
    "import random\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def getTiposEntidade():\n",
    "    return ['Problema','Teste','Tratamento','Anatomia']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "def replaceWhiteSpaces(str):\n",
    "    return re.sub('\\s{2,}',' ',str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def save_obj(name, obj):\n",
    "    existeDir = os.path.exists('../obj')\n",
    "    if not existeDir:\n",
    "        os.makedirs('../obj')\n",
    "    with open('../obj/'+ name + '.pkl', 'wb') as f:\n",
    "        pickle.dump(obj, f)\n",
    "\n",
    "def load_obj(name):\n",
    "    existeDir = os.path.exists('../obj')\n",
    "    if not existeDir:\n",
    "        os.makedirs('../obj')\n",
    "    try:\n",
    "        with open('../obj/' + name + '.pkl', 'rb') as f:\n",
    "            return pickle.load(f)\n",
    "    except:\n",
    "        return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "pastaCorpus = r'corpus\\train'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 196,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[6, 7]"
      ]
     },
     "execution_count": 196,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def getIndices(listaFrase, termos, indiceInicio):\n",
    "    sep='#SEP#'\n",
    "    listaFrase=sep.join(listaFrase)\n",
    "    tam_original=len(termos)\n",
    "    termos = termos.replace(' ',sep)\n",
    "    #indice=listaFrase.index(termos)\n",
    "    #print(indice)\n",
    "    #print('re.escape(termos):', re.escape(termos))\n",
    "    indices = [i.start() for i in re.finditer(re.escape(termos), listaFrase)]\n",
    "    #print(indices)\n",
    "    #print('termos:', termos)\n",
    "    #print('listaFrase:', listaFrase)\n",
    "    '''\n",
    "    for i in indices: # pega o primeiro q seja maior q o indiceInicio\n",
    "        #print('i:', i)\n",
    "        if i>indiceInicio:\n",
    "            indice = i\n",
    "            break\n",
    "    '''\n",
    "    tam=len(termos)\n",
    "    lista_indices = []\n",
    "    for indice in indices:\n",
    "        #print('indice:', indice)\n",
    "        inicioFrase=listaFrase[0:indice+tam]\n",
    "        numSEP = len(inicioFrase.split(sep))\n",
    "        inicio = numSEP - len(termos.split(sep))\n",
    "        fim = numSEP-1\n",
    "        if inicio>=indiceInicio:\n",
    "            for i in range(inicio,fim+1):\n",
    "                lista_indices.append(i)\n",
    "            indiceFim = indice + tam_original\n",
    "            break\n",
    "\n",
    "    return lista_indices\n",
    "\n",
    "getIndices(['oi','camarada','tudo','bem', 'com', 'vc', 'tudo', 'bem','e', 'vc'], 'tudo bem', 5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 201,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--fileName (sem extensao):-- 9053_goldstandard_train\n",
      "{(43, 75): ['Problema', 'Dispneia importante aos esforços'], (78, 111): ['Problema', 'dor tipo peso no peito no esforço'], (113, 118): ['Problema', 'Obeso'], (120, 123): ['Problema', 'has'], (125, 128): ['Problema', 'icc'], (134, 158): ['Teste', 'cintilografia miocardica'], (164, 171): ['Teste', 'avaliar'], (172, 178): ['Problema', 'angina'], (95, 100): ['Anatomia', 'peito'], (148, 158): ['Anatomia', 'miocardica']}\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: Dispneia importante aos esforços\n",
      "indiceAnterior: 0\n",
      "novos_indices: [11, 12, 13, 14]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: dor tipo peso no peito no esforço\n",
      "indiceAnterior: 11\n",
      "novos_indices: [16, 17, 18, 19, 20, 21, 22]\n",
      "tipo_entidade: Anatomia\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: peito\n",
      "indiceAnterior: 16\n",
      "novos_indices: [20]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: Obeso\n",
      "indiceAnterior: 20\n",
      "novos_indices: [24]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: has\n",
      "indiceAnterior: 24\n",
      "novos_indices: [26]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: icc\n",
      "indiceAnterior: 26\n",
      "novos_indices: [28]\n",
      "tipo_entidade: Teste\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: cintilografia miocardica\n",
      "indiceAnterior: 28\n",
      "novos_indices: [31, 32]\n",
      "tipo_entidade: Anatomia\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: miocardica\n",
      "indiceAnterior: 31\n",
      "novos_indices: [32]\n",
      "tipo_entidade: Teste\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: avaliar\n",
      "indiceAnterior: 32\n",
      "novos_indices: [34]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '22', '/', '04', '/', '2014', 'Dispneia', 'importante', 'aos', 'esforços', '+', 'dor', 'tipo', 'peso', 'no', 'peito', 'no', 'esforço', '.', 'Obeso', ',', 'has', ',', 'icc', 'c', '#', 'cintilografia', 'miocardica', 'para', 'avaliar', 'angina', '.']\n",
      "termos_entidade: angina\n",
      "indiceAnterior: 34\n",
      "novos_indices: [35]\n",
      "--fileName (sem extensao):-- 9053_goldstandard_train\n",
      "--fileName (sem extensao):-- 9348_goldstandard_train\n",
      "descontinua\n",
      "{(43, 57): ['Tratamento', 'Plastia Mitral'], (60, 73): ['Problema', 'Insuficiencia'], (77, 80): ['Tratamento', 'CRM'], (120, 127): ['Tratamento', 'AAS 100'], (135, 149): ['Tratamento', 'Metoprolol 25'], (156, 159): ['Tratamento', 'FSM'], (167, 183): ['Tratamento', 'Levotiroxina 175'], (191, 199): ['Tratamento', 'Sinva 40'], (206, 219): ['Tratamento', 'Fluoxetina 20'], (244, 252): ['Problema', 'dispneia mdoeardos - leves esforço'], (283, 306): ['Problema', 'dispneia mdoeardos - leves esforço'], (263, 265): ['Tratamento', 'cx'], (308, 344): ['Problema', 'Discreto edema mmii pricn a esquerda'], (350, 360): ['Problema', 'palpitação'], (361, 388): ['Problema', 'Dor a movimentação do torax'], (408, 418): ['Problema', 'ruidos adv'], (439, 445): ['Problema', 'sopros'], (447, 449): ['Teste', 'PA'], (463, 464): ['Teste', 'P'], (474, 476): ['Teste', 'Fr'], (501, 510): ['Teste', 'Ecocardio'], (513, 516): ['Teste', 'lab'], (51, 57): ['Anatomia', 'Mitral'], (323, 327): ['Anatomia', 'mmii'], (383, 388): ['Anatomia', 'torax']}\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Plastia Mitral\n",
      "indiceAnterior: 0\n",
      "novos_indices: [11, 12]\n",
      "tipo_entidade: Anatomia\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Mitral\n",
      "indiceAnterior: 11\n",
      "novos_indices: [12]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Insuficiencia\n",
      "indiceAnterior: 12\n",
      "novos_indices: [14]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: CRM\n",
      "indiceAnterior: 14\n",
      "novos_indices: [17]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: AAS 100\n",
      "indiceAnterior: 17\n",
      "novos_indices: [38, 39]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Metoprolol 25\n",
      "indiceAnterior: 38\n",
      "novos_indices: [43, 44]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: FSM\n",
      "indiceAnterior: 43\n",
      "novos_indices: [48]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Levotiroxina 175\n",
      "indiceAnterior: 48\n",
      "novos_indices: [52, 53]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Sinva 40\n",
      "indiceAnterior: 52\n",
      "novos_indices: [57, 58]\n",
      "tipo_entidade: Tratamento\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: Fluoxetina 20\n",
      "indiceAnterior: 57\n",
      "novos_indices: [62, 63]\n",
      "tipo_entidade: Problema\n",
      "linhaTokens: ['Data', 'de', 'Criação', 'do', 'Documento', ':', '06', '/', '05', '/', '2016', 'Plastia', 'Mitral', '(', 'Insuficiencia', ')', ',', 'CRM', 'Saf', '-', '2Mg', 'e', 'e', 'Saf', '-', '3MG', ')', '.', '(', '09', '/', '03', '/', '16', ')', '.', 'Uso', ':', 'AAS', '100', '-', '1xd', ';', 'Metoprolol', '25', '-', '1xd', ';', 'FSM', '-', '1xd', ';', 'Levotiroxina', '175', '-', '1xd', ';', 'Sinva', '40', '-', '1xd', ';', 'Fluoxetina', '20', '-', '1xd', '.', 'Refere', 'melhora', 'da', 'dispneia', 'depois', 'da', 'cx', 'porem', 'mantem', 'aos', 'mdoeardos', '-', 'leves', 'esforço', '.', 'Discreto', 'edema', 'mmii', 'pricn', 'a', 'esquerda', '.', 'Nega', 'palpitação', '.', 'Dor', 'a', 'movimentação', 'do', 'torax', '.', 'MV', 'normodist', 'sem', 'ruidos', 'adv', '.', 'RCR', ',', '2T', ',', 'BNf', 'sem', 'sopros', '.', 'PA', '120x70mmHg', 'P', '81', 'spm', ',', 'Fr', '12', 'rpm', '.', 'CD', '>', ':', 'mantida', '.', 'Ecocardio', 'e', 'lab', '.']\n",
      "termos_entidade: dispneia mdoeardos - leves esforço\n",
      "indiceAnterior: 62\n",
      "novos_indices: []\n"
     ]
    },
    {
     "ename": "IndexError",
     "evalue": "list index out of range",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mIndexError\u001b[0m                                Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-201-d4cb5ff2978b>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     74\u001b[0m                 \u001b[0mnovos_indices\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mgetIndices\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mlinhaTokens\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mtermos_entidade\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mindiceAnterior\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     75\u001b[0m                 \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'novos_indices:'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mnovos_indices\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 76\u001b[1;33m                 \u001b[0mindiceAnterior\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mnovos_indices\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m0\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     77\u001b[0m                 \u001b[1;31m#idx = sentence.index(\"x\")\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     78\u001b[0m                 \u001b[0mlistaEntidades\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mtermos_entidade\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mnovos_indices\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mIndexError\u001b[0m: list index out of range"
     ]
    }
   ],
   "source": [
    "dic_sentences = {}\n",
    "num=0\n",
    "listaEntidades=[]\n",
    "tokens=[]\n",
    "for filename in os.listdir(pastaCorpus):\n",
    "    f = os.path.join(pastaCorpus, filename)\n",
    "    if os.path.isfile(f):\n",
    "        fileNameSemExtensao=os.path.splitext(filename)[0]\n",
    "        print('--fileName (sem extensao):--', fileNameSemExtensao)\n",
    "        extension = os.path.splitext(filename)[1][1:]\n",
    "        if extension=='ann':\n",
    "            # tokens da frase\n",
    "            fileTxt = open(os.path.join(pastaCorpus, fileNameSemExtensao)+'.txt', \"r\", encoding='utf-8')\n",
    "            linha=fileTxt.readlines()\n",
    "            fileTxt.close()\n",
    "            fraseOriginal=linha[0]\n",
    "            #print('fraseOriginal:', fraseOriginal)\n",
    "            linha = linha[0]\n",
    "            # para tokenizar nesses tokens\n",
    "            linha = linha.strip().replace('/',' / ').replace(')',' ) ').replace('(',' ( ').replace(']',' ] ').replace('[',' [ ').replace(',',' , ').replace('.',' . ').replace(';',' ; ').replace('-',' - ').replace('+',' + ').replace(\"'\",\" ' \").replace(\" = \",\" = \").replace(\"#\",\" # \").replace(\" $ \",\" $ \").replace(\" ! \",\" ! \").replace(\"?\",\" ? \").replace(\"%\",\" % \").replace(\":\",\" : \").replace(\">\",\" > \").replace(\"<\",\" < \")\n",
    "            linha = replaceWhiteSpaces(linha)\n",
    "            linha = linha.split()\n",
    "            for numtoken, token in enumerate(linha):\n",
    "                tokens.append([token,numtoken])\n",
    "            linhaTokens=linha.copy()    \n",
    "            # agora, as entidades\n",
    "            fileAnn = open(f, \"r\", encoding='utf-8')\n",
    "            linha=fileAnn.readlines()\n",
    "            fileAnn.close()\n",
    "            \n",
    "            dicEntidades={}\n",
    "            for entidade_linha in linha:\n",
    "                if ';' not in entidade_linha: # tem descontinua?\n",
    "                    entidade = entidade_linha.split('\\t')\n",
    "                    tipo_entidade = entidade[1]\n",
    "                    inicio, fim = tipo_entidade.split()[1:3]\n",
    "                    tipo_entidade = tipo_entidade.split()[0]\n",
    "                    termos_entidade = entidade[2].replace('\\n','')\n",
    "                    termos_entidade = termos_entidade.strip().replace('/',' / ').replace(')',' ) ').replace('(',' ( ').replace(']',' ] ').replace('[',' [ ').replace(',',' , ').replace('.',' . ').replace(';',' ; ').replace('-',' - ').replace('+',' + ').replace(\"'\",\" ' \").replace(\" = \",\" = \").replace(\"#\",\" # \").replace(\" $ \",\" $ \").replace(\" ! \",\" ! \").replace(\"?\",\" ? \").replace(\"%\",\" % \").replace(\":\",\" : \").replace(\">\",\" > \").replace(\"<\",\" < \")\n",
    "                    dicEntidades[(int(inicio), int(fim))]=[tipo_entidade, replaceWhiteSpaces(termos_entidade)]\n",
    "                else:\n",
    "                    print('descontinua')\n",
    "                    entidade = entidade_linha.split('\\t')\n",
    "                    # ex T10\tProblema 244 252;279 306\tdispneia aos mdoeardos-leves esforço\n",
    "                    #Problema 244 252;279 306\n",
    "                    entidade_temp=entidade[1].split(';')\n",
    "                    entidade1=entidade_temp[0]\n",
    "                    tipo_entidade = entidade1\n",
    "                    inicio, fim = tipo_entidade.split()[1:3]\n",
    "                    tipo_entidade_string = tipo_entidade.split()[0]\n",
    "                    termos_entidade = entidade[2].replace('\\n','')\n",
    "                    termos_entidade = termos_entidade.strip().replace('/',' / ').replace(')',' ) ').replace('(',' ( ').replace(']',' ] ').replace('[',' [ ').replace(',',' , ').replace('.',' . ').replace(';',' ; ').replace('-',' - ').replace('+',' + ').replace(\"'\",\" ' \").replace(\" = \",\" = \").replace(\"#\",\" # \").replace(\" $ \",\" $ \").replace(\" ! \",\" ! \").replace(\"?\",\" ? \").replace(\"%\",\" % \").replace(\":\",\" : \").replace(\">\",\" > \").replace(\"<\",\" < \")\n",
    "                    dicEntidades[(int(inicio), int(fim))]=[tipo_entidade_string, replaceWhiteSpaces(termos_entidade)]\n",
    "                    \n",
    "                    entidade2=entidade_temp[1]\n",
    "                    inicio, fim = entidade2.split()[0:2]\n",
    "                    termos_entidade = entidade[2].replace('\\n','')\n",
    "                    termos_entidade = termos_entidade.strip().replace('/',' / ').replace(')',' ) ').replace('(',' ( ').replace(']',' ] ').replace('[',' [ ').replace(',',' , ').replace('.',' . ').replace(';',' ; ').replace('-',' - ').replace('+',' + ').replace(\"'\",\" ' \").replace(\" = \",\" = \").replace(\"#\",\" # \").replace(\" $ \",\" $ \").replace(\" ! \",\" ! \").replace(\"?\",\" ? \").replace(\"%\",\" % \").replace(\":\",\" : \").replace(\">\",\" > \").replace(\"<\",\" < \")\n",
    "                    dicEntidades[(int(inicio), int(fim))]=[tipo_entidade_string, replaceWhiteSpaces(termos_entidade)]\n",
    "                    \n",
    "                    \n",
    "            print(dicEntidades)\n",
    "            indicesDic = sorted(dicEntidades.keys(), key = lambda item: item[0])\n",
    "            #list_students.sort(key = lambda x: x[1])   #index 1 means second element\n",
    "            #print(indicesDic)\n",
    "\n",
    "            indiceAnterior=0\n",
    "            for i in indicesDic:\n",
    "                tipo_entidade,termos_entidade = dicEntidades[i]\n",
    "                print('tipo_entidade:',tipo_entidade)\n",
    "                print('linhaTokens:',linhaTokens)\n",
    "                print('termos_entidade:',termos_entidade)\n",
    "                print('indiceAnterior:', indiceAnterior)\n",
    "                novos_indices=getIndices(linhaTokens, termos_entidade, indiceAnterior)\n",
    "                print('novos_indices:', novos_indices)\n",
    "                indiceAnterior=novos_indices[0]\n",
    "                #idx = sentence.index(\"x\")\n",
    "                listaEntidades.append([termos_entidade, novos_indices])\n",
    "\n",
    "        if len(tokens)>0:\n",
    "            dic_sentences[num]=[tokens, listaEntidades]\n",
    "            listaEntidades=[]\n",
    "            tokens=[]\n",
    "            num=num+1\n",
    "        if num>10:\n",
    "            break\n",
    "            \n",
    "dic_sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 634,
   "metadata": {},
   "outputs": [],
   "source": [
    "def getIndice(palavrasFraseTemp, t2, indicesJaUsados):\n",
    "    indice=-1\n",
    "    indices = [n for n,x in enumerate(palavrasFraseTemp) if x==t2]\n",
    "    #print('---token t2---', t2)\n",
    "    #print('indices:', indices)\n",
    "    #print('indicesJaUsados:', indicesJaUsados)\n",
    "    if len(indicesJaUsados)==0:\n",
    "        indice=indices[0]\n",
    "    else:\n",
    "        for index in indices:\n",
    "            if index <= indicesJaUsados[-1]:\n",
    "                continue\n",
    "            else:\n",
    "                indice=index\n",
    "                break\n",
    "    #print('retornando:', indice)\n",
    "    return indice"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 635,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND cytokeratin_8 cytokeratin_18)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND promoter_1a promoter_1b)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND exon_1 exon_2)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND position_-153 position_-178 position_-286 position_-875 position_-1011)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND IFN(beta) IFN_gamma)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND RAR(alpha)_mRNA PML-RAR_mRNA)', 'sem': '(AND G#RNA_molecule G#RNA_molecule)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND collagen_type_I collagen_type_IV)', 'sem': '(AND G#protein_complex G#protein_complex)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND cyclin-dependent_kinase_4 cyclin-dependent_kinase_6)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(BUT_NOT Category_III_cell (AND Category_Va_cell Category_VI_cell Category_DFR_cell))', 'sem': '(BUT_NOT G#cell_line (AND G#cell_line G#cell_line G#cell_line))'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(OR amino-terminal_(729-766)_region carboxy-_terminal_(940-984)_region)', 'sem': '(OR G#protein_domain_or_region G#protein_domain_or_region)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(BUT_NOT (AND rheumatoid_synovial_fluid_monocyte rheumatoid_synovial_fluid_macrophage) (OR rheumatoid_synovial_fluid_lymphocyte rheumatoid_synovial_fluid_neutrophil))', 'sem': '(BUT_NOT (AND G#cell_type G#cell_type) (OR G#cell_type G#cell_type))'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND NF-ATc/B NF-ATc/C)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND NF-ATc/B NF-ATc/-C)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND TCR_alpha_beta_cell TCRgamma_delta_cell)', 'sem': '(AND G#cell_line G#cell_line)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND TCRalpha_beta_cell TCR_gamma_delta_cell)', 'sem': '(AND G#cell_line G#cell_line)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND p21(WAF1/CIP1)_mRNA p27(KIP1)_mRNA)', 'sem': '(AND G#RNA_molecule G#RNA_molecule)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND silencer_I silencer_II)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND site_1 site_2 site_3)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND STAT_3 STAT_5)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND GM-CSFRalpha GM-CSFRbeta)', 'sem': '(AND G#protein_subunit G#protein_subunit)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND cisacting_factor transacting_factor)', 'sem': '(AND G#protein_family_or_group G#protein_family_or_group)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND position_P1 position_P2 position_P3 position_P5)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND position_-30 position_-44 position_-213 position_-579)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND TRAF_1 TRAF_2 TRAF_3 TRAF_5)', 'sem': '(AND G#protein_molecule G#protein_molecule G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND NF-E2_binding_site tandem,_inverted_GATA_binding_site)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND zinc_finger_familiy POU_familiy)', 'sem': '(AND G#protein_family_or_group G#protein_family_or_group)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND exon_2 exon_5 exon_7)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND exon_2 exon_7)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND position_-585 position_-650)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND IL-2Ralpha_chain IL-2Rbeta_chain)', 'sem': '(AND G#protein_subunit G#protein_subunit)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND Sp1_binding_site Ap2_binding_site)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND gene_UL49 gene_UL50)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND polyclonal_CD3-CD16+_natural_killer(NK)_cell_line clonal_CD3-CD16+_natural_killer(NK)_cell_line)', 'sem': '(AND G#cell_line G#cell_line)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND CD4+_Tcell CD8+_T_cell)', 'sem': '(AND G#cell_line G#cell_line)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND topoisomerase_I topoisomerase_II)', 'sem': '(AND G#protein_family_or_group G#protein_family_or_group)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND phosphatase_1 phosphatase_2A)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: list index out of range\n",
      "{'lex': '(AND phosphatase_1 phosphatase_2A)', 'sem': '(AND G#protein_molecule G#protein_molecule)'}\n",
      "cai no except, e: No active exception to reraise\n",
      "{'lex': '(AND c-rel_(proto)oncogene v-rel_(proto)oncogene)', 'sem': '(AND G#DNA_domain_or_region G#DNA_domain_or_region)'}\n",
      "numErros: 15\n"
     ]
    }
   ],
   "source": [
    "# tratanto palavra com '-' como palavras separadas\n",
    "tree = ET.parse(arquivoXml)\n",
    "root = tree.getroot()\n",
    "\n",
    "dicSentences={}\n",
    "palavrasDescontinua=['AND_NOT', 'AND/OR', 'AS_WELL_AS', 'AND', 'OR', 'BUT_NOT', 'NEITHER_NOR', 'THAN']\n",
    "AllSentencesEnt = []\n",
    "AllSentences = []\n",
    "numFrase=0\n",
    "palavrasSentenca=[]\n",
    "numErros=0\n",
    "for sentence in root.iter('sentence'):\n",
    "    palavrasSentenca=[]\n",
    "    AllTokens=[]\n",
    "    AllEnt = []\n",
    "    num=0\n",
    "    \n",
    "    for cons in sentence.iter('cons'):\n",
    "        #print(cons.text)\n",
    "        token = cons.text\n",
    "        if token!=None:\n",
    "            token = token.replace('-','=-=').replace(\"'\",'')\n",
    "            tokens = token.split('=')\n",
    "            for t in tokens:\n",
    "                if t.strip()!='':\n",
    "                    palavrasSentenca.append(t)\n",
    "    \n",
    "    for cons in sentence.iter('cons'):\n",
    "        #print(cons.text)\n",
    "        token = cons.text\n",
    "        if token!=None:\n",
    "            token = token.replace('-','=-=').replace(\"'\",'')\n",
    "            tokens = token.split('=')\n",
    "            #print(tokens)\n",
    "            #print(len(tokens))\n",
    "            for t in tokens:\n",
    "                if t.strip()!='':\n",
    "                    AllTokens.append([t,num])\n",
    "                    num=num+1\n",
    "        else:\n",
    "            try:\n",
    "                #print('cons.attrib:',cons.attrib)\n",
    "                if 'sem' in cons.attrib:\n",
    "                    tag = cons.attrib['sem']\n",
    "                else:\n",
    "                    continue\n",
    "                \n",
    "                #print('tag[0:2]:'+tag[0:2]+'.')\n",
    "                isDescontinua=0\n",
    "\n",
    "                if tag[0:2]!='G#':\n",
    "                    isDescontinua = 1\n",
    "                    tag = getTipoEntidade(tag)\n",
    "                    #print('tag descontinua:',tag)\n",
    "                    #if tag=='ENT':\n",
    "                    if tag!='O':\n",
    "                        #print('--descontinuaaaaaa:',tag)\n",
    "                        #print(cons.attrib['lex'])\n",
    "                        lexDescontinua = cons.attrib['lex'].replace('(','').replace(')','').strip()\n",
    "                        for palavraDescontinua in palavrasDescontinua:\n",
    "                            if palavraDescontinua in lexDescontinua:\n",
    "                                tokens = lexDescontinua.split(palavraDescontinua)\n",
    "                                #print('palavraDescontinua:',palavraDescontinua)\n",
    "                                tokens.pop(0)\n",
    "                                #print('tokens:',tokens)\n",
    "                                tokens = tokens[0].split()\n",
    "                                #print('tokens:',tokens)\n",
    "                                \n",
    "                                for token in tokens:\n",
    "                                    tokensGravar=[]\n",
    "                                    indicesGravar=[]\n",
    "                                    \n",
    "                                    i=0\n",
    "                                    #tokensTemp = token.split('_')\n",
    "                                    # ver indice do token a partir da numPrimeira\n",
    "                                    palavrasFraseTemp = palavrasSentenca[num:len(palavrasSentenca)]\n",
    "                                    palavrasFraseTemp = [x.lower().replace('*','').replace('(','').replace(')','') for x in palavrasFraseTemp]\n",
    "                                    \n",
    "                                    #print('palavrasFraseTemp:',palavrasFraseTemp)\n",
    "                                    #print('tokensTemp:',tokensTemp)\n",
    "\n",
    "                                    indicesJaUsados=[] \n",
    "                                    for tokenTemp in token.split('_'):\n",
    "                                        \n",
    "                                    #palavrasFraseTemp = \n",
    "                                    #for tokenTemp in tokensTemp:\n",
    "                                        tokenEnt = tokenTemp.replace('-','=-=')\n",
    "                                        tokensEnt = tokenEnt.split('=')\n",
    "                                        for t2 in tokensEnt:\n",
    "                                            \n",
    "                                            #print('nova palavrasFraseTemp:',palavrasFraseTemp)\n",
    "                                            if t2.strip()!='':\n",
    "                                                t2=t2.lower().replace(\"'\",'')\n",
    "                                                t2 = t2.replace('*','')\n",
    "                                                indice=0\n",
    "                                                indice=getIndice(palavrasFraseTemp, t2, indicesJaUsados)\n",
    "                                                if indice<0:\n",
    "                                                    indice=getIndice(palavrasFraseTemp, t2+'s', indicesJaUsados)\n",
    "                                                    if indice<0:\n",
    "                                                        indice=getIndice(palavrasFraseTemp, t2[:len(t2)-1]+'ies', indicesJaUsados)\n",
    "                                                        if indice<0:\n",
    "                                                            indice=getIndice(palavrasFraseTemp, t2+'es', indicesJaUsados)\n",
    "                                                            if indice<0:\n",
    "                                                                #print('erro, e:', e)\n",
    "                                                                #print('t2:', t2)\n",
    "                                                                #print('cons.attrib:',cons.attrib)\n",
    "                                                                #print('palavrasFraseTemp:', palavrasFraseTemp)\n",
    "                                                                #print('palavrasSentenca:', palavrasSentenca)\n",
    "                                                                numErros=numErros+1\n",
    "                                                                raise\n",
    "                                                #print('indice:', indice)\n",
    "                                                #for pal in palavrasFraseTemp():\n",
    "                                                #if .index\n",
    "                                                #print(programming_languages.index(\"Python\"))\n",
    "                                                #palavrasFraseTemp[indice]='='\n",
    "                                                #print(palavrasFraseTemp)\n",
    "                                                #print('add:', indice+num)\n",
    "                                                indicesGravar.append(indice+num)\n",
    "                                                indicesJaUsados.append(indice)\n",
    "                                                tokensGravar.append(t2)\n",
    "                                                i=i+1\n",
    "                                                #palavrasFraseTemp = palavrasFraseTemp[indice:len(palavrasFraseTemp)]\n",
    "                                                #print('aaaaaaaaaaa:',tokenTemp)\n",
    "\n",
    "                                    #AllEnt.append([tokensGravar,indicesGravar])\n",
    "                                    AllEnt.append([tokensGravar,indicesGravar, tag])\n",
    "                                break\n",
    "                        #token\n",
    "                        pass # nao faz nada\n",
    "                else:\n",
    "                    tag = getTipoEntidade(tag)\n",
    "            except Exception as e:\n",
    "                print('cai no except, e:', e)\n",
    "                print(cons.attrib)\n",
    "                #raise\n",
    "                continue\n",
    "            #print(tag)\n",
    "            if tag!='O' and isDescontinua==0:\n",
    "                try:\n",
    "                    token = cons.attrib['lex']\n",
    "                except:\n",
    "                    continue\n",
    "                    \n",
    "                indices = []\n",
    "                tokensGravar=[]\n",
    "                i=0\n",
    "                for t in token.split('_'):\n",
    "                    tokenEnt = t.replace('-','=-=')\n",
    "                    tokensEnt = tokenEnt.split('=')\n",
    "                    for t2 in tokensEnt:\n",
    "                        if t2.strip()!='':\n",
    "                            indices.append(num+i)\n",
    "                            tokensGravar.append(t2)\n",
    "                            i=i+1\n",
    "\n",
    "                #AllEnt.append([tokensGravar,indices])\n",
    "                AllEnt.append([tokensGravar,indices, tag])\n",
    "    AllSentencesEnt.append(AllEnt)\n",
    "    dicSentences[numFrase]=[AllTokens, AllEnt]\n",
    "    numFrase=numFrase+1\n",
    "    AllSentences.append(AllTokens)\n",
    "\n",
    "print(\"numErros:\", numErros)\n",
    "#AllSentences\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 636,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[32,\n",
       " 48,\n",
       " 57,\n",
       " 98,\n",
       " 106,\n",
       " 119,\n",
       " 124,\n",
       " 169,\n",
       " 191,\n",
       " 192,\n",
       " 248,\n",
       " 258,\n",
       " 287,\n",
       " 310,\n",
       " 329,\n",
       " 337,\n",
       " 337,\n",
       " 363,\n",
       " 400,\n",
       " 401,\n",
       " 401,\n",
       " 402,\n",
       " 402,\n",
       " 402,\n",
       " 413,\n",
       " 454,\n",
       " 454,\n",
       " 455,\n",
       " 468,\n",
       " 483,\n",
       " 563,\n",
       " 591,\n",
       " 610,\n",
       " 620,\n",
       " 631,\n",
       " 632,\n",
       " 637,\n",
       " 649,\n",
       " 651,\n",
       " 654,\n",
       " 710,\n",
       " 728,\n",
       " 730,\n",
       " 759,\n",
       " 764,\n",
       " 764,\n",
       " 782,\n",
       " 818,\n",
       " 818,\n",
       " 819,\n",
       " 822,\n",
       " 864,\n",
       " 865,\n",
       " 910,\n",
       " 945,\n",
       " 969,\n",
       " 974,\n",
       " 976,\n",
       " 980,\n",
       " 995,\n",
       " 1000,\n",
       " 1012,\n",
       " 1015,\n",
       " 1021,\n",
       " 1023,\n",
       " 1024,\n",
       " 1029,\n",
       " 1029,\n",
       " 1034,\n",
       " 1036,\n",
       " 1050,\n",
       " 1054,\n",
       " 1058,\n",
       " 1118,\n",
       " 1126,\n",
       " 1159,\n",
       " 1216,\n",
       " 1312,\n",
       " 1315,\n",
       " 1338,\n",
       " 1347,\n",
       " 1378,\n",
       " 1378,\n",
       " 1395,\n",
       " 1406,\n",
       " 1477,\n",
       " 1478,\n",
       " 1584,\n",
       " 1601,\n",
       " 1633,\n",
       " 1636,\n",
       " 1638,\n",
       " 1682,\n",
       " 1754,\n",
       " 1796,\n",
       " 1800,\n",
       " 1808,\n",
       " 1811,\n",
       " 1818,\n",
       " 1823,\n",
       " 1832,\n",
       " 1863,\n",
       " 1864,\n",
       " 1866,\n",
       " 1892,\n",
       " 1908,\n",
       " 1912,\n",
       " 1925,\n",
       " 1931,\n",
       " 1960,\n",
       " 1961,\n",
       " 1962,\n",
       " 1964,\n",
       " 1975,\n",
       " 1996,\n",
       " 1996,\n",
       " 2013,\n",
       " 2013,\n",
       " 2030,\n",
       " 2037,\n",
       " 2058,\n",
       " 2168,\n",
       " 2181,\n",
       " 2187,\n",
       " 2220,\n",
       " 2235,\n",
       " 2248,\n",
       " 2256,\n",
       " 2296,\n",
       " 2322,\n",
       " 2335,\n",
       " 2342,\n",
       " 2348,\n",
       " 2356,\n",
       " 2398,\n",
       " 2411,\n",
       " 2441,\n",
       " 2492,\n",
       " 2494,\n",
       " 2495,\n",
       " 2501,\n",
       " 2504,\n",
       " 2514,\n",
       " 2516,\n",
       " 2548,\n",
       " 2608,\n",
       " 2615,\n",
       " 2654,\n",
       " 2664,\n",
       " 2687,\n",
       " 2704,\n",
       " 2706,\n",
       " 2707,\n",
       " 2716,\n",
       " 2728,\n",
       " 2766,\n",
       " 2781,\n",
       " 2836,\n",
       " 2856,\n",
       " 2892,\n",
       " 2894,\n",
       " 2895,\n",
       " 2896,\n",
       " 2896,\n",
       " 2901,\n",
       " 3017,\n",
       " 3034,\n",
       " 3038,\n",
       " 3087,\n",
       " 3116,\n",
       " 3183,\n",
       " 3191,\n",
       " 3209,\n",
       " 3224,\n",
       " 3273,\n",
       " 3277,\n",
       " 3301,\n",
       " 3302,\n",
       " 3334,\n",
       " 3335,\n",
       " 3336,\n",
       " 3394,\n",
       " 3396,\n",
       " 3400,\n",
       " 3401,\n",
       " 3492,\n",
       " 3507,\n",
       " 3517,\n",
       " 3524,\n",
       " 3541,\n",
       " 3547,\n",
       " 3587,\n",
       " 3619,\n",
       " 3693,\n",
       " 3700,\n",
       " 3714,\n",
       " 3748,\n",
       " 3764,\n",
       " 3818,\n",
       " 3855,\n",
       " 3869,\n",
       " 3876,\n",
       " 3890,\n",
       " 3894,\n",
       " 3901,\n",
       " 3903,\n",
       " 3937,\n",
       " 3938,\n",
       " 3941,\n",
       " 3952,\n",
       " 3956,\n",
       " 3958,\n",
       " 3958,\n",
       " 3966,\n",
       " 3975,\n",
       " 3978,\n",
       " 3995,\n",
       " 3995,\n",
       " 4003,\n",
       " 4050,\n",
       " 4111,\n",
       " 4112,\n",
       " 4116,\n",
       " 4144,\n",
       " 4148,\n",
       " 4191,\n",
       " 4193,\n",
       " 4197,\n",
       " 4197,\n",
       " 4204,\n",
       " 4211,\n",
       " 4212,\n",
       " 4224,\n",
       " 4226,\n",
       " 4227,\n",
       " 4228,\n",
       " 4230,\n",
       " 4231,\n",
       " 4232,\n",
       " 4305,\n",
       " 4311,\n",
       " 4320,\n",
       " 4346,\n",
       " 4347,\n",
       " 4364,\n",
       " 4391,\n",
       " 4421,\n",
       " 4426,\n",
       " 4427,\n",
       " 4433,\n",
       " 4450,\n",
       " 4481,\n",
       " 4513,\n",
       " 4587,\n",
       " 4591,\n",
       " 4600,\n",
       " 4602,\n",
       " 4635,\n",
       " 4638,\n",
       " 4642,\n",
       " 4643,\n",
       " 4648,\n",
       " 4651,\n",
       " 4678,\n",
       " 4679,\n",
       " 4683,\n",
       " 4715,\n",
       " 4783,\n",
       " 4790,\n",
       " 4792,\n",
       " 4795,\n",
       " 4798,\n",
       " 4798,\n",
       " 4835,\n",
       " 4848,\n",
       " 4855,\n",
       " 4866,\n",
       " 4868,\n",
       " 4884,\n",
       " 4919,\n",
       " 4933,\n",
       " 4940,\n",
       " 4993,\n",
       " 5003,\n",
       " 5039,\n",
       " 5046,\n",
       " 5047,\n",
       " 5074,\n",
       " 5080,\n",
       " 5092,\n",
       " 5100,\n",
       " 5101,\n",
       " 5127,\n",
       " 5128,\n",
       " 5131,\n",
       " 5132,\n",
       " 5141,\n",
       " 5163,\n",
       " 5168,\n",
       " 5172,\n",
       " 5172,\n",
       " 5178,\n",
       " 5179,\n",
       " 5194,\n",
       " 5204,\n",
       " 5206,\n",
       " 5208,\n",
       " 5212,\n",
       " 5254,\n",
       " 5275,\n",
       " 5283,\n",
       " 5305,\n",
       " 5310,\n",
       " 5360,\n",
       " 5369,\n",
       " 5370,\n",
       " 5371,\n",
       " 5371,\n",
       " 5386,\n",
       " 5389,\n",
       " 5396,\n",
       " 5399,\n",
       " 5402,\n",
       " 5410,\n",
       " 5435,\n",
       " 5435,\n",
       " 5456,\n",
       " 5547,\n",
       " 5603,\n",
       " 5611,\n",
       " 5625,\n",
       " 5701,\n",
       " 5751,\n",
       " 5757,\n",
       " 5816,\n",
       " 5859,\n",
       " 5863,\n",
       " 5939,\n",
       " 5977,\n",
       " 6000,\n",
       " 6000,\n",
       " 6009,\n",
       " 6019,\n",
       " 6034,\n",
       " 6037,\n",
       " 6065,\n",
       " 6100,\n",
       " 6101,\n",
       " 6104,\n",
       " 6109,\n",
       " 6109,\n",
       " 6129,\n",
       " 6129,\n",
       " 6129,\n",
       " 6144,\n",
       " 6151,\n",
       " 6174,\n",
       " 6195,\n",
       " 6212,\n",
       " 6214,\n",
       " 6216,\n",
       " 6254,\n",
       " 6331,\n",
       " 6379,\n",
       " 6438,\n",
       " 6440,\n",
       " 6443,\n",
       " 6445,\n",
       " 6472,\n",
       " 6560,\n",
       " 6560,\n",
       " 6610,\n",
       " 6612,\n",
       " 6623,\n",
       " 6624,\n",
       " 6633,\n",
       " 6656,\n",
       " 6663,\n",
       " 6667,\n",
       " 6671,\n",
       " 6683,\n",
       " 6688,\n",
       " 6689,\n",
       " 6831,\n",
       " 6852,\n",
       " 6855,\n",
       " 6876,\n",
       " 6899,\n",
       " 6900,\n",
       " 6945,\n",
       " 6947,\n",
       " 6954,\n",
       " 6962,\n",
       " 6987,\n",
       " 6992,\n",
       " 7025,\n",
       " 7026,\n",
       " 7029,\n",
       " 7048,\n",
       " 7098,\n",
       " 7102,\n",
       " 7122,\n",
       " 7134,\n",
       " 7168,\n",
       " 7192,\n",
       " 7199,\n",
       " 7211,\n",
       " 7216,\n",
       " 7216,\n",
       " 7228,\n",
       " 7248,\n",
       " 7306,\n",
       " 7317,\n",
       " 7321,\n",
       " 7324,\n",
       " 7330,\n",
       " 7365,\n",
       " 7421,\n",
       " 7444,\n",
       " 7463,\n",
       " 7474,\n",
       " 7483,\n",
       " 7502,\n",
       " 7615,\n",
       " 7627,\n",
       " 7628,\n",
       " 7632,\n",
       " 7633,\n",
       " 7644,\n",
       " 7651,\n",
       " 7656,\n",
       " 7660,\n",
       " 7662,\n",
       " 7664,\n",
       " 7669,\n",
       " 7689,\n",
       " 7704,\n",
       " 7708,\n",
       " 7715,\n",
       " 7728,\n",
       " 7736,\n",
       " 7766,\n",
       " 7792,\n",
       " 7821,\n",
       " 7855,\n",
       " 7897,\n",
       " 7933,\n",
       " 7957,\n",
       " 7957,\n",
       " 8140,\n",
       " 8141,\n",
       " 8159,\n",
       " 8245,\n",
       " 8245,\n",
       " 8247,\n",
       " 8279,\n",
       " 8279,\n",
       " 8300,\n",
       " 8308,\n",
       " 8355,\n",
       " 8395,\n",
       " 8399,\n",
       " 8430,\n",
       " 8433,\n",
       " 8435,\n",
       " 8438,\n",
       " 8439,\n",
       " 8567,\n",
       " 8567,\n",
       " 8571,\n",
       " 8581,\n",
       " 8583,\n",
       " 8595,\n",
       " 8599,\n",
       " 8604,\n",
       " 8631,\n",
       " 8670,\n",
       " 8685,\n",
       " 8685,\n",
       " 8732,\n",
       " 8777,\n",
       " 8782,\n",
       " 8791,\n",
       " 8813,\n",
       " 8871,\n",
       " 8871,\n",
       " 8881,\n",
       " 8934,\n",
       " 8949,\n",
       " 8973,\n",
       " 8979,\n",
       " 8980,\n",
       " 9033,\n",
       " 9048,\n",
       " 9056,\n",
       " 9206,\n",
       " 9235,\n",
       " 9249,\n",
       " 9251,\n",
       " 9252,\n",
       " 9293,\n",
       " 9303,\n",
       " 9329,\n",
       " 9333,\n",
       " 9337,\n",
       " 9347,\n",
       " 9347,\n",
       " 9379,\n",
       " 9451,\n",
       " 9468,\n",
       " 9515,\n",
       " 9540,\n",
       " 9541,\n",
       " 9544,\n",
       " 9545,\n",
       " 9546,\n",
       " 9551,\n",
       " 9552,\n",
       " 9555,\n",
       " 9625,\n",
       " 9647,\n",
       " 9658,\n",
       " 9660,\n",
       " 9676,\n",
       " 9679,\n",
       " 9679,\n",
       " 9693,\n",
       " 9696,\n",
       " 9729,\n",
       " 9748,\n",
       " 9771,\n",
       " 9841,\n",
       " 9928,\n",
       " 9936,\n",
       " 9961,\n",
       " 9993,\n",
       " 10020,\n",
       " 10036,\n",
       " 10080,\n",
       " 10081,\n",
       " 10082,\n",
       " 10084,\n",
       " 10085,\n",
       " 10091,\n",
       " 10113,\n",
       " 10134,\n",
       " 10148,\n",
       " 10192,\n",
       " 10196,\n",
       " 10207,\n",
       " 10211,\n",
       " 10270,\n",
       " 10307,\n",
       " 10326,\n",
       " 10363,\n",
       " 10371,\n",
       " 10401,\n",
       " 10403,\n",
       " 10409,\n",
       " 10506,\n",
       " 10574,\n",
       " 10586,\n",
       " 10587,\n",
       " 10593,\n",
       " 10599,\n",
       " 10632,\n",
       " 10643,\n",
       " 10646,\n",
       " 10648,\n",
       " 10658,\n",
       " 10667,\n",
       " 10680,\n",
       " 10685,\n",
       " 10686,\n",
       " 10686,\n",
       " 10732,\n",
       " 10762,\n",
       " 10801,\n",
       " 10815,\n",
       " 10855,\n",
       " 10857,\n",
       " 10862,\n",
       " 10865,\n",
       " 10870,\n",
       " 10878,\n",
       " 10908,\n",
       " 10909,\n",
       " 10917,\n",
       " 10920,\n",
       " 10934,\n",
       " 10937,\n",
       " 10948,\n",
       " 10968,\n",
       " 11003,\n",
       " 11020,\n",
       " 11043,\n",
       " 11065,\n",
       " 11067,\n",
       " 11078,\n",
       " 11085,\n",
       " 11088,\n",
       " 11128,\n",
       " 11135,\n",
       " 11178,\n",
       " 11201,\n",
       " 11202,\n",
       " 11203,\n",
       " 11226,\n",
       " 11233,\n",
       " 11250,\n",
       " 11254,\n",
       " 11258,\n",
       " 11259,\n",
       " 11270,\n",
       " 11282,\n",
       " 11292,\n",
       " 11327,\n",
       " 11327,\n",
       " 11338,\n",
       " 11359,\n",
       " 11412,\n",
       " 11449,\n",
       " 11512,\n",
       " 11530,\n",
       " 11542,\n",
       " 11548,\n",
       " 11549,\n",
       " 11555,\n",
       " 11589,\n",
       " 11589,\n",
       " 11600,\n",
       " 11600,\n",
       " 11601,\n",
       " 11622,\n",
       " 11663,\n",
       " 11663,\n",
       " 11734,\n",
       " 11741,\n",
       " 11845,\n",
       " 11846,\n",
       " 11847,\n",
       " 11848,\n",
       " 11849,\n",
       " 11852,\n",
       " 11852,\n",
       " 11853,\n",
       " 11856,\n",
       " 11867,\n",
       " 11869,\n",
       " 11883,\n",
       " 11884,\n",
       " 11910,\n",
       " 11913,\n",
       " 11915,\n",
       " 11916,\n",
       " 11921,\n",
       " 11925,\n",
       " 11931,\n",
       " 11932,\n",
       " 11943,\n",
       " 11975,\n",
       " 11991,\n",
       " 12010,\n",
       " 12053,\n",
       " 12095,\n",
       " 12099,\n",
       " 12109,\n",
       " 12138,\n",
       " 12167,\n",
       " 12168,\n",
       " 12171,\n",
       " 12172,\n",
       " 12175,\n",
       " 12175,\n",
       " 12205,\n",
       " 12278,\n",
       " 12285,\n",
       " 12293,\n",
       " 12372,\n",
       " 12401,\n",
       " 12420,\n",
       " 12430,\n",
       " 12456,\n",
       " 12458,\n",
       " 12504,\n",
       " 12519,\n",
       " 12558,\n",
       " 12610,\n",
       " 12646,\n",
       " 12651,\n",
       " 12652,\n",
       " 12653,\n",
       " 12653,\n",
       " 12678,\n",
       " 12684,\n",
       " 12701,\n",
       " 12703,\n",
       " 12739,\n",
       " 12780,\n",
       " 12808,\n",
       " 12827,\n",
       " 12830,\n",
       " 12833,\n",
       " 12834,\n",
       " 12835,\n",
       " 12836,\n",
       " 12837,\n",
       " 12850,\n",
       " 12855,\n",
       " 12857,\n",
       " 12864,\n",
       " 12876,\n",
       " 12884,\n",
       " 12927,\n",
       " 12948,\n",
       " 12966,\n",
       " 12986,\n",
       " 12989,\n",
       " 13008,\n",
       " 13008,\n",
       " 13010,\n",
       " 13011,\n",
       " 13016,\n",
       " 13062,\n",
       " 13072,\n",
       " 13085,\n",
       " 13089,\n",
       " 13094,\n",
       " 13103,\n",
       " 13104,\n",
       " 13161,\n",
       " 13180,\n",
       " 13197,\n",
       " 13197,\n",
       " 13231,\n",
       " 13233,\n",
       " 13264,\n",
       " 13267,\n",
       " 13275,\n",
       " 13284,\n",
       " 13292,\n",
       " 13302,\n",
       " 13310,\n",
       " 13311,\n",
       " 13312,\n",
       " 13313,\n",
       " 13314,\n",
       " 13315,\n",
       " 13342,\n",
       " 13343,\n",
       " 13344,\n",
       " 13345,\n",
       " 13360,\n",
       " 13365,\n",
       " 13397,\n",
       " 13410,\n",
       " 13420,\n",
       " 13420,\n",
       " 13420,\n",
       " 13426,\n",
       " 13524,\n",
       " 13551,\n",
       " 13563,\n",
       " 13564,\n",
       " 13573,\n",
       " 13574,\n",
       " 13576,\n",
       " 13598,\n",
       " 13604,\n",
       " 13605,\n",
       " 13716,\n",
       " 13749,\n",
       " 13766,\n",
       " 13766,\n",
       " 13832,\n",
       " 13854,\n",
       " 13878,\n",
       " 13879,\n",
       " 13890,\n",
       " 13904,\n",
       " 13914,\n",
       " 13916,\n",
       " 13958,\n",
       " 14006,\n",
       " 14006,\n",
       " 14016,\n",
       " 14030,\n",
       " 14037,\n",
       " 14081,\n",
       " 14098,\n",
       " 14142,\n",
       " 14158,\n",
       " 14189,\n",
       " 14190,\n",
       " 14192,\n",
       " 14193,\n",
       " 14195,\n",
       " 14262,\n",
       " 14264,\n",
       " 14267,\n",
       " 14274,\n",
       " 14277,\n",
       " 14380,\n",
       " 14398,\n",
       " 14408,\n",
       " 14426,\n",
       " 14447,\n",
       " 14450,\n",
       " 14481,\n",
       " 14485,\n",
       " 14486,\n",
       " 14487,\n",
       " 14488,\n",
       " 14489,\n",
       " 14490,\n",
       " 14548,\n",
       " 14576,\n",
       " 14580,\n",
       " 14647,\n",
       " 14655,\n",
       " 14673,\n",
       " 14678,\n",
       " 14718,\n",
       " 14718,\n",
       " 14739,\n",
       " 14762,\n",
       " 14763,\n",
       " 14765,\n",
       " 14766,\n",
       " 14767,\n",
       " 14807,\n",
       " 14810,\n",
       " 14810,\n",
       " 14813,\n",
       " 14828,\n",
       " 14831,\n",
       " 14866,\n",
       " 14897,\n",
       " 14900,\n",
       " 14949,\n",
       " 14952,\n",
       " 14978,\n",
       " 14981,\n",
       " 15004,\n",
       " 15063,\n",
       " 15064,\n",
       " 15070,\n",
       " 15075,\n",
       " 15077,\n",
       " 15078,\n",
       " 15111,\n",
       " 15122,\n",
       " 15123,\n",
       " 15123,\n",
       " 15158,\n",
       " 15165,\n",
       " 15172,\n",
       " 15183,\n",
       " 15203,\n",
       " 15212,\n",
       " 15214,\n",
       " 15230,\n",
       " 15231,\n",
       " 15232,\n",
       " 15239,\n",
       " 15270,\n",
       " 15314,\n",
       " 15335,\n",
       " 15364,\n",
       " 15366,\n",
       " 15403,\n",
       " 15414,\n",
       " 15429,\n",
       " 15461,\n",
       " 15464,\n",
       " 15468,\n",
       " 15473,\n",
       " 15513,\n",
       " 15515,\n",
       " 15517,\n",
       " 15532,\n",
       " 15598,\n",
       " 15604,\n",
       " 15611,\n",
       " 15653,\n",
       " 15715,\n",
       " 15727,\n",
       " 15737,\n",
       " 15738,\n",
       " 15849,\n",
       " 15856,\n",
       " 15886,\n",
       " 15899,\n",
       " 15964,\n",
       " 15967,\n",
       " 16112,\n",
       " 16114,\n",
       " 16132,\n",
       " 16134,\n",
       " 16153,\n",
       " 16155,\n",
       " 16158,\n",
       " 16159,\n",
       " 16160,\n",
       " 16174,\n",
       " 16189,\n",
       " 16190,\n",
       " 16268,\n",
       " 16319,\n",
       " 16321,\n",
       " 16324,\n",
       " 16327,\n",
       " 16360,\n",
       " 16360,\n",
       " 16380,\n",
       " 16406,\n",
       " 16412,\n",
       " 16430,\n",
       " 16432,\n",
       " 16432,\n",
       " 16434,\n",
       " 16475,\n",
       " 16524,\n",
       " 16555,\n",
       " 16557,\n",
       " 16580,\n",
       " 16582,\n",
       " 16588,\n",
       " 16589,\n",
       " 16596,\n",
       " 16597,\n",
       " 16602,\n",
       " 16608,\n",
       " 16625,\n",
       " 16635,\n",
       " 16637,\n",
       " 16640,\n",
       " 16642,\n",
       " 16650,\n",
       " 16652,\n",
       " 16654,\n",
       " 16654,\n",
       " 16660,\n",
       " 16660,\n",
       " 16668,\n",
       " 16674,\n",
       " 16676,\n",
       " 16681,\n",
       " 16716,\n",
       " 16729,\n",
       " 16739,\n",
       " 16745,\n",
       " 16751,\n",
       " 16786,\n",
       " 16790,\n",
       " 16794,\n",
       " 16794,\n",
       " 16794,\n",
       " 16837,\n",
       " 16844,\n",
       " 16902,\n",
       " 16929,\n",
       " 17033,\n",
       " 17038,\n",
       " 17080,\n",
       " 17087,\n",
       " 17105,\n",
       " 17122,\n",
       " 17125,\n",
       " 17132,\n",
       " 17161,\n",
       " 17172,\n",
       " 17223,\n",
       " 17232,\n",
       " 17280,\n",
       " 17303,\n",
       " 17308,\n",
       " 17309,\n",
       " 17338,\n",
       " 17341,\n",
       " 17363,\n",
       " 17370,\n",
       " 17372,\n",
       " 17400,\n",
       " 17420,\n",
       " 17431,\n",
       " 17474,\n",
       " 17513,\n",
       " 17520,\n",
       " 17521,\n",
       " 17526,\n",
       " 17584,\n",
       " 17628,\n",
       " 17655,\n",
       " 17675,\n",
       " 17746,\n",
       " 17917,\n",
       " 17918,\n",
       " 17943,\n",
       " 17945,\n",
       " ...]"
      ]
     },
     "execution_count": 636,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "frasesComDescontinuas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 637,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1015"
      ]
     },
     "execution_count": 637,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(frasesComDescontinuas)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 639,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[['This', 0],\n",
       "  ['delay', 1],\n",
       "  ['is', 2],\n",
       "  ['associated', 3],\n",
       "  ['with', 4],\n",
       "  ['down', 5],\n",
       "  ['-', 6],\n",
       "  ['regulation', 7],\n",
       "  ['of', 8],\n",
       "  ['many', 9],\n",
       "  ['erythroid', 10],\n",
       "  ['cell', 11],\n",
       "  ['-', 12],\n",
       "  ['specific', 13],\n",
       "  ['genes', 14],\n",
       "  [',', 15],\n",
       "  ['including', 16],\n",
       "  ['alpha', 17],\n",
       "  ['-', 18],\n",
       "  ['and', 19],\n",
       "  ['beta', 20],\n",
       "  ['-', 21],\n",
       "  ['globin', 22],\n",
       "  [',', 23],\n",
       "  ['band', 24],\n",
       "  ['3', 25],\n",
       "  [',', 26],\n",
       "  ['band', 27],\n",
       "  ['4.1', 28],\n",
       "  [',', 29],\n",
       "  ['and', 30],\n",
       "  ['the', 31],\n",
       "  ['erythroid', 32],\n",
       "  ['cell', 33],\n",
       "  ['-', 34],\n",
       "  ['specific', 35],\n",
       "  ['histone', 36],\n",
       "  ['H5', 37],\n",
       "  ['.', 38]],\n",
       " [[['erythroid', 'cell', '-', 'specific', 'gene'],\n",
       "   [10, 11, 12, 13, 14],\n",
       "   'DNA'],\n",
       "  [['alpha', '-', 'globin'], [17, 18, 22], 'DNA'],\n",
       "  [['beta', '-', 'globin'], [20, 21, 22], 'DNA'],\n",
       "  [['band', '3'], [24, 25], 'DNA'],\n",
       "  [['band', '4.1'], [27, 28], 'DNA'],\n",
       "  [['erythroid', 'cell', '-', 'specific', 'histone'],\n",
       "   [32, 33, 34, 35, 36],\n",
       "   'PROTEIN'],\n",
       "  [['H5'], [37], 'PROTEIN']]]"
      ]
     },
     "execution_count": 639,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#dicSentencesComLabel = load_obj('dicSentencesComLabel')\n",
    "dicSentences[32]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 640,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[['Constitutively', 0],\n",
       "  ['activated', 1],\n",
       "  ['Jak', 2],\n",
       "  ['-', 3],\n",
       "  ['STAT', 4],\n",
       "  ['pathway', 5],\n",
       "  ['in', 6],\n",
       "  ['T', 7],\n",
       "  ['cells', 8],\n",
       "  ['transformed', 9],\n",
       "  ['with', 10],\n",
       "  ['HTLV', 11],\n",
       "  ['-', 12],\n",
       "  ['I', 13],\n",
       "  ['.', 14]],\n",
       " [[['Jak'], [2], 'PROTEIN'],\n",
       "  [['-', 'STAT'], [3, 4], 'PROTEIN'],\n",
       "  [['T', 'cells'], [7, 8], 'CELL_TYPE']]]"
      ]
     },
     "execution_count": 640,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dicSentences[217]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 641,
   "metadata": {},
   "outputs": [],
   "source": [
    "dicSentencesComLabel = dicSentences.copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 642,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Array elements are not consecutive \n"
     ]
    }
   ],
   "source": [
    "def areConsecutive(arr):\n",
    "    # Sort the array\n",
    "    arr.sort()\n",
    "    n = len(arr)\n",
    "    # checking the adjacent elements\n",
    "    for i in range (1,n):\n",
    "        if(arr[i]!=arr[i-1]+1):\n",
    "            return False;\n",
    "             \n",
    "    return True;   \n",
    "     \n",
    "# Driver Code\n",
    "#arr = [5, 4, 2, 3, 1, 6]\n",
    "arr = [5, 4, 2, 3, 1, 8]\n",
    "\n",
    "if(areConsecutive(arr) == True):\n",
    "    print(\"Array elements are consecutive \")\n",
    "else:\n",
    "    print(\"Array elements are not consecutive \")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 643,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['The', 0], ['inhibition', 1], ['of', 2], ['c', 3], ['-', 4], ['fos', 5], ['and', 6], ['c', 7], ['-', 8], ['jun', 9], ['expression', 10], ['by', 11], ['IL', 12], ['-', 13], ['4', 14], ['in', 15], ['LPS', 16], ['-', 17], ['treated', 18], ['cells', 19], ['was', 20], ['shown', 21], ['to', 22], ['be', 23], ['due', 24], ['to', 25], ['a', 26], ['lower', 27], ['transcription', 28], ['rate', 29], ['of', 30], ['the', 31], ['c', 32], ['-', 33], ['fos', 34], ['and', 35], ['c', 36], ['-', 37], ['jun', 38], ['genes', 39], ['.', 40]]\n",
      "-------------\n",
      "[[['c', '-', 'fos'], [3, 4, 5], 'DNA'], [['IL', '-', '4'], [12, 13, 14], 'PROTEIN'], [['LPS', '-', 'treated', 'cell'], [16, 17, 18, 19], 'CELL_TYPE'], [['c', '-', 'fos', 'and', 'c', '-', 'jun', 'gene'], [32, 33, 34, 35, 36, 37, 38, 39], 'DNA'], [['c', '-', 'fos', 'gene'], [32, 33, 34, 35], 'DNA'], [['c', '-', 'jun', 'genes'], [36, 37, 38, 39], 'DNA']]\n"
     ]
    }
   ],
   "source": [
    "#for i in range(14950, 15000):\n",
    "#    print(i)\n",
    "#    print(dicSentencesComLabel[i][0])\n",
    "print(dicSentencesComLabel[14954][0])\n",
    "print('-------------')\n",
    "print(dicSentencesComLabel[14954][1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 644,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[['Activation', 0], ['of', 1], ['the', 2], ['CD28', 3], ['surface', 4], ['receptor', 5], ['provides', 6], ['a', 7], ['major', 8], ['costimulatory', 9], ['signal', 10], ['for', 11], ['T', 12], ['cell', 13], ['activation', 14], ['resulting', 15], ['in', 16], ['enhanced', 17], ['production', 18], ['of', 19], ['interleukin', 20], ['-', 21], ['2', 22], ['(', 23], ['IL', 24], ['-', 25], ['2', 26], [')', 27], ['and', 28], ['cell', 29], ['proliferation', 30], ['.', 31]], [[['CD28', 'surface', 'receptor'], [3, 4, 5], 'PROTEIN'], [['CD28'], [3], 'PROTEIN'], [['interleukin', '-', '2'], [20, 21, 22], 'PROTEIN'], [['IL', '-', '2'], [24, 25, 26], 'PROTEIN']]]\n"
     ]
    }
   ],
   "source": [
    "#print(dicSentences[0])\n",
    "dicSentencesComLabel = dicSentences.copy()\n",
    "print(dicSentencesComLabel[1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 645,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "18455"
      ]
     },
     "execution_count": 645,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(dicSentences)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 672,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[['In', 0],\n",
       "  ['this', 1],\n",
       "  ['study', 2],\n",
       "  [',', 3],\n",
       "  ['we', 4],\n",
       "  ['have', 5],\n",
       "  ['analysed', 6],\n",
       "  ['the', 7],\n",
       "  ['function', 8],\n",
       "  ['of', 9],\n",
       "  ['these', 10],\n",
       "  ['cis', 11],\n",
       "  ['-', 12],\n",
       "  ['acting', 13],\n",
       "  ['regulatory', 14],\n",
       "  ['sites', 15],\n",
       "  ['in', 16],\n",
       "  ['the', 17],\n",
       "  ['context', 18],\n",
       "  ['of', 19],\n",
       "  ['the', 20],\n",
       "  ['native', 21],\n",
       "  ['IL', 22],\n",
       "  ['-', 23],\n",
       "  ['2', 24],\n",
       "  ['enhancer', 25],\n",
       "  ['and', 26],\n",
       "  ['promoter', 27],\n",
       "  ['sequence', 28],\n",
       "  ['.', 29]],\n",
       " [[['cis', '-', 'acting', 'regulatory', 'site'], [11, 12, 13, 14, 15], 'DNA'],\n",
       "  [['IL', '-', '2', 'enhancer'], [22, 23, 24, 25], 'DNA'],\n",
       "  [['IL', '-', '2'], [22, 23, 24], 'PROTEIN'],\n",
       "  [['IL', '-', '2', 'promoter', 'sequence'], [27, 28, 29, 30, 31], 'DNA']]]"
      ]
     },
     "execution_count": 672,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dicSentences[2332]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 647,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "antibodies\n"
     ]
    }
   ],
   "source": [
    "texto='antibody'\n",
    "print(texto[:-1]+'ies')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 648,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[False, False, False, False, False, True, False, False]\n"
     ]
    }
   ],
   "source": [
    "palavrasDescontinua_underline=['AND_NOT', 'AND/OR', 'AS_WELL_AS', 'AND', 'OR', 'BUT_NOT', 'NEITHER_NOR', 'THAN']\n",
    "texto = 'CD28 surface receptor but not'\n",
    "texto = texto.replace('and not', 'and_not').replace('as well as', 'as_well_as').replace('neither nor', 'neither_nor').replace('but not', 'but_not')\n",
    "texto.split()[-1]\n",
    "tem = [texto.split()[-1]==palavra.lower() for palavra in palavrasDescontinua_underline]\n",
    "\n",
    "#tem = [' '+palavra.lower()+' ' in ' '+texto+' ' for palavra in palavrasDescontinua]\n",
    "a= True in tem\n",
    "print(tem)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 689,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "key: 999\n",
      "key: 1999\n",
      "key: 2999\n",
      "key: 3999\n",
      "key: 4999\n",
      "key: 5999\n",
      "key: 6999\n",
      "key: 7999\n",
      "key: 8999\n",
      "key: 9999\n",
      "key: 10999\n",
      "key: 11999\n",
      "key: 12999\n",
      "key: 13999\n",
      "key: 14999\n",
      "key: 15999\n",
      "key: 16999\n",
      "key: 17999\n",
      "numDescontinuas: 1395\n",
      "erro_corpus: 1760\n",
      "num_frases_sem_entidade: 1834\n"
     ]
    }
   ],
   "source": [
    "palavrasDescontinua_underline=['AND_NOT', 'AND/OR', 'AS_WELL_AS', 'AND', 'OR', 'BUT_NOT', 'NEITHER_NOR', 'THAN']\n",
    "num=0\n",
    "numDescontinuas=0\n",
    "erro_corpus=0\n",
    "num_frases_sem_entidade=0\n",
    "lista_erro_corpus=list()\n",
    "combinacaoEntidadesAll = list()\n",
    "combinacaoEntidades = list()\n",
    "for key, value in dicSentencesComLabel.items():\n",
    "    num=num+1\n",
    "    combinacaoEntidades = list()\n",
    "    #print('key:', key)\n",
    "    #print(value)\n",
    "    tokens=value[0].copy()\n",
    "    so_tokens = [t[0] for t in tokens]\n",
    "    entidades=value[1].copy()\n",
    "    #print(so_tokens)\n",
    "    #print(entidades)\n",
    "    for entidade in entidades:\n",
    "        erros_entidade = list()\n",
    "        #print(entidade[1])\n",
    "        texto_entidade=entidade[0]\n",
    "        indices = entidade[1]\n",
    "        tipo_entidade = entidade[2]\n",
    "        if areConsecutive(indices): # ver se não é descontinua\n",
    "            #print(entidade[1])\n",
    "            #print(frase)\n",
    "            frase = so_tokens.copy()\n",
    "            inicio=indices[0]\n",
    "            fim=indices[-1]\n",
    "            frase.insert(inicio, '<e1>')\n",
    "            frase.insert(fim+2, '</e1>')\n",
    "            if ' '.join(texto_entidade).strip()=='-' or ' '.join(texto_entidade).strip()=='=' or ' '.join(texto_entidade).strip()=='+' or ' '.join(texto_entidade).strip()==':' or ' '.join(texto_entidade).strip()==',' or ' '.join(texto_entidade).strip()==\"'\" or ' '.join(texto_entidade).strip()=='\"' or ' '.join(texto_entidade).strip()=='.' or ' '.join(texto_entidade).strip()==';' or ' '.join(texto_entidade).strip()=='/' or ' '.join(texto_entidade).strip()=='(' or ' '.join(texto_entidade).strip()==')' or ' '.join(texto_entidade).strip()=='[' or ' '.join(texto_entidade).strip()==']':\n",
    "                pass\n",
    "            #print('--texto_entidade--:', texto_entidade)\n",
    "            #print('frase:', frase)\n",
    "            #print('frase[inicio+1:fim+2]:', frase[inicio+1:fim+2])\n",
    "            #print(tokens[indice])\n",
    "            # o corpus tem alguns problemas, ex tem entidade descontinua sem o CC\n",
    "            # entao aqui, se não bater, não adicionar no arquivo de treinamento\n",
    "            # ex frase \"The inhibition of c - fos and c - jun expression by IL - 4 in LPS - treated cells was shown to be due to a lower transcription rate of the c - fos and c - jun genes .\"\n",
    "            #print(\"texto_entidade:\", texto_entidade)\n",
    "            #print(\"frase[inicio:fim]:\", frase[inicio+1:fim+2])\n",
    "            texto_entidade_comparar=' '.join(texto_entidade).strip().replace('/','').replace(')','').replace('(','').replace(']','').replace('[','').replace(',','').replace('.','').replace(';','').replace('-','').replace('+','').replace(\"'\",'')\n",
    "            texto_entidade_comparar = replaceWhiteSpaces(texto_entidade_comparar)\n",
    "            texto_frase_comparar = ' '.join(frase[inicio+1:fim+2]).strip().replace('/','').replace(')','').replace('(','').replace(']','').replace('[','').replace(',','').replace('.','').replace(';','').replace('-','').replace('+','').replace(\"'\",'')\n",
    "            texto_frase_comparar = replaceWhiteSpaces(texto_frase_comparar)\n",
    "            #tem = [palavra.lower() in texto_entidade_comparar for palavra in palavrasDescontinua]\n",
    "            #tem = [' '+palavra.lower()+' ' in ' '+texto_entidade_comparar+' ' for palavra in palavrasDescontinua]\n",
    "            #texto_frase_comparar2 = texto_frase_comparar.replace('and not', 'and_not').replace('as well as', 'as_well_as').replace('neither nor', 'neither_nor').replace('but not', 'but_not')\n",
    "            #print(frase)\n",
    "            #print('texto_frase_comparar2.split():', texto_frase_comparar2.split())\n",
    "            #print('texto_frase_comparar2.split():', texto_frase_comparar2.split()[0])\n",
    "            #tem = [texto_frase_comparar2.split()[-1]==palavra.lower() for palavra in palavrasDescontinua_underline]\n",
    "            #tem = [' '+palavra.lower()+' ' in ' '+texto_frase_comparar2+' ' for palavra in palavrasDescontinua_underline]\n",
    "            #tem_boolean = True in tem\n",
    "            #print([' '.join(frase).strip(), tipo_entidade])\n",
    "            #if not tem_boolean:\n",
    "            #if 1==2:\n",
    "            #    combinacaoEntidades.append([' '.join(frase).strip(), tipo_entidade]) # apendando entidades reais\n",
    "            texto_entidade_comparar = texto_entidade_comparar.lower()\n",
    "            texto_frase_comparar = texto_frase_comparar.lower()\n",
    "            if ((texto_entidade_comparar == texto_frase_comparar) or (texto_entidade_comparar+'s' == texto_frase_comparar) or (texto_entidade_comparar+'es' == texto_frase_comparar) or (texto_entidade_comparar+'ies' == texto_frase_comparar) or (texto_entidade_comparar[:-1]+'ies' == texto_frase_comparar) or (texto_entidade_comparar[:-1] == texto_frase_comparar.replace(' /','/'))):\n",
    "                combinacaoEntidades.append([' '.join(frase).strip(), tipo_entidade]) # apendando entidades reais\n",
    "            else:\n",
    "                #print('tem:', tem)\n",
    "                #print('texto_entidade_comparar:', texto_entidade_comparar)\n",
    "                #print('texto_frase_comparar:', texto_frase_comparar)\n",
    "                #print('texto_frase_comparar2.split()[-1]:', texto_frase_comparar2.split()[-1])\n",
    "                #print(\"' '.join(texto_entidade).strip()):\", ' '.join(texto_entidade).strip())\n",
    "                #print(\"' '.join(frase[inicio:fim].strip():\", ' '.join(frase[inicio+1:fim+2]).strip())\n",
    "                erro_corpus=erro_corpus+1\n",
    "                erros_entidade.append(indices)\n",
    "                #print('-----indices erro:----', indices)\n",
    "                lista_erro_corpus.append([' '.join(frase).strip(), tipo_entidade, ' '.join(so_tokens), entidade])\n",
    "        else: # agora, qdo são descontinuas\n",
    "            numDescontinuas=numDescontinuas+1\n",
    "            #print(entidade[1])\n",
    "            #frase = so_tokens.copy()\n",
    "            #inicio=indices[0]\n",
    "            #fim=indices[-1]\n",
    "            #frase.insert(inicio, '<e1>')\n",
    "            #frase.insert(fim+2, '</e1>')\n",
    "            \n",
    "    for entidade in entidades:\n",
    "            indices = entidade[1]\n",
    "            #print('indices:', indices)\n",
    "            if indices in erros_entidade:\n",
    "                continue\n",
    "            inicio=indices[0]\n",
    "            fim=indices[-1]\n",
    "            # agora, fazer a combinacao entre eles.. todas a seguir serão do tipo 'O'           \n",
    "            for indice in indices:\n",
    "                for i in range(indice, fim+1):\n",
    "                    # ver se nao tem antes\n",
    "                    frase = so_tokens.copy()\n",
    "                    frase.insert(indice, '<e1>')\n",
    "                    #print(i)\n",
    "                    frase.insert(i+2, '</e1>')\n",
    "                    frase_string=' '.join(frase).strip()\n",
    "                    #print(frase_string)\n",
    "                    #if frase_string not in combinacaoEntidades:\n",
    "                    # ver se frase não termina com pontuacao ('.',',',';','-',')','(',']','[','/','\"',)\n",
    "                    devePular = 0\n",
    "                    if '. </e1>' in frase_string or ', </e1>' in frase_string  or '; </e1>' in frase_string or '- </e1>' in frase_string  or ': </e1>' in frase_string  or '= </e1>' in frase_string  or '/ </e1>' in frase_string  or '( </e1>' in frase_string  or ') </e1>' in frase_string  or '[ </e1>' in frase_string  or '] </e1>' in frase_string  or ': </e1>' in frase_string or 'and </e1>' in frase_string or 'or </e1>' in frase_string:\n",
    "                        devePular=1\n",
    "                    if '<e1> .' in frase_string or '<e1> ,' in frase_string  or '<e1> ;' in frase_string or '<e1> -' in frase_string  or '<e1> :' in frase_string  or '<e1> =' in frase_string  or '<e1> /' in frase_string  or '<e1> (' in frase_string  or '<e1> )' in frase_string  or '<e1> [' in frase_string  or '<e1> ]' in frase_string  or '<e1> :' in frase_string  or '<e1> and' in frase_string  or '<e1> or' in frase_string:\n",
    "                        devePular=1\n",
    "                    if re.search(\"<e1> [0-9]* </e1>\", frase_string):\n",
    "                        devePular=1\n",
    "                        \n",
    "                    tem_frase = 0\n",
    "                    for frase in combinacaoEntidades:\n",
    "                        if frase[0] == frase_string:\n",
    "                            tem_frase=''\n",
    "                            break\n",
    "                    if tem_frase==0 and devePular==0:\n",
    "                        #print('inserindo:', frase_string)\n",
    "                        #print('indice:', indice)\n",
    "                        combinacaoEntidades.append([frase_string, 'O'])\n",
    "    # shuffle no combinacaoEntidades\n",
    "    if len(combinacaoEntidades)>0:\n",
    "        random.shuffle(combinacaoEntidades)\n",
    "        combinacaoEntidadesAll.append([' '.join(so_tokens).strip(), combinacaoEntidades])\n",
    "    else:\n",
    "        num_frases_sem_entidade = num_frases_sem_entidade+1\n",
    "        #print(\"key sem entidade\", key)\n",
    "        #print('len(combinacaoEntidades):', len(combinacaoEntidades))\n",
    "        #print(so_tokens)\n",
    "    combinacaoEntidades = list()\n",
    "    \n",
    "    if (num % 1000) ==0:\n",
    "    #if (num %30) == 0:\n",
    "        print('key:', key)\n",
    "        #break\n",
    "print('numDescontinuas:', numDescontinuas)\n",
    "print('erro_corpus:', erro_corpus)\n",
    "print('num_frases_sem_entidade:', num_frases_sem_entidade)\n",
    "#print(combinacaoEntidadesAll)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 690,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['This site is conserved among isolates of HIV - 2 and the closely related simian immunodeficiency virus , and transfection assays show this site to mediate HIV - 2 enhancer activation following stimulation of <e1> monocytic but not </e1> T - cell lines .',\n",
       "  'CELL_LINE',\n",
       "  'This site is conserved among isolates of HIV - 2 and the closely related simian immunodeficiency virus , and transfection assays show this site to mediate HIV - 2 enhancer activation following stimulation of monocytic but not T - cell lines .',\n",
       "  [['monocytic', 'cell', 'line'], [34, 35, 36], 'CELL_LINE']],\n",
       " ['The results identify functionally distinct epitopes on the CD4 coreceptor involved in activation of the <e1> Ras /protein kinase </e1> C and calcium pathways .',\n",
       "  'PROTEIN',\n",
       "  'The results identify functionally distinct epitopes on the CD4 coreceptor involved in activation of the Ras /protein kinase C and calcium pathways .',\n",
       "  [['Ras/protein', 'kinase', 'C'], [15, 16, 17], 'PROTEIN']],\n",
       " ['We have shown that interleukin - 1 ( IL - 1 ) and IL - 2 control <e1> IL - 2 receptor alpha ( IL - 2R alpha </e1> ) gene transcription in CD4 - CD8 -  murine T lymphocyte precursors .',\n",
       "  'DNA',\n",
       "  'We have shown that interleukin - 1 ( IL - 1 ) and IL - 2 control IL - 2 receptor alpha ( IL - 2R alpha ) gene transcription in CD4 - CD8 -  murine T lymphocyte precursors .',\n",
       "  [['IL', '-', '2', 'receptor', 'alpha', '(IL', '-', '2R', 'alpha)', 'gene'],\n",
       "   [17, 18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['We have shown that interleukin - 1 ( IL - 1 ) and IL - 2 control <e1> IL - 2 </e1> receptor alpha ( IL - 2R alpha ) gene transcription in CD4 - CD8 -  murine T lymphocyte precursors .',\n",
       "  'PROTEIN',\n",
       "  'We have shown that interleukin - 1 ( IL - 1 ) and IL - 2 control IL - 2 receptor alpha ( IL - 2R alpha ) gene transcription in CD4 - CD8 -  murine T lymphocyte precursors .',\n",
       "  [['IL', '-', '2 receptor alpha'], [17, 18, 19], 'PROTEIN']],\n",
       " ['We have shown that interleukin - 1 ( IL - 1 ) and IL - 2 control IL - 2 receptor alpha ( <e1> IL - 2R </e1> alpha ) gene transcription in CD4 - CD8 -  murine T lymphocyte precursors .',\n",
       "  'PROTEIN',\n",
       "  'We have shown that interleukin - 1 ( IL - 1 ) and IL - 2 control IL - 2 receptor alpha ( IL - 2R alpha ) gene transcription in CD4 - CD8 -  murine T lymphocyte precursors .',\n",
       "  [['IL', '-', '2R alpha'], [23, 24, 25], 'PROTEIN']],\n",
       " ['The cell cycle - dependent transcription factor , E2F - 1 , regulates the cyclin - like species of the DNA repair enzyme <e1> uracil - DNA glycosylase ( UDG </e1> ) gene in human osteosarcoma ( Saos - 2 ) cells .',\n",
       "  'DNA',\n",
       "  'The cell cycle - dependent transcription factor , E2F - 1 , regulates the cyclin - like species of the DNA repair enzyme uracil - DNA glycosylase ( UDG ) gene in human osteosarcoma ( Saos - 2 ) cells .',\n",
       "  [['uracil', '-', 'DNA', 'glycosylase', '(UDG)', 'gene'],\n",
       "   [23, 24, 25, 26, 27, 28],\n",
       "   'DNA']],\n",
       " ['The cell cycle - dependent transcription factor , E2F - 1 , regulates the cyclin - like species of the DNA repair enzyme uracil - DNA glycosylase ( UDG ) gene in <e1> human osteosarcoma ( Saos - 2 </e1> ) cells .',\n",
       "  'CELL_LINE',\n",
       "  'The cell cycle - dependent transcription factor , E2F - 1 , regulates the cyclin - like species of the DNA repair enzyme uracil - DNA glycosylase ( UDG ) gene in human osteosarcoma ( Saos - 2 ) cells .',\n",
       "  [['human', 'osteosarcoma', '(Saos', '-', '2)', 'cell'],\n",
       "   [32, 33, 34, 35, 36, 37],\n",
       "   'CELL_LINE']],\n",
       " ['Although it has been reported that there are some T cell lines that produce IFN - gamma in response to IL - 2 and IL - 12 stimulation , there has as yet been no report of a <e1> natural killer ( NK ) </e1> cell line that responds in a similar manner .',\n",
       "  'CELL_LINE',\n",
       "  'Although it has been reported that there are some T cell lines that produce IFN - gamma in response to IL - 2 and IL - 12 stimulation , there has as yet been no report of a natural killer ( NK ) cell line that responds in a similar manner .',\n",
       "  [['natural', 'killer', '(NK)', 'cell', 'line'],\n",
       "   [38, 39, 40, 41, 42],\n",
       "   'CELL_LINE']],\n",
       " ['In addition , when used together IL - 2 and IL - 12 synergized in the induction of IFN - gamma and GM - CSF and this synergy was attributed to an increased accumulation and stability of the <e1> IFN - gamma and </e1> GM - CSF mRNAs .',\n",
       "  'RNA',\n",
       "  'In addition , when used together IL - 2 and IL - 12 synergized in the induction of IFN - gamma and GM - CSF and this synergy was attributed to an increased accumulation and stability of the IFN - gamma and GM - CSF mRNAs .',\n",
       "  [['IFN', '-', 'gamma', 'mRNA'], [38, 39, 40, 41], 'RNA']],\n",
       " ['It contains a number of structural motifs , including <e1> Src homology 2 , Src homology 3 , and pleckstrin </e1> homology domains and a putative guanine nucleotide exchange domain .',\n",
       "  'PROTEIN',\n",
       "  'It contains a number of structural motifs , including Src homology 2 , Src homology 3 , and pleckstrin homology domains and a putative guanine nucleotide exchange domain .',\n",
       "  [['Src',\n",
       "    'homology',\n",
       "    '2,',\n",
       "    'Src',\n",
       "    'homology',\n",
       "    '3,',\n",
       "    'and',\n",
       "    'pleckstrin',\n",
       "    'homology',\n",
       "    'domain'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'PROTEIN']],\n",
       " ['It contains a number of structural motifs , including <e1> Src homology 2 , </e1> Src homology 3 , and pleckstrin homology domains and a putative guanine nucleotide exchange domain .',\n",
       "  'PROTEIN',\n",
       "  'It contains a number of structural motifs , including Src homology 2 , Src homology 3 , and pleckstrin homology domains and a putative guanine nucleotide exchange domain .',\n",
       "  [['Src', 'homology', '2', 'domain'], [9, 10, 11, 12], 'PROTEIN']],\n",
       " ['It contains a number of structural motifs , including Src homology 2 , <e1> Src homology 3 , </e1> and pleckstrin homology domains and a putative guanine nucleotide exchange domain .',\n",
       "  'PROTEIN',\n",
       "  'It contains a number of structural motifs , including Src homology 2 , Src homology 3 , and pleckstrin homology domains and a putative guanine nucleotide exchange domain .',\n",
       "  [['Src', 'homology', '3', 'domain'], [13, 14, 15, 16], 'PROTEIN']],\n",
       " ['The <e1> granulocyte - macrophage colony - stimulating factor ( GM - CSF ) </e1> gene promoter contains a consensus sequence for the polyomavirus enhancer binding - protein 2 ( PEBP2 ) transcription factor , which consists of alpha and beta subunits .',\n",
       "  'DNA',\n",
       "  'The granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene promoter contains a consensus sequence for the polyomavirus enhancer binding - protein 2 ( PEBP2 ) transcription factor , which consists of alpha and beta subunits .',\n",
       "  [['granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(GM',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'gene',\n",
       "    'promoter'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'DNA']],\n",
       " ['The granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene promoter contains a consensus sequence for the <e1> polyomavirus enhancer binding - protein 2 ( PEBP2 ) </e1> transcription factor , which consists of alpha and beta subunits .',\n",
       "  'PROTEIN',\n",
       "  'The granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene promoter contains a consensus sequence for the polyomavirus enhancer binding - protein 2 ( PEBP2 ) transcription factor , which consists of alpha and beta subunits .',\n",
       "  [['polyomavirus',\n",
       "    'enhancer',\n",
       "    'binding',\n",
       "    '-',\n",
       "    'protein',\n",
       "    '2',\n",
       "    '(PEBP2)',\n",
       "    'transcription',\n",
       "    'factor'],\n",
       "   [21, 22, 23, 24, 25, 26, 27, 28, 29],\n",
       "   'PROTEIN']],\n",
       " ['Activation of the <e1> TAL1 ( or SCL </e1> ) gene , originally identified through its involvement by a recurrent chromosomal translocation , is the most frequent molecular lesion recognized in T - cell acute lymphoblastic leukemia .',\n",
       "  'DNA',\n",
       "  'Activation of the TAL1 ( or SCL ) gene , originally identified through its involvement by a recurrent chromosomal translocation , is the most frequent molecular lesion recognized in T - cell acute lymphoblastic leukemia .',\n",
       "  [['TAL1', '(or', 'SCL)', 'gene'], [3, 4, 5, 6], 'DNA']],\n",
       " ['Regulation of transcription of the human erythropoietin receptor gene by proteins binding to <e1> GATA - 1 and </e1> Sp1 motifs .',\n",
       "  'DNA',\n",
       "  'Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA - 1 and Sp1 motifs .',\n",
       "  [['GATA', '-', '1', 'motif'], [13, 14, 15, 16], 'DNA']],\n",
       " ['The deduced amino acid sequence similarity to the proteins encoded by these two latter genes is approximately 65 % and includes domains and amino acid residues ( the <e1> leucine zipper - like and </e1> the RGD domain , a serine and a histidine residue in the NH2 - and in the COOH - terminal portion of the protein , respectively ) postulated to be important for nm23 function .',\n",
       "  'PROTEIN',\n",
       "  'The deduced amino acid sequence similarity to the proteins encoded by these two latter genes is approximately 65 % and includes domains and amino acid residues ( the leucine zipper - like and the RGD domain , a serine and a histidine residue in the NH2 - and in the COOH - terminal portion of the protein , respectively ) postulated to be important for nm23 function .',\n",
       "  [['leucine', 'zipper', '-', 'like', 'domain'],\n",
       "   [28, 29, 30, 31, 32],\n",
       "   'PROTEIN']],\n",
       " ['Secreted from activated T cells and macrophages , bone <e1> marrow - derived MIP - 1 alpha </e1> /GOS19 inhibits primitive hematopoietic stem cells and appears to be involved in the homeostatic control of stem cell proliferation .',\n",
       "  'PROTEIN',\n",
       "  'Secreted from activated T cells and macrophages , bone marrow - derived MIP - 1 alpha /GOS19 inhibits primitive hematopoietic stem cells and appears to be involved in the homeostatic control of stem cell proliferation .',\n",
       "  [['marrow', '-', 'derived', 'MIP', '-', '1', 'alpha/GOS19'],\n",
       "   [9, 10, 11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['We provide evidence for an additional binding site , the <e1> MIP - 1 alpha nuclear protein ( MNP </e1> ) site , which overlaps the ICK - 1 site .',\n",
       "  'DNA',\n",
       "  'We provide evidence for an additional binding site , the MIP - 1 alpha nuclear protein ( MNP ) site , which overlaps the ICK - 1 site .',\n",
       "  [['MIP', '-', '1', 'alpha', 'nuclear', 'protein', '(MNP)', 'site'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17],\n",
       "   'DNA']],\n",
       " ['Expression of <e1> nucleoside diphosphate ( </e1> NDP ) kinase , which is homologous to the nm23 gene product in a variety of species , has been found to be inversely associated with metastatic potential .',\n",
       "  'PROTEIN',\n",
       "  'Expression of nucleoside diphosphate ( NDP ) kinase , which is homologous to the nm23 gene product in a variety of species , has been found to be inversely associated with metastatic potential .',\n",
       "  [['nucleoside', 'diphosphate(NDP)', 'kinase'], [2, 3, 4], 'PROTEIN']],\n",
       " ['The <e1> major histocompatibility ( MHC ) class </e1> II genes encode cell surface proteins that bind antigenic peptide for presentation to T - cells .',\n",
       "  'DNA',\n",
       "  'The major histocompatibility ( MHC ) class II genes encode cell surface proteins that bind antigenic peptide for presentation to T - cells .',\n",
       "  [['major', 'histocompatibility', '(MHC)', 'class', 'II', 'genes'],\n",
       "   [1, 2, 3, 4, 5, 6],\n",
       "   'DNA']],\n",
       " ['CIITA mRNA is normally inducible by IFN - gamma in <e1> class II non - inducible , RB - defective </e1> lines , and in one line , re - expression of RB has no effect on CIITA mRNA induction levels .',\n",
       "  'CELL_LINE',\n",
       "  'CIITA mRNA is normally inducible by IFN - gamma in class II non - inducible , RB - defective lines , and in one line , re - expression of RB has no effect on CIITA mRNA induction levels .',\n",
       "  [['class', 'II', 'non', '-', 'inducible,', 'RB', '-', 'defective', 'line'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'CELL_LINE']],\n",
       " ['In addition , integrin ligation leads to nuclear translocation of the p50 and p65 subunits of the NF - kappa B transcription factor , to activation of a reporter gene driven by a promoter containing NF - kappa B sites , and to increased levels of mRNAs for immediate - early genes , including the <e1> cytokine interleukin ( IL ) - </e1> 1 beta .',\n",
       "  'PROTEIN',\n",
       "  'In addition , integrin ligation leads to nuclear translocation of the p50 and p65 subunits of the NF - kappa B transcription factor , to activation of a reporter gene driven by a promoter containing NF - kappa B sites , and to increased levels of mRNAs for immediate - early genes , including the cytokine interleukin ( IL ) - 1 beta .',\n",
       "  [['cytokine', 'interleukin', '(IL)', '-', '1', 'beta'],\n",
       "   [55, 56, 57, 58, 59, 60],\n",
       "   'PROTEIN']],\n",
       " ['With the recent characterization of the FY*A and <e1> FY*B alleles </e1> , these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid - specific repression of the DARC gene in Duffy - negative individuals .',\n",
       "  'DNA',\n",
       "  'With the recent characterization of the FY*A and FY*B alleles , these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid - specific repression of the DARC gene in Duffy - negative individuals .',\n",
       "  [['fyb', 'allele'], [8, 9], 'DNA']],\n",
       " ['Transient transfection assays with EGR - 1 promoter fragments linked to the <e1> chloramphenicol acetyltransferase ( CAT </e1> ) gene demonstrated that PWM induced EGR - 1 transcription is conferred by the CArG motif ( C C[AT]6GG ) in the EGR - 1 promoter .',\n",
       "  'DNA',\n",
       "  'Transient transfection assays with EGR - 1 promoter fragments linked to the chloramphenicol acetyltransferase ( CAT ) gene demonstrated that PWM induced EGR - 1 transcription is conferred by the CArG motif ( C C[AT]6GG ) in the EGR - 1 promoter .',\n",
       "  [['chloramphenicol', 'acetyltransferase', '(CAT)', 'gene'],\n",
       "   [12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['The 5 flanking region of the human alpha - globin gene is highly <e1> G + C rich and contains </e1> multiple copies of the consensus sequence for the Sp1 binding site .',\n",
       "  'DNA',\n",
       "  'The 5 flanking region of the human alpha - globin gene is highly G + C rich and contains multiple copies of the consensus sequence for the Sp1 binding site .',\n",
       "  [['G', '+', 'C', 'rich'], [13, 14, 15, 16], 'DNA']],\n",
       " ['We investigated the role of this <e1> G + C - rich region in augmenting </e1> alpha - globin promoter activity in the presence of the far - upstream alpha - globin enhancer , HS - 40 .',\n",
       "  'DNA',\n",
       "  'We investigated the role of this G + C - rich region in augmenting alpha - globin promoter activity in the presence of the far - upstream alpha - globin enhancer , HS - 40 .',\n",
       "  [['G', '+', 'C', '-', 'rich', 'region'], [6, 7, 8, 9, 10, 11], 'DNA']],\n",
       " ['We show that in transiently transfected erythroid cells , deletion of the <e1> alpha - globin G + C - rich 5 flanking region has no </e1> effect on alpha - globin promoter activity .',\n",
       "  'DNA',\n",
       "  'We show that in transiently transfected erythroid cells , deletion of the alpha - globin G + C - rich 5 flanking region has no effect on alpha - globin promoter activity .',\n",
       "  [['alpha',\n",
       "    '-',\n",
       "    'globin',\n",
       "    'G',\n",
       "    '+',\n",
       "    'C',\n",
       "    '-',\n",
       "    'rich',\n",
       "    \"5'\",\n",
       "    'flanking',\n",
       "    'region'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'DNA']],\n",
       " ['These results suggest that the <e1> alpha - globin G + C - rich 5 flanking region augments alpha </e1> - globin promoter activity in a chromatin - dependent manner .',\n",
       "  'DNA',\n",
       "  'These results suggest that the alpha - globin G + C - rich 5 flanking region augments alpha - globin promoter activity in a chromatin - dependent manner .',\n",
       "  [['alpha',\n",
       "    '-',\n",
       "    'globin',\n",
       "    'G',\n",
       "    '+',\n",
       "    'C',\n",
       "    '-',\n",
       "    'rich',\n",
       "    \"5'\",\n",
       "    'flanking',\n",
       "    'region'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['We further show that this <e1> G + C - rich region is required </e1> for the activation of alpha - globin gene expression during erythroid differentiation .',\n",
       "  'DNA',\n",
       "  'We further show that this G + C - rich region is required for the activation of alpha - globin gene expression during erythroid differentiation .',\n",
       "  [['G', '+', 'C', '-', 'rich', 'region'], [5, 6, 7, 8, 9, 10], 'DNA']],\n",
       " ['Finally , we show by both footprint analysis and functional assays that the ability of the <e1> G + C - rich region to increase </e1> alpha - globin promoter activity from a stably integrated alpha - globin gene is mediated by its multiple binding sites for the transcription factor Sp1 .',\n",
       "  'DNA',\n",
       "  'Finally , we show by both footprint analysis and functional assays that the ability of the G + C - rich region to increase alpha - globin promoter activity from a stably integrated alpha - globin gene is mediated by its multiple binding sites for the transcription factor Sp1 .',\n",
       "  [['G', '+', 'C', '-', 'rich', 'region'], [16, 17, 18, 19, 20, 21], 'DNA']],\n",
       " ['We have earlier shown that stimulation of human CD4+ T cells with SEA presented on <e1> Chinese hamster ovary ( CHO ) - </e1> DR transfectants coexpressing either B7 or LFA - 3 resulted in distinct cytokine profiles .',\n",
       "  'CELL_LINE',\n",
       "  'We have earlier shown that stimulation of human CD4+ T cells with SEA presented on Chinese hamster ovary ( CHO ) - DR transfectants coexpressing either B7 or LFA - 3 resulted in distinct cytokine profiles .',\n",
       "  [['Chinese', 'hamster', 'ovary', '(CHO)', '-', 'DR', 'transfectant'],\n",
       "   [15, 16, 17, 18, 19, 20, 21],\n",
       "   'CELL_LINE']],\n",
       " ['Maximal increase in IL - 2 transcription was recorded with <e1> CHO - DR/ B7 / </e1> LFA - 3 , suggesting a cooperative effect of B7 and LFA - 3 at the transcriptional level .',\n",
       "  'PROTEIN',\n",
       "  'Maximal increase in IL - 2 transcription was recorded with CHO - DR/ B7 / LFA - 3 , suggesting a cooperative effect of B7 and LFA - 3 at the transcriptional level .',\n",
       "  [['CHO', '-', 'DR/B7/LFA', '-', '3'], [10, 11, 12, 13, 14], 'PROTEIN']],\n",
       " ['The <e1> CHO - DR/ B7 / LFA - </e1> 3 triple transfectant induced a further increase in AP - 1 and NF - kappa B binding proteins compared with the double transfectants .',\n",
       "  'CELL_LINE',\n",
       "  'The CHO - DR/ B7 / LFA - 3 triple transfectant induced a further increase in AP - 1 and NF - kappa B binding proteins compared with the double transfectants .',\n",
       "  [['CHO', '-', 'DR/B7/LFA', '-', '3', 'triple', 'transfectant'],\n",
       "   [1, 2, 3, 4, 5, 6, 7],\n",
       "   'CELL_LINE']],\n",
       " ['Although all nm23 proteins contain <e1> nucleoside diphosphate ( NDP </e1> ) kinase activity , it has not been established that the enzyme activity mediated the various functions of nm23 proteins .',\n",
       "  'PROTEIN',\n",
       "  'Although all nm23 proteins contain nucleoside diphosphate ( NDP ) kinase activity , it has not been established that the enzyme activity mediated the various functions of nm23 proteins .',\n",
       "  [['nucleoside', 'diphosphate', '(NDP)', 'kinase'], [5, 6, 7, 8], 'PROTEIN']],\n",
       " ['Moreover , both the mutant nm23 - H2His protein and truncated nm23 - H2 protein containing <e1> N - terminal ( 1 - 60 </e1> ) peptide , which do not have NDP kinase activity , also inhibited erythroid differentiation of HEL cells .',\n",
       "  'PROTEIN',\n",
       "  'Moreover , both the mutant nm23 - H2His protein and truncated nm23 - H2 protein containing N - terminal ( 1 - 60 ) peptide , which do not have NDP kinase activity , also inhibited erythroid differentiation of HEL cells .',\n",
       "  [['N', '-', 'terminal', '(1', '-', '60)', 'peptide'],\n",
       "   [16, 17, 18, 19, 20, 21, 22],\n",
       "   'PROTEIN']],\n",
       " ['These results suggest that ( 1 ) the differentiation inhibitory activity of <e1> I - factor /nm23 </e1> protein is not restricted to monocytic differentiation of M1 cells , ( 2 ) the inhibitory activity is exhibited without species specificity , and ( 3 ) the differentiation inhibitory activity of the nm23/NDP kinase protein is independent of its enzyme activity and requires the presence of N - terminal peptides .',\n",
       "  'PROTEIN',\n",
       "  'These results suggest that ( 1 ) the differentiation inhibitory activity of I - factor /nm23 protein is not restricted to monocytic differentiation of M1 cells , ( 2 ) the inhibitory activity is exhibited without species specificity , and ( 3 ) the differentiation inhibitory activity of the nm23/NDP kinase protein is independent of its enzyme activity and requires the presence of N - terminal peptides .',\n",
       "  [['I', '-', 'factor/nm23', 'protein'], [12, 13, 14, 15], 'PROTEIN']],\n",
       " ['Costimulatory signals , such as activation of the CD28 cell surface molecule on T cells , lead to activation through a distinct region of the <e1> granulocyte - macrophage colony - stimulating factor ( GM - CSF </e1> ) promoter .',\n",
       "  'DNA',\n",
       "  'Costimulatory signals , such as activation of the CD28 cell surface molecule on T cells , lead to activation through a distinct region of the granulocyte - macrophage colony - stimulating factor ( GM - CSF ) promoter .',\n",
       "  [['granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(GM',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'promoter'],\n",
       "   [25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35],\n",
       "   'DNA']],\n",
       " ['Synergy between signal transduction pathways is obligatory for expression of c - fos in B and T cell lines : implication for c - fos control via <e1> surface immunoglobulin and </e1> T cell antigen receptors .',\n",
       "  'PROTEIN',\n",
       "  'Synergy between signal transduction pathways is obligatory for expression of c - fos in B and T cell lines : implication for c - fos control via surface immunoglobulin and T cell antigen receptors .',\n",
       "  [['surface', 'immunoglobulin', 'receptor'], [27, 28, 29], 'PROTEIN']],\n",
       " ['The <e1> human granulocyte - macrophage CSF ( GM - CSF </e1> ) gene is expressed in T cells in response to TCR activation that can be mimicked by treatment of the cells with PMA and Ca2+ ionophore .',\n",
       "  'DNA',\n",
       "  'The human granulocyte - macrophage CSF ( GM - CSF ) gene is expressed in T cells in response to TCR activation that can be mimicked by treatment of the cells with PMA and Ca2+ ionophore .',\n",
       "  [['human',\n",
       "    'granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    'CSF',\n",
       "    '(GM',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['The proximal promoter contains a region termed CLEO ( - 54 to - 31 ) that consists of a purine - rich element abutting an <e1> activator protein - 1 ( AP - 1 ) - </e1> like site , as well as an upstream nuclear factor - kappa B ( NF - kappa B ) site ( - 85 to - 76 ) and a CK - 1 element ( - 101 to - 92 ) .',\n",
       "  'DNA',\n",
       "  'The proximal promoter contains a region termed CLEO ( - 54 to - 31 ) that consists of a purine - rich element abutting an activator protein - 1 ( AP - 1 ) - like site , as well as an upstream nuclear factor - kappa B ( NF - kappa B ) site ( - 85 to - 76 ) and a CK - 1 element ( - 101 to - 92 ) .',\n",
       "  [['activator', 'protein', '-', '1', '(AP', '-', '1)', '-', 'like', 'site'],\n",
       "   [25, 26, 27, 28, 29, 30, 31, 32, 33, 34],\n",
       "   'DNA']],\n",
       " ['The proximal promoter contains a region termed CLEO ( - 54 to - 31 ) that consists of a purine - rich element abutting an activator protein - 1 ( AP - 1 ) - like site , as well as an <e1> upstream nuclear factor - kappa B ( NF - kappa B </e1> ) site ( - 85 to - 76 ) and a CK - 1 element ( - 101 to - 92 ) .',\n",
       "  'DNA',\n",
       "  'The proximal promoter contains a region termed CLEO ( - 54 to - 31 ) that consists of a purine - rich element abutting an activator protein - 1 ( AP - 1 ) - like site , as well as an upstream nuclear factor - kappa B ( NF - kappa B ) site ( - 85 to - 76 ) and a CK - 1 element ( - 101 to - 92 ) .',\n",
       "  [['upstream',\n",
       "    'nuclear',\n",
       "    'factor',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B)',\n",
       "    'site'],\n",
       "   [42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52],\n",
       "   'DNA']],\n",
       " ['The major inducible protein complex that binds to the <e1> human CLEO ( hCLEO </e1> ) element is an AP - 1 - like complex that is inducible by PMA alone , but shows increased binding in response to PMA together with Ca2+ ionophore .',\n",
       "  'DNA',\n",
       "  'The major inducible protein complex that binds to the human CLEO ( hCLEO ) element is an AP - 1 - like complex that is inducible by PMA alone , but shows increased binding in response to PMA together with Ca2+ ionophore .',\n",
       "  [['human', 'CLEO', '(hCLEO)', 'element'], [9, 10, 11, 12], 'DNA']],\n",
       " ['By using recombinant proteins , we confirmed that AP - 1 , NF - ATp , and a higher order <e1> NF - ATp / AP - </e1> 1 complex could all form with the hCLEO element , and we have also defined the sequence requirements for binding of each of these complexes .',\n",
       "  'PROTEIN',\n",
       "  'By using recombinant proteins , we confirmed that AP - 1 , NF - ATp , and a higher order NF - ATp / AP - 1 complex could all form with the hCLEO element , and we have also defined the sequence requirements for binding of each of these complexes .',\n",
       "  [['NF', '-', 'ATp/AP', '-', '1', 'complex'],\n",
       "   [20, 21, 22, 23, 24, 25],\n",
       "   'PROTEIN']],\n",
       " ['These results imply that at least three signals are required to activate the GM - CSF proximal promoter , and that the signals impinge on distinct transcription factors that bind to the <e1> hCLEO and </e1> NF - kappa B regions of the promoter .',\n",
       "  'DNA',\n",
       "  'These results imply that at least three signals are required to activate the GM - CSF proximal promoter , and that the signals impinge on distinct transcription factors that bind to the hCLEO and NF - kappa B regions of the promoter .',\n",
       "  [['hCLEO', 'region'], [32, 33], 'DNA']],\n",
       " ['In this report , we show that in monocytes and T cells IL - 10 stimulates tyrosine phosphorylation of the signal transducers and <e1> activators of transcription </e1> , STAT1 alpha and STAT3 , in a differential manner such that the relative formation of homo - and hetero dimers varies between the two cell types .',\n",
       "  'PROTEIN',\n",
       "  'In this report , we show that in monocytes and T cells IL - 10 stimulates tyrosine phosphorylation of the signal transducers and activators of transcription , STAT1 alpha and STAT3 , in a differential manner such that the relative formation of homo - and hetero dimers varies between the two cell types .',\n",
       "  [['activator', 'of', 'transcription'], [23, 24, 25], 'PROTEIN']],\n",
       " ['The inert quality of <e1> MRL - Ipr/Ipr ( Ipr ) peripheral CD4 - CD8 - ( CD4 - 8 - </e1> ) T cells manifests primarily as an inability to proliferate or produce IL - 2 in response to TCR or mitogenic stimulation .',\n",
       "  'CELL_LINE',\n",
       "  'The inert quality of MRL - Ipr/Ipr ( Ipr ) peripheral CD4 - CD8 - ( CD4 - 8 - ) T cells manifests primarily as an inability to proliferate or produce IL - 2 in response to TCR or mitogenic stimulation .',\n",
       "  [['MRL',\n",
       "    '-',\n",
       "    'Ipr/Ipr',\n",
       "    '(Ipr)',\n",
       "    'peripheral',\n",
       "    'CD4',\n",
       "    '-',\n",
       "    'CD8',\n",
       "    '-',\n",
       "    '(CD4',\n",
       "    '-',\n",
       "    '8',\n",
       "    '-',\n",
       "    ')',\n",
       "    'T',\n",
       "    'cell'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'CELL_LINE']],\n",
       " ['We demonstrate that cross - linking CD30 with an anti - CD30 - specific monoclonal antibody , which mimics the described biological activities of the <e1> CD30 </e1> ligand ( CD30L ) , results in HIV expression .',\n",
       "  'PROTEIN',\n",
       "  'We demonstrate that cross - linking CD30 with an anti - CD30 - specific monoclonal antibody , which mimics the described biological activities of the CD30 ligand ( CD30L ) , results in HIV expression .',\n",
       "  [['CD30 ligand'], [25], 'PROTEIN']],\n",
       " ['The regulation of <e1> interleukin ( IL ) - </e1> 2 gene expression has been investigated mainly in T lymphocytes , the predominant producers of IL - 2 .',\n",
       "  'DNA',\n",
       "  'The regulation of interleukin ( IL ) - 2 gene expression has been investigated mainly in T lymphocytes , the predominant producers of IL - 2 .',\n",
       "  [['interleukin', '(IL)', '-', '2', 'gene'], [3, 4, 5, 6, 7], 'DNA']],\n",
       " ['In the present study we analyzed the control of IL - 2 promoter activity in <e1> Epstein - Barr virus ( EBV ) - transformed B </e1> cell clones which are capable of secreting IL - 2 at a low level after stimulation with phorbol 12 - myristate 13 - acetate and the Ca2+ ionophore ionomycin .',\n",
       "  'CELL_LINE',\n",
       "  'In the present study we analyzed the control of IL - 2 promoter activity in Epstein - Barr virus ( EBV ) - transformed B cell clones which are capable of secreting IL - 2 at a low level after stimulation with phorbol 12 - myristate 13 - acetate and the Ca2+ ionophore ionomycin .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    '-',\n",
       "    'transformed',\n",
       "    'B',\n",
       "    'cell',\n",
       "    'clones'],\n",
       "   [15, 16, 17, 18, 19, 20, 21, 22, 23, 24],\n",
       "   'CELL_LINE']],\n",
       " ['Transient transfections using reporter constructs with multiples of transcription factor binding sites from the IL - 2 promoter [ <e1> distal nuclear factor ( NF ) </e1> - AT , proximal NF - AT , AP - 1/Octamer ( UPS ) or NF - chi B ( TCEd ) sites ] were performed .',\n",
       "  'PROTEIN',\n",
       "  'Transient transfections using reporter constructs with multiples of transcription factor binding sites from the IL - 2 promoter [ distal nuclear factor ( NF ) - AT , proximal NF - AT , AP - 1/Octamer ( UPS ) or NF - chi B ( TCEd ) sites ] were performed .',\n",
       "  [['distal', 'nuclear', 'factor', '(NF)', '-', 'AT'],\n",
       "   [19, 20, 21, 22, 23, 24],\n",
       "   'PROTEIN']],\n",
       " ['A weaker <e1> chi B complex </e1> formation and faster - migrating complexes were detected in non - IL - 2 - secreting cells .',\n",
       "  'DNA',\n",
       "  'A weaker chi B complex formation and faster - migrating complexes were detected in non - IL - 2 - secreting cells .',\n",
       "  [['chi', 'B', 'site'], [2, 3, 4], 'DNA']],\n",
       " ['However , TGF - beta 1 did not induce dephosphorylation of pRb in <e1> EBV ( or LMP - 1 ) - </e1> positive cells as opposed to EBV - negative cells , suggesting a dichotomy in the TGF - beta 1 signaling pathway leading to separable gene regulatory and growth inhibitory responses .',\n",
       "  'CELL_LINE',\n",
       "  'However , TGF - beta 1 did not induce dephosphorylation of pRb in EBV ( or LMP - 1 ) - positive cells as opposed to EBV - negative cells , suggesting a dichotomy in the TGF - beta 1 signaling pathway leading to separable gene regulatory and growth inhibitory responses .',\n",
       "  [['EBV', '(or', 'LMP', '-', '1)', '-', 'positive', 'cells'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'CELL_LINE']],\n",
       " ['In GD patients , the responses of peripheral blood mononuclear cells ( PBMC ) and <e1> TSH receptor ( TSHR ) - specific T </e1> cell lines to recombinant human TSHR extracellular domain , thyroglobulin , and TSHR peptides were examined on the day of surgery or RAI therapy ( day 0 ) and also 6 - 8 weeks and 3 - 6 months thereafter .',\n",
       "  'CELL_LINE',\n",
       "  'In GD patients , the responses of peripheral blood mononuclear cells ( PBMC ) and TSH receptor ( TSHR ) - specific T cell lines to recombinant human TSHR extracellular domain , thyroglobulin , and TSHR peptides were examined on the day of surgery or RAI therapy ( day 0 ) and also 6 - 8 weeks and 3 - 6 months thereafter .',\n",
       "  [['TSH', 'receptor', '(TSHR)', '-', 'specific', 'T', 'cell', 'line'],\n",
       "   [15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'CELL_LINE']],\n",
       " ['Human prostatic epithelial cells from an androgen - dependent LNCaP cell line were examined in response to conditioned medium ( CM ) derived from <e1> phytohemagglutinin ( PHA ) - </e1> stimulated lymphocytes .',\n",
       "  'CELL_LINE',\n",
       "  'Human prostatic epithelial cells from an androgen - dependent LNCaP cell line were examined in response to conditioned medium ( CM ) derived from phytohemagglutinin ( PHA ) - stimulated lymphocytes .',\n",
       "  [['phytohemagglutinin', '(PHA)', '-', 'stimulated', 'lymphocyte'],\n",
       "   [24, 25, 26, 27, 28],\n",
       "   'CELL_LINE']],\n",
       " ['Interleukin 4 activates a signal transducer and activator of <e1> transcription ( Stat </e1> ) protein which interacts with an interferon - gamma activation site - like sequence upstream of the I epsilon exon in a human B cell line .',\n",
       "  'PROTEIN',\n",
       "  'Interleukin 4 activates a signal transducer and activator of transcription ( Stat ) protein which interacts with an interferon - gamma activation site - like sequence upstream of the I epsilon exon in a human B cell line .',\n",
       "  [['transcription', '(Stat)', 'protein'], [9, 10, 11], 'PROTEIN']],\n",
       " ['Because these are the characteristics of a <e1> signal transducer and activator of transcription ( Stat </e1> ) protein , we determined whether antibodies to Stat proteins will interfere with gel mobility shift and found that antibodies to IL - 4 Stat , also known as Stat6 , but not antibodies to other Stat proteins , interfere with the formation of the IL - 4 NAF complex .',\n",
       "  'PROTEIN',\n",
       "  'Because these are the characteristics of a signal transducer and activator of transcription ( Stat ) protein , we determined whether antibodies to Stat proteins will interfere with gel mobility shift and found that antibodies to IL - 4 Stat , also known as Stat6 , but not antibodies to other Stat proteins , interfere with the formation of the IL - 4 NAF complex .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(Stat)',\n",
       "    'protein'],\n",
       "   [7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'PROTEIN']],\n",
       " ['We have previously found a high expression of <e1> human Ah receptor ( TCDD receptor </e1> ) mRNA in peripheral blood cells of individuals .',\n",
       "  'RNA',\n",
       "  'We have previously found a high expression of human Ah receptor ( TCDD receptor ) mRNA in peripheral blood cells of individuals .',\n",
       "  [['human', 'Ah', 'receptor', '(TCDD', 'receptor)', 'mRNA'],\n",
       "   [8, 9, 10, 11, 12, 13],\n",
       "   'RNA']],\n",
       " ['The data indicate that PKC - epsilon and , to a lesser extent PKC - alpha but not <e1> - zeta , </e1> can regulate the transcription factors AP - 1 and nuclear factor of activated T cells ( NF - AT - 1 ) .',\n",
       "  'PROTEIN',\n",
       "  'The data indicate that PKC - epsilon and , to a lesser extent PKC - alpha but not - zeta , can regulate the transcription factors AP - 1 and nuclear factor of activated T cells ( NF - AT - 1 ) .',\n",
       "  [['PKC', '-', 'zeta'], [18, 19, 20], 'PROTEIN']],\n",
       " ['Signaling by a wide variety of cytokines , including interferons , interleukins , and growth factors , involves activation of JAK kinases and <e1> Stat ( Signal transducers and activators of transcription </e1> ) proteins .',\n",
       "  'PROTEIN',\n",
       "  'Signaling by a wide variety of cytokines , including interferons , interleukins , and growth factors , involves activation of JAK kinases and Stat ( Signal transducers and activators of transcription ) proteins .',\n",
       "  [['Stat',\n",
       "    '(Signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription)',\n",
       "    'protein'],\n",
       "   [23, 24, 25, 26, 27, 28, 29, 30],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Epstein - Barr virus ( EBV ) - </e1> infected cells may sustain three distinct forms of virus latency .',\n",
       "  'CELL_TYPE',\n",
       "  'Epstein - Barr virus ( EBV ) - infected cells may sustain three distinct forms of virus latency .',\n",
       "  [['Epstein', '-', 'Barr', 'virus', '(EBV)', '-', 'infected', 'cell'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7],\n",
       "   'CELL_TYPE']],\n",
       " ['<e1> Interleukin ( IL ) </e1> - 10 inhibits nuclear factor kappa B ( NF kappa B ) activation in human monocytes .',\n",
       "  'PROTEIN',\n",
       "  'Interleukin ( IL ) - 10 inhibits nuclear factor kappa B ( NF kappa B ) activation in human monocytes .',\n",
       "  [['interleukin', '(IL)', '-', '10'], [0, 1, 2, 3], 'PROTEIN']],\n",
       " ['Our previous studies in human monocytes have demonstrated that <e1> interleukin ( IL ) </e1> - 10 inhibits lipopolysaccharide ( LPS ) - stimulated production of inflammatory cytokines , IL - 1 beta , IL - 6 , IL - 8 , and tumor necrosis factor ( TNF ) - alpha by blocking gene transcription .',\n",
       "  'PROTEIN',\n",
       "  'Our previous studies in human monocytes have demonstrated that interleukin ( IL ) - 10 inhibits lipopolysaccharide ( LPS ) - stimulated production of inflammatory cytokines , IL - 1 beta , IL - 6 , IL - 8 , and tumor necrosis factor ( TNF ) - alpha by blocking gene transcription .',\n",
       "  [['interleukin', '(IL)', '-', '10'], [9, 10, 11, 12], 'PROTEIN']],\n",
       " ['Our previous studies in human monocytes have demonstrated that interleukin ( IL ) - 10 inhibits lipopolysaccharide ( LPS ) - stimulated production of inflammatory cytokines , IL - 1 beta , IL - 6 , IL - 8 , and <e1> tumor necrosis factor ( TNF ) </e1> - alpha by blocking gene transcription .',\n",
       "  'PROTEIN',\n",
       "  'Our previous studies in human monocytes have demonstrated that interleukin ( IL ) - 10 inhibits lipopolysaccharide ( LPS ) - stimulated production of inflammatory cytokines , IL - 1 beta , IL - 6 , IL - 8 , and tumor necrosis factor ( TNF ) - alpha by blocking gene transcription .',\n",
       "  [['tumor', 'necrosis', 'factor', '(TNF)', '-', 'alpha'],\n",
       "   [41, 42, 43, 44, 45, 46],\n",
       "   'PROTEIN']],\n",
       " ['A DNA response element ( TR2RE - SV40 ) for the TR2 orphan receptor , a member of the steroid - thyroid hormone receptor superfamily , has been identified in the <e1> simian virus 40 ( SV40 ) </e1> +55 region ( nucleotide numbers 368 - 389 , 5 - GTTAAGGTTCGTAGGTCATGGA - 3 ) .',\n",
       "  'DNA',\n",
       "  'A DNA response element ( TR2RE - SV40 ) for the TR2 orphan receptor , a member of the steroid - thyroid hormone receptor superfamily , has been identified in the simian virus 40 ( SV40 ) +55 region ( nucleotide numbers 368 - 389 , 5 - GTTAAGGTTCGTAGGTCATGGA - 3 ) .',\n",
       "  [['simian', 'virus', '40', '(SV40)', '+55', 'region'],\n",
       "   [31, 32, 33, 34, 35, 36],\n",
       "   'DNA']],\n",
       " ['This study demonstrates that <e1> human immunodeficiency virus type 1 ( HIV - 1 ) </e1> Tat protein amplifies the activity of tumor necrosis factor ( TNF ) , a cytokine that stimulates HIV - 1 replication through activation of NF - kappa B .',\n",
       "  'PROTEIN',\n",
       "  'This study demonstrates that human immunodeficiency virus type 1 ( HIV - 1 ) Tat protein amplifies the activity of tumor necrosis factor ( TNF ) , a cytokine that stimulates HIV - 1 replication through activation of NF - kappa B .',\n",
       "  [['human',\n",
       "    'immunodeficiency',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HIV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'Tat',\n",
       "    'protein'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['Expression of the <e1> Epstein - Barr virus ( EBV ) latent membrane protein 1 ( LMP </e1> - 1 ) oncogene is regulated by the EBV nuclear protein 2 ( EBNA - 2 ) transactivator .',\n",
       "  'DNA',\n",
       "  'Expression of the Epstein - Barr virus ( EBV ) latent membrane protein 1 ( LMP - 1 ) oncogene is regulated by the EBV nuclear protein 2 ( EBNA - 2 ) transactivator .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    'latent',\n",
       "    'membrane',\n",
       "    'protein',\n",
       "    '1',\n",
       "    '(LMP',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'oncogene'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['Expression of the Epstein - Barr virus ( EBV ) latent membrane protein 1 ( LMP - 1 ) oncogene is regulated by the <e1> EBV nuclear protein 2 ( EBNA - 2 </e1> ) transactivator .',\n",
       "  'PROTEIN',\n",
       "  'Expression of the Epstein - Barr virus ( EBV ) latent membrane protein 1 ( LMP - 1 ) oncogene is regulated by the EBV nuclear protein 2 ( EBNA - 2 ) transactivator .',\n",
       "  [['EBV', 'nuclear', 'protein', '2', '(EBNA', '-', '2)', 'transactivator'],\n",
       "   [24, 25, 26, 27, 28, 29, 30, 31],\n",
       "   'PROTEIN']],\n",
       " ['A gst - EBNA - 2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA - 2 <e1> - </e1> PU.1 interaction .',\n",
       "  'PROTEIN',\n",
       "  'A gst - EBNA - 2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA - 2 - PU.1 interaction .',\n",
       "  [['PU.1'], [30], 'PROTEIN']],\n",
       " ['The <e1> tumor necrosis factor - alpha ( TNF alpha </e1> ) gene is an immediate early gene in activated T cells , in that it is rapidly induced without a requirement for protein synthesis .',\n",
       "  'DNA',\n",
       "  'The tumor necrosis factor - alpha ( TNF alpha ) gene is an immediate early gene in activated T cells , in that it is rapidly induced without a requirement for protein synthesis .',\n",
       "  [['tumor', 'necrosis', 'factor', '-', 'alpha', '(TNF', 'alpha)', 'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'DNA']],\n",
       " ['The <e1> Epstein - Barr virus ( EBV ) nuclear </e1> antigen 2 ( EBNA - 2 ) protein is essential for the immortalization of human primary B cells by EBV .',\n",
       "  'PROTEIN',\n",
       "  'The Epstein - Barr virus ( EBV ) nuclear antigen 2 ( EBNA - 2 ) protein is essential for the immortalization of human primary B cells by EBV .',\n",
       "  [['Epstein', '-', 'Barr', 'virus', '(EBV)', 'nuclear', 'antigen', '2'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> human interleukin - 3 ( IL - 3 </e1> ) gene is expressed almost exclusively in activated T cells .',\n",
       "  'DNA',\n",
       "  'The human interleukin - 3 ( IL - 3 ) gene is expressed almost exclusively in activated T cells .',\n",
       "  [['human', 'interleukin', '-', '3', '(IL', '-', '3)', 'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'DNA']],\n",
       " ['Furthermore , transcripts of PEBP2 alpha A and <e1> mouse AML1/ PEBP2 alpha </e1> B were detected in T lymphocytes in the thymuses from day 16 embryos and newborns , as well as 4 - week - old adult mice , by in situ hybridization .',\n",
       "  'PROTEIN',\n",
       "  'Furthermore , transcripts of PEBP2 alpha A and mouse AML1/ PEBP2 alpha B were detected in T lymphocytes in the thymuses from day 16 embryos and newborns , as well as 4 - week - old adult mice , by in situ hybridization .',\n",
       "  [['mouse', 'AML1/PEBP2', 'alpha', 'B'], [8, 9, 10, 11], 'PROTEIN']],\n",
       " ['Transcripts of <e1> mouse AML1/ PEBP2 alpha </e1> B were also detected in day 12 fetal hematopoietic liver and in the bone marrow cells of newborn mice .',\n",
       "  'PROTEIN',\n",
       "  'Transcripts of mouse AML1/ PEBP2 alpha B were also detected in day 12 fetal hematopoietic liver and in the bone marrow cells of newborn mice .',\n",
       "  [['mouse', 'AML1/PEBP2', 'alpha', 'B'], [2, 3, 4, 5], 'PROTEIN']],\n",
       " ['The implication of mouse <e1> AML1/ PEBP2 alpha </e1> B expression in hematopoietic cells other than those of T - cell lineage is discussed in relation to myeloid leukemogenesis .',\n",
       "  'PROTEIN',\n",
       "  'The implication of mouse AML1/ PEBP2 alpha B expression in hematopoietic cells other than those of T - cell lineage is discussed in relation to myeloid leukemogenesis .',\n",
       "  [['AML1/PEBP2', 'alpha', 'B'], [4, 5, 6], 'PROTEIN']],\n",
       " ['HS III was weak in HEL and Jurkat , and greatly enhanced in DU528 , a T - cell line that bears <e1> a t (1;14) and </e1> initiates tal - 1 transcription within exon 4 .',\n",
       "  'DNA',\n",
       "  'HS III was weak in HEL and Jurkat , and greatly enhanced in DU528 , a T - cell line that bears a t (1;14) and initiates tal - 1 transcription within exon 4 .',\n",
       "  [['a', 't', '(1;14)'], [22, 23, 24], 'DNA']],\n",
       " ['It is now demonstrated that HIV - 1 proviral latency in the monocytic cell line U1 , in which only extremely low levels of HIV - 1 expression are detected in the baseline unstimulated state , is associated with alterations in nuclear <e1> factor - kappa B ( NF - kappa B </e1> ) moieties demonstrated in these cells by electrophoretic mobility shift assays ( EMSAs ) and in situ UV cross - linking studies .',\n",
       "  'PROTEIN',\n",
       "  'It is now demonstrated that HIV - 1 proviral latency in the monocytic cell line U1 , in which only extremely low levels of HIV - 1 expression are detected in the baseline unstimulated state , is associated with alterations in nuclear factor - kappa B ( NF - kappa B ) moieties demonstrated in these cells by electrophoretic mobility shift assays ( EMSAs ) and in situ UV cross - linking studies .',\n",
       "  [['factor', '-', 'kappa', 'B', '(NF', '-', 'kappa', 'B)', 'moiety'],\n",
       "   [42, 43, 44, 45, 46, 47, 48, 49, 50],\n",
       "   'PROTEIN']],\n",
       " ['Viral transcription , as measured using LTR <e1> - </e1> CAT assays , was only slightly enhanced in the HIV - protease expressing cells , while secretion of IL - 2 and expression of the IL - 2 receptor were not affected .',\n",
       "  'PROTEIN',\n",
       "  'Viral transcription , as measured using LTR - CAT assays , was only slightly enhanced in the HIV - protease expressing cells , while secretion of IL - 2 and expression of the IL - 2 receptor were not affected .',\n",
       "  [['CAT'], [7], 'PROTEIN']],\n",
       " ['Inhibition of human immunodeficiency virus type 1 replication by a <e1> Tat - activated , transduced interferon </e1> gene : targeted expression to human immunodeficiency virus type 1 - infected cells .',\n",
       "  'DNA',\n",
       "  'Inhibition of human immunodeficiency virus type 1 replication by a Tat - activated , transduced interferon gene : targeted expression to human immunodeficiency virus type 1 - infected cells .',\n",
       "  [['Tat', '-', 'activated,', 'transduced', 'interferon', 'gene'],\n",
       "   [10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['To limit expression of a transduced <e1> HIV - 1 long terminal repeat ( LTR ) </e1> - IFNA2 ( the new approved nomenclature for IFN genes is used throughout this article ) hybrid gene to the HIV - 1 - infected cells , HIV - 1 LTR was modified .',\n",
       "  'DNA',\n",
       "  'To limit expression of a transduced HIV - 1 long terminal repeat ( LTR ) - IFNA2 ( the new approved nomenclature for IFN genes is used throughout this article ) hybrid gene to the HIV - 1 - infected cells , HIV - 1 LTR was modified .',\n",
       "  [['HIV', '-', '1', 'long', 'terminal', 'repeat', '(LTR)', '-', 'IFNA2'],\n",
       "   [6, 7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['DESIGN AND METHODS : The effect of all - trans and 9 - cis RA on HIV - 1 production in T - lymphoid ( <e1> H9 , </e1> CEM ) and monocytoid ( U937 , THP - 1 ) cell lines was measured during acute and chronic infection .',\n",
       "  'CELL_LINE',\n",
       "  'DESIGN AND METHODS : The effect of all - trans and 9 - cis RA on HIV - 1 production in T - lymphoid ( H9 , CEM ) and monocytoid ( U937 , THP - 1 ) cell lines was measured during acute and chronic infection .',\n",
       "  [['H9,', 'CEM'], [25, 26], 'CELL_LINE']],\n",
       " ['DESIGN AND METHODS : The effect of all - trans and 9 - cis RA on HIV - 1 production in T - lymphoid ( H9 , CEM ) and <e1> monocytoid ( U937 , THP - </e1> 1 ) cell lines was measured during acute and chronic infection .',\n",
       "  'CELL_LINE',\n",
       "  'DESIGN AND METHODS : The effect of all - trans and 9 - cis RA on HIV - 1 production in T - lymphoid ( H9 , CEM ) and monocytoid ( U937 , THP - 1 ) cell lines was measured during acute and chronic infection .',\n",
       "  [['monocytoid', '(U937,THP', '-', '1)', 'cell', 'lines'],\n",
       "   [30, 31, 32, 33, 34, 35],\n",
       "   'CELL_LINE']],\n",
       " ['The expression levels of human RAR alpha ( <e1> hRAR alpha , </e1> receptor for all - trans RA ) and the human retinoid - X receptor alpha ( hRXR alpha receptor for 9 - cis RA ) were determined by Northern blot analysis .',\n",
       "  'PROTEIN',\n",
       "  'The expression levels of human RAR alpha ( hRAR alpha , receptor for all - trans RA ) and the human retinoid - X receptor alpha ( hRXR alpha receptor for 9 - cis RA ) were determined by Northern blot analysis .',\n",
       "  [['hRAR', 'alpha,', 'receptor'], [8, 9, 10], 'PROTEIN']],\n",
       " ['On the basis of Western blotting experiments using antibodies to kappa B/Rel family proteins , the kappa B - binding activity constitutively expressed in T cells from RCC patients is composed mostly of the <e1> NF - kappa B1 ( p50 </e1> ) subunit .',\n",
       "  'PROTEIN',\n",
       "  'On the basis of Western blotting experiments using antibodies to kappa B/Rel family proteins , the kappa B - binding activity constitutively expressed in T cells from RCC patients is composed mostly of the NF - kappa B1 ( p50 ) subunit .',\n",
       "  [['NF', '-', 'kappa', 'B1', '(p50)', 'subunit'],\n",
       "   [34, 35, 36, 37, 38, 39],\n",
       "   'PROTEIN']],\n",
       " ['Transcription - independent turnover of I kappa B alpha during monocyte adherence : implications for a translational component regulating <e1> I kappa B alpha /MAD - 3 </e1> mRNA levels .',\n",
       "  'RNA',\n",
       "  'Transcription - independent turnover of I kappa B alpha during monocyte adherence : implications for a translational component regulating I kappa B alpha /MAD - 3 mRNA levels .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [19, 20, 21, 22, 23, 24, 25],\n",
       "   'RNA']],\n",
       " ['We identified <e1> I kappa B alpha /MAD - </e1> 3 as an immediate - early gene in human monocytes that is expressed in response to a variety of signals , including adhesion , lipopolysaccharide , and phorbol myristate acetate .',\n",
       "  'PROTEIN',\n",
       "  'We identified I kappa B alpha /MAD - 3 as an immediate - early gene in human monocytes that is expressed in response to a variety of signals , including adhesion , lipopolysaccharide , and phorbol myristate acetate .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3'], [2, 3, 4, 5, 6, 7], 'PROTEIN']],\n",
       " ['The demonstration that NF - kappa B can regulate <e1> I kappa B alpha /MAD - 3 </e1> gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha /MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha /MAD - 3 gene .',\n",
       "  'DNA',\n",
       "  'The demonstration that NF - kappa B can regulate I kappa B alpha /MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha /MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha /MAD - 3 gene .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'gene'],\n",
       "   [9, 10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['The demonstration that NF - kappa B can regulate I kappa B alpha /MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state <e1> I kappa B alpha /MAD - 3 </e1> mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha /MAD - 3 gene .',\n",
       "  'RNA',\n",
       "  'The demonstration that NF - kappa B can regulate I kappa B alpha /MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha /MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha /MAD - 3 gene .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [31, 32, 33, 34, 35, 36, 37],\n",
       "   'RNA']],\n",
       " ['The demonstration that NF - kappa B can regulate I kappa B alpha /MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha /MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the <e1> I kappa B alpha /MAD - 3 </e1> gene .',\n",
       "  'DNA',\n",
       "  'The demonstration that NF - kappa B can regulate I kappa B alpha /MAD - 3 gene transcription in other cell types suggested that the rapid increase in steady - state I kappa B alpha /MAD - 3 mRNA levels we observed within 30 min of monocyte adherence would result from NF - kappa B - dependent transcriptional stimulation of the I kappa B alpha /MAD - 3 gene .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'gene'],\n",
       "   [61, 62, 63, 64, 65, 66, 67],\n",
       "   'DNA']],\n",
       " ['Nuclear run - on analyses indicated that , instead , while several immediate - early cytokine genes , such as the <e1> interleukin 1 beta ( IL - 1 beta </e1> ) gene , were transcriptionally activated during monocyte adhesion , the rate of I kappa B alpha /MAD - 3 gene transcription remained constant .',\n",
       "  'DNA',\n",
       "  'Nuclear run - on analyses indicated that , instead , while several immediate - early cytokine genes , such as the interleukin 1 beta ( IL - 1 beta ) gene , were transcriptionally activated during monocyte adhesion , the rate of I kappa B alpha /MAD - 3 gene transcription remained constant .',\n",
       "  [['interleukin', '1', 'beta', '(IL', '-', '1', 'beta)', 'gene'],\n",
       "   [21, 22, 23, 24, 25, 26, 27, 28],\n",
       "   'DNA']],\n",
       " ['Nuclear run - on analyses indicated that , instead , while several immediate - early cytokine genes , such as the interleukin 1 beta ( IL - 1 beta ) gene , were transcriptionally activated during monocyte adhesion , the rate of <e1> I kappa B alpha /MAD - 3 </e1> gene transcription remained constant .',\n",
       "  'DNA',\n",
       "  'Nuclear run - on analyses indicated that , instead , while several immediate - early cytokine genes , such as the interleukin 1 beta ( IL - 1 beta ) gene , were transcriptionally activated during monocyte adhesion , the rate of I kappa B alpha /MAD - 3 gene transcription remained constant .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'gene'],\n",
       "   [42, 43, 44, 45, 46, 47, 48],\n",
       "   'DNA']],\n",
       " ['The adherence - dependent increase in <e1> I kappa B alpha /MAD - 3 </e1> mRNA levels was also not a consequence of mRNA stabilization events .',\n",
       "  'RNA',\n",
       "  'The adherence - dependent increase in I kappa B alpha /MAD - 3 mRNA levels was also not a consequence of mRNA stabilization events .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [6, 7, 8, 9, 10, 11, 12],\n",
       "   'RNA']],\n",
       " ['Interestingly , while increases in both IL - 1 beta and I kappa B alpha/MAD - 3 mRNA levels were detected in nuclei of adherent monocytes , cytoplasmic levels of IL - 1 beta mRNA increased during adherence whereas those of <e1> I kappa B alpha /MAD - 3 </e1> mRNA did not .',\n",
       "  'RNA',\n",
       "  'Interestingly , while increases in both IL - 1 beta and I kappa B alpha/MAD - 3 mRNA levels were detected in nuclei of adherent monocytes , cytoplasmic levels of IL - 1 beta mRNA increased during adherence whereas those of I kappa B alpha /MAD - 3 mRNA did not .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [41, 42, 43, 44, 45, 46, 47],\n",
       "   'RNA']],\n",
       " ['Taken together , our data suggest that two interactive mechanisms regulate <e1> monocytic I kappa B alpha /MAD - 3 </e1> mRNA levels .',\n",
       "  'RNA',\n",
       "  'Taken together , our data suggest that two interactive mechanisms regulate monocytic I kappa B alpha /MAD - 3 mRNA levels .',\n",
       "  [['monocytic', 'I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'RNA']],\n",
       " ['We propose that adherent monocytes regulate nuclear processing ( or decay ) of <e1> I kappa B alpha /MAD - 3 </e1> mRNA , thereby increasing mRNA levels without stimulating I kappa B alpha /MAD - 3 gene transcription .',\n",
       "  'RNA',\n",
       "  'We propose that adherent monocytes regulate nuclear processing ( or decay ) of I kappa B alpha /MAD - 3 mRNA , thereby increasing mRNA levels without stimulating I kappa B alpha /MAD - 3 gene transcription .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [13, 14, 15, 16, 17, 18, 19],\n",
       "   'RNA']],\n",
       " ['We propose that adherent monocytes regulate nuclear processing ( or decay ) of I kappa B alpha /MAD - 3 mRNA , thereby increasing mRNA levels without stimulating <e1> I kappa B alpha /MAD - 3 </e1> gene transcription .',\n",
       "  'DNA',\n",
       "  'We propose that adherent monocytes regulate nuclear processing ( or decay ) of I kappa B alpha /MAD - 3 mRNA , thereby increasing mRNA levels without stimulating I kappa B alpha /MAD - 3 gene transcription .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'gene'],\n",
       "   [28, 29, 30, 31, 32, 33, 34],\n",
       "   'DNA']],\n",
       " ['Moreover , since inhibition of protein synthesis leads to accumulation of <e1> I kappa B alpha /MAD - 3 </e1> mRNA without stimulating I kappa B alpha /MAD - 3 gene transcription , we suggest that low cytoplasmic levels of I kappa B alpha /MAD - 3 mRNA are maintained by a translation - dependent degradation mechanism .',\n",
       "  'RNA',\n",
       "  'Moreover , since inhibition of protein synthesis leads to accumulation of I kappa B alpha /MAD - 3 mRNA without stimulating I kappa B alpha /MAD - 3 gene transcription , we suggest that low cytoplasmic levels of I kappa B alpha /MAD - 3 mRNA are maintained by a translation - dependent degradation mechanism .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [11, 12, 13, 14, 15, 16, 17],\n",
       "   'RNA']],\n",
       " ['Moreover , since inhibition of protein synthesis leads to accumulation of I kappa B alpha /MAD - 3 mRNA without stimulating <e1> I kappa B alpha /MAD - 3 </e1> gene transcription , we suggest that low cytoplasmic levels of I kappa B alpha /MAD - 3 mRNA are maintained by a translation - dependent degradation mechanism .',\n",
       "  'DNA',\n",
       "  'Moreover , since inhibition of protein synthesis leads to accumulation of I kappa B alpha /MAD - 3 mRNA without stimulating I kappa B alpha /MAD - 3 gene transcription , we suggest that low cytoplasmic levels of I kappa B alpha /MAD - 3 mRNA are maintained by a translation - dependent degradation mechanism .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'gene'],\n",
       "   [21, 22, 23, 24, 25, 26, 27],\n",
       "   'DNA']],\n",
       " ['Moreover , since inhibition of protein synthesis leads to accumulation of I kappa B alpha /MAD - 3 mRNA without stimulating I kappa B alpha /MAD - 3 gene transcription , we suggest that low cytoplasmic levels of <e1> I kappa B alpha /MAD - 3 </e1> mRNA are maintained by a translation - dependent degradation mechanism .',\n",
       "  'RNA',\n",
       "  'Moreover , since inhibition of protein synthesis leads to accumulation of I kappa B alpha /MAD - 3 mRNA without stimulating I kappa B alpha /MAD - 3 gene transcription , we suggest that low cytoplasmic levels of I kappa B alpha /MAD - 3 mRNA are maintained by a translation - dependent degradation mechanism .',\n",
       "  [['I', 'kappa', 'B', 'alpha/MAD', '-', '3', 'mRNA'],\n",
       "   [38, 39, 40, 41, 42, 43, 44],\n",
       "   'RNA']],\n",
       " ['It contains a <e1> basic helix - loop - helix ( bHLH </e1> ) motif contiguous with a Per - Arnt - Sim ( PAS ) homology region .',\n",
       "  'PROTEIN',\n",
       "  'It contains a basic helix - loop - helix ( bHLH ) motif contiguous with a Per - Arnt - Sim ( PAS ) homology region .',\n",
       "  [['basic', 'helix', '-', 'loop', '-', 'helix', '(bHLH)', 'motif'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ['It contains a basic helix - loop - helix ( bHLH ) motif contiguous with a <e1> Per - Arnt - Sim ( PAS ) </e1> homology region .',\n",
       "  'PROTEIN',\n",
       "  'It contains a basic helix - loop - helix ( bHLH ) motif contiguous with a Per - Arnt - Sim ( PAS ) homology region .',\n",
       "  [['Per', '-', 'Arnt', '-', 'Sim', '(PAS)', 'homology', 'region'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'PROTEIN']],\n",
       " ['The aim of this present study was to investigate the role of protein kinase C ( PKC ) , downstream of p21ras , in activating <e1> interleukin - 2 ( IL - 2 </e1> ) gene expression .',\n",
       "  'DNA',\n",
       "  'The aim of this present study was to investigate the role of protein kinase C ( PKC ) , downstream of p21ras , in activating interleukin - 2 ( IL - 2 ) gene expression .',\n",
       "  [['interleukin', '-', '2', '(IL', '-', '2)', 'gene'],\n",
       "   [25, 26, 27, 28, 29, 30, 31],\n",
       "   'DNA']],\n",
       " ['Here , we report that stimulation through the IL - 2R induced tyrosine phosphorylation and subsequent nuclear translocation of stat3 , a newly identified member of the <e1> signal transducers and activators of transcription ( STAT </e1> ) family of proteins .',\n",
       "  'PROTEIN',\n",
       "  'Here , we report that stimulation through the IL - 2R induced tyrosine phosphorylation and subsequent nuclear translocation of stat3 , a newly identified member of the signal transducers and activators of transcription ( STAT ) family of proteins .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'family'],\n",
       "   [27, 28, 29, 30, 31, 32, 33, 34],\n",
       "   'PROTEIN']],\n",
       " ['Human T - cell leukemia virus type I Tax activation of <e1> NF - kappa B </e1> /Rel involves phosphorylation and degradation of I kappa B alpha and RelA ( p65 ) - mediated induction of the c - rel gene .',\n",
       "  'PROTEIN',\n",
       "  'Human T - cell leukemia virus type I Tax activation of NF - kappa B /Rel involves phosphorylation and degradation of I kappa B alpha and RelA ( p65 ) - mediated induction of the c - rel gene .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel'], [11, 12, 13, 14], 'PROTEIN']],\n",
       " ['Tax acts indirectly by inducing or modifying the action of various host transcription factors , including members of the <e1> NF - kappa B /Rel </e1> family of enhancer - binding proteins .',\n",
       "  'PROTEIN',\n",
       "  'Tax acts indirectly by inducing or modifying the action of various host transcription factors , including members of the NF - kappa B /Rel family of enhancer - binding proteins .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'family'], [19, 20, 21, 22, 23], 'PROTEIN']],\n",
       " ['In resting T cells , many of these <e1> NF - kappa B /Rel </e1> factors are sequestered in the cytoplasm by various ankyrin - rich inhibitory proteins , including I kappa B alpha .',\n",
       "  'PROTEIN',\n",
       "  'In resting T cells , many of these NF - kappa B /Rel factors are sequestered in the cytoplasm by various ankyrin - rich inhibitory proteins , including I kappa B alpha .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'factor'], [8, 9, 10, 11, 12], 'PROTEIN']],\n",
       " ['Therefore we investigated the modifications imposed on <e1> NF - kappa B /I kappa B </e1> components following stimulation and show that the final step of NF - kappa B induction in vivo involves phosphorylation of several members of the NF - kappa B /I kappa B protein families .',\n",
       "  'PROTEIN',\n",
       "  'Therefore we investigated the modifications imposed on NF - kappa B /I kappa B components following stimulation and show that the final step of NF - kappa B induction in vivo involves phosphorylation of several members of the NF - kappa B /I kappa B protein families .',\n",
       "  [['NF', '-', 'kappa', 'B/I', 'kappa', 'B', 'component'],\n",
       "   [7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['Therefore we investigated the modifications imposed on NF - kappa B /I kappa B components following stimulation and show that the final step of NF - kappa B induction in vivo involves phosphorylation of several members of the <e1> NF - kappa B /I kappa B protein </e1> families .',\n",
       "  'PROTEIN',\n",
       "  'Therefore we investigated the modifications imposed on NF - kappa B /I kappa B components following stimulation and show that the final step of NF - kappa B induction in vivo involves phosphorylation of several members of the NF - kappa B /I kappa B protein families .',\n",
       "  [['NF', '-', 'kappa', 'B/I', 'kappa', 'B', 'protein', 'family'],\n",
       "   [38, 39, 40, 41, 42, 43, 44, 45],\n",
       "   'PROTEIN']],\n",
       " ['We have shown that , within the thymus , a population of <e1> large , immature </e1> cells expresses CD21 .',\n",
       "  'CELL_TYPE',\n",
       "  'We have shown that , within the thymus , a population of large , immature cells expresses CD21 .',\n",
       "  [['large,', 'immature', 'cell'], [12, 13, 14], 'CELL_TYPE']],\n",
       " ['The regulation of <e1> nuclear factor ( NF ) - </e1> kappa B activation by the T cell receptor ( TcR ) /CD3 complex in primary human T cells has been studied at various times after activation .',\n",
       "  'PROTEIN',\n",
       "  'The regulation of nuclear factor ( NF ) - kappa B activation by the T cell receptor ( TcR ) /CD3 complex in primary human T cells has been studied at various times after activation .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['The regulation of nuclear factor ( NF ) - kappa B activation by the <e1> T cell receptor ( TcR </e1> ) /CD3 complex in primary human T cells has been studied at various times after activation .',\n",
       "  'PROTEIN',\n",
       "  'The regulation of nuclear factor ( NF ) - kappa B activation by the T cell receptor ( TcR ) /CD3 complex in primary human T cells has been studied at various times after activation .',\n",
       "  [['T', 'cell', 'receptor', '(TcR)/CD3', 'complex'],\n",
       "   [14, 15, 16, 17, 18],\n",
       "   'PROTEIN']],\n",
       " ['Only p50 NF - kappa B protein bound the kappa B element of <e1> interleukin - 2 receptor ( IL - 2R ) alpha </e1> chain promoter on resting T cells .',\n",
       "  'DNA',\n",
       "  'Only p50 NF - kappa B protein bound the kappa B element of interleukin - 2 receptor ( IL - 2R ) alpha chain promoter on resting T cells .',\n",
       "  [['interleukin',\n",
       "    '-',\n",
       "    '2',\n",
       "    'receptor',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2R)',\n",
       "    'alpha',\n",
       "    'chain',\n",
       "    'promoter'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'DNA']],\n",
       " ['Interestingly , all those early and late events , but not the immediate ones , were inhibited by a neutralizing <e1> anti - tumor necrosis factor alpha ( TNF - alpha ) </e1> monoclonal antibody .',\n",
       "  'PROTEIN',\n",
       "  'Interestingly , all those early and late events , but not the immediate ones , were inhibited by a neutralizing anti - tumor necrosis factor alpha ( TNF - alpha ) monoclonal antibody .',\n",
       "  [['anti',\n",
       "    '-',\n",
       "    'tumor',\n",
       "    'necrosis',\n",
       "    'factor',\n",
       "    'alpha',\n",
       "    '(TNF',\n",
       "    '-',\n",
       "    'alpha)',\n",
       "    'monoclonal',\n",
       "    'antibody'],\n",
       "   [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30],\n",
       "   'PROTEIN']],\n",
       " ['The cis - acting region , GM - kappa B/GC - box ( <e1> positions - 95 </e1> and - 73 ) , within the murine GM - CSF gene promoter is required for maximal induction by stimulation with phorbol - 12 - myristate acetate ( PMA ) and calcium ionophore ( A23187 ) in T cells .',\n",
       "  'DNA',\n",
       "  'The cis - acting region , GM - kappa B/GC - box ( positions - 95 and - 73 ) , within the murine GM - CSF gene promoter is required for maximal induction by stimulation with phorbol - 12 - myristate acetate ( PMA ) and calcium ionophore ( A23187 ) in T cells .',\n",
       "  [['position', '-', '95'], [13, 14, 15], 'DNA']],\n",
       " ['We report here that three copies of the GC - box can functionally compensate for the <e1> GM - kappa B/ GC - box </e1> region , suggesting that the GC - motif can function independently of the GM - kappa B motif .',\n",
       "  'DNA',\n",
       "  'We report here that three copies of the GC - box can functionally compensate for the GM - kappa B/ GC - box region , suggesting that the GC - motif can function independently of the GM - kappa B motif .',\n",
       "  [['GM', '-', 'kappa', 'B/GC', '-', 'box', 'region'],\n",
       "   [16, 17, 18, 19, 20, 21, 22],\n",
       "   'DNA']],\n",
       " ['We report here that three copies of the GC - box can functionally compensate for the <e1> GM - kappa B/ GC - </e1> box region , suggesting that the GC - motif can function independently of the GM - kappa B motif .',\n",
       "  'DNA',\n",
       "  'We report here that three copies of the GC - box can functionally compensate for the GM - kappa B/ GC - box region , suggesting that the GC - motif can function independently of the GM - kappa B motif .',\n",
       "  [['GM', '-', 'kappa', 'B/GC', '-', 'box'], [16, 17, 18, 19, 20, 21], 'DNA']],\n",
       " ['The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human , mouse , and Drosophila sequences , defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( <e1> tramtrack [ ttk ] - </e1> associated box ) here .',\n",
       "  'PROTEIN',\n",
       "  'The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human , mouse , and Drosophila sequences , defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk ] - associated box ) here .',\n",
       "  [['tramtrack', '[ttk]', '-', 'associated', 'box'],\n",
       "   [44, 45, 46, 47, 48],\n",
       "   'PROTEIN']],\n",
       " ['Alagille syndrome ( AGS ) is a well - defined genetic entity assigned to the short arm of <e1> Chromosome ( Chr </e1> ) 20 by a series of observations of AGS patients associated with microdeletions in this region .',\n",
       "  'DNA',\n",
       "  'Alagille syndrome ( AGS ) is a well - defined genetic entity assigned to the short arm of Chromosome ( Chr ) 20 by a series of observations of AGS patients associated with microdeletions in this region .',\n",
       "  [['Chromosome', '(Chr)', '20'], [18, 19, 20], 'DNA']],\n",
       " ['The differentiating agent retinoic acid ( RA ) has been previously reported to interfere with 12 - O - tetradecanoyl - phorbol - 13 - acetate ( TPA ) / Ca(2+) - induced signals for the regulation of the - 96 to - 66 - bp octamer motif found in the enhancer for the <e1> interleukin ( IL ) - </e1> 2 gene , which encodes a major T lymphocyte growth factor .',\n",
       "  'DNA',\n",
       "  'The differentiating agent retinoic acid ( RA ) has been previously reported to interfere with 12 - O - tetradecanoyl - phorbol - 13 - acetate ( TPA ) / Ca(2+) - induced signals for the regulation of the - 96 to - 66 - bp octamer motif found in the enhancer for the interleukin ( IL ) - 2 gene , which encodes a major T lymphocyte growth factor .',\n",
       "  [['interleukin', '(IL)', '-', '2', 'gene'], [54, 55, 56, 57, 58], 'DNA']],\n",
       " ['The IL - 2 octamer motif is a composite cis - element which binds Oct - 1 and Oct - 2 as well as a <e1> TPA / Ca(2+) - inducible </e1> nuclear factor , previously termed octamer - associated protein ( OAP40 ) .',\n",
       "  'PROTEIN',\n",
       "  'The IL - 2 octamer motif is a composite cis - element which binds Oct - 1 and Oct - 2 as well as a TPA / Ca(2+) - inducible nuclear factor , previously termed octamer - associated protein ( OAP40 ) .',\n",
       "  [['TPA/Ca(2+)', '-', 'inducible', 'nuclear', 'facto'],\n",
       "   [25, 26, 27, 28, 29],\n",
       "   'PROTEIN']],\n",
       " ['Mutations of the genuine octamer - binding site abrogate both the binding of Oct - 1 and Oct - 2 and the TPA / Ca(2+) - induced transactivation of the <e1> OAP /octamer </e1> motif .',\n",
       "  'DNA',\n",
       "  'Mutations of the genuine octamer - binding site abrogate both the binding of Oct - 1 and Oct - 2 and the TPA / Ca(2+) - induced transactivation of the OAP /octamer motif .',\n",
       "  [['OAP/octamer', 'motif'], [30, 31], 'DNA']],\n",
       " ['OAP confers to Oct - 2 responsivity to both TPA /Ca2+ and RA , since specific mutations of the <e1> AP - 1 / OAP - </e1> binding site significantly reduce the transactivation by Oct - 2 in response to TPA and Ca2+ and abolish the inhibition by RA .',\n",
       "  'DNA',\n",
       "  'OAP confers to Oct - 2 responsivity to both TPA /Ca2+ and RA , since specific mutations of the AP - 1 / OAP - binding site significantly reduce the transactivation by Oct - 2 in response to TPA and Ca2+ and abolish the inhibition by RA .',\n",
       "  [['AP', '-', '1/OAP', '-', 'binding', 'site'],\n",
       "   [19, 20, 21, 22, 23, 24],\n",
       "   'DNA']],\n",
       " ['The recent discovery of mutations in the <e1> common gamma chain ( gamma c </e1> ) gene , a constituent of several cytokine receptors , in XSCID provided an opportunity to test directly whether a previously unrecognized mutation in this same gene was responsible for XCID .',\n",
       "  'DNA',\n",
       "  'The recent discovery of mutations in the common gamma chain ( gamma c ) gene , a constituent of several cytokine receptors , in XSCID provided an opportunity to test directly whether a previously unrecognized mutation in this same gene was responsible for XCID .',\n",
       "  [['common', 'gamma', 'chain', '(gamma', 'c)', 'gene'],\n",
       "   [7, 8, 9, 10, 11, 12],\n",
       "   'DNA']],\n",
       " ['<e1> Tissue factor </e1> ( TF ) expression by cells of monocyte/macrophage lineage represents an important mechanism underlying the initiation of fibrin deposition at sites of extravascular inflammation .',\n",
       "  'PROTEIN',\n",
       "  'Tissue factor ( TF ) expression by cells of monocyte/macrophage lineage represents an important mechanism underlying the initiation of fibrin deposition at sites of extravascular inflammation .',\n",
       "  [['yissue', 'factor'], [0, 1], 'PROTEIN']],\n",
       " ['Thapsigargin induces IL - 2 receptor alpha - chain in <e1> human peripheral and Jurkat </e1> T cells via a protein kinase C - independent mechanism .',\n",
       "  'CELL_TYPE',\n",
       "  'Thapsigargin induces IL - 2 receptor alpha - chain in human peripheral and Jurkat T cells via a protein kinase C - independent mechanism .',\n",
       "  [['human', 'peripheral', 'T', 'cell'], [10, 11, 12, 13], 'CELL_TYPE']],\n",
       " ['Within this region we have identified a gene coding for a 1.3 - kb transcript , expressed only in restricted subsets of cells within the lymphoid lineage and expressed at high levels in leukemic cells carrying a <e1> t(14;14) (q11;q32) chromosome </e1> translocation or a inv(14)(q11;q32) chromosome inversion .',\n",
       "  'DNA',\n",
       "  'Within this region we have identified a gene coding for a 1.3 - kb transcript , expressed only in restricted subsets of cells within the lymphoid lineage and expressed at high levels in leukemic cells carrying a t(14;14) (q11;q32) chromosome translocation or a inv(14)(q11;q32) chromosome inversion .',\n",
       "  [['t(14;14)(q11;q32)', 'chromosome', 'translocation'], [37, 38, 39], 'DNA']],\n",
       " ['Identification of a region which directs the monocytic activity of the <e1> colony - stimulating factor 1 ( macrophage colony - stimulating factor ) </e1> receptor promoter and binds PEBP2/CBF ( AML1 ) .',\n",
       "  'DNA',\n",
       "  'Identification of a region which directs the monocytic activity of the colony - stimulating factor 1 ( macrophage colony - stimulating factor ) receptor promoter and binds PEBP2/CBF ( AML1 ) .',\n",
       "  [['colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '1',\n",
       "    '(macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor)',\n",
       "    'receptor',\n",
       "    'promoter'],\n",
       "   [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'DNA']],\n",
       " ['Competition and supershift experiments indicate that Mono B contains a member of the <e1> polyomavirus enhancer - binding protein 2/core - binding factor ( PEBP2/CBF </e1> ) family , which includes the AML1 gene product , while Mono A is a distinct complex preferentially expressed in monocytic cells .',\n",
       "  'PROTEIN',\n",
       "  'Competition and supershift experiments indicate that Mono B contains a member of the polyomavirus enhancer - binding protein 2/core - binding factor ( PEBP2/CBF ) family , which includes the AML1 gene product , while Mono A is a distinct complex preferentially expressed in monocytic cells .',\n",
       "  [['polyomavirus',\n",
       "    'enhancer',\n",
       "    '-',\n",
       "    'binding',\n",
       "    'protein',\n",
       "    '2/core',\n",
       "    '-',\n",
       "    'binding',\n",
       "    'factor',\n",
       "    '(PEBP2/CBF)',\n",
       "    'family'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'PROTEIN']],\n",
       " ['<e1> \" Plus </e1> \" clones replicated the virus efficiently , whereas \" minus \" clones did not .',\n",
       "  'CELL_LINE',\n",
       "  '\" Plus \" clones replicated the virus efficiently , whereas \" minus \" clones did not .',\n",
       "  [['\"Plus\"', 'clone'], [0, 1], 'CELL_LINE']],\n",
       " ['\" Plus \" clones replicated the virus efficiently , whereas <e1> \" minus </e1> \" clones did not .',\n",
       "  'CELL_LINE',\n",
       "  '\" Plus \" clones replicated the virus efficiently , whereas \" minus \" clones did not .',\n",
       "  [['\"minus\"', 'clone'], [10, 11], 'CELL_LINE']],\n",
       " ['We examined these clones for differences in <e1> nuclear factor ( NF ) - </e1> kappa B activity which might account for the observed phenomenon .',\n",
       "  'PROTEIN',\n",
       "  'We examined these clones for differences in nuclear factor ( NF ) - kappa B activity which might account for the observed phenomenon .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['Southern analysis using a <e1> human progesterone receptor ( hPR ) </e1> cDNA probe identified a germline TaqI restriction fragment length polymorphism ( RFLP ) defined by two alleles : T1 , represented by a 2.7 kb fragment ; and T2 , represented by a 1.9 kb fragment and characterised by an additional TaqI restriction site with respect to T1 .',\n",
       "  'DNA',\n",
       "  'Southern analysis using a human progesterone receptor ( hPR ) cDNA probe identified a germline TaqI restriction fragment length polymorphism ( RFLP ) defined by two alleles : T1 , represented by a 2.7 kb fragment ; and T2 , represented by a 1.9 kb fragment and characterised by an additional TaqI restriction site with respect to T1 .',\n",
       "  [['human', 'progesterone', 'receptor', '(hPR)', 'cDNA', 'probe'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['These LTRs differ by five point mutations and a 22 - bp duplication in SIVsmmPBj14 , which includes a <e1> nuclear factor kappa B ( NF kappa B </e1> ) site .',\n",
       "  'DNA',\n",
       "  'These LTRs differ by five point mutations and a 22 - bp duplication in SIVsmmPBj14 , which includes a nuclear factor kappa B ( NF kappa B ) site .',\n",
       "  [['nuclear', 'factor', 'kappa', 'B', '(NF', 'kappa', 'B)', 'site'],\n",
       "   [19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['The constitutive NF - kappa B appears to be functionally active , since a low level of <e1> tumour necrosis factor ( TNF </e1> ) transcript is detectable in monocytes , and this level can be increased by blocking transcript degradation using cycloheximide .',\n",
       "  'RNA',\n",
       "  'The constitutive NF - kappa B appears to be functionally active , since a low level of tumour necrosis factor ( TNF ) transcript is detectable in monocytes , and this level can be increased by blocking transcript degradation using cycloheximide .',\n",
       "  [['tumour', 'necrosis', 'factor', '(TNF)', 'transcript'],\n",
       "   [17, 18, 19, 20, 21],\n",
       "   'RNA']],\n",
       " ['Increased [ Ca2+ ]i activates <e1> Ca2+ /calmodulin - dependent </e1> kinases including the multifunctional Ca2+ /calmodulin - dependent protein kinase II ( CaM - K II ) , as well as calcineurin , a type 2B protein phosphatase .',\n",
       "  'PROTEIN',\n",
       "  'Increased [ Ca2+ ]i activates Ca2+ /calmodulin - dependent kinases including the multifunctional Ca2+ /calmodulin - dependent protein kinase II ( CaM - K II ) , as well as calcineurin , a type 2B protein phosphatase .',\n",
       "  [['Ca2+/calmodulin', '-', 'dependent', 'kinase'], [5, 6, 7, 8], 'PROTEIN']],\n",
       " ['Increased [ Ca2+ ]i activates Ca2+ /calmodulin - dependent kinases including the multifunctional <e1> Ca2+ /calmodulin - dependent protein kinase </e1> II ( CaM - K II ) , as well as calcineurin , a type 2B protein phosphatase .',\n",
       "  'PROTEIN',\n",
       "  'Increased [ Ca2+ ]i activates Ca2+ /calmodulin - dependent kinases including the multifunctional Ca2+ /calmodulin - dependent protein kinase II ( CaM - K II ) , as well as calcineurin , a type 2B protein phosphatase .',\n",
       "  [['Ca2+/calmodulin', '-', 'dependent', 'protein', 'kinase', 'II'],\n",
       "   [13, 14, 15, 16, 17, 18],\n",
       "   'PROTEIN']],\n",
       " ['H582 and HuT102 were also negative for the <e1> LFA - I alpha chain ( CDIIa </e1> ) mRNA .',\n",
       "  'RNA',\n",
       "  'H582 and HuT102 were also negative for the LFA - I alpha chain ( CDIIa ) mRNA .',\n",
       "  [['LFA', '-', 'I', 'alpha', 'chain', '(CDIIa)', 'mRNA'],\n",
       "   [8, 9, 10, 11, 12, 13, 14],\n",
       "   'RNA']],\n",
       " ['EBV nuclear antigen 2 ( EBNA2 ) , one of the first genes expressed after EBV infection of B - cells , is a transcriptional activator of <e1> viral and </e1> cellular genes and is essential for the transforming potential of the virus .',\n",
       "  'DNA',\n",
       "  'EBV nuclear antigen 2 ( EBNA2 ) , one of the first genes expressed after EBV infection of B - cells , is a transcriptional activator of viral and cellular genes and is essential for the transforming potential of the virus .',\n",
       "  [['viral', 'gene'], [27, 28], 'DNA']],\n",
       " ['The protein products of the <e1> Epstein - Barr virus ( EBV ) BMLF1 open </e1> reading frame have been characterized in the early productive cycle in B95 - 8 and Akata cells .',\n",
       "  'DNA',\n",
       "  'The protein products of the Epstein - Barr virus ( EBV ) BMLF1 open reading frame have been characterized in the early productive cycle in B95 - 8 and Akata cells .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    'BMLF1',\n",
       "    'open',\n",
       "    'reading',\n",
       "    'frame'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['SM is a phosphoprotein in EBV <e1> - infected </e1> cells and can be phosphorylated in vitro with casein kinase II ( CKII ) .',\n",
       "  'CELL_TYPE',\n",
       "  'SM is a phosphoprotein in EBV - infected cells and can be phosphorylated in vitro with casein kinase II ( CKII ) .',\n",
       "  [['infected', 'cell'], [6, 7], 'CELL_TYPE']],\n",
       " ['Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein , the <e1> herpes simplex virus ( HSV ) </e1> ICP27 protein and the herpesvirus saimiri ( HVS ) open reading frame 57 protein .',\n",
       "  'PROTEIN',\n",
       "  'Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein , the herpes simplex virus ( HSV ) ICP27 protein and the herpesvirus saimiri ( HVS ) open reading frame 57 protein .',\n",
       "  [['herpes', 'simplex', 'virus', '(HSV)', 'ICP27', 'protein'],\n",
       "   [41, 42, 43, 44, 45, 46],\n",
       "   'PROTEIN']],\n",
       " ['Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein , the herpes simplex virus ( HSV ) ICP27 protein and the <e1> herpesvirus saimiri ( HVS ) open reading frame </e1> 57 protein .',\n",
       "  'PROTEIN',\n",
       "  'Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein , the herpes simplex virus ( HSV ) ICP27 protein and the herpesvirus saimiri ( HVS ) open reading frame 57 protein .',\n",
       "  [['herpesvirus',\n",
       "    'saimiri',\n",
       "    '(HVS)',\n",
       "    'open',\n",
       "    'reading',\n",
       "    'frame',\n",
       "    '57',\n",
       "    'protein'],\n",
       "   [51, 52, 53, 54, 55, 56, 57, 58],\n",
       "   'PROTEIN']],\n",
       " ['This locus encodes a transcriptional trans - activator required for the constitutive expression of <e1> major histocompatibility complex ( MHC ) class </e1> II genes .',\n",
       "  'DNA',\n",
       "  'This locus encodes a transcriptional trans - activator required for the constitutive expression of major histocompatibility complex ( MHC ) class II genes .',\n",
       "  [['major', 'histocompatibility', 'complex', '(MHC)', 'class', 'II', 'genes'],\n",
       "   [14, 15, 16, 17, 18, 19, 20],\n",
       "   'DNA']],\n",
       " ['The <e1> interleukin 2 receptor alpha - chain ( IL - 2R alpha </e1> ) gene is rapidly and potently induced in T cells in response to mitogenic stimuli .',\n",
       "  'DNA',\n",
       "  'The interleukin 2 receptor alpha - chain ( IL - 2R alpha ) gene is rapidly and potently induced in T cells in response to mitogenic stimuli .',\n",
       "  [['interleukin',\n",
       "    '2',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    '-',\n",
       "    'chain',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2R',\n",
       "    'alpha)',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'DNA']],\n",
       " ['Among 258 X chromosome - containing sperm , 19 % had a repeat number equal to the <e1> donor s somatic </e1> DNA ( 47 repeats ) , 66 % were expansions and 15 % were contractions .',\n",
       "  'DNA',\n",
       "  'Among 258 X chromosome - containing sperm , 19 % had a repeat number equal to the donor s somatic DNA ( 47 repeats ) , 66 % were expansions and 15 % were contractions .',\n",
       "  [[\"donor's\", 'somatic', 'DNA'], [17, 18, 19], 'DNA']],\n",
       " ['The <e1> human platelet - activating factor receptor ( PAFR </e1> ) gene is transcribed by two distinct promoters ( promoter 1 and promoter 2 ) to generate two transcripts ( designated as PAFR transcript 1 and PAFR transcript 2 ) , though their open reading frames are identical .',\n",
       "  'DNA',\n",
       "  'The human platelet - activating factor receptor ( PAFR ) gene is transcribed by two distinct promoters ( promoter 1 and promoter 2 ) to generate two transcripts ( designated as PAFR transcript 1 and PAFR transcript 2 ) , though their open reading frames are identical .',\n",
       "  [['human',\n",
       "    'platelet',\n",
       "    '-',\n",
       "    'activating',\n",
       "    'factor',\n",
       "    'receptor',\n",
       "    '(PAFR)',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'DNA']],\n",
       " ['Functional analysis of the promoter 1 with a transient expression assay using <e1> chloramphenicol acetyltransferase ( CAT </e1> ) gene as a reporter showed that both PAF and TPA activated the promoter 1 but not the deleted promoter lacking the three consensus binding sites for NF - kappa B located from - 571 bp to - 459 bp .',\n",
       "  'DNA',\n",
       "  'Functional analysis of the promoter 1 with a transient expression assay using chloramphenicol acetyltransferase ( CAT ) gene as a reporter showed that both PAF and TPA activated the promoter 1 but not the deleted promoter lacking the three consensus binding sites for NF - kappa B located from - 571 bp to - 459 bp .',\n",
       "  [['chloramphenicol', 'acetyltransferase', '(CAT)', 'gene'],\n",
       "   [12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['In this study , we demonstrate that <e1> nuclear factor ( NF ) - </e1> kappa B and NF - kappa B - like transcription factors are activated after cross - linking CD40 on resting human tonsillar B cells and on B cell lines .',\n",
       "  'PROTEIN',\n",
       "  'In this study , we demonstrate that nuclear factor ( NF ) - kappa B and NF - kappa B - like transcription factors are activated after cross - linking CD40 on resting human tonsillar B cells and on B cell lines .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of <e1> c - Rel/ p65 </e1> heterodimers .',\n",
       "  'PROTEIN',\n",
       "  'Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c - Rel/ p65 heterodimers .',\n",
       "  [['c', '-', 'Rel/p65', 'heterodimers'], [18, 19, 20, 21], 'PROTEIN']],\n",
       " ['Transcriptional regulation is mediated by binding of <e1> c - Rel /p65 </e1> heterodimers to a kappa B - like site in the TF promoter .',\n",
       "  'PROTEIN',\n",
       "  'Transcriptional regulation is mediated by binding of c - Rel /p65 heterodimers to a kappa B - like site in the TF promoter .',\n",
       "  [['c', '-', 'Rel/p65', 'heterodimers'], [7, 8, 9, 10], 'PROTEIN']],\n",
       " ['Nuclear translocation of <e1> cytosolic c - Rel/ p65 </e1> heterodimers and other members of the NF - kappa B /Rel family requires dissociation and proteolytic degradation of the inhibitor protein , I kappa B alpha .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear translocation of cytosolic c - Rel/ p65 heterodimers and other members of the NF - kappa B /Rel family requires dissociation and proteolytic degradation of the inhibitor protein , I kappa B alpha .',\n",
       "  [['cytosolic', 'c', '-', 'Rel/p65', 'heterodimer'],\n",
       "   [3, 4, 5, 6, 7],\n",
       "   'PROTEIN']],\n",
       " ['Nuclear translocation of cytosolic c - Rel/ p65 heterodimers and other members of the <e1> NF - kappa B /Rel </e1> family requires dissociation and proteolytic degradation of the inhibitor protein , I kappa B alpha .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear translocation of cytosolic c - Rel/ p65 heterodimers and other members of the NF - kappa B /Rel family requires dissociation and proteolytic degradation of the inhibitor protein , I kappa B alpha .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'family'], [14, 15, 16, 17, 18], 'PROTEIN']],\n",
       " ['The protease inhibitors N alpha - tosylphenylalanyl chloromethyl ketone ( TPCK ) and N alpha - tosyl - L - lysine chloromethyl ketone ( TLCK ) block activation of <e1> NF - kappa B /Rel </e1> proteins by preventing degradation of I kappa B alpha .',\n",
       "  'PROTEIN',\n",
       "  'The protease inhibitors N alpha - tosylphenylalanyl chloromethyl ketone ( TPCK ) and N alpha - tosyl - L - lysine chloromethyl ketone ( TLCK ) block activation of NF - kappa B /Rel proteins by preventing degradation of I kappa B alpha .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'protein'], [29, 30, 31, 32, 33], 'PROTEIN']],\n",
       " ['These inhibitors specifically prevented degradation of I kappa B alpha and nuclear translocation of <e1> c - Rel /p65 </e1> heterodimers .',\n",
       "  'PROTEIN',\n",
       "  'These inhibitors specifically prevented degradation of I kappa B alpha and nuclear translocation of c - Rel /p65 heterodimers .',\n",
       "  [['c', '-', 'Rel/p65', 'heterodimer'], [14, 15, 16, 17], 'PROTEIN']],\n",
       " ['Taken together , these data indicated that inhibiting nuclear translocation of <e1> c - Rel /p65 </e1> heterodimers prevented LPS induction of TF gene transcription in monocytic cells .',\n",
       "  'PROTEIN',\n",
       "  'Taken together , these data indicated that inhibiting nuclear translocation of c - Rel /p65 heterodimers prevented LPS induction of TF gene transcription in monocytic cells .',\n",
       "  [['c', '-', 'Rel/p65', 'heterodimer'], [11, 12, 13, 14], 'PROTEIN']],\n",
       " ['A decreased number of <e1> calcitriol ( 1,25(OH)2D3 </e1> ) receptors has been observed in parathyroid glands of uremic animals .',\n",
       "  'PROTEIN',\n",
       "  'A decreased number of calcitriol ( 1,25(OH)2D3 ) receptors has been observed in parathyroid glands of uremic animals .',\n",
       "  [['calcitriol', '(1,25(OH)2D3)', 'receptors'], [4, 5, 6], 'PROTEIN']],\n",
       " ['Using a series of constructs containing deletions and mutations in this region , we found that the 3 - most site alone was sufficient for binding GA - binding protein alpha ( <e1> GABP alpha ) </e1> / GABP beta and for a low level of transcriptional activation .',\n",
       "  'PROTEIN',\n",
       "  'Using a series of constructs containing deletions and mutations in this region , we found that the 3 - most site alone was sufficient for binding GA - binding protein alpha ( GABP alpha ) / GABP beta and for a low level of transcriptional activation .',\n",
       "  [['GABP', 'alpha)/GABP', 'beta'], [32, 33, 34], 'PROTEIN']],\n",
       " ['Differences in conformation of the hinge region distinguish <e1> androgen - bound from antiandrogen </e1> - bound receptor complexes , which represents an important feature of antiandrogen action .',\n",
       "  'PROTEIN',\n",
       "  'Differences in conformation of the hinge region distinguish androgen - bound from antiandrogen - bound receptor complexes , which represents an important feature of antiandrogen action .',\n",
       "  [['androgen', '-', 'bound', 'receptor', 'complex'],\n",
       "   [8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['We have recently identified two regulatory elements in the <e1> murine immunoglobulin heavy - chain ( IgH </e1> ) enhancer , pi and microB , which exhibit striking similarity to binding sites for ets - related proteins .',\n",
       "  'DNA',\n",
       "  'We have recently identified two regulatory elements in the murine immunoglobulin heavy - chain ( IgH ) enhancer , pi and microB , which exhibit striking similarity to binding sites for ets - related proteins .',\n",
       "  [['murine', 'immunoglobulin', 'heavy', '-', 'chain', '(IgH)', 'enhancer'],\n",
       "   [9, 10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['Two cis - acting elements GM - kappa B/GC - box and CLE0 , of the <e1> granulocyte - macrophage colony - stimulating factor ( GM - CSF </e1> ) gene are required for maximal induction in Jurkat T cells by costimulation with phorbol - 12 - myristate acetate ( PMA ) and Ca2+ ionophore ( A23187 ) .',\n",
       "  'DNA',\n",
       "  'Two cis - acting elements GM - kappa B/GC - box and CLE0 , of the granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene are required for maximal induction in Jurkat T cells by costimulation with phorbol - 12 - myristate acetate ( PMA ) and Ca2+ ionophore ( A23187 ) .',\n",
       "  [['granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(GM',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'gene'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['The CLE0 sequence interacts with factors , related to a PMA - induced AP - 1 and a <e1> PMA / A23187 - induced NF </e1> - AT .',\n",
       "  'PROTEIN',\n",
       "  'The CLE0 sequence interacts with factors , related to a PMA - induced AP - 1 and a PMA / A23187 - induced NF - AT .',\n",
       "  [['PMA/A23187', '-', 'induced', 'NF', '-', 'AT'],\n",
       "   [18, 19, 20, 21, 22, 23],\n",
       "   'PROTEIN']],\n",
       " ['In contrast , cotransfection with a combination of NF - kappa B and AP - 1 significantly augmented transcription from the GM - CSF promoter containing the GM - kappa B/GC - box and the CLE0 ( <e1> AP - 1 /NF - </e1> AT ) .',\n",
       "  'PROTEIN',\n",
       "  'In contrast , cotransfection with a combination of NF - kappa B and AP - 1 significantly augmented transcription from the GM - CSF promoter containing the GM - kappa B/GC - box and the CLE0 ( AP - 1 /NF - AT ) .',\n",
       "  [['AP', '-', '1/NF', '-', 'AT'], [37, 38, 39, 40, 41], 'PROTEIN']],\n",
       " ['Expression of a constitutively active calcineurin ( CN ) , a <e1> Ca2+ /calmodulin - dependent protein </e1> phosphatase , potentiated by two fold the transcriptional activation by NF - kappa B /AP - 1 .',\n",
       "  'PROTEIN',\n",
       "  'Expression of a constitutively active calcineurin ( CN ) , a Ca2+ /calmodulin - dependent protein phosphatase , potentiated by two fold the transcriptional activation by NF - kappa B /AP - 1 .',\n",
       "  [['Ca2+/calmodulin', '-', 'dependent', 'protein', 'phosphatase'],\n",
       "   [11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['Expression of the <e1> human PRL ( hPRL </e1> ) gene in extrapituitary sites such as the uterus ( decidualized endometrial stroma and myometrium ) and cells of the hematopoietic lineage is directed by an alternative promoter which is located approximately 6 kilobases ( kb ) upstream of the pituitary - specific start site .',\n",
       "  'DNA',\n",
       "  'Expression of the human PRL ( hPRL ) gene in extrapituitary sites such as the uterus ( decidualized endometrial stroma and myometrium ) and cells of the hematopoietic lineage is directed by an alternative promoter which is located approximately 6 kilobases ( kb ) upstream of the pituitary - specific start site .',\n",
       "  [['human', 'PRL', '(hPRL)', 'gene'], [3, 4, 5, 6], 'DNA']],\n",
       " ['Expression of the human PRL ( hPRL ) gene in extrapituitary sites such as the uterus ( decidualized endometrial stroma and myometrium ) and cells of the hematopoietic lineage is directed by an alternative promoter which is located approximately <e1> 6 kilobases ( kb </e1> ) upstream of the pituitary - specific start site .',\n",
       "  'DNA',\n",
       "  'Expression of the human PRL ( hPRL ) gene in extrapituitary sites such as the uterus ( decidualized endometrial stroma and myometrium ) and cells of the hematopoietic lineage is directed by an alternative promoter which is located approximately 6 kilobases ( kb ) upstream of the pituitary - specific start site .',\n",
       "  [['6', 'kilobases', '(kb)', 'upstream'], [39, 40, 41, 42], 'DNA']],\n",
       " ['In order to delineate the tissue - specific mechanisms governing the control of nonpituitary PRL gene expression , we have cloned and sequenced 3 kb 5 - flanking DNA of the upstream <e1> decidual/lymphoid ( dPRL </e1> ) promoter .',\n",
       "  'DNA',\n",
       "  'In order to delineate the tissue - specific mechanisms governing the control of nonpituitary PRL gene expression , we have cloned and sequenced 3 kb 5 - flanking DNA of the upstream decidual/lymphoid ( dPRL ) promoter .',\n",
       "  [['decidual/lymphoid', '(dPRL)', 'promoter'], [32, 33, 34], 'DNA']],\n",
       " ['We investigated how these stimuli affect <e1> mitogen activated protein ( MAP </e1> ) kinases .',\n",
       "  'PROTEIN',\n",
       "  'We investigated how these stimuli affect mitogen activated protein ( MAP ) kinases .',\n",
       "  [['mitogen', 'activated', 'protein', '(MAP)', 'kinase'],\n",
       "   [6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ['Function of <e1> NF - kappa B /Rel binding </e1> sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell - specific binding of different NF - kappa B /Rel subunits .',\n",
       "  'DNA',\n",
       "  'Function of NF - kappa B /Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell - specific binding of different NF - kappa B /Rel subunits .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'binding', 'sites'],\n",
       "   [2, 3, 4, 5, 6, 7],\n",
       "   'DNA']],\n",
       " ['Function of NF - kappa B /Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell - specific binding of different <e1> NF - kappa B /Rel </e1> subunits .',\n",
       "  'PROTEIN',\n",
       "  'Function of NF - kappa B /Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell - specific binding of different NF - kappa B /Rel subunits .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'subunit'], [28, 29, 30, 31, 32], 'PROTEIN']],\n",
       " ['The promoter of the human major histocompatibility complex class II - associated invariant - chain gene ( Ii ) contains two <e1> NF - kappa B /Rel binding </e1> sites located at - 109 to - 118 ( Ii kappa B - 1 ) and - 163 to - 172 ( Ii kappa B - 2 ) from the transcription start site .',\n",
       "  'DNA',\n",
       "  'The promoter of the human major histocompatibility complex class II - associated invariant - chain gene ( Ii ) contains two NF - kappa B /Rel binding sites located at - 109 to - 118 ( Ii kappa B - 1 ) and - 163 to - 172 ( Ii kappa B - 2 ) from the transcription start site .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'binding', 'site'],\n",
       "   [21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['We report here that the differential function of each of these <e1> NF - kappa B /Rel </e1> sites in several distinct cell types depends on cell - specific binding of NF - kappa B /Rel transcription factors .',\n",
       "  'DNA',\n",
       "  'We report here that the differential function of each of these NF - kappa B /Rel sites in several distinct cell types depends on cell - specific binding of NF - kappa B /Rel transcription factors .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'site'], [11, 12, 13, 14, 15], 'DNA']],\n",
       " ['We report here that the differential function of each of these NF - kappa B /Rel sites in several distinct cell types depends on cell - specific binding of <e1> NF - kappa B /Rel transcription </e1> factors .',\n",
       "  'PROTEIN',\n",
       "  'We report here that the differential function of each of these NF - kappa B /Rel sites in several distinct cell types depends on cell - specific binding of NF - kappa B /Rel transcription factors .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'transcription', 'factor'],\n",
       "   [29, 30, 31, 32, 33, 34],\n",
       "   'PROTEIN']],\n",
       " ['Electrophoretic mobility supershift assays determine that members of the <e1> NF - kappa B /Rel </e1> family of transcription factors can bind to this site in vitro and that DNA - binding complexes that contain p50 , p52 , p65 , and cRel correlate with positive regulation whereas the presence of p50 correlates with negative regulation .',\n",
       "  'PROTEIN',\n",
       "  'Electrophoretic mobility supershift assays determine that members of the NF - kappa B /Rel family of transcription factors can bind to this site in vitro and that DNA - binding complexes that contain p50 , p52 , p65 , and cRel correlate with positive regulation whereas the presence of p50 correlates with negative regulation .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'family'], [9, 10, 11, 12, 13], 'PROTEIN']],\n",
       " ['This differential binding of specific <e1> NF - kappa B /Rel </e1> subunits is likely to mediate the disparate functions of these two NF - kappa B /Rel binding sites .',\n",
       "  'PROTEIN',\n",
       "  'This differential binding of specific NF - kappa B /Rel subunits is likely to mediate the disparate functions of these two NF - kappa B /Rel binding sites .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'subunit'], [5, 6, 7, 8, 9], 'PROTEIN']],\n",
       " ['This differential binding of specific NF - kappa B /Rel subunits is likely to mediate the disparate functions of these two <e1> NF - kappa B /Rel binding </e1> sites .',\n",
       "  'DNA',\n",
       "  'This differential binding of specific NF - kappa B /Rel subunits is likely to mediate the disparate functions of these two NF - kappa B /Rel binding sites .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'binding', 'site'],\n",
       "   [21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['Immunohistochemistry was performed with anti - ZEBRA , <e1> anti - EA - restricted , anti - VCA </e1> antibodies and in situ hybridization with BHLF1/NotI oligoprobes on tumour samples .',\n",
       "  'PROTEIN',\n",
       "  'Immunohistochemistry was performed with anti - ZEBRA , anti - EA - restricted , anti - VCA antibodies and in situ hybridization with BHLF1/NotI oligoprobes on tumour samples .',\n",
       "  [['anti', '-', 'EA', '-', 'restricted,', 'anti', '-', 'VCA', 'antibodY'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['In a mobility shift assay , only the <e1> NF - kappa B ( p50 </e1> /p50 ) homodimer was observed in a complex formed with the kappa B sequence in unstimulated SP - B21 cells .',\n",
       "  'PROTEIN',\n",
       "  'In a mobility shift assay , only the NF - kappa B ( p50 /p50 ) homodimer was observed in a complex formed with the kappa B sequence in unstimulated SP - B21 cells .',\n",
       "  [['NF', '-', 'kappa', 'B', '(p50/p50)', 'homodimer'],\n",
       "   [8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['Interestingly , PGE2 or di - butyryl ( Bt2 ) cAMP abolished the binding of <e1> NF - kappa B ( p50 </e1> /p65 ) heterodimer to the kappa B sequence in cells stimulated with anti - CD3 mAb but not with PMA /A23187 .',\n",
       "  'PROTEIN',\n",
       "  'Interestingly , PGE2 or di - butyryl ( Bt2 ) cAMP abolished the binding of NF - kappa B ( p50 /p65 ) heterodimer to the kappa B sequence in cells stimulated with anti - CD3 mAb but not with PMA /A23187 .',\n",
       "  [['NF', '-', 'kappa', 'B', '(p50/p65)', 'heterodimer'],\n",
       "   [15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['The P sequence of the <e1> human interleukin - 4 ( IL - 4 </e1> ) gene , which was defined as a responsive element for phorbol 12 - myristate 13 - acetate and calcium ionophore ( A23187 ) in Jurkat T cells , shares sequence similarity with the NF - kappa B and the NF - AT binding sites .',\n",
       "  'DNA',\n",
       "  'The P sequence of the human interleukin - 4 ( IL - 4 ) gene , which was defined as a responsive element for phorbol 12 - myristate 13 - acetate and calcium ionophore ( A23187 ) in Jurkat T cells , shares sequence similarity with the NF - kappa B and the NF - AT binding sites .',\n",
       "  [['human', 'interleukin', '-', '4', '(IL', '-', '4)', 'gene'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'DNA']],\n",
       " ['The P sequence of the human interleukin - 4 ( IL - 4 ) gene , which was defined as a responsive element for phorbol 12 - myristate 13 - acetate and calcium ionophore ( A23187 ) in Jurkat T cells , shares sequence similarity with the <e1> NF - kappa B and the </e1> NF - AT binding sites .',\n",
       "  'DNA',\n",
       "  'The P sequence of the human interleukin - 4 ( IL - 4 ) gene , which was defined as a responsive element for phorbol 12 - myristate 13 - acetate and calcium ionophore ( A23187 ) in Jurkat T cells , shares sequence similarity with the NF - kappa B and the NF - AT binding sites .',\n",
       "  [['NF', '-', 'kappa', 'B', 'binding', 'site'],\n",
       "   [47, 48, 49, 50, 51, 52],\n",
       "   'DNA']],\n",
       " ['The present work has studied mechanisms responsible for induction of <e1> early growth response 1 ( EGR - 1 </e1> ) gene expression during monocytic differentiation of U - 937 myeloid leukemia cells .',\n",
       "  'DNA',\n",
       "  'The present work has studied mechanisms responsible for induction of early growth response 1 ( EGR - 1 ) gene expression during monocytic differentiation of U - 937 myeloid leukemia cells .',\n",
       "  [['early', 'growth', 'response', '1', '(EGR', '-', '1)', 'gene'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17],\n",
       "   'DNA']],\n",
       " ['The EGR - 1 promoter contains six <e1> CC(A/T)6GG ( CArG </e1> ) motifs .',\n",
       "  'DNA',\n",
       "  'The EGR - 1 promoter contains six CC(A/T)6GG ( CArG ) motifs .',\n",
       "  [['CC(A/T)6GG', '(CArG)', 'motif'], [7, 8, 9], 'DNA']],\n",
       " ['Treatment of both U - 937 and TUR cells with okadaic acid , an inhibitor of <e1> serine/threonine protein phosphatases 1 </e1> and 2A , was associated with induction of monocytic differentiation and EGR - 1 transcription through the 5 - most CArG element .',\n",
       "  'PROTEIN',\n",
       "  'Treatment of both U - 937 and TUR cells with okadaic acid , an inhibitor of serine/threonine protein phosphatases 1 and 2A , was associated with induction of monocytic differentiation and EGR - 1 transcription through the 5 - most CArG element .',\n",
       "  [['serine/threonine', 'protein', 'phosphatase', '1'],\n",
       "   [16, 17, 18, 19],\n",
       "   'PROTEIN']],\n",
       " ['Since these findings supported the involvement of serine /threonine protein phosphorylation in the regulation of EGR - 1 expression , we studied activation of the <e1> 40S ribosomal protein S6 serine /threonine </e1> kinases , pp70S6K and pp90rsk .',\n",
       "  'PROTEIN',\n",
       "  'Since these findings supported the involvement of serine /threonine protein phosphorylation in the regulation of EGR - 1 expression , we studied activation of the 40S ribosomal protein S6 serine /threonine kinases , pp70S6K and pp90rsk .',\n",
       "  [['40S', 'ribosomal', 'protein', 'S6', 'serine/threonine', 'kinase'],\n",
       "   [25, 26, 27, 28, 29, 30],\n",
       "   'PROTEIN']],\n",
       " ['Since kappa B motifs are present in <e1> VCAM - 1 and intercellular adhesion molecule - 1 ( ICAM - 1 </e1> ) promoters , we used PDTC to study the regulatory mechanisms of VCAM - 1 and ICAM - 1 induction and subsequent monocyte adhesion in TNF - treated human umbilical vein endothelial cells ( HUVECs ) .',\n",
       "  'DNA',\n",
       "  'Since kappa B motifs are present in VCAM - 1 and intercellular adhesion molecule - 1 ( ICAM - 1 ) promoters , we used PDTC to study the regulatory mechanisms of VCAM - 1 and ICAM - 1 induction and subsequent monocyte adhesion in TNF - treated human umbilical vein endothelial cells ( HUVECs ) .',\n",
       "  [['VCAM',\n",
       "    '-',\n",
       "    '1',\n",
       "    'and',\n",
       "    'intercellular',\n",
       "    'adhesion',\n",
       "    'molecule',\n",
       "    '-',\n",
       "    '1',\n",
       "    '(ICAM',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'promoter'],\n",
       "   [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'DNA']],\n",
       " ['Since kappa B motifs are present in <e1> VCAM - 1 and </e1> intercellular adhesion molecule - 1 ( ICAM - 1 ) promoters , we used PDTC to study the regulatory mechanisms of VCAM - 1 and ICAM - 1 induction and subsequent monocyte adhesion in TNF - treated human umbilical vein endothelial cells ( HUVECs ) .',\n",
       "  'DNA',\n",
       "  'Since kappa B motifs are present in VCAM - 1 and intercellular adhesion molecule - 1 ( ICAM - 1 ) promoters , we used PDTC to study the regulatory mechanisms of VCAM - 1 and ICAM - 1 induction and subsequent monocyte adhesion in TNF - treated human umbilical vein endothelial cells ( HUVECs ) .',\n",
       "  [['VCAM', '-', '1', 'promotor'], [7, 8, 9, 10], 'DNA']],\n",
       " ['Since kappa B motifs are present in VCAM - 1 and <e1> intercellular adhesion molecule - 1 ( ICAM - 1 </e1> ) promoters , we used PDTC to study the regulatory mechanisms of VCAM - 1 and ICAM - 1 induction and subsequent monocyte adhesion in TNF - treated human umbilical vein endothelial cells ( HUVECs ) .',\n",
       "  'DNA',\n",
       "  'Since kappa B motifs are present in VCAM - 1 and intercellular adhesion molecule - 1 ( ICAM - 1 ) promoters , we used PDTC to study the regulatory mechanisms of VCAM - 1 and ICAM - 1 induction and subsequent monocyte adhesion in TNF - treated human umbilical vein endothelial cells ( HUVECs ) .',\n",
       "  [['intercellular',\n",
       "    'adhesion',\n",
       "    'molecule',\n",
       "    '-',\n",
       "    '1',\n",
       "    '(ICAM',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'promoter'],\n",
       "   [11, 12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'DNA']],\n",
       " ['The activity of the <e1> immunoglobulin heavy - chain ( IgH </e1> ) enhancer is restricted to B cells , although it binds both B - cell - restricted and ubiquitous transcription factors .',\n",
       "  'DNA',\n",
       "  'The activity of the immunoglobulin heavy - chain ( IgH ) enhancer is restricted to B cells , although it binds both B - cell - restricted and ubiquitous transcription factors .',\n",
       "  [['immunoglobulin', 'heavy', '-', 'chain', '(IgH)', 'enhancer'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['Activation of the enhancer in non - B cells upon overexpression of the <e1> basic helix - loop - helix ( bHLH </e1> ) protein E2A appears to be mediated not only by the binding of E2A to its cognate E box but also by the resulting displacement of a repressor from that same site .',\n",
       "  'PROTEIN',\n",
       "  'Activation of the enhancer in non - B cells upon overexpression of the basic helix - loop - helix ( bHLH ) protein E2A appears to be mediated not only by the binding of E2A to its cognate E box but also by the resulting displacement of a repressor from that same site .',\n",
       "  [['basic', 'helix', '-', 'loop', '-', 'helix', '(bHLH)', 'protein'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['We have identified a <e1> \" two - handed \" zinc </e1> finger protein , denoted ZEB , the DNA - binding specificity of which mimics that of the cellular repressor .',\n",
       "  'PROTEIN',\n",
       "  'We have identified a \" two - handed \" zinc finger protein , denoted ZEB , the DNA - binding specificity of which mimics that of the cellular repressor .',\n",
       "  [['\"two', '-', 'handed\"', 'zinc', 'finger', 'protein'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['Sodium salicylate and aspirin also inhibited NF - kappa B - dependent transcription from the Ig kappa enhancer and the <e1> human immunodeficiency virus ( HIV ) long </e1> terminal repeat ( LTR ) in transfected T cells .',\n",
       "  'DNA',\n",
       "  'Sodium salicylate and aspirin also inhibited NF - kappa B - dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus ( HIV ) long terminal repeat ( LTR ) in transfected T cells .',\n",
       "  [['human',\n",
       "    'immunodeficiency',\n",
       "    'virus',\n",
       "    '(HIV)',\n",
       "    'long',\n",
       "    'terminal',\n",
       "    'repeat'],\n",
       "   [20, 21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['The present paper studies the expression of the <e1> NM23 .H1 </e1> gene in cell lines which derive from primary or metastatic human malignant melanomas in relation to staging , infiltration degree , lymphocytic infiltration , cell morphology , cell pigmentation , karyotype , and disease - free survival .',\n",
       "  'DNA',\n",
       "  'The present paper studies the expression of the NM23 .H1 gene in cell lines which derive from primary or metastatic human malignant melanomas in relation to staging , infiltration degree , lymphocytic infiltration , cell morphology , cell pigmentation , karyotype , and disease - free survival .',\n",
       "  [['NM23.H1', 'gene'], [8, 9], 'DNA']],\n",
       " ['Activation of a novel <e1> serine /threonine </e1> kinase that phosphorylates c - Fos upon stimulation of T and B lymphocytes via antigen and cytokine receptors .',\n",
       "  'PROTEIN',\n",
       "  'Activation of a novel serine /threonine kinase that phosphorylates c - Fos upon stimulation of T and B lymphocytes via antigen and cytokine receptors .',\n",
       "  [['serine/threonine', 'kinase'], [4, 5], 'PROTEIN']],\n",
       " ['We have identified and characterized a novel <e1> serine /threonine </e1> kinase that phosphorylated the proto - oncogene product , c - Fos , and is termed Fos kinase .',\n",
       "  'PROTEIN',\n",
       "  'We have identified and characterized a novel serine /threonine kinase that phosphorylated the proto - oncogene product , c - Fos , and is termed Fos kinase .',\n",
       "  [['serine/threonine', 'kinase'], [7, 8], 'PROTEIN']],\n",
       " ['Fos kinase was shown to be distinct from other identified <e1> serine /threonine </e1> kinases , including protein kinase A , protein kinase C , casein kinase II , MAP kinases , p70S6K and p90RSK .',\n",
       "  'PROTEIN',\n",
       "  'Fos kinase was shown to be distinct from other identified serine /threonine kinases , including protein kinase A , protein kinase C , casein kinase II , MAP kinases , p70S6K and p90RSK .',\n",
       "  [['serine/threonine', 'kinase'], [10, 11], 'PROTEIN']],\n",
       " ['The antigenic specificity of an <e1> HLA DQ2 - restricted , HSV - 2 type - specific T - cell </e1> clone was mapped to amino acids 425 to 444 of VP16 of HSV - 2 by sequential use of an intertypic recombinant virus containing VP16 of HSV - 2 in an HSV - 1 background , recombinant VP16 fusion proteins , and synthetic peptides .',\n",
       "  'CELL_LINE',\n",
       "  'The antigenic specificity of an HLA DQ2 - restricted , HSV - 2 type - specific T - cell clone was mapped to amino acids 425 to 444 of VP16 of HSV - 2 by sequential use of an intertypic recombinant virus containing VP16 of HSV - 2 in an HSV - 1 background , recombinant VP16 fusion proteins , and synthetic peptides .',\n",
       "  [['HLA',\n",
       "    'DQ2',\n",
       "    '-',\n",
       "    'restricted,',\n",
       "    'HSV',\n",
       "    '-',\n",
       "    '2',\n",
       "    'type',\n",
       "    '-',\n",
       "    'specific',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'clone'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'CELL_LINE']],\n",
       " ['The antigenic specificity of an HLA DQ2 - restricted , HSV - 2 type - specific T - cell clone was mapped to <e1> amino acids 425 to 444 </e1> of VP16 of HSV - 2 by sequential use of an intertypic recombinant virus containing VP16 of HSV - 2 in an HSV - 1 background , recombinant VP16 fusion proteins , and synthetic peptides .',\n",
       "  'PROTEIN',\n",
       "  'The antigenic specificity of an HLA DQ2 - restricted , HSV - 2 type - specific T - cell clone was mapped to amino acids 425 to 444 of VP16 of HSV - 2 by sequential use of an intertypic recombinant virus containing VP16 of HSV - 2 in an HSV - 1 background , recombinant VP16 fusion proteins , and synthetic peptides .',\n",
       "  [['amino', 'acid', '425', 'to', '444'], [23, 24, 25, 26, 27], 'PROTEIN']],\n",
       " ['Two nuclear factor <e1> NF - IL6 ( </e1> positions - 153 to - 145 and - 83 to - 75 ) and one nuclear factor NF - kappa B ( positions - 72 to - 63 ) motifs are present within this fragment .',\n",
       "  'DNA',\n",
       "  'Two nuclear factor NF - IL6 ( positions - 153 to - 145 and - 83 to - 75 ) and one nuclear factor NF - kappa B ( positions - 72 to - 63 ) motifs are present within this fragment .',\n",
       "  [['NF', '-', 'IL6', 'motif'], [3, 4, 5, 6], 'DNA']],\n",
       " ['Two nuclear factor NF - IL6 ( positions - 153 to - 145 and - 83 to - 75 ) and one <e1> nuclear factor NF - kappa B ( positions - 72 to - 63 </e1> ) motifs are present within this fragment .',\n",
       "  'DNA',\n",
       "  'Two nuclear factor NF - IL6 ( positions - 153 to - 145 and - 83 to - 75 ) and one nuclear factor NF - kappa B ( positions - 72 to - 63 ) motifs are present within this fragment .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    'NF',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B',\n",
       "    '(positions',\n",
       "    '-',\n",
       "    '72',\n",
       "    'to',\n",
       "    '-',\n",
       "    '63)',\n",
       "    'motif'],\n",
       "   [22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34],\n",
       "   'DNA']],\n",
       " ['The t(17;19) translocation in acute lymphoblastic leukemias results in creation of E2A - hepatic leukemia factor ( HLF ) chimeric proteins that contain the DNA - binding and protein dimerization domains of the <e1> basic leucine zipper ( bZIP </e1> ) protein HLF fused to a portion of E2A proteins with transcriptional activation properties .',\n",
       "  'PROTEIN',\n",
       "  'The t(17;19) translocation in acute lymphoblastic leukemias results in creation of E2A - hepatic leukemia factor ( HLF ) chimeric proteins that contain the DNA - binding and protein dimerization domains of the basic leucine zipper ( bZIP ) protein HLF fused to a portion of E2A proteins with transcriptional activation properties .',\n",
       "  [['basic', 'leucine', 'zipper', '(bZIP)', 'protein'],\n",
       "   [33, 34, 35, 36, 37],\n",
       "   'PROTEIN']],\n",
       " ['Wild - type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the <e1> proline - and </e1> acidic amino acid - rich ( PAR ) and C/EBP subfamilies ; however , E2A - HLF proteins were significantly less tolerant of certain deviations from the HLF consensus binding site .',\n",
       "  'PROTEIN',\n",
       "  'Wild - type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the proline - and acidic amino acid - rich ( PAR ) and C/EBP subfamilies ; however , E2A - HLF proteins were significantly less tolerant of certain deviations from the HLF consensus binding site .',\n",
       "  [['proline', '-', 'subfamily'], [20, 21, 22], 'PROTEIN']],\n",
       " ['Wild - type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the proline - and <e1> acidic amino acid - rich ( </e1> PAR ) and C/EBP subfamilies ; however , E2A - HLF proteins were significantly less tolerant of certain deviations from the HLF consensus binding site .',\n",
       "  'PROTEIN',\n",
       "  'Wild - type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the proline - and acidic amino acid - rich ( PAR ) and C/EBP subfamilies ; however , E2A - HLF proteins were significantly less tolerant of certain deviations from the HLF consensus binding site .',\n",
       "  [['acidic', 'amino', 'acid', '-', 'rich', 'subfamily'],\n",
       "   [23, 24, 25, 26, 27, 28],\n",
       "   'PROTEIN']],\n",
       " ['Both <e1> wild - type and </e1> chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing HLF or C/EBP consensus binding sites .',\n",
       "  'PROTEIN',\n",
       "  'Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing HLF or C/EBP consensus binding sites .',\n",
       "  [['wild', '-', 'type', 'HLF'], [1, 2, 3, 4], 'PROTEIN']],\n",
       " ['Exposure of monocytic cells to bacterial lipopolysaccharide ( LPS ) activates the <e1> NF - kappa B /Rel </e1> family of proteins and leads to the rapid induction of inflammatory gene products , including tissue factor ( TF ) .',\n",
       "  'PROTEIN',\n",
       "  'Exposure of monocytic cells to bacterial lipopolysaccharide ( LPS ) activates the NF - kappa B /Rel family of proteins and leads to the rapid induction of inflammatory gene products , including tissue factor ( TF ) .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'family'], [12, 13, 14, 15, 16], 'PROTEIN']],\n",
       " ['In fact , under low - ionic - strength conditions , the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with <e1> c - Rel /p65 </e1> dimers .',\n",
       "  'PROTEIN',\n",
       "  'In fact , under low - ionic - strength conditions , the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c - Rel /p65 dimers .',\n",
       "  [['c', '-', 'Rel/p65', 'dimers'], [25, 26, 27, 28], 'PROTEIN']],\n",
       " ['Antibodies against the NF - kappa B and Rel proteins and UV cross - linking studies revealed the presence of c - Rel and p65 and the absence of p50 in the TF complex and further showed that <e1> c - Rel/ p65 </e1> heterodimers selectively bound to the TF kappa B - like site .',\n",
       "  'PROTEIN',\n",
       "  'Antibodies against the NF - kappa B and Rel proteins and UV cross - linking studies revealed the presence of c - Rel and p65 and the absence of p50 in the TF complex and further showed that c - Rel/ p65 heterodimers selectively bound to the TF kappa B - like site .',\n",
       "  [['c', '-', 'Rel/p65', 'heterodimer'], [38, 39, 40, 41], 'PROTEIN']],\n",
       " ['Taken together , our results demonstrated that binding of <e1> c - Rel/ p65 </e1> heterodimers to a novel kappa B - like site mediated LPS induction of TF gene expression in monocytic cells .',\n",
       "  'PROTEIN',\n",
       "  'Taken together , our results demonstrated that binding of c - Rel/ p65 heterodimers to a novel kappa B - like site mediated LPS induction of TF gene expression in monocytic cells .',\n",
       "  [['c', '-', 'Rel/p65', 'heterodimer'], [9, 10, 11, 12], 'PROTEIN']],\n",
       " ['TN also inhibits proliferation driven by <e1> alpha CD3 /IL - </e1> 2 or by phorbol ester/IL - 2 , and it prevents high level induction of IL - 2R .',\n",
       "  'PROTEIN',\n",
       "  'TN also inhibits proliferation driven by alpha CD3 /IL - 2 or by phorbol ester/IL - 2 , and it prevents high level induction of IL - 2R .',\n",
       "  [['alpha', 'CD3/IL', '-', '2'], [6, 7, 8, 9], 'PROTEIN']],\n",
       " ['This activation was due to the translocation of p65 and c - Rel NF.kappa B proteins from cytoplasmic stores to the nucleus , where they bound the kappa B sequence of the IL - 2R alpha promoter either as p50.p65 or as <e1> p50. c - </e1> Rel heterodimers .',\n",
       "  'PROTEIN',\n",
       "  'This activation was due to the translocation of p65 and c - Rel NF.kappa B proteins from cytoplasmic stores to the nucleus , where they bound the kappa B sequence of the IL - 2R alpha promoter either as p50.p65 or as p50. c - Rel heterodimers .',\n",
       "  [['p50.c', '-', 'Rel'], [42, 43, 44], 'PROTEIN']],\n",
       " ['All four complexes contain CREB and are bound to the <e1> cAMP response element ( CRE ) </e1> core sequence ( TGACGTCA ) , as indicated by antibody and oligonucleotide competition experiments .',\n",
       "  'DNA',\n",
       "  'All four complexes contain CREB and are bound to the cAMP response element ( CRE ) core sequence ( TGACGTCA ) , as indicated by antibody and oligonucleotide competition experiments .',\n",
       "  [['cAMP', 'response', 'element', '(CRE)', 'core', 'sequence'],\n",
       "   [10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['Translational initiation of <e1> encephalomyocarditis virus ( EMCV </e1> ) mRNA occurs by ribosomal entry into the 5 nontranslated region of the EMCV mRNA , rather than by ribosomal scanning .',\n",
       "  'RNA',\n",
       "  'Translational initiation of encephalomyocarditis virus ( EMCV ) mRNA occurs by ribosomal entry into the 5 nontranslated region of the EMCV mRNA , rather than by ribosomal scanning .',\n",
       "  [['encephalomyocarditis', 'virus', '(EMCV)', 'mRNA'], [3, 4, 5, 6], 'RNA']],\n",
       " ['In this study we have identified the peroxisome proliferator - activated receptor ( PPAR ) as a new <e1> thyroid hormone receptor ( THR ) auxiliary </e1> nuclear protein , heterodimerizing with THR in solution .',\n",
       "  'PROTEIN',\n",
       "  'In this study we have identified the peroxisome proliferator - activated receptor ( PPAR ) as a new thyroid hormone receptor ( THR ) auxiliary nuclear protein , heterodimerizing with THR in solution .',\n",
       "  [['thyroid',\n",
       "    'hormone',\n",
       "    'receptor',\n",
       "    '(THR)',\n",
       "    'auxiliary',\n",
       "    'nuclear',\n",
       "    'protein'],\n",
       "   [18, 19, 20, 21, 22, 23, 24],\n",
       "   'PROTEIN']],\n",
       " ['To examine whether the AP - 1 enhancer activity is involved in RA - induced monocytic differentiation , THP - 1 cells were transiently transfected with a <e1> chloramphenicol acetyl transferase ( CAT ) - </e1> reporter gene containing 5 copies of the AP - 1 binding sites .',\n",
       "  'DNA',\n",
       "  'To examine whether the AP - 1 enhancer activity is involved in RA - induced monocytic differentiation , THP - 1 cells were transiently transfected with a chloramphenicol acetyl transferase ( CAT ) - reporter gene containing 5 copies of the AP - 1 binding sites .',\n",
       "  [['chloramphenicol',\n",
       "    'acetyl',\n",
       "    'transferase',\n",
       "    '(CAT)',\n",
       "    '-',\n",
       "    'reporter',\n",
       "    'gene'],\n",
       "   [27, 28, 29, 30, 31, 32, 33],\n",
       "   'DNA']],\n",
       " ['These events are accompanied by marked increases in the expression of <e1> RAG - 1 and </e1> RAG - 2 RNAs .',\n",
       "  'RNA',\n",
       "  'These events are accompanied by marked increases in the expression of RAG - 1 and RAG - 2 RNAs .',\n",
       "  [['RAG', '-', '1', 'RNA'], [11, 12, 13, 14], 'RNA']],\n",
       " ['As documented in the accompanying paper ( Klug et al. , this issue ) , an active v - abl protein also suppresses the activity of <e1> NF - kappa B </e1> /rel and expression controlled by the kappa intron enhancer .',\n",
       "  'PROTEIN',\n",
       "  'As documented in the accompanying paper ( Klug et al. , this issue ) , an active v - abl protein also suppresses the activity of NF - kappa B /rel and expression controlled by the kappa intron enhancer .',\n",
       "  [['NF', '-', 'kappa', 'B/rel'], [26, 27, 28, 29], 'PROTEIN']],\n",
       " ['To investigate the effects of <e1> human immunodeficiency virus type 1 ( HIV - 1 </e1> ) Tat on interleukin - 2 ( IL - 2 ) expression , we used IL - 2 promoter - chloramphenicol acetyltransferase constructs and IL - 2 - secreting Jurkat T cells as a model system .',\n",
       "  'PROTEIN',\n",
       "  'To investigate the effects of human immunodeficiency virus type 1 ( HIV - 1 ) Tat on interleukin - 2 ( IL - 2 ) expression , we used IL - 2 promoter - chloramphenicol acetyltransferase constructs and IL - 2 - secreting Jurkat T cells as a model system .',\n",
       "  [['human',\n",
       "    'immunodeficiency',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HIV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'Tat'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['To investigate the effects of human immunodeficiency virus type 1 ( HIV - 1 ) Tat on interleukin - 2 ( IL - 2 ) expression , we used IL - 2 promoter <e1> - chloramphenicol </e1> acetyltransferase constructs and IL - 2 - secreting Jurkat T cells as a model system .',\n",
       "  'PROTEIN',\n",
       "  'To investigate the effects of human immunodeficiency virus type 1 ( HIV - 1 ) Tat on interleukin - 2 ( IL - 2 ) expression , we used IL - 2 promoter - chloramphenicol acetyltransferase constructs and IL - 2 - secreting Jurkat T cells as a model system .',\n",
       "  [['chloramphenicol', 'acetyltransferase'], [33, 34], 'PROTEIN']],\n",
       " ['The gene encoding the <e1> 105 - kDa protein ( p105 </e1> ) precursor of the p50 subunit of transcription factor NF - kappa B also encodes a p70 I kappa B protein , I kappa B gamma , which is identical to the C - terminal 607 amino acids of p105 .',\n",
       "  'PROTEIN',\n",
       "  'The gene encoding the 105 - kDa protein ( p105 ) precursor of the p50 subunit of transcription factor NF - kappa B also encodes a p70 I kappa B protein , I kappa B gamma , which is identical to the C - terminal 607 amino acids of p105 .',\n",
       "  [['105', '-', 'kDa', 'protein', '(p105)', 'precursor'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['The I kappa B gamma isoforms also display differences in specificity and affinity for <e1> Rel/ NF - kappa B </e1> proteins .',\n",
       "  'PROTEIN',\n",
       "  'The I kappa B gamma isoforms also display differences in specificity and affinity for Rel/ NF - kappa B proteins .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B', 'protein'], [14, 15, 16, 17, 18], 'PROTEIN']],\n",
       " ['Some antioxidants , including butylated hydroxyanisole ( BHA ) , tetrahydropapaveroline ( THP ) , nordihydroguiauretic acid , and 10,11 - dihydroxyaporphine ( DHA ) , were found to be potent inhibitors of the production of <e1> tumor necrosis factor ( TNF ) </e1> - alpha , IL - 1 beta , and IL - 6 by human peripheral blood mononuclear cells ( PBMC ) stimulated by lipopolysaccharide ( LPS ) ( IC50s in the low micromolar range ) .',\n",
       "  'PROTEIN',\n",
       "  'Some antioxidants , including butylated hydroxyanisole ( BHA ) , tetrahydropapaveroline ( THP ) , nordihydroguiauretic acid , and 10,11 - dihydroxyaporphine ( DHA ) , were found to be potent inhibitors of the production of tumor necrosis factor ( TNF ) - alpha , IL - 1 beta , and IL - 6 by human peripheral blood mononuclear cells ( PBMC ) stimulated by lipopolysaccharide ( LPS ) ( IC50s in the low micromolar range ) .',\n",
       "  [['tumor', 'necrosis', 'factor', '(TNF)', '-', 'alpha'],\n",
       "   [36, 37, 38, 39, 40, 41],\n",
       "   'PROTEIN']],\n",
       " ['It plays an important role in modulating the balance of <e1> T helper ( Th ) </e1> cell subsets , favoring expansion of the Th2 lineage relative to Th1 .',\n",
       "  'CELL_TYPE',\n",
       "  'It plays an important role in modulating the balance of T helper ( Th ) cell subsets , favoring expansion of the Th2 lineage relative to Th1 .',\n",
       "  [['T', 'helper', '(Th)', 'cell', 'subset'],\n",
       "   [10, 11, 12, 13, 14],\n",
       "   'CELL_TYPE']],\n",
       " ['Examination of the primary amino acid sequence of this protein indicates that it is a member of the <e1> signal transducers and activators of transcription ( Stat </e1> ) family of DNA binding proteins , hereby designated IL - 4 Stat .',\n",
       "  'PROTEIN',\n",
       "  'Examination of the primary amino acid sequence of this protein indicates that it is a member of the signal transducers and activators of transcription ( Stat ) family of DNA binding proteins , hereby designated IL - 4 Stat .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(Stat)',\n",
       "    'family'],\n",
       "   [18, 19, 20, 21, 22, 23, 24, 25],\n",
       "   'PROTEIN']],\n",
       " ['To characterize mechanisms responsible for these LIF effects , levels of HIV mRNA , activation of the DNA binding protein nuclear factor <e1> ( NF ) </e1> - kB , signal transduction pathways , and potential interactions with other cytokines were analyzed .',\n",
       "  'PROTEIN',\n",
       "  'To characterize mechanisms responsible for these LIF effects , levels of HIV mRNA , activation of the DNA binding protein nuclear factor ( NF ) - kB , signal transduction pathways , and potential interactions with other cytokines were analyzed .',\n",
       "  [['(NF)', '-', 'kB'], [22, 23, 24], 'PROTEIN']],\n",
       " ['These findings suggest that although human B lymphocytes can express VDR mRNA and <e1> protein , </e1> they exhibit a functional block for vitamin D - dependent gene regulation .',\n",
       "  'PROTEIN',\n",
       "  'These findings suggest that although human B lymphocytes can express VDR mRNA and protein , they exhibit a functional block for vitamin D - dependent gene regulation .',\n",
       "  [['VDR', 'protein'], [13, 14], 'PROTEIN']],\n",
       " ['In this study , we have analysed the function of these cis - acting regulatory sites in the context of the native IL - 2 enhancer and <e1> promoter sequence . </e1>',\n",
       "  'DNA',\n",
       "  'In this study , we have analysed the function of these cis - acting regulatory sites in the context of the native IL - 2 enhancer and promoter sequence .',\n",
       "  [['IL', '-', '2', 'promoter', 'sequence'], [27, 28, 29, 30, 31], 'DNA']],\n",
       " ['One major and one minor transcription start site were identified <e1> 101 and 130 base pairs ( bp </e1> ) upstream , respectively , from the protein translation start ATG .',\n",
       "  'DNA',\n",
       "  'One major and one minor transcription start site were identified 101 and 130 base pairs ( bp ) upstream , respectively , from the protein translation start ATG .',\n",
       "  [['101', 'and', '130', 'base', 'pairs', '(bp)', 'upstream'],\n",
       "   [10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['CD14 Sp1 site oligonucleotides bound preferentially to a 105 - kDa Sp1 species , which is present in higher relative levels in <e1> monocytic than </e1> non - monocytic cells , suggesting that modification of Sp1 , such as phosphorylation , may explain how the Sp1 site mediates monocytic specific promoter activity .',\n",
       "  'CELL_TYPE',\n",
       "  'CD14 Sp1 site oligonucleotides bound preferentially to a 105 - kDa Sp1 species , which is present in higher relative levels in monocytic than non - monocytic cells , suggesting that modification of Sp1 , such as phosphorylation , may explain how the Sp1 site mediates monocytic specific promoter activity .',\n",
       "  [['monocytic', 'cell'], [22, 23], 'CELL_TYPE']],\n",
       " ['By deleted and mutated analysis of the IL - 8 promoters , the <e1> AP - 1 and </e1> kappa B - like sites were identified as the responsive elements for PMA and ionomycin .',\n",
       "  'DNA',\n",
       "  'By deleted and mutated analysis of the IL - 8 promoters , the AP - 1 and kappa B - like sites were identified as the responsive elements for PMA and ionomycin .',\n",
       "  [['AP', '-', '1', 'site'], [13, 14, 15, 16], 'DNA']],\n",
       " ['FK506 suppressed the transcriptions through the <e1> AP - 1 or </e1> kappa B - like sites induced by PMA plus Ca(2+) - mobilizing agents , but not those induced by Ca(2+) - independent stimuli .',\n",
       "  'DNA',\n",
       "  'FK506 suppressed the transcriptions through the AP - 1 or kappa B - like sites induced by PMA plus Ca(2+) - mobilizing agents , but not those induced by Ca(2+) - independent stimuli .',\n",
       "  [['AP', '-', '1', 'site'], [6, 7, 8, 9], 'DNA']],\n",
       " ['Furthermore , we confirmed the previous report that FK506 suppressed the PMA / ionomycin - induced activation through authentic kappa B site of <e1> immunoglobulin ( Ig </e1> ) gene , to which NF - kappa B binding was also decreased by FK506 , indicating that both IL - 8 kappa B - like site and Ig kappa B site are FK506 - sensitive in spite of the difference of binding factors .',\n",
       "  'DNA',\n",
       "  'Furthermore , we confirmed the previous report that FK506 suppressed the PMA / ionomycin - induced activation through authentic kappa B site of immunoglobulin ( Ig ) gene , to which NF - kappa B binding was also decreased by FK506 , indicating that both IL - 8 kappa B - like site and Ig kappa B site are FK506 - sensitive in spite of the difference of binding factors .',\n",
       "  [['immunoglobulin', '(Ig)', 'gene'], [23, 24, 25], 'DNA']],\n",
       " ['Our results indicate that not only the reported IL - 2 NF - AT and NFIL - 2A sites and Ig kappa B site , but also the IL - 8 <e1> AP - 1 and </e1> kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .',\n",
       "  'DNA',\n",
       "  'Our results indicate that not only the reported IL - 2 NF - AT and NFIL - 2A sites and Ig kappa B site , but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .',\n",
       "  [['AP', '-', '1', 'site'], [31, 32, 33, 34], 'DNA']],\n",
       " ['The cognate interaction between T cells and antigen - presenting cells ( APCs ) , mediated by <e1> major histocompatibility complex ( MHC ) class </e1> II molecules , results in the delivery of activation signals to the APC .',\n",
       "  'PROTEIN',\n",
       "  'The cognate interaction between T cells and antigen - presenting cells ( APCs ) , mediated by major histocompatibility complex ( MHC ) class II molecules , results in the delivery of activation signals to the APC .',\n",
       "  [['major',\n",
       "    'histocompatibility',\n",
       "    'complex',\n",
       "    '(MHC)',\n",
       "    'class',\n",
       "    'II',\n",
       "    'molecule'],\n",
       "   [17, 18, 19, 20, 21, 22, 23],\n",
       "   'PROTEIN']],\n",
       " ['In normal adults there is a direct significant correlation between plasma cortisol and <e1> Type I and </e1> between plasma cortisol and Type II receptors in mononuclear leukocytes , while in Cushing s syndrome the correlation is inverse between plasma cortisol at 8 a.m. and Type II receptors .',\n",
       "  'PROTEIN',\n",
       "  'In normal adults there is a direct significant correlation between plasma cortisol and Type I and between plasma cortisol and Type II receptors in mononuclear leukocytes , while in Cushing s syndrome the correlation is inverse between plasma cortisol at 8 a.m. and Type II receptors .',\n",
       "  [['Type', 'I', 'receptor'], [13, 14, 15], 'PROTEIN']],\n",
       " ['In an aged population the mean numbers of <e1> Type I and </e1> of Type II receptors are lower and plasma cortisol is higher than in adult controls , but the increase of plasma cortisol is not followed by a clinical picture of hypercorticism .',\n",
       "  'PROTEIN',\n",
       "  'In an aged population the mean numbers of Type I and of Type II receptors are lower and plasma cortisol is higher than in adult controls , but the increase of plasma cortisol is not followed by a clinical picture of hypercorticism .',\n",
       "  [['Type', 'I', 'receptor'], [8, 9, 10], 'PROTEIN']],\n",
       " ['After dexamethasone suppression ( 1 mg at 11 p.m. ) Type I receptors always decrease in controls while the response of <e1> Type II is </e1> not homogeneous .',\n",
       "  'PROTEIN',\n",
       "  'After dexamethasone suppression ( 1 mg at 11 p.m. ) Type I receptors always decrease in controls while the response of Type II is not homogeneous .',\n",
       "  [['Type', 'II', 'receptor'], [21, 22, 23], 'PROTEIN']],\n",
       " ['RARs are members of the steroid/thyroid hormone receptor superfamily and exhibit a molecular structure that possess discrete DNA - binding and <e1> RA ( ligand ) - </e1> binding domains .',\n",
       "  'PROTEIN',\n",
       "  'RARs are members of the steroid/thyroid hormone receptor superfamily and exhibit a molecular structure that possess discrete DNA - binding and RA ( ligand ) - binding domains .',\n",
       "  [['RA', '(ligand)', '-', 'binding', 'domain'],\n",
       "   [21, 22, 23, 24, 25],\n",
       "   'PROTEIN']],\n",
       " ['Several cell lines of hematopoietic origin including the leukemic T cell line HPB.ALL and the erythroleukemic cell line K562 were responsive to thrombin , whereas others such as THP1 , a myelomonocytic cell line , and BL2 , a <e1> Burkitt lymphoma were refractory </e1> to thrombin or TRP stimulation .',\n",
       "  'CELL_LINE',\n",
       "  'Several cell lines of hematopoietic origin including the leukemic T cell line HPB.ALL and the erythroleukemic cell line K562 were responsive to thrombin , whereas others such as THP1 , a myelomonocytic cell line , and BL2 , a Burkitt lymphoma were refractory to thrombin or TRP stimulation .',\n",
       "  [['Burkitt', 'lymphoma', 'cell', 'line'], [39, 40, 41, 42], 'CELL_LINE']],\n",
       " ['An ability of the Epstein - Barr virus latent membrane protein LMP1 to enhance the survival of infected B cells through upregulation of the bcl - 2 oncogene was first suggested by experiments involving gene transfection and the selection of stable <e1> LMP1 + </e1> clones ( S.Henderson , M. Rowe , C.Gregory , F.Wang , E.Kieff , and A.Rickinson , Cell 65 : 1107 - 1115 , 1991 ) .',\n",
       "  'CELL_LINE',\n",
       "  'An ability of the Epstein - Barr virus latent membrane protein LMP1 to enhance the survival of infected B cells through upregulation of the bcl - 2 oncogene was first suggested by experiments involving gene transfection and the selection of stable LMP1 + clones ( S.Henderson , M. Rowe , C.Gregory , F.Wang , E.Kieff , and A.Rickinson , Cell 65 : 1107 - 1115 , 1991 ) .',\n",
       "  [['LMP1+', 'clone'], [41, 42], 'CELL_LINE']],\n",
       " ['However , it was not possible to ascertain whether Bcl - 2 upregulation was a specific consequence of LMP1 expression or an artifact of the selection procedure whereby rare <e1> Bcl - 2 + </e1> cells already present in the starting population might best be able to tolerate the potentially toxic effects of LMP1 .',\n",
       "  'CELL_LINE',\n",
       "  'However , it was not possible to ascertain whether Bcl - 2 upregulation was a specific consequence of LMP1 expression or an artifact of the selection procedure whereby rare Bcl - 2 + cells already present in the starting population might best be able to tolerate the potentially toxic effects of LMP1 .',\n",
       "  [['Bcl', '-', '2+', 'cell'], [29, 30, 31, 32], 'CELL_LINE']],\n",
       " ['However , all 20 cases lacked the t(15;17) and 17 cases tested lacked the <e1> promyelocytic/retinoic acid receptor alpha ( RAR alpha ) </e1> fusion transcript in RT - PCR assays ; 12 cases had 46,XX or 46,XY karyotypes , whereas 2 cases had abnormalities of chromosome 17q : 1 with del(17)(q25) and the other with t(11;17)(q23;q21) and the promyelocytic leukemia zinc finger/ RAR alpha fusion transcript .',\n",
       "  'RNA',\n",
       "  'However , all 20 cases lacked the t(15;17) and 17 cases tested lacked the promyelocytic/retinoic acid receptor alpha ( RAR alpha ) fusion transcript in RT - PCR assays ; 12 cases had 46,XX or 46,XY karyotypes , whereas 2 cases had abnormalities of chromosome 17q : 1 with del(17)(q25) and the other with t(11;17)(q23;q21) and the promyelocytic leukemia zinc finger/ RAR alpha fusion transcript .',\n",
       "  [['promyelocytic/retinoic',\n",
       "    'acid',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    '(RAR',\n",
       "    'alpha)',\n",
       "    'fusion',\n",
       "    'transcript'],\n",
       "   [14, 15, 16, 17, 18, 19, 20, 21],\n",
       "   'RNA']],\n",
       " ['However , all 20 cases lacked the t(15;17) and 17 cases tested lacked the promyelocytic/retinoic acid receptor alpha ( RAR alpha ) fusion transcript in RT - PCR assays ; 12 cases had 46,XX or 46,XY karyotypes , whereas 2 cases had abnormalities of chromosome 17q : 1 with del(17)(q25) and the other with t(11;17)(q23;q21) and the <e1> promyelocytic leukemia zinc finger/ RAR alpha fusion </e1> transcript .',\n",
       "  'RNA',\n",
       "  'However , all 20 cases lacked the t(15;17) and 17 cases tested lacked the promyelocytic/retinoic acid receptor alpha ( RAR alpha ) fusion transcript in RT - PCR assays ; 12 cases had 46,XX or 46,XY karyotypes , whereas 2 cases had abnormalities of chromosome 17q : 1 with del(17)(q25) and the other with t(11;17)(q23;q21) and the promyelocytic leukemia zinc finger/ RAR alpha fusion transcript .',\n",
       "  [['promyelocytic',\n",
       "    'leukemia',\n",
       "    'zinc',\n",
       "    'finger/RAR',\n",
       "    'alpha',\n",
       "    'fusion',\n",
       "    'transcript'],\n",
       "   [57, 58, 59, 60, 61, 62, 63],\n",
       "   'RNA']],\n",
       " ['Four of 6 cases tested showed functional NK cell - mediated cytotoxicity , suggesting a relationship between these unique CD33+ , CD56+ , CD16 - acute leukemias and <e1> normal CD56+ , CD16 - NK precursor </e1> cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Four of 6 cases tested showed functional NK cell - mediated cytotoxicity , suggesting a relationship between these unique CD33+ , CD56+ , CD16 - acute leukemias and normal CD56+ , CD16 - NK precursor cells .',\n",
       "  [['normal', 'CD56+,', 'CD16', '-', 'NK', 'precursor', 'cell'],\n",
       "   [28, 29, 30, 31, 32, 33, 34],\n",
       "   'CELL_TYPE']],\n",
       " ['Using a combination of panning and multiparameter flow cytometric sorting , we identified a <e1> normal CD56+ , CD33+ , CD16 - </e1> counterpart cell at a frequency of 1 % to 2 % in the peripheral blood of healthy individuals .',\n",
       "  'CELL_TYPE',\n",
       "  'Using a combination of panning and multiparameter flow cytometric sorting , we identified a normal CD56+ , CD33+ , CD16 - counterpart cell at a frequency of 1 % to 2 % in the peripheral blood of healthy individuals .',\n",
       "  [['normal', 'CD56+,', 'CD33+,', 'CD16', '-', 'counterpart', 'cell'],\n",
       "   [14, 15, 16, 17, 18, 19, 20],\n",
       "   'CELL_TYPE']],\n",
       " ['IL - 4 , a product of the T - helper 0 ( Th0 ) and 2 ( Th2 ) subset , was originally described as a B - cell stimulatory factor and has subsequently been found to suppress IL - 1 alpha , IL - 1 beta , IL - 6 , IL - 8 , and TNF - alpha gene expression in monocytes stimulated with LPS , and to upregulate <e1> IL - 1 receptor antagonist ( IL1 - RA </e1> ) gene expression .',\n",
       "  'DNA',\n",
       "  'IL - 4 , a product of the T - helper 0 ( Th0 ) and 2 ( Th2 ) subset , was originally described as a B - cell stimulatory factor and has subsequently been found to suppress IL - 1 alpha , IL - 1 beta , IL - 6 , IL - 8 , and TNF - alpha gene expression in monocytes stimulated with LPS , and to upregulate IL - 1 receptor antagonist ( IL1 - RA ) gene expression .',\n",
       "  [['IL', '-', '1', 'receptor', 'antagonist', '(IL1', '-', 'RA)', 'gene'],\n",
       "   [72, 73, 74, 75, 76, 77, 78, 79, 80],\n",
       "   'DNA']],\n",
       " ['<e1> IL - 1 beta and </e1> IL - 6 genes contain AP - 1 binding sites as regulatory elements , the AP - 1 protein being composed of c - jun and c - fos gene products .',\n",
       "  'DNA',\n",
       "  'IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements , the AP - 1 protein being composed of c - jun and c - fos gene products .',\n",
       "  [['IL', '-', '1', 'beta', 'gene'], [0, 1, 2, 3, 4], 'DNA']],\n",
       " ['Analysis of the chromatin organization of the integrated <e1> human immunodeficiency virus type 1 ( HIV - 1 </e1> ) genome has previously revealed a major constitutive DNase I - hypersensitive site associated with the pol gene ( E . Verdin , J . Virol . 65 : 6790 - 6799 , 1991 ) .',\n",
       "  'DNA',\n",
       "  'Analysis of the chromatin organization of the integrated human immunodeficiency virus type 1 ( HIV - 1 ) genome has previously revealed a major constitutive DNase I - hypersensitive site associated with the pol gene ( E . Verdin , J . Virol . 65 : 6790 - 6799 , 1991 ) .',\n",
       "  [['human',\n",
       "    'immunodeficiency',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HIV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'genome'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['In the present report , high - resolution mapping of this site with DNase I and micrococcal nuclease identified a nucleosome - free region centered around <e1> nucleotides ( nt ) 4490 </e1> to 4766 .',\n",
       "  'DNA',\n",
       "  'In the present report , high - resolution mapping of this site with DNase I and micrococcal nuclease identified a nucleosome - free region centered around nucleotides ( nt ) 4490 to 4766 .',\n",
       "  [['nucleotides', '(nt)', '4490', 'to', '4766'],\n",
       "   [26, 27, 28, 29, 30],\n",
       "   'DNA']],\n",
       " ['An <e1> HHV - 6 ( GS ) </e1> cDNA clone , pCD41 , encoding for a 41 - kDa nuclear protein was identified and characterized previously ( Chang and Balachandran , J. Virol . 65 , 2884 - 2894 and 7085 , 1991 ) .',\n",
       "  'DNA',\n",
       "  'An HHV - 6 ( GS ) cDNA clone , pCD41 , encoding for a 41 - kDa nuclear protein was identified and characterized previously ( Chang and Balachandran , J. Virol . 65 , 2884 - 2894 and 7085 , 1991 ) .',\n",
       "  [['HHV', '-', '6', '(GS)', 'cDNA', 'clone'], [1, 2, 3, 4, 5, 6], 'DNA']],\n",
       " ['Using this cDNA as the probe , a 3.8 - kb EcoRI genomic fragment encoding the <e1> HHV - 6 </e1> ( GS ) P41 was cloned and designated as pGD41 .',\n",
       "  'PROTEIN',\n",
       "  'Using this cDNA as the probe , a 3.8 - kb EcoRI genomic fragment encoding the HHV - 6 ( GS ) P41 was cloned and designated as pGD41 .',\n",
       "  [['HHV', '-', '6(GS)P41'], [16, 17, 18], 'PROTEIN']],\n",
       " ['Wild - type <e1> Chinese hamster ovary ( CHO ) - </e1> K1 cells can be activated by endotoxin to release arachidonate following transfection with human CD14 ( CHO/ CD14 ) .',\n",
       "  'CELL_LINE',\n",
       "  'Wild - type Chinese hamster ovary ( CHO ) - K1 cells can be activated by endotoxin to release arachidonate following transfection with human CD14 ( CHO/ CD14 ) .',\n",
       "  [['Chinese', 'hamster', 'ovary', '(CHO)', '-', 'K1', 'cell'],\n",
       "   [3, 4, 5, 6, 7, 8, 9],\n",
       "   'CELL_LINE']],\n",
       " ['Wild - type Chinese hamster ovary ( CHO ) - K1 cells can be activated by endotoxin to release arachidonate following transfection with human CD14 ( <e1> CHO/ </e1> CD14 ) .',\n",
       "  'PROTEIN',\n",
       "  'Wild - type Chinese hamster ovary ( CHO ) - K1 cells can be activated by endotoxin to release arachidonate following transfection with human CD14 ( CHO/ CD14 ) .',\n",
       "  [['CHO/CD14'], [26], 'PROTEIN']],\n",
       " ['We sought to determine if this pathway were present in <e1> CHO/ CD14 </e1> cells and to elucidate the relationship of NF - kappa B activation to the CD14 receptor system .',\n",
       "  'CELL_LINE',\n",
       "  'We sought to determine if this pathway were present in CHO/ CD14 cells and to elucidate the relationship of NF - kappa B activation to the CD14 receptor system .',\n",
       "  [['CHO/CD14', 'cell'], [10, 11], 'CELL_LINE']],\n",
       " ['LPS - stimulated translocation of NF - kappa B in <e1> CHO/ CD14 </e1> cells resembled the same response in the murine macrophage - like cell line RAW 264.7 .',\n",
       "  'CELL_LINE',\n",
       "  'LPS - stimulated translocation of NF - kappa B in CHO/ CD14 cells resembled the same response in the murine macrophage - like cell line RAW 264.7 .',\n",
       "  [['CHO/CD14', 'cell'], [10, 11], 'CELL_LINE']],\n",
       " ['Furthermore , the TK inhibitors herbimycin A and genistein failed to inhibit translocation of NF - kappa B in <e1> CHO/CD14 or </e1> RAW 264.7 cells , although both of these agents inhibited LPS - induced TK activity in RAW 264.7 cells .',\n",
       "  'CELL_LINE',\n",
       "  'Furthermore , the TK inhibitors herbimycin A and genistein failed to inhibit translocation of NF - kappa B in CHO/CD14 or RAW 264.7 cells , although both of these agents inhibited LPS - induced TK activity in RAW 264.7 cells .',\n",
       "  [['CHO/CD14', 'cell'], [19, 20], 'CELL_LINE']],\n",
       " ['Resolution of the NF - kappa B complex in gel shift analysis shows that the binding protein , mobilized in naive Mono Mac 6 cells , consists mainly of p50 <e1> - </e1> p65 heterodimers , while in tolerant cells , the p50 homodimer is predominant .',\n",
       "  'PROTEIN',\n",
       "  'Resolution of the NF - kappa B complex in gel shift analysis shows that the binding protein , mobilized in naive Mono Mac 6 cells , consists mainly of p50 - p65 heterodimers , while in tolerant cells , the p50 homodimer is predominant .',\n",
       "  [['p65'], [30], 'PROTEIN']],\n",
       " ['This exon was inserted between <e1> glutamine - rich regions 2 and 3 </e1> , carboxy terminal of a tentative leucine - zipper structure .',\n",
       "  'DNA',\n",
       "  'This exon was inserted between glutamine - rich regions 2 and 3 , carboxy terminal of a tentative leucine - zipper structure .',\n",
       "  [['glutamine', '-', 'rich', 'region', '2', 'and', '3'],\n",
       "   [5, 6, 7, 8, 9, 10, 11],\n",
       "   'DNA']],\n",
       " ['In addition , a new combination isoform containing <e1> Oct2a s amino terminal </e1> insert ( exon 7a ) and Oct2b s carboxy terminal insert ( exon 13 ) was found that created a novel large isoform , Oct2ab .',\n",
       "  'PROTEIN',\n",
       "  'In addition , a new combination isoform containing Oct2a s amino terminal insert ( exon 7a ) and Oct2b s carboxy terminal insert ( exon 13 ) was found that created a novel large isoform , Oct2ab .',\n",
       "  [[\"Oct2a's\", 'amino', 'terminal', 'insert'], [8, 9, 10, 11], 'PROTEIN']],\n",
       " ['In addition , a new combination isoform containing Oct2a s amino terminal insert ( exon 7a ) and <e1> Oct2b s carboxy terminal </e1> insert ( exon 13 ) was found that created a novel large isoform , Oct2ab .',\n",
       "  'PROTEIN',\n",
       "  'In addition , a new combination isoform containing Oct2a s amino terminal insert ( exon 7a ) and Oct2b s carboxy terminal insert ( exon 13 ) was found that created a novel large isoform , Oct2ab .',\n",
       "  [[\"Oct2b's\", 'carboxy', 'terminal', 'insert'], [18, 19, 20, 21], 'PROTEIN']],\n",
       " ['The role of the <e1> human immunodeficiency virus ( HIV - 1 ) </e1> Nef protein in T cell activation pathways was investigated using a Jurkat CD4 + cell line stably transfected with a Nef expression vector .',\n",
       "  'PROTEIN',\n",
       "  'The role of the human immunodeficiency virus ( HIV - 1 ) Nef protein in T cell activation pathways was investigated using a Jurkat CD4 + cell line stably transfected with a Nef expression vector .',\n",
       "  [['human', 'immunodeficiency', 'virus', '(HIV', '-', '1)', 'Nef', 'protein'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['The role of the human immunodeficiency virus ( HIV - 1 ) Nef protein in T cell activation pathways was investigated using a <e1> Jurkat CD4 + cell </e1> line stably transfected with a Nef expression vector .',\n",
       "  'CELL_LINE',\n",
       "  'The role of the human immunodeficiency virus ( HIV - 1 ) Nef protein in T cell activation pathways was investigated using a Jurkat CD4 + cell line stably transfected with a Nef expression vector .',\n",
       "  [['Jurkat', 'CD4+', 'cell', 'line'], [23, 24, 25, 26], 'CELL_LINE']],\n",
       " ['Secretion of IL - 2 and TNF - alpha , surface expression of IL - 2R , and DNA - binding activity of NF - kappa B and <e1> AP - 1 ( Fos/Jun </e1> ) complex in response to phorbol myristate acetate , TNF - alpha , or immobilized antibodies to CD3 were monitored .',\n",
       "  'PROTEIN',\n",
       "  'Secretion of IL - 2 and TNF - alpha , surface expression of IL - 2R , and DNA - binding activity of NF - kappa B and AP - 1 ( Fos/Jun ) complex in response to phorbol myristate acetate , TNF - alpha , or immobilized antibodies to CD3 were monitored .',\n",
       "  [['AP', '-', '1', '(Fos/Jun)', 'complex'], [28, 29, 30, 31, 32], 'PROTEIN']],\n",
       " ['These parameters were not modified by Nef expression in Jurkat cells , whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in <e1> Nef + Jurkat </e1> cells .',\n",
       "  'CELL_LINE',\n",
       "  'These parameters were not modified by Nef expression in Jurkat cells , whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef + Jurkat cells .',\n",
       "  [['Nef+', 'Jurkat', 'cell'], [26, 27, 28], 'CELL_LINE']],\n",
       " ['One of the cellular targets of the trans - activating effects of Tax is the <e1> NF - kappa B /Rel </e1> family of transcription factors , pleiotropic regulators of immunoregulatory , cytokine and viral gene expression .',\n",
       "  'PROTEIN',\n",
       "  'One of the cellular targets of the trans - activating effects of Tax is the NF - kappa B /Rel family of transcription factors , pleiotropic regulators of immunoregulatory , cytokine and viral gene expression .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'family'], [15, 16, 17, 18, 19], 'PROTEIN']],\n",
       " ['In FCS - liquid - suspension culture supplemented with saturating Ep level and <e1> low - dose IL - 3 /GM - </e1> CSF , adult HPC undergo unilineage erythropoietic differentiation : Here again , treatment with high - dose RA induces a shift from the erythroid to granulocytic differentiation pathway .',\n",
       "  'PROTEIN',\n",
       "  'In FCS - liquid - suspension culture supplemented with saturating Ep level and low - dose IL - 3 /GM - CSF , adult HPC undergo unilineage erythropoietic differentiation : Here again , treatment with high - dose RA induces a shift from the erythroid to granulocytic differentiation pathway .',\n",
       "  [['low', '-', 'dose', 'IL', '-', '3/GM', '-', 'CSF'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['We have previously shown that a <e1> human B lymphoma cell line , </e1> B104 , expressed surface IgM ( sIgM ) and surface IgD ( sIgD ) , and that crosslinking of sIgM and sIgD by anti - IgM antibody ( Ab ) and anti - IgD Ab , respectively , induced Ca2+ influx to almost the same degree , whereas only sIgM - crosslinking caused B104 cell death .',\n",
       "  'CELL_LINE',\n",
       "  'We have previously shown that a human B lymphoma cell line , B104 , expressed surface IgM ( sIgM ) and surface IgD ( sIgD ) , and that crosslinking of sIgM and sIgD by anti - IgM antibody ( Ab ) and anti - IgD Ab , respectively , induced Ca2+ influx to almost the same degree , whereas only sIgM - crosslinking caused B104 cell death .',\n",
       "  [['human', 'B', 'lymphoma', 'cell', 'line,', 'B104'],\n",
       "   [6, 7, 8, 9, 10, 11],\n",
       "   'CELL_LINE']],\n",
       " ['We have previously shown that a human B lymphoma cell line , B104 , expressed surface IgM ( sIgM ) and surface IgD ( sIgD ) , and that crosslinking of sIgM and sIgD by <e1> anti - IgM antibody ( </e1> Ab ) and anti - IgD Ab , respectively , induced Ca2+ influx to almost the same degree , whereas only sIgM - crosslinking caused B104 cell death .',\n",
       "  'PROTEIN',\n",
       "  'We have previously shown that a human B lymphoma cell line , B104 , expressed surface IgM ( sIgM ) and surface IgD ( sIgD ) , and that crosslinking of sIgM and sIgD by anti - IgM antibody ( Ab ) and anti - IgD Ab , respectively , induced Ca2+ influx to almost the same degree , whereas only sIgM - crosslinking caused B104 cell death .',\n",
       "  [['anti', '-', 'IgM', 'antibody', '(Ab)'], [35, 36, 37, 38, 39], 'PROTEIN']],\n",
       " ['Interferon augments PML and PML/RAR alpha expression in normal <e1> myeloid and </e1> acute promyelocytic cells and cooperates with all - trans retinoic acid to induce maturation of a retinoid - resistant promyelocytic cell line .',\n",
       "  'CELL_TYPE',\n",
       "  'Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all - trans retinoic acid to induce maturation of a retinoid - resistant promyelocytic cell line .',\n",
       "  [['myeloid', 'cell'], [9, 10], 'CELL_TYPE']],\n",
       " ['Similarly , interferons could act on APL cells , alone or in combination with all - trans retinoic acid ( RA ) , especially if the PML/RAR alpha fusion transcript that results from the <e1> t(15; 17) is </e1> induced by interferon .',\n",
       "  'DNA',\n",
       "  'Similarly , interferons could act on APL cells , alone or in combination with all - trans retinoic acid ( RA ) , especially if the PML/RAR alpha fusion transcript that results from the t(15; 17) is induced by interferon .',\n",
       "  [['t(15;', '17)'], [34, 35], 'DNA']],\n",
       " ['We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes , lymphocytes , and polymorphonucleate cells , but is markedly induced by interferon ; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line , which carries the <e1> t(15; 17) , </e1> and in APL blasts from patients ; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA ; that interferons alone have minimal maturation effect on NB4 cells ; and , finally , that interferon gamma , but not alpha or beta , induces maturation and growth suppression of NB4 cells with de novo retinoid resistance , and partially restores RA response .',\n",
       "  'DNA',\n",
       "  'We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes , lymphocytes , and polymorphonucleate cells , but is markedly induced by interferon ; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line , which carries the t(15; 17) , and in APL blasts from patients ; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA ; that interferons alone have minimal maturation effect on NB4 cells ; and , finally , that interferon gamma , but not alpha or beta , induces maturation and growth suppression of NB4 cells with de novo retinoid resistance , and partially restores RA response .',\n",
       "  [['t(15;', '17)'], [52, 53], 'DNA']],\n",
       " ['We have cloned the <e1> latent membrane protein 1 ( LMP1 </e1> ) homologs from the simian EBV naturally infecting baboons ( cercopithicine herpesvirus 12 , herpesvirus papio ) and rhesus monkeys ( cercopithicine herpesvirus 15 ) for a comparative study with the human EBV oncogene .',\n",
       "  'PROTEIN',\n",
       "  'We have cloned the latent membrane protein 1 ( LMP1 ) homologs from the simian EBV naturally infecting baboons ( cercopithicine herpesvirus 12 , herpesvirus papio ) and rhesus monkeys ( cercopithicine herpesvirus 15 ) for a comparative study with the human EBV oncogene .',\n",
       "  [['latent', 'membrane', 'protein', '1', '(LMP1)', 'homolog'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['The conserved TRAF3 binding sites in LMP1 and the <e1> CD30 Hodgkin s disease </e1> marker provides further evidence that a TRAF3 - mediated signal transduction pathway may be important in malignant transformation .',\n",
       "  'PROTEIN',\n",
       "  'The conserved TRAF3 binding sites in LMP1 and the CD30 Hodgkin s disease marker provides further evidence that a TRAF3 - mediated signal transduction pathway may be important in malignant transformation .',\n",
       "  [['CD30', \"Hodgkin's\", 'disease', 'marker'], [9, 10, 11, 12], 'PROTEIN']],\n",
       " ['G(Anh)MTetra was found to strongly induce <e1> interleukin ( IL ) - </e1> 1 beta and IL - 6 mRNA expression after 2 h and IL - 1 beta and IL - 6 protein secretion after 48 h of activation .',\n",
       "  'PROTEIN',\n",
       "  'G(Anh)MTetra was found to strongly induce interleukin ( IL ) - 1 beta and IL - 6 mRNA expression after 2 h and IL - 1 beta and IL - 6 protein secretion after 48 h of activation .',\n",
       "  [['interleukin', '(IL)', '-', '1', 'beta'], [6, 7, 8, 9, 10], 'PROTEIN']],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal bands 6q26 - 27 </e1> , 1p21 - 22 , 3q21 - 24 , 8p12 , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "  'DNA',\n",
       "  'Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal bands 6q26 - 27 , 1p21 - 22 , 3q21 - 24 , 8p12 , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "  [['human', 'chromosomal', 'band', '6q26', '-', '27'],\n",
       "   [49, 50, 51, 52, 53, 54],\n",
       "   'DNA']],\n",
       " ['To further elucidate the role of this variant octamer motif in the regulation of <e1> germline transcription </e1> from the unrearranged kappa locus , we have quantitated the relative binding affinity of Oct - 1 and Oct - 2 for the variant octamer motif and determined the functional role of this octamer motif in transcriptional activation .',\n",
       "  'DNA',\n",
       "  'To further elucidate the role of this variant octamer motif in the regulation of germline transcription from the unrearranged kappa locus , we have quantitated the relative binding affinity of Oct - 1 and Oct - 2 for the variant octamer motif and determined the functional role of this octamer motif in transcriptional activation .',\n",
       "  [['germline', 'promotor'], [14, 15], 'DNA']],\n",
       " ['We also find significant differences in activation of <e1> germline and </e1> V region promoters by kappa enhancers .',\n",
       "  'DNA',\n",
       "  'We also find significant differences in activation of germline and V region promoters by kappa enhancers .',\n",
       "  [['germline', 'promotor'], [8, 9], 'DNA']],\n",
       " ['These findings have important implications in regulation of <e1> germline transcription </e1> as well as concomitant activation of the V - J recombination of the kappa light chain locus .',\n",
       "  'DNA',\n",
       "  'These findings have important implications in regulation of germline transcription as well as concomitant activation of the V - J recombination of the kappa light chain locus .',\n",
       "  [['germline', 'promotor'], [8, 9], 'DNA']],\n",
       " ['In the present study , we showed that CD14+ adherent human monocytes can differentiate into CD1+relB+ dendritic cells ( DC ) by the combination of GM - CSF plus interleukin - 4 ( IL - 4 ) and that they differentiate into <e1> tartrate - resistant acid phosphatase ( TRAP ) - positive osteoclast - like multinucleated </e1> giant cells ( MGC ) by the combination of M - CSF plus IL - 4 .',\n",
       "  'CELL_TYPE',\n",
       "  'In the present study , we showed that CD14+ adherent human monocytes can differentiate into CD1+relB+ dendritic cells ( DC ) by the combination of GM - CSF plus interleukin - 4 ( IL - 4 ) and that they differentiate into tartrate - resistant acid phosphatase ( TRAP ) - positive osteoclast - like multinucleated giant cells ( MGC ) by the combination of M - CSF plus IL - 4 .',\n",
       "  [['tartrate',\n",
       "    '-',\n",
       "    'resistant',\n",
       "    'acid',\n",
       "    'phosphatase',\n",
       "    '(TRAP)',\n",
       "    '-',\n",
       "    'positive',\n",
       "    'osteoclast',\n",
       "    '-',\n",
       "    'like',\n",
       "    'multinucleated',\n",
       "    'giant',\n",
       "    'cell'],\n",
       "   [42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55],\n",
       "   'CELL_TYPE']],\n",
       " ['Here we report that tepoxalin selectively inhibits intercellular adhesion molecule - 1 <e1> ( ICAM - 1 , CD54 </e1> ) /MAC - 1 ( CD11b/CD18 ) dependent adhesion of polymorphonuclear cells to IL - 1 activated human umbilical vein endothelial cells .',\n",
       "  'PROTEIN',\n",
       "  'Here we report that tepoxalin selectively inhibits intercellular adhesion molecule - 1 ( ICAM - 1 , CD54 ) /MAC - 1 ( CD11b/CD18 ) dependent adhesion of polymorphonuclear cells to IL - 1 activated human umbilical vein endothelial cells .',\n",
       "  [['(ICAM', '-', '1,', 'CD54)/MAC', '-', '1'],\n",
       "   [12, 13, 14, 15, 16, 17],\n",
       "   'PROTEIN']],\n",
       " ['Expression of other adhesion molecules such as lymphocyte function associated - antigen - 1 ( <e1> CD11a </e1> /CD18 ) and CD54 were unaffected .',\n",
       "  'PROTEIN',\n",
       "  'Expression of other adhesion molecules such as lymphocyte function associated - antigen - 1 ( CD11a /CD18 ) and CD54 were unaffected .',\n",
       "  [['CD11a/CD18'], [15], 'PROTEIN']],\n",
       " ['While Jurkat cells co - expressed two discrete cell - surface isoforms of CD43 , recognized by mAb J393 and mAb G10 - 2 , respectively , only <e1> J393/ </e1> CD43 signaled apoptosis .',\n",
       "  'PROTEIN',\n",
       "  'While Jurkat cells co - expressed two discrete cell - surface isoforms of CD43 , recognized by mAb J393 and mAb G10 - 2 , respectively , only J393/ CD43 signaled apoptosis .',\n",
       "  [['J393/CD43'], [28], 'PROTEIN']],\n",
       " ['<e1> J393/ </e1> CD43 was found to be hyposialylated , bearing predominantly O - linked monosaccharide glycans , whereas G10 - 2/ CD43 bore complex sialylated tetra - and hexasaccharide chains .',\n",
       "  'PROTEIN',\n",
       "  'J393/ CD43 was found to be hyposialylated , bearing predominantly O - linked monosaccharide glycans , whereas G10 - 2/ CD43 bore complex sialylated tetra - and hexasaccharide chains .',\n",
       "  [['J393/CD43'], [0], 'PROTEIN']],\n",
       " ['J393/ CD43 was found to be hyposialylated , bearing predominantly O - linked monosaccharide glycans , whereas <e1> G10 - 2/ </e1> CD43 bore complex sialylated tetra - and hexasaccharide chains .',\n",
       "  'PROTEIN',\n",
       "  'J393/ CD43 was found to be hyposialylated , bearing predominantly O - linked monosaccharide glycans , whereas G10 - 2/ CD43 bore complex sialylated tetra - and hexasaccharide chains .',\n",
       "  [['G10', '-', '2/CD43'], [17, 18, 19], 'PROTEIN']],\n",
       " ['Tyrosine kinase inhibition by herbimycin A diminished <e1> J393/ </e1> CD43 - mediated apoptosis , whereas inhibition of phosphotyrosine phosphatase activity by bis(maltolato)oxovanadium - IV enhanced cell death .',\n",
       "  'PROTEIN',\n",
       "  'Tyrosine kinase inhibition by herbimycin A diminished J393/ CD43 - mediated apoptosis , whereas inhibition of phosphotyrosine phosphatase activity by bis(maltolato)oxovanadium - IV enhanced cell death .',\n",
       "  [['J393/CD43'], [7], 'PROTEIN']],\n",
       " ['Sterol regulatory element ( SRE ) has been recognized to regulate various key genes coding for especially <e1> low density lipoprotein ( LDL ) </e1> - receptor , 3 - hydroxy - 3 - methylglutaryl coenzyme A ( HMG - CoA ) reductase and HMG - CoA synthase known to play a crucial role in the cholesterol feedback mechanism .',\n",
       "  'PROTEIN',\n",
       "  'Sterol regulatory element ( SRE ) has been recognized to regulate various key genes coding for especially low density lipoprotein ( LDL ) - receptor , 3 - hydroxy - 3 - methylglutaryl coenzyme A ( HMG - CoA ) reductase and HMG - CoA synthase known to play a crucial role in the cholesterol feedback mechanism .',\n",
       "  [['low', 'density', 'lipoprotein', '(LDL)', '-', 'receptor'],\n",
       "   [17, 18, 19, 20, 21, 22],\n",
       "   'PROTEIN']],\n",
       " ['Sterol regulatory element ( SRE ) has been recognized to regulate various key genes coding for especially low density lipoprotein ( LDL ) - receptor , <e1> 3 - hydroxy - 3 - methylglutaryl coenzyme A ( HMG - CoA </e1> ) reductase and HMG - CoA synthase known to play a crucial role in the cholesterol feedback mechanism .',\n",
       "  'PROTEIN',\n",
       "  'Sterol regulatory element ( SRE ) has been recognized to regulate various key genes coding for especially low density lipoprotein ( LDL ) - receptor , 3 - hydroxy - 3 - methylglutaryl coenzyme A ( HMG - CoA ) reductase and HMG - CoA synthase known to play a crucial role in the cholesterol feedback mechanism .',\n",
       "  [['3',\n",
       "    '-',\n",
       "    'hydroxy',\n",
       "    '-',\n",
       "    '3',\n",
       "    '-',\n",
       "    'methylglutaryl',\n",
       "    'coenzyme',\n",
       "    'A',\n",
       "    '(HMG',\n",
       "    '-',\n",
       "    'CoA)',\n",
       "    'reductase'],\n",
       "   [26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> interferon regulatory factor - 1 ( IRF - 1 </e1> ) gene is both an immediate - early G1 phase gene and an S phase gene inducible by PRL in rat Nb2 T lymphocytes .',\n",
       "  'DNA',\n",
       "  'The interferon regulatory factor - 1 ( IRF - 1 ) gene is both an immediate - early G1 phase gene and an S phase gene inducible by PRL in rat Nb2 T lymphocytes .',\n",
       "  [['interferon', 'regulatory', 'factor', '-', '1', '(IRF', '-', '1)', 'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['Upon transfection into Nb2 T cells , 1.7 kilobases ( kb ) of IRF - 1 5 - flanking DNA linked to a <e1> chloramphenicol acetyl transferase ( CAT ) </e1> reporter gene mediated a 30 - fold induction of CAT enzyme activity in response to 24 h of PRL stimulation .',\n",
       "  'DNA',\n",
       "  'Upon transfection into Nb2 T cells , 1.7 kilobases ( kb ) of IRF - 1 5 - flanking DNA linked to a chloramphenicol acetyl transferase ( CAT ) reporter gene mediated a 30 - fold induction of CAT enzyme activity in response to 24 h of PRL stimulation .',\n",
       "  [['chloramphenicol', 'acetyl', 'transferase', '(CAT)', 'reporter', 'gene'],\n",
       "   [23, 24, 25, 26, 27, 28],\n",
       "   'DNA']],\n",
       " ['By assaying CAT enzyme activity across a 24 - h PRL induction time course , we were able to assign G1 vs. S phase PRL responses of the IRF - 1 gene to different regions of the IRF - 1 <e1> 5 - flanking and </e1> promoter DNA .',\n",
       "  'DNA',\n",
       "  'By assaying CAT enzyme activity across a 24 - h PRL induction time course , we were able to assign G1 vs. S phase PRL responses of the IRF - 1 gene to different regions of the IRF - 1 5 - flanking and promoter DNA .',\n",
       "  [[\"5'\", '-', 'flanking', 'DNA'], [40, 41, 42, 43], 'DNA']],\n",
       " ['The 0.2 - kb <e1> IRF - CAT construct </e1> was induced by PRL stimulation during the G1 phase of the cell cycle .',\n",
       "  'DNA',\n",
       "  'The 0.2 - kb IRF - CAT construct was induced by PRL stimulation during the G1 phase of the cell cycle .',\n",
       "  [['IRF', '-', 'CAT', 'construc'], [4, 5, 6, 7], 'DNA']],\n",
       " ['We identified several anti - Ig response elements within Zp , which were originally defined as <e1> 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA ) </e1> response elements ( ZI repeats and ZII , an AP - 1 - like domain ) .',\n",
       "  'DNA',\n",
       "  'We identified several anti - Ig response elements within Zp , which were originally defined as 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA ) response elements ( ZI repeats and ZII , an AP - 1 - like domain ) .',\n",
       "  [['12',\n",
       "    '-',\n",
       "    'O',\n",
       "    '-',\n",
       "    'tetradecanoylphorbol',\n",
       "    '-',\n",
       "    '13',\n",
       "    '-',\n",
       "    'acetate',\n",
       "    '(TPA)',\n",
       "    'response',\n",
       "    'element'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27],\n",
       "   'DNA']],\n",
       " ['These findings suggest that Zp responds directly to changes in the activity of both PKC and <e1> calcium /calmodulin - dependent protein </e1> kinase .',\n",
       "  'PROTEIN',\n",
       "  'These findings suggest that Zp responds directly to changes in the activity of both PKC and calcium /calmodulin - dependent protein kinase .',\n",
       "  [['calcium/calmodulin', '-', 'dependent', 'protein', 'kinase'],\n",
       "   [16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['Two multicopy basal enhancer motifs within the SCMV MIE enhancer , namely , 11 copies of the 16 - bp cyclic AMP response element ( CRE ) and 3 copies of novel 17 - bp <e1> serum response factor ( SRF ) </e1> binding sites referred to as the SNE ( SRF/NFkappaB - like element ) , as well as four classical NFkappaB sites within the HCMV version , contribute to TPA responsiveness in transient assays in monocyte and T - cell types .',\n",
       "  'DNA',\n",
       "  'Two multicopy basal enhancer motifs within the SCMV MIE enhancer , namely , 11 copies of the 16 - bp cyclic AMP response element ( CRE ) and 3 copies of novel 17 - bp serum response factor ( SRF ) binding sites referred to as the SNE ( SRF/NFkappaB - like element ) , as well as four classical NFkappaB sites within the HCMV version , contribute to TPA responsiveness in transient assays in monocyte and T - cell types .',\n",
       "  [['serum', 'response', 'factor', '(SRF)', 'binding', 'sites'],\n",
       "   [35, 36, 37, 38, 39, 40],\n",
       "   'DNA']],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( <e1> SRF/ ETS </e1> element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  'DNA',\n",
       "  'Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['SRF/ETS', 'element'], [22, 23], 'DNA']],\n",
       " ['EL - 4 cells were transfected with a plasmid containing the IL - 2 promoter and enhancer region linked to the <e1> chloramphenicol acetyltransferase ( CAT ) </e1> reporter gene .',\n",
       "  'DNA',\n",
       "  'EL - 4 cells were transfected with a plasmid containing the IL - 2 promoter and enhancer region linked to the chloramphenicol acetyltransferase ( CAT ) reporter gene .',\n",
       "  [['chloramphenicol', 'acetyltransferase', '(CAT)', 'reporter', 'gene'],\n",
       "   [21, 22, 23, 24, 25],\n",
       "   'DNA']],\n",
       " ['Skeletal myogenesis is regulated by a group of transcription factors ( MyoD , myogenin , myf5 , and myf6 ) that are <e1> \" basic helix - loop - helix </e1> \" proteins that bind to the promoters of muscle - specific genes and promote their expression .',\n",
       "  'PROTEIN',\n",
       "  'Skeletal myogenesis is regulated by a group of transcription factors ( MyoD , myogenin , myf5 , and myf6 ) that are \" basic helix - loop - helix \" proteins that bind to the promoters of muscle - specific genes and promote their expression .',\n",
       "  [['\"basic', 'helix', '-', 'loop', '-', 'helix\"', 'protein'],\n",
       "   [22, 23, 24, 25, 26, 27, 28],\n",
       "   'PROTEIN']],\n",
       " ['In previous studies , it was shown that the fusion region of the pml/RAR - alpha protein , expressed by <e1> acute promyelocytic leukemia ( APL </e1> ) cells , can be specifically recognized in vitro by donor ( D. E. ) CD4 T cells in a HLA class II DR11 - restricted fashion .',\n",
       "  'CELL_LINE',\n",
       "  'In previous studies , it was shown that the fusion region of the pml/RAR - alpha protein , expressed by acute promyelocytic leukemia ( APL ) cells , can be specifically recognized in vitro by donor ( D. E. ) CD4 T cells in a HLA class II DR11 - restricted fashion .',\n",
       "  [['acute', 'promyelocytic', 'leukemia', '(APL)', 'cell'],\n",
       "   [20, 21, 22, 23, 24],\n",
       "   'CELL_LINE']],\n",
       " ['We then generated new donor <e1> anti - pml/ RAR - alpha CD4(+) T - cell </e1> clones .',\n",
       "  'CELL_LINE',\n",
       "  'We then generated new donor anti - pml/ RAR - alpha CD4(+) T - cell clones .',\n",
       "  [['anti', '-', 'pml/RAR', '-', 'alpha', 'CD4(+)', 'T', '-', 'cell', 'clone'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'CELL_LINE']],\n",
       " ['We then generated new donor <e1> anti - pml/ RAR - </e1> alpha CD4(+) T - cell clones .',\n",
       "  'PROTEIN',\n",
       "  'We then generated new donor anti - pml/ RAR - alpha CD4(+) T - cell clones .',\n",
       "  [['anti', '-', 'pml/RAR', '-', 'alpha'], [5, 6, 7, 8, 9], 'PROTEIN']],\n",
       " ['One clone ( <e1> C3/5 , CD3(+) , CD4(+) , </e1> CD8( - ) ) was selected for further analysis .',\n",
       "  'CELL_LINE',\n",
       "  'One clone ( C3/5 , CD3(+) , CD4(+) , CD8( - ) ) was selected for further analysis .',\n",
       "  [['C3/5,', 'CD3(+),', 'CD4(+),', 'CD8(', '-', ')'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'CELL_LINE']],\n",
       " ['In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of <e1> Rel/nuclear factor kappaB ( NF - kappaB </e1> ) factors in primary murine B lymphocytes .',\n",
       "  'PROTEIN',\n",
       "  'In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF - kappaB ) factors in primary murine B lymphocytes .',\n",
       "  [['Rel/nuclear', 'factor', 'kappaB', '(NF', '-', 'kappaB)', 'factors'],\n",
       "   [17, 18, 19, 20, 21, 22, 23],\n",
       "   'PROTEIN']],\n",
       " ['B lymphocyte stimulation via both CD40 and <e1> surface Ig ( sIg </e1> ) receptors substantially induced fra - 1 expression , and for both receptors , induction was protein kinase C ( PKC ) dependent .',\n",
       "  'PROTEIN',\n",
       "  'B lymphocyte stimulation via both CD40 and surface Ig ( sIg ) receptors substantially induced fra - 1 expression , and for both receptors , induction was protein kinase C ( PKC ) dependent .',\n",
       "  [['surface', 'Ig', '(sIg)', 'receptor'], [7, 8, 9, 10], 'PROTEIN']],\n",
       " ['The <e1> granulocyte - macrophage colony - stimulating factor ( GM - CSF </e1> ) gene has been studied extensively as a model system of transcriptional induction during T - lymphocyte activation .',\n",
       "  'DNA',\n",
       "  'The granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene has been studied extensively as a model system of transcriptional induction during T - lymphocyte activation .',\n",
       "  [['granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(GM',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'DNA']],\n",
       " ['<e1> Nuclear factor kappa B ( NF - kappa B ; heterodimer of p50 and </e1> p65 ) proteins have been suggested to play an important role in gene transcription of inflammatory mediators when monocytes are stimulated with lipopolysaccharide .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear factor kappa B ( NF - kappa B ; heterodimer of p50 and p65 ) proteins have been suggested to play an important role in gene transcription of inflammatory mediators when monocytes are stimulated with lipopolysaccharide .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    'kappa',\n",
       "    'B',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B;',\n",
       "    'heterodimer',\n",
       "    'of',\n",
       "    'p50',\n",
       "    'and',\n",
       "    'p65)',\n",
       "    'protein'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> Epstein - Barr virus ( EBV ) transforming </e1> protein LMP1 appears to be a constitutively activated tumor necrosis factor receptor ( TNFR ) on the basis of an intrinsic ability to aggregate in the plasma membrane and an association of its cytoplasmic carboxyl terminus ( CT ) with TNFR - associated factors ( TRAFs ) .',\n",
       "  'PROTEIN',\n",
       "  'The Epstein - Barr virus ( EBV ) transforming protein LMP1 appears to be a constitutively activated tumor necrosis factor receptor ( TNFR ) on the basis of an intrinsic ability to aggregate in the plasma membrane and an association of its cytoplasmic carboxyl terminus ( CT ) with TNFR - associated factors ( TRAFs ) .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    'transforming',\n",
       "    'protein',\n",
       "    'LMP1'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['The negative effects of point mutations in the <e1> LMP1 (1 - 231) core TRAF binding </e1> motif on TRAF binding and NF - kappaB activation genetically link the TRAFs to LMP1 (1 - 231) - mediated NF - kappaB activation .',\n",
       "  'DNA',\n",
       "  'The negative effects of point mutations in the LMP1 (1 - 231) core TRAF binding motif on TRAF binding and NF - kappaB activation genetically link the TRAFs to LMP1 (1 - 231) - mediated NF - kappaB activation .',\n",
       "  [['LMP1(1', '-', '231)', 'core', 'TRAF', 'binding', 'motif'],\n",
       "   [8, 9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['The gene encoding the <e1> Epstein - Barr virus ( EBV ) - </e1> specific dUTPase was amplified from virus DNA by PCR .',\n",
       "  'PROTEIN',\n",
       "  'The gene encoding the Epstein - Barr virus ( EBV ) - specific dUTPase was amplified from virus DNA by PCR .',\n",
       "  [['Epstein', '-', 'Barr', 'virus', '(EBV)', '-', 'specific', 'dUTPase'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['MAbs against the dUTPase reacted with a protein of approximately 31 kDa in <e1> 12 - O - tetradecanoyl - phorbol - 13 - acetate ( TPA ) - stimulated </e1> B cells harbouring either type 1 or type 2 EBV .',\n",
       "  'CELL_LINE',\n",
       "  'MAbs against the dUTPase reacted with a protein of approximately 31 kDa in 12 - O - tetradecanoyl - phorbol - 13 - acetate ( TPA ) - stimulated B cells harbouring either type 1 or type 2 EBV .',\n",
       "  [['12',\n",
       "    '-',\n",
       "    'O',\n",
       "    '-',\n",
       "    'tetradecanoyl',\n",
       "    '-',\n",
       "    'phorbol',\n",
       "    '-',\n",
       "    '13',\n",
       "    '-',\n",
       "    'acetate',\n",
       "    '(TPA)',\n",
       "    '-',\n",
       "    'stimulated',\n",
       "    'B',\n",
       "    'cell'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28],\n",
       "   'CELL_LINE']],\n",
       " ['Two pp56(lck) mutants lacking either the entire catalytic domain or the entire NH2 regulatory domain were generated , and their abilities to trigger transactivation of the <e1> TCR - regulated nuclear factor of activated T cells ( NF - AT </e1> ) region of the IL - 2 promoter were compared .',\n",
       "  'DNA',\n",
       "  'Two pp56(lck) mutants lacking either the entire catalytic domain or the entire NH2 regulatory domain were generated , and their abilities to trigger transactivation of the TCR - regulated nuclear factor of activated T cells ( NF - AT ) region of the IL - 2 promoter were compared .',\n",
       "  [['TCR',\n",
       "    '-',\n",
       "    'regulated',\n",
       "    'nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'AT)',\n",
       "    'region'],\n",
       "   [26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38],\n",
       "   'DNA']],\n",
       " ['Functional studies in <e1> extra - renal , nonepithelial </e1> cells such as smooth muscle cells and more recently circulating human lymphocytes have provided increasing evidence that aldosterone produces not only classical genomic effects , but also rapid non - genomic effects on transmembrane electrolyte movements .',\n",
       "  'CELL_TYPE',\n",
       "  'Functional studies in extra - renal , nonepithelial cells such as smooth muscle cells and more recently circulating human lymphocytes have provided increasing evidence that aldosterone produces not only classical genomic effects , but also rapid non - genomic effects on transmembrane electrolyte movements .',\n",
       "  [['extra', '-', 'renal,', 'nonepithelial', 'cell'],\n",
       "   [3, 4, 5, 6, 7],\n",
       "   'CELL_TYPE']],\n",
       " ['The <e1> macrophage colony - stimulating factor ( M - CSF </e1> ) receptor is expressed in a tissue - specific fashion from two distinct promoters in monocytes/macrophages and the placenta .',\n",
       "  'PROTEIN',\n",
       "  'The macrophage colony - stimulating factor ( M - CSF ) receptor is expressed in a tissue - specific fashion from two distinct promoters in monocytes/macrophages and the placenta .',\n",
       "  [['macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(M',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'receptor'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['A Western blot analysis was used to investigate HER - 2/neu expression , whereas a chromium - release assay using the K562 cell line as target was used to measure <e1> natural killer ( NK </e1> ) cell activity .',\n",
       "  'CELL_TYPE',\n",
       "  'A Western blot analysis was used to investigate HER - 2/neu expression , whereas a chromium - release assay using the K562 cell line as target was used to measure natural killer ( NK ) cell activity .',\n",
       "  [['natural', 'killer', '(NK)', 'cell'], [30, 31, 32, 33], 'CELL_TYPE']],\n",
       " ['The <e1> interleukin 2 receptor alpha - chain ( IL - 2R alpha </e1> ) gene is a key regulator of lymphocyte proliferation .',\n",
       "  'DNA',\n",
       "  'The interleukin 2 receptor alpha - chain ( IL - 2R alpha ) gene is a key regulator of lymphocyte proliferation .',\n",
       "  [['interleukin',\n",
       "    '2',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    '-',\n",
       "    'chain',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2R',\n",
       "    'alpha)',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'DNA']],\n",
       " ['These are essential for IL - 2 inducibility of <e1> PRRIII /CAT reporter </e1> constructs .',\n",
       "  'DNA',\n",
       "  'These are essential for IL - 2 inducibility of PRRIII /CAT reporter constructs .',\n",
       "  [['PRRIII/CAT', 'reporter', 'construct'], [9, 10, 11], 'DNA']],\n",
       " ['This led to the hypothesis that some of the <e1> Rel/ NF - kappa B </e1> proteins were key nuclear factors in functions of accessory cells of the immune response .',\n",
       "  'PROTEIN',\n",
       "  'This led to the hypothesis that some of the Rel/ NF - kappa B proteins were key nuclear factors in functions of accessory cells of the immune response .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B', 'protein'], [9, 10, 11, 12, 13], 'PROTEIN']],\n",
       " ['Therefore , we investigated in situ the nuclear localization of <e1> Rel/ NF - kappa B </e1> proteins in accessory cells of the immune system by immunohistochemistry and double labeling by immunofluorescence from five normal human tonsils and five lymph nodes with follicular hyperplasia .',\n",
       "  'PROTEIN',\n",
       "  'Therefore , we investigated in situ the nuclear localization of Rel/ NF - kappa B proteins in accessory cells of the immune system by immunohistochemistry and double labeling by immunofluorescence from five normal human tonsils and five lymph nodes with follicular hyperplasia .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B', 'protein'], [10, 11, 12, 13, 14], 'PROTEIN']],\n",
       " ['p52 and RelB were detected in the nuclei in both <e1> CD1a+ and </e1> CD68+ cells from the T cell area , whereas p50 was found only in CD68 - and CD1a - cells .',\n",
       "  'CELL_LINE',\n",
       "  'p52 and RelB were detected in the nuclei in both CD1a+ and CD68+ cells from the T cell area , whereas p50 was found only in CD68 - and CD1a - cells .',\n",
       "  [['CD1a+', 'cell'], [10, 11], 'CELL_LINE']],\n",
       " ['These results show that , physiologically , high levels of nuclear of p50 , p52 and RelB are restricted to accessory cells of the immune system , which include FDC in GC , and DC and macrophages in the T cell zone , that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB , whereas macrophages from the T cell area , known to present the antigen to T cells , do have both nuclear p52 and RelB , and that in the T cell zone , p52 and RelB are located in nuclei of both <e1> CD1a+ </e1> , CD68+ or both , cells APC , whereas p50 is restricted to CD1a - and CD68 -  APC .',\n",
       "  'CELL_LINE',\n",
       "  'These results show that , physiologically , high levels of nuclear of p50 , p52 and RelB are restricted to accessory cells of the immune system , which include FDC in GC , and DC and macrophages in the T cell zone , that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB , whereas macrophages from the T cell area , known to present the antigen to T cells , do have both nuclear p52 and RelB , and that in the T cell zone , p52 and RelB are located in nuclei of both CD1a+ , CD68+ or both , cells APC , whereas p50 is restricted to CD1a - and CD68 -  APC .',\n",
       "  [['CD1a+cell'], [101], 'CELL_LINE']],\n",
       " ['These results show that , physiologically , high levels of nuclear of p50 , p52 and RelB are restricted to accessory cells of the immune system , which include FDC in GC , and DC and macrophages in the T cell zone , that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB , whereas macrophages from the T cell area , known to present the antigen to T cells , do have both nuclear p52 and RelB , and that in the T cell zone , p52 and RelB are located in nuclei of both CD1a+ , <e1> CD68+ </e1> or both , cells APC , whereas p50 is restricted to CD1a - and CD68 -  APC .',\n",
       "  'CELL_LINE',\n",
       "  'These results show that , physiologically , high levels of nuclear of p50 , p52 and RelB are restricted to accessory cells of the immune system , which include FDC in GC , and DC and macrophages in the T cell zone , that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB , whereas macrophages from the T cell area , known to present the antigen to T cells , do have both nuclear p52 and RelB , and that in the T cell zone , p52 and RelB are located in nuclei of both CD1a+ , CD68+ or both , cells APC , whereas p50 is restricted to CD1a - and CD68 -  APC .',\n",
       "  [['CD68+cell'], [103], 'CELL_LINE']],\n",
       " ['These results show that , physiologically , high levels of nuclear of p50 , p52 and RelB are restricted to accessory cells of the immune system , which include FDC in GC , and DC and macrophages in the T cell zone , that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB , whereas macrophages from the T cell area , known to present the antigen to T cells , do have both nuclear p52 and RelB , and that in the T cell zone , p52 and RelB are located in nuclei of both CD1a+ , CD68+ or both , cells APC , whereas p50 is restricted to <e1> CD1a - and </e1> CD68 -  APC .',\n",
       "  'CELL_TYPE',\n",
       "  'These results show that , physiologically , high levels of nuclear of p50 , p52 and RelB are restricted to accessory cells of the immune system , which include FDC in GC , and DC and macrophages in the T cell zone , that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB , whereas macrophages from the T cell area , known to present the antigen to T cells , do have both nuclear p52 and RelB , and that in the T cell zone , p52 and RelB are located in nuclei of both CD1a+ , CD68+ or both , cells APC , whereas p50 is restricted to CD1a - and CD68 -  APC .',\n",
       "  [['CD1a', '-', 'APC'], [115, 116, 117], 'CELL_TYPE']],\n",
       " ['Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the <e1> monocytic but </e1> not the granulocytic lineage .',\n",
       "  'CELL_TYPE',\n",
       "  'Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage .',\n",
       "  [['monocytic', 'lineage'], [19, 20], 'CELL_TYPE']],\n",
       " ['The MNDA mRNA level in primary granulocytes was unaffected by addition of interferon alpha and other agents including interferon gamma , endotoxin , <e1> poly (I).poly (C) , and </e1> FMLP .',\n",
       "  'PROTEIN',\n",
       "  'The MNDA mRNA level in primary granulocytes was unaffected by addition of interferon alpha and other agents including interferon gamma , endotoxin , poly (I).poly (C) , and FMLP .',\n",
       "  [['poly', '(I).poly', '(C)'], [23, 24, 25], 'PROTEIN']],\n",
       " ['Furthermore , these cell lines appear resistant to lysis by <e1> natural killer ( NK </e1> ) cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Furthermore , these cell lines appear resistant to lysis by natural killer ( NK ) cells .',\n",
       "  [['natural', 'killer', '(NK)', 'cell'], [10, 11, 12, 13], 'CELL_TYPE']],\n",
       " ['To determine the E1A domain ( s ) responsible for these properties several cell lines were created by transforming <e1> baby rat kidney ( BRK </e1> ) cells with a set of plasmids expressing different Ad2/Ad12 hybrid E1A gene products .',\n",
       "  'CELL_LINE',\n",
       "  'To determine the E1A domain ( s ) responsible for these properties several cell lines were created by transforming baby rat kidney ( BRK ) cells with a set of plasmids expressing different Ad2/Ad12 hybrid E1A gene products .',\n",
       "  [['baby', 'rat', 'kidney', '(BRK)', 'cell'],\n",
       "   [19, 20, 21, 22, 23],\n",
       "   'CELL_LINE']],\n",
       " ['The MHC class 1 gene expression was inhibited in cells expressing the Ad12 13S mRNA product and in cells transformed with Ad2/Ad12 hybrid E1A gene product harboring the C - terminal part of the <e1> conserved region ( CR </e1> ) 3 of Ad12 .',\n",
       "  'DNA',\n",
       "  'The MHC class 1 gene expression was inhibited in cells expressing the Ad12 13S mRNA product and in cells transformed with Ad2/Ad12 hybrid E1A gene product harboring the C - terminal part of the conserved region ( CR ) 3 of Ad12 .',\n",
       "  [['conserved', 'region', '(CR)', '3'], [34, 35, 36, 37], 'DNA']],\n",
       " ['Cell specific expression of <e1> human Bruton s agammaglobulinemia tyrosine kinase </e1> gene ( Btk ) is regulated by Sp1 - and Spi - 1/PU.1 - family members .',\n",
       "  'DNA',\n",
       "  'Cell specific expression of human Bruton s agammaglobulinemia tyrosine kinase gene ( Btk ) is regulated by Sp1 - and Spi - 1/PU.1 - family members .',\n",
       "  [['human', \"Bruton's\", 'agammaglobulinemia', 'tyrosine', 'kinase', 'gene'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['<e1> Bruton s agammaglobulinemia tyrosine </e1> kinase ( Btk ) is a cytoplasmic tyrosine kinase involved in the human disease X - linked agammaglobulinemia ( XLA ) .',\n",
       "  'PROTEIN',\n",
       "  'Bruton s agammaglobulinemia tyrosine kinase ( Btk ) is a cytoplasmic tyrosine kinase involved in the human disease X - linked agammaglobulinemia ( XLA ) .',\n",
       "  [[\"Bruton's\", 'agammaglobulinemia', 'tyrosine', 'kinase'],\n",
       "   [0, 1, 2, 3],\n",
       "   'PROTEIN']],\n",
       " ['Therefore , it is important to determine whether CD14 is expressed in gingival fibroblasts and to define the P - LPS - mediated <e1> signal - transducing mechanism </e1> in the cells .',\n",
       "  'PROTEIN',\n",
       "  'Therefore , it is important to determine whether CD14 is expressed in gingival fibroblasts and to define the P - LPS - mediated signal - transducing mechanism in the cells .',\n",
       "  [['signal', '-', 'transducing', 'molecule'], [23, 24, 25, 26], 'PROTEIN']],\n",
       " ['P - LPS - induced expression of the <e1> monocyte chemoattractant protein 1 ( MCP - 1 </e1> ) gene in the cells was inhibited markedly by treatment with anti - human CD14 antibody and was completely inhibited by herbimycin A , a potent inhibitor of tyrosine kinase .',\n",
       "  'DNA',\n",
       "  'P - LPS - induced expression of the monocyte chemoattractant protein 1 ( MCP - 1 ) gene in the cells was inhibited markedly by treatment with anti - human CD14 antibody and was completely inhibited by herbimycin A , a potent inhibitor of tyrosine kinase .',\n",
       "  [['monocyte', 'chemoattractant', 'protein', '1', '(MCP', '-', '1)', 'gene'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['We have developed a monoclonal antibody , Yae , which is specific for <e1> Pan/ E2A </e1> proteins , and have used the Yae antibody to examine a variety of endocrine and nonendocrine cell lineages for differences in Pan/ E2A  protein expression , subcellular localization , and heteromeric complex formation .',\n",
       "  'PROTEIN',\n",
       "  'We have developed a monoclonal antibody , Yae , which is specific for Pan/ E2A proteins , and have used the Yae antibody to examine a variety of endocrine and nonendocrine cell lineages for differences in Pan/ E2A  protein expression , subcellular localization , and heteromeric complex formation .',\n",
       "  [['Pan/E2A', 'protein'], [13, 14], 'PROTEIN']],\n",
       " ['NF - kappa B , a <e1> 50 kDa/65 kDa ( p50/p65 </e1> ) heterodimer , is a ubiquitous transcription factor involved in the positive regulation of various immune genes .',\n",
       "  'PROTEIN',\n",
       "  'NF - kappa B , a 50 kDa/65 kDa ( p50/p65 ) heterodimer , is a ubiquitous transcription factor involved in the positive regulation of various immune genes .',\n",
       "  [['50', 'kDa/65', 'kDa', '(p50/p65)', 'heterodimer'],\n",
       "   [6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ['Although inhibition of IL - 4 - driven germline C epsilon transcription by NAC was not sufficient , the agent remarkably diminished anti - CD40 mAb - mediated up - regulation of <e1> germline C </e1> epsilon transcription .',\n",
       "  'DNA',\n",
       "  'Although inhibition of IL - 4 - driven germline C epsilon transcription by NAC was not sufficient , the agent remarkably diminished anti - CD40 mAb - mediated up - regulation of germline C epsilon transcription .',\n",
       "  [['germline', 'promotor'], [32, 33], 'DNA']],\n",
       " ['Using electrophoretic mobility shift assay , we demonstrated that a short treatment of human T lymphocytes with PGE2 induces specific binding activity to CRE and <e1> AP - 2 , but </e1> not AP - 1 , DNA elements .',\n",
       "  'DNA',\n",
       "  'Using electrophoretic mobility shift assay , we demonstrated that a short treatment of human T lymphocytes with PGE2 induces specific binding activity to CRE and AP - 2 , but not AP - 1 , DNA elements .',\n",
       "  [['AP', '-', '2', 'DNA', 'element'], [25, 26, 27, 28, 29], 'DNA']],\n",
       " ['Using electrophoretic mobility shift assay , we demonstrated that a short treatment of human T lymphocytes with PGE2 induces specific binding activity to CRE and AP - 2 , but not <e1> AP - 1 , DNA </e1> elements .',\n",
       "  'DNA',\n",
       "  'Using electrophoretic mobility shift assay , we demonstrated that a short treatment of human T lymphocytes with PGE2 induces specific binding activity to CRE and AP - 2 , but not AP - 1 , DNA elements .',\n",
       "  [['AP', '-', '1,', 'DNA', 'element'], [31, 32, 33, 34, 35], 'DNA']],\n",
       " ['Nasal T/NK - cell lymphomas can be further separated into those of <e1> natural killer ( NK ) </e1> cell lineage or of T - cell lineage , with differences in cellular phenotype , T - cell receptor ( TcR ) gene rearrangement and TcR transcript expression .',\n",
       "  'CELL_TYPE',\n",
       "  'Nasal T/NK - cell lymphomas can be further separated into those of natural killer ( NK ) cell lineage or of T - cell lineage , with differences in cellular phenotype , T - cell receptor ( TcR ) gene rearrangement and TcR transcript expression .',\n",
       "  [['natural', 'killer', '(NK)', 'cell', 'lineage'],\n",
       "   [12, 13, 14, 15, 16],\n",
       "   'CELL_TYPE']],\n",
       " ['Nasal T/NK - cell lymphomas can be further separated into those of natural killer ( NK ) cell lineage or of T - cell lineage , with differences in cellular phenotype , <e1> T - cell receptor ( TcR </e1> ) gene rearrangement and TcR transcript expression .',\n",
       "  'DNA',\n",
       "  'Nasal T/NK - cell lymphomas can be further separated into those of natural killer ( NK ) cell lineage or of T - cell lineage , with differences in cellular phenotype , T - cell receptor ( TcR ) gene rearrangement and TcR transcript expression .',\n",
       "  [['T', '-', 'cell', 'receptor', '(TcR)', 'gene'],\n",
       "   [32, 33, 34, 35, 36, 37],\n",
       "   'DNA']],\n",
       " ['The induction of <e1> immediate - early ( IE ) </e1> response genes , such as egr - 1 , c - fos , and c - jun , occurs rapidly after the activation of T lymphocytes .',\n",
       "  'DNA',\n",
       "  'The induction of immediate - early ( IE ) response genes , such as egr - 1 , c - fos , and c - jun , occurs rapidly after the activation of T lymphocytes .',\n",
       "  [['immediate', '-', 'early', '(IE)', 'response', 'gene'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'DNA']],\n",
       " ['The <e1> interleukin - 2 ( IL - 2 </e1> ) promoter consists of several independent T cell receptor ( TcR ) responsive elements .',\n",
       "  'DNA',\n",
       "  'The interleukin - 2 ( IL - 2 ) promoter consists of several independent T cell receptor ( TcR ) responsive elements .',\n",
       "  [['interleukin', '-', '2', '(IL', '-', '2)', 'promoter'],\n",
       "   [1, 2, 3, 4, 5, 6, 7],\n",
       "   'DNA']],\n",
       " ['The interleukin - 2 ( IL - 2 ) promoter consists of several independent <e1> T cell receptor ( TcR ) </e1> responsive elements .',\n",
       "  'DNA',\n",
       "  'The interleukin - 2 ( IL - 2 ) promoter consists of several independent T cell receptor ( TcR ) responsive elements .',\n",
       "  [['T', 'cell', 'receptor', '(TcR)', 'responsive', 'element'],\n",
       "   [14, 15, 16, 17, 18, 19],\n",
       "   'DNA']],\n",
       " ['Calcineurin , a <e1> Ca2+ /calmodulin - dependent protein </e1> phosphatase , is the FK - 506 - and CsA - sensitive enzyme required for TcR mediated activation of the IL - 2 promoter .',\n",
       "  'PROTEIN',\n",
       "  'Calcineurin , a Ca2+ /calmodulin - dependent protein phosphatase , is the FK - 506 - and CsA - sensitive enzyme required for TcR mediated activation of the IL - 2 promoter .',\n",
       "  [['Ca2+/calmodulin', '-', 'dependent', 'protein', 'phosphatase'],\n",
       "   [3, 4, 5, 6, 7],\n",
       "   'PROTEIN']],\n",
       " ['The PML/RAR alpha fusion gene resulting from the <e1> t (15;17) translocation is </e1> a specific marker for acute promyelocytic leukemia ( APL ) .',\n",
       "  'DNA',\n",
       "  'The PML/RAR alpha fusion gene resulting from the t (15;17) translocation is a specific marker for acute promyelocytic leukemia ( APL ) .',\n",
       "  [['t', '(15;17)', 'translocation'], [8, 9, 10], 'DNA']],\n",
       " ['The effect of DM on expression of IL - 2R alpha ( Tac , p55 , CD25 ) and <e1> beta ( p75 </e1> ) genes in activated T cells was examined next .',\n",
       "  'DNA',\n",
       "  'The effect of DM on expression of IL - 2R alpha ( Tac , p55 , CD25 ) and beta ( p75 ) genes in activated T cells was examined next .',\n",
       "  [['beta', '(p75)', 'gene'], [19, 20, 21], 'DNA']],\n",
       " ['p27Kip1 directly inhibits the catalytic activity of <e1> cyclin/cdks ( cyclin - dependent kinase </e1> ) complexes and/or interferes physically with cyclin/cdks activation by CAK .',\n",
       "  'PROTEIN',\n",
       "  'p27Kip1 directly inhibits the catalytic activity of cyclin/cdks ( cyclin - dependent kinase ) complexes and/or interferes physically with cyclin/cdks activation by CAK .',\n",
       "  [['cyclin/cdks', '(cyclin', '-', 'dependent', 'kinase)', 'complex'],\n",
       "   [7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Naive ( CD45RA+ ) </e1> T lymphocytes are more sensitive to oxidative stress - induced signals than memory ( CD45RO+ ) cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Naive ( CD45RA+ ) T lymphocytes are more sensitive to oxidative stress - induced signals than memory ( CD45RO+ ) cells .',\n",
       "  [['Naive', '(CD45RA+)', 'T', 'lymphocyte'], [0, 1, 2, 3], 'CELL_TYPE']],\n",
       " ['Naive ( CD45RA+ ) T lymphocytes are more sensitive to oxidative stress - induced signals than <e1> memory ( CD45RO+ </e1> ) cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Naive ( CD45RA+ ) T lymphocytes are more sensitive to oxidative stress - induced signals than memory ( CD45RO+ ) cells .',\n",
       "  [['memory', '(CD45RO+)', 'cell'], [16, 17, 18], 'CELL_TYPE']],\n",
       " ['Formation of reactive oxygen intermediates ( ROI ) after oxidative stress has been shown to be an activation signal for T lymphocytes , e.g. , expression of IL - 2 and its <e1> receptor are induced . </e1>',\n",
       "  'PROTEIN',\n",
       "  'Formation of reactive oxygen intermediates ( ROI ) after oxidative stress has been shown to be an activation signal for T lymphocytes , e.g. , expression of IL - 2 and its receptor are induced .',\n",
       "  [['Il', '-', '2', 'receptor'], [32, 33, 34, 35], 'PROTEIN']],\n",
       " ['When <e1> CD45RA+ ( naive ) </e1> and CD45RO+ ( memory ) T lymphocytes were directly stimulated with H2O2 , NF - kappaB nuclear translocation was stronger in naive cells than in memory cells and it could be induced with lower doses .',\n",
       "  'CELL_TYPE',\n",
       "  'When CD45RA+ ( naive ) and CD45RO+ ( memory ) T lymphocytes were directly stimulated with H2O2 , NF - kappaB nuclear translocation was stronger in naive cells than in memory cells and it could be induced with lower doses .',\n",
       "  [['CD45RA+', '(naive)', 'T', 'lymphocyte'], [1, 2, 3, 4], 'CELL_TYPE']],\n",
       " ['When CD45RA+ ( naive ) and <e1> CD45RO+ ( memory ) </e1> T lymphocytes were directly stimulated with H2O2 , NF - kappaB nuclear translocation was stronger in naive cells than in memory cells and it could be induced with lower doses .',\n",
       "  'CELL_TYPE',\n",
       "  'When CD45RA+ ( naive ) and CD45RO+ ( memory ) T lymphocytes were directly stimulated with H2O2 , NF - kappaB nuclear translocation was stronger in naive cells than in memory cells and it could be induced with lower doses .',\n",
       "  [['CD45RO+', '(memory)', 'T', 'lymphocyte'], [6, 7, 8, 9], 'CELL_TYPE']],\n",
       " ['Subsequent studies have revealed that ( i ) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the NF - kappa B2 ( p100 ) and NF - kappa B1 ( p105 ) genes ; ( ii ) in contrast to RelA <e1> - I kappa B </e1> alpha , RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation ; ( iii ) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo ; ( iv ) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA , which is required for I kappa B alpha binding ; ( v ) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain , which mediates cytoplasmic retention of RelA ; and ( vi ) as observed with I kappa B alpha , nuclear RelA stimulates p100 mRNA and protein expression .',\n",
       "  'PROTEIN',\n",
       "  'Subsequent studies have revealed that ( i ) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the NF - kappa B2 ( p100 ) and NF - kappa B1 ( p105 ) genes ; ( ii ) in contrast to RelA - I kappa B alpha , RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation ; ( iii ) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo ; ( iv ) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA , which is required for I kappa B alpha binding ; ( v ) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain , which mediates cytoplasmic retention of RelA ; and ( vi ) as observed with I kappa B alpha , nuclear RelA stimulates p100 mRNA and protein expression .',\n",
       "  [['I', 'kappa', 'B', 'alpha'], [58, 59, 60, 61], 'PROTEIN']],\n",
       " ['The constitutively active type of the CN A subunit , which lacks the <e1> auto - inhibitory and </e1> calmodulin - binding domains , acts in synergy with PMA to activate transcription from the GM - CSF promoter .',\n",
       "  'PROTEIN',\n",
       "  'The constitutively active type of the CN A subunit , which lacks the auto - inhibitory and calmodulin - binding domains , acts in synergy with PMA to activate transcription from the GM - CSF promoter .',\n",
       "  [['auto', '-', 'inhibitory', 'domain'], [13, 14, 15, 16], 'PROTEIN']],\n",
       " ['Activated viral gene expression associated with phenotypic conversion of group I cell lines in to group II or <e1> III restores </e1> the Egr - 1 gene expression .',\n",
       "  'CELL_LINE',\n",
       "  'Activated viral gene expression associated with phenotypic conversion of group I cell lines in to group II or III restores the Egr - 1 gene expression .',\n",
       "  [['group', 'III'], [18, 19], 'CELL_LINE']],\n",
       " ['Stat3 recruitment by two distinct <e1> ligand - induced , tyrosine - phosphorylated docking </e1> sites in the interleukin - 10 receptor intracellular domain .',\n",
       "  'PROTEIN',\n",
       "  'Stat3 recruitment by two distinct ligand - induced , tyrosine - phosphorylated docking sites in the interleukin - 10 receptor intracellular domain .',\n",
       "  [['ligand',\n",
       "    '-',\n",
       "    'induced,',\n",
       "    'tyrosine',\n",
       "    '-',\n",
       "    'phosphorylated',\n",
       "    'docking',\n",
       "    'site'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['To define the mechanism underlying <e1> signal transducer and activator of transcription ( STAT </e1> ) protein recruitment to the interleukin 10 ( IL - 10 ) receptor , the STAT proteins activated by IL - 10 in different cell populations were first defined using electrophoretic mobility shift assays .',\n",
       "  'PROTEIN',\n",
       "  'To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the interleukin 10 ( IL - 10 ) receptor , the STAT proteins activated by IL - 10 in different cell populations were first defined using electrophoretic mobility shift assays .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'protein'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the <e1> interleukin 10 ( IL - 10 </e1> ) receptor , the STAT proteins activated by IL - 10 in different cell populations were first defined using electrophoretic mobility shift assays .',\n",
       "  'PROTEIN',\n",
       "  'To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the interleukin 10 ( IL - 10 ) receptor , the STAT proteins activated by IL - 10 in different cell populations were first defined using electrophoretic mobility shift assays .',\n",
       "  [['interleukin', '10', '(IL', '-', '10)', 'receptor'],\n",
       "   [18, 19, 20, 21, 22, 23],\n",
       "   'PROTEIN']],\n",
       " ['A switch from <e1> human fetal ( gamma </e1> ) - to adult ( beta ) - globin expression occurs within erythroid precursor cells of the adult lineage .',\n",
       "  'PROTEIN',\n",
       "  'A switch from human fetal ( gamma ) - to adult ( beta ) - globin expression occurs within erythroid precursor cells of the adult lineage .',\n",
       "  [['human', 'fetal', '(gamma)', 'globin'], [3, 4, 5, 6], 'PROTEIN']],\n",
       " ['A switch from human fetal ( gamma ) - to <e1> adult ( beta ) </e1> - globin expression occurs within erythroid precursor cells of the adult lineage .',\n",
       "  'PROTEIN',\n",
       "  'A switch from human fetal ( gamma ) - to adult ( beta ) - globin expression occurs within erythroid precursor cells of the adult lineage .',\n",
       "  [['adult', '(beta)', '-', 'globin'], [10, 11, 12, 13], 'PROTEIN']],\n",
       " ['A dramatic increase in the intracellular levels of NF - kappaB subunits c - Rel and NF - kappaB2 p100 and a moderate increase in NF - kappaB2 p52 and <e1> RelA </e1> ( p65 ) were detected in HIV - 1 - infected cells , whereas NF - kappaB1 p105/p50 levels were not altered relative to the levels in uninfected cells .',\n",
       "  'PROTEIN',\n",
       "  'A dramatic increase in the intracellular levels of NF - kappaB subunits c - Rel and NF - kappaB2 p100 and a moderate increase in NF - kappaB2 p52 and RelA ( p65 ) were detected in HIV - 1 - infected cells , whereas NF - kappaB1 p105/p50 levels were not altered relative to the levels in uninfected cells .',\n",
       "  [['RelA(p65)'], [30], 'PROTEIN']],\n",
       " ['Nuclear translocation of NF - kappaB subunits may ultimately increase the intracellular pool of <e1> NF - kappaB </e1> /IkappaBalpha by an autoregulatory mechanism .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear translocation of NF - kappaB subunits may ultimately increase the intracellular pool of NF - kappaB /IkappaBalpha by an autoregulatory mechanism .',\n",
       "  [['NF', '-', 'kappaB/IkappaBalpha'], [14, 15, 16], 'PROTEIN']],\n",
       " ['Enhanced turnover of IkappaBalpha and the accumulation of <e1> NF - kappaB /Rel </e1> proteins may contribute to the chronically activated state of HIV - 1 - infected cells .',\n",
       "  'PROTEIN',\n",
       "  'Enhanced turnover of IkappaBalpha and the accumulation of NF - kappaB /Rel proteins may contribute to the chronically activated state of HIV - 1 - infected cells .',\n",
       "  [['NF', '-', 'kappaB/Rel', 'protein'], [8, 9, 10, 11], 'PROTEIN']],\n",
       " ['Enhanced turnover of IkappaBalpha and the accumulation of <e1> NF - kappaB </e1> /Rel proteins may contribute to the chronically activated state of HIV - 1 - infected cells .',\n",
       "  'PROTEIN',\n",
       "  'Enhanced turnover of IkappaBalpha and the accumulation of NF - kappaB /Rel proteins may contribute to the chronically activated state of HIV - 1 - infected cells .',\n",
       "  [['NF', '-', 'kappaB/Rel'], [8, 9, 10], 'PROTEIN']],\n",
       " ['We have previously shown that c - Jun is a potent inhibitor of the <e1> rat prolactin ( rPRL </e1> ) promoter activity induced by either oncogenic Ras or phorbol esters .',\n",
       "  'DNA',\n",
       "  'We have previously shown that c - Jun is a potent inhibitor of the rat prolactin ( rPRL ) promoter activity induced by either oncogenic Ras or phorbol esters .',\n",
       "  [['rat', 'prolactin', '(rPRL)', 'promoter'], [14, 15, 16, 17], 'DNA']],\n",
       " ['Because <e1> interferon ( IFN ) </e1> regulatory factors ( IRF - 1 and IRF - 2 ) and other IFN - inducible gene products regulate cell growth , we analyzed the effects of ATRA on the expression of these genes .',\n",
       "  'PROTEIN',\n",
       "  'Because interferon ( IFN ) regulatory factors ( IRF - 1 and IRF - 2 ) and other IFN - inducible gene products regulate cell growth , we analyzed the effects of ATRA on the expression of these genes .',\n",
       "  [['interferon', '(IFN)', 'regulatory', 'factor'], [1, 2, 3, 4], 'PROTEIN']],\n",
       " ['We have recently performed a detailed molecular analysis of 20q deletions in <e1> peripheral blood ( PB </e1> ) granulocytes and defined a commonly deleted region of 16 to 21 centimorgan ( cM ) .',\n",
       "  'CELL_TYPE',\n",
       "  'We have recently performed a detailed molecular analysis of 20q deletions in peripheral blood ( PB ) granulocytes and defined a commonly deleted region of 16 to 21 centimorgan ( cM ) .',\n",
       "  [['peripheral', 'blood', '(PB)', 'granulocyte'],\n",
       "   [12, 13, 14, 15],\n",
       "   'CELL_TYPE']],\n",
       " ['Interleukin - 6 ( IL - 6 ) mediates autocrine and paracrine growth of <e1> multiple myeloma ( MM </e1> ) cells and inhibits tumor cell apoptosis .',\n",
       "  'CELL_LINE',\n",
       "  'Interleukin - 6 ( IL - 6 ) mediates autocrine and paracrine growth of multiple myeloma ( MM ) cells and inhibits tumor cell apoptosis .',\n",
       "  [['multiple', 'myeloma', '(MM)', 'cell'], [14, 15, 16, 17], 'CELL_LINE']],\n",
       " ['Because <e1> dephosphorylated ( activated </e1> ) pRB blocks transition from G1 to S phase of the cell cycle whereas phosphorylated ( inactivated ) pRB releases this growth arrest , we characterized the role of pRB in IL - 6 - mediated MM cell growth .',\n",
       "  'PROTEIN',\n",
       "  'Because dephosphorylated ( activated ) pRB blocks transition from G1 to S phase of the cell cycle whereas phosphorylated ( inactivated ) pRB releases this growth arrest , we characterized the role of pRB in IL - 6 - mediated MM cell growth .',\n",
       "  [['dephosphorylated', '(activated)', 'pRB'], [1, 2, 3], 'PROTEIN']],\n",
       " ['Because dephosphorylated ( activated ) pRB blocks transition from G1 to S phase of the cell cycle whereas <e1> phosphorylated ( inactivated </e1> ) pRB releases this growth arrest , we characterized the role of pRB in IL - 6 - mediated MM cell growth .',\n",
       "  'PROTEIN',\n",
       "  'Because dephosphorylated ( activated ) pRB blocks transition from G1 to S phase of the cell cycle whereas phosphorylated ( inactivated ) pRB releases this growth arrest , we characterized the role of pRB in IL - 6 - mediated MM cell growth .',\n",
       "  [['phosphorylated', '(inactivated)', 'pRB'], [18, 19, 20], 'PROTEIN']],\n",
       " ['One type , EA/S , is located in the upstream promoter region , and the other , <e1> E </e1> ( gre ) , is located in a tandem repeat with enhancer properties .',\n",
       "  'DNA',\n",
       "  'One type , EA/S , is located in the upstream promoter region , and the other , E ( gre ) , is located in a tandem repeat with enhancer properties .',\n",
       "  [['E(gre)'], [17], 'DNA']],\n",
       " ['In lymphoid cell lines only , the <e1> E ( gre ) - </e1> binding protein complexes included ALF1 or HEB and E2A basic helix - loop - helix proteins .',\n",
       "  'PROTEIN',\n",
       "  'In lymphoid cell lines only , the E ( gre ) - binding protein complexes included ALF1 or HEB and E2A basic helix - loop - helix proteins .',\n",
       "  [['E(gre)', '-', 'binding', 'protein', 'complex'],\n",
       "   [7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['In lymphoid cell lines only , the <e1> E </e1> ( gre ) - binding protein complexes included ALF1 or HEB and E2A basic helix - loop - helix proteins .',\n",
       "  'DNA',\n",
       "  'In lymphoid cell lines only , the E ( gre ) - binding protein complexes included ALF1 or HEB and E2A basic helix - loop - helix proteins .',\n",
       "  [['E(gre)'], [7], 'DNA']],\n",
       " ['Ectopic ALF1 and E2A proteins required intact <e1> E ( </e1> gre ) motifs for mediating transcriptional activation .',\n",
       "  'DNA',\n",
       "  'Ectopic ALF1 and E2A proteins required intact E ( gre ) motifs for mediating transcriptional activation .',\n",
       "  [['E(gre)', 'motif'], [7, 8], 'DNA']],\n",
       " ['Ectopic ALF1 and E2A proteins required intact <e1> E </e1> ( gre ) motifs for mediating transcriptional activation .',\n",
       "  'DNA',\n",
       "  'Ectopic ALF1 and E2A proteins required intact E ( gre ) motifs for mediating transcriptional activation .',\n",
       "  [['E(gre)'], [7], 'DNA']],\n",
       " ['ALF1 transactivated transcription of Akv MLV through the two <e1> E ( </e1> gre ) motifs equally , whereas E2A protein required the promoter - proximal E ( gre ) motif .',\n",
       "  'DNA',\n",
       "  'ALF1 transactivated transcription of Akv MLV through the two E ( gre ) motifs equally , whereas E2A protein required the promoter - proximal E ( gre ) motif .',\n",
       "  [['E(gre)', 'motif'], [9, 10], 'DNA']],\n",
       " ['ALF1 transactivated transcription of Akv MLV through the two <e1> E </e1> ( gre ) motifs equally , whereas E2A protein required the promoter - proximal E ( gre ) motif .',\n",
       "  'DNA',\n",
       "  'ALF1 transactivated transcription of Akv MLV through the two E ( gre ) motifs equally , whereas E2A protein required the promoter - proximal E ( gre ) motif .',\n",
       "  [['E(gre)'], [9], 'DNA']],\n",
       " ['ALF1 transactivated transcription of Akv MLV through the two E ( gre ) motifs equally , whereas E2A protein required the promoter - proximal <e1> E </e1> ( gre ) motif .',\n",
       "  'DNA',\n",
       "  'ALF1 transactivated transcription of Akv MLV through the two E ( gre ) motifs equally , whereas E2A protein required the promoter - proximal E ( gre ) motif .',\n",
       "  [['E(gre)'], [24], 'DNA']],\n",
       " ['In T - and B - cell lines , the <e1> E ( </e1> gre ) motifs were of major importance for Akv MLV transcriptional activity , while the EA/S motif had some effect .',\n",
       "  'DNA',\n",
       "  'In T - and B - cell lines , the E ( gre ) motifs were of major importance for Akv MLV transcriptional activity , while the EA/S motif had some effect .',\n",
       "  [['E(gre)', 'motif'], [10, 11], 'DNA']],\n",
       " ['In T - and B - cell lines , the <e1> E </e1> ( gre ) motifs were of major importance for Akv MLV transcriptional activity , while the EA/S motif had some effect .',\n",
       "  'DNA',\n",
       "  'In T - and B - cell lines , the E ( gre ) motifs were of major importance for Akv MLV transcriptional activity , while the EA/S motif had some effect .',\n",
       "  [['E(gre)'], [10], 'DNA']],\n",
       " ['In contrast , neither <e1> E </e1> ( gre ) nor EA/S motifs contributed pronouncedly to Akv MLV transcription in NIH 3T3 cells lacking DNA - binding ALF1 or HEB and E2A proteins .',\n",
       "  'DNA',\n",
       "  'In contrast , neither E ( gre ) nor EA/S motifs contributed pronouncedly to Akv MLV transcription in NIH 3T3 cells lacking DNA - binding ALF1 or HEB and E2A proteins .',\n",
       "  [['E(gre)'], [4], 'DNA']],\n",
       " ['Moreover , ectopic Id1 repressed <e1> E </e1> ( gre ) - directed but not EA/S - directed MLV transcription in lymphoid cell lines .',\n",
       "  'DNA',\n",
       "  'Moreover , ectopic Id1 repressed E ( gre ) - directed but not EA/S - directed MLV transcription in lymphoid cell lines .',\n",
       "  [['E(gre)'], [5], 'DNA']],\n",
       " ['In conclusion , <e1> E </e1> ( gre ) motifs and interacting basic helix - loop - helix proteins are important determinants for MLV transcriptional activity in lymphocytic cell lines .',\n",
       "  'DNA',\n",
       "  'In conclusion , E ( gre ) motifs and interacting basic helix - loop - helix proteins are important determinants for MLV transcriptional activity in lymphocytic cell lines .',\n",
       "  [['E(gre)'], [3], 'DNA']],\n",
       " ['The <e1> E2A - HLF ( for hepatic leukaemia factor ) </e1> fusion gene , formed by action of the t(17;19) (q22;p13) chromosomal translocation , drives the leukaemic transformation of early B - cell precursors , but the mechanism of this activity remains unknown .',\n",
       "  'DNA',\n",
       "  'The E2A - HLF ( for hepatic leukaemia factor ) fusion gene , formed by action of the t(17;19) (q22;p13) chromosomal translocation , drives the leukaemic transformation of early B - cell precursors , but the mechanism of this activity remains unknown .',\n",
       "  [['E2A',\n",
       "    '-',\n",
       "    'HLF',\n",
       "    '(for',\n",
       "    'hepatic',\n",
       "    'leukaemia',\n",
       "    'factor)',\n",
       "    'fusion',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['The E2A - HLF ( for hepatic leukaemia factor ) fusion gene , formed by action of the <e1> t(17;19) (q22;p13) chromosomal </e1> translocation , drives the leukaemic transformation of early B - cell precursors , but the mechanism of this activity remains unknown .',\n",
       "  'DNA',\n",
       "  'The E2A - HLF ( for hepatic leukaemia factor ) fusion gene , formed by action of the t(17;19) (q22;p13) chromosomal translocation , drives the leukaemic transformation of early B - cell precursors , but the mechanism of this activity remains unknown .',\n",
       "  [['t(17;19)', '(q22;p13)'], [18, 19], 'DNA']],\n",
       " ['Some patients with acquired immunodeficiency syndrome ( AIDS ) develop glucocorticoid resistance characterized by low receptor affinity ( Kd ) for glucocorticoids in <e1> mononuclear , </e1> cells and high values of ACTH and cortisol .',\n",
       "  'CELL_TYPE',\n",
       "  'Some patients with acquired immunodeficiency syndrome ( AIDS ) develop glucocorticoid resistance characterized by low receptor affinity ( Kd ) for glucocorticoids in mononuclear , cells and high values of ACTH and cortisol .',\n",
       "  [['mononuclear', 'cell'], [23, 24], 'CELL_TYPE']],\n",
       " ['Transfection of trans - dominant negative expression vectors of ras and raf , together with AP - 1 - dependent reporter constructs , as well as Western blot analysis using <e1> anti - ERK ( extracellular signal - regulated kinase </e1> ) antibodies , indicated that the Ras/Raf/ERK pathway did not appear to mediate the effect of the antioxidant .',\n",
       "  'PROTEIN',\n",
       "  'Transfection of trans - dominant negative expression vectors of ras and raf , together with AP - 1 - dependent reporter constructs , as well as Western blot analysis using anti - ERK ( extracellular signal - regulated kinase ) antibodies , indicated that the Ras/Raf/ERK pathway did not appear to mediate the effect of the antioxidant .',\n",
       "  [['anti',\n",
       "    '-',\n",
       "    'ERK',\n",
       "    '(extracellular',\n",
       "    'signal',\n",
       "    '-',\n",
       "    'regulated',\n",
       "    'kinase)',\n",
       "    'antibody'],\n",
       "   [30, 31, 32, 33, 34, 35, 36, 37, 38],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> cyclosporin A ( CsA ) / FK506 - sensitive nuclear factor </e1> of activated T cells ( NFAT ) plays a key role in the inducible expression of cytokine genes in T cells .',\n",
       "  'PROTEIN',\n",
       "  'The cyclosporin A ( CsA ) / FK506 - sensitive nuclear factor of activated T cells ( NFAT ) plays a key role in the inducible expression of cytokine genes in T cells .',\n",
       "  [['cyclosporin',\n",
       "    'A',\n",
       "    '(CsA)/FK506',\n",
       "    '-',\n",
       "    'sensitive',\n",
       "    'nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['Reverse transcription - PCR analysis showed that all seven EBV - positive tumour tissues constitutively expressed <e1> EBV nuclear antigen ( EBNA ) </e1> 1 mRNA , but not EBNA2 mRNA .',\n",
       "  'RNA',\n",
       "  'Reverse transcription - PCR analysis showed that all seven EBV - positive tumour tissues constitutively expressed EBV nuclear antigen ( EBNA ) 1 mRNA , but not EBNA2 mRNA .',\n",
       "  [['EBV', 'nuclear', 'antigen', '(EBNA)', '1', 'mRNA'],\n",
       "   [16, 17, 18, 19, 20, 21],\n",
       "   'RNA']],\n",
       " ['<e1> Latent membrane protein ( LMP ) </e1> 2A mRNA was detected in three of seven cases ; however , neither LMP1 nor LMP2B mRNA was detected in any of the tumours tested .',\n",
       "  'RNA',\n",
       "  'Latent membrane protein ( LMP ) 2A mRNA was detected in three of seven cases ; however , neither LMP1 nor LMP2B mRNA was detected in any of the tumours tested .',\n",
       "  [['latent', 'membrane', 'protein', '(LMP)', '2A', 'mRNA'],\n",
       "   [0, 1, 2, 3, 4, 5],\n",
       "   'RNA']],\n",
       " ['<e1> Latent membrane protein ( LMP </e1> ) 2A mRNA was detected in three of seven cases ; however , neither LMP1 nor LMP2B mRNA was detected in any of the tumours tested .',\n",
       "  'PROTEIN',\n",
       "  'Latent membrane protein ( LMP ) 2A mRNA was detected in three of seven cases ; however , neither LMP1 nor LMP2B mRNA was detected in any of the tumours tested .',\n",
       "  [['latent', 'membrane', 'protein', '(LMP)', '2A'],\n",
       "   [0, 1, 2, 3, 4],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Glutathione - S - transferase ( GST ) - Grb2 </e1> fusion proteins have been used to identify the potential role of Grb2 - binding proteins in platelet activation by the platelet low - affinity IgG receptor , Fc gamma RIIA .',\n",
       "  'PROTEIN',\n",
       "  'Glutathione - S - transferase ( GST ) - Grb2 fusion proteins have been used to identify the potential role of Grb2 - binding proteins in platelet activation by the platelet low - affinity IgG receptor , Fc gamma RIIA .',\n",
       "  [['glutathione',\n",
       "    '-',\n",
       "    'S',\n",
       "    '-',\n",
       "    'transferase',\n",
       "    '(GST)',\n",
       "    '-',\n",
       "    'Grb2',\n",
       "    'fusion',\n",
       "    'protein'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['The SH3 domains of Grb2 form a stable complex with SOS1 and two proteins of <e1> 75 kD and </e1> 120 kD , which undergo tyrosine phosphorylation in Fc gamma RIIA stimulated cells .',\n",
       "  'PROTEIN',\n",
       "  'The SH3 domains of Grb2 form a stable complex with SOS1 and two proteins of 75 kD and 120 kD , which undergo tyrosine phosphorylation in Fc gamma RIIA stimulated cells .',\n",
       "  [['75', 'kD', 'protein'], [15, 16, 17], 'PROTEIN']],\n",
       " ['The SH3 domains of Grb2 form a stable complex with SOS1 and two proteins of 75 kD and <e1> 120 kD , </e1> which undergo tyrosine phosphorylation in Fc gamma RIIA stimulated cells .',\n",
       "  'PROTEIN',\n",
       "  'The SH3 domains of Grb2 form a stable complex with SOS1 and two proteins of 75 kD and 120 kD , which undergo tyrosine phosphorylation in Fc gamma RIIA stimulated cells .',\n",
       "  [['120', 'kD', 'protein'], [18, 19, 20], 'PROTEIN']],\n",
       " ['Expression of the <e1> human interleukin - 2 ( IL - 2 ) receptor alpha </e1> chain gene is potently upregulated by its own ligand , IL - 2 .',\n",
       "  'DNA',\n",
       "  'Expression of the human interleukin - 2 ( IL - 2 ) receptor alpha chain gene is potently upregulated by its own ligand , IL - 2 .',\n",
       "  [['human',\n",
       "    'interleukin',\n",
       "    '-',\n",
       "    '2',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2)',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    'chain',\n",
       "    'gene'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['Cloning and characterization of the beta subunit of human proximal sequence element - binding transcription factor and its involvement in transcription of small nuclear RNA genes by <e1> RNA polymerases II </e1> and III .',\n",
       "  'PROTEIN',\n",
       "  'Cloning and characterization of the beta subunit of human proximal sequence element - binding transcription factor and its involvement in transcription of small nuclear RNA genes by RNA polymerases II and III .',\n",
       "  [['rna', 'polymerase', 'ii'], [27, 28, 29], 'PROTEIN']],\n",
       " ['The <e1> proximal sequence element ( PSE ) - binding </e1> transcription factor ( PTF ) , which binds the PSE of both RNA polymerase II - and RNA polymerase III - transcribed mammalian small nuclear RNA ( snRNA ) genes , is essential for their transcription .',\n",
       "  'PROTEIN',\n",
       "  'The proximal sequence element ( PSE ) - binding transcription factor ( PTF ) , which binds the PSE of both RNA polymerase II - and RNA polymerase III - transcribed mammalian small nuclear RNA ( snRNA ) genes , is essential for their transcription .',\n",
       "  [['proximal',\n",
       "    'sequence',\n",
       "    'element',\n",
       "    '(PSE)',\n",
       "    '-',\n",
       "    'binding',\n",
       "    'transcription',\n",
       "    'factor'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['The proximal sequence element ( PSE ) - binding transcription factor ( PTF ) , which binds the PSE of both <e1> RNA polymerase II - and RNA polymerase III - transcribed mammalian small nuclear RNA ( snRNA </e1> ) genes , is essential for their transcription .',\n",
       "  'DNA',\n",
       "  'The proximal sequence element ( PSE ) - binding transcription factor ( PTF ) , which binds the PSE of both RNA polymerase II - and RNA polymerase III - transcribed mammalian small nuclear RNA ( snRNA ) genes , is essential for their transcription .',\n",
       "  [['RNA',\n",
       "    'polymerase',\n",
       "    'II',\n",
       "    '-',\n",
       "    'and',\n",
       "    'RNA',\n",
       "    'polymerase',\n",
       "    'III',\n",
       "    '-',\n",
       "    'transcribed',\n",
       "    'mammalian',\n",
       "    'small',\n",
       "    'nuclear',\n",
       "    'RNA',\n",
       "    '(snRNA)',\n",
       "    'gene'],\n",
       "   [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36],\n",
       "   'DNA']],\n",
       " ['The proximal sequence element ( PSE ) - binding transcription factor ( PTF ) , which binds the PSE of both RNA polymerase II - and RNA polymerase III - transcribed <e1> mammalian small nuclear RNA ( snRNA </e1> ) genes , is essential for their transcription .',\n",
       "  'DNA',\n",
       "  'The proximal sequence element ( PSE ) - binding transcription factor ( PTF ) , which binds the PSE of both RNA polymerase II - and RNA polymerase III - transcribed mammalian small nuclear RNA ( snRNA ) genes , is essential for their transcription .',\n",
       "  [['mammalian', 'small', 'nuclear', 'RNA', '(snRNA)', 'gene'],\n",
       "   [31, 32, 33, 34, 35, 36],\n",
       "   'DNA']],\n",
       " ['Along with our previous demonstration of both physical interactions between <e1> PTF gamma / </e1> PTF delta and TBP and the involvement of TFIIIB90 in the transcription of class III snRNA genes , these results are consistent with the notion that a TBP - containing complex related to TFIIIB is required for the transcription of class III snRNA genes , and acts through weak interaction with the four - subunit PTF .',\n",
       "  'PROTEIN',\n",
       "  'Along with our previous demonstration of both physical interactions between PTF gamma / PTF delta and TBP and the involvement of TFIIIB90 in the transcription of class III snRNA genes , these results are consistent with the notion that a TBP - containing complex related to TFIIIB is required for the transcription of class III snRNA genes , and acts through weak interaction with the four - subunit PTF .',\n",
       "  [['PTF', 'gamma/PTF', 'delta'], [10, 11, 12], 'PROTEIN']],\n",
       " ['The <e1> NF - kappaB /Rel </e1> family of transcription factors regulates the inducible expression of many genes in activated human monocytes and endothelial cells .',\n",
       "  'PROTEIN',\n",
       "  'The NF - kappaB /Rel family of transcription factors regulates the inducible expression of many genes in activated human monocytes and endothelial cells .',\n",
       "  [['NF', '-', 'kappaB/Rel', 'family'], [1, 2, 3, 4], 'PROTEIN']],\n",
       " ['We observed that in a <e1> monocytic ( U937 ) </e1> and a bronchial epithelial ( H292 ) cell - line dexamethasone strongly suppressed basal and induced ICAM - 1 expression .',\n",
       "  'CELL_LINE',\n",
       "  'We observed that in a monocytic ( U937 ) and a bronchial epithelial ( H292 ) cell - line dexamethasone strongly suppressed basal and induced ICAM - 1 expression .',\n",
       "  [['monocytic', '(U937)', 'cell', 'line'], [5, 6, 7, 8], 'CELL_LINE']],\n",
       " ['We observed that in a monocytic ( U937 ) and a <e1> bronchial epithelial ( H292 ) cell </e1> - line dexamethasone strongly suppressed basal and induced ICAM - 1 expression .',\n",
       "  'CELL_LINE',\n",
       "  'We observed that in a monocytic ( U937 ) and a bronchial epithelial ( H292 ) cell - line dexamethasone strongly suppressed basal and induced ICAM - 1 expression .',\n",
       "  [['bronchial', 'epithelial', '(H292)', 'cell', '-', 'line'],\n",
       "   [11, 12, 13, 14, 15, 16],\n",
       "   'CELL_LINE']],\n",
       " ['Subsequent analysis of the human ICAM - 1 promoter has revealed that both 12 - O - tetradecanoylphorbol 13 - acetate ( TPA ) and tumour necrosis factor - alpha ( TNF - alpha ) upregulate ICAM - 1 expression through the presence of a <e1> nuclear factor ( NF - kappa B ) </e1> target sequence ( TGGAAATTCC ) .',\n",
       "  'DNA',\n",
       "  'Subsequent analysis of the human ICAM - 1 promoter has revealed that both 12 - O - tetradecanoylphorbol 13 - acetate ( TPA ) and tumour necrosis factor - alpha ( TNF - alpha ) upregulate ICAM - 1 expression through the presence of a nuclear factor ( NF - kappa B ) target sequence ( TGGAAATTCC ) .',\n",
       "  [['nuclear', 'factor', '(NF', '-', 'kappa', 'B)', 'target', 'sequence'],\n",
       "   [45, 46, 47, 48, 49, 50, 51, 52],\n",
       "   'DNA']],\n",
       " ['It is crucial that these results mirror recent observations indicating that murine adult HPCs transduced with dominant negative <e1> ATRA receptor ( RAR </e1> ) gene are immortalized and show a selective blockade of granulocytic differentiation .',\n",
       "  'DNA',\n",
       "  'It is crucial that these results mirror recent observations indicating that murine adult HPCs transduced with dominant negative ATRA receptor ( RAR ) gene are immortalized and show a selective blockade of granulocytic differentiation .',\n",
       "  [['ATRA', 'receptor', '(RAR)', 'gene'], [18, 19, 20, 21], 'DNA']],\n",
       " ['The common target of CsA and FK506 is calcineurin , a <e1> Ca2+/calmodulin - regulated , serine/threonine - specific protein </e1> phosphatase that regulates the nuclear import of a transcription factor , NF - AT , required for expression of T cell activation genes .',\n",
       "  'PROTEIN',\n",
       "  'The common target of CsA and FK506 is calcineurin , a Ca2+/calmodulin - regulated , serine/threonine - specific protein phosphatase that regulates the nuclear import of a transcription factor , NF - AT , required for expression of T cell activation genes .',\n",
       "  [['Ca2+/calmodulin',\n",
       "    '-',\n",
       "    'regulated,',\n",
       "    'serine/threonine',\n",
       "    '-',\n",
       "    'specific',\n",
       "    'protein',\n",
       "    'phosphatase'],\n",
       "   [11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'PROTEIN']],\n",
       " ['The Oct - 2 transcription factor is a member of the <e1> POU ( Pit - Oct - Unc </e1> ) family of transcription factors and is expressed only in B lymphocytes and in neuronal cells but not in other cell types .',\n",
       "  'PROTEIN',\n",
       "  'The Oct - 2 transcription factor is a member of the POU ( Pit - Oct - Unc ) family of transcription factors and is expressed only in B lymphocytes and in neuronal cells but not in other cell types .',\n",
       "  [['POU', '(Pit', '-', 'Oct', '-', 'Unc)', 'family'],\n",
       "   [11, 12, 13, 14, 15, 16, 17],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> human tumor necrosis factor alpha ( TNF - alpha </e1> ) gene is one of the earliest genes transcribed after the stimulation of a B cell through its antigen receptor or via the CD - 40 pathway .',\n",
       "  'DNA',\n",
       "  'The human tumor necrosis factor alpha ( TNF - alpha ) gene is one of the earliest genes transcribed after the stimulation of a B cell through its antigen receptor or via the CD - 40 pathway .',\n",
       "  [['human',\n",
       "    'tumor',\n",
       "    'necrosis',\n",
       "    'factor',\n",
       "    'alpha',\n",
       "    '(TNF',\n",
       "    '-',\n",
       "    'alpha)',\n",
       "    'gene'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['Furthermore , in T cells , two molecules of NFATp bind to the TNF - alpha promoter element kappa 3 in association with ATF - 2 and Jun proteins bound to an immediately adjacent <e1> cyclic AMP response element ( CRE </e1> ) site .',\n",
       "  'DNA',\n",
       "  'Furthermore , in T cells , two molecules of NFATp bind to the TNF - alpha promoter element kappa 3 in association with ATF - 2 and Jun proteins bound to an immediately adjacent cyclic AMP response element ( CRE ) site .',\n",
       "  [['cyclic', 'AMP', 'response', 'element', '(CRE)', 'site'],\n",
       "   [34, 35, 36, 37, 38, 39],\n",
       "   'DNA']],\n",
       " ['In this work , we report that these anergic T cells are defective in their ability to up - regulate protein binding and transactivation at two critical IL - 2 DNA enhancer elements : NF - AT ( nuclear factor of activated T cells ; a sequence that binds a <e1> heterotrimeric NFATp , Fos , and Jun </e1> protein complex ) and Activator Protein - 1 ( AP - 1 ) ( that binds Fos and Jun heterodimers ) .',\n",
       "  'PROTEIN',\n",
       "  'In this work , we report that these anergic T cells are defective in their ability to up - regulate protein binding and transactivation at two critical IL - 2 DNA enhancer elements : NF - AT ( nuclear factor of activated T cells ; a sequence that binds a heterotrimeric NFATp , Fos , and Jun protein complex ) and Activator Protein - 1 ( AP - 1 ) ( that binds Fos and Jun heterodimers ) .',\n",
       "  [['heterotrimeric', 'NFATp,', 'Fos,', 'and', 'Jun', 'protein', 'complex'],\n",
       "   [50, 51, 52, 53, 54, 55, 56],\n",
       "   'PROTEIN']],\n",
       " ['However , the reduced expression of these proteins was not the result of a global TCR/CD3 - signaling defect because CD3 cross - linking induced an equivalent increase in intracellular - free calcium ions , as well as NFATp dephosphorylation , translocation to the nucleus , and DNA binding in both <e1> normal and anergic </e1> T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'However , the reduced expression of these proteins was not the result of a global TCR/CD3 - signaling defect because CD3 cross - linking induced an equivalent increase in intracellular - free calcium ions , as well as NFATp dephosphorylation , translocation to the nucleus , and DNA binding in both normal and anergic T cells .',\n",
       "  [['normal', 'T', 'cell'], [51, 52, 53], 'CELL_TYPE']],\n",
       " ['Nuclear factor of activated T cells - family proteins ( <e1> NFAT1/ </e1> NFATp , NFATc , NFAT3 , and NFAT4/NFATx/NFATc3 ) play a key role in the transcription of cytokine genes and other genes during the immune response .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear factor of activated T cells - family proteins ( NFAT1/ NFATp , NFATc , NFAT3 , and NFAT4/NFATx/NFATc3 ) play a key role in the transcription of cytokine genes and other genes during the immune response .',\n",
       "  [['NFAT1/NFATp'], [10], 'PROTEIN']],\n",
       " ['However , subsequent analysis of transcription factor generation revealed that B7 stimulation induced both activator protein - 1 ( AP - 1 ) and <e1> nuclear factor - kappaB ( NF - kappaB </e1> ) complexes , but not NF - AT .',\n",
       "  'PROTEIN',\n",
       "  'However , subsequent analysis of transcription factor generation revealed that B7 stimulation induced both activator protein - 1 ( AP - 1 ) and nuclear factor - kappaB ( NF - kappaB ) complexes , but not NF - AT .',\n",
       "  [['nuclear', 'factor', '-', 'kappaB', '(NF', '-', 'kappaB)', 'complex'],\n",
       "   [24, 25, 26, 27, 28, 29, 30, 31],\n",
       "   'PROTEIN']],\n",
       " ['Expression of the <e1> human immunodeficiency virus type 1 ( HIV </e1> ) protease in cultured cells leads to apoptosis , preceded by cleavage of bcl - 2 , a key negative regulator of cell death .',\n",
       "  'PROTEIN',\n",
       "  'Expression of the human immunodeficiency virus type 1 ( HIV ) protease in cultured cells leads to apoptosis , preceded by cleavage of bcl - 2 , a key negative regulator of cell death .',\n",
       "  [['human', 'immunodeficiency', 'virus', 'type', '1', '(HIV)', 'protease'],\n",
       "   [3, 4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Alpha 4 beta 1 ( CD49d/CD29 </e1> ) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti - CD3 stimulation .',\n",
       "  'PROTEIN',\n",
       "  'Alpha 4 beta 1 ( CD49d/CD29 ) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti - CD3 stimulation .',\n",
       "  [['Alpha', '4', 'beta', '1', '(CD49d/CD29)', 'integrin'],\n",
       "   [0, 1, 2, 3, 4, 5],\n",
       "   'PROTEIN']],\n",
       " ['Comparison of the dose response to anti - CD3 stimulation demonstrated that half - maximal induction of IL - 2 was achieved using the same dose of anti - CD3 for both <e1> freshly isolated and cultured </e1> T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Comparison of the dose response to anti - CD3 stimulation demonstrated that half - maximal induction of IL - 2 was achieved using the same dose of anti - CD3 for both freshly isolated and cultured T cells .',\n",
       "  [['freshly', 'isolated', 'T', 'cell'], [32, 33, 34, 35], 'CELL_TYPE']],\n",
       " ['We investigated which STAT complexes are formed upon stimulation of <e1> B cell precursor acute lymphoblastic leukemia ( BCP - ALL </e1> ) cells with IL - 7 .',\n",
       "  'CELL_LINE',\n",
       "  'We investigated which STAT complexes are formed upon stimulation of B cell precursor acute lymphoblastic leukemia ( BCP - ALL ) cells with IL - 7 .',\n",
       "  [['B',\n",
       "    'cell',\n",
       "    'precursor',\n",
       "    'acute',\n",
       "    'lymphoblastic',\n",
       "    'leukemia',\n",
       "    '(BCP',\n",
       "    '-',\n",
       "    'ALL)',\n",
       "    'cell'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'CELL_LINE']],\n",
       " ['Activation of the <e1> chimeric G - CSF - R /IL - 7R </e1> alpha with G - CSF resulted in a full proliferative response and induced the phosphorylation of JAK1 but not JAK2 .',\n",
       "  'PROTEIN',\n",
       "  'Activation of the chimeric G - CSF - R /IL - 7R alpha with G - CSF resulted in a full proliferative response and induced the phosphorylation of JAK1 but not JAK2 .',\n",
       "  [['chimeric', 'G', '-', 'CSF', '-', 'R/IL', '-', '7R', 'alpha'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['Activation of the chimeric G - CSF - R <e1> /IL - 7R </e1> alpha with G - CSF resulted in a full proliferative response and induced the phosphorylation of JAK1 but not JAK2 .',\n",
       "  'PROTEIN',\n",
       "  'Activation of the chimeric G - CSF - R /IL - 7R alpha with G - CSF resulted in a full proliferative response and induced the phosphorylation of JAK1 but not JAK2 .',\n",
       "  [['IL', '-', '7R alpha'], [9, 10, 11], 'PROTEIN']],\n",
       " ['Major STAT complexes activated by <e1> G - CSF - R /IL - 7R </e1> alpha contained STAT1 or STAT5 , while some formation of STAT3 - containing complexes was also seen .',\n",
       "  'PROTEIN',\n",
       "  'Major STAT complexes activated by G - CSF - R /IL - 7R alpha contained STAT1 or STAT5 , while some formation of STAT3 - containing complexes was also seen .',\n",
       "  [['G', '-', 'CSF', '-', 'R/IL', '-', '7R', 'alpha'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['Major STAT complexes activated by G - CSF - R <e1> /IL - 7R </e1> alpha contained STAT1 or STAT5 , while some formation of STAT3 - containing complexes was also seen .',\n",
       "  'PROTEIN',\n",
       "  'Major STAT complexes activated by G - CSF - R /IL - 7R alpha contained STAT1 or STAT5 , while some formation of STAT3 - containing complexes was also seen .',\n",
       "  [['IL', '-', '7R alpha'], [10, 11, 12], 'PROTEIN']],\n",
       " ['Activation protein 1 - dependent transcriptional activation of interleukin 2 gene by <e1> Ca2+ /calmodulin kinase type </e1> IV/Gr .',\n",
       "  'PROTEIN',\n",
       "  'Activation protein 1 - dependent transcriptional activation of interleukin 2 gene by Ca2+ /calmodulin kinase type IV/Gr .',\n",
       "  [['Ca2+/calmodulin', 'kinase', 'type', 'IV/Gr'],\n",
       "   [12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> Ca2+ /calmodulin - dependent protein kinase ( CaMK </e1> ) type IV/Gr is selectively expressed in T lymphocytes and is activated after signaling via the T cell antigen receptor ( TCR ) , indicating that it mediates some of the Ca(2+) - dependent transcriptional events that follow TCR engagement .',\n",
       "  'PROTEIN',\n",
       "  'The Ca2+ /calmodulin - dependent protein kinase ( CaMK ) type IV/Gr is selectively expressed in T lymphocytes and is activated after signaling via the T cell antigen receptor ( TCR ) , indicating that it mediates some of the Ca(2+) - dependent transcriptional events that follow TCR engagement .',\n",
       "  [['Ca2+/calmodulin',\n",
       "    '-',\n",
       "    'dependent',\n",
       "    'protein',\n",
       "    'kinase',\n",
       "    '(CaMK)',\n",
       "    'type',\n",
       "    'IV/Gr'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['AP - 1 is an integral component of the <e1> nuclear factor of activated T cells ( NFAT ) </e1> transcriptional complex , which is required for interleukin 2 gene expression in T cells .',\n",
       "  'PROTEIN',\n",
       "  'AP - 1 is an integral component of the nuclear factor of activated T cells ( NFAT ) transcriptional complex , which is required for interleukin 2 gene expression in T cells .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells',\n",
       "    '(NFAT)',\n",
       "    'transcriptional',\n",
       "    'complex'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16, 17],\n",
       "   'PROTEIN']],\n",
       " ['In this study the genetic control of <e1> major histocompatibility complex ( MHC ) class </e1> II gene expression during the transition from B cell to plasma cell has been analyzed .',\n",
       "  'DNA',\n",
       "  'In this study the genetic control of major histocompatibility complex ( MHC ) class II gene expression during the transition from B cell to plasma cell has been analyzed .',\n",
       "  [['major', 'histocompatibility', 'complex', '(MHC)', 'class', 'II', 'gene'],\n",
       "   [7, 8, 9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['Treatment of B lymphocytes with the cytokine IL - 4 ( IL - 4 ) , in the absence of prior activation , induces a weak up - regulation of VDR expression but fails to generate <e1> vitamin D - responsive element ( VDRE ) - reactive nuclear </e1> protein complexes or to initiate the genomic transcription of 25 - hydroxyvitamin D3 24 - hydroxylase .',\n",
       "  'PROTEIN',\n",
       "  'Treatment of B lymphocytes with the cytokine IL - 4 ( IL - 4 ) , in the absence of prior activation , induces a weak up - regulation of VDR expression but fails to generate vitamin D - responsive element ( VDRE ) - reactive nuclear protein complexes or to initiate the genomic transcription of 25 - hydroxyvitamin D3 24 - hydroxylase .',\n",
       "  [['vitamin',\n",
       "    'D',\n",
       "    '-',\n",
       "    'responsive',\n",
       "    'element',\n",
       "    '(VDRE)',\n",
       "    '-',\n",
       "    'reactive',\n",
       "    'nuclear',\n",
       "    'protein',\n",
       "    'complex'],\n",
       "   [36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46],\n",
       "   'PROTEIN']],\n",
       " ['First , Tax was found to interact with the <e1> 35 - kDa ( alpha </e1> ) subunit of TFIIA in the yeast two - hybrid interaction system .',\n",
       "  'PROTEIN',\n",
       "  'First , Tax was found to interact with the 35 - kDa ( alpha ) subunit of TFIIA in the yeast two - hybrid interaction system .',\n",
       "  [['35', '-', 'kDa', '(alpha)', 'subunit'], [9, 10, 11, 12, 13], 'PROTEIN']],\n",
       " ['The regulation of transcription factors belonging to the <e1> signal transducer and activator of transcription ( STAT </e1> ) family was analyzed in PHA - activated mononuclear cells and in purified T cells activated by cross - linking cell surface CD3 .',\n",
       "  'PROTEIN',\n",
       "  'The regulation of transcription factors belonging to the signal transducer and activator of transcription ( STAT ) family was analyzed in PHA - activated mononuclear cells and in purified T cells activated by cross - linking cell surface CD3 .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'family'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['The present results show that Jurkat T cells acutely exposed to micromolar concentrations of H2O2 exhibit substantial increases in AP - 1 binding activity and the expression of <e1> c - jun but </e1> not c - fos mRNA .',\n",
       "  'RNA',\n",
       "  'The present results show that Jurkat T cells acutely exposed to micromolar concentrations of H2O2 exhibit substantial increases in AP - 1 binding activity and the expression of c - jun but not c - fos mRNA .',\n",
       "  [['c', '-', 'jun', 'mRNA'], [28, 29, 30, 31], 'RNA']],\n",
       " ['The preferential induction of c - jun by H2O2 did not represent redox stabilization of mRNA transcripts , and oxidative signals closely resembled PHA/ PMA stimulation by effectively transactivating the full length c - jun promoter via the <e1> proximal jun1 tumor promoter - responsive element ( TRE ) - like </e1> promoter element .',\n",
       "  'DNA',\n",
       "  'The preferential induction of c - jun by H2O2 did not represent redox stabilization of mRNA transcripts , and oxidative signals closely resembled PHA/ PMA stimulation by effectively transactivating the full length c - jun promoter via the proximal jun1 tumor promoter - responsive element ( TRE ) - like promoter element .',\n",
       "  [['proximal',\n",
       "    'jun1',\n",
       "    'tumor',\n",
       "    'promoter',\n",
       "    '-',\n",
       "    'responsive',\n",
       "    'element',\n",
       "    '(TRE)',\n",
       "    '-',\n",
       "    'like',\n",
       "    'promoter',\n",
       "    'element'],\n",
       "   [38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49],\n",
       "   'DNA']],\n",
       " ['Pb - induced activation of NF - kappa B is blocked by antibodies for p65 and p50 subunits but not cRel , indicating that the <e1> p65 : </e1> p50 heterodimer ( NF - kappa B ) is involved .',\n",
       "  'PROTEIN',\n",
       "  'Pb - induced activation of NF - kappa B is blocked by antibodies for p65 and p50 subunits but not cRel , indicating that the p65 : p50 heterodimer ( NF - kappa B ) is involved .',\n",
       "  [['p65:p50', 'heterodimer'], [25, 26], 'PROTEIN']],\n",
       " ['Treatment of the <e1> acute promyelocytic ( APL ) </e1> cell line NB4 with interferon alpha ( IFN ( alpha ) ) , as well as IFN ( beta ) and gamma , results in an increased expression of the transcripts coding for retinoic - acid receptor type alpha ( RAR ( alpha ) ) and the leukemia - specific retinoic acid receptor PML - RAR .',\n",
       "  'CELL_LINE',\n",
       "  'Treatment of the acute promyelocytic ( APL ) cell line NB4 with interferon alpha ( IFN ( alpha ) ) , as well as IFN ( beta ) and gamma , results in an increased expression of the transcripts coding for retinoic - acid receptor type alpha ( RAR ( alpha ) ) and the leukemia - specific retinoic acid receptor PML - RAR .',\n",
       "  [['acute', 'promyelocytic', '(APL)', 'cell', 'line'],\n",
       "   [3, 4, 5, 6, 7],\n",
       "   'CELL_LINE']],\n",
       " ['Treatment of the acute promyelocytic ( APL ) cell line NB4 with interferon alpha ( <e1> IFN </e1> ( alpha ) ) , as well as IFN ( beta ) and gamma , results in an increased expression of the transcripts coding for retinoic - acid receptor type alpha ( RAR ( alpha ) ) and the leukemia - specific retinoic acid receptor PML - RAR .',\n",
       "  'PROTEIN',\n",
       "  'Treatment of the acute promyelocytic ( APL ) cell line NB4 with interferon alpha ( IFN ( alpha ) ) , as well as IFN ( beta ) and gamma , results in an increased expression of the transcripts coding for retinoic - acid receptor type alpha ( RAR ( alpha ) ) and the leukemia - specific retinoic acid receptor PML - RAR .',\n",
       "  [['IFN(alpha)'], [15], 'PROTEIN']],\n",
       " ['Treatment of the acute promyelocytic ( APL ) cell line NB4 with interferon alpha ( IFN ( alpha ) ) , as well as IFN ( beta ) and gamma , results in an increased expression of the transcripts coding for retinoic - acid receptor type alpha ( <e1> RAR </e1> ( alpha ) ) and the leukemia - specific retinoic acid receptor PML - RAR .',\n",
       "  'PROTEIN',\n",
       "  'Treatment of the acute promyelocytic ( APL ) cell line NB4 with interferon alpha ( IFN ( alpha ) ) , as well as IFN ( beta ) and gamma , results in an increased expression of the transcripts coding for retinoic - acid receptor type alpha ( RAR ( alpha ) ) and the leukemia - specific retinoic acid receptor PML - RAR .',\n",
       "  [['RAR(alpha)'], [48], 'PROTEIN']],\n",
       " ['Up - regulation of <e1> RAR </e1> ( alpha ) and PML - RAR gene expression by IFN ( alpha ) is accompanied by a strong potentiation in the induction of 2 retinoid - dependent granulocytic markers , i.e. , granulocyte - colony - stimulating factor receptor mRNA and leukocyte alkaline phosphatase .',\n",
       "  'PROTEIN',\n",
       "  'Up - regulation of RAR ( alpha ) and PML - RAR gene expression by IFN ( alpha ) is accompanied by a strong potentiation in the induction of 2 retinoid - dependent granulocytic markers , i.e. , granulocyte - colony - stimulating factor receptor mRNA and leukocyte alkaline phosphatase .',\n",
       "  [['RAR(alpha)'], [4], 'PROTEIN']],\n",
       " ['Up - regulation of RAR ( alpha ) and PML - RAR gene expression by <e1> IFN </e1> ( alpha ) is accompanied by a strong potentiation in the induction of 2 retinoid - dependent granulocytic markers , i.e. , granulocyte - colony - stimulating factor receptor mRNA and leukocyte alkaline phosphatase .',\n",
       "  'PROTEIN',\n",
       "  'Up - regulation of RAR ( alpha ) and PML - RAR gene expression by IFN ( alpha ) is accompanied by a strong potentiation in the induction of 2 retinoid - dependent granulocytic markers , i.e. , granulocyte - colony - stimulating factor receptor mRNA and leukocyte alkaline phosphatase .',\n",
       "  [['IFN(alpha)'], [15], 'PROTEIN']],\n",
       " ['However , <e1> IFN </e1> ( alpha ) does not have any effects on the retinoid - dependent regulation of the myeloid surface markers CD11b and CD33 .',\n",
       "  'PROTEIN',\n",
       "  'However , IFN ( alpha ) does not have any effects on the retinoid - dependent regulation of the myeloid surface markers CD11b and CD33 .',\n",
       "  [['IFN(alpha)'], [2], 'PROTEIN']],\n",
       " ['The IFN - dependent increase in <e1> RAR </e1> ( alpha ) levels and the enhancing effect of the cytokine on retinoid - dependent granulocytic markers expression may be a characteristic of PML - RAR positive cells , since the phenomena are not observed in HL - 60 promyelocytes .',\n",
       "  'PROTEIN',\n",
       "  'The IFN - dependent increase in RAR ( alpha ) levels and the enhancing effect of the cytokine on retinoid - dependent granulocytic markers expression may be a characteristic of PML - RAR positive cells , since the phenomena are not observed in HL - 60 promyelocytes .',\n",
       "  [['RAR(alpha)'], [6], 'PROTEIN']],\n",
       " ['Interleukin - 12 ( IL - 12 ) is a key inducer of differentiation of <e1> uncommitted T helper ( TH </e1> ) cells toward the TH1 phenotype , which regulates cellular immunity , whereas IL - 10 inhibits TH1 functions and potentiates TH2 - regulated responses ( i.e. , humoral immunity ) .',\n",
       "  'CELL_TYPE',\n",
       "  'Interleukin - 12 ( IL - 12 ) is a key inducer of differentiation of uncommitted T helper ( TH ) cells toward the TH1 phenotype , which regulates cellular immunity , whereas IL - 10 inhibits TH1 functions and potentiates TH2 - regulated responses ( i.e. , humoral immunity ) .',\n",
       "  [['uncommitted', 'T', 'helper', '(TH)', 'cell'],\n",
       "   [15, 16, 17, 18, 19],\n",
       "   'CELL_TYPE']],\n",
       " ['The PML gene is fused to the <e1> retinoic acid receptor alpha ( RAR alpha </e1> ) gene in t(15;17) acute promyelocytic leukemia ( APL ) , creating a PML - RAR alpha fusion oncoprotein .',\n",
       "  'DNA',\n",
       "  'The PML gene is fused to the retinoic acid receptor alpha ( RAR alpha ) gene in t(15;17) acute promyelocytic leukemia ( APL ) , creating a PML - RAR alpha fusion oncoprotein .',\n",
       "  [['retinoic', 'acid', 'receptor', 'alpha', '(RAR', 'alpha)', 'gene'],\n",
       "   [7, 8, 9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['Early studies in murine T cell lines indicated that transcriptional transactivation functions encoded in the <e1> glucocorticoid receptor ( GR ) N - </e1> terminal domain are required for glucocorticoid - mediated apoptosis .',\n",
       "  'PROTEIN',\n",
       "  'Early studies in murine T cell lines indicated that transcriptional transactivation functions encoded in the glucocorticoid receptor ( GR ) N - terminal domain are required for glucocorticoid - mediated apoptosis .',\n",
       "  [['glucocorticoid', 'receptor', '(GR)', 'N', '-', 'terminal', 'domain'],\n",
       "   [15, 16, 17, 18, 19, 20, 21],\n",
       "   'PROTEIN']],\n",
       " ['GR expression levels were shown to be rate - limiting for initiating the apoptotic pathway , and a positive correlation between steroid sensitivity and GR - mediated induction of an integrated <e1> mouse mammary tumor virus ( MMTV ) LTR </e1> reporter gene was observed .',\n",
       "  'DNA',\n",
       "  'GR expression levels were shown to be rate - limiting for initiating the apoptotic pathway , and a positive correlation between steroid sensitivity and GR - mediated induction of an integrated mouse mammary tumor virus ( MMTV ) LTR reporter gene was observed .',\n",
       "  [['mouse', 'mammary', 'tumor', 'virus', '(MMTV)', 'LTR', 'reporter', 'gene'],\n",
       "   [31, 32, 33, 34, 35, 36, 37, 38],\n",
       "   'DNA']],\n",
       " ['Our data support the notion that <e1> NF </e1> ( kappa ) B and I ( kappa ) B proteases play obligate roles in T cell activation and mitogenesis , roles that are enhanced significantly by NAC .',\n",
       "  'PROTEIN',\n",
       "  'Our data support the notion that NF ( kappa ) B and I ( kappa ) B proteases play obligate roles in T cell activation and mitogenesis , roles that are enhanced significantly by NAC .',\n",
       "  [['NF(kappa)B'], [6], 'PROTEIN']],\n",
       " ['Our data support the notion that NF ( kappa ) B and <e1> I ( </e1> kappa ) B proteases play obligate roles in T cell activation and mitogenesis , roles that are enhanced significantly by NAC .',\n",
       "  'PROTEIN',\n",
       "  'Our data support the notion that NF ( kappa ) B and I ( kappa ) B proteases play obligate roles in T cell activation and mitogenesis , roles that are enhanced significantly by NAC .',\n",
       "  [['I(kappa)B', 'protease'], [12, 13], 'PROTEIN']],\n",
       " ['Cytokines that bind to the <e1> interleukin - 2 ( IL - 2 ) receptor common </e1> gamma chain ( gamma c ) , including IL - 2 , IL - 4 , IL - 7 , IL - 9 , and IL - 15 , are important for the growth and differentiation of T and B lymphocytes , natural killer cells , macrophages , and monoctyes .',\n",
       "  'PROTEIN',\n",
       "  'Cytokines that bind to the interleukin - 2 ( IL - 2 ) receptor common gamma chain ( gamma c ) , including IL - 2 , IL - 4 , IL - 7 , IL - 9 , and IL - 15 , are important for the growth and differentiation of T and B lymphocytes , natural killer cells , macrophages , and monoctyes .',\n",
       "  [['interleukin',\n",
       "    '-',\n",
       "    '2',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2)',\n",
       "    'receptor',\n",
       "    'common',\n",
       "    'gamma',\n",
       "    'chain'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'PROTEIN']],\n",
       " ['We demonstrated that CMV infection increased both IL - 6 protein and <e1> mRNA in peripheral blood </e1> mononuclear cells .',\n",
       "  'RNA',\n",
       "  'We demonstrated that CMV infection increased both IL - 6 protein and mRNA in peripheral blood mononuclear cells .',\n",
       "  [['IL', '-', '6', 'mRNA'], [12, 13, 14, 15], 'RNA']],\n",
       " ['VitD3 induction resulted in the formation of <e1> VDR /RXR DNA - binding </e1> complexes on both VitD3 response elements and RA response elements ( RAREs ) .',\n",
       "  'PROTEIN',\n",
       "  'VitD3 induction resulted in the formation of VDR /RXR DNA - binding complexes on both VitD3 response elements and RA response elements ( RAREs ) .',\n",
       "  [['VDR/RXR', 'DNA', '-', 'binding', 'complex'],\n",
       "   [7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['Concomitant stimulation by VitD3 inhibited the RA - stimulated formation of <e1> RAR beta /RXR </e1> heterodimers , favoring VDR /RXR binding to the RARE .',\n",
       "  'PROTEIN',\n",
       "  'Concomitant stimulation by VitD3 inhibited the RA - stimulated formation of RAR beta /RXR heterodimers , favoring VDR /RXR binding to the RARE .',\n",
       "  [['RAR', 'beta/RXR', 'heterodimer'], [11, 12, 13], 'PROTEIN']],\n",
       " ['<e1> Translocation ( </e1> 3 ; 14 ) ( q27 ; q11 ) : a new variant translocation in a patient with non - Hodgkin s lymphoma of B - cell type with BCL6 rearrangement .',\n",
       "  'DNA',\n",
       "  'Translocation ( 3 ; 14 ) ( q27 ; q11 ) : a new variant translocation in a patient with non - Hodgkin s lymphoma of B - cell type with BCL6 rearrangement .',\n",
       "  [['translocation', '(3;14)(q27;q11)'], [0, 1], 'DNA']],\n",
       " ['Chromosome analysis revealed a t(3;14)(q27;q11) , which is a new variant translocation of <e1> t(3;14) (q27;q32) . </e1>',\n",
       "  'DNA',\n",
       "  'Chromosome analysis revealed a t(3;14)(q27;q11) , which is a new variant translocation of t(3;14) (q27;q32) .',\n",
       "  [['t(3;14)', '(q27;q32)'], [13, 14], 'DNA']],\n",
       " ['Although the band 14q11 is a locus of T - cell receptor alpha - and delta - chains ( TCR alpha/delta ) , lymphoma cells expressed <e1> B - cell , IgGk </e1> phenotype .',\n",
       "  'CELL_TYPE',\n",
       "  'Although the band 14q11 is a locus of T - cell receptor alpha - and delta - chains ( TCR alpha/delta ) , lymphoma cells expressed B - cell , IgGk phenotype .',\n",
       "  [['B', '-', 'cell,', 'IgGk', 'phenotype'],\n",
       "   [26, 27, 28, 29, 30],\n",
       "   'CELL_TYPE']],\n",
       " ['The translocation found in acute promyelocytic leukemia rearranges the promyelocytic leukemia gene ( PML ) on chromosome 15 with the <e1> retinoic acid receptor alpha ( </e1> RARalpha ) on chromosome 17 .',\n",
       "  'DNA',\n",
       "  'The translocation found in acute promyelocytic leukemia rearranges the promyelocytic leukemia gene ( PML ) on chromosome 15 with the retinoic acid receptor alpha ( RARalpha ) on chromosome 17 .',\n",
       "  [['retinoic', 'acid', 'receptor', 'alpha', 'gene'],\n",
       "   [20, 21, 22, 23, 24],\n",
       "   'DNA']],\n",
       " ['However , in vitro clonal growth assays performed on peripheral blood from transgenic versus control mice revealed a marked reduction of myeloid progenitors , especially in those responding to <e1> granulocyte/ macrophage colony - stimulating factor . </e1>',\n",
       "  'PROTEIN',\n",
       "  'However , in vitro clonal growth assays performed on peripheral blood from transgenic versus control mice revealed a marked reduction of myeloid progenitors , especially in those responding to granulocyte/ macrophage colony - stimulating factor .',\n",
       "  [['granulocyte/', 'macrophage', 'colony', '-', 'stimulating', 'factor'],\n",
       "   [29, 30, 31, 32, 33, 34],\n",
       "   'PROTEIN']],\n",
       " ['Previous work has shown that C/EBP sites and C/EBP transcriptional activators are necessary for HIV - 1 LTR activity in <e1> monocytes/macrophages </e1> .',\n",
       "  'CELL_TYPE',\n",
       "  'Previous work has shown that C/EBP sites and C/EBP transcriptional activators are necessary for HIV - 1 LTR activity in monocytes/macrophages .',\n",
       "  [['monocyte/macrophage'], [20], 'CELL_TYPE']],\n",
       " ['These data identify C/EBP proteins as regulators of HIV - 1 expression in <e1> monocytes/macrophages </e1> .',\n",
       "  'CELL_TYPE',\n",
       "  'These data identify C/EBP proteins as regulators of HIV - 1 expression in monocytes/macrophages .',\n",
       "  [['monocyte/macrophage'], [13], 'CELL_TYPE']],\n",
       " ['The contribution to T cell - specific expression by other promoter sites was assessed in a transient expression assay with IL - 3 promoter constructs linked to a luciferase gene , focusing initially on the <e1> core binding factor ( CBF </e1> ) site , which is footprinted in vivo upon T cell activation .',\n",
       "  'DNA',\n",
       "  'The contribution to T cell - specific expression by other promoter sites was assessed in a transient expression assay with IL - 3 promoter constructs linked to a luciferase gene , focusing initially on the core binding factor ( CBF ) site , which is footprinted in vivo upon T cell activation .',\n",
       "  [['core', 'binding', 'factor', '(CBF)', 'site'],\n",
       "   [35, 36, 37, 38, 39],\n",
       "   'DNA']],\n",
       " ['In this work , we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL - 2 are unresponsive to IFN - gamma , as determined by a lack of activation of jak kinases and the transcription factor , <e1> STAT1 </e1> ( alpha ) , a signal transducer and activator of transcription .',\n",
       "  'PROTEIN',\n",
       "  'In this work , we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL - 2 are unresponsive to IFN - gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1 ( alpha ) , a signal transducer and activator of transcription .',\n",
       "  [['STAT1(alpha)'], [46], 'PROTEIN']],\n",
       " ['IL - 4 and IL - 10 inhibit the cytokine production and mRNA expression by <e1> monocytes/macrophages </e1> .',\n",
       "  'CELL_TYPE',\n",
       "  'IL - 4 and IL - 10 inhibit the cytokine production and mRNA expression by monocytes/macrophages .',\n",
       "  [['monocyte/macrophage'], [15], 'CELL_TYPE']],\n",
       " ['The mechanism of action of the immunosuppressive drug cyclosporin A ( CsA ) is the inactivation of the <e1> Ca2+ /calmodulin - dependent serine - threonine </e1> phosphatase calcineurin by the drug - immunophilin complex .',\n",
       "  'PROTEIN',\n",
       "  'The mechanism of action of the immunosuppressive drug cyclosporin A ( CsA ) is the inactivation of the Ca2+ /calmodulin - dependent serine - threonine phosphatase calcineurin by the drug - immunophilin complex .',\n",
       "  [['Ca2+/calmodulin',\n",
       "    '-',\n",
       "    'dependent',\n",
       "    'serine',\n",
       "    '-',\n",
       "    'threonine',\n",
       "    'phosphatase'],\n",
       "   [18, 19, 20, 21, 22, 23, 24],\n",
       "   'PROTEIN']],\n",
       " ['Inactive calcineurin is unable to activate the nuclear factor of activated T cells ( NFAT ) , a transcription factor required for expression of the <e1> interleukin 2 ( IL - 2 </e1> ) gene .',\n",
       "  'DNA',\n",
       "  'Inactive calcineurin is unable to activate the nuclear factor of activated T cells ( NFAT ) , a transcription factor required for expression of the interleukin 2 ( IL - 2 ) gene .',\n",
       "  [['interleukin', '2', '(IL', '-', '2)', 'gene'],\n",
       "   [25, 26, 27, 28, 29, 30],\n",
       "   'DNA']],\n",
       " ['Incubation of <e1> B - chronic lymphocytic leukemia ( B - CLL </e1> ) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates , MARCKS ( myristoylated , alanine - rich C kinase substrate ) and MRP ( MARCKS - related protein ) , and of a third protein , with an apparent m.w. of 60,000 that was the most prominent protein kinase C substrate in these cells .',\n",
       "  'CELL_LINE',\n",
       "  'Incubation of B - chronic lymphocytic leukemia ( B - CLL ) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates , MARCKS ( myristoylated , alanine - rich C kinase substrate ) and MRP ( MARCKS - related protein ) , and of a third protein , with an apparent m.w. of 60,000 that was the most prominent protein kinase C substrate in these cells .',\n",
       "  [['B', '-', 'chronic', 'lymphocytic', 'leukemia', '(B', '-', 'CLL)', 'cell'],\n",
       "   [2, 3, 4, 5, 6, 7, 8, 9, 10],\n",
       "   'CELL_LINE']],\n",
       " ['Incubation of B - chronic lymphocytic leukemia ( B - CLL ) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates , MARCKS ( <e1> myristoylated , alanine - rich C kinase </e1> substrate ) and MRP ( MARCKS - related protein ) , and of a third protein , with an apparent m.w. of 60,000 that was the most prominent protein kinase C substrate in these cells .',\n",
       "  'PROTEIN',\n",
       "  'Incubation of B - chronic lymphocytic leukemia ( B - CLL ) cells with phorbol esters resulted in the phosphorylation of two major PKC substrates , MARCKS ( myristoylated , alanine - rich C kinase substrate ) and MRP ( MARCKS - related protein ) , and of a third protein , with an apparent m.w. of 60,000 that was the most prominent protein kinase C substrate in these cells .',\n",
       "  [['myristoylated,', 'alanine', '-', 'rich', 'C', 'kinase', 'substrate'],\n",
       "   [28, 29, 30, 31, 32, 33, 34],\n",
       "   'PROTEIN']],\n",
       " ['Both cytokines activated factors that bound to the <e1> sis - inducible element </e1> and included STAT1 and STAT3 .',\n",
       "  'DNA',\n",
       "  'Both cytokines activated factors that bound to the sis - inducible element and included STAT1 and STAT3 .',\n",
       "  [['sis', '-', 'inducible', 'elemen'], [8, 9, 10, 11], 'DNA']],\n",
       " ['This cellular system offers the advantage that MHC class II induction is studied in a <e1> \" physiologic \" </e1> cell lineage that , as a result of this expression within the thymus , is thought to participate to the selection and maturation of the T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'This cellular system offers the advantage that MHC class II induction is studied in a \" physiologic \" cell lineage that , as a result of this expression within the thymus , is thought to participate to the selection and maturation of the T cells .',\n",
       "  [['\"physiologic\"', 'cell', 'lineage'], [15, 16, 17], 'CELL_TYPE']],\n",
       " ['We report the effect of E3330 on transcriptional activation of <e1> tumor necrosis factor ( TNF ) - </e1> alpha gene and on nuclear factor ( NF ) - kappa B activation .',\n",
       "  'DNA',\n",
       "  'We report the effect of E3330 on transcriptional activation of tumor necrosis factor ( TNF ) - alpha gene and on nuclear factor ( NF ) - kappa B activation .',\n",
       "  [['tumor', 'necrosis', 'factor', '(TNF)', '-', 'alpha', 'gene'],\n",
       "   [10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['We report the effect of E3330 on transcriptional activation of tumor necrosis factor ( TNF ) - alpha gene and on <e1> nuclear factor ( NF ) - </e1> kappa B activation .',\n",
       "  'PROTEIN',\n",
       "  'We report the effect of E3330 on transcriptional activation of tumor necrosis factor ( TNF ) - alpha gene and on nuclear factor ( NF ) - kappa B activation .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [21, 22, 23, 24, 25, 26],\n",
       "   'PROTEIN']],\n",
       " ['To investigate the inhibitory mechanisms , we constructed a <e1> secreted - type placental alkaline phosphatase ( PLAP ) </e1> reporter gene whose transcription is controlled by a 1.4 - kb human TNF - alpha promoter .',\n",
       "  'DNA',\n",
       "  'To investigate the inhibitory mechanisms , we constructed a secreted - type placental alkaline phosphatase ( PLAP ) reporter gene whose transcription is controlled by a 1.4 - kb human TNF - alpha promoter .',\n",
       "  [['secreted',\n",
       "    '-',\n",
       "    'type',\n",
       "    'placental',\n",
       "    'alkaline',\n",
       "    'phosphatase',\n",
       "    '(PLAP)',\n",
       "    'reporter',\n",
       "    'gene'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16, 17],\n",
       "   'DNA']],\n",
       " ['In vitro mutagenesis and transient transfection experiments indicate that the <e1> C - terminal serine / threonine / </e1> proline - rich region of BSAP contains a potent transactivation domain of 55 amino acids which is active from promoter and enhancer positions .',\n",
       "  'PROTEIN',\n",
       "  'In vitro mutagenesis and transient transfection experiments indicate that the C - terminal serine / threonine / proline - rich region of BSAP contains a potent transactivation domain of 55 amino acids which is active from promoter and enhancer positions .',\n",
       "  [['C', '-', 'terminal', 'serine/threonine/proline', '-', 'rich', 'region'],\n",
       "   [10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['A theoretical pathway of transcriptional regulation of the <e1> androgen receptor ( AR </e1> ) gene is via a cAMP response element ( CRE ) present in its promoter region ( - 508 to - 501 ) .',\n",
       "  'DNA',\n",
       "  'A theoretical pathway of transcriptional regulation of the androgen receptor ( AR ) gene is via a cAMP response element ( CRE ) present in its promoter region ( - 508 to - 501 ) .',\n",
       "  [['androgen', 'receptor', '(AR)', 'gene'], [8, 9, 10, 11], 'DNA']],\n",
       " ['Biochemical analysis of the region - 158/ - 90 revealed a binding site for transcription factors of the <e1> polyomavirus enhancer - binding protein 2/core - binding factor ( PEBP2/CBF </e1> ) family at position - 103 .',\n",
       "  'PROTEIN',\n",
       "  'Biochemical analysis of the region - 158/ - 90 revealed a binding site for transcription factors of the polyomavirus enhancer - binding protein 2/core - binding factor ( PEBP2/CBF ) family at position - 103 .',\n",
       "  [['polyomavirus',\n",
       "    'enhancer',\n",
       "    '-',\n",
       "    'binding',\n",
       "    'protein',\n",
       "    '2/core',\n",
       "    '-',\n",
       "    'binding',\n",
       "    'factor',\n",
       "    '(PEBP2/CBF)',\n",
       "    'family'],\n",
       "   [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28],\n",
       "   'PROTEIN']],\n",
       " ['The activation of T cells requires engagement of the T cell receptor/CD3 complex and co - stimulatory molecules , and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors , such as <e1> nuclear factor ( NF ) - </e1> kappa B and NF - AT .',\n",
       "  'PROTEIN',\n",
       "  'The activation of T cells requires engagement of the T cell receptor/CD3 complex and co - stimulatory molecules , and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors , such as nuclear factor ( NF ) - kappa B and NF - AT .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [42, 43, 44, 45, 46, 47],\n",
       "   'PROTEIN']],\n",
       " ['A result of this activation process is the induction of a number of genes , including those encoding cytokines such as interleukin - 2 , tumor necrosis factor - alpha , and <e1> interferon ( IFN ) </e1> - gamma which have important immunoregulatory effects .',\n",
       "  'PROTEIN',\n",
       "  'A result of this activation process is the induction of a number of genes , including those encoding cytokines such as interleukin - 2 , tumor necrosis factor - alpha , and interferon ( IFN ) - gamma which have important immunoregulatory effects .',\n",
       "  [['interferon', '(IFN)', '-', 'gamma'], [32, 33, 34, 35], 'PROTEIN']],\n",
       " ['A result of this activation process is the induction of a number of genes , including those encoding cytokines such as interleukin - 2 , tumor necrosis factor - alpha , and interferon ( IFN ) - gamma which have important <e1> immunoregulatory effects </e1> .',\n",
       "  'PROTEIN',\n",
       "  'A result of this activation process is the induction of a number of genes , including those encoding cytokines such as interleukin - 2 , tumor necrosis factor - alpha , and interferon ( IFN ) - gamma which have important immunoregulatory effects .',\n",
       "  [['immunoregulatory', 'cytokine'], [41, 42], 'PROTEIN']],\n",
       " ['Absence of T - cell - and B - cell - specific transcription factors TCF - 1 , GATA - 3 , and BSAP in <e1> Hodgkin s Reed - Sternberg </e1> cells .',\n",
       "  'CELL_LINE',\n",
       "  'Absence of T - cell - and B - cell - specific transcription factors TCF - 1 , GATA - 3 , and BSAP in Hodgkin s Reed - Sternberg cells .',\n",
       "  [[\"Hodgkin's\", 'Reed', '-', 'Sternberg', 'cell'],\n",
       "   [25, 26, 27, 28, 29],\n",
       "   'CELL_LINE']],\n",
       " ['Based on the presence of <e1> T cell receptor - beta ( TcR - beta ) </e1> gene rearrangements in L428 and HDLM - 1 cells , the expression of CD2 in HDLM - 1 cells , and the presence of immunoglobulin heavy - chain ( IgH ) gene rearrangement in KM - H2 cells , some researchers have concluded that these long - term cell lines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "  'DNA',\n",
       "  'Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in L428 and HDLM - 1 cells , the expression of CD2 in HDLM - 1 cells , and the presence of immunoglobulin heavy - chain ( IgH ) gene rearrangement in KM - H2 cells , some researchers have concluded that these long - term cell lines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "  [['T',\n",
       "    'cell',\n",
       "    'receptor',\n",
       "    '-',\n",
       "    'beta',\n",
       "    '(TcR',\n",
       "    '-',\n",
       "    'beta)',\n",
       "    'gene',\n",
       "    'rearrangement'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in L428 and HDLM - 1 cells , the expression of CD2 in HDLM - 1 cells , and the presence of <e1> immunoglobulin heavy - chain ( IgH ) </e1> gene rearrangement in KM - H2 cells , some researchers have concluded that these long - term cell lines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "  'DNA',\n",
       "  'Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in L428 and HDLM - 1 cells , the expression of CD2 in HDLM - 1 cells , and the presence of immunoglobulin heavy - chain ( IgH ) gene rearrangement in KM - H2 cells , some researchers have concluded that these long - term cell lines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "  [['immunoglobulin', 'heavy', '-', 'chain', '(IgH)', 'gene', 'rearrangement'],\n",
       "   [39, 40, 41, 42, 43, 44, 45],\n",
       "   'DNA']],\n",
       " ['Active Raf - 1 phosphorylates and activates the <e1> mitogen - activated protein ( MAP ) kinase /extracellular signal - regulated </e1> kinase kinase 1 ( MEK1 ) , which in turn phosphorylates and activates the MAP kinases/extracellular signal regulated kinases , ERK1 and ERK2 .',\n",
       "  'PROTEIN',\n",
       "  'Active Raf - 1 phosphorylates and activates the mitogen - activated protein ( MAP ) kinase /extracellular signal - regulated kinase kinase 1 ( MEK1 ) , which in turn phosphorylates and activates the MAP kinases/extracellular signal regulated kinases , ERK1 and ERK2 .',\n",
       "  [['mitogen',\n",
       "    '-',\n",
       "    'activated',\n",
       "    'protein',\n",
       "    '(MAP)',\n",
       "    'kinase/extracellular',\n",
       "    'signal',\n",
       "    '-',\n",
       "    'regulated',\n",
       "    'kinase',\n",
       "    'kinase',\n",
       "    '1'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'PROTEIN']],\n",
       " ['Active Raf - 1 phosphorylates and activates the <e1> mitogen - activated protein ( MAP </e1> ) kinase /extracellular signal - regulated kinase kinase 1 ( MEK1 ) , which in turn phosphorylates and activates the MAP kinases/extracellular signal regulated kinases , ERK1 and ERK2 .',\n",
       "  'PROTEIN',\n",
       "  'Active Raf - 1 phosphorylates and activates the mitogen - activated protein ( MAP ) kinase /extracellular signal - regulated kinase kinase 1 ( MEK1 ) , which in turn phosphorylates and activates the MAP kinases/extracellular signal regulated kinases , ERK1 and ERK2 .',\n",
       "  [['mitogen', '-', 'activated', 'protein', '(MAP)', 'kinase'],\n",
       "   [8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['The genetic elements and regulatory mechanisms responsible for <e1> human interleukin 9 ( IL - 9 </e1> ) gene expression in a human T cell leukemia virus type I - transformed human T cell line , C5MJ2 , were investigated .',\n",
       "  'DNA',\n",
       "  'The genetic elements and regulatory mechanisms responsible for human interleukin 9 ( IL - 9 ) gene expression in a human T cell leukemia virus type I - transformed human T cell line , C5MJ2 , were investigated .',\n",
       "  [['human', 'interleukin', '9', '(IL', '-', '9)', 'gene'],\n",
       "   [8, 9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['We describe the isolation of human LH - 2 , a putative transcription factor containing two cysteine - rich regions ( LIM domains ) and a <e1> homeobox ( Hox ) DNA - </e1> binding domain .',\n",
       "  'PROTEIN',\n",
       "  'We describe the isolation of human LH - 2 , a putative transcription factor containing two cysteine - rich regions ( LIM domains ) and a homeobox ( Hox ) DNA - binding domain .',\n",
       "  [['homeobox', '(Hox)', 'DNA', '-', 'binding', 'domain'],\n",
       "   [26, 27, 28, 29, 30, 31],\n",
       "   'PROTEIN']],\n",
       " ['Expression of <e1> c - fos and </e1> c - jun proteins and AP - 1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin - stimulated lymphocytes .',\n",
       "  'PROTEIN',\n",
       "  'Expression of c - fos and c - jun proteins and AP - 1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin - stimulated lymphocytes .',\n",
       "  [['c', '-', 'fos', 'protein'], [2, 3, 4, 5], 'PROTEIN']],\n",
       " ['We have used Western blotting to investigate the presence of these proteins during the cell cycles of two different cellular systems : a continuously growing myeloid leukemic cell line , HL60 , and normal cells stimulated into cycle , <e1> phyto -  hemagglutinin ( PHA ) - stimulated normal human peripheral </e1> blood lymphocytes ( PBL ) .',\n",
       "  'CELL_LINE',\n",
       "  'We have used Western blotting to investigate the presence of these proteins during the cell cycles of two different cellular systems : a continuously growing myeloid leukemic cell line , HL60 , and normal cells stimulated into cycle , phyto -  hemagglutinin ( PHA ) - stimulated normal human peripheral blood lymphocytes ( PBL ) .',\n",
       "  [['phyto',\n",
       "    '-',\n",
       "    'hemagglutinin',\n",
       "    '(PHA)',\n",
       "    '-',\n",
       "    'stimulated',\n",
       "    'normal',\n",
       "    'human',\n",
       "    'peripheral',\n",
       "    'blood',\n",
       "    'lymphocyte'],\n",
       "   [39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49],\n",
       "   'CELL_LINE']],\n",
       " ['Octamer binding factors and their coactivator can activate the <e1> murine PU.1 ( spi - 1 </e1> ) promoter .',\n",
       "  'DNA',\n",
       "  'Octamer binding factors and their coactivator can activate the murine PU.1 ( spi - 1 ) promoter .',\n",
       "  [['murine', 'PU.1', '(spi', '-', '1)', 'promoter'],\n",
       "   [9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['Finally , we show that the B cell coactivator OBF - 1/Bob1/OCA - B is only expressed in B cells and not in myeloid cells , and that OBF - 1/Bob1/OCA - B can transactivate the PU.1 promoter in <e1> HeLa and </e1> myeloid cells .',\n",
       "  'CELL_LINE',\n",
       "  'Finally , we show that the B cell coactivator OBF - 1/Bob1/OCA - B is only expressed in B cells and not in myeloid cells , and that OBF - 1/Bob1/OCA - B can transactivate the PU.1 promoter in HeLa and myeloid cells .',\n",
       "  [['HeLa', 'cell'], [39, 40], 'CELL_LINE']],\n",
       " ['Because the binding site showed some sequence similarity with the <e1> nuclear factor of activated T cells ( NFAT ) </e1> binding site , we compared the kinetics of induction of the two binding complexes and the molecular masses of the two proteins .',\n",
       "  'DNA',\n",
       "  'Because the binding site showed some sequence similarity with the nuclear factor of activated T cells ( NFAT ) binding site , we compared the kinetics of induction of the two binding complexes and the molecular masses of the two proteins .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells',\n",
       "    '(NFAT)',\n",
       "    'binding',\n",
       "    'site'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'DNA']],\n",
       " ['Further evidence for the translational suppression of TNF is given by experiments using <e1> chloram - phenicol acetyltransferase ( CAT </e1> ) constructs containing elements of the TNF gene that are involved in TNF translational regulation .',\n",
       "  'DNA',\n",
       "  'Further evidence for the translational suppression of TNF is given by experiments using chloram - phenicol acetyltransferase ( CAT ) constructs containing elements of the TNF gene that are involved in TNF translational regulation .',\n",
       "  [['chloram', '-', 'phenicol', 'acetyltransferase', '(CAT)', 'construct'],\n",
       "   [13, 14, 15, 16, 17, 18],\n",
       "   'DNA']],\n",
       " ['<e1> Recombinant human tumor necrosis factor ( TNF ) binding protein </e1> - 1 ( r - h TBP - 1 ) and recombinant human soluble dimeric TNF receptor ( rhu TNFR : Fc ) were used to determine the relative contributions of TNF to phorbol myristate acetate ( PMA ) and cytokine - induced human immunodeficiency virus type 1 ( HIV - 1 ) replication in chronically infected cell lines .',\n",
       "  'PROTEIN',\n",
       "  'Recombinant human tumor necrosis factor ( TNF ) binding protein - 1 ( r - h TBP - 1 ) and recombinant human soluble dimeric TNF receptor ( rhu TNFR : Fc ) were used to determine the relative contributions of TNF to phorbol myristate acetate ( PMA ) and cytokine - induced human immunodeficiency virus type 1 ( HIV - 1 ) replication in chronically infected cell lines .',\n",
       "  [['Recombinant',\n",
       "    'human',\n",
       "    'tumor',\n",
       "    'necrosis',\n",
       "    'factor',\n",
       "    '(TNF)',\n",
       "    'binding',\n",
       "    'protein',\n",
       "    '-',\n",
       "    '1'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['Recombinant human tumor necrosis factor ( TNF ) binding protein - 1 ( r - h TBP - 1 ) and recombinant human soluble dimeric TNF receptor ( <e1> rhu TNFR </e1> : Fc ) were used to determine the relative contributions of TNF to phorbol myristate acetate ( PMA ) and cytokine - induced human immunodeficiency virus type 1 ( HIV - 1 ) replication in chronically infected cell lines .',\n",
       "  'PROTEIN',\n",
       "  'Recombinant human tumor necrosis factor ( TNF ) binding protein - 1 ( r - h TBP - 1 ) and recombinant human soluble dimeric TNF receptor ( rhu TNFR : Fc ) were used to determine the relative contributions of TNF to phorbol myristate acetate ( PMA ) and cytokine - induced human immunodeficiency virus type 1 ( HIV - 1 ) replication in chronically infected cell lines .',\n",
       "  [['rhu', 'TNFR:Fc'], [28, 29], 'PROTEIN']],\n",
       " ['Treatment of HIV - 1 - infected promonocytic U1 cells with r - h - TBP - 1 or <e1> rhu TNFR </e1> : Fc reduced PMA - induced HIV - 1 p24 antigen production in a concentration - dependent manner , with a maximal inhibition of approximately 90 % .',\n",
       "  'PROTEIN',\n",
       "  'Treatment of HIV - 1 - infected promonocytic U1 cells with r - h - TBP - 1 or rhu TNFR : Fc reduced PMA - induced HIV - 1 p24 antigen production in a concentration - dependent manner , with a maximal inhibition of approximately 90 % .',\n",
       "  [['rhu', 'TNFR:Fc'], [19, 20], 'PROTEIN']],\n",
       " ['Maximal inhibition of p24 antigen production in T - lymphocytic ACH - 2 cells was 47 % with r - hTBP - 1 and 42 % with <e1> rhu TNFR </e1> : Fc .',\n",
       "  'PROTEIN',\n",
       "  'Maximal inhibition of p24 antigen production in T - lymphocytic ACH - 2 cells was 47 % with r - hTBP - 1 and 42 % with rhu TNFR : Fc .',\n",
       "  [['rhu', 'TNFR:Fc'], [27, 28], 'PROTEIN']],\n",
       " ['r - hTBP - 1 and <e1> rhu TNFR </e1> : Fc also decreased p24 antigen synthesized by U1 cells in response to other stimuli , including phytohemagglutinin ( PHA ) - induced supernatant , granulocyte - macrophage colony - stimulating factor , interleukin - 6 , and TNF .',\n",
       "  'PROTEIN',\n",
       "  'r - hTBP - 1 and rhu TNFR : Fc also decreased p24 antigen synthesized by U1 cells in response to other stimuli , including phytohemagglutinin ( PHA ) - induced supernatant , granulocyte - macrophage colony - stimulating factor , interleukin - 6 , and TNF .',\n",
       "  [['rhu', 'TNFR:Fc'], [6, 7], 'PROTEIN']],\n",
       " ['r - hTBP - 1 and rhu TNFR : Fc also decreased p24 antigen synthesized by U1 cells in response to other stimuli , including <e1> phytohemagglutinin ( PHA ) - </e1> induced supernatant , granulocyte - macrophage colony - stimulating factor , interleukin - 6 , and TNF .',\n",
       "  'PROTEIN',\n",
       "  'r - hTBP - 1 and rhu TNFR : Fc also decreased p24 antigen synthesized by U1 cells in response to other stimuli , including phytohemagglutinin ( PHA ) - induced supernatant , granulocyte - macrophage colony - stimulating factor , interleukin - 6 , and TNF .',\n",
       "  [['phytohemagglutinin', '(PHA)', '-', 'induced', 'supernatant'],\n",
       "   [25, 26, 27, 28, 29],\n",
       "   'PROTEIN']],\n",
       " ['Both r - hTBP - 1 and <e1> rhu TNFR </e1> : Fc blocked PMA induction of nuclear factor ( NK ) -  kappa B DNA - binding activity in U1 cells in association with decreases in HIV - 1 replication .',\n",
       "  'PROTEIN',\n",
       "  'Both r - hTBP - 1 and rhu TNFR : Fc blocked PMA induction of nuclear factor ( NK ) -  kappa B DNA - binding activity in U1 cells in association with decreases in HIV - 1 replication .',\n",
       "  [['rhu', 'TNFR:Fc'], [7, 8], 'PROTEIN']],\n",
       " ['Both r - hTBP - 1 and rhu TNFR : Fc blocked PMA induction of <e1> nuclear factor ( NK ) - </e1>  kappa B DNA - binding activity in U1 cells in association with decreases in HIV - 1 replication .',\n",
       "  'PROTEIN',\n",
       "  'Both r - hTBP - 1 and rhu TNFR : Fc blocked PMA induction of nuclear factor ( NK ) -  kappa B DNA - binding activity in U1 cells in association with decreases in HIV - 1 replication .',\n",
       "  [['nuclear', 'factor', '(NK)', '-', 'kappa', 'B'],\n",
       "   [15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['T - cell prolymphocytic leukemia ( T - PLL ) , a rare form of mature T - cell leukemias , and ataxia telangiectasia clonal proliferation , a related condition occurring in patients suffering from ataxia telangiectasia , have been associated to translocations involving the 14q32.1 or Xq28 regions , where are located the <e1> TCL1 and </e1> MTCP1 putative oncogenes , respectively .',\n",
       "  'DNA',\n",
       "  'T - cell prolymphocytic leukemia ( T - PLL ) , a rare form of mature T - cell leukemias , and ataxia telangiectasia clonal proliferation , a related condition occurring in patients suffering from ataxia telangiectasia , have been associated to translocations involving the 14q32.1 or Xq28 regions , where are located the TCL1 and MTCP1 putative oncogenes , respectively .',\n",
       "  [['TCL1', 'oncogene'], [54, 55], 'DNA']],\n",
       " ['A variety of cytokines and growth factors act through an induction of gene expression mediated by a family of latent transcription factors called <e1> STAT ( signal transducers and activators of transcription </e1> ) proteins .',\n",
       "  'PROTEIN',\n",
       "  'A variety of cytokines and growth factors act through an induction of gene expression mediated by a family of latent transcription factors called STAT ( signal transducers and activators of transcription ) proteins .',\n",
       "  [['STAT',\n",
       "    '(signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription)',\n",
       "    'protein'],\n",
       "   [23, 24, 25, 26, 27, 28, 29, 30],\n",
       "   'PROTEIN']],\n",
       " ['These phosphotyrosines serve as docking sites for latent , cytoplasmic transcription factors known as <e1> signal transducers and activators of transcription ( Stat </e1> ) proteins .',\n",
       "  'PROTEIN',\n",
       "  'These phosphotyrosines serve as docking sites for latent , cytoplasmic transcription factors known as signal transducers and activators of transcription ( Stat ) proteins .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(Stat)',\n",
       "    'protein'],\n",
       "   [14, 15, 16, 17, 18, 19, 20, 21],\n",
       "   'PROTEIN']],\n",
       " ['Receptor/Stat interaction is mediated by the <e1> src homology 2 ( SH2 </e1> ) domain of the corresponding Stat protein .',\n",
       "  'PROTEIN',\n",
       "  'Receptor/Stat interaction is mediated by the src homology 2 ( SH2 ) domain of the corresponding Stat protein .',\n",
       "  [['src', 'homology', '2', '(SH2)', 'domain'], [6, 7, 8, 9, 10], 'PROTEIN']],\n",
       " ['<e1> Human T - cell leukemia virus type I ( HTLV - I ) - infected T - </e1> cell lines constitutively produce high levels of interleukin - 1alpha ( IL - 1alpha ) .',\n",
       "  'CELL_LINE',\n",
       "  'Human T - cell leukemia virus type I ( HTLV - I ) - infected T - cell lines constitutively produce high levels of interleukin - 1alpha ( IL - 1alpha ) .',\n",
       "  [['human',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'leukemia',\n",
       "    'virus',\n",
       "    'type',\n",
       "    'I',\n",
       "    '(HTLV',\n",
       "    '-',\n",
       "    'I)',\n",
       "    '-',\n",
       "    'infected',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'line'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'CELL_LINE']],\n",
       " ['IL - 1alpha promoter constructs drive transcription of the <e1> chloramphenicol acetyltransferase ( CAT ) </e1> reporter gene in HTLV - I - positive MT - 2 cells , which constitutively produce IL - 1alpha .',\n",
       "  'DNA',\n",
       "  'IL - 1alpha promoter constructs drive transcription of the chloramphenicol acetyltransferase ( CAT ) reporter gene in HTLV - I - positive MT - 2 cells , which constitutively produce IL - 1alpha .',\n",
       "  [['chloramphenicol', 'acetyltransferase', '(CAT)', 'reporter', 'gene'],\n",
       "   [9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['A mutant Tax protein deficient in transactivation of genes by the <e1> nuclear factor ( NF ) </e1> - kappaB pathway was unable to induce transcriptional activity of IL - 1alpha promoter - CAT constructs , but was rescued by exogenous provision of p65/p50 NF - kappaB .',\n",
       "  'PROTEIN',\n",
       "  'A mutant Tax protein deficient in transactivation of genes by the nuclear factor ( NF ) - kappaB pathway was unable to induce transcriptional activity of IL - 1alpha promoter - CAT constructs , but was rescued by exogenous provision of p65/p50 NF - kappaB .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappaB'],\n",
       "   [11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['The protein product of the <e1> c - fps/fes ( c - fes ) proto </e1> - oncogene has been implicated in the normal development of myeloid cells ( macrophages and neutrophils ) .',\n",
       "  'DNA',\n",
       "  'The protein product of the c - fps/fes ( c - fes ) proto - oncogene has been implicated in the normal development of myeloid cells ( macrophages and neutrophils ) .',\n",
       "  [['c', '-', 'fps/fes', '(c', '-', 'fes)', 'proto', '-', 'oncogene'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['Although a <e1> 13 - kilobase - pair ( kb ) human c - </e1> fes transgene exhibits high levels of expression in mice , the sequences that confer myeloid - cell - specific expression of the human c - fes gene have not been defined .',\n",
       "  'DNA',\n",
       "  'Although a 13 - kilobase - pair ( kb ) human c - fes transgene exhibits high levels of expression in mice , the sequences that confer myeloid - cell - specific expression of the human c - fes gene have not been defined .',\n",
       "  [['13',\n",
       "    '-',\n",
       "    'kilobase',\n",
       "    '-',\n",
       "    'pair',\n",
       "    '(kb)',\n",
       "    'human',\n",
       "    'c',\n",
       "    '-',\n",
       "    'fes',\n",
       "    'transgene'],\n",
       "   [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'DNA']],\n",
       " ['This unidentified factor binds immediately 3 of the <e1> PU.1 /Elf - 1 </e1> sites and appears to be myeloid cell specific .',\n",
       "  'DNA',\n",
       "  'This unidentified factor binds immediately 3 of the PU.1 /Elf - 1 sites and appears to be myeloid cell specific .',\n",
       "  [['PU.1/Elf', '-', '1', 'site'], [8, 9, 10, 11], 'DNA']],\n",
       " ['IL - 10 markedly reduces nuclear factor <e1> ( NF ) - </e1> kappa B/Rel nuclear activity induced in PBMC by stimulation with the anti - CD3 mAb OKT3 .',\n",
       "  'PROTEIN',\n",
       "  'IL - 10 markedly reduces nuclear factor ( NF ) - kappa B/Rel nuclear activity induced in PBMC by stimulation with the anti - CD3 mAb OKT3 .',\n",
       "  [['(NF)', '-', 'kappa', 'B/Rel'], [7, 8, 9, 10], 'PROTEIN']],\n",
       " ['Finally , we have studied the progression of one case of CLL into Richter s syndrome and have found that the <e1> Richter s </e1> cells expressed about 25 - fold less A - myb RNA than the CLL cells from the same patient . The pattern of c - myb and B - myb was clearly distinct from that of A - myb .',\n",
       "  'CELL_LINE',\n",
       "  'Finally , we have studied the progression of one case of CLL into Richter s syndrome and have found that the Richter s cells expressed about 25 - fold less A - myb RNA than the CLL cells from the same patient . The pattern of c - myb and B - myb was clearly distinct from that of A - myb .',\n",
       "  [[\"Richter's\", 'cell'], [21, 22], 'CELL_LINE']],\n",
       " ['In the present study we demonstrate that also the <e1> signal transducers and activators of transcription ( STAT ) </e1> family members STAT1 p91 and STAT3 p92 and the product of the c - fps/fes protooncogene become tyrosine - phosphorylated upon GM - CSF stimulation and physically associated with both GM - CSF receptor beta common subunit and JAK2 .',\n",
       "  'PROTEIN',\n",
       "  'In the present study we demonstrate that also the signal transducers and activators of transcription ( STAT ) family members STAT1 p91 and STAT3 p92 and the product of the c - fps/fes protooncogene become tyrosine - phosphorylated upon GM - CSF stimulation and physically associated with both GM - CSF receptor beta common subunit and JAK2 .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'family',\n",
       "    'member'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16, 17],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Epstein - Barr virus nuclear antigen 2 ( EBNA2 ) - oestrogen receptor </e1> fusion proteins complement the EBNA2 - deficient Epstein - Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines .',\n",
       "  'PROTEIN',\n",
       "  'Epstein - Barr virus nuclear antigen 2 ( EBNA2 ) - oestrogen receptor fusion proteins complement the EBNA2 - deficient Epstein - Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    'nuclear',\n",
       "    'antigen',\n",
       "    '2',\n",
       "    '(EBNA2)',\n",
       "    '-',\n",
       "    'oestrogen',\n",
       "    'receptor',\n",
       "    'fusion',\n",
       "    'protein'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['To develop a transformation system with a conditional <e1> Epstein - Barr virus nuclear antigen 2 ( EBNA2 </e1> ) gene , we fused the hormone binding domain of the oestrogen receptor to the N or C terminus of EBNA2 .',\n",
       "  'DNA',\n",
       "  'To develop a transformation system with a conditional Epstein - Barr virus nuclear antigen 2 ( EBNA2 ) gene , we fused the hormone binding domain of the oestrogen receptor to the N or C terminus of EBNA2 .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    'nuclear',\n",
       "    'antigen',\n",
       "    '2',\n",
       "    '(EBNA2)',\n",
       "    'gene'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['The functional Ets binding site was found to bind Ets family proteins , principally GA - binding protein and Elf - 1 and could be transactivated by GABPalpha and <e1> - beta synergistically </e1> .',\n",
       "  'PROTEIN',\n",
       "  'The functional Ets binding site was found to bind Ets family proteins , principally GA - binding protein and Elf - 1 and could be transactivated by GABPalpha and - beta synergistically .',\n",
       "  [['GABP', '-', 'beta'], [29, 30, 31], 'PROTEIN']],\n",
       " ['Of five positive clones isolated from 0.75 x 10(6) yeast colonies , four were members of the <e1> CREB/activating transcription factor ( ATF </e1> ) family : CREB , two isoforms of the cyclic AMP - responsive element modulator ( CREM ) , and ATF - 1 .',\n",
       "  'PROTEIN',\n",
       "  'Of five positive clones isolated from 0.75 x 10(6) yeast colonies , four were members of the CREB/activating transcription factor ( ATF ) family : CREB , two isoforms of the cyclic AMP - responsive element modulator ( CREM ) , and ATF - 1 .',\n",
       "  [['CREB/activating', 'transcription', 'factor', '(ATF)', 'family'],\n",
       "   [17, 18, 19, 20, 21],\n",
       "   'PROTEIN']],\n",
       " ['This shows that in a eukaryotic nucleus , Tax specifically interacts with the basic domain <e1> - leucine </e1> zipper region of ATF - 1 , CREB , and CREM .',\n",
       "  'PROTEIN',\n",
       "  'This shows that in a eukaryotic nucleus , Tax specifically interacts with the basic domain - leucine zipper region of ATF - 1 , CREB , and CREM .',\n",
       "  [['leucine', 'zipper'], [15, 16], 'PROTEIN']],\n",
       " ['<e1> Interleukin - 2 ( IL - 2 </e1> ) promoter - reporter gene behavior closely parallels the endogenous gene in response to T cell receptor and costimulatory signals .',\n",
       "  'DNA',\n",
       "  'Interleukin - 2 ( IL - 2 ) promoter - reporter gene behavior closely parallels the endogenous gene in response to T cell receptor and costimulatory signals .',\n",
       "  [['interleukin', '-', '2', '(IL', '-', '2)', 'promoter'],\n",
       "   [0, 1, 2, 3, 4, 5, 6],\n",
       "   'DNA']],\n",
       " ['Interleukin - 2 ( IL - 2 ) promoter <e1> - reporter </e1> gene behavior closely parallels the endogenous gene in response to T cell receptor and costimulatory signals .',\n",
       "  'DNA',\n",
       "  'Interleukin - 2 ( IL - 2 ) promoter - reporter gene behavior closely parallels the endogenous gene in response to T cell receptor and costimulatory signals .',\n",
       "  [['reporter', 'gene'], [9, 10], 'DNA']],\n",
       " ['Both primary activation , with phytohemagglutinin or <e1> antibodies to CD3 </e1> , and costimulation , provided by pairs of CD2 antibodies or B7 - positive ( B cells ) or B7 - negative ( endothelial ) accessory cells , are mediated through the same cis - elements .',\n",
       "  'PROTEIN',\n",
       "  'Both primary activation , with phytohemagglutinin or antibodies to CD3 , and costimulation , provided by pairs of CD2 antibodies or B7 - positive ( B cells ) or B7 - negative ( endothelial ) accessory cells , are mediated through the same cis - elements .',\n",
       "  [['antibody', 'to', 'CD3'], [7, 8, 9], 'PROTEIN']],\n",
       " ['Both primary activation , with phytohemagglutinin or antibodies to CD3 , and costimulation , provided by pairs of CD2 antibodies or <e1> B7 - positive ( B </e1> cells ) or B7 - negative ( endothelial ) accessory cells , are mediated through the same cis - elements .',\n",
       "  'CELL_TYPE',\n",
       "  'Both primary activation , with phytohemagglutinin or antibodies to CD3 , and costimulation , provided by pairs of CD2 antibodies or B7 - positive ( B cells ) or B7 - negative ( endothelial ) accessory cells , are mediated through the same cis - elements .',\n",
       "  [['B7', '-', 'positive', '(B', 'cells)'],\n",
       "   [21, 22, 23, 24, 25],\n",
       "   'CELL_TYPE']],\n",
       " ['Both primary activation , with phytohemagglutinin or antibodies to CD3 , and costimulation , provided by pairs of CD2 antibodies or B7 - positive ( B cells ) or <e1> B7 - negative ( endothelial ) </e1> accessory cells , are mediated through the same cis - elements .',\n",
       "  'CELL_TYPE',\n",
       "  'Both primary activation , with phytohemagglutinin or antibodies to CD3 , and costimulation , provided by pairs of CD2 antibodies or B7 - positive ( B cells ) or B7 - negative ( endothelial ) accessory cells , are mediated through the same cis - elements .',\n",
       "  [['B7', '-', 'negative', '(endothelial)', 'accessory', 'cell'],\n",
       "   [29, 30, 31, 32, 33, 34],\n",
       "   'CELL_TYPE']],\n",
       " ['Interestingly , the <e1> nuclear factor of activated T cell sites </e1> are much less important in normal T cells than in Jurkat T cells .',\n",
       "  'DNA',\n",
       "  'Interestingly , the nuclear factor of activated T cell sites are much less important in normal T cells than in Jurkat T cells .',\n",
       "  [['nuclear', 'factor', 'of', 'activated', 'T', 'cells', 'site'],\n",
       "   [3, 4, 5, 6, 7, 8, 9],\n",
       "   'DNA']],\n",
       " ['In addition , we demonstrate a unique involvement of the RXR - RXR pathway in mediating growth inhibition of <e1> erythroid but </e1> not myeloid progenitor cells .',\n",
       "  'CELL_TYPE',\n",
       "  'In addition , we demonstrate a unique involvement of the RXR - RXR pathway in mediating growth inhibition of erythroid but not myeloid progenitor cells .',\n",
       "  [['erythroid', 'cell'], [19, 20], 'CELL_TYPE']],\n",
       " ['Inhibition of vitamin D receptor <e1> - retinoid X </e1> receptor - vitamin D response element complex formation by nuclear extracts of vitamin D - resistant New World primate cells .',\n",
       "  'PROTEIN',\n",
       "  'Inhibition of vitamin D receptor - retinoid X receptor - vitamin D response element complex formation by nuclear extracts of vitamin D - resistant New World primate cells .',\n",
       "  [['retinoid', 'X', 'receptor'], [5, 6, 7], 'PROTEIN']],\n",
       " ['Inhibition of vitamin D receptor - retinoid X receptor <e1> - vitamin D response </e1> element complex formation by nuclear extracts of vitamin D - resistant New World primate cells .',\n",
       "  'DNA',\n",
       "  'Inhibition of vitamin D receptor - retinoid X receptor - vitamin D response element complex formation by nuclear extracts of vitamin D - resistant New World primate cells .',\n",
       "  [['vitamin', 'D', 'response', 'element'], [9, 10, 11, 12], 'DNA']],\n",
       " ['Nuclear and post - nuclear extracts were prepared from two B - lymphoblastoid cell lines known to be representative of the <e1> vitamin D - resistant and </e1> wild type phenotypes , respectively .',\n",
       "  'CELL_LINE',\n",
       "  'Nuclear and post - nuclear extracts were prepared from two B - lymphoblastoid cell lines known to be representative of the vitamin D - resistant and wild type phenotypes , respectively .',\n",
       "  [['vitamin', 'D', '-', 'resistant', 'phenotype'],\n",
       "   [21, 22, 23, 24, 25],\n",
       "   'CELL_LINE']],\n",
       " ['To define novel proteins involved in the early transcriptional response during the activation of human T lymphocytes , we used a high - resolution , two - dimensional gel electrophoresis system to identify <e1> nuclear , deoxyribonucleic acid ( DNA </e1> ) binding proteins exhibiting rapid changes in phosphorylation following cell stimulation .',\n",
       "  'PROTEIN',\n",
       "  'To define novel proteins involved in the early transcriptional response during the activation of human T lymphocytes , we used a high - resolution , two - dimensional gel electrophoresis system to identify nuclear , deoxyribonucleic acid ( DNA ) binding proteins exhibiting rapid changes in phosphorylation following cell stimulation .',\n",
       "  [['nuclear,', 'deoxyribonucleic', 'acid', '(DNA)', 'binding', 'protein'],\n",
       "   [33, 34, 35, 36, 37, 38],\n",
       "   'PROTEIN']],\n",
       " ['Interactions of a transcriptional activator in the env gene of the mouse mammary tumor virus with <e1> activation - dependent , T cell - specific transacting </e1> factors .',\n",
       "  'PROTEIN',\n",
       "  'Interactions of a transcriptional activator in the env gene of the mouse mammary tumor virus with activation - dependent , T cell - specific transacting factors .',\n",
       "  [['activation',\n",
       "    '-',\n",
       "    'dependent,',\n",
       "    'T',\n",
       "    'cell',\n",
       "    '-',\n",
       "    'specific',\n",
       "    'transacting',\n",
       "    'factor'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23, 24],\n",
       "   'PROTEIN']],\n",
       " ['We have isolated a novel cDNA clone encoding <e1> interferon ( IFN ) consensus sequence - </e1> binding protein in adult T - cell leukemia cell line or activated T cells ( ICSAT ) ; this protein is the human homolog of the recently cloned Pip/LSIRF .',\n",
       "  'PROTEIN',\n",
       "  'We have isolated a novel cDNA clone encoding interferon ( IFN ) consensus sequence - binding protein in adult T - cell leukemia cell line or activated T cells ( ICSAT ) ; this protein is the human homolog of the recently cloned Pip/LSIRF .',\n",
       "  [['interferon', '(IFN)', 'consensus', 'sequence', '-', 'binding', 'protein'],\n",
       "   [8, 9, 10, 11, 12, 13, 14],\n",
       "   'PROTEIN']],\n",
       " ['ICSAT is structurally most closely related to the previously cloned ICSBP , a member of the <e1> IFN regulatory factor ( IRF </e1> ) family of proteins that binds to interferon consensus sequences ( ICSs ) found in many promoters of the IFN - regulated genes .',\n",
       "  'PROTEIN',\n",
       "  'ICSAT is structurally most closely related to the previously cloned ICSBP , a member of the IFN regulatory factor ( IRF ) family of proteins that binds to interferon consensus sequences ( ICSs ) found in many promoters of the IFN - regulated genes .',\n",
       "  [['IFN', 'regulatory', 'factor', '(IRF)', 'family'],\n",
       "   [16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['Among T - cell lines investigated , ICSAT was abundantly expressed in <e1> human T - cell leukemia virus type 1 ( HTLV - 1 ) - infected </e1> T cells .',\n",
       "  'CELL_LINE',\n",
       "  'Among T - cell lines investigated , ICSAT was abundantly expressed in human T - cell leukemia virus type 1 ( HTLV - 1 ) - infected T cells .',\n",
       "  [['human',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'leukemia',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HTLV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    '-',\n",
       "    'infected',\n",
       "    'T',\n",
       "    'cell'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'CELL_LINE']],\n",
       " ['The JAK kinases and the <e1> signal transducers and activators of transcription ( STAT </e1> ) factors have been found to be essential components .',\n",
       "  'PROTEIN',\n",
       "  'The JAK kinases and the signal transducers and activators of transcription ( STAT ) factors have been found to be essential components .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'factor'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['The developmental stage - specificity of PYBF and the location of its binding site between the <e1> fetal and adult beta - globin ( HBB ) - </e1> like genes suggest that PBYF and its binding site may function in fetal - to - adult globin gene switching .',\n",
       "  'DNA',\n",
       "  'The developmental stage - specificity of PYBF and the location of its binding site between the fetal and adult beta - globin ( HBB ) - like genes suggest that PBYF and its binding site may function in fetal - to - adult globin gene switching .',\n",
       "  [['fetal',\n",
       "    'and',\n",
       "    'adult',\n",
       "    'beta',\n",
       "    '-',\n",
       "    'globin',\n",
       "    '(HBB)',\n",
       "    '-',\n",
       "    'like',\n",
       "    'gene'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23, 24, 25],\n",
       "   'DNA']],\n",
       " ['Here , we describe the effect of 383 - bp ( delta383 ) and 99 - bp ( delta99 ) sequences containing the PYBF - binding site on transcription from various globin and non - globin promoters , using a transient assay with the cat reporter gene in <e1> murine erythroleukemia ( MEL </e1> ) cells , a cell line with abundant PYBF activity .',\n",
       "  'CELL_LINE',\n",
       "  'Here , we describe the effect of 383 - bp ( delta383 ) and 99 - bp ( delta99 ) sequences containing the PYBF - binding site on transcription from various globin and non - globin promoters , using a transient assay with the cat reporter gene in murine erythroleukemia ( MEL ) cells , a cell line with abundant PYBF activity .',\n",
       "  [['murine', 'erythroleukemia', '(MEL)', 'cell'],\n",
       "   [48, 49, 50, 51],\n",
       "   'CELL_LINE']],\n",
       " ['We show that both delta383 and delta99 specifically enhance expression of cat for plasmids containing a <e1> human adult globin ( HBB </e1> ) promoter , whereas expression of similar constructs using human fetal ( A gamma - ) globin ( HBG1 ) or simian virus 40 ( SV40 ) promoters is not enhanced .',\n",
       "  'DNA',\n",
       "  'We show that both delta383 and delta99 specifically enhance expression of cat for plasmids containing a human adult globin ( HBB ) promoter , whereas expression of similar constructs using human fetal ( A gamma - ) globin ( HBG1 ) or simian virus 40 ( SV40 ) promoters is not enhanced .',\n",
       "  [['human', 'adult', 'globin', '(HBB)', 'promoter'],\n",
       "   [16, 17, 18, 19, 20],\n",
       "   'DNA']],\n",
       " ['Ten mutants of the simian immunodeficiency virus ( SIV ) SIVmac239 bearing deletions ( delta ) or substitutions ( subst ) in the <e1> NF - kappaB and/or Sp1 </e1> binding elements were created , and the replicative capacities of the mutants were analyzed .',\n",
       "  'DNA',\n",
       "  'Ten mutants of the simian immunodeficiency virus ( SIV ) SIVmac239 bearing deletions ( delta ) or substitutions ( subst ) in the NF - kappaB and/or Sp1 binding elements were created , and the replicative capacities of the mutants were analyzed .',\n",
       "  [['NF', '-', 'kappaB', 'binding', 'element'], [23, 24, 25, 26, 27], 'DNA']],\n",
       " ['Further , in transcriptional assays in vivo , ICER inhibits calcineurin - mediated expression of the interleukin 2 promoter as well as Tax - mediated transactivation of the <e1> human T - lymphotropic virus type I ( HTLV - I </e1> ) promoter .',\n",
       "  'DNA',\n",
       "  'Further , in transcriptional assays in vivo , ICER inhibits calcineurin - mediated expression of the interleukin 2 promoter as well as Tax - mediated transactivation of the human T - lymphotropic virus type I ( HTLV - I ) promoter .',\n",
       "  [['human',\n",
       "    'T',\n",
       "    '-',\n",
       "    'lymphotropic',\n",
       "    'virus',\n",
       "    'type',\n",
       "    'I',\n",
       "    '(HTLV',\n",
       "    '-',\n",
       "    'I)',\n",
       "    'promoter'],\n",
       "   [28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38],\n",
       "   'DNA']],\n",
       " ['EBNA - 5 is one of the <e1> Epstein - Barr virus ( EBV ) - encoded </e1> nuclear proteins required for immortalization of human B lymphocytes .',\n",
       "  'PROTEIN',\n",
       "  'EBNA - 5 is one of the Epstein - Barr virus ( EBV ) - encoded nuclear proteins required for immortalization of human B lymphocytes .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    '-',\n",
       "    'encoded',\n",
       "    'nuclear',\n",
       "    'protein'],\n",
       "   [7, 8, 9, 10, 11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['Cyclic AMP <e1> - responsive </e1> element - dependent activation of Epstein - Barr virus zebra promoter by human herpesvirus 6 .',\n",
       "  'DNA',\n",
       "  'Cyclic AMP - responsive element - dependent activation of Epstein - Barr virus zebra promoter by human herpesvirus 6 .',\n",
       "  [['responsive', 'element'], [2, 3], 'DNA']],\n",
       " ['We have recently shown that infection of <e1> Epstein - Barr virus ( EBV ) genome - positive </e1> B cells by human herpesvirus 6 ( HHV - 6 ) results in the expression of the immediate - early EBV Zebra gene , followed by virus replication ( L.Flamand , I.Stefanescu , D.V.Ablashi , and J.Menezes , J.Virol.67 : 6768 - 6777 , 1993 ) .',\n",
       "  'CELL_LINE',\n",
       "  'We have recently shown that infection of Epstein - Barr virus ( EBV ) genome - positive B cells by human herpesvirus 6 ( HHV - 6 ) results in the expression of the immediate - early EBV Zebra gene , followed by virus replication ( L.Flamand , I.Stefanescu , D.V.Ablashi , and J.Menezes , J.Virol.67 : 6768 - 6777 , 1993 ) .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    'genome',\n",
       "    '-',\n",
       "    'positive',\n",
       "    'B',\n",
       "    'cell'],\n",
       "   [7, 8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'CELL_LINE']],\n",
       " ['Mutation of the <e1> consensus AP - 1/ CRE </e1> site within ZII abolished the inducibility of Zp by HHV - 6 , whereas positioning of the ZII domain upstream of the beta - globin minimal promoter conferred responsiveness following HHV - 6 infection .',\n",
       "  'DNA',\n",
       "  'Mutation of the consensus AP - 1/ CRE site within ZII abolished the inducibility of Zp by HHV - 6 , whereas positioning of the ZII domain upstream of the beta - globin minimal promoter conferred responsiveness following HHV - 6 infection .',\n",
       "  [['consensus', 'AP', '-', '1/CRE', 'site'], [3, 4, 5, 6, 7], 'DNA']],\n",
       " ['Antibodies against <e1> CRE - binding ( CREB </e1> ) protein but not against c - Fos or c - Jun were able to supershift the DNA - protein complex , identifying the nature of the transcription factor which binds to ZII as a member of the CREB family of proteins .',\n",
       "  'PROTEIN',\n",
       "  'Antibodies against CRE - binding ( CREB ) protein but not against c - Fos or c - Jun were able to supershift the DNA - protein complex , identifying the nature of the transcription factor which binds to ZII as a member of the CREB family of proteins .',\n",
       "  [['CRE', '-', 'binding', '(CREB)', 'protein'], [2, 3, 4, 5, 6], 'PROTEIN']],\n",
       " ['This work aimed to ascertain the role of kappaB - responsive elements of the <e1> human immunodeficiency virus type 1 ( HIV - 1 </e1> ) enhancer not only in early initiation but also in long - term maintenance of proviral transcription in cells of the monocytic lineage .',\n",
       "  'DNA',\n",
       "  'This work aimed to ascertain the role of kappaB - responsive elements of the human immunodeficiency virus type 1 ( HIV - 1 ) enhancer not only in early initiation but also in long - term maintenance of proviral transcription in cells of the monocytic lineage .',\n",
       "  [['human',\n",
       "    'immunodeficiency',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HIV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'enhancer'],\n",
       "   [14, 15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'DNA']],\n",
       " ['Together , our results indicate that occupancy of the viral enhancer by <e1> NF - kappaB ( p50/p65 </e1> ) heterodimers is required for ongoing transcription of integrated HIV provirus in monocytes , even in cells chronically infected and permanently producing functional HIV Tat protein .',\n",
       "  'PROTEIN',\n",
       "  'Together , our results indicate that occupancy of the viral enhancer by NF - kappaB ( p50/p65 ) heterodimers is required for ongoing transcription of integrated HIV provirus in monocytes , even in cells chronically infected and permanently producing functional HIV Tat protein .',\n",
       "  [['NF', '-', 'kappaB', '(p50/p65)', 'heterodimer'],\n",
       "   [12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['The expression of cell surface markers including the <e1> interleukin 2 receptor alpha ( IL - 2R alpha </e1> ) chain ( CD25 ) , CD69 and L - selectin ( CD62 ) is normal in mitogen - activated Rel - / - T cells , but cytokine production is impaired .',\n",
       "  'PROTEIN',\n",
       "  'The expression of cell surface markers including the interleukin 2 receptor alpha ( IL - 2R alpha ) chain ( CD25 ) , CD69 and L - selectin ( CD62 ) is normal in mitogen - activated Rel - / - T cells , but cytokine production is impaired .',\n",
       "  [['interleukin',\n",
       "    '2',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2R',\n",
       "    'alpha)',\n",
       "    'chain'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['Here we demonstrate that CD28RE binds an inducible protein with a molecular mass of approximately 35 kDa called nuclear factor of mitogenic - activated T cells ( NF - MATp35 ) that is clearly different from the known <e1> NF -  kappaB/ Rel family </e1> members .',\n",
       "  'PROTEIN',\n",
       "  'Here we demonstrate that CD28RE binds an inducible protein with a molecular mass of approximately 35 kDa called nuclear factor of mitogenic - activated T cells ( NF - MATp35 ) that is clearly different from the known NF -  kappaB/ Rel family members .',\n",
       "  [['NF', '-', 'kappaB/Rel', 'family', 'member'],\n",
       "   [38, 39, 40, 41, 42],\n",
       "   'PROTEIN']],\n",
       " ['The work reported here resolves , at the level of gene regulation , the controversy as to whether or not <e1> human monocytes </e1> /macrophages can produce nitric oxide ( NO ) when stimulated with lipopolysaccharide ( LPS ) , with or without co - stimulation by interferon - gamma ( IFN - gamma ) .',\n",
       "  'CELL_TYPE',\n",
       "  'The work reported here resolves , at the level of gene regulation , the controversy as to whether or not human monocytes /macrophages can produce nitric oxide ( NO ) when stimulated with lipopolysaccharide ( LPS ) , with or without co - stimulation by interferon - gamma ( IFN - gamma ) .',\n",
       "  [['human', 'monocytes/macrophage'], [20, 21], 'CELL_TYPE']],\n",
       " ['Studies included structural comparison of the promoters for human and mouse <e1> inducible NO synthase ( iNOS </e1> ) genes , transfection and assay of human and mouse iNOS promoter regions in response to LPS +/ - IFN - gamma , and electrophoretic mobility shift assays of kappa B response elements .',\n",
       "  'DNA',\n",
       "  'Studies included structural comparison of the promoters for human and mouse inducible NO synthase ( iNOS ) genes , transfection and assay of human and mouse iNOS promoter regions in response to LPS +/ - IFN - gamma , and electrophoretic mobility shift assays of kappa B response elements .',\n",
       "  [['inducible', 'NO', 'synthase', '(iNOS)', 'gene'],\n",
       "   [11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/ - IFN - gamma were found : ( 1 ) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS / IFN - gamma induced expression of the mouse iNOS gene ; and ( 2 ) and absence of one or more nuclear factors in human macrophages ( e.g. , an <e1> LPS - inducible nuclear factor - kappa B/ Rel </e1> complex ) , that is ( are ) required for maximal expression of the gene .',\n",
       "  'PROTEIN',\n",
       "  'Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/ - IFN - gamma were found : ( 1 ) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS / IFN - gamma induced expression of the mouse iNOS gene ; and ( 2 ) and absence of one or more nuclear factors in human macrophages ( e.g. , an LPS - inducible nuclear factor - kappa B/ Rel complex ) , that is ( are ) required for maximal expression of the gene .',\n",
       "  [['LPS',\n",
       "    '-',\n",
       "    'inducible',\n",
       "    'nuclear',\n",
       "    'factor',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B/Rel',\n",
       "    'complex'],\n",
       "   [72, 73, 74, 75, 76, 77, 78, 79, 80],\n",
       "   'PROTEIN']],\n",
       " ['X inactivation analysis in a female with hypomelanosis of Ito associated with a <e1> balanced X ; </e1> 17 translocation : evidence for functional disomy of Xp .',\n",
       "  'DNA',\n",
       "  'X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X ; 17 translocation : evidence for functional disomy of Xp .',\n",
       "  [['balanced', 'X;17', 'translocation'], [13, 14, 15], 'DNA']],\n",
       " ['X inactivation analysis was performed on normal and hypopigmented skin samples obtained from a female with hypomelanosis of Ito associated with a <e1> balanced whole arm X ; </e1> 17 translocation .',\n",
       "  'DNA',\n",
       "  'X inactivation analysis was performed on normal and hypopigmented skin samples obtained from a female with hypomelanosis of Ito associated with a balanced whole arm X ; 17 translocation .',\n",
       "  [['balanced', 'whole', 'arm', 'X;17', 'translocation'],\n",
       "   [22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['Severe skewing of X inactivation resulting in inactivity of the intact X was found in blood and cultures of both types of skin , but analysis of DNA prepared directly from hypopigmented skin showed significant inactivation of the translocated X , inconsistent with the usual mechanism of phenotypic expression in <e1> X ; </e1> autosome translocations .',\n",
       "  'DNA',\n",
       "  'Severe skewing of X inactivation resulting in inactivity of the intact X was found in blood and cultures of both types of skin , but analysis of DNA prepared directly from hypopigmented skin showed significant inactivation of the translocated X , inconsistent with the usual mechanism of phenotypic expression in X ; autosome translocations .',\n",
       "  [['X;autosome', 'translocation'], [50, 51], 'DNA']],\n",
       " ['Injection of SEA to adult mice activates CD4+ T cells expressing certain <e1> T - cell receptor ( TCR ) variable region beta - </e1> chain families and induces strong and rapid production of interleukin 2 ( IL - 2 ) .',\n",
       "  'PROTEIN',\n",
       "  'Injection of SEA to adult mice activates CD4+ T cells expressing certain T - cell receptor ( TCR ) variable region beta - chain families and induces strong and rapid production of interleukin 2 ( IL - 2 ) .',\n",
       "  [['T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'receptor',\n",
       "    '(TCR)',\n",
       "    'variable',\n",
       "    'region',\n",
       "    'beta',\n",
       "    '-',\n",
       "    'chain',\n",
       "    'families'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'PROTEIN']],\n",
       " ['In contrast , in vivo footprints on <e1> GT ( CACCC </e1> ) motifs differed between the cells expressing the fetal or the adult globin program .',\n",
       "  'DNA',\n",
       "  'In contrast , in vivo footprints on GT ( CACCC ) motifs differed between the cells expressing the fetal or the adult globin program .',\n",
       "  [['GT', '(CACCC)', 'motif'], [7, 8, 9], 'DNA']],\n",
       " ['The objective of this study was to develop U937 transfectants expressing antisense VDR mRNA , and to use these to examine the role of 1,25(OH)2D3 <e1> - </e1> VDR interaction in this lineage .',\n",
       "  'PROTEIN',\n",
       "  'The objective of this study was to develop U937 transfectants expressing antisense VDR mRNA , and to use these to examine the role of 1,25(OH)2D3 - VDR interaction in this lineage .',\n",
       "  [['VDR'], [25], 'PROTEIN']],\n",
       " ['We now report that galectin - 3 is abundantly expressed in a number of <e1> human T lymphotropic virus ( HTLV ) - I - infected human T </e1> cell lines , including F6T , HUT 102 , K3T , MT - 2 , and SLB - I , but is not expressed in non - HTLV - I - infected T cell lines such as Jurkat , CEM , and MOLT - 4 .',\n",
       "  'CELL_LINE',\n",
       "  'We now report that galectin - 3 is abundantly expressed in a number of human T lymphotropic virus ( HTLV ) - I - infected human T cell lines , including F6T , HUT 102 , K3T , MT - 2 , and SLB - I , but is not expressed in non - HTLV - I - infected T cell lines such as Jurkat , CEM , and MOLT - 4 .',\n",
       "  [['human',\n",
       "    'T',\n",
       "    'lymphotropic',\n",
       "    'virus',\n",
       "    '(HTLV)',\n",
       "    '-',\n",
       "    'I',\n",
       "    '-',\n",
       "    'infected',\n",
       "    'human',\n",
       "    'T',\n",
       "    'cell',\n",
       "    'line'],\n",
       "   [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'CELL_LINE']],\n",
       " ['Mutagenesis of the <e1> activator protein - 1 [ AP - 1 </e1> ] site at - 72 abolished basal promoter activity and LPS /zymosan inducibility , while mutagenesis of an NF - kappaB - like site at - 20 to - 10 had no effect .',\n",
       "  'DNA',\n",
       "  'Mutagenesis of the activator protein - 1 [ AP - 1 ] site at - 72 abolished basal promoter activity and LPS /zymosan inducibility , while mutagenesis of an NF - kappaB - like site at - 20 to - 10 had no effect .',\n",
       "  [['activator', 'protein', '-', '1', '[AP', '-', '1]', 'site'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10],\n",
       "   'DNA']],\n",
       " ['Binding of LPS - <e1> LPS binding protein ( LBP </e1> ) complexes to CD14 , a surface receptor that mediates many LPS responses , was found to be crucial , as pretreatment of THP - 1 cells with the monoclonal antibody 60b , which blocks this binding , inhibited JNK activation .',\n",
       "  'PROTEIN',\n",
       "  'Binding of LPS - LPS binding protein ( LBP ) complexes to CD14 , a surface receptor that mediates many LPS responses , was found to be crucial , as pretreatment of THP - 1 cells with the monoclonal antibody 60b , which blocks this binding , inhibited JNK activation .',\n",
       "  [['LPS', 'binding', 'protein', '(LBP)', 'complex'],\n",
       "   [4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['Deletional and site - directed mutagenesis revealed the presence of multiple functionally critical cis elements within this region , one of which was a <e1> nuclear factor ( NF ) - kappaB </e1> consensus sequence .',\n",
       "  'DNA',\n",
       "  'Deletional and site - directed mutagenesis revealed the presence of multiple functionally critical cis elements within this region , one of which was a nuclear factor ( NF ) - kappaB consensus sequence .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappaB', 'consensus', 'sequence'],\n",
       "   [24, 25, 26, 27, 28, 29, 30],\n",
       "   'DNA']],\n",
       " ['In combination with TNF - alpha , IL - 10 stimulated activating protein - 1 ( AP - 1 ) and <e1> nuclear factor ( NF ) - </e1> kappa B binding activities and cooperated to increase HIV - 1 steady - state mRNA levels and enhance long terminal repeat - directed transcription through activation of the NF - kappa B binding sites , suggesting the IL - 10 effect occurs at least in part at the transcriptional level .',\n",
       "  'PROTEIN',\n",
       "  'In combination with TNF - alpha , IL - 10 stimulated activating protein - 1 ( AP - 1 ) and nuclear factor ( NF ) - kappa B binding activities and cooperated to increase HIV - 1 steady - state mRNA levels and enhance long terminal repeat - directed transcription through activation of the NF - kappa B binding sites , suggesting the IL - 10 effect occurs at least in part at the transcriptional level .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [21, 22, 23, 24, 25, 26],\n",
       "   'PROTEIN']],\n",
       " ['This raises the intriguing possibility that physical association of the <e1> HsN3 proteasome subunit </e1> with HTLV - I Tax coupled with the independent interaction of Tax with either p100 or p65 - I kappa B alpha targets these cytoplasmic NF - kappa B/Rel complexes to the proteasome for processing .',\n",
       "  'PROTEIN',\n",
       "  'This raises the intriguing possibility that physical association of the HsN3 proteasome subunit with HTLV - I Tax coupled with the independent interaction of Tax with either p100 or p65 - I kappa B alpha targets these cytoplasmic NF - kappa B/Rel complexes to the proteasome for processing .',\n",
       "  [['HsN3', 'proteasome', 'subuni'], [10, 11, 12], 'PROTEIN']],\n",
       " ['Here , we studied the role of <e1> serine /threonine </e1> phosphatases in STAT3 signaling in human antigen - specific CD4(+) T cell lines and cutaneous T cell lymphoma lines , expressing a constitutively activated STAT3 .',\n",
       "  'PROTEIN',\n",
       "  'Here , we studied the role of serine /threonine phosphatases in STAT3 signaling in human antigen - specific CD4(+) T cell lines and cutaneous T cell lymphoma lines , expressing a constitutively activated STAT3 .',\n",
       "  [['serine/threonine', 'phosphatase'], [7, 8], 'PROTEIN']],\n",
       " ['Pretreatment with the broad serine /threonine kinase inhibitor staurosporine partly blocked the calyculin A - induced STAT3 phosphorylation , whereas inhibitors of <e1> serine /threonine </e1> kinases , such as mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase , mitogen - activated protein p38 kinase , and phosphatidylinositol 3 - kinase , did not .',\n",
       "  'PROTEIN',\n",
       "  'Pretreatment with the broad serine /threonine kinase inhibitor staurosporine partly blocked the calyculin A - induced STAT3 phosphorylation , whereas inhibitors of serine /threonine kinases , such as mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase , mitogen - activated protein p38 kinase , and phosphatidylinositol 3 - kinase , did not .',\n",
       "  [['serine/threonine', 'kinase'], [22, 23], 'PROTEIN']],\n",
       " ['RESULTS : <e1> Nuclear factor ( NF ) </e1> - kappaB is the main transcription factor involved in the gene activation that follows CD23 cross - linking in monocytes .',\n",
       "  'PROTEIN',\n",
       "  'RESULTS : Nuclear factor ( NF ) - kappaB is the main transcription factor involved in the gene activation that follows CD23 cross - linking in monocytes .',\n",
       "  [['Nuclear', 'factor', '(NF)', '-', 'kappaB'], [2, 3, 4, 5, 6], 'PROTEIN']],\n",
       " ['We have examined the influence of the affinity and concentration of exogenous peptide and the density of specific MHC molecules on the proliferation of a <e1> CD4+ , DQA1*0501/DQB1*0201 ( DQ2.1 ) - restricted , HSV - 2 - </e1> specific T cell clone .',\n",
       "  'CELL_LINE',\n",
       "  'We have examined the influence of the affinity and concentration of exogenous peptide and the density of specific MHC molecules on the proliferation of a CD4+ , DQA1*0501/DQB1*0201 ( DQ2.1 ) - restricted , HSV - 2 - specific T cell clone .',\n",
       "  [['CD4+,',\n",
       "    'DQA1*0501/DQB1*0201',\n",
       "    '(DQ2.1)',\n",
       "    '-',\n",
       "    'restricted,',\n",
       "    'HSV',\n",
       "    '-',\n",
       "    '2',\n",
       "    '-',\n",
       "    'specific',\n",
       "    'T',\n",
       "    'cell',\n",
       "    'clone'],\n",
       "   [25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37],\n",
       "   'CELL_LINE']],\n",
       " ['One such example is the excessive expression of <e1> \" normal </e1> \" lymphokines of cytokines which accompanies many lymphoproliferative diseases .',\n",
       "  'PROTEIN',\n",
       "  'One such example is the excessive expression of \" normal \" lymphokines of cytokines which accompanies many lymphoproliferative diseases .',\n",
       "  [['\"normal\"', 'lymphokine'], [8, 9], 'PROTEIN']],\n",
       " ['<e1> Single C motif - 1 ( SCM - </e1> 1 ) /lymphotactin is a C - type chemokine whose expression is activation dependent , cyclosporin A sensitive and restricted to CD8+ T cells , double - negative thymocytes , gammadelta - type T cells , and NK cells .',\n",
       "  'PROTEIN',\n",
       "  'Single C motif - 1 ( SCM - 1 ) /lymphotactin is a C - type chemokine whose expression is activation dependent , cyclosporin A sensitive and restricted to CD8+ T cells , double - negative thymocytes , gammadelta - type T cells , and NK cells .',\n",
       "  [['Single', 'C', 'motif', '-', '1', '(SCM', '-', '1)/lymphotactin'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Human monocyte IL - 1 receptor antagonist ( IL - 1ra ) messenger </e1> ribonucleic acid ( mRNA ) expression and protein secretion are inhibited by dexamethasone .',\n",
       "  'RNA',\n",
       "  'Human monocyte IL - 1 receptor antagonist ( IL - 1ra ) messenger ribonucleic acid ( mRNA ) expression and protein secretion are inhibited by dexamethasone .',\n",
       "  [['human',\n",
       "    'monocyte',\n",
       "    'IL',\n",
       "    '-',\n",
       "    '1',\n",
       "    'receptor',\n",
       "    'antagonist',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '1ra)',\n",
       "    'messenger',\n",
       "    'ribonucleic',\n",
       "    'acid'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'RNA']],\n",
       " ['The ability of Qp to bind <e1> signal transducer and activator of transcription ( STAT </e1> ) proteins was directly demonstrated by electrophoretic mobility - shift assay , and mutation of potential STAT - binding sites reduced Qp responsiveness to Janus kinase ( JAK ) - 1 .',\n",
       "  'PROTEIN',\n",
       "  'The ability of Qp to bind signal transducer and activator of transcription ( STAT ) proteins was directly demonstrated by electrophoretic mobility - shift assay , and mutation of potential STAT - binding sites reduced Qp responsiveness to Janus kinase ( JAK ) - 1 .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'protein'],\n",
       "   [6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['Consistent with a role for STATs in Qp function , Qp using Burkitt s lymphoma Rael cells and <e1> cultured nasopharyngeal carcinoma ( NPC </e1> ) cells contained nuclear STAT protein .',\n",
       "  'CELL_TYPE',\n",
       "  'Consistent with a role for STATs in Qp function , Qp using Burkitt s lymphoma Rael cells and cultured nasopharyngeal carcinoma ( NPC ) cells contained nuclear STAT protein .',\n",
       "  [['cultured', 'nasopharyngeal', 'carcinoma', '(NPC)', 'cell'],\n",
       "   [18, 19, 20, 21, 22],\n",
       "   'CELL_TYPE']],\n",
       " ['We show here that the response of the HIV - 1 long terminal repeat ( LTR ) to mitogenic or Tat - mediated activation is sensitive to the suppressive action of a <e1> Herpesvirus saimiri ( HVS ) - transformed CD8+ T </e1> cell clone from an HIV - infected individual and supernatants from CD8+ T cells of HIV - 1 - infected asymptomatic subjects ( CD4+ > 350/microliters ) .',\n",
       "  'CELL_LINE',\n",
       "  'We show here that the response of the HIV - 1 long terminal repeat ( LTR ) to mitogenic or Tat - mediated activation is sensitive to the suppressive action of a Herpesvirus saimiri ( HVS ) - transformed CD8+ T cell clone from an HIV - infected individual and supernatants from CD8+ T cells of HIV - 1 - infected asymptomatic subjects ( CD4+ > 350/microliters ) .',\n",
       "  [['Herpesvirus',\n",
       "    'saimiri',\n",
       "    '(HVS)',\n",
       "    '-',\n",
       "    'transformed',\n",
       "    'CD8+',\n",
       "    'T',\n",
       "    'cell',\n",
       "    'clone'],\n",
       "   [32, 33, 34, 35, 36, 37, 38, 39, 40],\n",
       "   'CELL_LINE']],\n",
       " ['However , the response to HIV - 1 Tat by a LTR in which the <e1> interleukin ( IL ) - 2 homology NFAT - </e1> 1 region was mutated resulted in almost complete elimination of suppression by CD8+ T cells .',\n",
       "  'DNA',\n",
       "  'However , the response to HIV - 1 Tat by a LTR in which the interleukin ( IL ) - 2 homology NFAT - 1 region was mutated resulted in almost complete elimination of suppression by CD8+ T cells .',\n",
       "  [['interleukin', '(IL)', '-', '2', 'homology', 'NFAT', '-', '1', 'region'],\n",
       "   [15, 16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'DNA']],\n",
       " ['Taken together , these observations suggest that mitogenic activation , mediated primarily through the <e1> NF kappa B enhancer </e1> , is susceptible to CD8 - mediated inhibition , however , inhibition of Tat - mediated activation may rely upon a different pathway that is NFAT - 1 dependent .',\n",
       "  'DNA',\n",
       "  'Taken together , these observations suggest that mitogenic activation , mediated primarily through the NF kappa B enhancer , is susceptible to CD8 - mediated inhibition , however , inhibition of Tat - mediated activation may rely upon a different pathway that is NFAT - 1 dependent .',\n",
       "  [['NF', 'kappa', 'B', 'enhance'], [14, 15, 16, 17], 'DNA']],\n",
       " ['<e1> Nuclear factor ( NF ) - </e1> kappa B is a redox sensitive cytosolic transcription factor .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear factor ( NF ) - kappa B is a redox sensitive cytosolic transcription factor .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappa', 'B'],\n",
       "   [0, 1, 2, 3, 4, 5],\n",
       "   'PROTEIN']],\n",
       " ['PMA and TNF alpha induced activation of <e1> ( NF ) - </e1> kappa B in human Jurkat T - cells was partially inhibited by ADT ( 0.1 mM ) pretreatment .',\n",
       "  'PROTEIN',\n",
       "  'PMA and TNF alpha induced activation of ( NF ) - kappa B in human Jurkat T - cells was partially inhibited by ADT ( 0.1 mM ) pretreatment .',\n",
       "  [['(NF)', '-', 'kappa', 'B'], [7, 8, 9, 10], 'PROTEIN']],\n",
       " ['Although little information as to what signal transduction pathways mediate NF - kappa B activation in monocytes - macrophages is available , our previous work indicated that classical <e1> protein kinase C ( PKC </e1> ) isoenzymes were not involved in the HIV - mediated NF - kappa B activation .',\n",
       "  'PROTEIN',\n",
       "  'Although little information as to what signal transduction pathways mediate NF - kappa B activation in monocytes - macrophages is available , our previous work indicated that classical protein kinase C ( PKC ) isoenzymes were not involved in the HIV - mediated NF - kappa B activation .',\n",
       "  [['protein', 'kinase', 'C', '(PKC)', 'isoenzyme'],\n",
       "   [28, 29, 30, 31, 32],\n",
       "   'PROTEIN']],\n",
       " ['That PKC - zeta is specific in regulating NF - kappa B is concluded from the inability of <e1> PKC - zeta </e1> ( mut ) to interfere with the basal or phorbol myristate acetate - inducible CREB - or AP1 - dependent transcriptional activity .',\n",
       "  'PROTEIN',\n",
       "  'That PKC - zeta is specific in regulating NF - kappa B is concluded from the inability of PKC - zeta ( mut ) to interfere with the basal or phorbol myristate acetate - inducible CREB - or AP1 - dependent transcriptional activity .',\n",
       "  [['PKC', '-', 'zeta(mut)'], [18, 19, 20], 'PROTEIN']],\n",
       " ['The consequent decrease in the nuclear levels of c - Jun and JunD leads to diminished binding of <e1> c - Jun /c - </e1> Fos and JunD /c - Fos heterodimers to the AP - 1 consensus sequence in the TNF promoter and , thus , to decreased transactivation of the TNF gene .',\n",
       "  'PROTEIN',\n",
       "  'The consequent decrease in the nuclear levels of c - Jun and JunD leads to diminished binding of c - Jun /c - Fos and JunD /c - Fos heterodimers to the AP - 1 consensus sequence in the TNF promoter and , thus , to decreased transactivation of the TNF gene .',\n",
       "  [['c', '-', 'Jun/c', '-', 'Fos'], [18, 19, 20, 21, 22], 'PROTEIN']],\n",
       " ['The consequent decrease in the nuclear levels of c - Jun and JunD leads to diminished binding of c - Jun /c - Fos and <e1> JunD /c - Fos </e1> heterodimers to the AP - 1 consensus sequence in the TNF promoter and , thus , to decreased transactivation of the TNF gene .',\n",
       "  'PROTEIN',\n",
       "  'The consequent decrease in the nuclear levels of c - Jun and JunD leads to diminished binding of c - Jun /c - Fos and JunD /c - Fos heterodimers to the AP - 1 consensus sequence in the TNF promoter and , thus , to decreased transactivation of the TNF gene .',\n",
       "  [['JunD/c', '-', 'Fos', 'heterodimer'], [25, 26, 27, 28], 'PROTEIN']],\n",
       " ['Moreover , we provide evidence that <e1> TCR/ </e1> CD3 and IL - 2 induce Stat3 activation via distinct signaling pathways .',\n",
       "  'PROTEIN',\n",
       "  'Moreover , we provide evidence that TCR/ CD3 and IL - 2 induce Stat3 activation via distinct signaling pathways .',\n",
       "  [['TCR/CD3'], [6], 'PROTEIN']],\n",
       " ['PPARgamma is also expressed in hematopoietic cells and is up - regulated in activated <e1> monocytes/ </e1> macrophages .',\n",
       "  'CELL_TYPE',\n",
       "  'PPARgamma is also expressed in hematopoietic cells and is up - regulated in activated monocytes/ macrophages .',\n",
       "  [['monocyte/macrophage'], [14], 'CELL_TYPE']],\n",
       " ['CD45 - dependent events such as tyrosine phosphorylation of Shc , activation of nuclear factor - kappa B ( NF - kappa B ) , activator protein - 1 ( AP - 1 ) , transcription factors , and stimulation of <e1> interleukin - 2 ( IL - 2 </e1> ) promoter and of CD69 and CD25 surface expression paralleled activation of the tyrosine kinases lck and fyn .',\n",
       "  'DNA',\n",
       "  'CD45 - dependent events such as tyrosine phosphorylation of Shc , activation of nuclear factor - kappa B ( NF - kappa B ) , activator protein - 1 ( AP - 1 ) , transcription factors , and stimulation of interleukin - 2 ( IL - 2 ) promoter and of CD69 and CD25 surface expression paralleled activation of the tyrosine kinases lck and fyn .',\n",
       "  [['interleukin', '-', '2', '(IL', '-', '2)', 'promoter'],\n",
       "   [41, 42, 43, 44, 45, 46, 47],\n",
       "   'DNA']],\n",
       " ['The data demonstrate that the T - cell antigen receptor <e1> - CD3 ( TcR - CD3 </e1> ) complex is functionally linked to two different protein tyrosine kinase ( PTK ) modules with separate specific functions and that CD45 may be an important regulator of this coupling .',\n",
       "  'PROTEIN',\n",
       "  'The data demonstrate that the T - cell antigen receptor - CD3 ( TcR - CD3 ) complex is functionally linked to two different protein tyrosine kinase ( PTK ) modules with separate specific functions and that CD45 may be an important regulator of this coupling .',\n",
       "  [['-', 'CD3', '(TcR', '-', 'CD3)', 'complex'],\n",
       "   [10, 11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['The data demonstrate that the T - cell antigen receptor <e1> - </e1> CD3 ( TcR - CD3 ) complex is functionally linked to two different protein tyrosine kinase ( PTK ) modules with separate specific functions and that CD45 may be an important regulator of this coupling .',\n",
       "  'PROTEIN',\n",
       "  'The data demonstrate that the T - cell antigen receptor - CD3 ( TcR - CD3 ) complex is functionally linked to two different protein tyrosine kinase ( PTK ) modules with separate specific functions and that CD45 may be an important regulator of this coupling .',\n",
       "  [['CD3'], [10], 'PROTEIN']],\n",
       " ['Here we demonstrate that these analogs , as well as the 6 - cis - locked conformer , <e1> 1alpha,25 - dihydroxy - lumisterol3 ( JN ) prime </e1> NB4 cells for monocytic differentiation .',\n",
       "  'CELL_LINE',\n",
       "  'Here we demonstrate that these analogs , as well as the 6 - cis - locked conformer , 1alpha,25 - dihydroxy - lumisterol3 ( JN ) prime NB4 cells for monocytic differentiation .',\n",
       "  [['1alpha,25',\n",
       "    '-',\n",
       "    'dihydroxy',\n",
       "    '-',\n",
       "    'lumisterol3',\n",
       "    '(JN)',\n",
       "    'prime',\n",
       "    'NB4',\n",
       "    'cell'],\n",
       "   [18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'CELL_LINE']],\n",
       " ['Rheumatoid arthritis ( RA ) is a chronic autoimmune inflammatory disease in which unknown arthrogenic autoantigen is presented to <e1> CD4 + T </e1> cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Rheumatoid arthritis ( RA ) is a chronic autoimmune inflammatory disease in which unknown arthrogenic autoantigen is presented to CD4 + T cells .',\n",
       "  [['CD4+', 'T', 'cell'], [19, 20, 21], 'CELL_TYPE']],\n",
       " ['Circulating dendritic cells ( DC ) are phenotypically and functionally identical with <e1> normal peripheral blood ( PB </e1> ) DC .',\n",
       "  'CELL_TYPE',\n",
       "  'Circulating dendritic cells ( DC ) are phenotypically and functionally identical with normal peripheral blood ( PB ) DC .',\n",
       "  [['normal', 'peripheral', 'blood', '(PB)', 'DC'],\n",
       "   [12, 13, 14, 15, 16],\n",
       "   'CELL_TYPE']],\n",
       " ['Thymocyte - thymic epithelial cell interaction leads to high - level replication of human immunodeficiency virus exclusively in <e1> mature CD4 (+) CD8( - ) CD3 </e1> (+) thymocytes : a critical role for tumor necrosis factor and interleukin - 7 .',\n",
       "  'CELL_TYPE',\n",
       "  'Thymocyte - thymic epithelial cell interaction leads to high - level replication of human immunodeficiency virus exclusively in mature CD4 (+) CD8( - ) CD3 (+) thymocytes : a critical role for tumor necrosis factor and interleukin - 7 .',\n",
       "  [['mature', 'CD4(+)', 'CD8(', '-', ')', 'CD3(+)', 'thymocyte'],\n",
       "   [18, 19, 20, 21, 22, 23, 24],\n",
       "   'CELL_TYPE']],\n",
       " ['In this report we demonstrate that interaction with thymic epithelial cells ( TEC ) induces a high - level replication of the T - tropic primary isolate HIV - 1 ( B - LAIp ) exclusively in the mature <e1> CD4 (+) CD8( - ) CD3 </e1> (+) thymocytes .',\n",
       "  'CELL_TYPE',\n",
       "  'In this report we demonstrate that interaction with thymic epithelial cells ( TEC ) induces a high - level replication of the T - tropic primary isolate HIV - 1 ( B - LAIp ) exclusively in the mature CD4 (+) CD8( - ) CD3 (+) thymocytes .',\n",
       "  [['CD4(+)', 'CD8(', '-', ')', 'CD3(+)', 'thymocyte'],\n",
       "   [39, 40, 41, 42, 43, 44],\n",
       "   'CELL_TYPE']],\n",
       " ['<e1> Tumor necrosis factor </e1> ( TNF ) and interleukin - 7 ( IL - 7 ) , secreted during this interaction , are critical cytokines for HIV long terminal repeat transactivation through NF - kappaB - dependent activation .',\n",
       "  'PROTEIN',\n",
       "  'Tumor necrosis factor ( TNF ) and interleukin - 7 ( IL - 7 ) , secreted during this interaction , are critical cytokines for HIV long terminal repeat transactivation through NF - kappaB - dependent activation .',\n",
       "  [['rumor', 'necrosis', 'factor'], [0, 1, 2], 'PROTEIN']],\n",
       " ['The requirement for TNF is further confirmed by the observation that the inability of the <e1> intermediate CD4 (+) CD8( - ) CD3 ( - </e1> ) thymocytes to replicate the virus is associated with a defect in TNF production during their interaction with TEC and correlates with the absence of nuclear NF - kappaB activity in these freshly isolated thymocytes .',\n",
       "  'CELL_TYPE',\n",
       "  'The requirement for TNF is further confirmed by the observation that the inability of the intermediate CD4 (+) CD8( - ) CD3 ( - ) thymocytes to replicate the virus is associated with a defect in TNF production during their interaction with TEC and correlates with the absence of nuclear NF - kappaB activity in these freshly isolated thymocytes .',\n",
       "  [['intermediate', 'CD4(+)', 'CD8(', '-', ')', 'CD3(', '-', ')', 'thymocyte'],\n",
       "   [15, 16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'CELL_TYPE']],\n",
       " ['The other major subpopulation expressing the CD4 receptor , namely , the <e1> double - positive ( DP ) CD4 (+) CD8(+) CD3 </e1> (+/ - ) thymocytes , despite the entry of the virus , do not produce a significant level of virus , presumably because they are unresponsive to TNF and IL - 7 .',\n",
       "  'CELL_TYPE',\n",
       "  'The other major subpopulation expressing the CD4 receptor , namely , the double - positive ( DP ) CD4 (+) CD8(+) CD3 (+/ - ) thymocytes , despite the entry of the virus , do not produce a significant level of virus , presumably because they are unresponsive to TNF and IL - 7 .',\n",
       "  [['double',\n",
       "    '-',\n",
       "    'positive',\n",
       "    '(DP)',\n",
       "    'CD4(+)',\n",
       "    'CD8(+)',\n",
       "    'CD3(+/',\n",
       "    '-',\n",
       "    ')',\n",
       "    'thymocyte'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20, 21],\n",
       "   'CELL_TYPE']],\n",
       " ['Together , these data suggest that in vivo , despite an efficient entry of the virus in all the <e1> CD4 (+) </e1> subpopulations , a high viral load may be generated exclusively within the mature CD4 (+) CD8( - ) CD3 (+) subset of thymocytes .',\n",
       "  'CELL_TYPE',\n",
       "  'Together , these data suggest that in vivo , despite an efficient entry of the virus in all the CD4 (+) subpopulations , a high viral load may be generated exclusively within the mature CD4 (+) CD8( - ) CD3 (+) subset of thymocytes .',\n",
       "  [['CD4(+)', 'subpopulation'], [19, 20], 'CELL_TYPE']],\n",
       " ['Together , these data suggest that in vivo , despite an efficient entry of the virus in all the CD4 (+) subpopulations , a high viral load may be generated exclusively within the <e1> mature CD4 (+) CD8( - ) CD3 (+) subset </e1> of thymocytes .',\n",
       "  'CELL_TYPE',\n",
       "  'Together , these data suggest that in vivo , despite an efficient entry of the virus in all the CD4 (+) subpopulations , a high viral load may be generated exclusively within the mature CD4 (+) CD8( - ) CD3 (+) subset of thymocytes .',\n",
       "  [['mature',\n",
       "    'CD4(+)',\n",
       "    'CD8(',\n",
       "    '-',\n",
       "    ')',\n",
       "    'CD3(+)',\n",
       "    'subset',\n",
       "    'of',\n",
       "    'thymocyte'],\n",
       "   [33, 34, 35, 36, 37, 38, 39, 40, 41],\n",
       "   'CELL_TYPE']],\n",
       " ['However , stimulation with MBP did not produce an increase in the binding activity of <e1> nuclear factor ( NF ) </e1> - kappaB or activator protein - 1 .',\n",
       "  'PROTEIN',\n",
       "  'However , stimulation with MBP did not produce an increase in the binding activity of nuclear factor ( NF ) - kappaB or activator protein - 1 .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappaB'],\n",
       "   [15, 16, 17, 18, 19],\n",
       "   'PROTEIN']],\n",
       " ['MBP also induced transient increases in mRNA for <e1> macrophage inflammatory protein ( MIP ) </e1> - 1alpha and MIP - 1beta , but did not stimulate the release of either chemokine .',\n",
       "  'PROTEIN',\n",
       "  'MBP also induced transient increases in mRNA for macrophage inflammatory protein ( MIP ) - 1alpha and MIP - 1beta , but did not stimulate the release of either chemokine .',\n",
       "  [['macrophage', 'inflammatory', 'protein', '(MIP)', '-', '1alpha'],\n",
       "   [8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['We also show that expression of the B1 transcript from a second gene , MTCP1 , occurred at a relatively high level only in two T - PLL tumours from A - T patients with t(X;14) translocations whereas the <e1> MTCP1 /A1 </e1> transcript is much more widely expressed in both tumour and non tumour cells of A - T and non - A - T individuals .',\n",
       "  'RNA',\n",
       "  'We also show that expression of the B1 transcript from a second gene , MTCP1 , occurred at a relatively high level only in two T - PLL tumours from A - T patients with t(X;14) translocations whereas the MTCP1 /A1 transcript is much more widely expressed in both tumour and non tumour cells of A - T and non - A - T individuals .',\n",
       "  [['MTCP1/A1', 'transcript'], [39, 40], 'RNA']],\n",
       " ['The flow of information from calcium - mobilizing receptors to <e1> nuclear factor of activated T cells ( NFAT ) - </e1> dependent genes is critically dependent on interaction between the phosphatase calcineurin and the transcription factor NFAT .',\n",
       "  'DNA',\n",
       "  'The flow of information from calcium - mobilizing receptors to nuclear factor of activated T cells ( NFAT ) - dependent genes is critically dependent on interaction between the phosphatase calcineurin and the transcription factor NFAT .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells',\n",
       "    '(NFAT)',\n",
       "    '-',\n",
       "    'dependent',\n",
       "    'gene'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'DNA']],\n",
       " ['Compounds that interfere selectively with the calcineurin <e1> - </e1> NFAT interaction without affecting calcineurin phosphatase activity may be useful as therapeutic agents that are less toxic than current drugs .',\n",
       "  'PROTEIN',\n",
       "  'Compounds that interfere selectively with the calcineurin - NFAT interaction without affecting calcineurin phosphatase activity may be useful as therapeutic agents that are less toxic than current drugs .',\n",
       "  [['NFAT'], [7], 'PROTEIN']],\n",
       " ['An inhibitory , \" dominant - negative , \" form of the <e1> calcineurin catalytic ( A </e1> ) subunit was prepared , which lacks the calmodulin - binding domain , autoinhibitory domain and most of its catalytic core but possesses the regulatory ( B ) subunit binding domain .',\n",
       "  'PROTEIN',\n",
       "  'An inhibitory , \" dominant - negative , \" form of the calcineurin catalytic ( A ) subunit was prepared , which lacks the calmodulin - binding domain , autoinhibitory domain and most of its catalytic core but possesses the regulatory ( B ) subunit binding domain .',\n",
       "  [['calcineurin', 'catalytic', '(A)', 'subunit'],\n",
       "   [12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['An inhibitory , \" dominant - negative , \" form of the calcineurin catalytic ( A ) subunit was prepared , which lacks the calmodulin - binding domain , autoinhibitory domain and most of its catalytic core but possesses the <e1> regulatory ( B </e1> ) subunit binding domain .',\n",
       "  'PROTEIN',\n",
       "  'An inhibitory , \" dominant - negative , \" form of the calcineurin catalytic ( A ) subunit was prepared , which lacks the calmodulin - binding domain , autoinhibitory domain and most of its catalytic core but possesses the regulatory ( B ) subunit binding domain .',\n",
       "  [['regulatory', '(B)', 'subunit'], [40, 41, 42], 'PROTEIN']],\n",
       " ['When tested for its ability to block calcineurin - dependent signaling in Jurkat cells , expression of this <e1> \" B - subunit knock - out \" </e1> ( BKO ) construct suppressed reporter gene activity driven by NF - AT , the pivotal promoter element for interleukin ( IL ) - 2 gene induction .',\n",
       "  'DNA',\n",
       "  'When tested for its ability to block calcineurin - dependent signaling in Jurkat cells , expression of this \" B - subunit knock - out \" ( BKO ) construct suppressed reporter gene activity driven by NF - AT , the pivotal promoter element for interleukin ( IL ) - 2 gene induction .',\n",
       "  [['\"B', '-', 'subunit', 'knock', '-', 'out\"', '(BKO)', 'construct'],\n",
       "   [18, 19, 20, 21, 22, 23, 24, 25],\n",
       "   'DNA']],\n",
       " ['When tested for its ability to block calcineurin - dependent signaling in Jurkat cells , expression of this \" B - subunit knock - out \" ( BKO ) construct suppressed reporter gene activity driven by NF - AT , the pivotal promoter element for <e1> interleukin ( IL ) - </e1> 2 gene induction .',\n",
       "  'DNA',\n",
       "  'When tested for its ability to block calcineurin - dependent signaling in Jurkat cells , expression of this \" B - subunit knock - out \" ( BKO ) construct suppressed reporter gene activity driven by NF - AT , the pivotal promoter element for interleukin ( IL ) - 2 gene induction .',\n",
       "  [['interleukin', '(IL)', '-', '2', 'gene'], [45, 46, 47, 48, 49], 'DNA']],\n",
       " ['The <e1> Rh : </e1> 33 cells behaved as normal Rh ( D ) positive cells .',\n",
       "  'CELL_LINE',\n",
       "  'The Rh : 33 cells behaved as normal Rh ( D ) positive cells .',\n",
       "  [['Rh:33', 'cell'], [1, 2], 'CELL_LINE']],\n",
       " ['The Rh : 33 cells behaved as <e1> normal Rh ( D </e1> ) positive cells .',\n",
       "  'CELL_TYPE',\n",
       "  'The Rh : 33 cells behaved as normal Rh ( D ) positive cells .',\n",
       "  [['normal', 'Rh(D)', 'positive', 'cell'], [7, 8, 9, 10], 'CELL_TYPE']],\n",
       " ['In addition , H - 7 ( 10 microM ) , a specific inhibitor of <e1> serine /threonine </e1> kinases , significantly blocked IL - 10 mediated c - fos expression ( p < 0.05 ) .',\n",
       "  'PROTEIN',\n",
       "  'In addition , H - 7 ( 10 microM ) , a specific inhibitor of serine /threonine kinases , significantly blocked IL - 10 mediated c - fos expression ( p < 0.05 ) .',\n",
       "  [['serine/threonine', 'kinase'], [15, 16], 'PROTEIN']],\n",
       " ['In conclusion , these data show that IL - 10 induces c - fos expression in human B - cells by activation of tyrosine and <e1> serine /threonine </e1> kinases .',\n",
       "  'PROTEIN',\n",
       "  'In conclusion , these data show that IL - 10 induces c - fos expression in human B - cells by activation of tyrosine and serine /threonine kinases .',\n",
       "  [['serine/threonine', 'kinase'], [25, 26], 'PROTEIN']],\n",
       " ['Peroxisome proliferator - activated receptor activators target human endothelial cells to inhibit leukocyte <e1> - endothelial </e1> cell interaction .',\n",
       "  'CELL_TYPE',\n",
       "  'Peroxisome proliferator - activated receptor activators target human endothelial cells to inhibit leukocyte - endothelial cell interaction .',\n",
       "  [['endothelial', 'cell'], [13, 14], 'CELL_TYPE']],\n",
       " ['Both <e1> PPAR - alpha and </e1> PPAR - gamma mRNAs were detected in HAECs by using reverse transcription - polymerase chain reaction and a ribonuclease protection assay ; however , we have yet to determine which , if any , of the PPARs are mediating this process .',\n",
       "  'RNA',\n",
       "  'Both PPAR - alpha and PPAR - gamma mRNAs were detected in HAECs by using reverse transcription - polymerase chain reaction and a ribonuclease protection assay ; however , we have yet to determine which , if any , of the PPARs are mediating this process .',\n",
       "  [['PPAR', '-', 'alpha', 'mRNA'], [1, 2, 3, 4], 'RNA']],\n",
       " ['Further analysis of the MBP promoter region identified a <e1> C/EBP ( CCAAT/enhancer - binding protein ) consensus </e1> binding site 6 bp upstream of the functional GATA - binding site in the MBP gene .',\n",
       "  'DNA',\n",
       "  'Further analysis of the MBP promoter region identified a C/EBP ( CCAAT/enhancer - binding protein ) consensus binding site 6 bp upstream of the functional GATA - binding site in the MBP gene .',\n",
       "  [['C/EBP',\n",
       "    '(CCAAT/enhancer',\n",
       "    '-',\n",
       "    'binding',\n",
       "    'protein)',\n",
       "    'consensus',\n",
       "    'binding',\n",
       "    'site'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['We have isolated the 5 region of the <e1> ecto - 5 - nucleotidase ( low K ( m ) </e1> 5 - NT ) gene and established that a 969 - base pair ( bp ) fragment confers cell - specific expression of a CAT reporter gene that correlates with the expression of endogenous ecto - 5 - NT mRNA and enzymatic activity .',\n",
       "  'DNA',\n",
       "  'We have isolated the 5 region of the ecto - 5 - nucleotidase ( low K ( m ) 5 - NT ) gene and established that a 969 - base pair ( bp ) fragment confers cell - specific expression of a CAT reporter gene that correlates with the expression of endogenous ecto - 5 - NT mRNA and enzymatic activity .',\n",
       "  [['ecto',\n",
       "    '-',\n",
       "    \"5'\",\n",
       "    '-',\n",
       "    'nucleotidase',\n",
       "    '(low',\n",
       "    'K(m)',\n",
       "    \"5'\",\n",
       "    '-',\n",
       "    'NT)',\n",
       "    'gene'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'DNA']],\n",
       " ['We have isolated the 5 region of the ecto - 5 - nucleotidase ( low K ( m ) 5 - NT ) gene and established that a <e1> 969 - base pair ( bp </e1> ) fragment confers cell - specific expression of a CAT reporter gene that correlates with the expression of endogenous ecto - 5 - NT mRNA and enzymatic activity .',\n",
       "  'DNA',\n",
       "  'We have isolated the 5 region of the ecto - 5 - nucleotidase ( low K ( m ) 5 - NT ) gene and established that a 969 - base pair ( bp ) fragment confers cell - specific expression of a CAT reporter gene that correlates with the expression of endogenous ecto - 5 - NT mRNA and enzymatic activity .',\n",
       "  [['969', '-', 'base', 'pair', '(bp)', 'fragment'],\n",
       "   [28, 29, 30, 31, 32, 33],\n",
       "   'DNA']],\n",
       " ['1 - (5 - Isoquinolinylsulphonyl) - 2 - methylpiperazine dihydrochloride ( H7 ) , an inhibitor of a putative STAT3 serine kinase , and 4 - (4 - fluorophenyl) - 2 - (4 - methylsulphinylphenyl) - 5 - (4 - pyridyl) 1H - imidazole ( SB 203580 ) , an inhibitor of <e1> p38 mitogen - activated protein ( MAP </e1> ) kinase , did not dampen any of these serine phosphorylation responses .',\n",
       "  'PROTEIN',\n",
       "  '1 - (5 - Isoquinolinylsulphonyl) - 2 - methylpiperazine dihydrochloride ( H7 ) , an inhibitor of a putative STAT3 serine kinase , and 4 - (4 - fluorophenyl) - 2 - (4 - methylsulphinylphenyl) - 5 - (4 - pyridyl) 1H - imidazole ( SB 203580 ) , an inhibitor of p38 mitogen - activated protein ( MAP ) kinase , did not dampen any of these serine phosphorylation responses .',\n",
       "  [['p38', 'mitogen', '-', 'activated', 'protein', '(MAP)', 'kinase'],\n",
       "   [51, 52, 53, 54, 55, 56, 57],\n",
       "   'PROTEIN']],\n",
       " ['The GATA - 1 nuclear bodies differed from previously described nuclear structures and there was no co - localization with nuclear antigens involved in RNA processing or other <e1> ubiquitous ( Spl , c - Jun and TBP ) or haemopoietic ( NF </e1> - E2 ) transcription factors .',\n",
       "  'PROTEIN',\n",
       "  'The GATA - 1 nuclear bodies differed from previously described nuclear structures and there was no co - localization with nuclear antigens involved in RNA processing or other ubiquitous ( Spl , c - Jun and TBP ) or haemopoietic ( NF - E2 ) transcription factors .',\n",
       "  [['ubiquitous',\n",
       "    '(Spl,',\n",
       "    'c',\n",
       "    '-',\n",
       "    'Jun',\n",
       "    'and',\n",
       "    'TBP)',\n",
       "    'or',\n",
       "    'haemopoietic',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'E2)',\n",
       "    'transcription',\n",
       "    'factor'],\n",
       "   [28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41],\n",
       "   'PROTEIN']],\n",
       " ['In gene transfection assays , the effect of TNFalpha requires the presence of an <e1> inducible nuclear factor - kappaB ( NF - kappaB ) ( Rel </e1> A ) binding site in the IL - 8 promoter .',\n",
       "  'DNA',\n",
       "  'In gene transfection assays , the effect of TNFalpha requires the presence of an inducible nuclear factor - kappaB ( NF - kappaB ) ( Rel A ) binding site in the IL - 8 promoter .',\n",
       "  [['inducible',\n",
       "    'nuclear',\n",
       "    'factor',\n",
       "    '-',\n",
       "    'kappaB',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'kappaB)',\n",
       "    '(Rel',\n",
       "    'A)',\n",
       "    'binding',\n",
       "    'site'],\n",
       "   [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25],\n",
       "   'DNA']],\n",
       " ['By using Jurkat and primary human T lymphocytes , we demonstrate that the simultaneous activation of two second messengers of the TCR - initiated signal transduction , protein kinase C ( PKC ) and calcineurin , results in the synergistic activation of the <e1> IkappaBalpha kinase ( IKK </e1> ) complex but not of another putative IkappaBalpha kinase , p90 ( rsk ) .',\n",
       "  'PROTEIN',\n",
       "  'By using Jurkat and primary human T lymphocytes , we demonstrate that the simultaneous activation of two second messengers of the TCR - initiated signal transduction , protein kinase C ( PKC ) and calcineurin , results in the synergistic activation of the IkappaBalpha kinase ( IKK ) complex but not of another putative IkappaBalpha kinase , p90 ( rsk ) .',\n",
       "  [['IkappaBalpha', 'kinase', '(IKK)', 'complex'],\n",
       "   [43, 44, 45, 46],\n",
       "   'PROTEIN']],\n",
       " ['By using Jurkat and primary human T lymphocytes , we demonstrate that the simultaneous activation of two second messengers of the TCR - initiated signal transduction , protein kinase C ( PKC ) and calcineurin , results in the synergistic activation of the IkappaBalpha kinase ( IKK ) complex but not of another putative IkappaBalpha kinase , <e1> p90 </e1> ( rsk ) .',\n",
       "  'PROTEIN',\n",
       "  'By using Jurkat and primary human T lymphocytes , we demonstrate that the simultaneous activation of two second messengers of the TCR - initiated signal transduction , protein kinase C ( PKC ) and calcineurin , results in the synergistic activation of the IkappaBalpha kinase ( IKK ) complex but not of another putative IkappaBalpha kinase , p90 ( rsk ) .',\n",
       "  [['p90(rsk)'], [57], 'PROTEIN']],\n",
       " ['We also demonstrate that the IKK complex , but not <e1> p90 </e1> ( rsk ) , is responsible for the in vivo phosphorylation of IkappaBalpha mediated by the co - activation of PKC and calcineurin .',\n",
       "  'PROTEIN',\n",
       "  'We also demonstrate that the IKK complex , but not p90 ( rsk ) , is responsible for the in vivo phosphorylation of IkappaBalpha mediated by the co - activation of PKC and calcineurin .',\n",
       "  [['p90(rsk)'], [10], 'PROTEIN']],\n",
       " ['The primary IL - 13 receptor complex on human monocytes is believed to be a heterodimer comprised of the IL - 4R alpha chain and the IL - 2R gamma chain <e1> ( gamma(c) ) - </e1> like molecule , IL - 13R alpha1 .',\n",
       "  'PROTEIN',\n",
       "  'The primary IL - 13 receptor complex on human monocytes is believed to be a heterodimer comprised of the IL - 4R alpha chain and the IL - 2R gamma chain ( gamma(c) ) - like molecule , IL - 13R alpha1 .',\n",
       "  [['(gamma(c))', '-', 'like', 'molecule'], [31, 32, 33, 34], 'PROTEIN']],\n",
       " ['Analysis of cell lines Daudi and THP - 1 that differentially express gamma(c) and IL - 13R alpha1 showed that IL - 13 can activate STAT6 in IL - 13R alpha1 - positive THP - 1 cells but not in <e1> gamma(c) - positive , IL - 13R alpha1 - negative Daudi </e1> cells .',\n",
       "  'CELL_LINE',\n",
       "  'Analysis of cell lines Daudi and THP - 1 that differentially express gamma(c) and IL - 13R alpha1 showed that IL - 13 can activate STAT6 in IL - 13R alpha1 - positive THP - 1 cells but not in gamma(c) - positive , IL - 13R alpha1 - negative Daudi cells .',\n",
       "  [['gamma(c)',\n",
       "    '-',\n",
       "    'positive,',\n",
       "    'IL',\n",
       "    '-',\n",
       "    '13R',\n",
       "    'alpha1',\n",
       "    '-',\n",
       "    'negative',\n",
       "    'Daudi',\n",
       "    'cell'],\n",
       "   [40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50],\n",
       "   'CELL_LINE']],\n",
       " ['Both TNF - alpha and NF - kappa B are also involved in the stimulation of the pathway that leads to the expression of <e1> major histocompatibility complex ( MHC ) class </e1> I molecules and , hence , antigen presentation to the T cells .',\n",
       "  'PROTEIN',\n",
       "  'Both TNF - alpha and NF - kappa B are also involved in the stimulation of the pathway that leads to the expression of major histocompatibility complex ( MHC ) class I molecules and , hence , antigen presentation to the T cells .',\n",
       "  [['major',\n",
       "    'histocompatibility',\n",
       "    'complex',\n",
       "    '(MHC)',\n",
       "    'class',\n",
       "    'I',\n",
       "    'molecule'],\n",
       "   [24, 25, 26, 27, 28, 29, 30],\n",
       "   'PROTEIN']],\n",
       " ['A newly identified motif called the <e1> B29 conserved sequence </e1> ( BCS ) , found upstream of both human and murine B29 promoters , appears to stimulate B29 transcription through a novel mechanism .',\n",
       "  'DNA',\n",
       "  'A newly identified motif called the B29 conserved sequence ( BCS ) , found upstream of both human and murine B29 promoters , appears to stimulate B29 transcription through a novel mechanism .',\n",
       "  [['B29', 'conserved', 'sequenc'], [6, 7, 8], 'DNA']],\n",
       " ['The transcriptional mechanisms that drive <e1> colony - forming unit granulocyte - macrophage ( CFU - GM ) </e1> myeloid progenitors to differentiate into cells of either the granulocytic or monocytic lineage are not fully understood .',\n",
       "  'CELL_LINE',\n",
       "  'The transcriptional mechanisms that drive colony - forming unit granulocyte - macrophage ( CFU - GM ) myeloid progenitors to differentiate into cells of either the granulocytic or monocytic lineage are not fully understood .',\n",
       "  [['colony',\n",
       "    '-',\n",
       "    'forming',\n",
       "    'unit',\n",
       "    'granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    '(CFU',\n",
       "    '-',\n",
       "    'GM)',\n",
       "    'myeloid',\n",
       "    'progenitor'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'CELL_LINE']],\n",
       " ['Because the elevated <e1> Myb </e1> : Maf status seen in differentiating cells can be recapitulated by overexpression of c - Maf in myeloid cell lines , we inducibly expressed the c - Maf cDNA in 2 bipotent human myeloid progenitor cells .',\n",
       "  'PROTEIN',\n",
       "  'Because the elevated Myb : Maf status seen in differentiating cells can be recapitulated by overexpression of c - Maf in myeloid cell lines , we inducibly expressed the c - Maf cDNA in 2 bipotent human myeloid progenitor cells .',\n",
       "  [['Myb:Maf'], [3], 'PROTEIN']],\n",
       " ['Elevated levels of c - Maf protein led to marked increases in <e1> Myb : </e1> Maf complexes and the accumulation of monocyte/macrophage cells , followed by eventual programmed cell death .',\n",
       "  'PROTEIN',\n",
       "  'Elevated levels of c - Maf protein led to marked increases in Myb : Maf complexes and the accumulation of monocyte/macrophage cells , followed by eventual programmed cell death .',\n",
       "  [['Myb:Maf', 'complex'], [12, 13], 'PROTEIN']],\n",
       " ['<e1> AML1 ( </e1> CBFalpha2 ) cooperates with B cell - specific activating protein ( BSAP/PAX5 ) in activation of the B cell - specific BLK gene promoter .',\n",
       "  'PROTEIN',\n",
       "  'AML1 ( CBFalpha2 ) cooperates with B cell - specific activating protein ( BSAP/PAX5 ) in activation of the B cell - specific BLK gene promoter .',\n",
       "  [['AML1', '(CBFalpha2)'], [0, 1], 'PROTEIN']],\n",
       " ['AML1 ( CBFalpha2 ) cooperates with <e1> B cell - specific activating protein ( </e1> BSAP/PAX5 ) in activation of the B cell - specific BLK gene promoter .',\n",
       "  'PROTEIN',\n",
       "  'AML1 ( CBFalpha2 ) cooperates with B cell - specific activating protein ( BSAP/PAX5 ) in activation of the B cell - specific BLK gene promoter .',\n",
       "  [['B', 'cell', '-', 'specific', 'activating', 'protein', '(BSAP/PAX5)'],\n",
       "   [6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['To understand the function of AML1 during B cell differentiation , we analyzed regulatory regions of B cell - specific genes for potential AML1 - binding sites and have identified a putative AML1 - binding site in the promoter of the <e1> B cell - specific tyrosine kinase gene , </e1> blk .',\n",
       "  'DNA',\n",
       "  'To understand the function of AML1 during B cell differentiation , we analyzed regulatory regions of B cell - specific genes for potential AML1 - binding sites and have identified a putative AML1 - binding site in the promoter of the B cell - specific tyrosine kinase gene , blk .',\n",
       "  [['B', 'cell', '-', 'specific', 'tyrosine', 'kinase', 'gene', 'blk'],\n",
       "   [41, 42, 43, 44, 45, 46, 47, 48],\n",
       "   'DNA']],\n",
       " ['Expression of the <e1> class A macrophage scavenger receptor ( </e1> MSR ) contributes to the uptake of modified low density lipoproteins ( LDL ) by macrophages and transformation of these cells into lipid - laden foam cells , which characterize atherosclerosis .',\n",
       "  'PROTEIN',\n",
       "  'Expression of the class A macrophage scavenger receptor ( MSR ) contributes to the uptake of modified low density lipoproteins ( LDL ) by macrophages and transformation of these cells into lipid - laden foam cells , which characterize atherosclerosis .',\n",
       "  [['class', 'A', 'macrophage', 'scavenger', 'receptor', '(MSR)'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['Expression of the class A macrophage scavenger receptor ( MSR ) contributes to the uptake of <e1> modified low density lipoproteins ( </e1> LDL ) by macrophages and transformation of these cells into lipid - laden foam cells , which characterize atherosclerosis .',\n",
       "  'PROTEIN',\n",
       "  'Expression of the class A macrophage scavenger receptor ( MSR ) contributes to the uptake of modified low density lipoproteins ( LDL ) by macrophages and transformation of these cells into lipid - laden foam cells , which characterize atherosclerosis .',\n",
       "  [['modified', 'low', 'density', 'lipoprotein', '(LDL)'],\n",
       "   [16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['Many environmental factors , in particular , proinflammatory cytokines and <e1> growth factors , </e1> can exert regulatory effects on MSR expression , whereas intracellular accumulation of cholesterol itself does not influence MSR levels to any considerable extent .',\n",
       "  'PROTEIN',\n",
       "  'Many environmental factors , in particular , proinflammatory cytokines and growth factors , can exert regulatory effects on MSR expression , whereas intracellular accumulation of cholesterol itself does not influence MSR levels to any considerable extent .',\n",
       "  [['proinflammatory', 'growth', 'factor'], [10, 11, 12], 'PROTEIN']],\n",
       " ['In the present study , by using an in vitro model , we examined whether stimulation with interleukin - 6 ( IL - 6 ) , an <e1> immunoregulatory , </e1> multipotential cytokine , modulates the expression and activities of the MSR in macrophages .',\n",
       "  'PROTEIN',\n",
       "  'In the present study , by using an in vitro model , we examined whether stimulation with interleukin - 6 ( IL - 6 ) , an immunoregulatory , multipotential cytokine , modulates the expression and activities of the MSR in macrophages .',\n",
       "  [['immunoregulatory', 'cytokine'], [27, 28], 'PROTEIN']],\n",
       " ['When treated with IL - 6 , macrophages derived from peripheral monocytes and <e1> phorbol 12 - myristate 13 - acetate ( PMA ) - differentiated THP - 1 </e1> monocytic cells showed significantly reduced uptake and/or binding of the MSR ligand , acetylated LDL .',\n",
       "  'CELL_LINE',\n",
       "  'When treated with IL - 6 , macrophages derived from peripheral monocytes and phorbol 12 - myristate 13 - acetate ( PMA ) - differentiated THP - 1 monocytic cells showed significantly reduced uptake and/or binding of the MSR ligand , acetylated LDL .',\n",
       "  [['phorbol',\n",
       "    '12',\n",
       "    '-',\n",
       "    'myristate',\n",
       "    '13',\n",
       "    '-',\n",
       "    'acetate',\n",
       "    '(PMA)',\n",
       "    '-',\n",
       "    'differentiated',\n",
       "    'THP',\n",
       "    '-',\n",
       "    '1',\n",
       "    'monocytic',\n",
       "    'cell'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27],\n",
       "   'CELL_LINE']],\n",
       " ['This effect was paralleled by a reduction in the expression of MSR protein and <e1> mRNA . </e1>',\n",
       "  'RNA',\n",
       "  'This effect was paralleled by a reduction in the expression of MSR protein and mRNA .',\n",
       "  [['MSR', 'mRNA'], [14, 15], 'RNA']],\n",
       " ['All bacterial pathogens produce <e1> lipoproteins ( </e1> BLPs ) , which trigger the innate immune response .',\n",
       "  'PROTEIN',\n",
       "  'All bacterial pathogens produce lipoproteins ( BLPs ) , which trigger the innate immune response .',\n",
       "  [['lipoproteins', '(BLPs)'], [4, 5], 'PROTEIN']],\n",
       " ['BLPs were found to induce apoptosis in THP - 1 monocytic cells through <e1> human Toll - like receptor - 2 ( </e1> hTLR2 ) .',\n",
       "  'PROTEIN',\n",
       "  'BLPs were found to induce apoptosis in THP - 1 monocytic cells through human Toll - like receptor - 2 ( hTLR2 ) .',\n",
       "  [['human', 'Toll', '-', 'like', 'receptor', '-', '2', '(hTLR2)'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['This prompted us to investigate the expression of the BCL - 6 protein in Hodgkin s disease ( HD ) , focusing on the nodular lymphocyte predominance subtype ( NLPHD ) , which differs from classical HD by virtue of the B - cell nature of the malignant cell population ( so - called <e1> L & </e1> H cells ) and its relationship with germinal centers .',\n",
       "  'CELL_TYPE',\n",
       "  'This prompted us to investigate the expression of the BCL - 6 protein in Hodgkin s disease ( HD ) , focusing on the nodular lymphocyte predominance subtype ( NLPHD ) , which differs from classical HD by virtue of the B - cell nature of the malignant cell population ( so - called L & H cells ) and its relationship with germinal centers .',\n",
       "  [['L&H', 'cell'], [54, 55], 'CELL_TYPE']],\n",
       " ['Strong nuclear positivity for the BCL - 6 protein was detected in <e1> tumor ( L </e1> & H ) cells in all cases of NLPHD .',\n",
       "  'CELL_TYPE',\n",
       "  'Strong nuclear positivity for the BCL - 6 protein was detected in tumor ( L & H ) cells in all cases of NLPHD .',\n",
       "  [['tumor', '(L&H)', 'cell'], [12, 13, 14], 'CELL_TYPE']],\n",
       " ['Notably , the nuclei of reactive CD3+/CD4+ T cells nearby to and rosetting around <e1> L & </e1> H cells in NLPHD were also strongly BCL - 6 + , but lacked CD40 ligand ( CD40L ) expression .',\n",
       "  'CELL_TYPE',\n",
       "  'Notably , the nuclei of reactive CD3+/CD4+ T cells nearby to and rosetting around L & H cells in NLPHD were also strongly BCL - 6 + , but lacked CD40 ligand ( CD40L ) expression .',\n",
       "  [['L&H', 'cell'], [14, 15], 'CELL_TYPE']],\n",
       " ['Furthermore , our studies showed association of the <e1> IKK - alpha /beta </e1> heterodimer with NIK , IkappaB - alpha and - epsilon in unstimulated cells .',\n",
       "  'PROTEIN',\n",
       "  'Furthermore , our studies showed association of the IKK - alpha /beta heterodimer with NIK , IkappaB - alpha and - epsilon in unstimulated cells .',\n",
       "  [['IKK', '-', 'alpha/beta', 'heterodimer'], [8, 9, 10, 11], 'PROTEIN']],\n",
       " ['Furthermore , our studies showed association of the IKK - alpha /beta heterodimer with NIK , IkappaB - alpha and <e1> - epsilon in </e1> unstimulated cells .',\n",
       "  'PROTEIN',\n",
       "  'Furthermore , our studies showed association of the IKK - alpha /beta heterodimer with NIK , IkappaB - alpha and - epsilon in unstimulated cells .',\n",
       "  [['IkappaB', '-', 'epsilon'], [20, 21, 22], 'PROTEIN']],\n",
       " ['NIK can not phosphorylate IkappaB - alpha directly , but it appears to be a functionally important subunit , because mutated NIK inhibited stimulus - induced kappaB - dependent transcription more effectively than mutated IKK - alpha or <e1> - beta . </e1>',\n",
       "  'PROTEIN',\n",
       "  'NIK can not phosphorylate IkappaB - alpha directly , but it appears to be a functionally important subunit , because mutated NIK inhibited stimulus - induced kappaB - dependent transcription more effectively than mutated IKK - alpha or - beta .',\n",
       "  [['IKK', '-', 'beta'], [38, 39, 40], 'PROTEIN']],\n",
       " ['The aim of this study was to examine the ability of tumor necrosis factor alpha ( TNFalpha , a proinflammatory cytokine ) and <e1> interleukin ( IL ) </e1> - 10 ( an anti - inflammatory cytokine ) to differentially regulate the sensitivity of human monocytes /macrophages to glucocorticoids .',\n",
       "  'PROTEIN',\n",
       "  'The aim of this study was to examine the ability of tumor necrosis factor alpha ( TNFalpha , a proinflammatory cytokine ) and interleukin ( IL ) - 10 ( an anti - inflammatory cytokine ) to differentially regulate the sensitivity of human monocytes /macrophages to glucocorticoids .',\n",
       "  [['interleukin', '(IL)', '-', '10'], [23, 24, 25, 26], 'PROTEIN']],\n",
       " ['Block of granulocytic differentiation of 32Dcl3 cells by <e1> AML1/ETO </e1> ( MTG8 ) but not by highly expressed Bcl - 2 .',\n",
       "  'DNA',\n",
       "  'Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO ( MTG8 ) but not by highly expressed Bcl - 2 .',\n",
       "  [['AML1/ETO(MTG8)'], [8], 'DNA']],\n",
       " ['The chimeric gene , <e1> AML1/ETO ( </e1> MTG8 ) , generated in t(8;21) acute myeloid leukemia enhances the expression of Bcl - 2 .',\n",
       "  'DNA',\n",
       "  'The chimeric gene , AML1/ETO ( MTG8 ) , generated in t(8;21) acute myeloid leukemia enhances the expression of Bcl - 2 .',\n",
       "  [['AML1/ETO', '(MTG8)'], [4, 5], 'DNA']],\n",
       " ['<e1> Human Toll - like receptor 2 ( </e1> TLR2 ) is a signaling receptor that responds to LPS and activates NF - kappaB .',\n",
       "  'PROTEIN',\n",
       "  'Human Toll - like receptor 2 ( TLR2 ) is a signaling receptor that responds to LPS and activates NF - kappaB .',\n",
       "  [['human', 'Toll', '-', 'like', 'receptor', '2', '(TLR2)'],\n",
       "   [0, 1, 2, 3, 4, 5, 6],\n",
       "   'PROTEIN']],\n",
       " ['Concomitant with receptor oligomerization , the <e1> IL - 1R - associated kinase ( </e1> IRAK ) is recruited to the TLR2 complex .',\n",
       "  'PROTEIN',\n",
       "  'Concomitant with receptor oligomerization , the IL - 1R - associated kinase ( IRAK ) is recruited to the TLR2 complex .',\n",
       "  [['IL', '-', '1R', '-', 'associated', 'kinase', '(IRAK)'],\n",
       "   [6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Janus kinase 3 ( </e1> JAK3 ) is a cytoplasmic tyrosine kinase required for T cell development and activated by cytokines that utilize the interleukin - 2 ( IL - 2 ) receptor common gamma chain ( gamma(c) ) .',\n",
       "  'PROTEIN',\n",
       "  'Janus kinase 3 ( JAK3 ) is a cytoplasmic tyrosine kinase required for T cell development and activated by cytokines that utilize the interleukin - 2 ( IL - 2 ) receptor common gamma chain ( gamma(c) ) .',\n",
       "  [['Janus', 'kinase', '3', '(JAK3)'], [0, 1, 2, 3], 'PROTEIN']],\n",
       " ['Janus kinase 3 ( JAK3 ) is a cytoplasmic tyrosine kinase required for T cell development and activated by cytokines that utilize the <e1> interleukin - 2 ( IL - 2 ) receptor common </e1> gamma chain ( gamma(c) ) .',\n",
       "  'PROTEIN',\n",
       "  'Janus kinase 3 ( JAK3 ) is a cytoplasmic tyrosine kinase required for T cell development and activated by cytokines that utilize the interleukin - 2 ( IL - 2 ) receptor common gamma chain ( gamma(c) ) .',\n",
       "  [['interleukin',\n",
       "    '-',\n",
       "    '2',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2)',\n",
       "    'receptor',\n",
       "    'gamma',\n",
       "    'chain',\n",
       "    '(gamma(c))'],\n",
       "   [23, 24, 25, 26, 27, 28, 29, 30, 31, 32],\n",
       "   'PROTEIN']],\n",
       " ['Here we provide novel evidence that AG - 490 potently inhibits the autokinase activity of JAK3 and tyrosine phosphorylation and DNA binding of <e1> signal transducer and activator of transcription 5a and 5b ( </e1> STAT5a/b ) .',\n",
       "  'PROTEIN',\n",
       "  'Here we provide novel evidence that AG - 490 potently inhibits the autokinase activity of JAK3 and tyrosine phosphorylation and DNA binding of signal transducer and activator of transcription 5a and 5b ( STAT5a/b ) .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '5a',\n",
       "    'and',\n",
       "    '5b',\n",
       "    '(STAT5a/b)'],\n",
       "   [23, 24, 25, 26, 27, 28, 29, 30, 31, 32],\n",
       "   'PROTEIN']],\n",
       " ['C/EBP beta was detected in the synovial lining and in <e1> sublining cells of synovial tissue </e1> from patients with both rheumatoid and osteoarthritis .',\n",
       "  'CELL_TYPE',\n",
       "  'C/EBP beta was detected in the synovial lining and in sublining cells of synovial tissue from patients with both rheumatoid and osteoarthritis .',\n",
       "  [['sublining', 'cell', 'of', 'synovial', 'tissue'],\n",
       "   [10, 11, 12, 13, 14],\n",
       "   'CELL_TYPE']],\n",
       " ['The regulation of the production or activity of C/EBP beta , to inhibit inflammatory mediator expression by synovial macrophages and <e1> fibroblasts , </e1> offers a novel approach to therapeutic intervention .',\n",
       "  'CELL_TYPE',\n",
       "  'The regulation of the production or activity of C/EBP beta , to inhibit inflammatory mediator expression by synovial macrophages and fibroblasts , offers a novel approach to therapeutic intervention .',\n",
       "  [['synovial', 'fibroblast'], [20, 21], 'CELL_TYPE']],\n",
       " ['Direct interaction of <e1> hematopoietic transcription factors PU.1 </e1> and GATA - 1 : functional antagonism in erythroid cells .',\n",
       "  'PROTEIN',\n",
       "  'Direct interaction of hematopoietic transcription factors PU.1 and GATA - 1 : functional antagonism in erythroid cells .',\n",
       "  [['hematopoietic', 'transcription', 'factor', 'pu.1'],\n",
       "   [3, 4, 5, 6],\n",
       "   'PROTEIN']],\n",
       " ['Restoration of terminal differentiation in the <e1> mouse erythroleukemia ( MEL </e1> ) cells requires a decline in the level of PU.1 , indicating that PU.1 can block erythroid differentiation .',\n",
       "  'CELL_LINE',\n",
       "  'Restoration of terminal differentiation in the mouse erythroleukemia ( MEL ) cells requires a decline in the level of PU.1 , indicating that PU.1 can block erythroid differentiation .',\n",
       "  [['mouse', 'erythroleukemia', '(MEL)', 'cell'], [6, 7, 8, 9], 'CELL_LINE']],\n",
       " ['Both the <e1> DNA binding and </e1> transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells .',\n",
       "  'PROTEIN',\n",
       "  'Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells .',\n",
       "  [['DNA', 'binding', 'domain'], [2, 3, 4], 'PROTEIN']],\n",
       " ['To better clarify the molecular basis of IL - 12 action , we set out to characterize genes up - regulated by IL - 12 , first by contrasting <e1> IL - 12 - and IFN </e1> - alpha - inducible genes .',\n",
       "  'DNA',\n",
       "  'To better clarify the molecular basis of IL - 12 action , we set out to characterize genes up - regulated by IL - 12 , first by contrasting IL - 12 - and IFN - alpha - inducible genes .',\n",
       "  [['IL', '-', '12', '-', 'inducible', 'gene'],\n",
       "   [29, 30, 31, 32, 33, 34],\n",
       "   'DNA']],\n",
       " ['Alternative splicing of the <e1> GC receptor ( GCR ) pre </e1> - mRNA generates a second GCR , termed GCRbeta , which does not bind GC but antagonizes the transactivating activity of the classic GCR .',\n",
       "  'RNA',\n",
       "  'Alternative splicing of the GC receptor ( GCR ) pre - mRNA generates a second GCR , termed GCRbeta , which does not bind GC but antagonizes the transactivating activity of the classic GCR .',\n",
       "  [['GC', 'receptor', '(GCR)', 'pre', '-', 'mRNA'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'RNA']],\n",
       " ['<e1> Bronchoalveolar lavage ( BAL </e1> ) cells and peripheral blood mononuclear cells ( PBMC ) were examined for GCRbeta immunoreactivity using a GCRbeta - specific antibody by immunohistochemical staining .',\n",
       "  'CELL_TYPE',\n",
       "  'Bronchoalveolar lavage ( BAL ) cells and peripheral blood mononuclear cells ( PBMC ) were examined for GCRbeta immunoreactivity using a GCRbeta - specific antibody by immunohistochemical staining .',\n",
       "  [['bronchoalveolar', 'lavage', '(BAL)', 'cell'], [0, 1, 2, 3], 'CELL_TYPE']],\n",
       " ['In the present study , we have identified a cellular context ( the <e1> interleukin - 2 [ IL - 2 ] - dependent HT - </e1> 2 line ) in which the EPO stimulation of the EPOR fails to support cellular proliferation , STAT - 5 induction , or MAPK activation , despite efficient phosphorylation of the EPOR and JAK2 and inhibition of apoptosis after withdrawal of IL - 2 .',\n",
       "  'CELL_LINE',\n",
       "  'In the present study , we have identified a cellular context ( the interleukin - 2 [ IL - 2 ] - dependent HT - 2 line ) in which the EPO stimulation of the EPOR fails to support cellular proliferation , STAT - 5 induction , or MAPK activation , despite efficient phosphorylation of the EPOR and JAK2 and inhibition of apoptosis after withdrawal of IL - 2 .',\n",
       "  [['interleukin',\n",
       "    '-',\n",
       "    '2',\n",
       "    '[IL',\n",
       "    '-',\n",
       "    '2]',\n",
       "    '-',\n",
       "    'dependent',\n",
       "    'HT',\n",
       "    '-',\n",
       "    '2',\n",
       "    'line'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24],\n",
       "   'CELL_LINE']],\n",
       " ['HIV - 1 expressing IkappaB - alphaS32/36A down - regulates viral expression and is highly attenuated in both <e1> Jurkat and </e1> peripheral blood mononuclear cells .',\n",
       "  'CELL_LINE',\n",
       "  'HIV - 1 expressing IkappaB - alphaS32/36A down - regulates viral expression and is highly attenuated in both Jurkat and peripheral blood mononuclear cells .',\n",
       "  [['Jurkat', 'cell'], [18, 19], 'CELL_LINE']],\n",
       " ['Excess beta - catenin can squelch reporter gene activation by LEF - 1 <e1> - beta - </e1> catenin complexes but not activation by the transcription factor VP16 .',\n",
       "  'PROTEIN',\n",
       "  'Excess beta - catenin can squelch reporter gene activation by LEF - 1 - beta - catenin complexes but not activation by the transcription factor VP16 .',\n",
       "  [['beta', '-', 'catenin'], [13, 14, 15], 'PROTEIN']],\n",
       " ['A site in the <e1> Epstein - Barr virus ( EBV ) </e1> transforming protein LMP1 that constitutively associates with the tumor necrosis factor receptor 1 ( TNFR1 ) - associated death domain protein TRADD to mediate NF - kappaB and c - Jun N - terminal kinase activation is critical for long - term lymphoblastoid cell proliferation .',\n",
       "  'PROTEIN',\n",
       "  'A site in the Epstein - Barr virus ( EBV ) transforming protein LMP1 that constitutively associates with the tumor necrosis factor receptor 1 ( TNFR1 ) - associated death domain protein TRADD to mediate NF - kappaB and c - Jun N - terminal kinase activation is critical for long - term lymphoblastoid cell proliferation .',\n",
       "  [['Epstein', '-', 'Barr', 'virus', '(EBV)', 'transforming', 'protein'],\n",
       "   [4, 5, 6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ['A site in the Epstein - Barr virus ( EBV ) transforming protein LMP1 that constitutively associates with the <e1> tumor necrosis factor receptor 1 ( TNFR1 ) - associated death </e1> domain protein TRADD to mediate NF - kappaB and c - Jun N - terminal kinase activation is critical for long - term lymphoblastoid cell proliferation .',\n",
       "  'PROTEIN',\n",
       "  'A site in the Epstein - Barr virus ( EBV ) transforming protein LMP1 that constitutively associates with the tumor necrosis factor receptor 1 ( TNFR1 ) - associated death domain protein TRADD to mediate NF - kappaB and c - Jun N - terminal kinase activation is critical for long - term lymphoblastoid cell proliferation .',\n",
       "  [['tumor',\n",
       "    'necrosis',\n",
       "    'factor',\n",
       "    'receptor',\n",
       "    '1',\n",
       "    '(TNFR1)',\n",
       "    '-',\n",
       "    'associated',\n",
       "    'death',\n",
       "    'domain',\n",
       "    'protein'],\n",
       "   [19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29],\n",
       "   'PROTEIN']],\n",
       " ['LMP1 is partially blocked for NF - kappaB activation by a TRADD mutant consisting of <e1> residues 122 to 293 </e1> .',\n",
       "  'PROTEIN',\n",
       "  'LMP1 is partially blocked for NF - kappaB activation by a TRADD mutant consisting of residues 122 to 293 .',\n",
       "  [['residue', '122', 'to', '293'], [15, 16, 17, 18], 'PROTEIN']],\n",
       " ['Interestingly , apoptosis induced by NF - kappa B suppression , in contrast to that induced by TPEN ( N,N,N,N - tetrakis [2 - pyridylmethyl]ethylenediamine ) or soluble Fas ligand ( CD95 ) , was observed in the absence of active death effector proteases caspase - 1 - like ( IL - 1 converting enzyme ) , caspase - 3 - like ( CPP32/Yama/apopain ) , and caspase - 6 - like and without cleavage of caspase - 3 substrates <e1> poly( ADP - ribose) </e1> polymerase and DNA fragmentation factor - 45 .',\n",
       "  'PROTEIN',\n",
       "  'Interestingly , apoptosis induced by NF - kappa B suppression , in contrast to that induced by TPEN ( N,N,N,N - tetrakis [2 - pyridylmethyl]ethylenediamine ) or soluble Fas ligand ( CD95 ) , was observed in the absence of active death effector proteases caspase - 1 - like ( IL - 1 converting enzyme ) , caspase - 3 - like ( CPP32/Yama/apopain ) , and caspase - 6 - like and without cleavage of caspase - 3 substrates poly( ADP - ribose) polymerase and DNA fragmentation factor - 45 .',\n",
       "  [['poly(ADP', '-', 'ribose)', 'polymerase'], [80, 81, 82, 83], 'PROTEIN']],\n",
       " ['The Ras <e1> - </e1> Aiolos interaction was confirmed in vitro and in vivo by co - immunoprecipitation .',\n",
       "  'PROTEIN',\n",
       "  'The Ras - Aiolos interaction was confirmed in vitro and in vivo by co - immunoprecipitation .',\n",
       "  [['Aiolos'], [2], 'PROTEIN']],\n",
       " ['OBJECTIVE : This study focuses on the functional analysis of the <e1> human IL - 5 ( hIL - 5 </e1> ) promoter and characterization of cis  - regulatory elements and transcription factors involved in the suppression of IL - 5 transcription in T cells .',\n",
       "  'DNA',\n",
       "  'OBJECTIVE : This study focuses on the functional analysis of the human IL - 5 ( hIL - 5 ) promoter and characterization of cis  - regulatory elements and transcription factors involved in the suppression of IL - 5 transcription in T cells .',\n",
       "  [['human', 'IL', '-', '5', '(hIL', '-', '5)', 'promoter'],\n",
       "   [11, 12, 13, 14, 15, 16, 17, 18],\n",
       "   'DNA']],\n",
       " ['We show that the BR3 sequence contains a novel negative regulatory element located at positions - 90 to - 79 of the hIL - 5 promoter , which binds Oct1 , <e1> octamer - like , and </e1> YY1 nuclear factors .',\n",
       "  'PROTEIN',\n",
       "  'We show that the BR3 sequence contains a novel negative regulatory element located at positions - 90 to - 79 of the hIL - 5 promoter , which binds Oct1 , octamer - like , and YY1 nuclear factors .',\n",
       "  [['octamer', '-', 'like', 'nuclear', 'factor'],\n",
       "   [31, 32, 33, 34, 35],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Human T - cell leukemia virus type 1 ( HTLV - 1 </e1> ) Tax transforms normal T - cells in the presence of interleukin ( IL ) - 2 in vitro .',\n",
       "  'PROTEIN',\n",
       "  'Human T - cell leukemia virus type 1 ( HTLV - 1 ) Tax transforms normal T - cells in the presence of interleukin ( IL ) - 2 in vitro .',\n",
       "  [['human',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'leukemia',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HTLV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'Tax'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['RESULTS : A human IL - 5 promoter/enhancer - luciferase gene construct , <e1> pIL - 5( - 511) </e1> Luc , was transcribed on activation of IL - 5 - producing T - cell clones , but not IL - 5 - nonproducing clones .',\n",
       "  'DNA',\n",
       "  'RESULTS : A human IL - 5 promoter/enhancer - luciferase gene construct , pIL - 5( - 511) Luc , was transcribed on activation of IL - 5 - producing T - cell clones , but not IL - 5 - nonproducing clones .',\n",
       "  [['pIL', '-', '5(', '-', '511)Luc'], [13, 14, 15, 16, 17], 'DNA']],\n",
       " ['<e1> pIL - 5( - 511) </e1> Luc was transcribed by T - cell hybridomas derived from fusion between IL - 5 - producing T - cell clones and an IL - 5 gene - nonexpressing T - cell line , but not by hybridomas derived from IL - 5 - nonproducing T - cell clones .',\n",
       "  'DNA',\n",
       "  'pIL - 5( - 511) Luc was transcribed by T - cell hybridomas derived from fusion between IL - 5 - producing T - cell clones and an IL - 5 gene - nonexpressing T - cell line , but not by hybridomas derived from IL - 5 - nonproducing T - cell clones .',\n",
       "  [['pIL', '-', '5(', '-', '511)Luc'], [0, 1, 2, 3, 4], 'DNA']],\n",
       " ['Of even more interest , IkappaBalpha overexpression inhibited the production of <e1> matrix metalloproteinases 1 </e1> and 3 while not affecting their tissue inhibitor .',\n",
       "  'PROTEIN',\n",
       "  'Of even more interest , IkappaBalpha overexpression inhibited the production of matrix metalloproteinases 1 and 3 while not affecting their tissue inhibitor .',\n",
       "  [['matrix', 'metalloproteinase', '1'], [11, 12, 13], 'PROTEIN']],\n",
       " ['Oligoclonal expansion of B cells in the livers with ILFs was confirmed by an analysis of <e1> immunoglobulin heavy chain ( IgH </e1> ) gene rearrangement determined by polymerase chain reaction ( PCR ) .',\n",
       "  'DNA',\n",
       "  'Oligoclonal expansion of B cells in the livers with ILFs was confirmed by an analysis of immunoglobulin heavy chain ( IgH ) gene rearrangement determined by polymerase chain reaction ( PCR ) .',\n",
       "  [['immunoglobulin', 'heavy', 'chain', '(IgH)', 'gene'],\n",
       "   [16, 17, 18, 19, 20],\n",
       "   'DNA']],\n",
       " ['Furthermore , SLP - 76 and Vav have a synergistic effect on <e1> interleukin ( IL ) - </e1> 2 promoter activity in T cells .',\n",
       "  'DNA',\n",
       "  'Furthermore , SLP - 76 and Vav have a synergistic effect on interleukin ( IL ) - 2 promoter activity in T cells .',\n",
       "  [['interleukin', '(IL)', '-', '2', 'promoter'],\n",
       "   [12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['Our results demonstrated that : ( i ) PGN induced phosphorylation of the transcription factors ATF - 1 and CREB ; ( ii ) ATF - 1 and CREB bound DNA as a dimer and induced transcriptional activation of a CRE reporter plasmid , which was inhibited by dominant negative CREB and ATF - 1 ; ( iii ) PGN induced phosphorylation of c - Jun , protein synthesis of JunB and c - Fos , and transcriptional activation of the AP - 1 reporter plasmid , which was inhibited by dominant negative c - Fos ; and ( iv ) PGN - induced activation of <e1> CREB </e1> /ATF and AP - 1 was mediated through CD14 .',\n",
       "  'PROTEIN',\n",
       "  'Our results demonstrated that : ( i ) PGN induced phosphorylation of the transcription factors ATF - 1 and CREB ; ( ii ) ATF - 1 and CREB bound DNA as a dimer and induced transcriptional activation of a CRE reporter plasmid , which was inhibited by dominant negative CREB and ATF - 1 ; ( iii ) PGN induced phosphorylation of c - Jun , protein synthesis of JunB and c - Fos , and transcriptional activation of the AP - 1 reporter plasmid , which was inhibited by dominant negative c - Fos ; and ( iv ) PGN - induced activation of CREB /ATF and AP - 1 was mediated through CD14 .',\n",
       "  [['CREB/ATF'], [106], 'PROTEIN']],\n",
       " ['This is the first study to demonstrate activation of <e1> CREB </e1> /ATF and AP - 1 transcription factors by PGN or by any other component of Gram - positive bacteria .',\n",
       "  'PROTEIN',\n",
       "  'This is the first study to demonstrate activation of CREB /ATF and AP - 1 transcription factors by PGN or by any other component of Gram - positive bacteria .',\n",
       "  [['CREB/ATF'], [9], 'PROTEIN']],\n",
       " ['ICSAT ( Interferon Consensus Sequence binding protein for Activated T cells ) is a lymphocyte - specific member of the <e1> interferon regulatory factor ( IRF </e1> ) family of transcription factors , originally identified through Southwestern screening of the ATL ( Adult T - cell leukemia ) - 16T expression library .',\n",
       "  'PROTEIN',\n",
       "  'ICSAT ( Interferon Consensus Sequence binding protein for Activated T cells ) is a lymphocyte - specific member of the interferon regulatory factor ( IRF ) family of transcription factors , originally identified through Southwestern screening of the ATL ( Adult T - cell leukemia ) - 16T expression library .',\n",
       "  [['interferon', 'regulatory', 'factor', '(IRF)', 'family'],\n",
       "   [20, 21, 22, 23, 24],\n",
       "   'PROTEIN']],\n",
       " ['ICSAT ( Interferon Consensus Sequence binding protein for Activated T cells ) is a lymphocyte - specific member of the interferon regulatory factor ( IRF ) family of transcription factors , originally identified through Southwestern screening of the <e1> ATL ( Adult T - cell leukemia ) - </e1> 16T expression library .',\n",
       "  'DNA',\n",
       "  'ICSAT ( Interferon Consensus Sequence binding protein for Activated T cells ) is a lymphocyte - specific member of the interferon regulatory factor ( IRF ) family of transcription factors , originally identified through Southwestern screening of the ATL ( Adult T - cell leukemia ) - 16T expression library .',\n",
       "  [['ATL(Adult',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'leukemia)',\n",
       "    '-',\n",
       "    '16T',\n",
       "    'expression',\n",
       "    'library'],\n",
       "   [38, 39, 40, 41, 42, 43, 44, 45, 46],\n",
       "   'DNA']],\n",
       " ['We now demonstrate that parasite - induced NF - kappaB activation plays a crucial role in the survival of <e1> T. parva - transformed T cells </e1> by conveying protection against an apoptotic signal that accompanies parasite - mediated transformation .',\n",
       "  'CELL_TYPE',\n",
       "  'We now demonstrate that parasite - induced NF - kappaB activation plays a crucial role in the survival of T. parva - transformed T cells by conveying protection against an apoptotic signal that accompanies parasite - mediated transformation .',\n",
       "  [['T.', 'parva', '-', 'tranformed', 'T', 'cell'],\n",
       "   [19, 20, 21, 22, 23, 24],\n",
       "   'CELL_TYPE']],\n",
       " ['<e1> Wild - type ( wt </e1> ) cells were inducible either by the tryptophan photoproduct 6 - formylindolo [ 3 , 2 - b ] carbazole ( FICZ ) or by UV - irradiation but very low or undetectable levels were observed in the c12 cells .',\n",
       "  'CELL_LINE',\n",
       "  'Wild - type ( wt ) cells were inducible either by the tryptophan photoproduct 6 - formylindolo [ 3 , 2 - b ] carbazole ( FICZ ) or by UV - irradiation but very low or undetectable levels were observed in the c12 cells .',\n",
       "  [['Wild', '-', 'type', '(wt)', 'cell'], [0, 1, 2, 3, 4], 'CELL_LINE']],\n",
       " ['Protein kinase B ( c - Akt ) , phosphatidylinositol 3 - kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an <e1> EPO - independent , apoptosis - resistant </e1> subclone ( HCD57 - SREI cells ) .',\n",
       "  'CELL_LINE',\n",
       "  'Protein kinase B ( c - Akt ) , phosphatidylinositol 3 - kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO - independent , apoptosis - resistant subclone ( HCD57 - SREI cells ) .',\n",
       "  [['EPO', '-', 'independent,', 'apoptosis', '-', 'resistant', 'subclone'],\n",
       "   [33, 34, 35, 36, 37, 38, 39],\n",
       "   'CELL_LINE']],\n",
       " ['Enforced expression of Id3 , which has the capacity to inhibit many <e1> basic helix - loop - helix ( bHLH ) </e1> transcription factors , in human CD34(+) hematopoietic progenitor cells that have not undergone T cell receptor ( TCR ) gene rearrangements inhibits development of the transduced cells into TCR alpha beta and gamma delta cells in a fetal thymic organ culture ( FTOC ) .',\n",
       "  'PROTEIN',\n",
       "  'Enforced expression of Id3 , which has the capacity to inhibit many basic helix - loop - helix ( bHLH ) transcription factors , in human CD34(+) hematopoietic progenitor cells that have not undergone T cell receptor ( TCR ) gene rearrangements inhibits development of the transduced cells into TCR alpha beta and gamma delta cells in a fetal thymic organ culture ( FTOC ) .',\n",
       "  [['basic',\n",
       "    'helix',\n",
       "    '-',\n",
       "    'loop',\n",
       "    '-',\n",
       "    'helix',\n",
       "    '(bHLH)',\n",
       "    'transcription',\n",
       "    'factor'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['Enforced expression of Id3 , which has the capacity to inhibit many basic helix - loop - helix ( bHLH ) transcription factors , in human CD34(+) hematopoietic progenitor cells that have not undergone <e1> T cell receptor ( TCR ) </e1> gene rearrangements inhibits development of the transduced cells into TCR alpha beta and gamma delta cells in a fetal thymic organ culture ( FTOC ) .',\n",
       "  'DNA',\n",
       "  'Enforced expression of Id3 , which has the capacity to inhibit many basic helix - loop - helix ( bHLH ) transcription factors , in human CD34(+) hematopoietic progenitor cells that have not undergone T cell receptor ( TCR ) gene rearrangements inhibits development of the transduced cells into TCR alpha beta and gamma delta cells in a fetal thymic organ culture ( FTOC ) .',\n",
       "  [['T', 'cell', 'receptor', '(TCR)', 'gene', 'rearrangement'],\n",
       "   [34, 35, 36, 37, 38, 39],\n",
       "   'DNA']],\n",
       " ['Here we document that overexpression of Id3 , in progenitors that have initiated TCR gene rearrangements ( pre - T cells ) , inhibits development into <e1> TCRalpha beta but </e1> not into TCRgamma delta T cells .',\n",
       "  'CELL_LINE',\n",
       "  'Here we document that overexpression of Id3 , in progenitors that have initiated TCR gene rearrangements ( pre - T cells ) , inhibits development into TCRalpha beta but not into TCRgamma delta T cells .',\n",
       "  [['TCRalpha', 'beta', 'cell'], [26, 27, 28], 'CELL_LINE']],\n",
       " ['We also observed that cell surface CD4( - )CD8( - )CD3( - ) cells with rearranged TCR genes developed from <e1> Id3 - transduced but not from control </e1> - transduced pre - T cells in an FTOC .',\n",
       "  'CELL_LINE',\n",
       "  'We also observed that cell surface CD4( - )CD8( - )CD3( - ) cells with rearranged TCR genes developed from Id3 - transduced but not from control - transduced pre - T cells in an FTOC .',\n",
       "  [['Id3', '-', 'transduced', 'pre', '-', 'T', 'cell'],\n",
       "   [20, 21, 22, 23, 24, 25, 26],\n",
       "   'CELL_LINE']],\n",
       " ['These cells had properties of both <e1> natural killer ( </e1> NK ) and pre - T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'These cells had properties of both natural killer ( NK ) and pre - T cells .',\n",
       "  [['natural', 'killer', 'cell'], [6, 7, 8], 'CELL_TYPE']],\n",
       " ['Our results indicate that the signaling events initiated in PBMCs by oligomerization of CD4 at the <e1> D1/ CDR2 - </e1> loop can trigger HIV - 1 upregulation in infected individuals .',\n",
       "  'PROTEIN',\n",
       "  'Our results indicate that the signaling events initiated in PBMCs by oligomerization of CD4 at the D1/ CDR2 - loop can trigger HIV - 1 upregulation in infected individuals .',\n",
       "  [['D1/CDR2', '-', 'loop'], [16, 17, 18], 'PROTEIN']],\n",
       " ['Here , we demonstrate that signaling through the TNF receptor family member , the <e1> lymphotoxin - beta ( LT - beta </e1> ) receptor ( LT - betaR ) , also regulates HIV - 1 replication .',\n",
       "  'PROTEIN',\n",
       "  'Here , we demonstrate that signaling through the TNF receptor family member , the lymphotoxin - beta ( LT - beta ) receptor ( LT - betaR ) , also regulates HIV - 1 replication .',\n",
       "  [['lymphotoxin', '-', 'beta', '(LT', '-', 'beta)', 'receptor'],\n",
       "   [14, 15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['Latent membrane protein 1 ( LMP1 ) acts like a permanently activated receptor of the <e1> tumor necrosis factor ( TNF ) - </e1> receptor superfamily and is absolutely required for B cell immortalization by Epstein - Barr virus .',\n",
       "  'PROTEIN',\n",
       "  'Latent membrane protein 1 ( LMP1 ) acts like a permanently activated receptor of the tumor necrosis factor ( TNF ) - receptor superfamily and is absolutely required for B cell immortalization by Epstein - Barr virus .',\n",
       "  [['tumor', 'necrosis', 'factor', '(TNF)', '-', 'receptor', 'superfamily'],\n",
       "   [15, 16, 17, 18, 19, 20, 21],\n",
       "   'PROTEIN']],\n",
       " ['The interaction of LMP1 and JAK3 leads to the enhanced tyrosine auto/transphosphorylation of JAK3 within minutes after crosslinking of a conditional <e1> NGF - R : </e1> LMP1 chimera and is a prerequisite for the activation of STAT transcription factors .',\n",
       "  'PROTEIN',\n",
       "  'The interaction of LMP1 and JAK3 leads to the enhanced tyrosine auto/transphosphorylation of JAK3 within minutes after crosslinking of a conditional NGF - R : LMP1 chimera and is a prerequisite for the activation of STAT transcription factors .',\n",
       "  [['NGF', '-', 'R:LMP1', 'chimera'], [21, 22, 23, 24], 'PROTEIN']],\n",
       " ['A well - studied example is <e1> nuclear factors of activated T - cell ( NFAT </e1> ) sites which are composite elements of a NFATp/c and an activating protein 1 ( AP - 1 ) binding site .',\n",
       "  'DNA',\n",
       "  'A well - studied example is nuclear factors of activated T - cell ( NFAT ) sites which are composite elements of a NFATp/c and an activating protein 1 ( AP - 1 ) binding site .',\n",
       "  [['nuclear',\n",
       "    'factors',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    '(NFAT)',\n",
       "    'site'],\n",
       "   [6, 7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['In this study , we show that <e1> USF/ c - </e1> Myc up - regulates , while YY1 down - regulates the promoter activity of CXCR4 , a coreceptor for T cell - tropic HIV - 1 entry .',\n",
       "  'PROTEIN',\n",
       "  'In this study , we show that USF/ c - Myc up - regulates , while YY1 down - regulates the promoter activity of CXCR4 , a coreceptor for T cell - tropic HIV - 1 entry .',\n",
       "  [['USF/c', '-', 'Myc'], [7, 8, 9], 'PROTEIN']],\n",
       " ['RCC - S did not alter the cytoplasmic levels of RelA and NF - kappaB1 but did suppress their nuclear localization and inhibited the activation of <e1> RelA /NF - kappaB1 binding </e1> complexes .',\n",
       "  'PROTEIN',\n",
       "  'RCC - S did not alter the cytoplasmic levels of RelA and NF - kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF - kappaB1 binding complexes .',\n",
       "  [['RelA/NF', '-', 'kappaB1', 'binding', 'complex'],\n",
       "   [26, 27, 28, 29, 30],\n",
       "   'PROTEIN']],\n",
       " ['We investigated the involvement of <e1> signal transducers and activators of transcription ( STAT </e1> ) factors in this phenomenon and reported the specific , time - dependent , activation of STAT1 protein starting at day 0/1 of cultivation and maximally expressed at day 5 .',\n",
       "  'PROTEIN',\n",
       "  'We investigated the involvement of signal transducers and activators of transcription ( STAT ) factors in this phenomenon and reported the specific , time - dependent , activation of STAT1 protein starting at day 0/1 of cultivation and maximally expressed at day 5 .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'factor'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['The molecular events leading to enhanced STAT1 activation and cytokine responsiveness concerned both <e1> Y701 and </e1> S727 STAT1 phosphorylation .',\n",
       "  'PROTEIN',\n",
       "  'The molecular events leading to enhanced STAT1 activation and cytokine responsiveness concerned both Y701 and S727 STAT1 phosphorylation .',\n",
       "  [['Y701', 'STAT1'], [13, 14], 'PROTEIN']],\n",
       " ['PML mRNA and <e1> protein , </e1> while barely detectable in quiescent HPCs , are consistently induced by growth factor stimulation through the erythroid or granulocytic lineage .',\n",
       "  'PROTEIN',\n",
       "  'PML mRNA and protein , while barely detectable in quiescent HPCs , are consistently induced by growth factor stimulation through the erythroid or granulocytic lineage .',\n",
       "  [['PML', 'protein'], [3, 4], 'PROTEIN']],\n",
       " ['GR binding parameters were analyzed in relation to the results of the combined dexamethasone <e1> - </e1> CRH test , which reflects corticosteroid receptor function at the hypothalamus , in 30 patients and 9 controls .',\n",
       "  'PROTEIN',\n",
       "  'GR binding parameters were analyzed in relation to the results of the combined dexamethasone - CRH test , which reflects corticosteroid receptor function at the hypothalamus , in 30 patients and 9 controls .',\n",
       "  [['CRH'], [14], 'PROTEIN']],\n",
       " ['Recent studies have shown that the non - steroidal anti - inflammatory drugs ( NSAIDs ) activate heat shock transcription factor ( HSF1 ) from a latent cytoplasmic form to a <e1> nuclear , DNA binding </e1> state .',\n",
       "  'PROTEIN',\n",
       "  'Recent studies have shown that the non - steroidal anti - inflammatory drugs ( NSAIDs ) activate heat shock transcription factor ( HSF1 ) from a latent cytoplasmic form to a nuclear , DNA binding state .',\n",
       "  [['nuclear,', 'DNA', 'binding', 'state'], [31, 32, 33, 34], 'PROTEIN']],\n",
       " ['Exposure to NSAIDs had a complex effect on HSP gene expression and while sulindac activated the stress responsive <e1> HSP70B </e1> promoter , sodium salicylate did not .',\n",
       "  'DNA',\n",
       "  'Exposure to NSAIDs had a complex effect on HSP gene expression and while sulindac activated the stress responsive HSP70B promoter , sodium salicylate did not .',\n",
       "  [['HSP70B promoter'], [18], 'DNA']],\n",
       " ['The <e1> human T - cell leukemia virus type 1 ( HTLV - 1 ) transcriptional trans </e1> - activator Tax has been demonstrated to have transforming activity in multiple cell culture and transgenic - mouse models .',\n",
       "  'PROTEIN',\n",
       "  'The human T - cell leukemia virus type 1 ( HTLV - 1 ) transcriptional trans - activator Tax has been demonstrated to have transforming activity in multiple cell culture and transgenic - mouse models .',\n",
       "  [['human',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'leukemia',\n",
       "    'virus',\n",
       "    'type',\n",
       "    '1',\n",
       "    '(HTLV',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'transcriptional',\n",
       "    'trans',\n",
       "    '-',\n",
       "    'activator'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15],\n",
       "   'PROTEIN']],\n",
       " ['In addition to activating transcription from the viral long terminal repeat ( LTR ) through the <e1> cyclic AMP response element binding protein/activating transcription factor ( CREB/ATF </e1> ) family of transcription factors , Tax activates the expression of multiple cellular promoters through the NF - kappaB pathway of transcriptional activation .',\n",
       "  'PROTEIN',\n",
       "  'In addition to activating transcription from the viral long terminal repeat ( LTR ) through the cyclic AMP response element binding protein/activating transcription factor ( CREB/ATF ) family of transcription factors , Tax activates the expression of multiple cellular promoters through the NF - kappaB pathway of transcriptional activation .',\n",
       "  [['cyclic',\n",
       "    'AMP',\n",
       "    'response',\n",
       "    'element',\n",
       "    'binding',\n",
       "    'protein/activating',\n",
       "    'transcription',\n",
       "    'factor',\n",
       "    '(CREB/ATF)',\n",
       "    'family'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23, 24, 25],\n",
       "   'PROTEIN']],\n",
       " ['This NF - kappaB binding complex is composed of <e1> transcriptionally active p65 ( </e1> RelA ) /p50 heterodimers and results primarily from the targeted degradation of IkappaB - alpha , an inhibitor that sequesters Rel/kappaB in the cytoplasm .',\n",
       "  'PROTEIN',\n",
       "  'This NF - kappaB binding complex is composed of transcriptionally active p65 ( RelA ) /p50 heterodimers and results primarily from the targeted degradation of IkappaB - alpha , an inhibitor that sequesters Rel/kappaB in the cytoplasm .',\n",
       "  [['transcriptionally', 'active', 'p65(RelA)/p50', 'heterodimer'],\n",
       "   [9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['To investigate the effect of treatment with a pan anti gamma/delta antibody , lymphocytes were incubated for 3 hr with the antibody , and then <e1> interleukin ( IL ) </e1> - 10 , IL - 12 and progesterone - induced blocking factor ( PIBF ) expression ( by immuno - cytochemistry ) as well as natural killer ( NK ) cell activity were determined .',\n",
       "  'PROTEIN',\n",
       "  'To investigate the effect of treatment with a pan anti gamma/delta antibody , lymphocytes were incubated for 3 hr with the antibody , and then interleukin ( IL ) - 10 , IL - 12 and progesterone - induced blocking factor ( PIBF ) expression ( by immuno - cytochemistry ) as well as natural killer ( NK ) cell activity were determined .',\n",
       "  [['interleukin', '(IL)', '-', '10'], [25, 26, 27, 28], 'PROTEIN']],\n",
       " ['To investigate the effect of treatment with a pan anti gamma/delta antibody , lymphocytes were incubated for 3 hr with the antibody , and then interleukin ( IL ) - 10 , IL - 12 and progesterone - induced blocking factor ( PIBF ) expression ( by immuno - cytochemistry ) as well as <e1> natural killer ( NK </e1> ) cell activity were determined .',\n",
       "  'CELL_TYPE',\n",
       "  'To investigate the effect of treatment with a pan anti gamma/delta antibody , lymphocytes were incubated for 3 hr with the antibody , and then interleukin ( IL ) - 10 , IL - 12 and progesterone - induced blocking factor ( PIBF ) expression ( by immuno - cytochemistry ) as well as natural killer ( NK ) cell activity were determined .',\n",
       "  [['natural', 'killer', '(NK)', 'cell'], [54, 55, 56, 57], 'CELL_TYPE']],\n",
       " ['The pathways leading to activation in <e1> lamina propria ( LP ) </e1> T cells are different from peripheral T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'The pathways leading to activation in lamina propria ( LP ) T cells are different from peripheral T cells .',\n",
       "  [['lamina', 'propria', '(LP)', 'T', 'cell'], [6, 7, 8, 9, 10], 'CELL_TYPE']],\n",
       " ['This study characterized molecular events involved in CD28 costimulation of IL - 2 production in <e1> LP mononuclear cells ( </e1> LPMC ) .',\n",
       "  'CELL_TYPE',\n",
       "  'This study characterized molecular events involved in CD28 costimulation of IL - 2 production in LP mononuclear cells ( LPMC ) .',\n",
       "  [['LP', 'mononuclear', 'cell', '(LPMC)'], [15, 16, 17, 18], 'CELL_TYPE']],\n",
       " ['Further , CTLA - 4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3 , cyclin - dependent kinase <e1> ( </e1> cdk ) 4 , and cdk6 when the T cells were stimulated with anti - CD3/ CD28 and with anti - CD3 alone .',\n",
       "  'PROTEIN',\n",
       "  'Further , CTLA - 4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3 , cyclin - dependent kinase ( cdk ) 4 , and cdk6 when the T cells were stimulated with anti - CD3/ CD28 and with anti - CD3 alone .',\n",
       "  [['(cdk)4'], [24], 'PROTEIN']],\n",
       " ['Further , CTLA - 4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3 , cyclin - dependent kinase ( cdk ) 4 , and cdk6 when the T cells were stimulated with <e1> anti - CD3/ </e1> CD28 and with anti - CD3 alone .',\n",
       "  'PROTEIN',\n",
       "  'Further , CTLA - 4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3 , cyclin - dependent kinase ( cdk ) 4 , and cdk6 when the T cells were stimulated with anti - CD3/ CD28 and with anti - CD3 alone .',\n",
       "  [['anti', '-', 'CD3/CD28'], [38, 39, 40], 'PROTEIN']],\n",
       " ['The contact of <e1> natural killer ( NK </e1> ) cells with foreign cells and with certain virus - infected or tumor cells triggers the cytolytic machinery of NK cells .',\n",
       "  'CELL_TYPE',\n",
       "  'The contact of natural killer ( NK ) cells with foreign cells and with certain virus - infected or tumor cells triggers the cytolytic machinery of NK cells .',\n",
       "  [['natural', 'killer', '(NK)', 'cell'], [3, 4, 5, 6], 'CELL_TYPE']],\n",
       " ['In the culture system reported here , ( 1 ) the growth factor ( GF ) stimulus induces <e1> cord blood ( CB ) </e1> progenitor cells to proliferate and differentiate/mature exclusively along the erythroid lineage ; ( 2 ) this erythropoietic wave is characterized by less than 4 % apoptotic cells ; ( 3 ) asymmetric divisions are virtually absent , ie , nonresponsive hematopoietic progenitors with no erythropoietic potential are forced into apoptosis ; ( 4 ) the system is cell division controlled ( cdc ) , ie , the number of divisions performed by each cell is monitored .',\n",
       "  'CELL_TYPE',\n",
       "  'In the culture system reported here , ( 1 ) the growth factor ( GF ) stimulus induces cord blood ( CB ) progenitor cells to proliferate and differentiate/mature exclusively along the erythroid lineage ; ( 2 ) this erythropoietic wave is characterized by less than 4 % apoptotic cells ; ( 3 ) asymmetric divisions are virtually absent , ie , nonresponsive hematopoietic progenitors with no erythropoietic potential are forced into apoptosis ; ( 4 ) the system is cell division controlled ( cdc ) , ie , the number of divisions performed by each cell is monitored .',\n",
       "  [['cord', 'blood', '(CB)', 'progenitor', 'cell'],\n",
       "   [18, 19, 20, 21, 22],\n",
       "   'CELL_TYPE']],\n",
       " ['In addition , competitive single - cell RT - PCR was used to assay CD34 mRNA transcripts in <e1> sibling CD34 (+) CD38( - </e1> ) cells differentiating in unilineage erythroid cultures : this analysis allowed us to semiquantitate the gradual downmodulation of CD34 mRNA from progenitor cells through their differentiating erythroid progeny .',\n",
       "  'CELL_LINE',\n",
       "  'In addition , competitive single - cell RT - PCR was used to assay CD34 mRNA transcripts in sibling CD34 (+) CD38( - ) cells differentiating in unilineage erythroid cultures : this analysis allowed us to semiquantitate the gradual downmodulation of CD34 mRNA from progenitor cells through their differentiating erythroid progeny .',\n",
       "  [['sibling', 'CD34(+)CD38(', '-', ')', 'cell'],\n",
       "   [18, 19, 20, 21, 22],\n",
       "   'CELL_LINE']],\n",
       " ['It is concluded that this novel culture system , coupled with single - cell RT - PCR analysis , may eliminate the ambiguities intrinsic to molecular studies on heterogeneous populations of <e1> hematopoietic progenitors </e1> /precursors growing in culture , particularly in the initial stages of development .',\n",
       "  'CELL_TYPE',\n",
       "  'It is concluded that this novel culture system , coupled with single - cell RT - PCR analysis , may eliminate the ambiguities intrinsic to molecular studies on heterogeneous populations of hematopoietic progenitors /precursors growing in culture , particularly in the initial stages of development .',\n",
       "  [['hematopoietic', 'progenitors/precursor'], [31, 32], 'CELL_TYPE']],\n",
       " ['However , this technique can be complicated by excessive lyonization of normal cells mimicking clonal cell growth : We analyzed XCI patterns at the <e1> human androgen receptor ( HUMARA </e1> ) locus in 146 healthy females , 65 women with secondary neutrophilia , 31 women with reactive thrombocytosis , and 86 women with chronic MPDs .',\n",
       "  'DNA',\n",
       "  'However , this technique can be complicated by excessive lyonization of normal cells mimicking clonal cell growth : We analyzed XCI patterns at the human androgen receptor ( HUMARA ) locus in 146 healthy females , 65 women with secondary neutrophilia , 31 women with reactive thrombocytosis , and 86 women with chronic MPDs .',\n",
       "  [['human', 'androgen', 'receptor', '(HUMARA)', 'locus'],\n",
       "   [24, 25, 26, 27, 28],\n",
       "   'DNA']],\n",
       " ['These results point out the involvement of <e1> NF - kappa B /Rel family </e1> proteins in growth signaling pathways by either regulating proteins involved in the IL - 2 signaling or by functionally interfering with the cell cycle progression .',\n",
       "  'PROTEIN',\n",
       "  'These results point out the involvement of NF - kappa B /Rel family proteins in growth signaling pathways by either regulating proteins involved in the IL - 2 signaling or by functionally interfering with the cell cycle progression .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'family', 'protein'],\n",
       "   [7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['To investigate the molecular basis of the mitogenic effect of high molecular weight dextran sulfate ( HMDS ) , monocyte - derived macrophages were transfected with recombinant plasmid containing <e1> chloramphenicol acetyl transferase ( CAT ) </e1> reporter gene under the control of the HIV - 1 long terminal repeat ( LTR ) promoter , which is regulated by transcription factor NF - kappaB .',\n",
       "  'DNA',\n",
       "  'To investigate the molecular basis of the mitogenic effect of high molecular weight dextran sulfate ( HMDS ) , monocyte - derived macrophages were transfected with recombinant plasmid containing chloramphenicol acetyl transferase ( CAT ) reporter gene under the control of the HIV - 1 long terminal repeat ( LTR ) promoter , which is regulated by transcription factor NF - kappaB .',\n",
       "  [['chloramphenicol', 'acetyl', 'transferase', '(CAT)', 'reporter', 'gene'],\n",
       "   [29, 30, 31, 32, 33, 34],\n",
       "   'DNA']],\n",
       " ['To investigate the molecular basis of the mitogenic effect of high molecular weight dextran sulfate ( HMDS ) , monocyte - derived macrophages were transfected with recombinant plasmid containing chloramphenicol acetyl transferase ( CAT ) reporter gene under the control of the <e1> HIV - 1 long terminal repeat ( LTR </e1> ) promoter , which is regulated by transcription factor NF - kappaB .',\n",
       "  'DNA',\n",
       "  'To investigate the molecular basis of the mitogenic effect of high molecular weight dextran sulfate ( HMDS ) , monocyte - derived macrophages were transfected with recombinant plasmid containing chloramphenicol acetyl transferase ( CAT ) reporter gene under the control of the HIV - 1 long terminal repeat ( LTR ) promoter , which is regulated by transcription factor NF - kappaB .',\n",
       "  [['HIV', '-', '1', 'long', 'terminal', 'repeat', '(LTR)', 'promoter'],\n",
       "   [42, 43, 44, 45, 46, 47, 48, 49],\n",
       "   'DNA']],\n",
       " ['MATERIALS AND METHODS : Human monocytes were stimulated with PMA ( 50 ng/ml ) alone or LPS ( 100 ng/ml ) with and without a nonspecific <e1> serine /threonine protein </e1> kinase inhibitor staurosporine ( Stauro ) , a specific pan - PKC inhibitor bisindolylmaleimide ( Bis ) , or an inhibitor of PTK genistein ( Gen ) .',\n",
       "  'PROTEIN',\n",
       "  'MATERIALS AND METHODS : Human monocytes were stimulated with PMA ( 50 ng/ml ) alone or LPS ( 100 ng/ml ) with and without a nonspecific serine /threonine protein kinase inhibitor staurosporine ( Stauro ) , a specific pan - PKC inhibitor bisindolylmaleimide ( Bis ) , or an inhibitor of PTK genistein ( Gen ) .',\n",
       "  [['serine/threonine', 'protein', 'kinase'], [26, 27, 28], 'PROTEIN']],\n",
       " ['Our previous studies pertaining to macrophage response to LPS identified a novel DNA - binding domain located from - 550 to - 487 in the human TNF - alpha promoter that contains transcriptional activity , but lacks any known NF - kappaB <e1> - binding </e1> sites .',\n",
       "  'DNA',\n",
       "  'Our previous studies pertaining to macrophage response to LPS identified a novel DNA - binding domain located from - 550 to - 487 in the human TNF - alpha promoter that contains transcriptional activity , but lacks any known NF - kappaB - binding sites .',\n",
       "  [['binding', 'site'], [42, 43], 'DNA']],\n",
       " ['Efforts to pinpoint the exact site of action and specificity of HePTP in the signaling cascade revealed that HePTP acts directly on the <e1> mitogen - activated protein ( MAP </e1> ) kinases Erk 1 and 2 and consequently reduces the magnitude and duration of their catalytic activation in intact T cells .',\n",
       "  'PROTEIN',\n",
       "  'Efforts to pinpoint the exact site of action and specificity of HePTP in the signaling cascade revealed that HePTP acts directly on the mitogen - activated protein ( MAP ) kinases Erk 1 and 2 and consequently reduces the magnitude and duration of their catalytic activation in intact T cells .',\n",
       "  [['mitogen', '-', 'activated', 'protein', '(MAP)', 'kinase'],\n",
       "   [23, 24, 25, 26, 27, 28],\n",
       "   'PROTEIN']],\n",
       " ['These results suggest that haemoglobin production in UT - 7 cells is limited by a deficiency of <e1> erythroid - specific aminolaevulinic acid synthase ( ALAS - E </e1> ) activity or globin synthesis as a consequence of their immaturity as a multipotential cell line .',\n",
       "  'PROTEIN',\n",
       "  'These results suggest that haemoglobin production in UT - 7 cells is limited by a deficiency of erythroid - specific aminolaevulinic acid synthase ( ALAS - E ) activity or globin synthesis as a consequence of their immaturity as a multipotential cell line .',\n",
       "  [['erythroid',\n",
       "    '-',\n",
       "    'specific',\n",
       "    'aminolaevulinic',\n",
       "    'acid',\n",
       "    'synthase',\n",
       "    '(ALAS',\n",
       "    '-',\n",
       "    'E)',\n",
       "    'activity'],\n",
       "   [17, 18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'PROTEIN']],\n",
       " ['Acute inflammatory injury in rat lung induced by deposition of immunoglobulin G immune complexes requires expression of cytokines and chemokines as well as activation of the transcription factor <e1> nuclear factor ( NF ) </e1> - kappaB .',\n",
       "  'PROTEIN',\n",
       "  'Acute inflammatory injury in rat lung induced by deposition of immunoglobulin G immune complexes requires expression of cytokines and chemokines as well as activation of the transcription factor nuclear factor ( NF ) - kappaB .',\n",
       "  [['nuclear', 'factor', '(NF)', '-', 'kappaB'],\n",
       "   [28, 29, 30, 31, 32],\n",
       "   'PROTEIN']],\n",
       " ['A region between - 3134 and - 2729 bp upstream from the transcription site of the <e1> human pro - interleukin 1beta ( proIL - 1beta </e1> ) gene was identified as an LPS - responsive enhancer element .',\n",
       "  'DNA',\n",
       "  'A region between - 3134 and - 2729 bp upstream from the transcription site of the human pro - interleukin 1beta ( proIL - 1beta ) gene was identified as an LPS - responsive enhancer element .',\n",
       "  [['human',\n",
       "    'pro',\n",
       "    '-',\n",
       "    'interleukin',\n",
       "    '1beta',\n",
       "    '(proIL',\n",
       "    '-',\n",
       "    '1beta)',\n",
       "    'gene'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23, 24],\n",
       "   'DNA']],\n",
       " ['Transient transfection of endothelial cells with <e1> ICAM - 1 promoter luciferase reporter gene ( ICAM - 1LUC </e1> ) constructs indicated that deletion of upstream NF - kappa B site ( - 533 bases from translation start site ) had no effect on thrombin responsiveness , whereas mutation/deletion of downstream NF - kappa B site ( - 223 bases from the translation start site ) prevented the activation of ICAM - 1 promoter , indicating that the downstream NF - kappa B site is critical for thrombin inducibility .',\n",
       "  'DNA',\n",
       "  'Transient transfection of endothelial cells with ICAM - 1 promoter luciferase reporter gene ( ICAM - 1LUC ) constructs indicated that deletion of upstream NF - kappa B site ( - 533 bases from translation start site ) had no effect on thrombin responsiveness , whereas mutation/deletion of downstream NF - kappa B site ( - 223 bases from the translation start site ) prevented the activation of ICAM - 1 promoter , indicating that the downstream NF - kappa B site is critical for thrombin inducibility .',\n",
       "  [['ICAM',\n",
       "    '-',\n",
       "    '1',\n",
       "    'promoter',\n",
       "    'luciferase',\n",
       "    'reporter',\n",
       "    'gene',\n",
       "    '(ICAM',\n",
       "    '-',\n",
       "    '1LUC)',\n",
       "    'construct'],\n",
       "   [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['The influence on interleukin ( IL ) - 2 , IL - 4 and <e1> interferon ( IFN ) </e1> - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  'PROTEIN',\n",
       "  'The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  [['interferon', '(IFN)', '-', 'gamma'], [14, 15, 16, 17], 'PROTEIN']],\n",
       " ['The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; <e1> IL - 2 receptor ( IL - 2R </e1> ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  'PROTEIN',\n",
       "  'The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  [['IL', '-', '2', 'receptor', '(IL', '-', '2R)', 'alpha'],\n",
       "   [22, 23, 24, 25, 26, 27, 28, 29],\n",
       "   'PROTEIN']],\n",
       " ['The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , <e1> beta - , and </e1> gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  'PROTEIN',\n",
       "  'The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  [['IL', '-', '2R', 'beta'], [34, 35, 36, 37], 'PROTEIN']],\n",
       " ['The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and <e1> gamma - chain ; and the </e1> signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  'PROTEIN',\n",
       "  'The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  [['IL', '-', '2R', 'gamma', '-', 'chain'],\n",
       "   [38, 39, 40, 41, 42, 43],\n",
       "   'PROTEIN']],\n",
       " ['The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase <e1> ( </e1> Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  'PROTEIN',\n",
       "  'The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  [['(Jak)1'], [49], 'PROTEIN']],\n",
       " ['The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription <e1> ( </e1> Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  'PROTEIN',\n",
       "  'The influence on interleukin ( IL ) - 2 , IL - 4 and interferon ( IFN ) - gamma production ; IL - 2 receptor ( IL - 2R ) alpha - , beta - , and gamma - chain ; and the signaling pathway molecules Janus kinase ( Jak ) 1 , Jak3 , signal transducers and activators of transcription ( Stat ) 1 , Stat3 , and Stat5 should be investigated .',\n",
       "  [['(Stat)1'], [62], 'PROTEIN']],\n",
       " ['HLA class I Ags have been implicated to play a major role in this process , since signaling via HLA class I molecules can induce the proliferation of <e1> aortic endothelial as </e1> well as smooth muscle cells .',\n",
       "  'CELL_TYPE',\n",
       "  'HLA class I Ags have been implicated to play a major role in this process , since signaling via HLA class I molecules can induce the proliferation of aortic endothelial as well as smooth muscle cells .',\n",
       "  [['aortic', 'endothelial', 'cell'], [28, 29, 30], 'CELL_TYPE']],\n",
       " ['PG490 inhibits <e1> interleukin ( IL </e1> ) - 2 expression by normal human peripheral blood lymphocytes stimulated with phorbol 12 - myristate 13 - acetate ( PMA ) and antibody to CD3 ( IC50 of 10 ng/ml ) , and with PMA and ionomycin ( Iono , IC50 of 40 ng/ml ) .',\n",
       "  'PROTEIN',\n",
       "  'PG490 inhibits interleukin ( IL ) - 2 expression by normal human peripheral blood lymphocytes stimulated with phorbol 12 - myristate 13 - acetate ( PMA ) and antibody to CD3 ( IC50 of 10 ng/ml ) , and with PMA and ionomycin ( Iono , IC50 of 40 ng/ml ) .',\n",
       "  [['interleukin(IL)', '-', '2'], [2, 3, 4], 'PROTEIN']],\n",
       " ['PG490 inhibits the induction of DNA binding activity at the <e1> purine - box/antigen receptor response element ( ARRE ) /nuclear factor of activated T - cells ( NF </e1> - AT ) target sequence but not at the NF - kappaB site .',\n",
       "  'DNA',\n",
       "  'PG490 inhibits the induction of DNA binding activity at the purine - box/antigen receptor response element ( ARRE ) /nuclear factor of activated T - cells ( NF - AT ) target sequence but not at the NF - kappaB site .',\n",
       "  [['purine',\n",
       "    '-',\n",
       "    'box/antigen',\n",
       "    'receptor',\n",
       "    'response',\n",
       "    'element',\n",
       "    '(ARRE)/nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cells',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'AT)',\n",
       "    'target',\n",
       "    'sequence'],\n",
       "   [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27],\n",
       "   'DNA']],\n",
       " ['Previous studies established a potential role for the Src - family kinase Lck in JAK <e1> - </e1> STAT signaling .',\n",
       "  'PROTEIN',\n",
       "  'Previous studies established a potential role for the Src - family kinase Lck in JAK - STAT signaling .',\n",
       "  [['STAT'], [15], 'PROTEIN']],\n",
       " ['Therefore , this study was designed to analyze the role of Lck in IFN - alpha signaling by using the Jurkat , JCam ( an Lck - defective cell line derived from Jurkat ) , and <e1> JCam/ </e1> Lck ( JCam cells with Lck restored ) .',\n",
       "  'CELL_LINE',\n",
       "  'Therefore , this study was designed to analyze the role of Lck in IFN - alpha signaling by using the Jurkat , JCam ( an Lck - defective cell line derived from Jurkat ) , and JCam/ Lck ( JCam cells with Lck restored ) .',\n",
       "  [['JCam/Lck'], [36], 'CELL_LINE']],\n",
       " ['We took advantage of our monoclonal model of germinal center B cell differentiation , IgM+ IgD+ CL - 01 cells , to define the role of the I gamma 3 evolutionarily conserved sequence ( ECS ) in the <e1> germline transcriptional </e1> activation of the human C gamma 3 gene .',\n",
       "  'DNA',\n",
       "  'We took advantage of our monoclonal model of germinal center B cell differentiation , IgM+ IgD+ CL - 01 cells , to define the role of the I gamma 3 evolutionarily conserved sequence ( ECS ) in the germline transcriptional activation of the human C gamma 3 gene .',\n",
       "  [['germline', 'promotor'], [38, 39], 'DNA']],\n",
       " ['Targeted mutational analysis demonstrated that a tandem <e1> NF - kappa B /Rel binding </e1> motif is critical for the gamma 3 ECS responsiveness to both CD40L and IL - 4 , while a STAT - 6 - binding site is additionally required for IL - 4 inducibility .',\n",
       "  'DNA',\n",
       "  'Targeted mutational analysis demonstrated that a tandem NF - kappa B /Rel binding motif is critical for the gamma 3 ECS responsiveness to both CD40L and IL - 4 , while a STAT - 6 - binding site is additionally required for IL - 4 inducibility .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'binding', 'motif'],\n",
       "   [7, 8, 9, 10, 11, 12],\n",
       "   'DNA']],\n",
       " ['Moreover , <e1> tyrosine - phosphorylated LAT </e1> / pp36 / 38 in detergent lysates prepared from anti - CD3 stimulated T cells associated with Grb2 but not GrpL .',\n",
       "  'PROTEIN',\n",
       "  'Moreover , tyrosine - phosphorylated LAT / pp36 / 38 in detergent lysates prepared from anti - CD3 stimulated T cells associated with Grb2 but not GrpL .',\n",
       "  [['tyrosine', '-', 'phosphorylated', 'LAT/pp36/38'],\n",
       "   [2, 3, 4, 5],\n",
       "   'PROTEIN']],\n",
       " ['Moreover , tyrosine - phosphorylated LAT / pp36 / <e1> 38 </e1> in detergent lysates prepared from anti - CD3 stimulated T cells associated with Grb2 but not GrpL .',\n",
       "  'PROTEIN',\n",
       "  'Moreover , tyrosine - phosphorylated LAT / pp36 / 38 in detergent lysates prepared from anti - CD3 stimulated T cells associated with Grb2 but not GrpL .',\n",
       "  [['pp38'], [9], 'PROTEIN']],\n",
       " ['A functional role of the GrpL <e1> - SLP - </e1> 76 complex is suggested by the ability of GrpL to act alone or in concert with SLP - 76 to augment NF - AT activation in Jurkat T cells .',\n",
       "  'PROTEIN',\n",
       "  'A functional role of the GrpL - SLP - 76 complex is suggested by the ability of GrpL to act alone or in concert with SLP - 76 to augment NF - AT activation in Jurkat T cells .',\n",
       "  [['SLP', '-', '76'], [6, 7, 8], 'PROTEIN']],\n",
       " ['Differential induction of <e1> interferon ( IFN ) - inducible </e1> protein 10 following differentiation of a monocyte , macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites .',\n",
       "  'PROTEIN',\n",
       "  'Differential induction of interferon ( IFN ) - inducible protein 10 following differentiation of a monocyte , macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites .',\n",
       "  [['interferon', '(IFN)', '-', 'inducible', 'protein', '10'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['The gene expression of <e1> interferon ( IFN ) - inducible </e1> protein 10 ( IP - 10 ) ( a CXC chemokine ) was markedly augmented by the IFNgamma treatment in PMA - or RA - differentiated U937 cells , but only marginally in undifferentiated or VitD3 - treated cells .',\n",
       "  'PROTEIN',\n",
       "  'The gene expression of interferon ( IFN ) - inducible protein 10 ( IP - 10 ) ( a CXC chemokine ) was markedly augmented by the IFNgamma treatment in PMA - or RA - differentiated U937 cells , but only marginally in undifferentiated or VitD3 - treated cells .',\n",
       "  [['interferon', '(IFN)', '-', 'inducible', 'protein', '10'],\n",
       "   [4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['Increased expression of IFNgamma - induced IP - 10 mRNA following the differentiation of U937 cells was mediated largely by augmented transcriptional activity of the gene and was related to differentiation - dependent changes of the proteins bound to <e1> IFN stimulus response element ( </e1> ISRE ) and kB sites , suggesting that these nuclear proteins may determine the IP - 10 mRNA inducibility by IFNgamma .',\n",
       "  'DNA',\n",
       "  'Increased expression of IFNgamma - induced IP - 10 mRNA following the differentiation of U937 cells was mediated largely by augmented transcriptional activity of the gene and was related to differentiation - dependent changes of the proteins bound to IFN stimulus response element ( ISRE ) and kB sites , suggesting that these nuclear proteins may determine the IP - 10 mRNA inducibility by IFNgamma .',\n",
       "  [['IFN', 'stimulus', 'response', 'element', '(ISRE)'],\n",
       "   [39, 40, 41, 42, 43],\n",
       "   'DNA']],\n",
       " ['The <e1> STP - C488 P10 - - > R </e1> mutant was also defective in Rat - 1 fibroblast transformation , and fibroblast cell transformation was blocked by a TRAF2 dominant - negative mutant .',\n",
       "  'PROTEIN',\n",
       "  'The STP - C488 P10 - - > R mutant was also defective in Rat - 1 fibroblast transformation , and fibroblast cell transformation was blocked by a TRAF2 dominant - negative mutant .',\n",
       "  [['STP', '-', 'C488', 'P10', '-', '-', '>R', 'mutant'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['CD40 expression could be enhanced in CD40 - positive MM by stimulation with IFN - gamma and tumor necrosis factor - alpha but not by <e1> interleukin ( IL ) </e1> - 1beta or CD40 triggering .',\n",
       "  'PROTEIN',\n",
       "  'CD40 expression could be enhanced in CD40 - positive MM by stimulation with IFN - gamma and tumor necrosis factor - alpha but not by interleukin ( IL ) - 1beta or CD40 triggering .',\n",
       "  [['interleukin', '(IL)', '-', '1beta'], [25, 26, 27, 28], 'PROTEIN']],\n",
       " ['Furthermore , CD40 ligation of a <e1> HLA - A2+ , MelanA/MART1+ MM cell </e1> line enhanced its susceptibility to specific lysis by a HLA - A2 - restricted , MelanA/MART - 1 - specific CTL clone .',\n",
       "  'CELL_LINE',\n",
       "  'Furthermore , CD40 ligation of a HLA - A2+ , MelanA/MART1+ MM cell line enhanced its susceptibility to specific lysis by a HLA - A2 - restricted , MelanA/MART - 1 - specific CTL clone .',\n",
       "  [['HLA', '-', 'A2+,', 'MelanA/MART1+', 'MM', 'cell', 'line'],\n",
       "   [6, 7, 8, 9, 10, 11, 12],\n",
       "   'CELL_LINE']],\n",
       " ['Furthermore , CD40 ligation of a HLA - A2+ , MelanA/MART1+ MM cell line enhanced its susceptibility to specific lysis by a <e1> HLA - A2 - restricted , MelanA/MART - 1 - specific CTL </e1> clone .',\n",
       "  'CELL_LINE',\n",
       "  'Furthermore , CD40 ligation of a HLA - A2+ , MelanA/MART1+ MM cell line enhanced its susceptibility to specific lysis by a HLA - A2 - restricted , MelanA/MART - 1 - specific CTL clone .',\n",
       "  [['HLA',\n",
       "    '-',\n",
       "    'A2',\n",
       "    '-',\n",
       "    'restricted,',\n",
       "    'MelanA/MART',\n",
       "    '-',\n",
       "    '1',\n",
       "    '-',\n",
       "    'specific',\n",
       "    'CTL',\n",
       "    'clone'],\n",
       "   [22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33],\n",
       "   'CELL_LINE']],\n",
       " ['These results indicate that CD40 <e1> - </e1> CD40L interactions may play an important role in augmenting antitumor immunity and inducing apoptosis in some CD40 - positive immunogenic human MMs .',\n",
       "  'PROTEIN',\n",
       "  'These results indicate that CD40 - CD40L interactions may play an important role in augmenting antitumor immunity and inducing apoptosis in some CD40 - positive immunogenic human MMs .',\n",
       "  [['CD40L'], [5], 'PROTEIN']],\n",
       " ['These include overrepresentation of clinically aggressive histologic types and frequent infection of <e1> Reed - Sternberg ( RS </e1> ) cells by Epstein - Barr virus ( EBV ) .',\n",
       "  'CELL_LINE',\n",
       "  'These include overrepresentation of clinically aggressive histologic types and frequent infection of Reed - Sternberg ( RS ) cells by Epstein - Barr virus ( EBV ) .',\n",
       "  [['Reed', '-', 'Sternberg', '(RS)', 'cell'],\n",
       "   [12, 13, 14, 15, 16],\n",
       "   'CELL_LINE']],\n",
       " ['Recently , we have reported that the histogenesis of HD of the general population may be assessed by monitoring the expression pattern of BCL - 6 , a transcription factor expressed in <e1> germinal center ( GC ) </e1> B cells , and of CD138/syndecan - 1 ( syn - 1 ) , a proteoglycan associated with post - GC , terminal B - cell differentiation .',\n",
       "  'CELL_LINE',\n",
       "  'Recently , we have reported that the histogenesis of HD of the general population may be assessed by monitoring the expression pattern of BCL - 6 , a transcription factor expressed in germinal center ( GC ) B cells , and of CD138/syndecan - 1 ( syn - 1 ) , a proteoglycan associated with post - GC , terminal B - cell differentiation .',\n",
       "  [['germinal', 'center', '(GC)', 'B', 'cell'],\n",
       "   [32, 33, 34, 35, 36],\n",
       "   'CELL_LINE']],\n",
       " ['Although BCL - 6 ( - )/syn - 1(+) RS cells of HIV - HD express CD40 , they are not surrounded by <e1> CD40 ligand - positive ( CD40L + ) </e1> reactive T lymphocytes , which , in HD of the general population , are thought to regulate the disease phenotype through CD40 /CD40L interactions .',\n",
       "  'CELL_TYPE',\n",
       "  'Although BCL - 6 ( - )/syn - 1(+) RS cells of HIV - HD express CD40 , they are not surrounded by CD40 ligand - positive ( CD40L + ) reactive T lymphocytes , which , in HD of the general population , are thought to regulate the disease phenotype through CD40 /CD40L interactions .',\n",
       "  [['CD40',\n",
       "    'ligand',\n",
       "    '-',\n",
       "    'positive',\n",
       "    '(CD40L+)',\n",
       "    'reactive',\n",
       "    'T',\n",
       "    'lymphocyte'],\n",
       "   [23, 24, 25, 26, 27, 28, 29, 30],\n",
       "   'CELL_TYPE']],\n",
       " ['On first encounter with antigen , <e1> naive CD4+ T helper ( Th </e1> ) cells differentiate into cytokine - producing effector cells .',\n",
       "  'CELL_TYPE',\n",
       "  'On first encounter with antigen , naive CD4+ T helper ( Th ) cells differentiate into cytokine - producing effector cells .',\n",
       "  [['naive', 'CD4+', 'T', 'helper', '(Th)', 'cell'],\n",
       "   [6, 7, 8, 9, 10, 11],\n",
       "   'CELL_TYPE']],\n",
       " ['T lymphocytes express several low molecular weight transmembrane adaptor proteins that recruit <e1> src homology ( SH ) 2 domain - </e1> containing intracellular molecules to the cell membrane via tyrosine - based signaling motifs .',\n",
       "  'PROTEIN',\n",
       "  'T lymphocytes express several low molecular weight transmembrane adaptor proteins that recruit src homology ( SH ) 2 domain - containing intracellular molecules to the cell membrane via tyrosine - based signaling motifs .',\n",
       "  [['src',\n",
       "    'homology',\n",
       "    '(SH)2',\n",
       "    'domain',\n",
       "    '-',\n",
       "    'containing',\n",
       "    'intracellular',\n",
       "    'molecule'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19],\n",
       "   'PROTEIN']],\n",
       " ['T lymphocytes express several low molecular weight transmembrane adaptor proteins that recruit <e1> src homology ( SH </e1> ) 2 domain - containing intracellular molecules to the cell membrane via tyrosine - based signaling motifs .',\n",
       "  'PROTEIN',\n",
       "  'T lymphocytes express several low molecular weight transmembrane adaptor proteins that recruit src homology ( SH ) 2 domain - containing intracellular molecules to the cell membrane via tyrosine - based signaling motifs .',\n",
       "  [['src', 'homology', '(SH)2', 'domain'], [12, 13, 14, 15], 'PROTEIN']],\n",
       " ['1,25 - Dihydroxyvitamin D3 induces differentiation of a retinoic acid - resistant acute promyelocytic leukemia cell line ( UF - 1 ) associated with expression of <e1> p21 </e1> ( WAF1/CIP1 ) and p27 ( KIP1 ) .',\n",
       "  'PROTEIN',\n",
       "  '1,25 - Dihydroxyvitamin D3 induces differentiation of a retinoic acid - resistant acute promyelocytic leukemia cell line ( UF - 1 ) associated with expression of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) .',\n",
       "  [['p21(WAF1/CIP1)'], [26], 'PROTEIN']],\n",
       " ['1,25 - Dihydroxyvitamin D3 induces differentiation of a retinoic acid - resistant acute promyelocytic leukemia cell line ( UF - 1 ) associated with expression of p21 ( WAF1/CIP1 ) and <e1> p27 </e1> ( KIP1 ) .',\n",
       "  'PROTEIN',\n",
       "  '1,25 - Dihydroxyvitamin D3 induces differentiation of a retinoic acid - resistant acute promyelocytic leukemia cell line ( UF - 1 ) associated with expression of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) .',\n",
       "  [['p27(KIP1)'], [31], 'PROTEIN']],\n",
       " ['RXRs heterodimerize with <e1> 1, 25 - dihydroxyvitamin D3 [ 1,25(OH)2D3 ] </e1> receptor ( VDR ) , enabling their efficient transcriptional activation .',\n",
       "  'PROTEIN',\n",
       "  'RXRs heterodimerize with 1, 25 - dihydroxyvitamin D3 [ 1,25(OH)2D3 ] receptor ( VDR ) , enabling their efficient transcriptional activation .',\n",
       "  [['1,', '25', '-', 'dihydroxyvitamin', 'D3', '[1,25(OH)2D3]', 'receptor'],\n",
       "   [3, 4, 5, 6, 7, 8, 9],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> cyclin - dependent kinase ( cdk </e1> ) inhibitor p21 ( WAF1/CIP1 ) has a vitamin D3 - responsive element ( VDRE ) in its promoter , and 1,25(OH)2D3 enhances the expression of p21 ( WAF1/CIP1 ) and induces differentiation of selected myeloid leukemic cell lines .',\n",
       "  'PROTEIN',\n",
       "  'The cyclin - dependent kinase ( cdk ) inhibitor p21 ( WAF1/CIP1 ) has a vitamin D3 - responsive element ( VDRE ) in its promoter , and 1,25(OH)2D3 enhances the expression of p21 ( WAF1/CIP1 ) and induces differentiation of selected myeloid leukemic cell lines .',\n",
       "  [['cyclin', '-', 'dependent', 'kinase', '(cdk)', 'inhibitor'],\n",
       "   [1, 2, 3, 4, 5, 6],\n",
       "   'PROTEIN']],\n",
       " ['The cyclin - dependent kinase ( cdk ) inhibitor <e1> p21 </e1> ( WAF1/CIP1 ) has a vitamin D3 - responsive element ( VDRE ) in its promoter , and 1,25(OH)2D3 enhances the expression of p21 ( WAF1/CIP1 ) and induces differentiation of selected myeloid leukemic cell lines .',\n",
       "  'PROTEIN',\n",
       "  'The cyclin - dependent kinase ( cdk ) inhibitor p21 ( WAF1/CIP1 ) has a vitamin D3 - responsive element ( VDRE ) in its promoter , and 1,25(OH)2D3 enhances the expression of p21 ( WAF1/CIP1 ) and induces differentiation of selected myeloid leukemic cell lines .',\n",
       "  [['p21(WAF1/CIP1)'], [9], 'PROTEIN']],\n",
       " ['The cyclin - dependent kinase ( cdk ) inhibitor p21 ( WAF1/CIP1 ) has a vitamin D3 - responsive element ( VDRE ) in its promoter , and 1,25(OH)2D3 enhances the expression of <e1> p21 </e1> ( WAF1/CIP1 ) and induces differentiation of selected myeloid leukemic cell lines .',\n",
       "  'PROTEIN',\n",
       "  'The cyclin - dependent kinase ( cdk ) inhibitor p21 ( WAF1/CIP1 ) has a vitamin D3 - responsive element ( VDRE ) in its promoter , and 1,25(OH)2D3 enhances the expression of p21 ( WAF1/CIP1 ) and induces differentiation of selected myeloid leukemic cell lines .',\n",
       "  [['p21(WAF1/CIP1)'], [33], 'PROTEIN']],\n",
       " ['Associated with these findings , the levels of <e1> p21 </e1> ( WAF1/CIP1 ) and p27 ( KIP1 ) mRNA and protein increased in these cells .',\n",
       "  'PROTEIN',\n",
       "  'Associated with these findings , the levels of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) mRNA and protein increased in these cells .',\n",
       "  [['p21(WAF1/CIP1)'], [8], 'PROTEIN']],\n",
       " ['Associated with these findings , the levels of p21 ( WAF1/CIP1 ) and <e1> p27 ( </e1> KIP1 ) mRNA and protein increased in these cells .',\n",
       "  'RNA',\n",
       "  'Associated with these findings , the levels of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) mRNA and protein increased in these cells .',\n",
       "  [['p27(KIP1)', 'mRNA'], [13, 14], 'RNA']],\n",
       " ['Associated with these findings , the levels of p21 ( WAF1/CIP1 ) and <e1> p27 </e1> ( KIP1 ) mRNA and protein increased in these cells .',\n",
       "  'PROTEIN',\n",
       "  'Associated with these findings , the levels of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) mRNA and protein increased in these cells .',\n",
       "  [['p27(KIP1)'], [13], 'PROTEIN']],\n",
       " ['Northern blot analysis showed that <e1> p21 </e1> ( WAF1/CIP1 ) and p27 ( KIP1 ) transcripts were induced after 6 hours exposure to 1,25(OH)2D3 and then decreased to basal levels over 48 hours .',\n",
       "  'PROTEIN',\n",
       "  'Northern blot analysis showed that p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) transcripts were induced after 6 hours exposure to 1,25(OH)2D3 and then decreased to basal levels over 48 hours .',\n",
       "  [['p21(WAF1/CIP1)'], [5], 'PROTEIN']],\n",
       " ['Northern blot analysis showed that p21 ( WAF1/CIP1 ) and <e1> p27 </e1> ( KIP1 ) transcripts were induced after 6 hours exposure to 1,25(OH)2D3 and then decreased to basal levels over 48 hours .',\n",
       "  'PROTEIN',\n",
       "  'Northern blot analysis showed that p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) transcripts were induced after 6 hours exposure to 1,25(OH)2D3 and then decreased to basal levels over 48 hours .',\n",
       "  [['p27(KIP1)'], [10], 'PROTEIN']],\n",
       " ['Western blot experiments showed that <e1> p21 </e1> ( WAF1/CIP1 ) protein levels increased and became detectable after 12 hours of 1,25(OH)2D3 treatment and induction of p27 ( KIP1 ) protein was much more gradual and sustained in UF - 1 cells .',\n",
       "  'PROTEIN',\n",
       "  'Western blot experiments showed that p21 ( WAF1/CIP1 ) protein levels increased and became detectable after 12 hours of 1,25(OH)2D3 treatment and induction of p27 ( KIP1 ) protein was much more gradual and sustained in UF - 1 cells .',\n",
       "  [['p21(WAF1/CIP1)'], [5], 'PROTEIN']],\n",
       " ['Western blot experiments showed that p21 ( WAF1/CIP1 ) protein levels increased and became detectable after 12 hours of 1,25(OH)2D3 treatment and induction of <e1> p27 </e1> ( KIP1 ) protein was much more gradual and sustained in UF - 1 cells .',\n",
       "  'PROTEIN',\n",
       "  'Western blot experiments showed that p21 ( WAF1/CIP1 ) protein levels increased and became detectable after 12 hours of 1,25(OH)2D3 treatment and induction of p27 ( KIP1 ) protein was much more gradual and sustained in UF - 1 cells .',\n",
       "  [['p27(KIP1)'], [24], 'PROTEIN']],\n",
       " ['Interestingly , the combination of 1, 25(OH)2D3 and RA markedly enhanced the levels of <e1> p27 </e1> ( KIP1 ) transcript and protein as compared with levels induced by 1, 25(OH)2D3 alone .',\n",
       "  'PROTEIN',\n",
       "  'Interestingly , the combination of 1, 25(OH)2D3 and RA markedly enhanced the levels of p27 ( KIP1 ) transcript and protein as compared with levels induced by 1, 25(OH)2D3 alone .',\n",
       "  [['p27(KIP1)'], [13], 'PROTEIN']],\n",
       " ['In addition , exogenous <e1> p27 </e1> ( KIP1 ) expression can enhance the level of CD11b antigen in myeloid leukemic cells .',\n",
       "  'PROTEIN',\n",
       "  'In addition , exogenous p27 ( KIP1 ) expression can enhance the level of CD11b antigen in myeloid leukemic cells .',\n",
       "  [['p27(KIP1)'], [4], 'PROTEIN']],\n",
       " ['In contrast , RA alone can induce G1 arrest of UF - 1 cells ; however , it did not result in an increase of <e1> p21 </e1> ( WAF1/CIP1 ) and p27 ( KIP1 ) transcript and protein expression in RA - resistant cells .',\n",
       "  'PROTEIN',\n",
       "  'In contrast , RA alone can induce G1 arrest of UF - 1 cells ; however , it did not result in an increase of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) transcript and protein expression in RA - resistant cells .',\n",
       "  [['p21(WAF1/CIP1)'], [25], 'PROTEIN']],\n",
       " ['In contrast , RA alone can induce G1 arrest of UF - 1 cells ; however , it did not result in an increase of p21 ( WAF1/CIP1 ) and <e1> p27 </e1> ( KIP1 ) transcript and protein expression in RA - resistant cells .',\n",
       "  'PROTEIN',\n",
       "  'In contrast , RA alone can induce G1 arrest of UF - 1 cells ; however , it did not result in an increase of p21 ( WAF1/CIP1 ) and p27 ( KIP1 ) transcript and protein expression in RA - resistant cells .',\n",
       "  [['p27(KIP1)'], [30], 'PROTEIN']],\n",
       " ['Treatment of <e1> human umbilical vein endothelial cell ( HUVEC </e1> ) monolayers for 6 hours with 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine ( BSO ) decreased GSH levels and increased the ratio of GSSG to GSH without cell toxicity .',\n",
       "  'CELL_LINE',\n",
       "  'Treatment of human umbilical vein endothelial cell ( HUVEC ) monolayers for 6 hours with 0.2 mmol/L diamide and 1 mmol/L buthionine sulfoximine ( BSO ) decreased GSH levels and increased the ratio of GSSG to GSH without cell toxicity .',\n",
       "  [['human',\n",
       "    'umbilical',\n",
       "    'vein',\n",
       "    'endothelial',\n",
       "    'cell',\n",
       "    '(HUVEC)',\n",
       "    'monolayer'],\n",
       "   [2, 3, 4, 5, 6, 7, 8],\n",
       "   'CELL_LINE']],\n",
       " ['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , CD3+ , CD8+ and CD68+ cells , and the presence of <e1> oestrogen ( ER ) and </e1> progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  'PROTEIN',\n",
       "  'Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , CD3+ , CD8+ and CD68+ cells , and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  [['oestrogen', '(ER)', 'and', 'progesterone', 'receptor'],\n",
       "   [49, 50, 51, 52, 53],\n",
       "   'PROTEIN']],\n",
       " ['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , CD3+ , CD8+ and CD68+ cells , and the presence of <e1> oestrogen ( </e1> ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  'PROTEIN',\n",
       "  'Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , CD3+ , CD8+ and CD68+ cells , and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  [['oestrogen', 'receptor'], [49, 50], 'PROTEIN']],\n",
       " ['This study therefore examined the effect of <e1> angiotensin ( ANG </e1> ) II on NF - kappaB activation in monocytic cells , a major cellular component of human atheroma , by electrophoretic mobility shift assay .',\n",
       "  'PROTEIN',\n",
       "  'This study therefore examined the effect of angiotensin ( ANG ) II on NF - kappaB activation in monocytic cells , a major cellular component of human atheroma , by electrophoretic mobility shift assay .',\n",
       "  [['angiotensin', '(ANG)', 'II'], [7, 8, 9], 'PROTEIN']],\n",
       " ['Induction of HL - 60 and U - 937 cell differentiation into <e1> monocytes </e1> /macrophages by IFN - gamma or PMA results in a dephosphorylation and consequent activation of 4E - BP1 .',\n",
       "  'CELL_TYPE',\n",
       "  'Induction of HL - 60 and U - 937 cell differentiation into monocytes /macrophages by IFN - gamma or PMA results in a dephosphorylation and consequent activation of 4E - BP1 .',\n",
       "  [['monocytes/macrophage'], [12], 'CELL_TYPE']],\n",
       " ['Dephosphorylation of 4E - BP1 was also observed when U - 937 cells were induced to differentiate into <e1> monocytes </e1> /macrophages following treatment with retinoic acid or DMSO .',\n",
       "  'CELL_TYPE',\n",
       "  'Dephosphorylation of 4E - BP1 was also observed when U - 937 cells were induced to differentiate into monocytes /macrophages following treatment with retinoic acid or DMSO .',\n",
       "  [['monocytes/macrophage'], [18], 'CELL_TYPE']],\n",
       " ['3. SMX - NHOH and SMX - NO were rapidly reduced back to the parent compound by cysteine ( CYS ) , GSH , human peripheral blood cells and plasma , suggesting that this is an important and <e1> ubiquitous bioinactivation </e1> mechanism .',\n",
       "  'PROTEIN',\n",
       "  '3. SMX - NHOH and SMX - NO were rapidly reduced back to the parent compound by cysteine ( CYS ) , GSH , human peripheral blood cells and plasma , suggesting that this is an important and ubiquitous bioinactivation mechanism .',\n",
       "  [['ubiquitous', 'protein'], [38, 39], 'PROTEIN']],\n",
       " ['In lymph nodes , expression of Bcl - 6 protein is restricted to <e1> germinal center ( GC ) B </e1> - cells and 10 % to 15 % of CD3/CD4+ intrafollicular T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'In lymph nodes , expression of Bcl - 6 protein is restricted to germinal center ( GC ) B - cells and 10 % to 15 % of CD3/CD4+ intrafollicular T cells .',\n",
       "  [['germinal', 'center', '(GC)', 'B', '-', 'cell'],\n",
       "   [13, 14, 15, 16, 17, 18],\n",
       "   'CELL_TYPE']],\n",
       " ['Double staining for <e1> Bcl - 6 </e1> /CD20 , Bcl - 6 /CD3 , and Bcl - 6 /CD57 was performed in selected cases .',\n",
       "  'PROTEIN',\n",
       "  'Double staining for Bcl - 6 /CD20 , Bcl - 6 /CD3 , and Bcl - 6 /CD57 was performed in selected cases .',\n",
       "  [['Bcl', '-', '6/CD20'], [3, 4, 5], 'PROTEIN']],\n",
       " ['Double staining for Bcl - 6 /CD20 , <e1> Bcl - 6 </e1> /CD3 , and Bcl - 6 /CD57 was performed in selected cases .',\n",
       "  'PROTEIN',\n",
       "  'Double staining for Bcl - 6 /CD20 , Bcl - 6 /CD3 , and Bcl - 6 /CD57 was performed in selected cases .',\n",
       "  [['Bcl', '-', '6/CD3'], [8, 9, 10], 'PROTEIN']],\n",
       " ['Double staining for Bcl - 6 /CD20 , Bcl - 6 /CD3 , and <e1> Bcl - 6 </e1> /CD57 was performed in selected cases .',\n",
       "  'PROTEIN',\n",
       "  'Double staining for Bcl - 6 /CD20 , Bcl - 6 /CD3 , and Bcl - 6 /CD57 was performed in selected cases .',\n",
       "  [['Bcl', '-', '6/CD57'], [14, 15, 16], 'PROTEIN']],\n",
       " ['RESULTS : In FH and HIV adenopathy , staining for Bcl - 6 revealed densely populated GCs with well - defined and regular GC borders , whereas <e1> Bcl - 6 + </e1> cells were rare in the interfollicular areas .',\n",
       "  'CELL_TYPE',\n",
       "  'RESULTS : In FH and HIV adenopathy , staining for Bcl - 6 revealed densely populated GCs with well - defined and regular GC borders , whereas Bcl - 6 + cells were rare in the interfollicular areas .',\n",
       "  [['Bcl', '-', '6+', 'cell'], [27, 28, 29, 30], 'CELL_TYPE']],\n",
       " ['In FL , follicles were densely populated , and their borders were irregular , with some <e1> Bcl - 6 + </e1> cells in the interfollicular zones .',\n",
       "  'CELL_TYPE',\n",
       "  'In FL , follicles were densely populated , and their borders were irregular , with some Bcl - 6 + cells in the interfollicular zones .',\n",
       "  [['Bcl', '-', '6+', 'cell'], [16, 17, 18, 19], 'CELL_TYPE']],\n",
       " ['In AITL /GC , GCs were less dense , GC borders were ill defined and irregular , and the number of <e1> interfollicular Bcl - 6 + </e1> cells was markedly increased .',\n",
       "  'CELL_TYPE',\n",
       "  'In AITL /GC , GCs were less dense , GC borders were ill defined and irregular , and the number of interfollicular Bcl - 6 + cells was markedly increased .',\n",
       "  [['interfollicular', 'Bcl', '-', '6+', 'cell'],\n",
       "   [21, 22, 23, 24, 25],\n",
       "   'CELL_TYPE']],\n",
       " ['Double staining revealed that these <e1> interfollicular Bcl - 6 + </e1> cells in AITL /GC were Bcl6+/CD3+/CD20 - /CD57 - T cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Double staining revealed that these interfollicular Bcl - 6 + cells in AITL /GC were Bcl6+/CD3+/CD20 - /CD57 - T cells .',\n",
       "  [['interfollicular', 'Bcl', '-', '6+', 'cell'],\n",
       "   [5, 6, 7, 8, 9],\n",
       "   'CELL_TYPE']],\n",
       " ['( 2 ) Intrafollicular CD3+ T cells , many of which were also positive for Bcl - 6 , were markedly depleted in AITL /GC , with increased interfollicular <e1> Bcl - 6 +/CD3+ </e1> cells , suggesting an outward migration of intrafollicular T cells in this condition .',\n",
       "  'CELL_TYPE',\n",
       "  '( 2 ) Intrafollicular CD3+ T cells , many of which were also positive for Bcl - 6 , were markedly depleted in AITL /GC , with increased interfollicular Bcl - 6 +/CD3+ cells , suggesting an outward migration of intrafollicular T cells in this condition .',\n",
       "  [['Bcl', '-', '6+/CD3+', 'cell'], [29, 30, 31, 32], 'CELL_TYPE']],\n",
       " ['( 3 ) <e1> Interfollicular Bcl - 6 +/CD3+ </e1> cells in AITL/GC were too numerous to be accounted for by migration alone , suggesting local proliferation .',\n",
       "  'CELL_TYPE',\n",
       "  '( 3 ) Interfollicular Bcl - 6 +/CD3+ cells in AITL/GC were too numerous to be accounted for by migration alone , suggesting local proliferation .',\n",
       "  [['interfollicular', 'Bcl', '-', '6+/CD3+', 'cell'],\n",
       "   [3, 4, 5, 6, 7],\n",
       "   'CELL_TYPE']],\n",
       " ['<e1> Glycoprotein ( GP </e1> ) IX is a subunit of the von Willebrand receptor , GPIb - V - IX , which mediates adhesion of platelets to the subendothelium of damaged blood vessels .',\n",
       "  'PROTEIN',\n",
       "  'Glycoprotein ( GP ) IX is a subunit of the von Willebrand receptor , GPIb - V - IX , which mediates adhesion of platelets to the subendothelium of damaged blood vessels .',\n",
       "  [['glycoprotein', '(GP)', 'IX'], [0, 1, 2], 'PROTEIN']],\n",
       " ['In this study , transient cotransfection of several <e1> GPIX promoter /reporter </e1> constructs into 293T kidney fibroblasts with a Fli - 1 expression vector shows that the oncogenic protein Fli - 1 can transactivate the GPIX promoter when an intact GPIX Ets site is present .',\n",
       "  'DNA',\n",
       "  'In this study , transient cotransfection of several GPIX promoter /reporter constructs into 293T kidney fibroblasts with a Fli - 1 expression vector shows that the oncogenic protein Fli - 1 can transactivate the GPIX promoter when an intact GPIX Ets site is present .',\n",
       "  [['GPIX', 'promoter/reporter', 'construct'], [8, 9, 10], 'DNA']],\n",
       " ['Comparative studies showed that Fli - 1 was also able to transactivate the <e1> GPIbalpha and </e1> , to a lesser extent , the GPIIb promoter .',\n",
       "  'DNA',\n",
       "  'Comparative studies showed that Fli - 1 was also able to transactivate the GPIbalpha and , to a lesser extent , the GPIIb promoter .',\n",
       "  [['GPIbalpha', 'promotor'], [13, 14], 'DNA']],\n",
       " ['According to current models the inhibitory capacity of <e1> I </e1> ( kappa ) B ( alpha ) would be mediated through the retention of Rel/NF - kappaB proteins in the cytosol .',\n",
       "  'PROTEIN',\n",
       "  'According to current models the inhibitory capacity of I ( kappa ) B ( alpha ) would be mediated through the retention of Rel/NF - kappaB proteins in the cytosol .',\n",
       "  [['I(kappa)B(alpha)'], [8], 'PROTEIN']],\n",
       " ['However , <e1> I </e1> ( kappa ) B ( alpha ) has also been detected in the nucleus of cell lines and when overexpressed by transient transfection .',\n",
       "  'PROTEIN',\n",
       "  'However , I ( kappa ) B ( alpha ) has also been detected in the nucleus of cell lines and when overexpressed by transient transfection .',\n",
       "  [['I(kappa)B(alpha)'], [2], 'PROTEIN']],\n",
       " ['To gain better insight into the potential role of <e1> nuclear I </e1> ( kappa ) B ( alpha ) in a physiological context we have analysed its presence in the nucleus of human peripheral blood T lymphocytes ( PBL ) .',\n",
       "  'PROTEIN',\n",
       "  'To gain better insight into the potential role of nuclear I ( kappa ) B ( alpha ) in a physiological context we have analysed its presence in the nucleus of human peripheral blood T lymphocytes ( PBL ) .',\n",
       "  [['nuclear', 'I(kappa)B(alpha)'], [9, 10], 'PROTEIN']],\n",
       " ['To gain better insight into the potential role of nuclear <e1> I </e1> ( kappa ) B ( alpha ) in a physiological context we have analysed its presence in the nucleus of human peripheral blood T lymphocytes ( PBL ) .',\n",
       "  'PROTEIN',\n",
       "  'To gain better insight into the potential role of nuclear I ( kappa ) B ( alpha ) in a physiological context we have analysed its presence in the nucleus of human peripheral blood T lymphocytes ( PBL ) .',\n",
       "  [['I(kappa)B(alpha)'], [10], 'PROTEIN']],\n",
       " ['We demonstrate the nuclear localization of <e1> I </e1> ( kappa ) B ( alpha ) in PBL by different techniques : Western blot , indirect immunofluorescence and electron microscopy .',\n",
       "  'PROTEIN',\n",
       "  'We demonstrate the nuclear localization of I ( kappa ) B ( alpha ) in PBL by different techniques : Western blot , indirect immunofluorescence and electron microscopy .',\n",
       "  [['I(kappa)B(alpha)'], [6], 'PROTEIN']],\n",
       " ['Low levels of nuclear <e1> I </e1> ( kappa ) B ( alpha ) were detected in resting cells whereas a superinduction was obtained after PMA activation .',\n",
       "  'PROTEIN',\n",
       "  'Low levels of nuclear I ( kappa ) B ( alpha ) were detected in resting cells whereas a superinduction was obtained after PMA activation .',\n",
       "  [['I(kappa)B(alpha)'], [4], 'PROTEIN']],\n",
       " ['The nuclear pool of <e1> I </e1> ( kappa ) B ( alpha ) showed a higher stability than cytosolic I ( kappa ) B ( alpha ) and was partially independent of the resynthesis of the protein .',\n",
       "  'PROTEIN',\n",
       "  'The nuclear pool of I ( kappa ) B ( alpha ) showed a higher stability than cytosolic I ( kappa ) B ( alpha ) and was partially independent of the resynthesis of the protein .',\n",
       "  [['I(kappa)B(alpha)'], [4], 'PROTEIN']],\n",
       " ['The nuclear pool of I ( kappa ) B ( alpha ) showed a higher stability than cytosolic <e1> I </e1> ( kappa ) B ( alpha ) and was partially independent of the resynthesis of the protein .',\n",
       "  'PROTEIN',\n",
       "  'The nuclear pool of I ( kappa ) B ( alpha ) showed a higher stability than cytosolic I ( kappa ) B ( alpha ) and was partially independent of the resynthesis of the protein .',\n",
       "  [['I(kappa)B(alpha)'], [18], 'PROTEIN']],\n",
       " ['Unexpectedly , the presence of <e1> nuclear I </e1> ( kappa ) B ( alpha ) did not inhibit NF - kappaB binding to DNA and this phenomenon was not due to the presence of IkappaBbeta at the nuclear level .',\n",
       "  'PROTEIN',\n",
       "  'Unexpectedly , the presence of nuclear I ( kappa ) B ( alpha ) did not inhibit NF - kappaB binding to DNA and this phenomenon was not due to the presence of IkappaBbeta at the nuclear level .',\n",
       "  [['nuclear', 'I(kappa)B(alpha)'], [5, 6], 'PROTEIN']],\n",
       " ['Unexpectedly , the presence of nuclear <e1> I </e1> ( kappa ) B ( alpha ) did not inhibit NF - kappaB binding to DNA and this phenomenon was not due to the presence of IkappaBbeta at the nuclear level .',\n",
       "  'PROTEIN',\n",
       "  'Unexpectedly , the presence of nuclear I ( kappa ) B ( alpha ) did not inhibit NF - kappaB binding to DNA and this phenomenon was not due to the presence of IkappaBbeta at the nuclear level .',\n",
       "  [['I(kappa)B(alpha)'], [6], 'PROTEIN']],\n",
       " ['Immunoprecipitation experiments failed to demonstrate an association between nuclear <e1> I </e1> ( kappa ) B ( alpha ) and NF - kappaB proteins .',\n",
       "  'PROTEIN',\n",
       "  'Immunoprecipitation experiments failed to demonstrate an association between nuclear I ( kappa ) B ( alpha ) and NF - kappaB proteins .',\n",
       "  [['I(kappa)B(alpha)'], [9], 'PROTEIN']],\n",
       " ['Our results demonstrate that in resting and PMA - activated human PBL , <e1> I </e1> ( kappa ) B ( alpha ) is present in the nucleus in an apparently inactive form unable to disrupt NF - kappaB binding from DNA .',\n",
       "  'PROTEIN',\n",
       "  'Our results demonstrate that in resting and PMA - activated human PBL , I ( kappa ) B ( alpha ) is present in the nucleus in an apparently inactive form unable to disrupt NF - kappaB binding from DNA .',\n",
       "  [['I(kappa)B(alpha)'], [13], 'PROTEIN']],\n",
       " ['The main aims of this work were to examine in women : the relationship between the freely exchangeable Ca2+ ( FECa2+ ) in the dense tubules and the activity of the <e1> sarco ( endo ) plasmic reticulum ( </e1> SER ) Ca2+ - ATPase ( SERCA ) in platelets , and the relationship of these parameters with blood pressure and serum lipoproteins .',\n",
       "  'PROTEIN',\n",
       "  'The main aims of this work were to examine in women : the relationship between the freely exchangeable Ca2+ ( FECa2+ ) in the dense tubules and the activity of the sarco ( endo ) plasmic reticulum ( SER ) Ca2+ - ATPase ( SERCA ) in platelets , and the relationship of these parameters with blood pressure and serum lipoproteins .',\n",
       "  [['sarco(endo)plasmic',\n",
       "    'reticulum',\n",
       "    '(SER)',\n",
       "    'Ca2+',\n",
       "    '-',\n",
       "    'ATPase',\n",
       "    '(SERCA)'],\n",
       "   [31, 32, 33, 34, 35, 36, 37],\n",
       "   'PROTEIN']],\n",
       " ['Relative expressions of SERCA 2 and 3 isoforms and <e1> Ras - related protein ( Rap </e1> ) 1 in platelet membranes were determined by Western immunoblots .',\n",
       "  'PROTEIN',\n",
       "  'Relative expressions of SERCA 2 and 3 isoforms and Ras - related protein ( Rap ) 1 in platelet membranes were determined by Western immunoblots .',\n",
       "  [['Ras', '-', 'related', 'protein', '(Rap)', '1'],\n",
       "   [9, 10, 11, 12, 13, 14],\n",
       "   'PROTEIN']],\n",
       " ['In response to hypoxia , sickle red blood cells ( SS RBC ) and <e1> leukocytes </e1> exhibit increased adherence to the vascular endothelium , while diapedesis of leukocytes through the blood vessel increases .',\n",
       "  'CELL_TYPE',\n",
       "  'In response to hypoxia , sickle red blood cells ( SS RBC ) and leukocytes exhibit increased adherence to the vascular endothelium , while diapedesis of leukocytes through the blood vessel increases .',\n",
       "  [['leukocyte\\\\'], [14], 'CELL_TYPE']],\n",
       " ['In response to hypoxia , sickle red blood cells ( SS RBC ) and leukocytes exhibit increased adherence to the vascular endothelium , while diapedesis of <e1> leukocytes </e1> through the blood vessel increases .',\n",
       "  'CELL_TYPE',\n",
       "  'In response to hypoxia , sickle red blood cells ( SS RBC ) and leukocytes exhibit increased adherence to the vascular endothelium , while diapedesis of leukocytes through the blood vessel increases .',\n",
       "  [['leukocyte\\\\'], [26], 'CELL_TYPE']],\n",
       " ['Furthermore , CoCl2 also caused time - dependent tyrosine phosphorylation of <e1> mitogen - activated protein ( MAP </e1> ) kinase isoform ERK2 without significantly affecting ERK1 , indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway .',\n",
       "  'PROTEIN',\n",
       "  'Furthermore , CoCl2 also caused time - dependent tyrosine phosphorylation of mitogen - activated protein ( MAP ) kinase isoform ERK2 without significantly affecting ERK1 , indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway .',\n",
       "  [['mitogen', '-', 'activated', 'protein', '(MAP)', 'kinase'],\n",
       "   [11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['In transient cotransfection experiments , dominant negative mutants of the IL - 1 signaling pathway , including MyD88 , IRAK , IRAK2 , and TRAF6 inhibited both IL - 1 - and LPS - induced NF - kappaB <e1> - </e1> luciferase activity .',\n",
       "  'PROTEIN',\n",
       "  'In transient cotransfection experiments , dominant negative mutants of the IL - 1 signaling pathway , including MyD88 , IRAK , IRAK2 , and TRAF6 inhibited both IL - 1 - and LPS - induced NF - kappaB - luciferase activity .',\n",
       "  [['luciferase'], [38], 'PROTEIN']],\n",
       " ['The multiple biologic activities of retinoic acid ( RA ) are mediated through RAR and <e1> retinoid X receptor ( RXR ) </e1> nuclear receptors that interact with specific DNA target sequences as heterodimers ( RXR - RAR ) or homodimers ( RXR - RXR ) .',\n",
       "  'PROTEIN',\n",
       "  'The multiple biologic activities of retinoic acid ( RA ) are mediated through RAR and retinoid X receptor ( RXR ) nuclear receptors that interact with specific DNA target sequences as heterodimers ( RXR - RAR ) or homodimers ( RXR - RXR ) .',\n",
       "  [['retinoid', 'X', 'receptor', '(RXR)', 'nuclear', 'receptor'],\n",
       "   [15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['This RXR agonist activity is blocked by RAR - specific antagonists , suggesting extensive cross - talk between the partners of the RXR <e1> - </e1> RARalpha403 heterodimer .',\n",
       "  'PROTEIN',\n",
       "  'This RXR agonist activity is blocked by RAR - specific antagonists , suggesting extensive cross - talk between the partners of the RXR - RARalpha403 heterodimer .',\n",
       "  [['RARalpha403'], [23], 'PROTEIN']],\n",
       " ['However , the <e1> histone deacetylase ( HDAC </e1> ) inhibitor trichostatin A readily activates an RXR - RAR reporter construct in the multipotent EML cells but not in the committed MPRO promyelocytes , indicating that differences in HDAC - containing repressor complexes in these two closely related but distinct hematopoietic lineages might account for the differential activation of the RXR - RARalpha403 heterodimers that we observed at these different stages of myeloid development .',\n",
       "  'PROTEIN',\n",
       "  'However , the histone deacetylase ( HDAC ) inhibitor trichostatin A readily activates an RXR - RAR reporter construct in the multipotent EML cells but not in the committed MPRO promyelocytes , indicating that differences in HDAC - containing repressor complexes in these two closely related but distinct hematopoietic lineages might account for the differential activation of the RXR - RARalpha403 heterodimers that we observed at these different stages of myeloid development .',\n",
       "  [['histone', 'deacetylase', '(HDAC)', 'inhibitor'],\n",
       "   [3, 4, 5, 6],\n",
       "   'PROTEIN']],\n",
       " ['In this report we show that the functional synergy between IL - 12 and IL - 2 in CD8+CD18bright T cells correlates with the activation of the stress kinases , <e1> p38 mitogen - activated protein ( MAP </e1> ) kinase and stress - activated protein kinase ( SAPK ) /Jun N - terminal kinase , but not with the activation of the extracellular signal - regulated kinases .',\n",
       "  'PROTEIN',\n",
       "  'In this report we show that the functional synergy between IL - 12 and IL - 2 in CD8+CD18bright T cells correlates with the activation of the stress kinases , p38 mitogen - activated protein ( MAP ) kinase and stress - activated protein kinase ( SAPK ) /Jun N - terminal kinase , but not with the activation of the extracellular signal - regulated kinases .',\n",
       "  [['p38', 'mitogen', '-', 'activated', 'protein', '(MAP)', 'kinase'],\n",
       "   [30, 31, 32, 33, 34, 35, 36],\n",
       "   'PROTEIN']],\n",
       " ['In this report we show that the functional synergy between IL - 12 and IL - 2 in CD8+CD18bright T cells correlates with the activation of the stress kinases , p38 mitogen - activated protein ( MAP ) kinase and <e1> stress - activated protein kinase ( SAPK ) /Jun N </e1> - terminal kinase , but not with the activation of the extracellular signal - regulated kinases .',\n",
       "  'PROTEIN',\n",
       "  'In this report we show that the functional synergy between IL - 12 and IL - 2 in CD8+CD18bright T cells correlates with the activation of the stress kinases , p38 mitogen - activated protein ( MAP ) kinase and stress - activated protein kinase ( SAPK ) /Jun N - terminal kinase , but not with the activation of the extracellular signal - regulated kinases .',\n",
       "  [['stress',\n",
       "    '-',\n",
       "    'activated',\n",
       "    'protein',\n",
       "    'kinase',\n",
       "    '(SAPK)/Jun',\n",
       "    'N',\n",
       "    '-',\n",
       "    'terminal',\n",
       "    'kinase'],\n",
       "   [40, 41, 42, 43, 44, 45, 46, 47, 48, 49],\n",
       "   'PROTEIN']],\n",
       " ['We investigated expression of the IL - 2Ralpha in <e1> bronchoalveolar lavage ( BAL </e1> ) cells in active pulmonary tuberculosis , and evaluated the mechanism Mycobacterium tuberculosis induces in the IL - 2Ralpha using the THP - 1 mononuclear phagocyte cell line .',\n",
       "  'CELL_TYPE',\n",
       "  'We investigated expression of the IL - 2Ralpha in bronchoalveolar lavage ( BAL ) cells in active pulmonary tuberculosis , and evaluated the mechanism Mycobacterium tuberculosis induces in the IL - 2Ralpha using the THP - 1 mononuclear phagocyte cell line .',\n",
       "  [['bronchoalveolar', 'lavage', '(BAL)', 'cell'],\n",
       "   [9, 10, 11, 12],\n",
       "   'CELL_TYPE']],\n",
       " ['The IL - 2Ralpha promoter containing the <e1> nuclear factor kappa B ( NF - kappaB </e1> ) site was transcriptionally induced by M. tuberculosis and this NF - kappaB site could confer inducibility to a heterologous herpes thymidine kinase ( TK ) promoter by M. tuberculosis .',\n",
       "  'DNA',\n",
       "  'The IL - 2Ralpha promoter containing the nuclear factor kappa B ( NF - kappaB ) site was transcriptionally induced by M. tuberculosis and this NF - kappaB site could confer inducibility to a heterologous herpes thymidine kinase ( TK ) promoter by M. tuberculosis .',\n",
       "  [['nuclear', 'factor', 'kappa', 'B', '(NF', '-', 'kappaB)', 'site'],\n",
       "   [7, 8, 9, 10, 11, 12, 13, 14],\n",
       "   'DNA']],\n",
       " ['The IL - 2Ralpha promoter containing the nuclear factor kappa B ( NF - kappaB ) site was transcriptionally induced by M. tuberculosis and this NF - kappaB site could confer inducibility to a <e1> heterologous herpes thymidine kinase ( TK </e1> ) promoter by M. tuberculosis .',\n",
       "  'DNA',\n",
       "  'The IL - 2Ralpha promoter containing the nuclear factor kappa B ( NF - kappaB ) site was transcriptionally induced by M. tuberculosis and this NF - kappaB site could confer inducibility to a heterologous herpes thymidine kinase ( TK ) promoter by M. tuberculosis .',\n",
       "  [['heterologous', 'herpes', 'thymidine', 'kinase', '(TK)', 'promoter'],\n",
       "   [34, 35, 36, 37, 38, 39],\n",
       "   'DNA']],\n",
       " ['Allelic variation at the 3 - end of the <e1> vitamin D receptor ( VDR </e1> ) gene has been associated with a 3 - 5 - fold increased risk of developing prostate cancer and with differences in bone mineralization .',\n",
       "  'DNA',\n",
       "  'Allelic variation at the 3 - end of the vitamin D receptor ( VDR ) gene has been associated with a 3 - 5 - fold increased risk of developing prostate cancer and with differences in bone mineralization .',\n",
       "  [['vitamin', 'D', 'receptor', '(VDR)', 'gene'], [9, 10, 11, 12, 13], 'DNA']],\n",
       " ['Similarly , IL - 2 neither activates JNK nor increases AP - 1 binding activity to a consensus <e1> o - tetradecanoylphorbol 13 - acetate ( TPA ) </e1> response element .',\n",
       "  'DNA',\n",
       "  'Similarly , IL - 2 neither activates JNK nor increases AP - 1 binding activity to a consensus o - tetradecanoylphorbol 13 - acetate ( TPA ) response element .',\n",
       "  [['o',\n",
       "    '-',\n",
       "    'tetradecanoylphorbol',\n",
       "    '13',\n",
       "    '-',\n",
       "    'acetate',\n",
       "    '(TPA)',\n",
       "    'response',\n",
       "    'element'],\n",
       "   [18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['We conclude from these studies that the phosphorylation of TRAF2 is likely to play an important role in regulating signaling by virtue of its ability to influence the CD40 <e1> - </e1> TRAF2 interaction .',\n",
       "  'PROTEIN',\n",
       "  'We conclude from these studies that the phosphorylation of TRAF2 is likely to play an important role in regulating signaling by virtue of its ability to influence the CD40 - TRAF2 interaction .',\n",
       "  [['TRAF2'], [29], 'PROTEIN']],\n",
       " ['Engagement of the <e1> T - cell receptor ( TCR ) - </e1> CD3 complex induces a rapid increase in the activities of Src - family and Syk/Zap - 70 - family kinases [ 1 ] [ 2 ] .',\n",
       "  'PROTEIN',\n",
       "  'Engagement of the T - cell receptor ( TCR ) - CD3 complex induces a rapid increase in the activities of Src - family and Syk/Zap - 70 - family kinases [ 1 ] [ 2 ] .',\n",
       "  [['T', '-', 'cell', 'receptor', '(TCR)', '-', 'CD3', 'complex'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ['Overexpression of wild - type Grf40 in Jurkat cells induced a significant increase of <e1> SLP - 76 - dependent interleukin ( IL ) - </e1> 2 promoter and nuclear factor of activated T cell ( NF - AT ) activation upon T cell receptor ( TCR ) stimulation , whereas the COOH - terminal SH3 - deleted Grf40 mutant lacked any recognizable increase in IL - 2 promoter activity .',\n",
       "  'DNA',\n",
       "  'Overexpression of wild - type Grf40 in Jurkat cells induced a significant increase of SLP - 76 - dependent interleukin ( IL ) - 2 promoter and nuclear factor of activated T cell ( NF - AT ) activation upon T cell receptor ( TCR ) stimulation , whereas the COOH - terminal SH3 - deleted Grf40 mutant lacked any recognizable increase in IL - 2 promoter activity .',\n",
       "  [['SLP',\n",
       "    '-',\n",
       "    '76',\n",
       "    '-',\n",
       "    'dependent',\n",
       "    'interleukin',\n",
       "    '(IL)',\n",
       "    '-',\n",
       "    '2',\n",
       "    'promoter'],\n",
       "   [14, 15, 16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'DNA']],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of <e1> TNF receptors 1 </e1> and 2 ; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  'PROTEIN',\n",
       "  'Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['tnf', 'receptor', '1'], [15, 16, 17], 'PROTEIN']],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> PKC isoforms alpha </e1> , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  'PROTEIN',\n",
       "  'Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['pkc', 'isoform', 'alpha'], [21, 22, 23], 'PROTEIN']],\n",
       " ['In particular , PU.1 induces expression of the <e1> macrophage colony - stimulating factor ( M - CSF </e1> ) receptor and the development of monocytes , whereas C/EBPalpha increases the expression of the granulocyte colony - stimulating factor ( G - CSF ) receptor and leads to mature granulocytes .',\n",
       "  'PROTEIN',\n",
       "  'In particular , PU.1 induces expression of the macrophage colony - stimulating factor ( M - CSF ) receptor and the development of monocytes , whereas C/EBPalpha increases the expression of the granulocyte colony - stimulating factor ( G - CSF ) receptor and leads to mature granulocytes .',\n",
       "  [['macrophage',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(M',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'receptor'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['In particular , PU.1 induces expression of the macrophage colony - stimulating factor ( M - CSF ) receptor and the development of monocytes , whereas C/EBPalpha increases the expression of the <e1> granulocyte colony - stimulating factor ( G - CSF </e1> ) receptor and leads to mature granulocytes .',\n",
       "  'PROTEIN',\n",
       "  'In particular , PU.1 induces expression of the macrophage colony - stimulating factor ( M - CSF ) receptor and the development of monocytes , whereas C/EBPalpha increases the expression of the granulocyte colony - stimulating factor ( G - CSF ) receptor and leads to mature granulocytes .',\n",
       "  [['granulocyte',\n",
       "    'colony',\n",
       "    '-',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(G',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'receptor'],\n",
       "   [32, 33, 34, 35, 36, 37, 38, 39, 40],\n",
       "   'PROTEIN']],\n",
       " ['On the other hand , the PML/RARalpha fusion protein causes transcriptional repression by recruiting the <e1> nuclear corepressor ( N - CoR ) histone </e1> deacetylase complex to the DNA , which results in decreased histone acetylation and a repressive chromatin organization .',\n",
       "  'PROTEIN',\n",
       "  'On the other hand , the PML/RARalpha fusion protein causes transcriptional repression by recruiting the nuclear corepressor ( N - CoR ) histone deacetylase complex to the DNA , which results in decreased histone acetylation and a repressive chromatin organization .',\n",
       "  [['nuclear',\n",
       "    'corepressor',\n",
       "    '(N',\n",
       "    '-',\n",
       "    'CoR)',\n",
       "    'histone',\n",
       "    'deacetylase',\n",
       "    'complex'],\n",
       "   [15, 16, 17, 18, 19, 20, 21, 22],\n",
       "   'PROTEIN']],\n",
       " ['The immunodominant , CD8(+) cytotoxic T lymphocyte ( CTL ) response to the HLA - B8 - restricted peptide , RAKFKQLL , located in the Epstein - Barr virus immediate - early antigen , BZLF1 , is characterized by a diverse <e1> T cell receptor ( TCR </e1> ) repertoire .',\n",
       "  'PROTEIN',\n",
       "  'The immunodominant , CD8(+) cytotoxic T lymphocyte ( CTL ) response to the HLA - B8 - restricted peptide , RAKFKQLL , located in the Epstein - Barr virus immediate - early antigen , BZLF1 , is characterized by a diverse T cell receptor ( TCR ) repertoire .',\n",
       "  [['T', 'cell', 'receptor', '(TCR)', 'repertoire'],\n",
       "   [41, 42, 43, 44, 45],\n",
       "   'PROTEIN']],\n",
       " ['Here , we show that this diversity can be partitioned on the basis of crossreactive cytotoxicity patterns involving the recognition of a self peptide - RSKFRQIV - located in a <e1> serine /threonine </e1> kinase and a bacterial peptide - RRKYKQII - located in Staphylococcus aureus replication initiation protein .',\n",
       "  'PROTEIN',\n",
       "  'Here , we show that this diversity can be partitioned on the basis of crossreactive cytotoxicity patterns involving the recognition of a self peptide - RSKFRQIV - located in a serine /threonine kinase and a bacterial peptide - RRKYKQII - located in Staphylococcus aureus replication initiation protein .',\n",
       "  [['serine/threonine', 'kinase'], [30, 31], 'PROTEIN']],\n",
       " ['RANTES ( <e1> Regulated upon Activation , Normal T cell Expressed and </e1> Secreted ) is a chemoattractant cytokine ( chemokine ) important in the generation of inflammatory infiltrate and human immunodeficiency virus entry into immune cells .',\n",
       "  'PROTEIN',\n",
       "  'RANTES ( Regulated upon Activation , Normal T cell Expressed and Secreted ) is a chemoattractant cytokine ( chemokine ) important in the generation of inflammatory infiltrate and human immunodeficiency virus entry into immune cells .',\n",
       "  [['Regulated',\n",
       "    'upon',\n",
       "    'Activation,',\n",
       "    'Normal',\n",
       "    'T',\n",
       "    'cell',\n",
       "    'Expressed',\n",
       "    'and',\n",
       "    'Secreted'],\n",
       "   [2, 3, 4, 5, 6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ['Here , we report that expression of FasL protein and <e1> mRNA in </e1> activated NK cells is also regulated by redox .',\n",
       "  'RNA',\n",
       "  'Here , we report that expression of FasL protein and mRNA in activated NK cells is also regulated by redox .',\n",
       "  [['FasL', 'mRNA'], [10, 11], 'RNA']],\n",
       " ['We evaluated 49 female patients with MPD and informative at the <e1> X - linked androgen receptor ( AR </e1> ) locus to establish the X chromosome inactivation pattern of hemopoietic cells .',\n",
       "  'DNA',\n",
       "  'We evaluated 49 female patients with MPD and informative at the X - linked androgen receptor ( AR ) locus to establish the X chromosome inactivation pattern of hemopoietic cells .',\n",
       "  [['X', '-', 'linked', 'androgen', 'receptor', '(AR)', 'locus'],\n",
       "   [11, 12, 13, 14, 15, 16, 17],\n",
       "   'DNA']],\n",
       " ['<e1> Class II major histocompatibility ( class II </e1> ) genes are regulated in a B - cell - specific and gamma interferon - inducible fashion .',\n",
       "  'DNA',\n",
       "  'Class II major histocompatibility ( class II ) genes are regulated in a B - cell - specific and gamma interferon - inducible fashion .',\n",
       "  [['class', 'II', 'major', 'histocompatibility', '(class', 'II)', 'gene'],\n",
       "   [0, 1, 2, 3, 4, 5, 6],\n",
       "   'DNA']],\n",
       " ['Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF - kappaB - mediated transcription and transcription mediated by a chimeric protein , <e1> GAL4 - p65 ( 286 </e1> - 551 ) , which contained the GAL4 DNA binding domain fused to the carboxyl - terminal region of p65 ( amino acids 286 - 551 ) .',\n",
       "  'PROTEIN',\n",
       "  'Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF - kappaB - mediated transcription and transcription mediated by a chimeric protein , GAL4 - p65 ( 286 - 551 ) , which contained the GAL4 DNA binding domain fused to the carboxyl - terminal region of p65 ( amino acids 286 - 551 ) .',\n",
       "  [['GAL4', '-', 'p65(286', '-', '551)'], [29, 30, 31, 32, 33], 'PROTEIN']],\n",
       " ['Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF - kappaB - mediated transcription and transcription mediated by a chimeric protein , GAL4 - p65 ( 286 - 551 ) , which contained the GAL4 DNA binding domain fused to the carboxyl - terminal region of p65 ( <e1> amino acids 286 - 551 </e1> ) .',\n",
       "  'PROTEIN',\n",
       "  'Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF - kappaB - mediated transcription and transcription mediated by a chimeric protein , GAL4 - p65 ( 286 - 551 ) , which contained the GAL4 DNA binding domain fused to the carboxyl - terminal region of p65 ( amino acids 286 - 551 ) .',\n",
       "  [['amino', 'acid', '286', '-', '551'], [55, 56, 57, 58, 59], 'PROTEIN']],\n",
       " ['Transcription of the germ - line IgH genes is controlled by <e1> intervening ( I </e1> ) regions upstream of their switch regions .',\n",
       "  'DNA',\n",
       "  'Transcription of the germ - line IgH genes is controlled by intervening ( I ) regions upstream of their switch regions .',\n",
       "  [['intervening', '(I)', 'region'], [11, 12, 13], 'DNA']],\n",
       " ['The I alpha1 promoter activates transcription of the human germ - line C alpha1 gene for IgA1 and mediates the <e1> transforming growth factor ( TGF ) </e1> - beta1 responsiveness of this locus .',\n",
       "  'PROTEIN',\n",
       "  'The I alpha1 promoter activates transcription of the human germ - line C alpha1 gene for IgA1 and mediates the transforming growth factor ( TGF ) - beta1 responsiveness of this locus .',\n",
       "  [['transforming', 'growth', 'factor', '(TGF)', '-', 'beta1'],\n",
       "   [20, 21, 22, 23, 24, 25],\n",
       "   'PROTEIN']],\n",
       " ['Here we show that the I alpha1 promoter contains several binding sites for the <e1> AML /PEBP2/CBF family of transcription </e1> factors and that AML and Ets proteins are major regulators of the basal and TGF - beta - inducible promoter activity .',\n",
       "  'PROTEIN',\n",
       "  'Here we show that the I alpha1 promoter contains several binding sites for the AML /PEBP2/CBF family of transcription factors and that AML and Ets proteins are major regulators of the basal and TGF - beta - inducible promoter activity .',\n",
       "  [['AML/PEBP2/CBF', 'family', 'of', 'transcription', 'factor'],\n",
       "   [14, 15, 16, 17, 18],\n",
       "   'PROTEIN']],\n",
       " ['We previously identified a Fas ligand regulatory element ( FLRE ) in the <e1> Fas ligand ( fasL </e1> ) promoter that binds Egr family proteins and demonstrated that Egr - 3 ( PILOT ) but not Egr - 1 ( NGFI - A , Krox - 24 , Tis - 8 , and Zif - 268 ) induces transcription of fasL .',\n",
       "  'DNA',\n",
       "  'We previously identified a Fas ligand regulatory element ( FLRE ) in the Fas ligand ( fasL ) promoter that binds Egr family proteins and demonstrated that Egr - 3 ( PILOT ) but not Egr - 1 ( NGFI - A , Krox - 24 , Tis - 8 , and Zif - 268 ) induces transcription of fasL .',\n",
       "  [['Fas', 'ligand', '(fasL)', 'promoter'], [13, 14, 15, 16], 'DNA']],\n",
       " ['The <e1> aberrant CD4( - ) CD8( - ) T </e1> cells from lpr/lpr and gld/gld mice , which have mutations in the genes encoding Fas and FasL , respectively , have an activated phenotype and constitutively express high levels of fasL mRNA , prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL .',\n",
       "  'CELL_TYPE',\n",
       "  'The aberrant CD4( - ) CD8( - ) T cells from lpr/lpr and gld/gld mice , which have mutations in the genes encoding Fas and FasL , respectively , have an activated phenotype and constitutively express high levels of fasL mRNA , prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL .',\n",
       "  [['aberrant', 'CD4(', '-', ')CD8(', '-', ')', 'T', 'cell'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'CELL_TYPE']],\n",
       " ['We show here that in circulating monocytes , NF - Y binding activity is not detected on the CCAAT motif present in the <e1> promoters of genes </e1> such as major histocompatibility complex ( MHC ) class II , gp91 - phox , mig , and fibronectin , whereas during macrophage differentiation , a progressive increase in NF - Y binding activity is observed on these promoters .',\n",
       "  'DNA',\n",
       "  'We show here that in circulating monocytes , NF - Y binding activity is not detected on the CCAAT motif present in the promoters of genes such as major histocompatibility complex ( MHC ) class II , gp91 - phox , mig , and fibronectin , whereas during macrophage differentiation , a progressive increase in NF - Y binding activity is observed on these promoters .',\n",
       "  [['promoter', 'of', 'gene'], [23, 24, 25], 'DNA']],\n",
       " ['We show here that in circulating monocytes , NF - Y binding activity is not detected on the CCAAT motif present in the promoters of genes such as <e1> major histocompatibility complex ( MHC ) </e1> class II , gp91 - phox , mig , and fibronectin , whereas during macrophage differentiation , a progressive increase in NF - Y binding activity is observed on these promoters .',\n",
       "  'DNA',\n",
       "  'We show here that in circulating monocytes , NF - Y binding activity is not detected on the CCAAT motif present in the promoters of genes such as major histocompatibility complex ( MHC ) class II , gp91 - phox , mig , and fibronectin , whereas during macrophage differentiation , a progressive increase in NF - Y binding activity is observed on these promoters .',\n",
       "  [['major', 'histocompatibility', 'complex', '(MHC)', 'class', 'II'],\n",
       "   [28, 29, 30, 31, 32, 33],\n",
       "   'DNA']],\n",
       " ['Paradoxically , removal of interdomain B ( to create the construct designated Delta ) , containing the Y292 , Y315 , and Y319 sites , did not eliminate the ability of ZAP - 70 to induce multiple gene reporters in Syk - deficient DT - 40 B cells and <e1> ZAP - 70 /Syk - deficient Jurkat </e1> cells .',\n",
       "  'CELL_LINE',\n",
       "  'Paradoxically , removal of interdomain B ( to create the construct designated Delta ) , containing the Y292 , Y315 , and Y319 sites , did not eliminate the ability of ZAP - 70 to induce multiple gene reporters in Syk - deficient DT - 40 B cells and ZAP - 70 /Syk - deficient Jurkat cells .',\n",
       "  [['ZAP', '-', '70/Syk', '-', 'deficient', 'Jurkat', 'cell'],\n",
       "   [49, 50, 51, 52, 53, 54, 55],\n",
       "   'CELL_LINE']],\n",
       " ['Cross - linking CD19 on early human B lineage cells induces the formation of a <e1> CD19 /Vav/phosphatidylinositol - 3 kinase </e1> complex , tyrosine phosphorylation of CD19 and Vav , and activation of the Ras pathway .',\n",
       "  'PROTEIN',\n",
       "  'Cross - linking CD19 on early human B lineage cells induces the formation of a CD19 /Vav/phosphatidylinositol - 3 kinase complex , tyrosine phosphorylation of CD19 and Vav , and activation of the Ras pathway .',\n",
       "  [['CD19/Vav/phosphatidylinositol', '-', '3', 'kinase', 'complex'],\n",
       "   [15, 16, 17, 18, 19],\n",
       "   'PROTEIN']],\n",
       " ['Although NF - kappaB/Rel factors are known to induce the expression of T - cell growth factor interleukin ( IL ) - 2 , it is unclear how they participate in the IL - 2 - independent growth of HTLV - I <e1> - transformed </e1> cells .',\n",
       "  'CELL_TYPE',\n",
       "  'Although NF - kappaB/Rel factors are known to induce the expression of T - cell growth factor interleukin ( IL ) - 2 , it is unclear how they participate in the IL - 2 - independent growth of HTLV - I - transformed cells .',\n",
       "  [['transformed', 'cell'], [42, 43], 'CELL_TYPE']],\n",
       " ['These results raise the possibility that NF - kappaB/Rel may participate in the growth control of HTLV - I - transformed T cells by regulating genes driven by both <e1> kappaB and </e1> certain STAT enhancers .',\n",
       "  'DNA',\n",
       "  'These results raise the possibility that NF - kappaB/Rel may participate in the growth control of HTLV - I - transformed T cells by regulating genes driven by both kappaB and certain STAT enhancers .',\n",
       "  [['kappaB', 'enhancer'], [29, 30], 'DNA']],\n",
       " ['Sequence analysis revealed the presence of a previously unrecognized composite binding site for both the Sp1 and NF - kappaB transcription factors at <e1> positions - 295 to - 286 </e1> .',\n",
       "  'DNA',\n",
       "  'Sequence analysis revealed the presence of a previously unrecognized composite binding site for both the Sp1 and NF - kappaB transcription factors at positions - 295 to - 286 .',\n",
       "  [['position', '-', '295', 'to', '-', '286'],\n",
       "   [23, 24, 25, 26, 27, 28],\n",
       "   'DNA']],\n",
       " ['Heterokaryons formed by the fusion of anergic murine T cells to normal murine T cells also failed to accumulate intracellular IL - 2 protein in response to stimulation either with the combination of <e1> CD3 and </e1> CD28 mAbs or with ionomycin plus a protein kinase C - activating phorbol ester .',\n",
       "  'PROTEIN',\n",
       "  'Heterokaryons formed by the fusion of anergic murine T cells to normal murine T cells also failed to accumulate intracellular IL - 2 protein in response to stimulation either with the combination of CD3 and CD28 mAbs or with ionomycin plus a protein kinase C - activating phorbol ester .',\n",
       "  [['CD3', 'mAb'], [33, 34], 'PROTEIN']],\n",
       " ['Members of the <e1> cyclic adenosine monophosphate ( cAMP ) response element binding ( CREB ) /activating transcription factor </e1> 1 ( ATF - 1 ) family of transcription factors bind three 21 - bp repeats ( Tax - responsive element - 1 , or TRE - 1 ) within the viral promoter and are important for basal and Tax - mediated transcription .',\n",
       "  'PROTEIN',\n",
       "  'Members of the cyclic adenosine monophosphate ( cAMP ) response element binding ( CREB ) /activating transcription factor 1 ( ATF - 1 ) family of transcription factors bind three 21 - bp repeats ( Tax - responsive element - 1 , or TRE - 1 ) within the viral promoter and are important for basal and Tax - mediated transcription .',\n",
       "  [['cyclic',\n",
       "    'adenosine',\n",
       "    'monophosphate',\n",
       "    '(cAMP)',\n",
       "    'response',\n",
       "    'element',\n",
       "    'binding',\n",
       "    '(CREB)/activating',\n",
       "    'transcription',\n",
       "    'factor',\n",
       "    '1',\n",
       "    '(ATF',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'family'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17],\n",
       "   'PROTEIN']],\n",
       " ['Members of the <e1> cyclic adenosine monophosphate ( cAMP ) </e1> response element binding ( CREB ) /activating transcription factor 1 ( ATF - 1 ) family of transcription factors bind three 21 - bp repeats ( Tax - responsive element - 1 , or TRE - 1 ) within the viral promoter and are important for basal and Tax - mediated transcription .',\n",
       "  'DNA',\n",
       "  'Members of the cyclic adenosine monophosphate ( cAMP ) response element binding ( CREB ) /activating transcription factor 1 ( ATF - 1 ) family of transcription factors bind three 21 - bp repeats ( Tax - responsive element - 1 , or TRE - 1 ) within the viral promoter and are important for basal and Tax - mediated transcription .',\n",
       "  [['cyclic', 'adenosine', 'monophosphate', '(cAMP)', 'response', 'element'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'DNA']],\n",
       " ['Oxidized low - density lipoproteins ( oxLDLs ) are considered to be involved in the pathogenesis of the lesions , and we have previously demonstrated that oxLDLs inhibit not only <e1> interleukin ( IL ) - 2 </e1> - receptor expression on the surface of in vitro - activated T - lymphocytes but also their proliferation .',\n",
       "  'PROTEIN',\n",
       "  'Oxidized low - density lipoproteins ( oxLDLs ) are considered to be involved in the pathogenesis of the lesions , and we have previously demonstrated that oxLDLs inhibit not only interleukin ( IL ) - 2 - receptor expression on the surface of in vitro - activated T - lymphocytes but also their proliferation .',\n",
       "  [['interleukin', '(IL)', '-', '2', '-', 'receptor'],\n",
       "   [30, 31, 32, 33, 34, 35],\n",
       "   'PROTEIN']],\n",
       " ['The study of NF - kappaB showed that oxLDLs led to a decrease of <e1> activation - induced p65/ </e1> p50 NF - kappaB heterodimer binding to DNA , whereas the presence of the constitutive nuclear form of p50 dimer was unchanged .',\n",
       "  'PROTEIN',\n",
       "  'The study of NF - kappaB showed that oxLDLs led to a decrease of activation - induced p65/ p50 NF - kappaB heterodimer binding to DNA , whereas the presence of the constitutive nuclear form of p50 dimer was unchanged .',\n",
       "  [['activation', '-', 'induced', 'p65/p50'], [14, 15, 16, 17], 'PROTEIN']],\n",
       " ['The <e1> B29 ( immunoglobulin beta - chain </e1> ) gene is a genetic target for early B - cell factor .',\n",
       "  'DNA',\n",
       "  'The B29 ( immunoglobulin beta - chain ) gene is a genetic target for early B - cell factor .',\n",
       "  [['B29', '(immunoglobulin', 'beta', '-', 'chain)', 'gene'],\n",
       "   [1, 2, 3, 4, 5, 6],\n",
       "   'DNA']],\n",
       " ['Interleukin - 12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells , and also generated by the interaction between activated T cells and antigen - presenting cells via CD40 <e1> - </e1> CD40 ligand ( CD40L ) .',\n",
       "  'PROTEIN',\n",
       "  'Interleukin - 12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells , and also generated by the interaction between activated T cells and antigen - presenting cells via CD40 - CD40 ligand ( CD40L ) .',\n",
       "  [['CD40'], [43], 'PROTEIN']],\n",
       " ['These cells , stimulated by an agonistic monoclonal antibody against CD40 or by transfection with a CD40L expression vector , secreted p40 and showed enhanced <e1> p40 mRNA </e1> expression .',\n",
       "  'RNA',\n",
       "  'These cells , stimulated by an agonistic monoclonal antibody against CD40 or by transfection with a CD40L expression vector , secreted p40 and showed enhanced p40 mRNA expression .',\n",
       "  [['p40', 'mRN'], [25, 26], 'RNA']],\n",
       " ['Sequence analysis of the p40 promoter region identified two <e1> potential nuclear factor ( NF ) - kappaB </e1> binding sites conserved between mouse and human .',\n",
       "  'DNA',\n",
       "  'Sequence analysis of the p40 promoter region identified two potential nuclear factor ( NF ) - kappaB binding sites conserved between mouse and human .',\n",
       "  [['potential',\n",
       "    'nuclear',\n",
       "    'factor',\n",
       "    '(NF)',\n",
       "    '-',\n",
       "    'kappaB',\n",
       "    'binding',\n",
       "    'site'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'DNA']],\n",
       " ['Moreover , transfection of Daudi cells with the polymerized NF - kappaB binding sequence ligated to a <e1> thymidine kinase /chloramphenicol acetyltransferase ( CAT </e1> ) reporter plasmid greatly induced CAT activity , but transfection with the polymerized mutated NF - kappaB binding sequence did not .',\n",
       "  'DNA',\n",
       "  'Moreover , transfection of Daudi cells with the polymerized NF - kappaB binding sequence ligated to a thymidine kinase /chloramphenicol acetyltransferase ( CAT ) reporter plasmid greatly induced CAT activity , but transfection with the polymerized mutated NF - kappaB binding sequence did not .',\n",
       "  [['thymidine',\n",
       "    'kinase/chloramphenicol',\n",
       "    'acetyltransferase',\n",
       "    '(CAT)',\n",
       "    'reporter',\n",
       "    'plasmid'],\n",
       "   [17, 18, 19, 20, 21, 22],\n",
       "   'DNA']],\n",
       " ['We have mapped the <e1> DNase - I - hypersensitive ( HS </e1> ) regions of the human GATA - 3 gene in T - cells and non - T - cells and studied their transcriptional activities .',\n",
       "  'DNA',\n",
       "  'We have mapped the DNase - I - hypersensitive ( HS ) regions of the human GATA - 3 gene in T - cells and non - T - cells and studied their transcriptional activities .',\n",
       "  [['DNase', '-', 'I', '-', 'hypersensitive', '(HS)', 'regions'],\n",
       "   [4, 5, 6, 7, 8, 9, 10],\n",
       "   'DNA']],\n",
       " ['The 3 - CAGGTG E - box could bind USF proteins , the ubiquitous repressor ZEB , or the basic helix - loop - helix proteins E2A and HEB , and we showed that a competition between ZEB and <e1> E2A /HEB </e1> proteins is involved in the silencer activity .',\n",
       "  'PROTEIN',\n",
       "  'The 3 - CAGGTG E - box could bind USF proteins , the ubiquitous repressor ZEB , or the basic helix - loop - helix proteins E2A and HEB , and we showed that a competition between ZEB and E2A /HEB proteins is involved in the silencer activity .',\n",
       "  [['E2A/HEB', 'protein'], [39, 40], 'PROTEIN']],\n",
       " ['Two variants of the <e1> IL - 4R alpha - chain ( IL - 4Ralpha </e1> ) gene have been recently identified in association with different atopic disorders .',\n",
       "  'DNA',\n",
       "  'Two variants of the IL - 4R alpha - chain ( IL - 4Ralpha ) gene have been recently identified in association with different atopic disorders .',\n",
       "  [['IL', '-', '4R', 'alpha', '-', 'chain', '(IL', '-', '4Ralpha)', 'gene'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'DNA']],\n",
       " ['Previous studies found that P1 , an element of the <e1> interleukin 4 ( IL - 4 </e1> ) promoter that binds AP - 1 , is important for Th2 - restricted IL - 4 expression .',\n",
       "  'DNA',\n",
       "  'Previous studies found that P1 , an element of the interleukin 4 ( IL - 4 ) promoter that binds AP - 1 , is important for Th2 - restricted IL - 4 expression .',\n",
       "  [['interleukin', '4', '(IL', '-', '4)', 'promoter'],\n",
       "   [10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['We examined the effect of Tax activity on the growth of the <e1> interleukin - 2 ( IL - 2 ) - dependent T - </e1> cell line CTLL - 2 .',\n",
       "  'CELL_LINE',\n",
       "  'We examined the effect of Tax activity on the growth of the interleukin - 2 ( IL - 2 ) - dependent T - cell line CTLL - 2 .',\n",
       "  [['interleukin',\n",
       "    '-',\n",
       "    '2',\n",
       "    '(IL',\n",
       "    '-',\n",
       "    '2)',\n",
       "    '-',\n",
       "    'dependent',\n",
       "    'T',\n",
       "    '-',\n",
       "    'cell',\n",
       "    'line'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'CELL_LINE']],\n",
       " ['However , both pathways were necessary for another transformation - related activity ( colony formation in soft agar ) of <e1> CTLL - 2/ </e1> Tax .',\n",
       "  'PROTEIN',\n",
       "  'However , both pathways were necessary for another transformation - related activity ( colony formation in soft agar ) of CTLL - 2/ Tax .',\n",
       "  [['CTLL', '-', '2/Tax'], [20, 21, 22], 'PROTEIN']],\n",
       " ['Regulation of the human interleukin - 2 gene by the <e1> alpha and </e1> beta isoforms of the glucocorticoid receptor .',\n",
       "  'PROTEIN',\n",
       "  'Regulation of the human interleukin - 2 gene by the alpha and beta isoforms of the glucocorticoid receptor .',\n",
       "  [['alpha', 'isoform'], [10, 11], 'PROTEIN']],\n",
       " ['The immunosuppressive effects of glucocorticoids are largely due to transcriptional inhibition of immunologically relevant genes , such as the <e1> interleukin - 2 ( IL - 2 </e1> ) gene .',\n",
       "  'DNA',\n",
       "  'The immunosuppressive effects of glucocorticoids are largely due to transcriptional inhibition of immunologically relevant genes , such as the interleukin - 2 ( IL - 2 ) gene .',\n",
       "  [['interleukin', '-', '2', '(IL', '-', '2)', 'gene'],\n",
       "   [19, 20, 21, 22, 23, 24, 25],\n",
       "   'DNA']],\n",
       " ['We previously demonstrated that GRbeta could antagonize GRalpha - mediated transactivation of a <e1> glucocorticoid - responsive element ( GRE ) - driven </e1> reporter gene in COS - 7 cells .',\n",
       "  'DNA',\n",
       "  'We previously demonstrated that GRbeta could antagonize GRalpha - mediated transactivation of a glucocorticoid - responsive element ( GRE ) - driven reporter gene in COS - 7 cells .',\n",
       "  [['glucocorticoid',\n",
       "    '-',\n",
       "    'responsive',\n",
       "    'element',\n",
       "    '(GRE)',\n",
       "    '-',\n",
       "    'driven',\n",
       "    'reporter',\n",
       "    'gene'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21],\n",
       "   'DNA']],\n",
       " ['Using a recently developed transfection technique , we demonstrate that in primary human lymphocytes , stimulation of a 548 bp IL - 2 promoter <e1> - </e1> luciferase reporter construct by phorbol ester and calcium ionophore is reversed by dexamethasone to a similar extent as in Jurkat T lymphoma cells transfected with a GRalpha expression vector .',\n",
       "  'PROTEIN',\n",
       "  'Using a recently developed transfection technique , we demonstrate that in primary human lymphocytes , stimulation of a 548 bp IL - 2 promoter - luciferase reporter construct by phorbol ester and calcium ionophore is reversed by dexamethasone to a similar extent as in Jurkat T lymphoma cells transfected with a GRalpha expression vector .',\n",
       "  [['luciferase'], [24], 'PROTEIN']],\n",
       " ['When <e1> immunoglobulin ( Ig ) expressing </e1> B cells are fused with non - B cells , Ig expression is rapidly suppressed at the level of transcription , a phenomenon termed extinction .',\n",
       "  'CELL_TYPE',\n",
       "  'When immunoglobulin ( Ig ) expressing B cells are fused with non - B cells , Ig expression is rapidly suppressed at the level of transcription , a phenomenon termed extinction .',\n",
       "  [['immunoglobulin', '(Ig)', 'expressing', 'B', 'cell'],\n",
       "   [1, 2, 3, 4, 5],\n",
       "   'CELL_TYPE']],\n",
       " ['IL - 4 gene regulation in general involves the <e1> nuclear factor of activated T cells ( NFAT </e1> ) family of transcription factors , of which NFAT1 and NFAT2 are most prominent in peripheral T cells .',\n",
       "  'PROTEIN',\n",
       "  'IL - 4 gene regulation in general involves the nuclear factor of activated T cells ( NFAT ) family of transcription factors , of which NFAT1 and NFAT2 are most prominent in peripheral T cells .',\n",
       "  [['nuclear', 'factor', 'of', 'activated', 'T', 'cells', '(NFAT)', 'family'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['We report here that this activation of HIV replication takes place at the transcriptional level through activation of the <e1> Rel/ NF - </e1> kappaB transcription factors .',\n",
       "  'PROTEIN',\n",
       "  'We report here that this activation of HIV replication takes place at the transcriptional level through activation of the Rel/ NF - kappaB transcription factors .',\n",
       "  [['Rel/NF', '-', 'kappaB'], [19, 20, 21], 'PROTEIN']],\n",
       " ['The cotransfection of this LTR with a mutated IkappaBalpha molecule formally demonstrates that LTR transactivation is regulated by members of the <e1> Rel/ NF - kappaB </e1> family in thymocytes .',\n",
       "  'PROTEIN',\n",
       "  'The cotransfection of this LTR with a mutated IkappaBalpha molecule formally demonstrates that LTR transactivation is regulated by members of the Rel/ NF - kappaB family in thymocytes .',\n",
       "  [['Rel/NF', '-', 'kappaB', 'family'], [21, 22, 23, 24], 'PROTEIN']],\n",
       " ['Serial sectioning of 6 micrometer was performed using a cryostat , and samples were immunohistochemically stained using the streptoavidin <e1> - biotin </e1> peroxidase method and a monoclonal antibody against c - fos .',\n",
       "  'PROTEIN',\n",
       "  'Serial sectioning of 6 micrometer was performed using a cryostat , and samples were immunohistochemically stained using the streptoavidin - biotin peroxidase method and a monoclonal antibody against c - fos .',\n",
       "  [['biotin', 'peroxidase'], [19, 20], 'PROTEIN']],\n",
       " ['T cell reactivity to Sjogren s syndrome related antigen <e1> La </e1> ( SSB ) .',\n",
       "  'PROTEIN',\n",
       "  'T cell reactivity to Sjogren s syndrome related antigen La ( SSB ) .',\n",
       "  [['La(SSB)'], [9], 'PROTEIN']],\n",
       " ['Many patients with primary Sjogren s syndrome ( SS ) make high titer IgG autoantibodies to the <e1> La </e1> ( SSB ) antigen , suggesting antigen specific T cell - B cell interactions .',\n",
       "  'PROTEIN',\n",
       "  'Many patients with primary Sjogren s syndrome ( SS ) make high titer IgG autoantibodies to the La ( SSB ) antigen , suggesting antigen specific T cell - B cell interactions .',\n",
       "  [['La(SSB)'], [17], 'PROTEIN']],\n",
       " ['<e1> Tumor necrosis factor ( TNF ) </e1> - alpha - induced HIV - 1 replication in OM10.1 or Ach2 cells was significantly inhibited by non - cytotoxic doses of AuTG ( > 10 microM in OM10.1 cells and > 25 F.M in Ach2 cells ) , while 25 microM of the counter - anion thioglucose ( TG ) or gold compound containing divalent gold ion , HAuCl3 , had no effect .',\n",
       "  'PROTEIN',\n",
       "  'Tumor necrosis factor ( TNF ) - alpha - induced HIV - 1 replication in OM10.1 or Ach2 cells was significantly inhibited by non - cytotoxic doses of AuTG ( > 10 microM in OM10.1 cells and > 25 F.M in Ach2 cells ) , while 25 microM of the counter - anion thioglucose ( TG ) or gold compound containing divalent gold ion , HAuCl3 , had no effect .',\n",
       "  [['Tumor', 'necrosis', 'factor', '(TNF)', '-', 'alpha'],\n",
       "   [0, 1, 2, 3, 4, 5],\n",
       "   'PROTEIN']],\n",
       " ['Tumor necrosis factor ( TNF ) - alpha - induced HIV - 1 replication in <e1> OM10.1 or </e1> Ach2 cells was significantly inhibited by non - cytotoxic doses of AuTG ( > 10 microM in OM10.1 cells and > 25 F.M in Ach2 cells ) , while 25 microM of the counter - anion thioglucose ( TG ) or gold compound containing divalent gold ion , HAuCl3 , had no effect .',\n",
       "  'CELL_LINE',\n",
       "  'Tumor necrosis factor ( TNF ) - alpha - induced HIV - 1 replication in OM10.1 or Ach2 cells was significantly inhibited by non - cytotoxic doses of AuTG ( > 10 microM in OM10.1 cells and > 25 F.M in Ach2 cells ) , while 25 microM of the counter - anion thioglucose ( TG ) or gold compound containing divalent gold ion , HAuCl3 , had no effect .',\n",
       "  [['OM10.1', 'cell'], [15, 16], 'CELL_LINE']],\n",
       " ['Although both promoters lack any TATA box , they contain two CAAT box - like motifs and three binding sites of <e1> GA - binding protein ( GABP ) </e1> transcription factors .',\n",
       "  'PROTEIN',\n",
       "  'Although both promoters lack any TATA box , they contain two CAAT box - like motifs and three binding sites of GA - binding protein ( GABP ) transcription factors .',\n",
       "  [['GA', '-', 'binding', 'protein', '(GABP)', 'transcription', 'factor'],\n",
       "   [21, 22, 23, 24, 25, 26, 27],\n",
       "   'PROTEIN']],\n",
       " ['In concert with the coactivator CREB binding protein/p300 , which interacts with GABPalpha , the binding of GABPalpha and <e1> - beta to </e1> the dyad symmetry element controls the induction of IL - 16 promoter in T cells .',\n",
       "  'PROTEIN',\n",
       "  'In concert with the coactivator CREB binding protein/p300 , which interacts with GABPalpha , the binding of GABPalpha and - beta to the dyad symmetry element controls the induction of IL - 16 promoter in T cells .',\n",
       "  [['GAPB', '-', 'beta'], [19, 20, 21], 'PROTEIN']],\n",
       " ['Co - expression of <e1> p65 ( Rel </e1> A ) with the FasL promoter enhanced its activity , and co - expression of IkappaB dramatically inhibited the inducible promoter activity .',\n",
       "  'PROTEIN',\n",
       "  'Co - expression of p65 ( Rel A ) with the FasL promoter enhanced its activity , and co - expression of IkappaB dramatically inhibited the inducible promoter activity .',\n",
       "  [['p65', '(Rel', 'A)'], [4, 5, 6], 'PROTEIN']],\n",
       " ['Promoter sequence , <e1> exon : </e1> intron structure , and synteny of genetic location show that a chicken cytokine with T - cell proliferative activity is IL2 and not IL15 .',\n",
       "  'DNA',\n",
       "  'Promoter sequence , exon : intron structure , and synteny of genetic location show that a chicken cytokine with T - cell proliferative activity is IL2 and not IL15 .',\n",
       "  [['exon:intron', 'structure'], [3, 4], 'DNA']],\n",
       " ['These include ( 5 - 3 ) a composite <e1> NF - AT/ \" AP - 1 </e1> \" element , a CD28 response element , an AP - 1 element , an NF - AT element , and the AP - 1 part of an AP - 1/octamer composite element .',\n",
       "  'DNA',\n",
       "  'These include ( 5 - 3 ) a composite NF - AT/ \" AP - 1 \" element , a CD28 response element , an AP - 1 element , an NF - AT element , and the AP - 1 part of an AP - 1/octamer composite element .',\n",
       "  [['NF', '-', 'AT/', '\"AP', '-', '1\"', 'element'],\n",
       "   [9, 10, 11, 12, 13, 14, 15],\n",
       "   'DNA']],\n",
       " ['The problem of the neuro - immuno interactions on the level of the protein trans - factors , stimulating <e1> interleukin - 2 ( IL - 2 </e1> ) gene expression was discussed .',\n",
       "  'DNA',\n",
       "  'The problem of the neuro - immuno interactions on the level of the protein trans - factors , stimulating interleukin - 2 ( IL - 2 ) gene expression was discussed .',\n",
       "  [['interleukin', '-', '2', '(IL', '-', '2)', 'gene'],\n",
       "   [19, 20, 21, 22, 23, 24, 25],\n",
       "   'DNA']],\n",
       " ['The binding of these proteins to the regulatory region of IL - 2 gene in vitro and stimulation of the IL - 2mRNA synthesis in <e1> splenic T - lymphocytes culture </e1> in normal conditions were shown .',\n",
       "  'CELL_LINE',\n",
       "  'The binding of these proteins to the regulatory region of IL - 2 gene in vitro and stimulation of the IL - 2mRNA synthesis in splenic T - lymphocytes culture in normal conditions were shown .',\n",
       "  [['splenic', 'T', '-', 'lymphocyte', 'culture'],\n",
       "   [25, 26, 27, 28, 29],\n",
       "   'CELL_LINE']],\n",
       " ['Interferon - alpha activates multiple STAT proteins and upregulates proliferation - associated IL - 2Ralpha , <e1> c - myc , and pim - 1 </e1> genes in human T cells .',\n",
       "  'DNA',\n",
       "  'Interferon - alpha activates multiple STAT proteins and upregulates proliferation - associated IL - 2Ralpha , c - myc , and pim - 1 genes in human T cells .',\n",
       "  [['c', '-', 'myc,', 'and', 'pim', '-', '1', 'gene'],\n",
       "   [16, 17, 18, 19, 20, 21, 22, 23],\n",
       "   'DNA']],\n",
       " ['Interferon - alpha ( IFN - alpha ) is a pleiotropic cytokine that has antiviral , antiproliferative , and <e1> immunoregulatory functions </e1> .',\n",
       "  'PROTEIN',\n",
       "  'Interferon - alpha ( IFN - alpha ) is a pleiotropic cytokine that has antiviral , antiproliferative , and immunoregulatory functions .',\n",
       "  [['immunoregulatory', 'cytokine'], [19, 20], 'PROTEIN']],\n",
       " ['Lactobacilli and vaginal host defense : activation of the human immunodeficiency virus type 1 long terminal repeat , <e1> cytokine </e1> production , and NF - kappaB .',\n",
       "  'PROTEIN',\n",
       "  'Lactobacilli and vaginal host defense : activation of the human immunodeficiency virus type 1 long terminal repeat , cytokine production , and NF - kappaB .',\n",
       "  [['cytokin'], [18], 'PROTEIN']],\n",
       " ['Lactobacilli , a component of the normal vaginal flora , can activate the <e1> human immunodeficiency virus ( HIV ) - 1 long </e1> terminal repeat ( LTR ) in the Jurkat T lymphocyte and THP - 1 macrophage cell lines .',\n",
       "  'DNA',\n",
       "  'Lactobacilli , a component of the normal vaginal flora , can activate the human immunodeficiency virus ( HIV ) - 1 long terminal repeat ( LTR ) in the Jurkat T lymphocyte and THP - 1 macrophage cell lines .',\n",
       "  [['human',\n",
       "    'immunodeficiency',\n",
       "    'virus',\n",
       "    '(HIV)',\n",
       "    '-',\n",
       "    '1',\n",
       "    'long',\n",
       "    'terminal',\n",
       "    'repeat'],\n",
       "   [13, 14, 15, 16, 17, 18, 19, 20, 21],\n",
       "   'DNA']],\n",
       " ['These findings suggest the presence in vaginal fluid of agent ( s ) derived from indigenous bacteria that can activate the HIV - 1 LTR , <e1> cytokine </e1> production , and NF - kappaB in cells of macrophage lineage , with possible influence on vaginal physiology and host defense .',\n",
       "  'PROTEIN',\n",
       "  'These findings suggest the presence in vaginal fluid of agent ( s ) derived from indigenous bacteria that can activate the HIV - 1 LTR , cytokine production , and NF - kappaB in cells of macrophage lineage , with possible influence on vaginal physiology and host defense .',\n",
       "  [['cytokin'], [26], 'PROTEIN']],\n",
       " ['Here we show that priming of CD4 T cells selectively enhances IL - 4 expression relative to IL - 2 expression by a transcriptional mechanism involving <e1> nuclear factor of activated T cells ( NFAT </e1> ) proteins .',\n",
       "  'PROTEIN',\n",
       "  'Here we show that priming of CD4 T cells selectively enhances IL - 4 expression relative to IL - 2 expression by a transcriptional mechanism involving nuclear factor of activated T cells ( NFAT ) proteins .',\n",
       "  [['nuclear', 'factor', 'of', 'activated', 'T', 'cells', '(NFAT)', 'protein'],\n",
       "   [26, 27, 28, 29, 30, 31, 32, 33],\n",
       "   'PROTEIN']],\n",
       " ['We compared U - 937 cell adhesion and adhesion molecule expression in <e1> human umbilical venous ( </e1> HUVECs ) and arterial ( HUAECs ) endothelial cells exposed to tumor necrosis factor ( TNF ) , interleukin - 1 , and lipopolysaccharide ( LPS ) .',\n",
       "  'CELL_TYPE',\n",
       "  'We compared U - 937 cell adhesion and adhesion molecule expression in human umbilical venous ( HUVECs ) and arterial ( HUAECs ) endothelial cells exposed to tumor necrosis factor ( TNF ) , interleukin - 1 , and lipopolysaccharide ( LPS ) .',\n",
       "  [['human', 'umbilical', 'venous', 'cell'], [12, 13, 14, 15], 'CELL_TYPE']],\n",
       " ['We compared U - 937 cell adhesion and adhesion molecule expression in human umbilical venous ( HUVECs ) and <e1> arterial ( HUAECs ) </e1> endothelial cells exposed to tumor necrosis factor ( TNF ) , interleukin - 1 , and lipopolysaccharide ( LPS ) .',\n",
       "  'CELL_TYPE',\n",
       "  'We compared U - 937 cell adhesion and adhesion molecule expression in human umbilical venous ( HUVECs ) and arterial ( HUAECs ) endothelial cells exposed to tumor necrosis factor ( TNF ) , interleukin - 1 , and lipopolysaccharide ( LPS ) .',\n",
       "  [['arterial', '(HUAECs)', 'endothelial', 'cell'],\n",
       "   [19, 20, 21, 22],\n",
       "   'CELL_TYPE']],\n",
       " ['TNF increased VCAM - 1 protein and <e1> mRNA in HUVECs that </e1> was blocked by pyrrolidinedithiocarbamate .',\n",
       "  'RNA',\n",
       "  'TNF increased VCAM - 1 protein and mRNA in HUVECs that was blocked by pyrrolidinedithiocarbamate .',\n",
       "  [['VCAM', '-', '1', 'mRNA'], [7, 8, 9, 10], 'RNA']],\n",
       " ['In addition , AR are not detectable on the surface of intact T cells when using anti - AR antibodies directed against the <e1> amino and </e1> carboxy terminus of the AR , although T cells contain AR , as revealed by reverse transcription - polymerase chain reactions and Western blotting .',\n",
       "  'PROTEIN',\n",
       "  'In addition , AR are not detectable on the surface of intact T cells when using anti - AR antibodies directed against the amino and carboxy terminus of the AR , although T cells contain AR , as revealed by reverse transcription - polymerase chain reactions and Western blotting .',\n",
       "  [['amino', 'terminus'], [23, 24], 'PROTEIN']],\n",
       " ['Interleukin - 4 is an immunomodulatory <e1> cytokine </e1> which plays a central role in the regulation of allergic and atopic immune responses .',\n",
       "  'PROTEIN',\n",
       "  'Interleukin - 4 is an immunomodulatory cytokine which plays a central role in the regulation of allergic and atopic immune responses .',\n",
       "  [['cytokin'], [6], 'PROTEIN']],\n",
       " ['B lymphocytes from patients with chronic lymphocytic leukemia contain <e1> signal transducer and activator of transcription ( STAT </e1> ) 1 and STAT3 constitutively phosphorylated on serine residues .',\n",
       "  'PROTEIN',\n",
       "  'B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription ( STAT ) 1 and STAT3 constitutively phosphorylated on serine residues .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    '1'],\n",
       "   [9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['To explore the pathogenesis of chronic lymphocytic leukemia ( CLL ) , we examined whether phosphorylation of one or more <e1> signal transducer and activator of transcription ( STAT </e1> ) factors was abnormal in cells from CLL patients .',\n",
       "  'PROTEIN',\n",
       "  'To explore the pathogenesis of chronic lymphocytic leukemia ( CLL ) , we examined whether phosphorylation of one or more signal transducer and activator of transcription ( STAT ) factors was abnormal in cells from CLL patients .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'factor'],\n",
       "   [20, 21, 22, 23, 24, 25, 26, 27],\n",
       "   'PROTEIN']],\n",
       " ['Interleukin - 10 ( IL - 10 ) helps maintain polarized T - helper cells in a <e1> T - helper lymphocyte 2 ( Th2 </e1> ) phenotype .',\n",
       "  'CELL_TYPE',\n",
       "  'Interleukin - 10 ( IL - 10 ) helps maintain polarized T - helper cells in a T - helper lymphocyte 2 ( Th2 ) phenotype .',\n",
       "  [['T', '-', 'helper', 'lymphocyte', '2', '(Th2)', 'phenotype'],\n",
       "   [17, 18, 19, 20, 21, 22, 23],\n",
       "   'CELL_TYPE']],\n",
       " ['The reduction in gene expression resulted from the ability of IL - 10 to suppress IFN - induced assembly of <e1> signal transducer and activator of transcription ( STAT </e1> ) factors to specific promoter motifs on IFNalpha - and IFNgamma - inducible genes .',\n",
       "  'PROTEIN',\n",
       "  'The reduction in gene expression resulted from the ability of IL - 10 to suppress IFN - induced assembly of signal transducer and activator of transcription ( STAT ) factors to specific promoter motifs on IFNalpha - and IFNgamma - inducible genes .',\n",
       "  [['signal',\n",
       "    'transducer',\n",
       "    'and',\n",
       "    'activator',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'factor'],\n",
       "   [20, 21, 22, 23, 24, 25, 26, 27],\n",
       "   'PROTEIN']],\n",
       " ['X chromosome inactivation and polymorphism of the <e1> human androgen receptor ( HUMARA </e1> ) gene has been applied for analyzing the clonality of blood cells .',\n",
       "  'DNA',\n",
       "  'X chromosome inactivation and polymorphism of the human androgen receptor ( HUMARA ) gene has been applied for analyzing the clonality of blood cells .',\n",
       "  [['human', 'androgen', 'receptor', '(HUMARA)', 'gene'],\n",
       "   [7, 8, 9, 10, 11],\n",
       "   'DNA']],\n",
       " ['The first objective of this study was to determine whether human DC mediate in vitro sensitization of naive CD4+ T cells to epitopes of the <e1> immediate early 62 ( IE62 </e1> ) protein of varicella zoster virus ( VZV ) .',\n",
       "  'PROTEIN',\n",
       "  'The first objective of this study was to determine whether human DC mediate in vitro sensitization of naive CD4+ T cells to epitopes of the immediate early 62 ( IE62 ) protein of varicella zoster virus ( VZV ) .',\n",
       "  [['immediate', 'early', '62', '(IE62)', 'protein'],\n",
       "   [25, 26, 27, 28, 29],\n",
       "   'PROTEIN']],\n",
       " ['IL - 10 treatment prevented the downregulation of <e1> p27 </e1> ( Kip1 ) , an inhibitory protein that controls progression out of the G0 phase of the cell cycle .',\n",
       "  'PROTEIN',\n",
       "  'IL - 10 treatment prevented the downregulation of p27 ( Kip1 ) , an inhibitory protein that controls progression out of the G0 phase of the cell cycle .',\n",
       "  [['p27(Kip1'], [8], 'PROTEIN']],\n",
       " ['Moreover , IL - 10 effects on the early G1 proteins <e1> p27 </e1> ( Kip1 ) and cyclin D2 were similarly reversed by exogenous IL - 2 .',\n",
       "  'PROTEIN',\n",
       "  'Moreover , IL - 10 effects on the early G1 proteins p27 ( Kip1 ) and cyclin D2 were similarly reversed by exogenous IL - 2 .',\n",
       "  [['p27(Kip1)'], [11], 'PROTEIN']],\n",
       " ['Our studies show that the mechanism of IL - 10 regulation of quiescent CD4(+) T - cell activation is mainly by blocking induction of IL - 2 that is critical to downregulation of <e1> p27 </e1> ( Kip1 ) and upregulation of D cyclins in T - cell activation and entry into the cell cycle .',\n",
       "  'PROTEIN',\n",
       "  'Our studies show that the mechanism of IL - 10 regulation of quiescent CD4(+) T - cell activation is mainly by blocking induction of IL - 2 that is critical to downregulation of p27 ( Kip1 ) and upregulation of D cyclins in T - cell activation and entry into the cell cycle .',\n",
       "  [['p27(Kip1)'], [33], 'PROTEIN']],\n",
       " ['Furthermore , the ability to suppress IL - 1RI and IL - 1RII mRNA levels was not unique to IFN - gamma because IL - 10 also inhibited expression of these genes in <e1> IL - 4 / IL - 13 - </e1> stimulated monocytes .',\n",
       "  'CELL_LINE',\n",
       "  'Furthermore , the ability to suppress IL - 1RI and IL - 1RII mRNA levels was not unique to IFN - gamma because IL - 10 also inhibited expression of these genes in IL - 4 / IL - 13 - stimulated monocytes .',\n",
       "  [['IL', '-', '4/IL', '-', '13', '-', 'stimulated', 'monocyte'],\n",
       "   [33, 34, 35, 36, 37, 38, 39, 40],\n",
       "   'CELL_LINE']],\n",
       " ['However , suppression of IL - 1R gene expression by IFN - gamma and IL - 10 was associated with decreased tyrosine phosphorylation and nuclear translocation of the <e1> IL - 4 / IL - 13 - inducible </e1> transcription factor , Stat6 , suggesting a potential mechanism by which IFN - gamma and IL - 10 may mediate their suppressive effects .',\n",
       "  'PROTEIN',\n",
       "  'However , suppression of IL - 1R gene expression by IFN - gamma and IL - 10 was associated with decreased tyrosine phosphorylation and nuclear translocation of the IL - 4 / IL - 13 - inducible transcription factor , Stat6 , suggesting a potential mechanism by which IFN - gamma and IL - 10 may mediate their suppressive effects .',\n",
       "  [['IL', '-', '4/IL', '-', '13', '-', 'inducible', 'transcription', 'factor'],\n",
       "   [28, 29, 30, 31, 32, 33, 34, 35, 36],\n",
       "   'PROTEIN']],\n",
       " ['Three days after establishing high - density PBMC cultures ( 1.5 x 10(6) cells/cm2 ) , in serum - containing medium , small adherent colonies of <e1> tartrate resistant acid phosphatase positive ( TRAP+ </e1> ) cells emerge , amidst massive monocyte cell death .',\n",
       "  'CELL_LINE',\n",
       "  'Three days after establishing high - density PBMC cultures ( 1.5 x 10(6) cells/cm2 ) , in serum - containing medium , small adherent colonies of tartrate resistant acid phosphatase positive ( TRAP+ ) cells emerge , amidst massive monocyte cell death .',\n",
       "  [['tartrate',\n",
       "    'resistant',\n",
       "    'acid',\n",
       "    'phosphatase',\n",
       "    'positive',\n",
       "    '(TRAP+)',\n",
       "    'cell'],\n",
       "   [26, 27, 28, 29, 30, 31, 32],\n",
       "   'CELL_LINE']],\n",
       " ['When cultured on bone , <e1> VR + , </e1> TRAP + cells of low multinuclearity appear and cover up to 50 % of the surface .',\n",
       "  'CELL_LINE',\n",
       "  'When cultured on bone , VR + , TRAP + cells of low multinuclearity appear and cover up to 50 % of the surface .',\n",
       "  [['VR+,', 'TRAP+', 'cell'], [5, 6, 7], 'CELL_LINE']],\n",
       " ['We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours , followed by coincubation of oleate with human recombinant tumor necrosis factor , <e1> interleukin ( IL ) </e1> - 1alpha , IL - 1beta , IL - 4 , Escherichia coli lipopolysaccharide ( LPS ) , or phorbol 12 - myristate 13 - acetate for a further 6 to 24 hours .',\n",
       "  'PROTEIN',\n",
       "  'We incubated sodium oleate with human umbilical vein endothelial cells for 0 to 72 hours , followed by coincubation of oleate with human recombinant tumor necrosis factor , interleukin ( IL ) - 1alpha , IL - 1beta , IL - 4 , Escherichia coli lipopolysaccharide ( LPS ) , or phorbol 12 - myristate 13 - acetate for a further 6 to 24 hours .',\n",
       "  [['interleukin', '(IL)', '-', '1alpha'], [28, 29, 30, 31], 'PROTEIN']],\n",
       " ['In this report , we show that Mycoplasma fermentans lipid - associated membrane proteins ( LAMPf ) induce the production of high levels of IL - 8 by <e1> THP - 1 ( human monocyte </e1> ) cells and PMN at the same extent as LPS .',\n",
       "  'CELL_LINE',\n",
       "  'In this report , we show that Mycoplasma fermentans lipid - associated membrane proteins ( LAMPf ) induce the production of high levels of IL - 8 by THP - 1 ( human monocyte ) cells and PMN at the same extent as LPS .',\n",
       "  [['THP', '-', '1', '(human', 'monocyte)', 'cell'],\n",
       "   [28, 29, 30, 31, 32, 33],\n",
       "   'CELL_LINE']],\n",
       " ['Regulation of IL - 6 synthesis in human peripheral blood mononuclear cells by C3a and <e1> C3a </e1> ( desArg ) .',\n",
       "  'PROTEIN',\n",
       "  'Regulation of IL - 6 synthesis in human peripheral blood mononuclear cells by C3a and C3a ( desArg ) .',\n",
       "  [['C3a(desArg)'], [15], 'PROTEIN']],\n",
       " ['In this study we investigated the effects of C3a and <e1> C3a </e1> ( desArg ) on gene expression and protein secretion of IL - 6 in human PBMCs , either alone or in combination with LPS or IL - 1beta .',\n",
       "  'PROTEIN',\n",
       "  'In this study we investigated the effects of C3a and C3a ( desArg ) on gene expression and protein secretion of IL - 6 in human PBMCs , either alone or in combination with LPS or IL - 1beta .',\n",
       "  [['C3a(desArg)'], [10], 'PROTEIN']],\n",
       " ['C3a or <e1> C3a </e1> ( desArg ) alone exhibited no effect on the expression or secretion of IL - 6 .',\n",
       "  'PROTEIN',\n",
       "  'C3a or C3a ( desArg ) alone exhibited no effect on the expression or secretion of IL - 6 .',\n",
       "  [['C3a(desArg)'], [2], 'PROTEIN']],\n",
       " ['However , when PBMC were stimulated with LPS or IL - 1beta , both C3a and <e1> C3a </e1> ( desArg ) were found to enhance IL - 6 release by PBMC in a dose - dependent manner .',\n",
       "  'PROTEIN',\n",
       "  'However , when PBMC were stimulated with LPS or IL - 1beta , both C3a and C3a ( desArg ) were found to enhance IL - 6 release by PBMC in a dose - dependent manner .',\n",
       "  [['C3a(desArg)'], [16], 'PROTEIN']],\n",
       " ['Northern blot analysis showed that C3a as well as <e1> C3a </e1> ( desArg ) enhanced LPS - induced mRNA levels for IL - 6 .',\n",
       "  'PROTEIN',\n",
       "  'Northern blot analysis showed that C3a as well as C3a ( desArg ) enhanced LPS - induced mRNA levels for IL - 6 .',\n",
       "  [['C3a(desArg)'], [9], 'PROTEIN']],\n",
       " ['Northern blot analysis showed that C3a as well as C3a ( desArg ) enhanced LPS <e1> - induced </e1> mRNA levels for IL - 6 .',\n",
       "  'RNA',\n",
       "  'Northern blot analysis showed that C3a as well as C3a ( desArg ) enhanced LPS - induced mRNA levels for IL - 6 .',\n",
       "  [['induced', 'mRNA'], [15, 16], 'RNA']],\n",
       " ['Pretreatment of PBMCs with pertussis toxin blocked the functions of C3a and <e1> C3a </e1> ( desArg ) , indicating that the actions of these two molecules are mediated by a G protein - coupled pathway .',\n",
       "  'PROTEIN',\n",
       "  'Pretreatment of PBMCs with pertussis toxin blocked the functions of C3a and C3a ( desArg ) , indicating that the actions of these two molecules are mediated by a G protein - coupled pathway .',\n",
       "  [['C3a(desArg)'], [12], 'PROTEIN']],\n",
       " ['Furthermore , we investigated the effects of C3a and <e1> C3a </e1> ( desArg ) on induction of NF - kappaB and activating protein - 1 binding .',\n",
       "  'PROTEIN',\n",
       "  'Furthermore , we investigated the effects of C3a and C3a ( desArg ) on induction of NF - kappaB and activating protein - 1 binding .',\n",
       "  [['C3a(desArg)'], [9], 'PROTEIN']],\n",
       " ['Here we summarize the importance of the <e1> IgH 3 </e1> LCR and its putative functional role in IgH gene expression and compare it with the 5 LCR regulatory region of the human beta - globin locus .',\n",
       "  'DNA',\n",
       "  'Here we summarize the importance of the IgH 3 LCR and its putative functional role in IgH gene expression and compare it with the 5 LCR regulatory region of the human beta - globin locus .',\n",
       "  [['IgH', \"3'LCR\"], [7, 8], 'DNA']],\n",
       " ['Here we summarize the importance of the IgH 3 LCR and its putative functional role in IgH gene expression and compare it with the <e1> 5 LCR regulatory </e1> region of the human beta - globin locus .',\n",
       "  'DNA',\n",
       "  'Here we summarize the importance of the IgH 3 LCR and its putative functional role in IgH gene expression and compare it with the 5 LCR regulatory region of the human beta - globin locus .',\n",
       "  [[\"5'LCR\", 'regulatory', 'region'], [24, 25, 26], 'DNA']],\n",
       " ['The stability of already formed complexed was somewhat different in the HLA - A3 and HLA - Cw*0702 system : both were more stable at 26 degrees C than at 37 degrees C but while the beta 2 - m and FCS did not influence the stability of the <e1> HLA - A3 /peptide </e1> complex , they seemed to cause opposite effects in the HLA - Cw*0702 system ( beta 2 - m stabilized and FCS destabilized the complex ) .',\n",
       "  'PROTEIN',\n",
       "  'The stability of already formed complexed was somewhat different in the HLA - A3 and HLA - Cw*0702 system : both were more stable at 26 degrees C than at 37 degrees C but while the beta 2 - m and FCS did not influence the stability of the HLA - A3 /peptide complex , they seemed to cause opposite effects in the HLA - Cw*0702 system ( beta 2 - m stabilized and FCS destabilized the complex ) .',\n",
       "  [['HLA', '-', 'A3/peptide', 'complex'], [49, 50, 51, 52], 'PROTEIN']],\n",
       " ['OCA - B associates with the Oct - 1 POU domain , a bipartite DNA - binding structure containing a <e1> POU - specific ( POU[S] </e1> ) domain joined by a flexible linker to a POU homeodomain ( POU[H] ) .',\n",
       "  'PROTEIN',\n",
       "  'OCA - B associates with the Oct - 1 POU domain , a bipartite DNA - binding structure containing a POU - specific ( POU[S] ) domain joined by a flexible linker to a POU homeodomain ( POU[H] ) .',\n",
       "  [['POU', '-', 'specific', '(POU[S])', 'domain'],\n",
       "   [20, 21, 22, 23, 24],\n",
       "   'PROTEIN']],\n",
       " ['OCA - B , however , interacts with a different surface of the DNA - bound Oct - 1 POU domain , interacting with both the <e1> POU(S) and </e1> POU(H) domains and the center of the ATGCAAAT octamer sequence .',\n",
       "  'PROTEIN',\n",
       "  'OCA - B , however , interacts with a different surface of the DNA - bound Oct - 1 POU domain , interacting with both the POU(S) and POU(H) domains and the center of the ATGCAAAT octamer sequence .',\n",
       "  [['POU(S)', 'domain'], [26, 27], 'PROTEIN']],\n",
       " ['<e1> Bipotential T/natural killer ( NK ) </e1> progenitor cells are present in the human thymus .',\n",
       "  'CELL_TYPE',\n",
       "  'Bipotential T/natural killer ( NK ) progenitor cells are present in the human thymus .',\n",
       "  [['Bipotential', 'T/natural', 'killer', '(NK)', 'progenitor', 'cell'],\n",
       "   [0, 1, 2, 3, 4, 5],\n",
       "   'CELL_TYPE']],\n",
       " ['Here we present evidence that a member ( s ) of the family of <e1> basic helix loop helix ( bHLH ) </e1> transcription factors determines lineage specification of NK/T cell progenitors .',\n",
       "  'PROTEIN',\n",
       "  'Here we present evidence that a member ( s ) of the family of basic helix loop helix ( bHLH ) transcription factors determines lineage specification of NK/T cell progenitors .',\n",
       "  [['basic', 'helix', 'loop', 'helix', '(bHLH)', 'transcription', 'factor'],\n",
       "   [14, 15, 16, 17, 18, 19, 20],\n",
       "   'PROTEIN']],\n",
       " ['In competition and antibody supershift assays in EMSA , complexes formed with P or P2 proved to contain <e1> nuclear factor of activated T cells ( NFAT ) </e1> family proteins as major components .',\n",
       "  'PROTEIN',\n",
       "  'In competition and antibody supershift assays in EMSA , complexes formed with P or P2 proved to contain nuclear factor of activated T cells ( NFAT ) family proteins as major components .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells',\n",
       "    '(NFAT)',\n",
       "    'family',\n",
       "    'protein'],\n",
       "   [18, 19, 20, 21, 22, 23, 24, 25, 26],\n",
       "   'PROTEIN']],\n",
       " ['<e1> Activator protein ( AP ) - 1 </e1> family proteins interacted with CLE0 , P , P2 and P4 .',\n",
       "  'PROTEIN',\n",
       "  'Activator protein ( AP ) - 1 family proteins interacted with CLE0 , P , P2 and P4 .',\n",
       "  [['activator', 'protein', '(AP)', '-', '1', 'family', 'protein'],\n",
       "   [0, 1, 2, 3, 4, 5, 6],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> nuclear factor of activated T cells ( NFAT </e1> ) group of transcription factors is retained in the cytoplasm of quiescent cells .',\n",
       "  'PROTEIN',\n",
       "  'The nuclear factor of activated T cells ( NFAT ) group of transcription factors is retained in the cytoplasm of quiescent cells .',\n",
       "  [['nuclear', 'factor', 'of', 'activated', 'T', 'cells', '(NFAT)', 'group'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['In UCSD - AML1 , we have also identified fusion transcripts between the <e1> ecotropic viral insertion site I ( EVI1 </e1> ) gene in 3q26 and GR6 and between EVI1 and Ribophorin I that maps 30 kb telomeric to GR6 in 3q21 .',\n",
       "  'DNA',\n",
       "  'In UCSD - AML1 , we have also identified fusion transcripts between the ecotropic viral insertion site I ( EVI1 ) gene in 3q26 and GR6 and between EVI1 and Ribophorin I that maps 30 kb telomeric to GR6 in 3q21 .',\n",
       "  [['ecotropic', 'viral', 'insertion', 'site', 'I', '(EVI1)', 'gene'],\n",
       "   [13, 14, 15, 16, 17, 18, 19],\n",
       "   'DNA']],\n",
       " ['The Ribophorin I <e1> - </e1> EVI1 fusion in particular may be a common occurrence in t(3;3) .',\n",
       "  'DNA',\n",
       "  'The Ribophorin I - EVI1 fusion in particular may be a common occurrence in t(3;3) .',\n",
       "  [['EVI1'], [3], 'DNA']],\n",
       " ['In the present study , the expression of bcl - 6 protein on normal epidermis , benign , and malignant tumors originating from epidermal cells , and <e1> squamous cell carcinoma ( SCC ) </e1> cell lines are investigated .',\n",
       "  'CELL_LINE',\n",
       "  'In the present study , the expression of bcl - 6 protein on normal epidermis , benign , and malignant tumors originating from epidermal cells , and squamous cell carcinoma ( SCC ) cell lines are investigated .',\n",
       "  [['squamous', 'cell', 'carcinoma', '(SCC)', 'cell', 'line'],\n",
       "   [27, 28, 29, 30, 31, 32],\n",
       "   'CELL_LINE']],\n",
       " ['Cotransfection of Sp3 along with CD11c promoter <e1> - </e1> luciferase constructs into Sp - deficient Drosophila Schneider 2 cells showed that Sp3 could activate the CD11c promoter .',\n",
       "  'PROTEIN',\n",
       "  'Cotransfection of Sp3 along with CD11c promoter - luciferase constructs into Sp - deficient Drosophila Schneider 2 cells showed that Sp3 could activate the CD11c promoter .',\n",
       "  [['luciferase'], [7], 'PROTEIN']],\n",
       " ['The functions of <e1> basic helix - loop - helix ( bHLH ) </e1> transcription factors in activating differentiation - linked gene expression and in inducing G1 cell cycle arrest are negatively regulated by members of the Id family of HLH proteins .',\n",
       "  'PROTEIN',\n",
       "  'The functions of basic helix - loop - helix ( bHLH ) transcription factors in activating differentiation - linked gene expression and in inducing G1 cell cycle arrest are negatively regulated by members of the Id family of HLH proteins .',\n",
       "  [['basic',\n",
       "    'helix',\n",
       "    '-',\n",
       "    'loop',\n",
       "    '-',\n",
       "    'helix',\n",
       "    '(bHLH)',\n",
       "    'transcription',\n",
       "    'factor'],\n",
       "   [3, 4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['These bHLH antagonists are induced during a mitogenic signalling response , and they function by sequestering their bHLH targets in inactive heterodimers that are unable to bind to specific <e1> gene regulatory ( E box </e1> ) sequences .',\n",
       "  'DNA',\n",
       "  'These bHLH antagonists are induced during a mitogenic signalling response , and they function by sequestering their bHLH targets in inactive heterodimers that are unable to bind to specific gene regulatory ( E box ) sequences .',\n",
       "  [['gene', 'regulatory', '(E', 'box)', 'sequence'],\n",
       "   [29, 30, 31, 32, 33],\n",
       "   'DNA']],\n",
       " ['Transcription factors of the <e1> NFAT ( nuclear factor of activated T cells </e1> ) family play important roles in immune and inflammatory responses by regulating the expression of genes encoding cytokines and immunoregulatory proteins .',\n",
       "  'PROTEIN',\n",
       "  'Transcription factors of the NFAT ( nuclear factor of activated T cells ) family play important roles in immune and inflammatory responses by regulating the expression of genes encoding cytokines and immunoregulatory proteins .',\n",
       "  [['NFAT', '(nuclear', 'factor', 'of', 'activated', 'T', 'cells)', 'family'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11],\n",
       "   'PROTEIN']],\n",
       " ['Here we describe cloning and characterization of full - length <e1> cDNA encoding murine ( m </e1> ) NFATc which predicts that the protein has all the conserved structural motifs of NFAT family members , including the rel homology domain , the NFAT homology domain and the nuclear translocation signals .',\n",
       "  'PROTEIN',\n",
       "  'Here we describe cloning and characterization of full - length cDNA encoding murine ( m ) NFATc which predicts that the protein has all the conserved structural motifs of NFAT family members , including the rel homology domain , the NFAT homology domain and the nuclear translocation signals .',\n",
       "  [['cDNA', 'encoding', 'murine', '(m)', 'NFATc'],\n",
       "   [10, 11, 12, 13, 14],\n",
       "   'PROTEIN']],\n",
       " ['Alternative splicing of the <e1> GC receptor ( R ) pre - </e1> messenger RNA generates a second GCR , termed GCR - beta , which does not bind GCs but antagonizes the transactivating activity of the classic GCR , termed GCR - alpha .',\n",
       "  'RNA',\n",
       "  'Alternative splicing of the GC receptor ( R ) pre - messenger RNA generates a second GCR , termed GCR - beta , which does not bind GCs but antagonizes the transactivating activity of the classic GCR , termed GCR - alpha .',\n",
       "  [['GC', 'receptor', '(R)', 'pre', '-', 'messenger', 'RNA'],\n",
       "   [4, 5, 6, 7, 8, 9, 10],\n",
       "   'RNA']],\n",
       " ['A survey of promoters has revealed that the <e1> wild - type , unfused </e1> EBNA3C can specifically repress expression from reporter plasmids containing the Epstein - Barr virus Cp latency - associated promoter .',\n",
       "  'PROTEIN',\n",
       "  'A survey of promoters has revealed that the wild - type , unfused EBNA3C can specifically repress expression from reporter plasmids containing the Epstein - Barr virus Cp latency - associated promoter .',\n",
       "  [['wild', '-', 'type,', 'unfused', 'EBNA3C'],\n",
       "   [8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['Repression of Cp activity required <e1> amino acids 207 to 368 </e1> , which encompasses a region resembling a basic DBD adjacent to a leucine zipper DNA binding motif and a site which binds to the cellular factor CBF1/RBP - Jkappa .',\n",
       "  'PROTEIN',\n",
       "  'Repression of Cp activity required amino acids 207 to 368 , which encompasses a region resembling a basic DBD adjacent to a leucine zipper DNA binding motif and a site which binds to the cellular factor CBF1/RBP - Jkappa .',\n",
       "  [['amino', 'acid', '207', 'to', '368'], [5, 6, 7, 8, 9], 'PROTEIN']],\n",
       " ['In addition , <e1> amino acids 346 to 543 </e1> , which were previously defined as important for the repressor activity of the GAL4 - EBNA3C fusion proteins , also appear to be necessary for the repression of Cp .',\n",
       "  'PROTEIN',\n",
       "  'In addition , amino acids 346 to 543 , which were previously defined as important for the repressor activity of the GAL4 - EBNA3C fusion proteins , also appear to be necessary for the repression of Cp .',\n",
       "  [['amino', 'acid', '346', 'to', '543'], [3, 4, 5, 6, 7], 'PROTEIN']],\n",
       " ['Since repression by these fusions was not observed in all cell types , it seems likely that EBNA3C either depends on a corepressor which may interact with <e1> amino acids 346 to 543 </e1> or is modified in a cell - specific manner in order to repress .',\n",
       "  'PROTEIN',\n",
       "  'Since repression by these fusions was not observed in all cell types , it seems likely that EBNA3C either depends on a corepressor which may interact with amino acids 346 to 543 or is modified in a cell - specific manner in order to repress .',\n",
       "  [['amino', 'acid', '346', 'to', '543'], [27, 28, 29, 30, 31], 'PROTEIN']],\n",
       " ['Considering that nuclear regulatory factor - kappa beta <e1> ( NF - kappa </e1> B ) /Rel is a common regulatory element of the promoter region of the inflammatory cytokine genes , herein , we tested the hypothesis that acute ethanol affects NF - kappa B activation in human monocytes .',\n",
       "  'PROTEIN',\n",
       "  'Considering that nuclear regulatory factor - kappa beta ( NF - kappa B ) /Rel is a common regulatory element of the promoter region of the inflammatory cytokine genes , herein , we tested the hypothesis that acute ethanol affects NF - kappa B activation in human monocytes .',\n",
       "  [['(NF', '-', 'kappa', 'B)/Rel'], [8, 9, 10, 11], 'PROTEIN']],\n",
       " ['A clinically relevant dose ( 25 mM ) of acute ethanol treatment in vitro increased NF - kappa B binding activity in monocytes with a preferential induction of the inhibitory , <e1> p50 </e1> /p50 , NF - kappa B /Rel homodimer , and resulted in no induction of the p65 /p50 heterodimer .',\n",
       "  'PROTEIN',\n",
       "  'A clinically relevant dose ( 25 mM ) of acute ethanol treatment in vitro increased NF - kappa B binding activity in monocytes with a preferential induction of the inhibitory , p50 /p50 , NF - kappa B /Rel homodimer , and resulted in no induction of the p65 /p50 heterodimer .',\n",
       "  [['p50/p50'], [31], 'PROTEIN']],\n",
       " ['A clinically relevant dose ( 25 mM ) of acute ethanol treatment in vitro increased NF - kappa B binding activity in monocytes with a preferential induction of the inhibitory , p50 /p50 , <e1> NF - kappa B /Rel </e1> homodimer , and resulted in no induction of the p65 /p50 heterodimer .',\n",
       "  'PROTEIN',\n",
       "  'A clinically relevant dose ( 25 mM ) of acute ethanol treatment in vitro increased NF - kappa B binding activity in monocytes with a preferential induction of the inhibitory , p50 /p50 , NF - kappa B /Rel homodimer , and resulted in no induction of the p65 /p50 heterodimer .',\n",
       "  [['NF', '-', 'kappa', 'B/Rel', 'homodimer'],\n",
       "   [34, 35, 36, 37, 38],\n",
       "   'PROTEIN']],\n",
       " ['A clinically relevant dose ( 25 mM ) of acute ethanol treatment in vitro increased NF - kappa B binding activity in monocytes with a preferential induction of the inhibitory , p50 /p50 , NF - kappa B /Rel homodimer , and resulted in no induction of the <e1> p65 /p50 </e1> heterodimer .',\n",
       "  'PROTEIN',\n",
       "  'A clinically relevant dose ( 25 mM ) of acute ethanol treatment in vitro increased NF - kappa B binding activity in monocytes with a preferential induction of the inhibitory , p50 /p50 , NF - kappa B /Rel homodimer , and resulted in no induction of the p65 /p50 heterodimer .',\n",
       "  [['p65/p50', 'heterodimer'], [48, 49], 'PROTEIN']],\n",
       " ['In contrast , lipopolysaccharide stimulation primarily induced the <e1> p65 /p50 </e1> heterodimer that has been shown to result in gene activation .',\n",
       "  'PROTEIN',\n",
       "  'In contrast , lipopolysaccharide stimulation primarily induced the p65 /p50 heterodimer that has been shown to result in gene activation .',\n",
       "  [['p65/p50', 'heterodimer'], [8, 9], 'PROTEIN']],\n",
       " ['Thus , such unique activation of the <e1> inhibitory p50 /p50 </e1> homodimer by acute ethanol treatment may result in inhibition rather than activation of NF - kappa B - regulated inflammatory cytokine genes .',\n",
       "  'PROTEIN',\n",
       "  'Thus , such unique activation of the inhibitory p50 /p50 homodimer by acute ethanol treatment may result in inhibition rather than activation of NF - kappa B - regulated inflammatory cytokine genes .',\n",
       "  [['inhibitory', 'p50/p50', 'homodimer'], [7, 8, 9], 'PROTEIN']],\n",
       " ['When monocytes are stimulated with LPS ( lipopolysaccharide ) repeatedly then the initially high expression of the <e1> TNF ( tumor necrosis factor </e1> ) gene is only very low , i.e. the cells are tolerant to LPS .',\n",
       "  'DNA',\n",
       "  'When monocytes are stimulated with LPS ( lipopolysaccharide ) repeatedly then the initially high expression of the TNF ( tumor necrosis factor ) gene is only very low , i.e. the cells are tolerant to LPS .',\n",
       "  [['TNF', '(tumor', 'necrosis', 'factor)', 'gene'],\n",
       "   [17, 18, 19, 20, 21],\n",
       "   'DNA']],\n",
       " ['Cyclosporin A ( CsA ) may achieve its immunosuppressive effects by inhibiting the calcium - and calmodulin - dependent phosphatase calcineurin which is required for activation of target genes by members of the <e1> NFAT ( nuclear factor of activated T cells ) transcription </e1> factor family .',\n",
       "  'PROTEIN',\n",
       "  'Cyclosporin A ( CsA ) may achieve its immunosuppressive effects by inhibiting the calcium - and calmodulin - dependent phosphatase calcineurin which is required for activation of target genes by members of the NFAT ( nuclear factor of activated T cells ) transcription factor family .',\n",
       "  [['NFAT',\n",
       "    '(nuclear',\n",
       "    'factor',\n",
       "    'of',\n",
       "    'activated',\n",
       "    'T',\n",
       "    'cells)',\n",
       "    'transcription',\n",
       "    'factor',\n",
       "    'family'],\n",
       "   [33, 34, 35, 36, 37, 38, 39, 40, 41, 42],\n",
       "   'PROTEIN']],\n",
       " ['A kappa B - site was identified in the promoter of the <e1> intercellular adhesion molecule - 1 ( ICAM - 1 </e1> ) gene , which is involved in regulation of ICAM - 1 expression by tumor necrosis factor alpha ( TNF - alpha ) and glucocorticoids .',\n",
       "  'DNA',\n",
       "  'A kappa B - site was identified in the promoter of the intercellular adhesion molecule - 1 ( ICAM - 1 ) gene , which is involved in regulation of ICAM - 1 expression by tumor necrosis factor alpha ( TNF - alpha ) and glucocorticoids .',\n",
       "  [['intercellular',\n",
       "    'adhesion',\n",
       "    'molecule',\n",
       "    '-',\n",
       "    '1',\n",
       "    '(ICAM',\n",
       "    '-',\n",
       "    '1)',\n",
       "    'gene'],\n",
       "   [12, 13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'DNA']],\n",
       " ['The second complex contained RelA , and exhibited higher affinity towards the <e1> ICAM - 1 kappa B than </e1> to the HIV kappa B site .',\n",
       "  'DNA',\n",
       "  'The second complex contained RelA , and exhibited higher affinity towards the ICAM - 1 kappa B than to the HIV kappa B site .',\n",
       "  [['ICAM', '-', '1', 'kappa', 'B', 'site'], [12, 13, 14, 15, 16, 17], 'DNA']],\n",
       " ['The glucocorticoid receptor was shown to repress activity of both the RelA homodimer and the <e1> NF - kappa B1 /RelA </e1> heterodimer .',\n",
       "  'PROTEIN',\n",
       "  'The glucocorticoid receptor was shown to repress activity of both the RelA homodimer and the NF - kappa B1 /RelA heterodimer .',\n",
       "  [['NF', '-', 'kappa', 'B1/RelA', 'heterodimer'],\n",
       "   [15, 16, 17, 18, 19],\n",
       "   'PROTEIN']],\n",
       " ['The NH2Cl - treated neutrophils showed a decrease in both PKC activity and PMA - induced phosphorylation of a 47 - kDa protein , which corresponds to the cytosolic factor of NADPH oxidase , <e1> p47 </e1> ( phox ) .',\n",
       "  'PROTEIN',\n",
       "  'The NH2Cl - treated neutrophils showed a decrease in both PKC activity and PMA - induced phosphorylation of a 47 - kDa protein , which corresponds to the cytosolic factor of NADPH oxidase , p47 ( phox ) .',\n",
       "  [['p47(phox)'], [34], 'PROTEIN']],\n",
       " ['In CsA - treated leukocytes stimulated by calcium ionophore , the degree of reduction in CN activity was accompanied by a similar degree of inhibition of each event tested : dephosphorylation of <e1> nuclear factor of activated T cell proteins </e1> , nuclear DNA binding , activation of a transfected reporter gene construct , IFN - gamma and IL - 2 mRNA accumulation , and IFN - gamma production .',\n",
       "  'PROTEIN',\n",
       "  'In CsA - treated leukocytes stimulated by calcium ionophore , the degree of reduction in CN activity was accompanied by a similar degree of inhibition of each event tested : dephosphorylation of nuclear factor of activated T cell proteins , nuclear DNA binding , activation of a transfected reporter gene construct , IFN - gamma and IL - 2 mRNA accumulation , and IFN - gamma production .',\n",
       "  [['nuclear', 'factor', 'of', 'activated', 'T', 'cells', 'protein'],\n",
       "   [32, 33, 34, 35, 36, 37, 38],\n",
       "   'PROTEIN']],\n",
       " ['The purpose of these studies was to identify whether transcription factors , associated with cytokine signalling , affected promoter activity of the <e1> corticotropin releasing hormone ( CRH </e1> ) gene .',\n",
       "  'DNA',\n",
       "  'The purpose of these studies was to identify whether transcription factors , associated with cytokine signalling , affected promoter activity of the corticotropin releasing hormone ( CRH ) gene .',\n",
       "  [['corticotropin', 'releasing', 'hormone', '(CRH)', 'gene'],\n",
       "   [22, 23, 24, 25, 26],\n",
       "   'DNA']],\n",
       " ['Complete suppression of AP - 1 activity was observed in <e1> Con A - treated , proliferating </e1> thymocytes .',\n",
       "  'CELL_LINE',\n",
       "  'Complete suppression of AP - 1 activity was observed in Con A - treated , proliferating thymocytes .',\n",
       "  [['Con', 'A', '-', 'treated,', 'proliferating', 'thymocyte'],\n",
       "   [10, 11, 12, 13, 14, 15],\n",
       "   'CELL_LINE']],\n",
       " ['T - cell receptor <e1> ( </e1> TCR ) /CD3 engagement results in the activation of nuclear factor of activated T cells ( NFAT ) , activator protein - 1 ( AP - 1 ) , and nuclear factor kappaB ( NFkappaB ) , whereas the CD28 responsive complex ( CD28RC ) is activated in response to the CD28 signal .',\n",
       "  'PROTEIN',\n",
       "  'T - cell receptor ( TCR ) /CD3 engagement results in the activation of nuclear factor of activated T cells ( NFAT ) , activator protein - 1 ( AP - 1 ) , and nuclear factor kappaB ( NFkappaB ) , whereas the CD28 responsive complex ( CD28RC ) is activated in response to the CD28 signal .',\n",
       "  [['(TCR)/CD3'], [4], 'PROTEIN']],\n",
       " ['Costimulation of <e1> phytohemagglutinin /anti - CD28 activated T </e1> lymphocytes with IL - 7 induces a fivefold enhanced IL - 2 - mRNA accumulation and a 2.5 - fold enhanced protein secretion .',\n",
       "  'CELL_LINE',\n",
       "  'Costimulation of phytohemagglutinin /anti - CD28 activated T lymphocytes with IL - 7 induces a fivefold enhanced IL - 2 - mRNA accumulation and a 2.5 - fold enhanced protein secretion .',\n",
       "  [['phytohemagglutinin/anti', '-', 'CD28', 'activated', 'T', 'lymphocyte'],\n",
       "   [2, 3, 4, 5, 6, 7],\n",
       "   'CELL_LINE']],\n",
       " ['The three - dimensional positioning of <e1> immunoglobulin ( Ig </e1> ) genes within the nucleus of human cells was investigated using in situ hybridization and confocal microscopy .',\n",
       "  'DNA',\n",
       "  'The three - dimensional positioning of immunoglobulin ( Ig ) genes within the nucleus of human cells was investigated using in situ hybridization and confocal microscopy .',\n",
       "  [['immunoglobulin', '(Ig)', 'gene'], [6, 7, 8], 'DNA']],\n",
       " ['Five healthy human leukocyte antigen - B8 ( HLA - B8 ) - positive virus carriers were studied to investigate the CD8+ cytotoxic T lymphocyte ( CTL ) response to an HLA - B8 - restricted peptide , RAKFKQLLQ , located in the <e1> Epstein - Barr virus ( EBV ) immediate - early trans - </e1> activator protein , BZLF1 .',\n",
       "  'PROTEIN',\n",
       "  'Five healthy human leukocyte antigen - B8 ( HLA - B8 ) - positive virus carriers were studied to investigate the CD8+ cytotoxic T lymphocyte ( CTL ) response to an HLA - B8 - restricted peptide , RAKFKQLLQ , located in the Epstein - Barr virus ( EBV ) immediate - early trans - activator protein , BZLF1 .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    'immediate',\n",
       "    '-',\n",
       "    'early',\n",
       "    'trans',\n",
       "    '-',\n",
       "    'activator',\n",
       "    'protein'],\n",
       "   [43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54],\n",
       "   'PROTEIN']],\n",
       " ['The RAKFKQLLQ - specific CTL precursor frequencies in all 5 persons were at least as dominant as those observed with two other <e1> EBV - associated , HLA - B8 - restricted latent </e1> epitopes , FLRGRAYGL and QAKWRLQTL .',\n",
       "  'PROTEIN',\n",
       "  'The RAKFKQLLQ - specific CTL precursor frequencies in all 5 persons were at least as dominant as those observed with two other EBV - associated , HLA - B8 - restricted latent epitopes , FLRGRAYGL and QAKWRLQTL .',\n",
       "  [['EBV',\n",
       "    '-',\n",
       "    'associated,',\n",
       "    'HLA',\n",
       "    '-',\n",
       "    'B8',\n",
       "    '-',\n",
       "    'restricted',\n",
       "    'latent',\n",
       "    'epitope'],\n",
       "   [22, 23, 24, 25, 26, 27, 28, 29, 30, 31],\n",
       "   'PROTEIN']],\n",
       " ['Most interestingly , expression of CD95 ( <e1> Fas /Apo - </e1> 1 ) and of CD23 was down - regulated in all K46 transfectants .',\n",
       "  'PROTEIN',\n",
       "  'Most interestingly , expression of CD95 ( Fas /Apo - 1 ) and of CD23 was down - regulated in all K46 transfectants .',\n",
       "  [['Fas/Apo', '-', '1'], [7, 8, 9], 'PROTEIN']],\n",
       " ['We investigated the <e1> CD8+ cytotoxic T lymphocyte ( CTL </e1> ) repertoire to an HLA B8 - restricted peptide , RAKFKQLLQ , located in the Epstein - Barr virus ( EBV ) immediate - early protein , BZLF1 .',\n",
       "  'PROTEIN',\n",
       "  'We investigated the CD8+ cytotoxic T lymphocyte ( CTL ) repertoire to an HLA B8 - restricted peptide , RAKFKQLLQ , located in the Epstein - Barr virus ( EBV ) immediate - early protein , BZLF1 .',\n",
       "  [['CD8+', 'cytotoxic', 'T', 'lymphocyte', '(CTL)', 'repertoire'],\n",
       "   [3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['We investigated the CD8+ cytotoxic T lymphocyte ( CTL ) repertoire to an HLA B8 - restricted peptide , RAKFKQLLQ , located in the <e1> Epstein - Barr virus ( EBV ) immediate - </e1> early protein , BZLF1 .',\n",
       "  'PROTEIN',\n",
       "  'We investigated the CD8+ cytotoxic T lymphocyte ( CTL ) repertoire to an HLA B8 - restricted peptide , RAKFKQLLQ , located in the Epstein - Barr virus ( EBV ) immediate - early protein , BZLF1 .',\n",
       "  [['Epstein',\n",
       "    '-',\n",
       "    'Barr',\n",
       "    'virus',\n",
       "    '(EBV)',\n",
       "    'immediate',\n",
       "    '-',\n",
       "    'early',\n",
       "    'protein'],\n",
       "   [24, 25, 26, 27, 28, 29, 30, 31, 32],\n",
       "   'PROTEIN']],\n",
       " ['TCR beta analysis showed that while there was loop length restriction in the putative peptide contact site of all responding beta chains , diverse and <e1> unique ( non - recurrent ) TCR </e1> beta clonotypes were selected in individuals during primary infection and continued to emerge after long - term virus exposure .',\n",
       "  'CELL_LINE',\n",
       "  'TCR beta analysis showed that while there was loop length restriction in the putative peptide contact site of all responding beta chains , diverse and unique ( non - recurrent ) TCR beta clonotypes were selected in individuals during primary infection and continued to emerge after long - term virus exposure .',\n",
       "  [['unique', '(non', '-', 'recurrent)', 'TCR', 'beta', 'clonotype'],\n",
       "   [25, 26, 27, 28, 29, 30, 31],\n",
       "   'CELL_LINE']],\n",
       " ['The distribution of myeloid lineage - associated cytokine receptors and lysosomal proteins was analyzed in <e1> human CD34+ cord blood cell ( CB </e1> ) subsets at different stages of myeloid commitment by reverse - transcriptase polymerase chain reaction ( RT - PCR ) .',\n",
       "  'CELL_LINE',\n",
       "  'The distribution of myeloid lineage - associated cytokine receptors and lysosomal proteins was analyzed in human CD34+ cord blood cell ( CB ) subsets at different stages of myeloid commitment by reverse - transcriptase polymerase chain reaction ( RT - PCR ) .',\n",
       "  [['human', 'CD34+', 'cord', 'blood', 'cell', '(CB)', 'subset'],\n",
       "   [15, 16, 17, 18, 19, 20, 21],\n",
       "   'CELL_LINE']],\n",
       " ['Messenger RNA ( mRNA ) levels for the <e1> granulocyte - colony stimulating factor ( G - CSF </e1> ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and tumor necrosis factor ( TNF ) receptors I ( p55 ) and II ( p75 ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "  'PROTEIN',\n",
       "  'Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and tumor necrosis factor ( TNF ) receptors I ( p55 ) and II ( p75 ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "  [['granulocyte',\n",
       "    '-',\n",
       "    'colony',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(G',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'receptor'],\n",
       "   [8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'PROTEIN']],\n",
       " ['Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , <e1> granulocyte - macrophage ( GM ) - CSF receptor </e1> alpha subunit and tumor necrosis factor ( TNF ) receptors I ( p55 ) and II ( p75 ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "  'PROTEIN',\n",
       "  'Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and tumor necrosis factor ( TNF ) receptors I ( p55 ) and II ( p75 ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "  [['granulocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    '(GM)',\n",
       "    '-',\n",
       "    'CSF',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    'subunit'],\n",
       "   [20, 21, 22, 23, 24, 25, 26, 27, 28],\n",
       "   'PROTEIN']],\n",
       " ['By contrast , the <e1> monocyte - macrophage colony stimulating factor ( M - CSF </e1> ) receptor was largely absent at this stage and in the CD34+Thy - 1 - CD45RA - subsets .',\n",
       "  'PROTEIN',\n",
       "  'By contrast , the monocyte - macrophage colony stimulating factor ( M - CSF ) receptor was largely absent at this stage and in the CD34+Thy - 1 - CD45RA - subsets .',\n",
       "  [['monocyte',\n",
       "    '-',\n",
       "    'macrophage',\n",
       "    'colony',\n",
       "    'stimulating',\n",
       "    'factor',\n",
       "    '(M',\n",
       "    '-',\n",
       "    'CSF)',\n",
       "    'receptor'],\n",
       "   [4, 5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['Cooperation of <e1> Spi - 1/ </e1> PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo - dependent differentiation in primary erythroblasts and induces their Kit ligand - dependent proliferation .',\n",
       "  'PROTEIN',\n",
       "  'Cooperation of Spi - 1/ PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo - dependent differentiation in primary erythroblasts and induces their Kit ligand - dependent proliferation .',\n",
       "  [['Spi', '-', '1/PU.1'], [2, 3, 4], 'PROTEIN']],\n",
       " ['<e1> Spi - 1/ </e1> PU.1 is a myeloid - and B - cell specific transcription factor which is also involved in Friend virus - induced murine erythroleukemia .',\n",
       "  'PROTEIN',\n",
       "  'Spi - 1/ PU.1 is a myeloid - and B - cell specific transcription factor which is also involved in Friend virus - induced murine erythroleukemia .',\n",
       "  [['Spi', '-', '1/PU.1'], [0, 1, 2], 'PROTEIN']],\n",
       " ['The pre - leukemic phase of Friend erythroleukemia results from activation of the erythropoietin receptor ( EpoR ) by the <e1> spleen focus forming virus ( SFFV ) </e1> envelope glycoprotein , followed by the emergence of leukemic clones characterized by overexpression of Spi - 1 and mutation of the p53 tumor suppressor gene .',\n",
       "  'PROTEIN',\n",
       "  'The pre - leukemic phase of Friend erythroleukemia results from activation of the erythropoietin receptor ( EpoR ) by the spleen focus forming virus ( SFFV ) envelope glycoprotein , followed by the emergence of leukemic clones characterized by overexpression of Spi - 1 and mutation of the p53 tumor suppressor gene .',\n",
       "  [['spleen',\n",
       "    'focus',\n",
       "    'forming',\n",
       "    'virus',\n",
       "    '(SFFV)',\n",
       "    'envelope',\n",
       "    'glycoprotein'],\n",
       "   [20, 21, 22, 23, 24, 25, 26],\n",
       "   'PROTEIN']],\n",
       " ['Avian erythroblasts expressing the <e1> activated mouse EpoR </e1> ( R129C ) differentiated into erythrocytes in response to hEpo .',\n",
       "  'PROTEIN',\n",
       "  'Avian erythroblasts expressing the activated mouse EpoR ( R129C ) differentiated into erythrocytes in response to hEpo .',\n",
       "  [['activated', 'mouse', 'EpoR(R129C)'], [4, 5, 6], 'PROTEIN']],\n",
       " ['Although devoid of any effect by itself , a mutant p53 cooperated with Spi - 1 and <e1> EpoR </e1> ( R129C ) to reinforce both phenotypes .',\n",
       "  'PROTEIN',\n",
       "  'Although devoid of any effect by itself , a mutant p53 cooperated with Spi - 1 and EpoR ( R129C ) to reinforce both phenotypes .',\n",
       "  [['EpoR(R129C)'], [17], 'PROTEIN']],\n",
       " ['Analysis of erythroblasts co - expressing Spi - 1 and the wild - type mouse EpoR showed that differentiation arrest and inhibition of apoptosis depended on specific cooperation between Spi - 1 and <e1> EpoR </e1> ( R129C ) .',\n",
       "  'PROTEIN',\n",
       "  'Analysis of erythroblasts co - expressing Spi - 1 and the wild - type mouse EpoR showed that differentiation arrest and inhibition of apoptosis depended on specific cooperation between Spi - 1 and EpoR ( R129C ) .',\n",
       "  [['EpoR(R129C)'], [33], 'PROTEIN']],\n",
       " ['They also suggest that the function of <e1> Spi - 1 </e1> /PU.1 in the late phase of Friend leukemia requires specific signaling from the gp55 - modified EpoR generated during the early phase of the disease .',\n",
       "  'PROTEIN',\n",
       "  'They also suggest that the function of Spi - 1 /PU.1 in the late phase of Friend leukemia requires specific signaling from the gp55 - modified EpoR generated during the early phase of the disease .',\n",
       "  [['Spi', '-', '1/PU.1'], [7, 8, 9], 'PROTEIN']],\n",
       " ['They also suggest that the function of Spi - 1 /PU.1 in the late phase of Friend leukemia requires specific signaling from the <e1> gp55 </e1> - modified EpoR generated during the early phase of the disease .',\n",
       "  'PROTEIN',\n",
       "  'They also suggest that the function of Spi - 1 /PU.1 in the late phase of Friend leukemia requires specific signaling from the gp55 - modified EpoR generated during the early phase of the disease .',\n",
       "  [['p55'], [23], 'PROTEIN']],\n",
       " ['The role of <e1> Rel/ NF - kappa B </e1> proteins in viral oncogenesis and the regulation of viral transcription .',\n",
       "  'PROTEIN',\n",
       "  'The role of Rel/ NF - kappa B proteins in viral oncogenesis and the regulation of viral transcription .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B', 'protein'], [3, 4, 5, 6, 7], 'PROTEIN']],\n",
       " ['<e1> Rel /NF - kappa </e1> B is a ubiquitous transcription factor that consists of multiple polypeptide subunits , and is subject to complex regulatory mechanisms that involve protein - protein interactions , phosphorylation , ubiquitination , proteolytic degradation , and nucleocytoplasmic translocation .',\n",
       "  'PROTEIN',\n",
       "  'Rel /NF - kappa B is a ubiquitous transcription factor that consists of multiple polypeptide subunits , and is subject to complex regulatory mechanisms that involve protein - protein interactions , phosphorylation , ubiquitination , proteolytic degradation , and nucleocytoplasmic translocation .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B'], [0, 1, 2, 3], 'PROTEIN']],\n",
       " ['The sophisticated control of <e1> Rel /NF - kappa </e1> B activity is not surprising since this transcription factor is involved in a wide array of cellular responses to extracellular cues , associated with growth , development , apoptosis , and pathogen invasion .',\n",
       "  'PROTEIN',\n",
       "  'The sophisticated control of Rel /NF - kappa B activity is not surprising since this transcription factor is involved in a wide array of cellular responses to extracellular cues , associated with growth , development , apoptosis , and pathogen invasion .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B'], [4, 5, 6, 7], 'PROTEIN']],\n",
       " ['Thus , it is not unexpected that this versatile cellular homeostatic switch would be affected by a variety of viral pathogens , which have evolved mechanisms to utilize various aspects of <e1> Rel /NF - kappa </e1> B activity to facilitate their replication , cell survival and possibly evasion of immune responses .',\n",
       "  'PROTEIN',\n",
       "  'Thus , it is not unexpected that this versatile cellular homeostatic switch would be affected by a variety of viral pathogens , which have evolved mechanisms to utilize various aspects of Rel /NF - kappa B activity to facilitate their replication , cell survival and possibly evasion of immune responses .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B'], [31, 32, 33, 34], 'PROTEIN']],\n",
       " ['This review will cover the molecular mechanisms that are utilized by mammalian oncogenic viruses to affect the activity of <e1> Rel/ NF - kappa </e1> B transcription factors and the role of Rel /NF - kappa B in the regulation of viral gene expression and replication .',\n",
       "  'PROTEIN',\n",
       "  'This review will cover the molecular mechanisms that are utilized by mammalian oncogenic viruses to affect the activity of Rel/ NF - kappa B transcription factors and the role of Rel /NF - kappa B in the regulation of viral gene expression and replication .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B'], [19, 20, 21, 22], 'PROTEIN']],\n",
       " ['This review will cover the molecular mechanisms that are utilized by mammalian oncogenic viruses to affect the activity of Rel/ NF - kappa B transcription factors and the role of <e1> Rel /NF - kappa </e1> B in the regulation of viral gene expression and replication .',\n",
       "  'PROTEIN',\n",
       "  'This review will cover the molecular mechanisms that are utilized by mammalian oncogenic viruses to affect the activity of Rel/ NF - kappa B transcription factors and the role of Rel /NF - kappa B in the regulation of viral gene expression and replication .',\n",
       "  [['Rel/NF', '-', 'kappa', 'B'], [30, 31, 32, 33], 'PROTEIN']],\n",
       " ['METHODS AND RESULTS : We measured levels of TF activity in peripheral blood mononuclear cells and <e1> highly purified monocytes </e1> /macrophages from 10 consecutive cardiac transplant recipients and 10 healthy control subjects .',\n",
       "  'CELL_TYPE',\n",
       "  'METHODS AND RESULTS : We measured levels of TF activity in peripheral blood mononuclear cells and highly purified monocytes /macrophages from 10 consecutive cardiac transplant recipients and 10 healthy control subjects .',\n",
       "  [['highly', 'purified', 'monocyte/macrophage'], [16, 17, 18], 'CELL_TYPE']],\n",
       " ['TF activity generated by both <e1> unstimulated and </e1> endotoxin - stimulated cells was significantly higher in transplant recipients than in control subjects ( P < .05 ) .',\n",
       "  'CELL_LINE',\n",
       "  'TF activity generated by both unstimulated and endotoxin - stimulated cells was significantly higher in transplant recipients than in control subjects ( P < .05 ) .',\n",
       "  [['unstimulated', 'cell'], [5, 6], 'CELL_LINE']],\n",
       " ['Despite differences in T cell responses induced by interleukin ( IL ) - 2 and IL - 7 , both cytokines modulate T cell functions by activation of <e1> signal transducers and activators of transcription ( STAT </e1> ) proteins .',\n",
       "  'PROTEIN',\n",
       "  'Despite differences in T cell responses induced by interleukin ( IL ) - 2 and IL - 7 , both cytokines modulate T cell functions by activation of signal transducers and activators of transcription ( STAT ) proteins .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    'protein'],\n",
       "   [28, 29, 30, 31, 32, 33, 34, 35],\n",
       "   'PROTEIN']],\n",
       " ['The kinetics of this translocation were delayed in <e1> IL - 7 - treated as </e1> compared to IL - 2 - treated cells .',\n",
       "  'CELL_LINE',\n",
       "  'The kinetics of this translocation were delayed in IL - 7 - treated as compared to IL - 2 - treated cells .',\n",
       "  [['IL', '-', '7', '-', 'treated', 'cell'],\n",
       "   [8, 9, 10, 11, 12, 13],\n",
       "   'CELL_LINE']],\n",
       " ['<e1> Transcription factor </e1> NF - kappaB regulates inducible Oct - 2 gene expression in precursor B lymphocytes .',\n",
       "  'PROTEIN',\n",
       "  'Transcription factor NF - kappaB regulates inducible Oct - 2 gene expression in precursor B lymphocytes .',\n",
       "  [['yranscription', 'factor'], [0, 1], 'PROTEIN']],\n",
       " ['We report that removal of the N - terminal 151 amino acids , encompassing all of the acidic domain but leaving intact the <e1> proline / serine / </e1> threonine - rich domain , results in a mutant protein with potent suppressive properties for MHC class II expression .',\n",
       "  'PROTEIN',\n",
       "  'We report that removal of the N - terminal 151 amino acids , encompassing all of the acidic domain but leaving intact the proline / serine / threonine - rich domain , results in a mutant protein with potent suppressive properties for MHC class II expression .',\n",
       "  [['proline/serine/threonine', '-', 'rich', 'domain'],\n",
       "   [23, 24, 25, 26],\n",
       "   'PROTEIN']],\n",
       " ['Rather , helenalin modifies the <e1> NF - kappaB/ IkappaB </e1> complex , preventing the release of IkappaB .',\n",
       "  'PROTEIN',\n",
       "  'Rather , helenalin modifies the NF - kappaB/ IkappaB complex , preventing the release of IkappaB .',\n",
       "  [['NF', '-', 'kappaB/IkappaB', 'complex'], [5, 6, 7, 8], 'PROTEIN']],\n",
       " ['Transcriptional up - regulation of the <e1> c - sis/platelet - derived growth factor - B ( PDGF - B ) proto </e1> - oncogene by the Tax protein of human T - cell leukemia virus type 1 has been implicated as one possible mechanism of cellular transformation by human T - cell leukemia virus type 1 .',\n",
       "  'DNA',\n",
       "  'Transcriptional up - regulation of the c - sis/platelet - derived growth factor - B ( PDGF - B ) proto - oncogene by the Tax protein of human T - cell leukemia virus type 1 has been implicated as one possible mechanism of cellular transformation by human T - cell leukemia virus type 1 .',\n",
       "  [['c',\n",
       "    '-',\n",
       "    'sis/platelet',\n",
       "    '-',\n",
       "    'derived',\n",
       "    'growth',\n",
       "    'factor',\n",
       "    '-',\n",
       "    'B',\n",
       "    '(PDGF',\n",
       "    '-',\n",
       "    'B)',\n",
       "    'proto',\n",
       "    '-',\n",
       "    'oncogene'],\n",
       "   [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20],\n",
       "   'DNA']],\n",
       " ['RelB protein and <e1> mRNA were </e1> detected constitutively in lymphocytes and in activated monocytes , differentiated DC , and monocyte - derived DC .',\n",
       "  'RNA',\n",
       "  'RelB protein and mRNA were detected constitutively in lymphocytes and in activated monocytes , differentiated DC , and monocyte - derived DC .',\n",
       "  [['RelB', 'mRNA'], [3, 4], 'RNA']],\n",
       " ['These <e1> RelB + </e1> APC were potent stimulators of the MLR .',\n",
       "  'CELL_TYPE',\n",
       "  'These RelB + APC were potent stimulators of the MLR .',\n",
       "  [['RelB+', 'APC'], [1, 2], 'CELL_TYPE']],\n",
       " ['The <e1> CAML ( calcium - modulator and cyclophilin ligand </e1> ) protein is a coinducer of NF - AT activation when overexpressed in Jurkat T cells .',\n",
       "  'PROTEIN',\n",
       "  'The CAML ( calcium - modulator and cyclophilin ligand ) protein is a coinducer of NF - AT activation when overexpressed in Jurkat T cells .',\n",
       "  [['CAML',\n",
       "    '(calcium',\n",
       "    '-',\n",
       "    'modulator',\n",
       "    'and',\n",
       "    'cyclophilin',\n",
       "    'ligand)',\n",
       "    'protein'],\n",
       "   [1, 2, 3, 4, 5, 6, 7, 8],\n",
       "   'PROTEIN']],\n",
       " ['Accordingly , we studied the role of NF - kappaB in <e1> germline Cepsilon </e1> transcription by using two human Burkitt s lymphoma B cell lines , DND39 and DG75 .',\n",
       "  'DNA',\n",
       "  'Accordingly , we studied the role of NF - kappaB in germline Cepsilon transcription by using two human Burkitt s lymphoma B cell lines , DND39 and DG75 .',\n",
       "  [['germline', 'promotor'], [11, 12], 'DNA']],\n",
       " ['Although IL - 4 activated <e1> signal transducers and activators of transcription ( STAT </e1> ) 6 in addition to NF - kappaB , NAC treatment or the transfection of decoy oligodeoxynucleotides for NF - kappaB or STAT6 only partly blocked IL - 4 - induced germline Cepsilon transcription .',\n",
       "  'PROTEIN',\n",
       "  'Although IL - 4 activated signal transducers and activators of transcription ( STAT ) 6 in addition to NF - kappaB , NAC treatment or the transfection of decoy oligodeoxynucleotides for NF - kappaB or STAT6 only partly blocked IL - 4 - induced germline Cepsilon transcription .',\n",
       "  [['signal',\n",
       "    'transducers',\n",
       "    'and',\n",
       "    'activators',\n",
       "    'of',\n",
       "    'transcription',\n",
       "    '(STAT)',\n",
       "    '6'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12],\n",
       "   'PROTEIN']],\n",
       " ['Although IL - 4 activated signal transducers and activators of transcription ( STAT ) 6 in addition to NF - kappaB , NAC treatment or the transfection of decoy oligodeoxynucleotides for NF - kappaB or STAT6 only partly blocked IL - 4 - induced <e1> germline Cepsilon </e1> transcription .',\n",
       "  'DNA',\n",
       "  'Although IL - 4 activated signal transducers and activators of transcription ( STAT ) 6 in addition to NF - kappaB , NAC treatment or the transfection of decoy oligodeoxynucleotides for NF - kappaB or STAT6 only partly blocked IL - 4 - induced germline Cepsilon transcription .',\n",
       "  [['germline', 'promotor'], [44, 45], 'DNA']],\n",
       " ['However , these two decoy oligodeoxynucleotides together almost completely abrogated IL - 4 - induced <e1> germline Cepsilon </e1> transcription .',\n",
       "  'DNA',\n",
       "  'However , these two decoy oligodeoxynucleotides together almost completely abrogated IL - 4 - induced germline Cepsilon transcription .',\n",
       "  [['germline', 'promotor'], [15, 16], 'DNA']],\n",
       " ['Of note , CD40 - mediated enhancement of IL - 4 - driven <e1> germline Cepsilon </e1> transcription was markedly decreased by NAC or by a decoy oligodeoxynucleotide for NF - kappaB .',\n",
       "  'DNA',\n",
       "  'Of note , CD40 - mediated enhancement of IL - 4 - driven germline Cepsilon transcription was markedly decreased by NAC or by a decoy oligodeoxynucleotide for NF - kappaB .',\n",
       "  [['germline', 'promotor'], [13, 14], 'DNA']],\n",
       " ['These results suggest that coordination of NF - kappaB and STAT6 may be required for induction of <e1> germline Cepsilon </e1> transcription by IL - 4 , and that CD40 - mediated NF - kappaB activation may be important in regulating both enhancement of germline Cepsilon transcription and class switching to IgE .',\n",
       "  'DNA',\n",
       "  'These results suggest that coordination of NF - kappaB and STAT6 may be required for induction of germline Cepsilon transcription by IL - 4 , and that CD40 - mediated NF - kappaB activation may be important in regulating both enhancement of germline Cepsilon transcription and class switching to IgE .',\n",
       "  [['germline', 'promotor'], [17, 18], 'DNA']],\n",
       " ['These results suggest that coordination of NF - kappaB and STAT6 may be required for induction of germline Cepsilon transcription by IL - 4 , and that CD40 - mediated NF - kappaB activation may be important in regulating both enhancement of <e1> germline Cepsilon </e1> transcription and class switching to IgE .',\n",
       "  'DNA',\n",
       "  'These results suggest that coordination of NF - kappaB and STAT6 may be required for induction of germline Cepsilon transcription by IL - 4 , and that CD40 - mediated NF - kappaB activation may be important in regulating both enhancement of germline Cepsilon transcription and class switching to IgE .',\n",
       "  [['germline', 'promotor'], [42, 43], 'DNA']],\n",
       " ['Is celiac disease due to molecular mimicry between gliadin peptide <e1> - HLA class II </e1> molecule - T cell interactions and those of some unidentified superantigen ?',\n",
       "  'PROTEIN',\n",
       "  'Is celiac disease due to molecular mimicry between gliadin peptide - HLA class II molecule - T cell interactions and those of some unidentified superantigen ?',\n",
       "  [['HLA', 'class', 'II', 'molecule'], [10, 11, 12, 13], 'PROTEIN']],\n",
       " ['Interferons exert their antiviral , antiproliferative and <e1> immunoregulatory activities </e1> by stimulating the expression of several genes .',\n",
       "  'PROTEIN',\n",
       "  'Interferons exert their antiviral , antiproliferative and immunoregulatory activities by stimulating the expression of several genes .',\n",
       "  [['immunoregulatory', 'cytokine'], [7, 8], 'PROTEIN']],\n",
       " ['HLA - DM is a <e1> major histocompatibility complex ( MHC ) class II - </e1> like molecule that facilitates antigen processing by catalyzing the exchange of invariant chain - derived peptides ( CLIP ) from class II molecules for antigenic peptides .',\n",
       "  'PROTEIN',\n",
       "  'HLA - DM is a major histocompatibility complex ( MHC ) class II - like molecule that facilitates antigen processing by catalyzing the exchange of invariant chain - derived peptides ( CLIP ) from class II molecules for antigenic peptides .',\n",
       "  [['major',\n",
       "    'histocompatibility',\n",
       "    'complex',\n",
       "    '(MHC)',\n",
       "    'class',\n",
       "    'II',\n",
       "    '-',\n",
       "    'like',\n",
       "    'molecule'],\n",
       "   [5, 6, 7, 8, 9, 10, 11, 12, 13],\n",
       "   'PROTEIN']],\n",
       " ['Expression of HLA - DO in a <e1> class II+ and DM+ , DO - human T cell </e1> line caused the accumulation of class II - CLIP complexes , indicating that HLA - DO blocked DM function in vivo and suggesting that HLA - DO is an important modulator of class II - restricted antigen processing .',\n",
       "  'CELL_LINE',\n",
       "  'Expression of HLA - DO in a class II+ and DM+ , DO - human T cell line caused the accumulation of class II - CLIP complexes , indicating that HLA - DO blocked DM function in vivo and suggesting that HLA - DO is an important modulator of class II - restricted antigen processing .',\n",
       "  [['class', 'II+', 'and', 'DM+,', 'DO', '-', 'human', 'T', 'cell', 'line'],\n",
       "   [7, 8, 9, 10, 11, 12, 13, 14, 15, 16],\n",
       "   'CELL_LINE']],\n",
       " ['Allelic variations of the <e1> vitamin D receptor ( VDR </e1> ) gene have been associated with the risk of developing prostate cancer in men and osteoporosis in postmenopausal women .',\n",
       "  'DNA',\n",
       "  'Allelic variations of the vitamin D receptor ( VDR ) gene have been associated with the risk of developing prostate cancer in men and osteoporosis in postmenopausal women .',\n",
       "  [['vitamin', 'D', 'receptor', '(VDR)', 'gene'], [4, 5, 6, 7, 8], 'DNA']],\n",
       " ['<e1> Tumor necrosis factor ( TNF ) </e1> - alpha controls T - cell activation and is a major inducer of human immunodeficiency virus ( HIV ) - 1 replication in chronically infected cells .',\n",
       "  'PROTEIN',\n",
       "  'Tumor necrosis factor ( TNF ) - alpha controls T - cell activation and is a major inducer of human immunodeficiency virus ( HIV ) - 1 replication in chronically infected cells .',\n",
       "  [['Tumor', 'necrosis', 'factor', '(TNF)', '-', 'alpha'],\n",
       "   [0, 1, 2, 3, 4, 5],\n",
       "   'PROTEIN']],\n",
       " ['Hypoxic endothelia showed a > 10 - fold increase in sensitivity to inhibitors of proteasome activation , and combinations of hypoxia and LPS enhanced proteasome - dependent cytoplasmic - to - nuclear localization of the <e1> nuclear transcription factor - kappa B p65 ( Rel A </e1> ) subunit .',\n",
       "  'PROTEIN',\n",
       "  'Hypoxic endothelia showed a > 10 - fold increase in sensitivity to inhibitors of proteasome activation , and combinations of hypoxia and LPS enhanced proteasome - dependent cytoplasmic - to - nuclear localization of the nuclear transcription factor - kappa B p65 ( Rel A ) subunit .',\n",
       "  [['nuclear',\n",
       "    'transcription',\n",
       "    'factor',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B',\n",
       "    'p65',\n",
       "    '(Rel',\n",
       "    'A)',\n",
       "    'subunit'],\n",
       "   [35, 36, 37, 38, 39, 40, 41, 42, 43, 44],\n",
       "   'PROTEIN']],\n",
       " ['The <e1> JAK ( Janus kinase </e1> ) family of protein tyrosine kinases and the STATs ( signal transducers and activators of transcription ) have been shown to be activated in response to a number of cytokines and growth factors .',\n",
       "  'PROTEIN',\n",
       "  'The JAK ( Janus kinase ) family of protein tyrosine kinases and the STATs ( signal transducers and activators of transcription ) have been shown to be activated in response to a number of cytokines and growth factors .',\n",
       "  [['JAK', '(Janus', 'kinase)', 'family'], [1, 2, 3, 4], 'PROTEIN']],\n",
       " ['In this study , we evaluated the activation of JAK /STAT pathway upon human interleukin - 5 ( hIL - 5 ) stimulation of two different hIL - 5 - responsive cell lines , <e1> hIL - 5 receptor alpha - subunit ( hIL - 5R alpha ) cDNA - transfected TF </e1> - 1 ( TF - h5R alpha ) and butyric - acid - treated YY - 1 ( YY - Bu ) , and peripheral eosinophils .',\n",
       "  'CELL_LINE',\n",
       "  'In this study , we evaluated the activation of JAK /STAT pathway upon human interleukin - 5 ( hIL - 5 ) stimulation of two different hIL - 5 - responsive cell lines , hIL - 5 receptor alpha - subunit ( hIL - 5R alpha ) cDNA - transfected TF - 1 ( TF - h5R alpha ) and butyric - acid - treated YY - 1 ( YY - Bu ) , and peripheral eosinophils .',\n",
       "  [['hIL',\n",
       "    '-',\n",
       "    '5',\n",
       "    'receptor',\n",
       "    'alpha',\n",
       "    '-',\n",
       "    'subunit',\n",
       "    '(hIL',\n",
       "    '-',\n",
       "    '5R',\n",
       "    'alpha)',\n",
       "    'cDNA',\n",
       "    '-',\n",
       "    'transfected',\n",
       "    'TF',\n",
       "    '-',\n",
       "    '1'],\n",
       "   [34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50],\n",
       "   'CELL_LINE']],\n",
       " ['<e1> Nuclear factor - kappa B ( NF - kappa B ) </e1> /Rel transcription factors may be involved in atherosclerosis , as is suggested by the presence of activated NF - kappa B in human atherosclerotic lesions .',\n",
       "  'PROTEIN',\n",
       "  'Nuclear factor - kappa B ( NF - kappa B ) /Rel transcription factors may be involved in atherosclerosis , as is suggested by the presence of activated NF - kappa B in human atherosclerotic lesions .',\n",
       "  [['nuclear',\n",
       "    'factor',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B',\n",
       "    '(NF',\n",
       "    '-',\n",
       "    'kappa',\n",
       "    'B)/Rel',\n",
       "    'transcription',\n",
       "    'factor'],\n",
       "   [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10],\n",
       "   'PROTEIN']],\n",
       " ...]"
      ]
     },
     "execution_count": 690,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lista_erro_corpus"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 693,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       " [['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of <e1> erythroid </e1> cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid <e1> cell </e1> - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid <e1> transcription </e1> factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an <e1> erythroid transcription factor </e1> that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'PROTEIN'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of <e1> erythroid cell </e1> - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - <e1> specific genes </e1> and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid <e1> cell - specific </e1> genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - <e1> specific </e1> genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of <e1> erythrocytes </e1> .',\n",
       "   'CELL_TYPE'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid <e1> cell - specific genes </e1> and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of <e1> erythroid cell - specific genes </e1> and is necessary for full maturation of erythrocytes .',\n",
       "   'DNA'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on <e1> GATA </e1> - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an <e1> erythroid transcription </e1> factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of <e1> erythroid cell - specific </e1> genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on <e1> GATA - 1 </e1> , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'PROTEIN'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an erythroid transcription factor that participates in the regulation of the majority of erythroid cell - specific <e1> genes </e1> and is necessary for full maturation of erythrocytes .',\n",
       "   'O'],\n",
       "  ['To address potential mechanisms by which estrogens suppress erythropoiesis , we have examined their effects on GATA - 1 , an <e1> erythroid </e1> transcription factor that participates in the regulation of the majority of erythroid cell - specific genes and is necessary for full maturation of erythrocytes .',\n",
       "   'O']]]"
      ]
     },
     "execution_count": 693,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combinacaoEntidadesAll[32]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 692,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['IL - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       " [['IL - 2 gene expression and <e1> NF </e1> - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['<e1> IL </e1> - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['IL - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - <e1> lipoxygenase </e1> .',\n",
       "   'O'],\n",
       "  ['IL - 2 gene expression and NF - kappa B activation through <e1> CD28 </e1> requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'PROTEIN'],\n",
       "  ['IL - 2 gene expression and <e1> NF - kappa B </e1> activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'PROTEIN'],\n",
       "  ['IL - <e1> 2 gene </e1> expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['<e1> IL - 2 gene </e1> expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'DNA'],\n",
       "  ['IL - 2 gene expression and NF - <e1> kappa </e1> B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['IL - 2 gene expression and NF - kappa <e1> B </e1> activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['<e1> IL - 2 </e1> gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['IL - 2 <e1> gene </e1> expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['IL - 2 gene expression and <e1> NF - kappa </e1> B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['IL - 2 gene expression and NF - <e1> kappa B </e1> activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "   'O'],\n",
       "  ['IL - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by <e1> 5 - lipoxygenase </e1> .',\n",
       "   'PROTEIN']]]"
      ]
     },
     "execution_count": 692,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combinacaoEntidadesAll[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 694,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "16621"
      ]
     },
     "execution_count": 694,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(combinacaoEntidadesAll)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 695,
   "metadata": {},
   "outputs": [],
   "source": [
    "save_obj('combinacaoEntidadesAll_sem_desc',combinacaoEntidadesAll)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 696,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "numTreinamento: 13296\n",
      "numTeste: 1662\n"
     ]
    }
   ],
   "source": [
    "# já ir gravando arquivos treinamento, test e dev...\n",
    "# pra fazer um teste sem descontinuas\n",
    "numTreinamento = len(combinacaoEntidadesAll)*0.8\n",
    "numTreinamento = int(numTreinamento)\n",
    "numTeste = (len(combinacaoEntidadesAll) - numTreinamento)/2\n",
    "numTeste = int(numTeste)\n",
    "numTotalEntidades=0\n",
    "numTotalEntidadesTrain=0\n",
    "numTotalEntidadesDev=0\n",
    "numTotalEntidadesTest=0\n",
    "\n",
    "print('numTreinamento:', numTreinamento)\n",
    "print('numTeste:', numTeste)\n",
    "\n",
    "f_train = open('genia.train', 'w')\n",
    "f_dev = open('genia.dev', 'w')\n",
    "f_test = open('genia.test', 'w')\n",
    "\n",
    "for i, combinacaoEntidades in enumerate(combinacaoEntidadesAll):\n",
    "    #print(dicSentences[i])\n",
    "    frase = combinacaoEntidades[0]\n",
    "    frases_entidade = combinacaoEntidades[1]\n",
    "    if i<=numTreinamento:\n",
    "        f_train.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_train.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesTrain=numTotalEntidadesTrain+1\n",
    "    elif i <= numTreinamento + numTeste:\n",
    "        f_dev.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_dev.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesDev=numTotalEntidadesDev+1\n",
    "    else:\n",
    "        f_test.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_test.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesTest=numTotalEntidadesTest+1\n",
    "\n",
    "f_train.close()\n",
    "f_test.close()\n",
    "f_dev.close()\n",
    "\n",
    "print('numTotalEntidades:', numTotalEntidades)\n",
    "print('numTotalEntidadesTrain:', numTotalEntidadesTrain)\n",
    "print('numTotalEntidadesDev:', numTotalEntidadesDev)\n",
    "print('numTotalEntidadesTest:', numTotalEntidadesTest)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## parte 2- tentar tirar verbos, CC, etc do O para nao ficar com mto FP"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 700,
   "metadata": {},
   "outputs": [],
   "source": [
    "# 1o. encontrar os postaggers das entidades...\n",
    "import xml.dom.minidom\n",
    "\n",
    "def getDicPosTagger(XMLfileName):\n",
    "    dicPostagger = {}\n",
    "    doc = xml.dom.minidom.parse(XMLfileName);\n",
    "    sentences = doc.getElementsByTagName(\"sentence\")\n",
    "    for sentence in sentences:\n",
    "        # ver se tem entidade do interesse\n",
    "        cons = sentence.getElementsByTagName(\"cons\")\n",
    "        list_w = sentence.getElementsByTagName(\"w\")\n",
    "        for i, w in enumerate(list_w):\n",
    "            texto = w.firstChild.data.lower()\n",
    "            postagger = w.getAttribute(\"c\")\n",
    "            if (postagger == '*'):\n",
    "                postagger = 'NN'\n",
    "            dicPostagger[texto] = postagger\n",
    "            for palavra in texto.split('-'):\n",
    "                if not palavra in dicPostagger.keys():\n",
    "                    dicPostagger[palavra] = postagger\n",
    "            for palavra in texto.split('/'):\n",
    "                if not palavra in dicPostagger.keys():\n",
    "                    dicPostagger[palavra] = postagger\n",
    "            if not texto.replace('(','').replace(')','') in dicPostagger.keys():\n",
    "                dicPostagger[texto] = postagger\n",
    "    #save_obj('dicPostagger', dicPostagger)\n",
    "    return dicPostagger\n",
    "\n",
    "pathCorpus=r'GENIAcorpus3.02.merged_corrigido.xml'\n",
    "dicPosTagger = getDicPosTagger(pathCorpus)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 706,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'-NN-NN-CD-NN-NN'"
      ]
     },
     "execution_count": 706,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def tipoPostaggerTokens(entidade_token, dicPostagger):\n",
    "    postagger = ''\n",
    "    for p in entidade_token:\n",
    "        if p.lower() in dicPostagger.keys():\n",
    "            postagger = postagger + '-' + dicPostagger.get(p.lower())\n",
    "        elif p.lower().replace(',','') in dicPostagger.keys():\n",
    "            postagger = postagger + '-' + dicPostagger.get(p.lower().replace(',',''))\n",
    "        elif p.lower().replace('(','').replace(')','') in dicPostagger.keys():\n",
    "            postagger = postagger + '-' + dicPostagger.get(p.lower().replace('(','').replace(')',''))\n",
    "        else:\n",
    "            for palavra in p.lower().split('/'):\n",
    "                if palavra in dicPostagger.keys():\n",
    "                    postagger = postagger + '-' + dicPostagger.get(palavra)\n",
    "            for palavra in p.lower().split('-'):\n",
    "                if palavra in dicPostagger.keys():\n",
    "                    postagger = postagger + '-' + dicPostagger.get(palavra)\n",
    "    return postagger\n",
    "\n",
    "tipoPostaggerTokens(['IL','-','2','gene','CD28'], dicPosTagger)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 732,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['bHLH'], [10], 'PROTEIN']\n",
      "[['It', 0], ['contains', 1], ['a', 2], ['basic', 3], ['helix', 4], ['-', 5], ['loop', 6], ['-', 7], ['helix', 8], ['(', 9], ['bHLH', 10], [')', 11], ['motif', 12], ['contiguous', 13], ['with', 14], ['a', 15], ['Per', 16], ['-', 17], ['Arnt', 18], ['-', 19], ['Sim', 20], ['(', 21], ['PAS', 22], [')', 23], ['homology', 24], ['region', 25], ['.', 26]]\n",
      "[['GSSG'], [16], 'PROTEIN']\n",
      "[['Because', 0], ['inhibition', 1], ['of', 2], ['DNA', 3], ['-', 4], ['binding', 5], ['activity', 6], ['is', 7], ['associated', 8], ['with', 9], ['increasing', 10], ['intracellular', 11], ['glutathione', 12], ['disulfide', 13], ['levels', 14], ['and', 15], ['GSSG', 16], ['can', 17], ['be', 18], ['shown', 19], ['to', 20], ['inhibit', 21], ['the', 22], ['DNA', 23], ['-', 24], ['binding', 25], ['activity', 26], ['directly', 27], ['in', 28], ['cell', 29], ['-', 30], ['free', 31], ['systems', 32], [',', 33], ['our', 34], ['studies', 35], ['suggest', 36], ['that', 37], ['GSSG', 38], ['is', 39], ['a', 40], ['physiologically', 41], ['relevant', 42], ['inhibitor', 43], ['in', 44], ['intact', 45], ['cells', 46], ['also', 47], ['.', 48]]\n",
      "[['GSSG'], [38], 'PROTEIN']\n",
      "[['Because', 0], ['inhibition', 1], ['of', 2], ['DNA', 3], ['-', 4], ['binding', 5], ['activity', 6], ['is', 7], ['associated', 8], ['with', 9], ['increasing', 10], ['intracellular', 11], ['glutathione', 12], ['disulfide', 13], ['levels', 14], ['and', 15], ['GSSG', 16], ['can', 17], ['be', 18], ['shown', 19], ['to', 20], ['inhibit', 21], ['the', 22], ['DNA', 23], ['-', 24], ['binding', 25], ['activity', 26], ['directly', 27], ['in', 28], ['cell', 29], ['-', 30], ['free', 31], ['systems', 32], [',', 33], ['our', 34], ['studies', 35], ['suggest', 36], ['that', 37], ['GSSG', 38], ['is', 39], ['a', 40], ['physiologically', 41], ['relevant', 42], ['inhibitor', 43], ['in', 44], ['intact', 45], ['cells', 46], ['also', 47], ['.', 48]]\n",
      "[['CD4+'], [33], 'PROTEIN']\n",
      "[['OBJECTIVE', 0], [':', 1], ['To', 2], ['determine', 3], ['whether', 4], ['activation', 5], ['of', 6], ['Epstein', 7], ['-', 8], ['Barr', 9], ['virus', 10], ['(', 11], ['EBV', 12], [')', 13], ['replication', 14], ['in', 15], ['tumour', 16], ['cells', 17], ['of', 18], ['AIDS', 19], ['-', 20], ['related', 21], ['non', 22], ['-', 23], ['Hodgkin', 24], ['s', 25], ['lymphoma', 26], ['(', 27], ['ARNHL', 28], [')', 29], ['is', 30], ['correlated', 31], ['with', 32], ['CD4+', 33], ['cell', 34], ['counts', 35], ['and', 36], ['influences', 37], ['antibody', 38], ['response', 39], ['to', 40], ['EBV', 41], ['[', 42], ['anti', 43], ['-', 44], ['Z', 45], ['Epstein', 46], ['-', 47], ['Barr', 48], ['replicative', 49], ['activator', 50], ['(', 51], ['ZEBRA', 52], [')', 53], [',', 54], ['anti', 55], ['-', 56], ['early', 57], ['antigen', 58], ['(', 59], ['EA', 60], [')', 61], [',', 62], ['anti', 63], ['-', 64], ['viral', 65], ['capsid', 66], ['antigen', 67], ['(', 68], ['VCA', 69], [')', 70], [']', 71], ['.', 72]]\n",
      "[['CD4+'], [28], 'PROTEIN']\n",
      "[['DESIGN', 0], [':', 1], ['Retrospective', 2], ['study', 3], ['based', 4], ['on', 5], ['immunohistochemistry', 6], ['and', 7], ['in', 8], ['situ', 9], ['hybridization', 10], ['to', 11], ['detect', 12], ['EBV', 13], ['replicative', 14], ['gene', 15], ['products', 16], ['in', 17], ['tissue', 18], ['samples', 19], ['from', 20], ['patients', 21], ['affected', 22], ['by', 23], ['ARNHL', 24], ['and', 25], ['correlation', 26], ['with', 27], ['CD4+', 28], ['cell', 29], ['counts', 30], ['and', 31], ['results', 32], ['of', 33], ['EBV', 34], ['serology', 35], ['(', 36], ['including', 37], ['anti', 38], ['-', 39], ['ZEBRA', 40], ['activity', 41], [')', 42], ['in', 43], ['sera', 44], ['from', 45], ['the', 46], ['same', 47], ['patients', 48], ['.', 49]]\n",
      "[['CD4+'], [7], 'PROTEIN']\n",
      "[['Results', 0], ['were', 1], ['statistically', 2], ['correlated', 3], ['with', 4], ['those', 5], ['of', 6], ['CD4+', 7], ['cell', 8], ['counts', 9], ['(', 10], ['17', 11], ['out', 12], ['of', 13], ['17', 14], [')', 15], ['and', 16], ['with', 17], ['anti', 18], ['-', 19], ['EBV', 20], ['antibody', 21], ['titres', 22], ['(', 23], ['13', 24], ['out', 25], ['of', 26], ['17', 27], [')', 28], ['assessed', 29], ['using', 30], ['standard', 31], ['immunofluorescence', 32], ['method', 33], ['and', 34], ['enzyme', 35], ['-', 36], ['linked', 37], ['immunosorbent', 38], ['assay', 39], ['procedure', 40], ['using', 41], ['recombinant', 42], ['ZEBRA', 43], ['protein', 44], ['and', 45], ['synthetic', 46], ['peptides', 47], ['as', 48], ['antigens', 49], ['.', 50]]\n",
      "[['CD4+'], [11], 'PROTEIN']\n",
      "[['Demonstration', 0], ['of', 1], ['replicative', 2], ['gene', 3], ['expression', 4], ['did', 5], ['not', 6], ['correlate', 7], ['with', 8], ['either', 9], ['low', 10], ['CD4+', 11], ['cell', 12], ['counts', 13], ['(', 14], ['P', 15], ['>', 16], ['0.05', 17], [')', 18], ['or', 19], ['anti', 20], ['-', 21], ['EBV', 22], ['antibody', 23], ['titres', 24], ['(', 25], ['P', 26], ['>', 27], ['0.05', 28], [')', 29], ['.', 30]]\n",
      "[['HRBC'], [41], 'CELL_TYPE']\n",
      "[['To', 0], ['study', 1], ['putative', 2], ['teratogenic', 3], ['effects', 4], ['of', 5], ['a', 6], ['T', 7], ['cell', 8], ['-', 9], ['mediated', 10], ['immune', 11], ['response', 12], ['versus', 13], ['an', 14], ['endotoxic', 15], ['challenge', 16], [',', 17], ['10', 18], ['-', 19], ['d', 20], ['-', 21], ['pregnant', 22], ['rats', 23], ['received', 24], ['a', 25], ['single', 26], ['intraperitoneal', 27], ['injection', 28], ['of', 29], ['5', 30], ['x', 31], ['10', 32], ['(', 33], ['8', 34], [')', 35], ['human', 36], ['red', 37], ['blood', 38], ['cells', 39], ['(', 40], ['HRBC', 41], [')', 42], ['or', 43], ['gram', 44], ['-', 45], ['negative', 46], ['bacterial', 47], ['endotoxin', 48], ['(', 49], ['Escherichia', 50], ['coli', 51], ['LPS', 52], [':', 53], ['30', 54], ['micrograms/kg', 55], [')', 56], ['.', 57]]\n",
      "[['HRBC'], [7], 'CELL_TYPE']\n",
      "[['In', 0], ['addition', 1], [',', 2], ['after', 3], ['novelty', 4], ['stress', 5], ['the', 6], ['HRBC', 7], ['group', 8], [',', 9], ['but', 10], ['not', 11], ['the', 12], ['LPS', 13], ['group', 14], [',', 15], ['showed', 16], ['increased', 17], ['ACTH', 18], ['and', 19], ['corticosterone', 20], ['levels', 21], ['.', 22]]\n",
      "[['HRBC'], [0], 'CELL_TYPE']\n",
      "[['HRBC', 0], ['and', 1], ['LPS', 2], ['indeed', 3], ['stimulated', 4], ['the', 5], ['maternal', 6], ['immune', 7], ['system', 8], ['as', 9], ['revealed', 10], ['by', 11], ['specific', 12], ['anti', 13], ['-', 14], ['HRBC', 15], ['antibody', 16], ['production', 17], ['and', 18], ['enhanced', 19], ['IL', 20], ['-', 21], ['1', 22], ['beta', 23], ['mRNA', 24], ['expression', 25], ['in', 26], ['splenocytes', 27], [',', 28], ['respectively', 29], ['.', 30]]\n",
      "[['HRBC'], [15], 'CELL_TYPE']\n",
      "[['HRBC', 0], ['and', 1], ['LPS', 2], ['indeed', 3], ['stimulated', 4], ['the', 5], ['maternal', 6], ['immune', 7], ['system', 8], ['as', 9], ['revealed', 10], ['by', 11], ['specific', 12], ['anti', 13], ['-', 14], ['HRBC', 15], ['antibody', 16], ['production', 17], ['and', 18], ['enhanced', 19], ['IL', 20], ['-', 21], ['1', 22], ['beta', 23], ['mRNA', 24], ['expression', 25], ['in', 26], ['splenocytes', 27], [',', 28], ['respectively', 29], ['.', 30]]\n",
      "[['myeloperoxidase'], [24], 'PROTEIN']\n",
      "[['In', 0], ['mice', 1], ['exposed', 2], ['to', 3], ['hypoxia', 4], ['(', 5], ['PO2', 6], ['approximately', 7], ['30', 8], ['-', 9], ['40', 10], ['Torr', 11], [')', 12], [',', 13], ['there', 14], ['was', 15], ['increased', 16], ['pulmonary', 17], ['leukostasis', 18], [',', 19], ['as', 20], ['evidenced', 21], ['by', 22], ['increased', 23], ['myeloperoxidase', 24], ['activity', 25], ['in', 26], ['tissue', 27], ['homogenates', 28], ['.', 29]]\n",
      "[['myeloperoxidase'], [31], 'PROTEIN']\n",
      "[['Leukemic', 0], ['blasts', 1], ['in', 2], ['the', 3], ['majority', 4], ['of', 5], ['cases', 6], ['shared', 7], ['unique', 8], ['morphologic', 9], ['features', 10], ['(', 11], ['deeply', 12], ['invaginated', 13], ['nuclear', 14], ['membranes', 15], [',', 16], ['scant', 17], ['cytoplasm', 18], ['with', 19], ['fine', 20], ['azurophilic', 21], ['granularity', 22], [',', 23], ['and', 24], ['finely', 25], ['granular', 26], ['Sudan', 27], ['black', 28], ['B', 29], ['and', 30], ['myeloperoxidase', 31], ['cytochemical', 32], ['reactivity', 33], [')', 34], ['that', 35], ['were', 36], ['remarkably', 37], ['similar', 38], ['to', 39], ['those', 40], ['of', 41], ['acute', 42], ['promyelocytic', 43], ['leukemia', 44], ['(', 45], ['APL', 46], [')', 47], [';', 48], ['particularly', 49], ['the', 50], ['microgranular', 51], ['variant', 52], ['(', 53], ['FAB', 54], ['AML', 55], ['-', 56], ['M3v', 57], [')', 58], ['.', 59]]\n",
      "[['RARE'], [23], 'DNA']\n",
      "[['VitD3', 0], ['induction', 1], ['resulted', 2], ['in', 3], ['the', 4], ['formation', 5], ['of', 6], ['VDR', 7], ['/RXR', 8], ['DNA', 9], ['-', 10], ['binding', 11], ['complexes', 12], ['on', 13], ['both', 14], ['VitD3', 15], ['response', 16], ['elements', 17], ['and', 18], ['RA', 19], ['response', 20], ['elements', 21], ['(', 22], ['RAREs', 23], [')', 24], ['.', 25]]\n",
      "[['RARE'], [8], 'DNA']\n",
      "[['Several', 0], ['DNA', 1], ['-', 2], ['binding', 3], ['complexes', 4], ['were', 5], ['detected', 6], ['on', 7], ['RAREs', 8], ['in', 9], ['undifferentiated', 10], ['cells', 11], ['.', 12]]\n",
      "[['RARE'], [13], 'DNA']\n",
      "[['Stimulation', 0], ['by', 1], ['RA', 2], ['resulted', 3], ['in', 4], ['increased', 5], ['RAR', 6], ['beta', 7], ['/RXR', 8], ['DNA', 9], ['binding', 10], [',', 11], ['activated', 12], ['RARE', 13], ['-', 14], ['dependent', 15], ['transcription', 16], [',', 17], ['and', 18], ['increased', 19], ['expression', 20], ['of', 21], ['RAR', 22], ['-', 23], ['beta', 24], ['.', 25]]\n",
      "[['RARE'], [22], 'DNA']\n",
      "[['Concomitant', 0], ['stimulation', 1], ['by', 2], ['VitD3', 3], ['inhibited', 4], ['the', 5], ['RA', 6], ['-', 7], ['stimulated', 8], ['formation', 9], ['of', 10], ['RAR', 11], ['beta', 12], ['/RXR', 13], ['heterodimers', 14], [',', 15], ['favoring', 16], ['VDR', 17], ['/RXR', 18], ['binding', 19], ['to', 20], ['the', 21], ['RARE', 22], ['.', 23]]\n",
      "[['RARE'], [9], 'DNA']\n",
      "[['In', 0], ['contrast', 1], [',', 2], ['neither', 3], ['the', 4], ['RA', 5], ['-', 6], ['stimulated', 7], [',', 8], ['RARE', 9], ['-', 10], ['mediated', 11], ['transcription', 12], ['nor', 13], ['the', 14], ['induced', 15], ['RAR', 16], ['-', 17], ['beta', 18], ['expression', 19], ['was', 20], ['suppressed', 21], ['by', 22], ['VitD3', 23], [',', 24], ['suggesting', 25], ['that', 26], ['VitD3', 27], ['selectively', 28], ['inhibited', 29], ['the', 30], ['retinoid', 31], ['-', 32], ['induced', 33], ['differentiation', 34], ['program', 35], ['but', 36], ['not', 37], ['the', 38], ['RARE', 39], ['-', 40], ['mediated', 41], ['signal', 42], ['.', 43]]\n",
      "[['RARE'], [39], 'DNA']\n",
      "[['In', 0], ['contrast', 1], [',', 2], ['neither', 3], ['the', 4], ['RA', 5], ['-', 6], ['stimulated', 7], [',', 8], ['RARE', 9], ['-', 10], ['mediated', 11], ['transcription', 12], ['nor', 13], ['the', 14], ['induced', 15], ['RAR', 16], ['-', 17], ['beta', 18], ['expression', 19], ['was', 20], ['suppressed', 21], ['by', 22], ['VitD3', 23], [',', 24], ['suggesting', 25], ['that', 26], ['VitD3', 27], ['selectively', 28], ['inhibited', 29], ['the', 30], ['retinoid', 31], ['-', 32], ['induced', 33], ['differentiation', 34], ['program', 35], ['but', 36], ['not', 37], ['the', 38], ['RARE', 39], ['-', 40], ['mediated', 41], ['signal', 42], ['.', 43]]\n",
      "[['myeloperoxidase'], [30], 'PROTEIN']\n",
      "[['The', 0], ['involvement', 1], ['of', 2], ['members', 3], ['of', 4], ['the', 5], ['PEBP2/CBF', 6], ['family', 7], ['in', 8], ['chromosome', 9], ['translocations', 10], ['associated', 11], ['with', 12], ['acute', 13], ['myeloid', 14], ['leukemia', 15], [',', 16], ['and', 17], ['in', 18], ['the', 19], ['transcriptional', 20], ['regulation', 21], ['of', 22], ['the', 23], ['myeloid', 24], ['-', 25], ['specific', 26], ['genes', 27], ['encoding', 28], ['for', 29], ['myeloperoxidase', 30], [',', 31], ['elastase', 32], [',', 33], ['and', 34], ['the', 35], ['colony', 36], ['-', 37], ['stimulating', 38], ['factor', 39], ['receptor', 40], [',', 41], ['highlights', 42], ['the', 43], ['relevance', 44], ['of', 45], ['the', 46], ['regulation', 47], ['of', 48], ['the', 49], ['CD36', 50], ['gene', 51], ['promoter', 52], ['in', 53], ['monocytic', 54], ['cells', 55], ['by', 56], ['members', 57], ['of', 58], ['the', 59], ['PEBP2/CBF', 60], ['family', 61], ['.', 62]]\n",
      "[['rhu', 'TNFR:Fc'], [28, 29], 'PROTEIN']\n",
      "[['Recombinant', 0], ['human', 1], ['tumor', 2], ['necrosis', 3], ['factor', 4], ['(', 5], ['TNF', 6], [')', 7], ['binding', 8], ['protein', 9], ['-', 10], ['1', 11], ['(', 12], ['r', 13], ['-', 14], ['h', 15], ['TBP', 16], ['-', 17], ['1', 18], [')', 19], ['and', 20], ['recombinant', 21], ['human', 22], ['soluble', 23], ['dimeric', 24], ['TNF', 25], ['receptor', 26], ['(', 27], ['rhu', 28], ['TNFR', 29], [':', 30], ['Fc', 31], [')', 32], ['were', 33], ['used', 34], ['to', 35], ['determine', 36], ['the', 37], ['relative', 38], ['contributions', 39], ['of', 40], ['TNF', 41], ['to', 42], ['phorbol', 43], ['myristate', 44], ['acetate', 45], ['(', 46], ['PMA', 47], [')', 48], ['and', 49], ['cytokine', 50], ['-', 51], ['induced', 52], ['human', 53], ['immunodeficiency', 54], ['virus', 55], ['type', 56], ['1', 57], ['(', 58], ['HIV', 59], ['-', 60], ['1', 61], [')', 62], ['replication', 63], ['in', 64], ['chronically', 65], ['infected', 66], ['cell', 67], ['lines', 68], ['.', 69]]\n",
      "[['rhu', 'TNFR:Fc'], [19, 20], 'PROTEIN']\n",
      "[['Treatment', 0], ['of', 1], ['HIV', 2], ['-', 3], ['1', 4], ['-', 5], ['infected', 6], ['promonocytic', 7], ['U1', 8], ['cells', 9], ['with', 10], ['r', 11], ['-', 12], ['h', 13], ['-', 14], ['TBP', 15], ['-', 16], ['1', 17], ['or', 18], ['rhu', 19], ['TNFR', 20], [':', 21], ['Fc', 22], ['reduced', 23], ['PMA', 24], ['-', 25], ['induced', 26], ['HIV', 27], ['-', 28], ['1', 29], ['p24', 30], ['antigen', 31], ['production', 32], ['in', 33], ['a', 34], ['concentration', 35], ['-', 36], ['dependent', 37], ['manner', 38], [',', 39], ['with', 40], ['a', 41], ['maximal', 42], ['inhibition', 43], ['of', 44], ['approximately', 45], ['90', 46], ['%', 47], ['.', 48]]\n",
      "[['rhu', 'TNFR:Fc'], [27, 28], 'PROTEIN']\n",
      "[['Maximal', 0], ['inhibition', 1], ['of', 2], ['p24', 3], ['antigen', 4], ['production', 5], ['in', 6], ['T', 7], ['-', 8], ['lymphocytic', 9], ['ACH', 10], ['-', 11], ['2', 12], ['cells', 13], ['was', 14], ['47', 15], ['%', 16], ['with', 17], ['r', 18], ['-', 19], ['hTBP', 20], ['-', 21], ['1', 22], ['and', 23], ['42', 24], ['%', 25], ['with', 26], ['rhu', 27], ['TNFR', 28], [':', 29], ['Fc', 30], ['.', 31]]\n",
      "[['rhu', 'TNFR:Fc'], [6, 7], 'PROTEIN']\n",
      "[['r', 0], ['-', 1], ['hTBP', 2], ['-', 3], ['1', 4], ['and', 5], ['rhu', 6], ['TNFR', 7], [':', 8], ['Fc', 9], ['also', 10], ['decreased', 11], ['p24', 12], ['antigen', 13], ['synthesized', 14], ['by', 15], ['U1', 16], ['cells', 17], ['in', 18], ['response', 19], ['to', 20], ['other', 21], ['stimuli', 22], [',', 23], ['including', 24], ['phytohemagglutinin', 25], ['(', 26], ['PHA', 27], [')', 28], ['-', 29], ['induced', 30], ['supernatant', 31], [',', 32], ['granulocyte', 33], ['-', 34], ['macrophage', 35], ['colony', 36], ['-', 37], ['stimulating', 38], ['factor', 39], [',', 40], ['interleukin', 41], ['-', 42], ['6', 43], [',', 44], ['and', 45], ['TNF', 46], ['.', 47]]\n",
      "[['rhu', 'TNFR:Fc'], [7, 8], 'PROTEIN']\n",
      "[['Both', 0], ['r', 1], ['-', 2], ['hTBP', 3], ['-', 4], ['1', 5], ['and', 6], ['rhu', 7], ['TNFR', 8], [':', 9], ['Fc', 10], ['blocked', 11], ['PMA', 12], ['induction', 13], ['of', 14], ['nuclear', 15], ['factor', 16], ['(', 17], ['NK', 18], [')', 19], ['-', 20], [' kappa', 21], ['B', 22], ['DNA', 23], ['-', 24], ['binding', 25], ['activity', 26], ['in', 27], ['U1', 28], ['cells', 29], ['in', 30], ['association', 31], ['with', 32], ['decreases', 33], ['in', 34], ['HIV', 35], ['-', 36], ['1', 37], ['replication', 38], ['.', 39]]\n",
      "[['CD4+'], [64], 'PROTEIN']\n",
      "[['We', 0], ['show', 1], ['here', 2], ['that', 3], ['the', 4], ['response', 5], ['of', 6], ['the', 7], ['HIV', 8], ['-', 9], ['1', 10], ['long', 11], ['terminal', 12], ['repeat', 13], ['(', 14], ['LTR', 15], [')', 16], ['to', 17], ['mitogenic', 18], ['or', 19], ['Tat', 20], ['-', 21], ['mediated', 22], ['activation', 23], ['is', 24], ['sensitive', 25], ['to', 26], ['the', 27], ['suppressive', 28], ['action', 29], ['of', 30], ['a', 31], ['Herpesvirus', 32], ['saimiri', 33], ['(', 34], ['HVS', 35], [')', 36], ['-', 37], ['transformed', 38], ['CD8+', 39], ['T', 40], ['cell', 41], ['clone', 42], ['from', 43], ['an', 44], ['HIV', 45], ['-', 46], ['infected', 47], ['individual', 48], ['and', 49], ['supernatants', 50], ['from', 51], ['CD8+', 52], ['T', 53], ['cells', 54], ['of', 55], ['HIV', 56], ['-', 57], ['1', 58], ['-', 59], ['infected', 60], ['asymptomatic', 61], ['subjects', 62], ['(', 63], ['CD4+', 64], ['>', 65], ['350/microliters', 66], [')', 67], ['.', 68]]\n",
      "[['CIS'], [18], 'PROTEIN']\n",
      "[['SOCS', 0], ['-', 1], ['3', 2], ['protein', 3], ['was', 4], ['detectable', 5], ['as', 6], ['early', 7], ['as', 8], ['30', 9], ['min', 10], ['following', 11], ['IL', 12], ['-', 13], ['2', 14], ['stimulation', 15], [',', 16], ['while', 17], ['CIS', 18], ['was', 19], ['seen', 20], ['only', 21], ['at', 22], ['low', 23], ['levels', 24], ['after', 25], ['2', 26], ['h', 27], ['.', 28]]\n",
      "[['CIS'], [1], 'PROTEIN']\n",
      "[['Unlike', 0], ['CIS', 1], [',', 2], ['SOCS', 3], ['-', 4], ['3', 5], ['was', 6], ['rapidly', 7], ['tyrosine', 8], ['phosphorylated', 9], ['in', 10], ['response', 11], ['to', 12], ['IL', 13], ['-', 14], ['2', 15], ['.', 16]]\n",
      "[['CIS'], [10], 'PROTEIN']\n",
      "[['Additionally', 0], [',', 1], ['in', 2], ['lymphocytes', 3], ['expressing', 4], ['SOCS', 5], ['-', 6], ['3', 7], ['but', 8], ['not', 9], ['CIS', 10], [',', 11], ['IL', 12], ['-', 13], ['2', 14], ['-', 15], ['induced', 16], ['tyrosine', 17], ['phosphorylation', 18], ['of', 19], ['STAT5b', 20], ['was', 21], ['markedly', 22], ['reduced', 23], [',', 24], ['while', 25], ['there', 26], ['was', 27], ['only', 28], ['a', 29], ['weak', 30], ['effect', 31], ['on', 32], ['IL', 33], ['-', 34], ['3', 35], ['-', 36], ['mediated', 37], ['STAT5b', 38], ['tyrosine', 39], ['phosphorylation', 40], ['.', 41]]\n",
      "[['transfectant'], [0], 'CELL_LINE']\n",
      "[['Transfectants', 0], ['grown', 1], ['in', 2], ['the', 3], ['presence', 4], ['of', 5], ['tetracycline', 6], ['contained', 7], ['about', 8], ['15,000', 9], ['receptors/cell', 10], [',', 11], ['a', 12], ['value', 13], ['approximately', 14], ['equal', 15], ['to', 16], ['basal', 17], ['level', 18], ['GR', 19], ['expression', 20], ['in', 21], ['glucocorticoid', 22], ['-', 23], ['sensitive', 24], ['6TG1.1', 25], ['cells', 26], ['before', 27], ['steroid', 28], ['treatment', 29], ['.', 30]]\n",
      "[['EVI1'], [13], 'PROTEIN']\n",
      "[['By', 0], ['using', 1], ['the', 2], ['yeast', 3], ['two', 4], ['-', 5], ['hybrid', 6], ['system', 7], [',', 8], ['we', 9], ['also', 10], ['show', 11], ['that', 12], ['EVI1', 13], ['(', 14], ['contained', 15], ['in', 16], ['its', 17], ['entirety', 18], ['in', 19], ['MDS1/EVI1', 20], ['and', 21], ['AML1/MDS1/EVI1', 22], [')', 23], ['physically', 24], ['interacts', 25], ['with', 26], ['SMAD3', 27], [',', 28], ['which', 29], ['is', 30], ['an', 31], ['intracellular', 32], ['mediator', 33], ['of', 34], ['TGF', 35], ['-', 36], ['beta1', 37], ['signaling', 38], ['.', 39]]\n",
      "[['EVI1'], [15], 'PROTEIN']\n",
      "[['We', 0], ['propose', 1], ['that', 2], ['mutations', 3], ['of', 4], ['MDS1/EVI1', 5], ['either', 6], ['by', 7], ['gene', 8], ['truncation', 9], ['resulting', 10], ['in', 11], ['the', 12], ['transcription', 13], ['repressor', 14], ['EVI1', 15], ['or', 16], ['by', 17], ['gene', 18], ['fusion', 19], ['to', 20], ['AML1', 21], ['lead', 22], ['to', 23], ['an', 24], ['altered', 25], ['cellular', 26], ['response', 27], ['to', 28], ['growth', 29], ['and', 30], ['differentiation', 31], ['factors', 32], ['that', 33], ['could', 34], ['result', 35], ['in', 36], ['leukemic', 37], ['transformation', 38], ['.', 39]]\n",
      "[['CD3+'], [20], 'CELL_TYPE']\n",
      "[['The', 0], ['percentage', 1], ['of', 2], ['CD3+', 3], ['cells', 4], ['among', 5], ['all', 6], ['immunocompetent', 7], ['cells', 8], ['in', 9], ['the', 10], ['tubal', 11], ['epithelium', 12], ['was', 13], ['46.6', 14], ['%', 15], ['(', 16], ['39.9', 17], ['%', 18], ['of', 19], ['CD3+', 20], ['were', 21], ['also', 22], ['CD8+', 23], [')', 24], [';', 25], ['the', 26], ['other', 27], ['53.4', 28], ['%', 29], ['were', 30], ['CD68+', 31], ['cells', 32], ['.', 33]]\n",
      "[['CD8+'], [23], 'CELL_TYPE']\n",
      "[['The', 0], ['percentage', 1], ['of', 2], ['CD3+', 3], ['cells', 4], ['among', 5], ['all', 6], ['immunocompetent', 7], ['cells', 8], ['in', 9], ['the', 10], ['tubal', 11], ['epithelium', 12], ['was', 13], ['46.6', 14], ['%', 15], ['(', 16], ['39.9', 17], ['%', 18], ['of', 19], ['CD3+', 20], ['were', 21], ['also', 22], ['CD8+', 23], [')', 24], [';', 25], ['the', 26], ['other', 27], ['53.4', 28], ['%', 29], ['were', 30], ['CD68+', 31], ['cells', 32], ['.', 33]]\n",
      "[['BCL2+'], [3], 'CELL_TYPE']\n",
      "[['The', 0], ['ratio', 1], ['of', 2], ['BCL2+', 3], ['to', 4], ['CD3+', 5], ['cells', 6], ['in', 7], ['ectopic', 8], ['pregnancy', 9], ['was', 10], ['0.41', 11], ['.', 12]]\n",
      "[['ringed', 'sideroblast'], [26, 27], 'CELL_TYPE']\n",
      "[['In', 0], ['the', 1], ['present', 2], ['study', 3], [',', 4], ['the', 5], ['clonal', 6], ['relationship', 7], ['was', 8], ['investigated', 9], ['between', 10], ['peripheral', 11], ['blood', 12], ['polymorphonuclear', 13], ['cells', 14], ['(', 15], ['PMNCs', 16], [')', 17], ['and', 18], ['marrow', 19], ['progenitor', 20], ['cells', 21], ['and', 22], ['the', 23], ['origin', 24], ['of', 25], ['ringed', 26], ['sideroblasts', 27], ['in', 28], ['patients', 29], ['with', 30], ['refractory', 31], ['anemia', 32], ['with', 33], ['ring', 34], ['sideroblasts', 35], ['(', 36], ['RARS', 37], [')', 38], ['by', 39], ['polymerase', 40], ['chain', 41], ['reaction', 42], ['(', 43], ['PCR', 44], [')', 45], ['of', 46], ['HUMARA', 47], ['gene', 48], ['.', 49]]\n",
      "[['ringed', 'sideroblast'], [3, 4], 'CELL_TYPE']\n",
      "[['The', 0], ['development', 1], ['of', 2], ['ringed', 3], ['sideroblasts', 4], ['in', 5], ['erythroid', 6], ['colonies', 7], ['by', 8], ['iron', 9], ['staining', 10], ['and', 11], ['their', 12], ['X', 13], ['-', 14], ['inactivation', 15], ['pattern', 16], ['were', 17], ['also', 18], ['examined', 19], ['.', 20]]\n",
      "[['ringed', 'sideroblast'], [5, 6], 'CELL_TYPE']\n",
      "[['All', 0], ['erythroid', 1], ['colonies', 2], ['consisted', 3], ['of', 4], ['ringed', 5], ['sideroblasts', 6], ['exclusively', 7], ['showed', 8], ['one', 9], ['pattern', 10], ['dominant', 11], ['in', 12], ['those', 13], ['of', 14], ['PMNCs', 15], ['.', 16]]\n",
      "[['ringed', 'sideroblast'], [23, 24], 'CELL_TYPE']\n",
      "[['Our', 0], ['findings', 1], ['suggest', 2], ['that', 3], ['non', 4], ['-', 5], ['clonal', 6], ['progenitor', 7], ['cells', 8], ['persist', 9], ['in', 10], ['some', 11], ['RARS', 12], ['cases', 13], [',', 14], ['that', 15], ['erythroid', 16], ['progenitors', 17], ['show', 18], ['mosaicism', 19], [',', 20], ['and', 21], ['that', 22], ['ringed', 23], ['sideroblasts', 24], ['may', 25], ['be', 26], ['derived', 27], ['from', 28], ['an', 29], ['abnormal', 30], ['clone', 31], ['involved', 32], ['in', 33], ['the', 34], ['pathogenesis', 35], ['of', 36], ['this', 37], ['disease', 38], ['.', 39]]\n",
      "[['CD4+'], [3], 'PROTEIN']\n",
      "[['The', 0], ['induction', 1], ['of', 2], ['CD4+', 3], ['T', 4], ['cell', 5], ['proliferative', 6], ['responses', 7], ['to', 8], ['eight', 9], ['synthetic', 10], ['peptides', 11], ['representing', 12], ['amino', 13], ['acid', 14], ['sequences', 15], ['of', 16], ['the', 17], ['VZV', 18], ['IE62', 19], ['protein', 20], ['was', 21], ['assessed', 22], ['using', 23], ['T', 24], ['cells', 25], ['and', 26], ['DC', 27], ['from', 28], ['VZV', 29], ['-', 30], ['susceptible', 31], ['donors', 32], ['.', 33]]\n",
      "[['EVI1'], [28], 'DNA']\n",
      "[['In', 0], ['UCSD', 1], ['-', 2], ['AML1', 3], [',', 4], ['we', 5], ['have', 6], ['also', 7], ['identified', 8], ['fusion', 9], ['transcripts', 10], ['between', 11], ['the', 12], ['ecotropic', 13], ['viral', 14], ['insertion', 15], ['site', 16], ['I', 17], ['(', 18], ['EVI1', 19], [')', 20], ['gene', 21], ['in', 22], ['3q26', 23], ['and', 24], ['GR6', 25], ['and', 26], ['between', 27], ['EVI1', 28], ['and', 29], ['Ribophorin', 30], ['I', 31], ['that', 32], ['maps', 33], ['30', 34], ['kb', 35], ['telomeric', 36], ['to', 37], ['GR6', 38], ['in', 39], ['3q21', 40], ['.', 41]]\n",
      "[['EVI1'], [15], 'DNA']\n",
      "[['All', 0], ['fusions', 1], ['splice', 2], ['the', 3], ['5', 4], ['ends', 5], ['of', 6], ['the', 7], ['3q21', 8], ['genes', 9], ['into', 10], ['exon', 11], ['2', 12], ['of', 13], ['the', 14], ['EVI1', 15], ['gene', 16], [',', 17], ['an', 18], ['event', 19], ['that', 20], ['is', 21], ['similar', 22], ['to', 23], ['the', 24], ['normal', 25], ['intergenic', 26], ['splicing', 27], ['of', 28], ['MDS1', 29], ['-', 30], ['EVI1', 31], ['and', 32], ['to', 33], ['those', 34], ['previously', 35], ['documented', 36], ['in', 37], ['leukemias', 38], ['with', 39], ['t(3;21)', 40], ['and', 41], ['t(3;12)', 42], [',', 43], ['in', 44], ['which', 45], ['acute', 46], ['myelogenous', 47], ['leukemia', 48], ['1', 49], ['-', 50], ['EVI1', 51], ['fusions', 52], ['and', 53], ['ETV6', 54], ['-', 55], ['EVI1', 56], ['fusions', 57], [',', 58], ['respectively', 59], [',', 60], ['occur', 61], ['.', 62]]\n",
      "[['EVI1'], [31], 'DNA']\n",
      "[['All', 0], ['fusions', 1], ['splice', 2], ['the', 3], ['5', 4], ['ends', 5], ['of', 6], ['the', 7], ['3q21', 8], ['genes', 9], ['into', 10], ['exon', 11], ['2', 12], ['of', 13], ['the', 14], ['EVI1', 15], ['gene', 16], [',', 17], ['an', 18], ['event', 19], ['that', 20], ['is', 21], ['similar', 22], ['to', 23], ['the', 24], ['normal', 25], ['intergenic', 26], ['splicing', 27], ['of', 28], ['MDS1', 29], ['-', 30], ['EVI1', 31], ['and', 32], ['to', 33], ['those', 34], ['previously', 35], ['documented', 36], ['in', 37], ['leukemias', 38], ['with', 39], ['t(3;21)', 40], ['and', 41], ['t(3;12)', 42], [',', 43], ['in', 44], ['which', 45], ['acute', 46], ['myelogenous', 47], ['leukemia', 48], ['1', 49], ['-', 50], ['EVI1', 51], ['fusions', 52], ['and', 53], ['ETV6', 54], ['-', 55], ['EVI1', 56], ['fusions', 57], [',', 58], ['respectively', 59], [',', 60], ['occur', 61], ['.', 62]]\n",
      "[['EVI1'], [51], 'DNA']\n",
      "[['All', 0], ['fusions', 1], ['splice', 2], ['the', 3], ['5', 4], ['ends', 5], ['of', 6], ['the', 7], ['3q21', 8], ['genes', 9], ['into', 10], ['exon', 11], ['2', 12], ['of', 13], ['the', 14], ['EVI1', 15], ['gene', 16], [',', 17], ['an', 18], ['event', 19], ['that', 20], ['is', 21], ['similar', 22], ['to', 23], ['the', 24], ['normal', 25], ['intergenic', 26], ['splicing', 27], ['of', 28], ['MDS1', 29], ['-', 30], ['EVI1', 31], ['and', 32], ['to', 33], ['those', 34], ['previously', 35], ['documented', 36], ['in', 37], ['leukemias', 38], ['with', 39], ['t(3;21)', 40], ['and', 41], ['t(3;12)', 42], [',', 43], ['in', 44], ['which', 45], ['acute', 46], ['myelogenous', 47], ['leukemia', 48], ['1', 49], ['-', 50], ['EVI1', 51], ['fusions', 52], ['and', 53], ['ETV6', 54], ['-', 55], ['EVI1', 56], ['fusions', 57], [',', 58], ['respectively', 59], [',', 60], ['occur', 61], ['.', 62]]\n",
      "[['EVI1'], [56], 'DNA']\n",
      "[['All', 0], ['fusions', 1], ['splice', 2], ['the', 3], ['5', 4], ['ends', 5], ['of', 6], ['the', 7], ['3q21', 8], ['genes', 9], ['into', 10], ['exon', 11], ['2', 12], ['of', 13], ['the', 14], ['EVI1', 15], ['gene', 16], [',', 17], ['an', 18], ['event', 19], ['that', 20], ['is', 21], ['similar', 22], ['to', 23], ['the', 24], ['normal', 25], ['intergenic', 26], ['splicing', 27], ['of', 28], ['MDS1', 29], ['-', 30], ['EVI1', 31], ['and', 32], ['to', 33], ['those', 34], ['previously', 35], ['documented', 36], ['in', 37], ['leukemias', 38], ['with', 39], ['t(3;21)', 40], ['and', 41], ['t(3;12)', 42], [',', 43], ['in', 44], ['which', 45], ['acute', 46], ['myelogenous', 47], ['leukemia', 48], ['1', 49], ['-', 50], ['EVI1', 51], ['fusions', 52], ['and', 53], ['ETV6', 54], ['-', 55], ['EVI1', 56], ['fusions', 57], [',', 58], ['respectively', 59], [',', 60], ['occur', 61], ['.', 62]]\n",
      "[['EVI1'], [3], 'DNA']\n",
      "[['The', 0], ['Ribophorin', 1], ['I', 2], ['-', 3], ['EVI1', 4], ['fusion', 5], ['in', 6], ['particular', 7], ['may', 8], ['be', 9], ['a', 10], ['common', 11], ['occurrence', 12], ['in', 13], ['t(3;3)', 14], ['.', 15]]\n",
      "[['bHLH'], [32], 'PROTEIN']\n",
      "[['Cdk2', 0], ['-', 1], ['dependent', 2], ['phosphorylation', 3], ['therefore', 4], ['provides', 5], ['a', 6], ['switch', 7], ['during', 8], ['late', 9], ['G1', 10], ['-', 11], ['to', 12], ['-', 13], ['S', 14], ['phase', 15], ['that', 16], ['both', 17], ['nullifies', 18], ['an', 19], ['early', 20], ['G1', 21], ['cell', 22], ['cycle', 23], ['regulatory', 24], ['function', 25], ['of', 26], ['Id3', 27], ['and', 28], ['modulates', 29], ['its', 30], ['target', 31], ['bHLH', 32], ['specificity', 33], ['.', 34]]\n",
      "[['bHLH'], [26], 'PROTEIN']\n",
      "[['These', 0], ['data', 1], ['also', 2], ['demonstrate', 3], ['that', 4], ['the', 5], ['ability', 6], ['of', 7], ['Id3', 8], ['to', 9], ['promote', 10], ['cell', 11], ['cycle', 12], ['S', 13], ['phase', 14], ['entry', 15], ['is', 16], ['not', 17], ['simply', 18], ['a', 19], ['function', 20], ['of', 21], ['its', 22], ['ability', 23], ['to', 24], ['modulate', 25], ['bHLH', 26], ['heterodimer', 27], ['-', 28], ['dependent', 29], ['gene', 30], ['expression', 31], ['and', 32], ['establish', 33], ['a', 34], ['biologically', 35], ['important', 36], ['mechanism', 37], ['through', 38], ['which', 39], ['Cdk2', 40], ['and', 41], ['Id', 42], ['-', 43], ['bHLH', 44], ['functions', 45], ['are', 46], ['integrated', 47], ['in', 48], ['the', 49], ['coordination', 50], ['of', 51], ['cell', 52], ['proliferation', 53], ['and', 54], ['differentiation', 55], ['.', 56]]\n",
      "[['myeloperoxidase'], [8], 'PROTEIN']\n",
      "[['The', 0], ['highly', 1], ['specific', 2], ['granulomonocyte', 3], ['-', 4], ['associated', 5], ['lysosomal', 6], ['proteins', 7], ['myeloperoxidase', 8], ['(', 9], ['MPO', 10], [')', 11], ['and', 12], ['lysozyme', 13], ['(', 14], ['LZ', 15], [')', 16], [',', 17], ['as', 18], ['well', 19], ['as', 20], ['the', 21], ['transcription', 22], ['factor', 23], ['PU.1', 24], [',', 25], ['were', 26], ['already', 27], ['detectable', 28], ['in', 29], ['the', 30], ['most', 31], ['immature', 32], ['CD34+Thy', 33], ['-', 34], ['1+', 35], ['subset', 36], ['.', 37]]\n",
      "[['CD4+'], [16], 'PROTEIN']\n",
      "[['Addition', 0], ['of', 1], ['neutralizing', 2], ['anti', 3], ['-', 4], ['TNF', 5], ['-', 6], ['alpha', 7], ['antibodies', 8], ['drastically', 9], ['reduced', 10], ['p24', 11], ['antigen', 12], ['release', 13], ['and', 14], ['prevented', 15], ['CD4+', 16], ['cell', 17], ['depletion', 18], ['associated', 19], ['with', 20], ['infection', 21], ['.', 22]]\n",
      "[['hematopoietic', 'precurser'], [12, 13], 'CELL_TYPE']\n",
      "[['These', 0], ['studies', 1], ['demonstrate', 2], ['that', 3], ['E2a', 4], ['-', 5], ['Pbx1', 6], ['initiates', 7], ['programmed', 8], ['cell', 9], ['death', 10], ['of', 11], ['hematopoietic', 12], ['precursers', 13], ['by', 14], ['a', 15], ['mechanism', 16], ['that', 17], ['requires', 18], ['its', 19], ['chimeric', 20], ['transcriptional', 21], ['properties', 22], [',', 23], ['but', 24], [',', 25], ['unlike', 26], ['other', 27], ['nuclear', 28], ['oncoproteins', 29], [',', 30], ['is', 31], ['independent', 32], ['of', 33], ['p53', 34], ['.', 35]]\n",
      "[['topoisomerase'], [10], 'PROTEIN']\n",
      "[['One', 0], ['hour', 1], ['pulse', 2], ['-', 3], ['treatment', 4], ['with', 5], ['3', 6], ['microM', 7], ['etoposide', 8], ['caused', 9], ['topoisomerase', 10], ['associated', 11], [',', 12], ['primary', 13], ['DNA', 14], ['breakage', 15], [',', 16], ['which', 17], ['was', 18], ['rapidly', 19], ['followed', 20], ['by', 21], ['apoptosis', 22], ['.', 23]]\n",
      "[['topoisomerase'], [9], 'PROTEIN']\n",
      "[['When', 0], ['used', 1], ['at', 2], ['differentiation', 3], ['-', 4], ['inducing', 5], ['concentrations', 6], [',', 7], ['both', 8], ['topoisomerase', 9], ['inhibitors', 10], ['caused', 11], ['a', 12], ['great', 13], ['stimulation', 14], ['of', 15], ['AP', 16], ['-', 17], ['1', 18], ['binding', 19], ['activity', 20], [',', 21], ['with', 22], ['maximum', 23], ['value', 24], ['at', 25], ['hour', 26], ['12', 27], ['in', 28], ['etoposide', 29], ['-', 30], ['treated', 31], ['cells', 32], ['and', 33], ['at', 34], ['hour', 35], ['48', 36], ['in', 37], ['ICRF', 38], ['-', 39], ['193', 40], ['-', 41], ['treated', 42], ['cells', 43], ['.', 44]]\n",
      "[['topoisomerase'], [32], 'PROTEIN']\n",
      "[['However', 0], [',', 1], ['there', 2], ['are', 3], ['other', 4], ['effects', 5], [',', 6], ['such', 7], ['as', 8], ['the', 9], ['early', 10], ['activation', 11], ['of', 12], ['protein', 13], ['kinase', 14], ['C', 15], [',', 16], ['which', 17], ['are', 18], ['probably', 19], ['derived', 20], ['from', 21], ['the', 22], ['production', 23], ['of', 24], ['primary', 25], ['DNA', 26], ['breakage', 27], ['by', 28], ['some', 29], ['anti', 30], ['-', 31], ['topoisomerase', 32], ['drugs', 33], ['.', 34]]\n",
      "[['chemoattractant'], [5], 'PROTEIN']\n",
      "[['Stimulation', 0], ['of', 1], ['human', 2], ['neutrophils', 3], ['with', 4], ['chemoattractants', 5], ['FMLP', 6], ['or', 7], ['platelet', 8], ['activating', 9], ['factor', 10], ['(', 11], ['PAF', 12], [')', 13], ['results', 14], ['in', 15], ['different', 16], ['but', 17], ['overlapping', 18], ['functional', 19], ['responses', 20], ['.', 21]]\n",
      "[['chemoattractant'], [10], 'PROTEIN']\n",
      "[['These', 0], ['results', 1], ['demonstrate', 2], ['distinct', 3], ['patterns', 4], ['of', 5], ['intracellular', 6], ['signaling', 7], ['for', 8], ['two', 9], ['chemoattractants', 10], ['and', 11], ['suggest', 12], ['that', 13], ['selective', 14], ['activation', 15], ['of', 16], ['intracellular', 17], ['signaling', 18], ['cascades', 19], ['may', 20], ['underlie', 21], ['different', 22], ['patterns', 23], ['of', 24], ['functional', 25], ['responses', 26], ['.', 27]]\n",
      "[['chemoattractant'], [38], 'PROTEIN']\n",
      "[['In', 0], ['order', 1], ['to', 2], ['elucidate', 3], ['possible', 4], ['mechanisms', 5], ['underlying', 6], ['endothelial', 7], ['cell', 8], ['activation', 9], ['by', 10], ['xenogeneic', 11], ['serum', 12], [',', 13], ['we', 14], ['focussed', 15], ['on', 16], ['transcription', 17], ['factor', 18], ['NF', 19], ['-', 20], ['kappa', 21], ['B', 22], [',', 23], ['a', 24], ['central', 25], ['regulator', 26], ['for', 27], ['the', 28], ['induction', 29], ['of', 30], ['different', 31], ['genes', 32], [',', 33], ['including', 34], ['adhesive', 35], ['molecules', 36], ['and', 37], ['chemoattractants', 38], ['.', 39]]\n",
      "[['CIS'], [36], 'PROTEIN']\n",
      "[['While', 0], ['IL', 1], ['-', 2], ['4', 3], ['does', 4], ['not', 5], ['activate', 6], ['STAT5', 7], [',', 8], ['it', 9], ['induces', 10], ['expression', 11], ['of', 12], ['STAT5', 13], ['-', 14], ['regulated', 15], ['genes', 16], ['in', 17], ['CTLL', 18], ['-', 19], ['2', 20], [',', 21], ['i.e.', 22], ['beta', 23], ['-', 24], ['casein', 25], [',', 26], ['a', 27], ['cytokine', 28], ['-', 29], ['inducible', 30], ['SH2', 31], ['-', 32], ['containing', 33], ['protein', 34], ['(', 35], ['CIS', 36], [')', 37], [',', 38], ['and', 39], ['oncostatin', 40], ['M', 41], ['(', 42], ['OSM', 43], [')', 44], [',', 45], ['suggesting', 46], ['that', 47], ['STAT6', 48], ['activated', 49], ['by', 50], ['IL', 51], ['-', 52], ['4', 53], ['substitutes', 54], ['for', 55], ['the', 56], ['function', 57], ['of', 58], ['STAT5', 59], ['in', 60], ['T', 61], ['cells', 62], ['.', 63]]\n",
      "[['CIS'], [40], 'PROTEIN']\n",
      "[['In', 0], ['apparent', 1], ['contradiction', 2], [',', 3], ['expression', 4], ['of', 5], ['a', 6], ['dominant', 7], ['negative', 8], ['form', 9], ['of', 10], ['Ras', 11], [',', 12], ['RasN17', 13], [',', 14], ['also', 15], ['inhibited', 16], ['IL', 17], ['-', 18], ['2', 19], ['-', 20], ['induced', 21], ['activation', 22], ['of', 23], ['the', 24], ['promoter', 25], ['containing', 26], ['the', 27], ['minimal', 28], ['beta', 29], ['-', 30], ['casein', 31], ['STAT5', 32], ['element', 33], ['as', 34], ['well', 35], ['as', 36], ['the', 37], ['promoters', 38], ['of', 39], ['CIS', 40], ['and', 41], ['OSM', 42], ['.', 43]]\n",
      "[['alphaCD3'], [20], 'PROTEIN']\n",
      "[['MATERIALS', 0], ['AND', 1], ['METHODS', 2], [':', 3], ['Lymphocyte', 4], ['samples', 5], ['were', 6], ['stimulated', 7], ['by', 8], ['either', 9], ['the', 10], ['mitogen', 11], ['phytohemagglutinin', 12], ['(', 13], ['PHA', 14], [')', 15], ['or', 16], ['the', 17], ['monoclonal', 18], ['antibody', 19], ['alphaCD3', 20], ['.', 21]]\n",
      "[['alphaCD3'], [12], 'PROTEIN']\n",
      "[['RESULTS', 0], [':', 1], ['Cord', 2], ['lymphocytes', 3], ['revealed', 4], ['a', 5], ['greater', 6], ['proliferation', 7], ['rate', 8], ['with', 9], ['PHA', 10], ['and', 11], ['alphaCD3', 12], ['than', 13], ['adult', 14], ['lymphocytes', 15], ['(', 16], ['p', 17], ['0.0081', 18], ['and', 19], ['0.0023', 20], [',', 21], ['respectively', 22], [')', 23], ['.', 24]]\n",
      "[['alphaCD3'], [61], 'PROTEIN']\n",
      "[['In', 0], ['addition', 1], [',', 2], ['Northern', 3], ['blot', 4], ['analysis', 5], ['of', 6], ['cord', 7], ['and', 8], ['adult', 9], ['samples', 10], ['revealed', 11], ['similar', 12], ['maximal', 13], ['increases', 14], ['in', 15], ['c', 16], ['-', 17], ['fos', 18], ['(', 19], ['99+/', 20], ['-', 21], ['15', 22], ['and', 23], ['126+/', 24], ['-', 25], ['11', 26], ['%', 27], [',', 28], ['p', 29], ['0.0126', 30], [')', 31], ['and', 32], ['c', 33], ['-', 34], ['jun', 35], ['(', 36], ['123+/', 37], ['-', 38], ['9', 39], ['and', 40], ['185+/', 41], ['-', 42], ['38', 43], ['%', 44], [',', 45], ['p', 46], ['0.0291', 47], [')', 48], ['mRNA', 49], ['expression', 50], [',', 51], ['respectively', 52], [',', 53], ['as', 54], ['early', 55], ['as', 56], ['15', 57], ['min', 58], ['post', 59], ['-', 60], ['alphaCD3', 61], ['stimulation', 62], ['.', 63]]\n",
      "[['autosome'], [13], 'DNA']\n",
      "[['We', 0], ['have', 1], ['analyzed', 2], ['de', 3], ['novo', 4], ['radiation', 5], ['-', 6], ['induced', 7], ['translocations', 8], ['between', 9], ['the', 10], ['Xi', 11], ['and', 12], ['autosomes', 13], ['to', 14], ['study', 15], ['the', 16], ['maintenance', 17], ['and', 18], ['spreading', 19], ['of', 20], ['X', 21], ['-', 22], ['chromosome', 23], ['inactivation', 24], ['(', 25], ['X', 26], ['inactivation', 27], [')', 28], ['in', 29], ['relation', 30], ['to', 31], ['the', 32], ['position', 33], ['of', 34], ['the', 35], ['X', 36], ['-', 37], ['inactivation', 38], ['center', 39], ['(', 40], ['XIC', 41], [')', 42], ['/XIST', 43], ['in', 44], ['differentiated', 45], ['cells', 46], ['.', 47]]\n",
      "[['branchial', 'myoblast'], [29, 30], 'CELL_TYPE']\n",
      "[['Musculin', 0], ['protein', 1], ['is', 2], ['closely', 3], ['related', 4], ['to', 5], ['human', 6], ['ABF', 7], ['-', 8], ['1', 9], [',', 10], ['which', 11], ['is', 12], ['expressed', 13], ['in', 14], ['activated', 15], ['B', 16], ['cells', 17], [',', 18], ['and', 19], ['to', 20], ['epicardin/capsulin/Pod', 21], ['-', 22], ['1', 23], [',', 24], ['which', 25], ['is', 26], ['expressed', 27], ['in', 28], ['branchial', 29], ['myoblasts', 30], [',', 31], ['visceral', 32], ['and', 33], ['urogenital', 34], ['mesoderm', 35], ['and', 36], ['epicardium', 37], ['.', 38]]\n",
      "[['CD4+'], [11], 'PROTEIN']\n",
      "[['In', 0], ['all', 1], ['3', 2], ['cases', 3], [',', 4], ['a', 5], ['characteristic', 6], ['immunophenotype', 7], ['was', 8], ['identified', 9], ['(', 10], ['CD4+', 11], [',', 12], ['CD13', 13], ['-', 14], [',', 15], ['CD33+', 16], [',', 17], ['CD65s+', 18], [')', 19], ['.', 20]]\n",
      "[['CD8+CD56+/CD57+'], [26], 'CELL_TYPE']\n",
      "[['These', 0], ['are', 1], [':', 2], ['helper', 3], ['-', 4], ['inducer', 5], ['(', 6], ['memory', 7], [')', 8], ['T', 9], ['cells', 10], ['(', 11], ['CD4+CD45R0+CD45RA', 12], ['-', 13], ['CD29highCD11a+', 14], [')', 15], [',', 16], ['CD20+', 17], ['B', 18], ['cells', 19], [',', 20], ['and', 21], ['cytotoxic', 22], ['T', 23], ['cells', 24], ['(', 25], ['CD8+CD56+/CD57+', 26], [')', 27], ['.', 28]]\n",
      "[['heterodimeric', 'NFKB2(p49)/RelA(p65)'], [6, 7], 'PROTEIN']\n",
      "[['In', 0], ['contrast', 1], [',', 2], ['the', 3], ['affinity', 4], ['of', 5], ['heterodimeric', 6], ['NFKB2', 7], ['(', 8], ['p49', 9], [')', 10], ['/', 11], ['RelA', 12], ['(', 13], ['p65', 14], [')', 15], ['for', 16], ['this', 17], ['site', 18], ['is', 19], ['approximately', 20], ['6', 21], ['-', 22], ['fold', 23], ['higher', 24], ['(', 25], ['KD', 26], ['11.8', 27], ['pM', 28], [')', 29], ['than', 30], ['that', 31], ['of', 32], ['p49', 33], ['alone', 34], ['.', 35]]\n",
      "[['autoantibody'], [4], 'PROTEIN']\n",
      "[['Target', 0], ['antigens', 1], ['defined', 2], ['by', 3], ['autoantibodies', 4], ['in', 5], ['IDDM', 6], ['include', 7], ['insulin', 8], [',', 9], ['a', 10], ['putative', 11], ['glycolipid', 12], ['that', 13], ['reacts', 14], ['with', 15], ['islet', 16], ['cell', 17], ['antibodies', 18], [',', 19], ['and', 20], ['a', 21], ['64,000', 22], ['-', 23], ['M(r)', 24], ['protein', 25], ['recently', 26], ['identified', 27], ['as', 28], ['glutamic', 29], ['acid', 30], ['decarboxylase', 31], ['.', 32]]\n",
      "[['CD34+/CD38(2+)'], [20], 'CELL_LINE']\n",
      "[['In', 0], ['immature', 1], ['hematopoietic', 2], ['cells', 3], [',', 4], ['tal', 5], ['-', 6], ['1', 7], ['and', 8], ['GATA', 9], ['-', 10], ['1', 11], ['genes', 12], ['are', 13], ['coexpressed', 14], ['in', 15], ['committed', 16], ['progenitors', 17], ['cells', 18], ['(', 19], ['CD34+/CD38(2+)', 20], [')', 21], [',', 22], ['whereas', 23], ['they', 24], ['are', 25], ['not', 26], ['detectable', 27], ['in', 28], ['the', 29], ['most', 30], ['primitive', 31], ['cells', 32], ['(', 33], ['CD34(2+)/CD38', 34], ['-', 35], [')', 36], ['.', 37]]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['myeloblast'], [20], 'CELL_TYPE']\n",
      "[['Egr', 0], ['-', 1], ['1', 2], ['antisense', 3], ['oligomers', 4], ['in', 5], ['the', 6], ['culture', 7], ['media', 8], ['blocked', 9], ['macrophage', 10], ['differentiation', 11], ['in', 12], ['both', 13], ['myeloid', 14], ['leukemia', 15], ['cell', 16], ['lines', 17], ['and', 18], ['normal', 19], ['myeloblasts', 20], ['.', 21]]\n",
      "[['myeloblast'], [16], 'CELL_TYPE']\n",
      "[['These', 0], ['observations', 1], ['indicate', 2], ['that', 3], ['expression', 4], ['of', 5], ['Egr', 6], ['-', 7], ['1', 8], ['is', 9], ['essential', 10], ['for', 11], ['and', 12], ['restricts', 13], ['differentiation', 14], ['of', 15], ['myeloblasts', 16], ['along', 17], ['the', 18], ['macrophage', 19], ['lineage', 20], ['.', 21]]\n",
      "[['PRE'], [5], 'DNA']\n",
      "[['The', 0], ['enhancer', 1], ['activity', 2], ['of', 3], ['the', 4], ['PRE', 5], ['was', 6], ['completely', 7], ['suppressed', 8], ['when', 9], ['the', 10], ['NRE', 11], ['was', 12], ['present', 13], ['.', 14]]\n",
      "[['hepatic', 'microsome'], [0, 1], 'CELL_TYPE']\n",
      "[['Hepatic', 0], ['microsomes', 1], ['and', 2], ['isolated', 3], ['hepatocytes', 4], ['in', 5], ['short', 6], ['term', 7], ['culture', 8], ['desulfate', 9], ['T3', 10], ['sulfate', 11], ['(', 12], ['T3SO4', 13], [')', 14], ['.', 15]]\n",
      "[['hepatic', 'microsome'], [19, 20], 'CELL_TYPE']\n",
      "[['Human', 0], ['fibroblasts', 1], ['contained', 2], ['roughly', 3], ['the', 4], ['same', 5], ['level', 6], ['of', 7], ['microsomal', 8], ['p', 9], ['-', 10], ['nitrophenyl', 11], ['sulfatase', 12], ['activity', 13], ['as', 14], ['that', 15], ['previously', 16], ['observed', 17], ['in', 18], ['hepatic', 19], ['microsomes', 20], ['.', 21]]\n",
      "[['transfectant'], [21], 'CELL_LINE']\n",
      "[['A', 0], ['number', 1], ['of', 2], ['genes', 3], ['known', 4], ['to', 5], ['be', 6], ['induced', 7], ['following', 8], ['T', 9], ['cell', 10], ['activation', 11], ['and', 12], ['associated', 13], ['with', 14], ['cell', 15], ['growth', 16], ['were', 17], ['increased', 18], ['in', 19], ['the', 20], ['transfectants', 21], [',', 22], ['including', 23], ['c', 24], ['-', 25], ['fos', 26], [',', 27], ['c', 28], ['-', 29], ['myc', 30], [',', 31], ['c', 32], ['-', 33], ['myb', 34], [',', 35], ['HLA', 36], ['-', 37], ['DR', 38], [',', 39], ['lck', 40], [',', 41], ['NF', 42], ['-', 43], ['kappa', 44], ['B', 45], [',', 46], ['interleukin', 47], ['-', 48], ['2', 49], ['and', 50], ['interleukin', 51], ['-', 52], ['2', 53], ['receptor', 54], ['alpha', 55], ['(', 56], ['IL', 57], ['-', 58], ['2R', 59], ['alpha', 60], [')', 61], ['.', 62]]\n",
      "[['myeloblast'], [32], 'CELL_LINE']\n",
      "[['Constitutive', 0], ['expression', 1], ['of', 2], ['1,25(OH)2D3', 3], ['receptor', 4], ['RNA', 5], ['was', 6], ['detected', 7], ['in', 8], ['various', 9], ['kinds', 10], ['of', 11], ['hematopoietic', 12], ['cells', 13], [',', 14], ['including', 15], ['macrophages', 16], ['and', 17], ['activated', 18], ['T', 19], ['lymphocytes', 20], [',', 21], ['as', 22], ['well', 23], ['as', 24], ['in', 25], ['cell', 26], ['lines', 27], ['KG', 28], ['-', 29], ['1', 30], ['(', 31], ['myeloblasts', 32], [')', 33], [',', 34], ['HL', 35], ['-', 36], ['60', 37], ['(', 38], ['promyelocytes', 39], [')', 40], [',', 41], ['ML', 42], ['-', 43], ['3', 44], ['(', 45], ['myelomonoblasts', 46], [')', 47], [',', 48], ['U937', 49], [',', 50], ['THP', 51], ['-', 52], ['1', 53], ['(', 54], ['monoblasts', 55], [')', 56], [',', 57], ['K562', 58], ['(', 59], ['erythroblasts', 60], [')', 61], [',', 62], ['and', 63], ['S', 64], ['-', 65], ['LB1', 66], ['(', 67], ['HTLV', 68], ['-', 69], ['1', 70], ['-', 71], ['transfected', 72], ['T', 73], ['lymphocytes', 74], [')', 75], ['.', 76]]\n",
      "[['CD4+'], [27], 'CELL_TYPE']\n",
      "[['1,25(OH)2D3', 0], ['receptors', 1], ['were', 2], ['expressed', 3], ['to', 4], ['a', 5], ['greater', 6], ['extent', 7], ['on', 8], ['CD8+', 9], ['T', 10], ['-', 11], ['lymphocytes', 12], ['than', 13], ['on', 14], ['CD4+', 15], ['T', 16], ['-', 17], ['lymphocytes', 18], ['in', 19], ['sarcoidosis', 20], [',', 21], ['whereas', 22], ['a', 23], ['greater', 24], ['proportion', 25], ['of', 26], ['CD4+', 27], ['than', 28], ['of', 29], ['CD8+', 30], ['T', 31], ['-', 32], ['lymphocytes', 33], ['from', 34], ['patients', 35], ['with', 36], ['tuberculosis', 37], ['were', 38], ['receptor', 39], ['-', 40], ['positive', 41], ['.', 42]]\n",
      "[['hematologic', 'neoplasm'], [34, 35], 'CELL_TYPE']\n",
      "[['The', 0], ['TCF', 1], ['-', 2], ['1', 3], ['protein', 4], ['was', 5], ['detectable', 6], ['in', 7], ['all', 8], ['samples', 9], ['of', 10], ['a', 11], ['set', 12], ['of', 13], ['22', 14], ['T', 15], ['-', 16], ['cell', 17], ['malignancies', 18], ['of', 19], ['various', 20], ['stages', 21], ['of', 22], ['maturation', 23], [',', 24], ['but', 25], ['was', 26], ['absent', 27], ['from', 28], ['a', 29], ['large', 30], ['number', 31], ['of', 32], ['other', 33], ['hematologic', 34], ['neoplasms', 35], ['.', 36]]\n",
      "[['nonpilus', 'adhesin'], [10, 11], 'PROTEIN']\n",
      "[['The', 0], ['RpoN', 1], ['mutant', 2], [',', 3], ['lacking', 4], ['pili', 5], [',', 6], ['flagella', 7], [',', 8], ['and', 9], ['nonpilus', 10], ['adhesins', 11], [',', 12], ['bound', 13], ['poorly', 14], ['and', 15], ['was', 16], ['resistant', 17], ['to', 18], ['ingestion', 19], ['by', 20], ['both', 21], ['macrophages', 22], ['and', 23], ['neutrophils', 24], ['.', 25]]\n",
      "[['autoantibody'], [15], 'PROTEIN']\n",
      "[['Several', 0], ['of', 1], ['the', 2], ['heterogeneous', 3], ['clinical', 4], ['manifestations', 5], ['of', 6], ['systemic', 7], ['lupus', 8], ['erythematosus', 9], ['have', 10], ['been', 11], ['associated', 12], ['with', 13], ['specific', 14], ['autoantibodies', 15], ['.', 16]]\n",
      "[['autoantibody'], [7], 'PROTEIN']\n",
      "[['Associations', 0], ['between', 1], ['HLA', 2], ['class', 3], ['II', 4], ['antigens', 5], ['and', 6], ['autoantibodies', 7], ['to', 8], ['the', 9], ['ribonucleoproteins', 10], ['Ro(SSA)', 11], ['and', 12], ['La(SSB)', 13], ['have', 14], ['been', 15], ['reported', 16], ['in', 17], ['these', 18], ['patients', 19], ['.', 20]]\n",
      "[['transcriptional', \"'silencer'\"], [6, 7], 'DNA']\n",
      "[['The', 0], ['element', 1], ['has', 2], ['characteristics', 3], ['of', 4], ['a', 5], ['transcriptional', 6], ['silencer', 7], ['since', 8], ['it', 9], ['functions', 10], ['in', 11], ['both', 12], ['orientations', 13], ['.', 14]]\n",
      "[['HLH'], [6], 'PROTEIN']\n",
      "[['Helix', 0], ['-', 1], ['loop', 2], ['-', 3], ['helix', 4], ['(', 5], ['HLH', 6], [')', 7], ['transcription', 8], ['factors', 9], ['are', 10], ['involved', 11], ['in', 12], ['cellular', 13], ['growth', 14], ['and', 15], ['differentiation', 16], ['.', 17]]\n"
     ]
    }
   ],
   "source": [
    "lista_postaggers_entidades = []\n",
    "for key, value in dicSentences.items():\n",
    "    entidades = value[1]\n",
    "    #print(entidades)\n",
    "    for entidade in entidades:\n",
    "        pos_tagger=tipoPostaggerTokens(entidade[0], dicPosTagger)\n",
    "        if pos_tagger=='-JJ':\n",
    "            print(entidade)\n",
    "            print(value[0])\n",
    "        if pos_tagger not in lista_postaggers_entidades:\n",
    "            lista_postaggers_entidades.append(pos_tagger)\n",
    "    \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 719,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['-NN-NN-CD-NN',\n",
       " '-NN-NN-NN-NN',\n",
       " '-NN',\n",
       " '-CD-NN-NN',\n",
       " '-NN-NN-NN',\n",
       " '-NN-NN-CD',\n",
       " '-JJ-NN-NNS',\n",
       " '-NN-NN-JJ-NN',\n",
       " '-NN-NN',\n",
       " '-NN-NN-NN-NN-NN']"
      ]
     },
     "execution_count": 719,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lista_postaggers_entidades[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 725,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True\n",
      "True\n",
      "True\n",
      "False\n",
      "False\n",
      "False\n",
      "False\n",
      "True\n"
     ]
    }
   ],
   "source": [
    "print('-CD' in lista_postaggers_entidades)\n",
    "print('-CC' in lista_postaggers_entidades) # -> só tem 2, um é em maiusculo, excluir\n",
    "print('-JJ' in lista_postaggers_entidades)\n",
    "print('-VBN' in lista_postaggers_entidades)\n",
    "print('-IN' in lista_postaggers_entidades)\n",
    "print('-TO' in lista_postaggers_entidades)\n",
    "print('-VBZ' in lista_postaggers_entidades)\n",
    "print('-NNS' in lista_postaggers_entidades)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 832,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "key: 999\n",
      "key: 1999\n",
      "key: 2999\n",
      "key: 3999\n",
      "key: 4999\n",
      "key: 5999\n",
      "key: 6999\n",
      "key: 7999\n",
      "key: 8999\n",
      "key: 9999\n",
      "key: 10999\n",
      "key: 11999\n",
      "key: 12999\n",
      "key: 13999\n",
      "key: 14999\n",
      "key: 15999\n",
      "key: 16999\n",
      "key: 17999\n",
      "numDescontinuas: 1395\n",
      "erro_corpus: 1760\n",
      "num_frases_sem_entidade: 1841\n"
     ]
    }
   ],
   "source": [
    "palavrasDescontinua_underline=['AND_NOT', 'AND/OR', 'AS_WELL_AS', 'AND', 'OR', 'BUT_NOT', 'NEITHER_NOR', 'THAN']\n",
    "num=0\n",
    "numDescontinuas=0\n",
    "erro_corpus=0\n",
    "num_frases_sem_entidade=0\n",
    "lista_erro_corpus=list()\n",
    "combinacaoEntidadesAll = list()\n",
    "combinacaoEntidades = list()\n",
    "pulando_termos_postagger = list()\n",
    "for key, value in dicSentencesComLabel.items():\n",
    "    num=num+1\n",
    "    combinacaoEntidades = list()\n",
    "    #print('key:', key)\n",
    "    #print(value)\n",
    "    tokens=value[0].copy()\n",
    "    so_tokens = [t[0] for t in tokens]\n",
    "    entidades=value[1].copy()\n",
    "    #print(so_tokens)\n",
    "    #print(entidades)\n",
    "    for entidade in entidades:\n",
    "        erros_entidade = list()\n",
    "        #print(entidade[1])\n",
    "        texto_entidade=entidade[0]\n",
    "        indices = entidade[1]\n",
    "        tipo_entidade = entidade[2]\n",
    "        if areConsecutive(indices): # ver se não é descontinua\n",
    "            #print(entidade[1])\n",
    "            #print(frase)\n",
    "            frase = so_tokens.copy()\n",
    "            inicio=indices[0]\n",
    "            fim=indices[-1]\n",
    "            frase.insert(inicio, '<e1>')\n",
    "            frase.insert(fim+2, '</e1>')\n",
    "            if ' '.join(texto_entidade).strip()=='-' or ' '.join(texto_entidade).strip()=='=' or ' '.join(texto_entidade).strip()=='+' or ' '.join(texto_entidade).strip()==':' or ' '.join(texto_entidade).strip()==',' or ' '.join(texto_entidade).strip()==\"'\" or ' '.join(texto_entidade).strip()=='\"' or ' '.join(texto_entidade).strip()=='.' or ' '.join(texto_entidade).strip()==';' or ' '.join(texto_entidade).strip()=='/' or ' '.join(texto_entidade).strip()=='(' or ' '.join(texto_entidade).strip()==')' or ' '.join(texto_entidade).strip()=='[' or ' '.join(texto_entidade).strip()==']':\n",
    "                pass\n",
    "            #print('--texto_entidade--:', texto_entidade)\n",
    "            #print('frase:', frase)\n",
    "            #print('frase[inicio+1:fim+2]:', frase[inicio+1:fim+2])\n",
    "            #print(tokens[indice])\n",
    "            # o corpus tem alguns problemas, ex tem entidade descontinua sem o CC\n",
    "            # entao aqui, se não bater, não adicionar no arquivo de treinamento\n",
    "            # ex frase \"The inhibition of c - fos and c - jun expression by IL - 4 in LPS - treated cells was shown to be due to a lower transcription rate of the c - fos and c - jun genes .\"\n",
    "            #print(\"texto_entidade:\", texto_entidade)\n",
    "            #print(\"frase[inicio:fim]:\", frase[inicio+1:fim+2])\n",
    "            texto_entidade_comparar=' '.join(texto_entidade).strip().replace('/','').replace(')','').replace('(','').replace(']','').replace('[','').replace(',','').replace('.','').replace(';','').replace('-','').replace('+','').replace(\"'\",'')\n",
    "            texto_entidade_comparar = replaceWhiteSpaces(texto_entidade_comparar)\n",
    "            texto_frase_comparar = ' '.join(frase[inicio+1:fim+2]).strip().replace('/','').replace(')','').replace('(','').replace(']','').replace('[','').replace(',','').replace('.','').replace(';','').replace('-','').replace('+','').replace(\"'\",'')\n",
    "            texto_frase_comparar = replaceWhiteSpaces(texto_frase_comparar)\n",
    "            #tem = [palavra.lower() in texto_entidade_comparar for palavra in palavrasDescontinua]\n",
    "            #tem = [' '+palavra.lower()+' ' in ' '+texto_entidade_comparar+' ' for palavra in palavrasDescontinua]\n",
    "            #texto_frase_comparar2 = texto_frase_comparar.replace('and not', 'and_not').replace('as well as', 'as_well_as').replace('neither nor', 'neither_nor').replace('but not', 'but_not')\n",
    "            #print(frase)\n",
    "            #print('texto_frase_comparar2.split():', texto_frase_comparar2.split())\n",
    "            #print('texto_frase_comparar2.split():', texto_frase_comparar2.split()[0])\n",
    "            #tem = [texto_frase_comparar2.split()[-1]==palavra.lower() for palavra in palavrasDescontinua_underline]\n",
    "            #tem = [' '+palavra.lower()+' ' in ' '+texto_frase_comparar2+' ' for palavra in palavrasDescontinua_underline]\n",
    "            #tem_boolean = True in tem\n",
    "            #print([' '.join(frase).strip(), tipo_entidade])\n",
    "            #if not tem_boolean:\n",
    "            #if 1==2:\n",
    "            #    combinacaoEntidades.append([' '.join(frase).strip(), tipo_entidade]) # apendando entidades reais\n",
    "            texto_entidade_comparar = texto_entidade_comparar.lower()\n",
    "            texto_frase_comparar = texto_frase_comparar.lower()\n",
    "            if ((texto_entidade_comparar == texto_frase_comparar) or (texto_entidade_comparar+'s' == texto_frase_comparar) or (texto_entidade_comparar+'es' == texto_frase_comparar) or (texto_entidade_comparar+'ies' == texto_frase_comparar) or (texto_entidade_comparar[:-1]+'ies' == texto_frase_comparar) or (texto_entidade_comparar[:-1] == texto_frase_comparar.replace(' /','/'))):\n",
    "                combinacaoEntidades.append([' '.join(frase).strip(), tipo_entidade]) # apendando entidades reais\n",
    "            else:\n",
    "                #print('tem:', tem)\n",
    "                #print('texto_entidade_comparar:', texto_entidade_comparar)\n",
    "                #print('texto_frase_comparar:', texto_frase_comparar)\n",
    "                #print('texto_frase_comparar2.split()[-1]:', texto_frase_comparar2.split()[-1])\n",
    "                #print(\"' '.join(texto_entidade).strip()):\", ' '.join(texto_entidade).strip())\n",
    "                #print(\"' '.join(frase[inicio:fim].strip():\", ' '.join(frase[inicio+1:fim+2]).strip())\n",
    "                erro_corpus=erro_corpus+1\n",
    "                erros_entidade.append(indices)\n",
    "                #print('-----indices erro:----', indices)\n",
    "                lista_erro_corpus.append([' '.join(frase).strip(), tipo_entidade, ' '.join(so_tokens), entidade])\n",
    "        else: # agora, qdo são descontinuas\n",
    "            numDescontinuas=numDescontinuas+1\n",
    "            #print(entidade[1])\n",
    "            #frase = so_tokens.copy()\n",
    "            #inicio=indices[0]\n",
    "            #fim=indices[-1]\n",
    "            #frase.insert(inicio, '<e1>')\n",
    "            #frase.insert(fim+2, '</e1>')\n",
    "            \n",
    "    for entidade in entidades:\n",
    "            indices = entidade[1]\n",
    "            #print('indices:', indices)\n",
    "            if indices in erros_entidade:\n",
    "                continue\n",
    "            inicio=indices[0]\n",
    "            fim=indices[-1]\n",
    "            # agora, fazer a combinacao entre eles.. todas a seguir serão do tipo 'O'           \n",
    "            for indice in indices:\n",
    "                for i in range(indice, fim+1):\n",
    "                    # ver se nao tem antes\n",
    "                    frase = so_tokens.copy()\n",
    "                    termo = frase[indice:i+2]\n",
    "                    frase.insert(indice, '<e1>')\n",
    "                    #print(i)\n",
    "                    \n",
    "                    frase.insert(i+2, '</e1>')\n",
    "                    frase_string=' '.join(frase).strip()\n",
    "                    #print(frase_string)\n",
    "                    #if frase_string not in combinacaoEntidades:\n",
    "                    # ver se frase não termina com pontuacao ('.',',',';','-',')','(',']','[','/','\"',)\n",
    "                    devePular = 0\n",
    "                    if '. </e1>' in frase_string or ', </e1>' in frase_string  or '; </e1>' in frase_string or '- </e1>' in frase_string  or ': </e1>' in frase_string  or '= </e1>' in frase_string  or '/ </e1>' in frase_string  or '( </e1>' in frase_string  or ') </e1>' in frase_string  or '[ </e1>' in frase_string  or '] </e1>' in frase_string  or ': </e1>' in frase_string or 'and </e1>' in frase_string or 'or </e1>' in frase_string:\n",
    "                        devePular=1\n",
    "                    if '<e1> .' in frase_string or '<e1> ,' in frase_string  or '<e1> ;' in frase_string or '<e1> -' in frase_string  or '<e1> :' in frase_string  or '<e1> =' in frase_string  or '<e1> /' in frase_string  or '<e1> (' in frase_string  or '<e1> )' in frase_string  or '<e1> [' in frase_string  or '<e1> ]' in frase_string  or '<e1> :' in frase_string  or '<e1> and' in frase_string  or '<e1> or' in frase_string:\n",
    "                        devePular=1\n",
    "                    if re.search(\"<e1> [0-9]* </e1>\", frase_string):\n",
    "                        devePular=1\n",
    "                    pos_tagger_termo = tipoPostaggerTokens(termo, dicPosTagger)\n",
    "                    if pos_tagger_termo not in lista_postaggers_entidades:\n",
    "                        pulando_termos_postagger.append([termo, pos_tagger_termo])\n",
    "                        devePular=1\n",
    "                        \n",
    "                    tem_frase = 0\n",
    "                    for frase in combinacaoEntidades:\n",
    "                        if frase[0] == frase_string:\n",
    "                            tem_frase=''\n",
    "                            break\n",
    "                    if tem_frase==0 and devePular==0:\n",
    "                        #print('inserindo:', frase_string)\n",
    "                        #print('indice:', indice)\n",
    "                        combinacaoEntidades.append([frase_string, 'O'])\n",
    "    # shuffle no combinacaoEntidades\n",
    "    if len(combinacaoEntidades)>0:\n",
    "        random.shuffle(combinacaoEntidades)\n",
    "        combinacaoEntidadesAll.append([' '.join(so_tokens).strip(), combinacaoEntidades])\n",
    "    else:\n",
    "        num_frases_sem_entidade = num_frases_sem_entidade+1\n",
    "        #print(\"key sem entidade\", key)\n",
    "        #print('len(combinacaoEntidades):', len(combinacaoEntidades))\n",
    "        #print(so_tokens)\n",
    "    combinacaoEntidades = list()\n",
    "    \n",
    "    if (num % 1000) ==0:\n",
    "    #if (num %3) == 0:\n",
    "        print('key:', key)\n",
    "        #break\n",
    "print('numDescontinuas:', numDescontinuas)\n",
    "print('erro_corpus:', erro_corpus)\n",
    "print('num_frases_sem_entidade:', num_frases_sem_entidade)\n",
    "#print(combinacaoEntidadesAll)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 833,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "174085\n"
     ]
    }
   ],
   "source": [
    "print(len(pulando_termos_postagger))\n",
    "#print(pulando_termos_postagger)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 834,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[['CD28', 'requires'], '-NN-VBZ'],\n",
       " [['5', '-', 'lipoxygenase', '.'], '-CD-NN-NN-.'],\n",
       " [['-', 'lipoxygenase', '.'], '-NN-NN-.'],\n",
       " [['lipoxygenase', '.'], '-NN-.'],\n",
       " [['CD28', 'surface', 'receptor', 'provides'], '-NN-NN-NN-VBZ'],\n",
       " [['surface', 'receptor', 'provides'], '-NN-NN-VBZ'],\n",
       " [['receptor', 'provides'], '-NN-VBZ'],\n",
       " [['interleukin', '-', '2', '('], '-NN-NN-CD-('],\n",
       " [['-', '2', '('], '-NN-CD-('],\n",
       " [['2', '('], '-CD-(']]"
      ]
     },
     "execution_count": 834,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pulando_termos_postagger[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 835,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['IL - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "  [['IL - <e1> 2 gene </e1> expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 gene expression and NF - kappa <e1> B </e1> activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 <e1> gene </e1> expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 gene expression and NF - kappa B activation through <e1> CD28 </e1> requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'PROTEIN'],\n",
       "   ['IL - 2 gene expression and <e1> NF </e1> - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 gene expression and NF - <e1> kappa B </e1> activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by <e1> 5 - lipoxygenase </e1> .',\n",
       "    'PROTEIN'],\n",
       "   ['<e1> IL </e1> - 2 gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 gene expression and <e1> NF - kappa B </e1> activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'PROTEIN'],\n",
       "   ['<e1> IL - 2 gene </e1> expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'DNA'],\n",
       "   ['IL - 2 gene expression and <e1> NF - kappa </e1> B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['<e1> IL - 2 </e1> gene expression and NF - kappa B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O'],\n",
       "   ['IL - 2 gene expression and NF - <e1> kappa </e1> B activation through CD28 requires reactive oxygen production by 5 - lipoxygenase .',\n",
       "    'O']]]]"
      ]
     },
     "execution_count": 835,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combinacaoEntidadesAll[:1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 744,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "numTreinamento: 13291\n",
      "numTeste: 1661\n"
     ]
    }
   ],
   "source": [
    "# já ir gravando arquivos treinamento, test e dev...\n",
    "# pra fazer um teste sem descontinuas\n",
    "numTreinamento = len(combinacaoEntidadesAll)*0.8\n",
    "numTreinamento = int(numTreinamento)\n",
    "numTeste = (len(combinacaoEntidadesAll) - numTreinamento)/2\n",
    "numTeste = int(numTeste)\n",
    "numTotalEntidades=0\n",
    "numTotalEntidadesTrain=0\n",
    "numTotalEntidadesDev=0\n",
    "numTotalEntidadesTest=0\n",
    "\n",
    "print('numTreinamento:', numTreinamento)\n",
    "print('numTeste:', numTeste)\n",
    "\n",
    "f_train = open('genia.train', 'w')\n",
    "f_dev = open('genia.dev', 'w')\n",
    "f_test = open('genia.test', 'w')\n",
    "\n",
    "for i, combinacaoEntidades in enumerate(combinacaoEntidadesAll):\n",
    "    #print(dicSentences[i])\n",
    "    frase = combinacaoEntidades[0]\n",
    "    frases_entidade = combinacaoEntidades[1]\n",
    "    if i<=numTreinamento:\n",
    "        f_train.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_train.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesTrain=numTotalEntidadesTrain+1\n",
    "    elif i <= numTreinamento + numTeste:\n",
    "        f_dev.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_dev.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesDev=numTotalEntidadesDev+1\n",
    "    else:\n",
    "        f_test.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_test.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesTest=numTotalEntidadesTest+1\n",
    "\n",
    "f_train.close()\n",
    "f_test.close()\n",
    "f_dev.close()\n",
    "\n",
    "print('numTotalEntidades:', numTotalEntidades)\n",
    "print('numTotalEntidadesTrain:', numTotalEntidadesTrain)\n",
    "print('numTotalEntidadesDev:', numTotalEntidadesDev)\n",
    "print('numTotalEntidadesTest:', numTotalEntidadesTest)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Agora, tratar descontinuas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 836,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['This delay is associated with down - regulation of many erythroid cell - specific genes , including alpha - globin, band 3 , band 4.1 , and the erythroid cell - specific histone H5 .',\n",
       "  [['This delay is associated with down - regulation of many erythroid cell - specific genes , including <e1> alpha - globin </e1> , band 3 , band 4.1 , and the erythroid cell - specific histone H5 .',\n",
       "    'DNA']]],\n",
       " ['Transient transfection experiments show that several elements in the promoter - proximal region of the IL - 2R alpha gene contribute to IL - 1 responsiveness , most importantly an NF - kappa B site conserved in the human gene .',\n",
       "  [['Transient transfection experiments show that several elements in the promoter - proximal region of the IL - 2R alpha gene contribute to IL - 1 responsiveness , most importantly an NF - kappa B site conserved in the <e1> human gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Finally , the status of our current knowledge concerning the roles of transcription factors in the commitment to erythroid cell typeis summarized .',\n",
       "  [['Finally , the status of our current knowledge concerning the roles of transcription factors in the commitment to <e1> erythroid cell type </e1> is summarized .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Finally , the status of our current knowledge concerning the roles of transcription factors in the commitment to erythroid , myeloid cell typeis summarized .',\n",
       "  [['Finally , the status of our current knowledge concerning the roles of transcription factors in the commitment to erythroid , <e1> myeloid cell type </e1> is summarized .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The results suggest that activation of protein kinase C , but not new protein synthesis , is required for IL - 2 induction of ifn - gamma cytoplasmic mrna .',\n",
       "  [['The results suggest that activation of protein kinase C , but not new protein synthesis , is required for IL - 2 induction of <e1> ifn - gamma cytoplasmic mrna </e1> .',\n",
       "    'RNA']]],\n",
       " ['One substrate is p95vav , which is expressed exclusively in hematopoietic cells .',\n",
       "  [['One substrate is p95vav , which is expressed exclusively in <e1> hematopoietic cells </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene promoter contains a consensus sequence for the polyomavirus enhancer binding - protein 2 ( PEBP2 ) transcription factor , which consists of alpha subunits .',\n",
       "  [['The granulocyte - macrophage colony - stimulating factor ( GM - CSF ) gene promoter contains a consensus sequence for the polyomavirus enhancer binding - protein 2 ( PEBP2 ) transcription factor , which consists of <e1> alpha subunits </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['PEBP2 alpha A1 and alpha B1 enhanced the expression of the GM - CSF promoter - driven reporter plasmid in unstimulated human jurkat t cell .',\n",
       "  [['PEBP2 alpha A1 and alpha B1 enhanced the expression of the GM - CSF promoter - driven reporter plasmid in <e1> unstimulated human jurkat t cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In both transformed lymphocytes, OKA stimulation induced intense phosphorylation of the constitutively expressed Sp1 protein in the nucleus , a property of OKA not shared by TNF , phorbol ester , or PHA and interleukin 2 .',\n",
       "  [['In both <e1> transformed lymphocytes </e1> , OKA stimulation induced intense phosphorylation of the constitutively expressed Sp1 protein in the nucleus , a property of OKA not shared by TNF , phorbol ester , or PHA and interleukin 2 .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The gata - 1 binding sitesin this promoter lacking a TATA sequence were necessary for a high level of transcription activation .',\n",
       "  [['The <e1> gata - 1 binding sites </e1> in this promoter lacking a TATA sequence were necessary for a high level of transcription activation .',\n",
       "    'DNA']]],\n",
       " ['Protein - DNA binding studies suggested that Sp1 and two other CCGCCC binding proteins from erythroid cellscould bind to the Sp1 binding motif .',\n",
       "  [['Protein - DNA binding studies suggested that Sp1 and two other CCGCCC binding proteins from <e1> erythroid cells </e1> could bind to the Sp1 binding motif .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The interleukin - 5 /receptor interaction activates lyn tyrosine kinaseand the Jak - STAT pathways in eosinophils .',\n",
       "  [['The interleukin - 5 /receptor interaction activates <e1> lyn tyrosine kinase </e1> and the Jak - STAT pathways in eosinophils .',\n",
       "    'PROTEIN']]],\n",
       " ['The interleukin - 5 /receptor interaction activates Lyn and jak2 tyrosine kinaseand the Jak - STAT pathways in eosinophils .',\n",
       "  [['The interleukin - 5 /receptor interaction activates Lyn and <e1> jak2 tyrosine kinase </e1> and the Jak - STAT pathways in eosinophils .',\n",
       "    'PROTEIN']]],\n",
       " ['It is a potent transcriptional activator of many viral promoter .',\n",
       "  [['It is a potent transcriptional activator of many <e1> viral promoter </e1> .',\n",
       "    'DNA']]],\n",
       " ['We have recently demonstrated that stimulation of human t cellwith IL - 12 induces tyrosine phosphorylation of the Janus family tyrosine kinase JAK2 and Tyk2 , implicating these kinases in the immediate biochemical response to IL - 12 .',\n",
       "  [['We have recently demonstrated that stimulation of <e1> human t cell </e1> with IL - 12 induces tyrosine phosphorylation of the Janus family tyrosine kinase JAK2 and Tyk2 , implicating these kinases in the immediate biochemical response to IL - 12 .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We have recently demonstrated that stimulation of human natural killer cellwith IL - 12 induces tyrosine phosphorylation of the Janus family tyrosine kinase JAK2 and Tyk2 , implicating these kinases in the immediate biochemical response to IL - 12 .',\n",
       "  [['We have recently demonstrated that stimulation of <e1> human natural killer cell </e1> with IL - 12 induces tyrosine phosphorylation of the Janus family tyrosine kinase JAK2 and Tyk2 , implicating these kinases in the immediate biochemical response to IL - 12 .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In the human monocytic cell line THP - 1 , either integrin - dependent cell adhesion to fibronectin or ligation of beta 1 integrins with antibodies causes a rapid and intense tyrosine phosphorylation of two sets of proteins of about 65 - 75 kda .',\n",
       "  [['In the human monocytic cell line THP - 1 , either integrin - dependent cell adhesion to fibronectin or ligation of beta 1 integrins with antibodies causes a rapid and intense tyrosine phosphorylation of two sets of proteins of about <e1> 65 - 75 kda </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['With the recent characterization of the fya allele, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid - specific repression of the DARC gene in Duffy - negative individuals .',\n",
       "  [['With the recent characterization of the <e1> fya allele </e1> , these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid - specific repression of the DARC gene in Duffy - negative individuals .',\n",
       "    'DNA']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 4, - 5 and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ <e1> human interleukin - 4 </e1> , - 5 and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 5and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ <e1> human interleukin - 5 </e1> and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 13and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ <e1> human interleukin - 13 </e1> and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 2 , - 4 , - 5 and - 13 and human granulocyte/macrophage - colony stimulating factor( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 2 , - 4 , - 5 and - 13 and <e1> human granulocyte/macrophage - colony stimulating factor </e1> ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 4, - 5 and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ <e1> human interleukin - 4 </e1> , - 5 and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 5and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ <e1> human interleukin - 5 </e1> and - 13 and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 13and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ <e1> human interleukin - 13 </e1> and human and mouse granulocyte/macrophage - colony stimulating factor ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 2 , - 4 , - 5 and - 13 and human granulocyte/macrophage - colony stimulating factor( GM - CSF ) ] .',\n",
       "  [['We have recently found a novel conserved motif in the promoters of several T - cell - expressed cytokines [ human interleukin - 2 , - 4 , - 5 and - 13 and <e1> human granulocyte/macrophage - colony stimulating factor </e1> ( GM - CSF ) ] .',\n",
       "    'PROTEIN']]],\n",
       " ['Our studies demonstrate that incubation of human T cells with low concentrations ( approximately 1 - 5 nM ) of calyculin A or okadaic acid , potent inhibitors of protein phosphatase type 1 pp - 1) and type 2A ( PP - 2A ) , induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus .',\n",
       "  [['Our studies demonstrate that incubation of human T cells with low concentrations ( approximately 1 - 5 nM ) of calyculin A or okadaic acid , potent inhibitors of <e1> protein phosphatase type 1 pp - 1 </e1> ) and type 2A ( PP - 2A ) , induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus .',\n",
       "    'PROTEIN']]],\n",
       " ['Our studies demonstrate that incubation of human T cells with low concentrations ( approximately 1 - 5 nM ) of calyculin A or okadaic acid , potent inhibitors of protein phosphatase type 2a( PP - 2A ) , induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus .',\n",
       "  [['Our studies demonstrate that incubation of human T cells with low concentrations ( approximately 1 - 5 nM ) of calyculin A or okadaic acid , potent inhibitors of <e1> protein phosphatase type 2a </e1> ( PP - 2A ) , induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus .',\n",
       "    'PROTEIN']]],\n",
       " ['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including hl - 60 cell .',\n",
       "  [['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including <e1> hl - 60 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , u937 cell .',\n",
       "  [['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , <e1> u937 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , U937 , hel/s cell .',\n",
       "  [['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , U937 , <e1> hel/s cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , U937 , HEL/S , ku812f cell .',\n",
       "  [['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , U937 , HEL/S , <e1> ku812f cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , U937 , HEL/S , KU812F , k562 cell .',\n",
       "  [['In the present experiment , we examined the effect of nm23 proteins on various differentiation induction systems of human leukemic cells including HL - 60 , U937 , HEL/S , KU812F , <e1> k562 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of hel cell, but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of <e1> hel cell </e1> , but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , ku812 cell, but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , <e1> ku812 cell </e1> , but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of hl - 60 cell .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of <e1> hl - 60 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of HL - 60 , u937 cell .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of HL - 60 , <e1> u937 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of hel cell, but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of <e1> hel cell </e1> , but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , ku812 cell, but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , <e1> ku812 cell </e1> , but not the induction of monocytic or granulocytic differentiation of HL - 60 , U937 and HEL/S cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of hl - 60 cell .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of <e1> hl - 60 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of HL - 60 , u937 cell .',\n",
       "  [['Native human erythrocyte NDP kinase protein inhibited the induction of erythroid differentiation of HEL , KU812 and K562 cells , but not the induction of monocytic or granulocytic differentiation of HL - 60 , <e1> u937 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - h1 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant human nm23 - h1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human - h2 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant human - h2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant mouse nm23 - m1 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant mouse nm23 - m1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant mouse nm23 - m2 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant mouse nm23 - m2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - h2, mouse nm23 - M1 , and - M2 proteins .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by recombinant <e1> human nm23 - h2 </e1> , mouse nm23 - M1 , and - M2 proteins .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - H1 , - H2 , mouse nm23 - m2proteins .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - H1 , - H2 , <e1> mouse nm23 - m2 </e1> proteins .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - h1 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant human nm23 - h1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human - h2 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant human - h2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant mouse nm23 - m1 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant mouse nm23 - m1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant mouse nm23 - m2 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant mouse nm23 - m2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - h2, mouse nm23 - M1 , and - M2 proteins .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by recombinant <e1> human nm23 - h2 </e1> , mouse nm23 - M1 , and - M2 proteins .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - H1 , - H2 , mouse nm23 - m2proteins .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - H1 , - H2 , <e1> mouse nm23 - m2 </e1> proteins .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - h1 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant human nm23 - h1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human - h2 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant human - h2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant mouse nm23 - m1 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant mouse nm23 - m1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant mouse nm23 - m2 protein .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by <e1> recombinant mouse nm23 - m2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - h2, mouse nm23 - M1 , and - M2 proteins .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by recombinant <e1> human nm23 - h2 </e1> , mouse nm23 - M1 , and - M2 proteins .',\n",
       "    'PROTEIN']]],\n",
       " ['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - H1 , - H2 , mouse nm23 - m2proteins .',\n",
       "  [['The erythroid differentiation of HEL cells was inhibited by recombinant human nm23 - H1 , - H2 , <e1> mouse nm23 - m2 </e1> proteins .',\n",
       "    'PROTEIN']]],\n",
       " ['Antigen complexed with major histocompatibility complex class i moleculeon the surface of antigen presenting cells interacts with the T cell receptor ( TCR ) on the surface of T cells and initiates an activation cascade .',\n",
       "  [['Antigen complexed with <e1> major histocompatibility complex class i molecule </e1> on the surface of antigen presenting cells interacts with the T cell receptor ( TCR ) on the surface of T cells and initiates an activation cascade .',\n",
       "    'PROTEIN']]],\n",
       " ['Antigen complexed with major histocompatibility complex class ii moleculeon the surface of antigen presenting cells interacts with the T cell receptor ( TCR ) on the surface of T cells and initiates an activation cascade .',\n",
       "  [['Antigen complexed with <e1> major histocompatibility complex class ii molecule </e1> on the surface of antigen presenting cells interacts with the T cell receptor ( TCR ) on the surface of T cells and initiates an activation cascade .',\n",
       "    'PROTEIN']]],\n",
       " ['DNase I footprinting and sequence analysis revealed the existence of multiple ap2 binding sitein the 5 - untranslated and proximal coding regions .',\n",
       "  [['DNase I footprinting and sequence analysis revealed the existence of multiple <e1> ap2 binding site </e1> in the 5 - untranslated and proximal coding regions .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting and sequence analysis revealed the existence of multiple AP2 and Sp1 binding sites in the 5 - untranslated region .',\n",
       "  [['DNase I footprinting and sequence analysis revealed the existence of multiple AP2 and Sp1 binding sites in the <e1> 5 - untranslated region </e1> .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting and sequence analysis revealed the existence of multiple ap2 binding sitein the 5 - untranslated and proximal coding regions .',\n",
       "  [['DNase I footprinting and sequence analysis revealed the existence of multiple <e1> ap2 binding site </e1> in the 5 - untranslated and proximal coding regions .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting and sequence analysis revealed the existence of multiple AP2 and Sp1 binding sites in the 5 - untranslated region .',\n",
       "  [['DNase I footprinting and sequence analysis revealed the existence of multiple AP2 and Sp1 binding sites in the <e1> 5 - untranslated region </e1> .',\n",
       "    'DNA']]],\n",
       " ['Synergy between signal transduction pathways is obligatory for expression of c - fos in b cell line: implication for c - fos control via surface immunoglobulin and T cell antigen receptors .',\n",
       "  [['Synergy between signal transduction pathways is obligatory for expression of c - fos in <e1> b cell line </e1> : implication for c - fos control via surface immunoglobulin and T cell antigen receptors .',\n",
       "    'CELL_LINE']]],\n",
       " ['These results suggest that cell - specific patterns of synergy are an essential feature for c - fos induction and may be relevant for c - fos control through b cell antigen receptor .',\n",
       "  [['These results suggest that cell - specific patterns of synergy are an essential feature for c - fos induction and may be relevant for c - fos control through <e1> b cell antigen receptor </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['In this report , we show that in monocytes and T cells IL - 10 stimulates tyrosine phosphorylation of the signal transducers and activators of transcription , STAT1 alpha and STAT3 , in a differential manner such that the relative formation of homo - dimervaries between the two cell types .',\n",
       "  [['In this report , we show that in monocytes and T cells IL - 10 stimulates tyrosine phosphorylation of the signal transducers and activators of transcription , STAT1 alpha and STAT3 , in a differential manner such that the relative formation of <e1> homo - dimer </e1> varies between the two cell types .',\n",
       "    'PROTEIN']]],\n",
       " ['Chemical cross - linking with 125I - labeled TGF - beta 1 showed an essentially normal TGF - beta receptor profile in ebv - positive burkitt s lymphoma cell line, and these receptors were shown to be functional in transducing signals , as evidenced by the TGF - beta 1 - mediated modulation of junB gene expression .',\n",
       "  [['Chemical cross - linking with 125I - labeled TGF - beta 1 showed an essentially normal TGF - beta receptor profile in <e1> ebv - positive burkitt s lymphoma cell line </e1> , and these receptors were shown to be functional in transducing signals , as evidenced by the TGF - beta 1 - mediated modulation of junB gene expression .',\n",
       "    'CELL_LINE']]],\n",
       " ['Chemical cross - linking with 125I - labeled TGF - beta 1 showed an essentially normal TGF - beta receptor profile in ebv - negative burkitt s lymphoma cell line, and these receptors were shown to be functional in transducing signals , as evidenced by the TGF - beta 1 - mediated modulation of junB gene expression .',\n",
       "  [['Chemical cross - linking with 125I - labeled TGF - beta 1 showed an essentially normal TGF - beta receptor profile in <e1> ebv - negative burkitt s lymphoma cell line </e1> , and these receptors were shown to be functional in transducing signals , as evidenced by the TGF - beta 1 - mediated modulation of junB gene expression .',\n",
       "    'CELL_LINE']]],\n",
       " ['By immunization with a recombinant fusion protein , we show that TCF - 1 knock - out mice readily yield antiserum titers against human tcf - 1 protein .',\n",
       "  [['By immunization with a recombinant fusion protein , we show that TCF - 1 knock - out mice readily yield antiserum titers against <e1> human tcf - 1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Electromobility shift assays utilizing this sequence demonstrated binding of a fetal - specific protein .',\n",
       "  [['Electromobility shift assays utilizing this sequence demonstrated binding of a <e1> fetal - specific protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Alanine substitutions introduced at two serine residues positioned within this N - terminal regulatory region of I kappa B alpha also yielded constitutive repressors that escaped from Tax - induced turnover and that potently inhibited immune activation pathways for NF - kappa B induction , including those initiated from antigen receptor .',\n",
       "  [['Alanine substitutions introduced at two serine residues positioned within this N - terminal regulatory region of I kappa B alpha also yielded constitutive repressors that escaped from Tax - induced turnover and that potently inhibited immune activation pathways for NF - kappa B induction , including those initiated from <e1> antigen receptor </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The expression of several cytoskeleton proteinincreased as determined by immunostaining on slides and by ELISA procedures .',\n",
       "  [['The expression of several <e1> cytoskeleton protein </e1> increased as determined by immunostaining on slides and by ELISA procedures .',\n",
       "    'PROTEIN']]],\n",
       " ['The interaction between lymphoid cellin growth and development is described .',\n",
       "  [['The interaction between <e1> lymphoid cell </e1> in growth and development is described .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We have previously described a mutant B lymphoblastoid cell line , Clone - 13 , that expresses HLA - DQ in the absence of hla - dp .',\n",
       "  [['We have previously described a mutant B lymphoblastoid cell line , Clone - 13 , that expresses HLA - DQ in the absence of <e1> hla - dp </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Indeed , transient transfection of hla - dra reporter constructindicated that the affected factor operates via cis - elements located between - 141 base pairs and the transcription initiation site .',\n",
       "  [['Indeed , transient transfection of <e1> hla - dra reporter construct </e1> indicated that the affected factor operates via cis - elements located between - 141 base pairs and the transcription initiation site .',\n",
       "    'DNA']]],\n",
       " ['Substitution promoters were then generated where the entire X - box , or only the x1 - boxesof HLA - DRA were replaced with the analogous regions of HLA - DQB .',\n",
       "  [['Substitution promoters were then generated where the entire X - box , or only the <e1> x1 - boxes </e1> of HLA - DRA were replaced with the analogous regions of HLA - DQB .',\n",
       "    'DNA']]],\n",
       " ['PU.1 expression is maintained at stable levels during differentiation of myeloid cell lines U937 and HL - 60 to monocytic cell .',\n",
       "  [['PU.1 expression is maintained at stable levels during differentiation of myeloid cell lines U937 and HL - 60 to <e1> monocytic cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Analysis of the role of protein kinase c - epsilon, and - zeta in T cell activation .',\n",
       "  [['Analysis of the role of <e1> protein kinase c - epsilon </e1> , and - zeta in T cell activation .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of the role of protein kinase c - zetain T cell activation .',\n",
       "  [['Analysis of the role of <e1> protein kinase c - zeta </e1> in T cell activation .',\n",
       "    'PROTEIN']]],\n",
       " ['To address this issue , mutationally active pkc - epsilon, or - zeta have been transfected into T cells and the consequences for T cell activation determined .',\n",
       "  [['To address this issue , mutationally active <e1> pkc - epsilon </e1> , or - zeta have been transfected into T cells and the consequences for T cell activation determined .',\n",
       "    'PROTEIN']]],\n",
       " ['To address this issue , mutationally active pkc - zetahave been transfected into T cells and the consequences for T cell activation determined .',\n",
       "  [['To address this issue , mutationally active <e1> pkc - zeta </e1> have been transfected into T cells and the consequences for T cell activation determined .',\n",
       "    'PROTEIN']]],\n",
       " ['Infection and replication of Tat - human immunodeficiency viruses : genetic analyses of LTR and tat mutations in primary human lymphoid cell .',\n",
       "  [['Infection and replication of Tat - human immunodeficiency viruses : genetic analyses of LTR and tat mutations in <e1> primary human lymphoid cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type ltrwith modifications in the NF - kappa B and/or Sp1 binding sites .',\n",
       "  [['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying <e1> wild - type ltr </e1> with modifications in the NF - kappa B and/or Sp1 binding sites .',\n",
       "    'DNA']]],\n",
       " ['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type or mutant LTRs with modifications in the nf - kappa b binding site .',\n",
       "  [['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type or mutant LTRs with modifications in the <e1> nf - kappa b binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type ltrwith modifications in the NF - kappa B and/or Sp1 binding sites .',\n",
       "  [['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying <e1> wild - type ltr </e1> with modifications in the NF - kappa B and/or Sp1 binding sites .',\n",
       "    'DNA']]],\n",
       " ['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type or mutant LTRs with modifications in the nf - kappa b binding site .',\n",
       "  [['To test these hypotheses , we studied several tat mutants , including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type or mutant LTRs with modifications in the <e1> nf - kappa b binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( ebna 2, 3A , 3B , 3C , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "  [['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( <e1> ebna 2 </e1> , 3A , 3B , 3C , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "    'PROTEIN']]],\n",
       " ['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( ebna 3a, 3B , 3C , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "  [['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( <e1> ebna 3a </e1> , 3B , 3C , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "    'PROTEIN']]],\n",
       " ['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( ebna 3b, 3C , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "  [['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( <e1> ebna 3b </e1> , 3C , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "    'PROTEIN']]],\n",
       " ['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( ebna 3c, - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "  [['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( <e1> ebna 3c </e1> , - LP ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "    'PROTEIN']]],\n",
       " ['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( ebna - lp) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "  [['In lymphoblastoid cell lines , six EBV - encoded nuclear antigens ( <e1> ebna - lp </e1> ) , three latent membrane proteins ( LMP1 , 2A , 2B ) , and two nuclear RNAs ( EBERs ) are expressed .',\n",
       "    'PROTEIN']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the dr beta gene, always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the <e1> dr beta gene </e1> , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the DR beta , dp alpha gene, always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the DR beta , <e1> dp alpha gene </e1> , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the DR beta , dp - beta gene, always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the DR beta , <e1> dp - beta gene </e1> , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the DR beta , dp - beta, and DQ alpha genes , always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the DR beta , <e1> dp - beta </e1> , and DQ alpha genes , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the dr beta gene, always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the <e1> dr beta gene </e1> , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the DR beta , dp alpha gene, always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the DR beta , <e1> dp alpha gene </e1> , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the DR beta , dp - beta gene, always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the DR beta , <e1> dp - beta gene </e1> , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['Significant sequence homology of this element was found in the DNA of the DR beta , dp - beta, and DQ alpha genes , always located downstream of the transcriptional start site .',\n",
       "  [['Significant sequence homology of this element was found in the DNA of the DR beta , <e1> dp - beta </e1> , and DQ alpha genes , always located downstream of the transcriptional start site .',\n",
       "    'DNA']]],\n",
       " ['The nuclear factor binds to the dr alpha elementbut not to the element in the DQ alpha gene .',\n",
       "  [['The nuclear factor binds to the <e1> dr alpha element </e1> but not to the element in the DQ alpha gene .',\n",
       "    'DNA']]],\n",
       " ['Transcriptional activity of core binding factor - alpha aml1) and beta subunits on murine leukemia virus enhancer cores .',\n",
       "  [['Transcriptional activity of <e1> core binding factor - alpha aml1 </e1> ) and beta subunits on murine leukemia virus enhancer cores .',\n",
       "    'PROTEIN']]],\n",
       " ['Transcriptional activity of core binding factor - betasubunits on murine leukemia virus enhancer cores .',\n",
       "  [['Transcriptional activity of <e1> core binding factor - beta </e1> subunits on murine leukemia virus enhancer cores .',\n",
       "    'PROTEIN']]],\n",
       " ['DNA - swap experiments using chloramphenicol acetyl - transferase assay demonstrated that androgen can suppress the transcriptional activities of SV40 early promoter via the interaction between this TR2RE - SV40 and the chimeric receptor AR/TR2/AR with the DNA - binding domain of the TR2 orphan receptor flanked by the n - terminal domainof the androgen receptor .',\n",
       "  [['DNA - swap experiments using chloramphenicol acetyl - transferase assay demonstrated that androgen can suppress the transcriptional activities of SV40 early promoter via the interaction between this TR2RE - SV40 and the chimeric receptor AR/TR2/AR with the DNA - binding domain of the TR2 orphan receptor flanked by the <e1> n - terminal domain </e1> of the androgen receptor .',\n",
       "    'PROTEIN']]],\n",
       " ['In addition , this TR2RE - SV40 can function as a repressor to suppress the transcriptional activities of both sv40 early promoter .',\n",
       "  [['In addition , this TR2RE - SV40 can function as a repressor to suppress the transcriptional activities of both <e1> sv40 early promoter </e1> .',\n",
       "    'DNA']]],\n",
       " ['In addition , this TR2RE - SV40 can function as a repressor to suppress the transcriptional activities of both sv40 late promoter .',\n",
       "  [['In addition , this TR2RE - SV40 can function as a repressor to suppress the transcriptional activities of both <e1> sv40 late promoter </e1> .',\n",
       "    'DNA']]],\n",
       " ['Mutations of the aml1 - binding sitecompletely eliminated EBNA - 2 responses .',\n",
       "  [['Mutations of the <e1> aml1 - binding site </e1> completely eliminated EBNA - 2 responses .',\n",
       "    'DNA']]],\n",
       " ['Mutations of the AML1 - or lbf4 - binding sitecompletely eliminated EBNA - 2 responses .',\n",
       "  [['Mutations of the AML1 - or <e1> lbf4 - binding site </e1> completely eliminated EBNA - 2 responses .',\n",
       "    'DNA']]],\n",
       " ['EBNA - 2 trans - activates cellular genelike CD23 , c - fgr , latent membrane protein 1 ( LMP1 ) and terminal protein 1 ( TP1 ) .',\n",
       "  [['EBNA - 2 trans - activates <e1> cellular gene </e1> like CD23 , c - fgr , latent membrane protein 1 ( LMP1 ) and terminal protein 1 ( TP1 ) .',\n",
       "    'DNA']]],\n",
       " ['Both positive regulatory elementwere identified in the proximal 5 flanking region of the IL - 3 gene .',\n",
       "  [['Both <e1> positive regulatory element </e1> were identified in the proximal 5 flanking region of the IL - 3 gene .',\n",
       "    'DNA']]],\n",
       " ['The pebp2 alpha a geneencode the DNA - binding subunit of a murine transcription factor , PEBP2 , which is implicated as a T - cell - specific transcriptional regulator .',\n",
       "  [['The <e1> pebp2 alpha a gene </e1> encode the DNA - binding subunit of a murine transcription factor , PEBP2 , which is implicated as a T - cell - specific transcriptional regulator .',\n",
       "    'DNA']]],\n",
       " ['The pebp2 alpha b geneencode the DNA - binding subunit of a murine transcription factor , PEBP2 , which is implicated as a T - cell - specific transcriptional regulator .',\n",
       "  [['The <e1> pebp2 alpha b gene </e1> encode the DNA - binding subunit of a murine transcription factor , PEBP2 , which is implicated as a T - cell - specific transcriptional regulator .',\n",
       "    'DNA']]],\n",
       " ['PEBP2 alpha B is the murine counterpart of human AML1 , which is located at the breakpoints of the 8;21 chromosome translocationassociated with acute myeloid leukemia .',\n",
       "  [['PEBP2 alpha B is the murine counterpart of human AML1 , which is located at the breakpoints of the <e1> 8;21 chromosome translocation </e1> associated with acute myeloid leukemia .',\n",
       "    'DNA']]],\n",
       " ['The transcripts were detected in all the cd4 - cd8 - cell population .',\n",
       "  [['The transcripts were detected in all the <e1> cd4 - cd8 - cell population </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The transcripts were detected in all the CD4 - CD8 - , cd4+ cd8+ cell population .',\n",
       "  [['The transcripts were detected in all the CD4 - CD8 - , <e1> cd4+ cd8+ cell population </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The transcripts were detected in all the CD4 - CD8 - , cd4+ cd8 - cell population .',\n",
       "  [['The transcripts were detected in all the CD4 - CD8 - , <e1> cd4+ cd8 - cell population </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The transcripts were detected in all the cd4 - cd8+ cell population .',\n",
       "  [['The transcripts were detected in all the <e1> cd4 - cd8+ cell population </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The amount of TcR at the cell surface is downmodulated , whereas the cd2 receptorare increased .',\n",
       "  [['The amount of TcR at the cell surface is downmodulated , whereas the <e1> cd2 receptor </e1> are increased .',\n",
       "    'PROTEIN']]],\n",
       " ['The measured binding to a TCF - 1 site is the same in the nuclei of resting cell .',\n",
       "  [['The measured binding to a TCF - 1 site is the same in the nuclei of <e1> resting cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The measured binding to a TCF - 1 site is the same in the nuclei of resting , activated cell .',\n",
       "  [['The measured binding to a TCF - 1 site is the same in the nuclei of resting , <e1> activated cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Using a highly sensitive mutation screening assay of the dna - binding region, none of the treated patients revealed any mutation , suggesting that the glucocorticoid receptor in the CLL patients tested is not altered in these domains .',\n",
       "  [['Using a highly sensitive mutation screening assay of the <e1> dna - binding region </e1> , none of the treated patients revealed any mutation , suggesting that the glucocorticoid receptor in the CLL patients tested is not altered in these domains .',\n",
       "    'PROTEIN']]],\n",
       " ['This conclusion is discussed in relation to the mechanism of corticoid resistance in mouse lymphoma cellin culture .',\n",
       "  [['This conclusion is discussed in relation to the mechanism of corticoid resistance in <e1> mouse lymphoma cell </e1> in culture .',\n",
       "    'CELL_LINE']]],\n",
       " ['The protein components of this complex are specifically competed by an AP1 consensus motif and were shown by supershift to include c - Jun and c - Fos , suggesting that this binding site is an AP1 motif and that the jun familyof transcription factors play a role in the regulation of the kappa light chain gene .',\n",
       "  [['The protein components of this complex are specifically competed by an AP1 consensus motif and were shown by supershift to include c - Jun and c - Fos , suggesting that this binding site is an AP1 motif and that the <e1> jun family </e1> of transcription factors play a role in the regulation of the kappa light chain gene .',\n",
       "    'PROTEIN']]],\n",
       " ['Distinct DNase - I hypersensitive sites are associated with TAL - 1 transcription in erythroid cell line .',\n",
       "  [['Distinct DNase - I hypersensitive sites are associated with TAL - 1 transcription in <e1> erythroid cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['The tal - 1 gene , frequently activated in human T - cell acute lymphoblastic leukemia ( T - ALL ) , is expressed in the erythroid cell lineageduring normal hematopoiesis .',\n",
       "  [['The tal - 1 gene , frequently activated in human T - cell acute lymphoblastic leukemia ( T - ALL ) , is expressed in the <e1> erythroid cell lineage </e1> during normal hematopoiesis .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The tal - 1 gene , frequently activated in human T - cell acute lymphoblastic leukemia ( T - ALL ) , is expressed in the erythroid , megakaryocytic cell lineageduring normal hematopoiesis .',\n",
       "  [['The tal - 1 gene , frequently activated in human T - cell acute lymphoblastic leukemia ( T - ALL ) , is expressed in the erythroid , <e1> megakaryocytic cell lineage </e1> during normal hematopoiesis .',\n",
       "    'CELL_TYPE']]],\n",
       " [' hs iv, and V were exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "  [[' <e1> hs iv </e1> , and V were exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "    'DNA']]],\n",
       " [' hs vwere exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "  [[' <e1> hs v </e1> were exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "    'DNA']]],\n",
       " [' hs iv, and V were exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "  [[' <e1> hs iv </e1> , and V were exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "    'DNA']]],\n",
       " [' hs vwere exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "  [[' <e1> hs v </e1> were exclusively observed in the erythroid/megakaryocytic cell lines that express tal - 1 from the promoters 1a and 1b .',\n",
       "    'DNA']]],\n",
       " ['M - TAT is a cytokine - dependent cell line with the potential to differentiate along the erythroid lineage .',\n",
       "  [['M - TAT is a cytokine - dependent cell line with the potential to differentiate along the <e1> erythroid lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These long term cultures are referred to as m - tat/epo cell, respectively .',\n",
       "  [['These long term cultures are referred to as <e1> m - tat/epo cell </e1> , respectively .',\n",
       "    'CELL_LINE']]],\n",
       " ['These long term cultures are referred to as m - tat/gm - csf cell, respectively .',\n",
       "  [['These long term cultures are referred to as <e1> m - tat/gm - csf cell </e1> , respectively .',\n",
       "    'CELL_LINE']]],\n",
       " ['These long term cultures are referred to as m - tat/scf cell, respectively .',\n",
       "  [['These long term cultures are referred to as <e1> m - tat/scf cell </e1> , respectively .',\n",
       "    'CELL_LINE']]],\n",
       " [' e2f - 1 mrnawere not detectable in granulocytes , monocytes and resting T - lymphocytes but were induced after the mitogenic stimulation of T - lymphocytes .',\n",
       "  [[' <e1> e2f - 1 mrna </e1> were not detectable in granulocytes , monocytes and resting T - lymphocytes but were induced after the mitogenic stimulation of T - lymphocytes .',\n",
       "    'RNA']]],\n",
       " ['Human immunodeficiency virus type 1 ( HIV - 1 ) replication is controlled by a complex array of virally encoded protein .',\n",
       "  [['Human immunodeficiency virus type 1 ( HIV - 1 ) replication is controlled by a complex array of <e1> virally encoded protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['A predominance of p50 NF - kappa B moieties and possibly p50 homodimers or closely related species , rather than the p50 - p56 heterodimer of NF - kappa B that is the predominant NF - kappa B species in most t lymphocytic cell, is demonstrated in the nuclei of U1 cells .',\n",
       "  [['A predominance of p50 NF - kappa B moieties and possibly p50 homodimers or closely related species , rather than the p50 - p56 heterodimer of NF - kappa B that is the predominant NF - kappa B species in most <e1> t lymphocytic cell </e1> , is demonstrated in the nuclei of U1 cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['OBJECTIVES : To analyze the effect of retinoic acids ( RA ) on HIV - 1 expression and correlate this effect with expression levels of RA receptors ( RARs ) in t - lymphoid cell line .',\n",
       "  [['OBJECTIVES : To analyze the effect of retinoic acids ( RA ) on HIV - 1 expression and correlate this effect with expression levels of RA receptors ( RARs ) in <e1> t - lymphoid cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Human RXR alpha was significantly expressed in u937 cell, weakly expressed in H9 cells and not detectable in CEM cells .',\n",
       "  [['Human RXR alpha was significantly expressed in <e1> u937 cell </e1> , weakly expressed in H9 cells and not detectable in CEM cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['CONCLUSIONS : In the present work , we show that human fetal erythroid progenitorare distinct in their transcription factors , and that the commitment to fetal or adult program occurs at a very early differentiation stage .',\n",
       "  [['CONCLUSIONS : In the present work , we show that <e1> human fetal erythroid progenitor </e1> are distinct in their transcription factors , and that the commitment to fetal or adult program occurs at a very early differentiation stage .',\n",
       "    'CELL_TYPE']]],\n",
       " ['CONCLUSIONS : In the present work , we show that human adult erythroid progenitorare distinct in their transcription factors , and that the commitment to fetal or adult program occurs at a very early differentiation stage .',\n",
       "  [['CONCLUSIONS : In the present work , we show that <e1> human adult erythroid progenitor </e1> are distinct in their transcription factors , and that the commitment to fetal or adult program occurs at a very early differentiation stage .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In contrast , stat1 proteins were not tyrosine phosphorylated after IL - 2 ligation , whereas tyrosine - phosphorylated stat1 proteins ( 91 kda protein) were translocated to the nucleus following interferon - gamma treatment of HeLa cells .',\n",
       "  [['In contrast , stat1 proteins were not tyrosine phosphorylated after IL - 2 ligation , whereas tyrosine - phosphorylated stat1 proteins ( <e1> 91 kda protein </e1> ) were translocated to the nucleus following interferon - gamma treatment of HeLa cells .',\n",
       "    'PROTEIN']]],\n",
       " ['The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human sequence, defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk ] - associated box ) here .',\n",
       "  [['The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other <e1> human sequence </e1> , defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk ] - associated box ) here .',\n",
       "    'DNA']]],\n",
       " ['The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human , mouse sequence, defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk ] - associated box ) here .',\n",
       "  [['The 160 N - terminal amino acids in the nonfinger region of clone 18 are highly homologous with similar regions of several other human , <e1> mouse sequence </e1> , defining a subfamily of Kruppel - like zinc finger proteins termed TAB ( tramtrack [ ttk ] - associated box ) here .',\n",
       "    'DNA']]],\n",
       " ['This protein appears to require both the s element, which are separated by 10 bp for optimal binding .',\n",
       "  [['This protein appears to require both the <e1> s element </e1> , which are separated by 10 bp for optimal binding .',\n",
       "    'DNA']]],\n",
       " ['Furthermore , transfected c - jun expression vectorpartially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "  [['Furthermore , transfected <e1> c - jun expression vector </e1> partially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "    'DNA']]],\n",
       " ['Furthermore , transfected c - jun - b expression vectorpartially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "  [['Furthermore , transfected c - <e1> jun - b expression vector </e1> partially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "    'DNA']]],\n",
       " ['Furthermore , transfected c - jun - d expression vectorpartially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "  [['Furthermore , transfected c - <e1> jun - d expression vector </e1> partially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "    'DNA']]],\n",
       " ['Furthermore , transfected c - fos expression vectorpartially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "  [['Furthermore , transfected <e1> c - fos expression vector </e1> partially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "    'DNA']]],\n",
       " ['Furthermore , transfected c - jun , jun - B , jun - D , c - fos - b expression vectorpartially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "  [['Furthermore , transfected c - jun , jun - B , jun - D , c - <e1> fos - b expression vector </e1> partially substitute for TPA and Ca2+ and cooperate with Oct - 2 for the transactivation of the combined OAP/octamer cis - element .',\n",
       "    'DNA']]],\n",
       " ['As in XSCID , X - chromosome inactivation in obligate carriers of XCID was nonrandom in t lymphocyte .',\n",
       "  [['As in XSCID , X - chromosome inactivation in obligate carriers of XCID was nonrandom in <e1> t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " [' pma - induced il - 2r alphais inhibited by the PKC inhibitor H7 , whereas TG - but not PMA - induced IL - 2R alpha was inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "  [[' <e1> pma - induced il - 2r alpha </e1> is inhibited by the PKC inhibitor H7 , whereas TG - but not PMA - induced IL - 2R alpha was inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "    'PROTEIN']]],\n",
       " ['PMA - but not TG - induced IL - 2R alpha is inhibited by the PKC inhibitor H7 , whereas tg - induced il - 2r alphawas inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "  [['PMA - but not TG - induced IL - 2R alpha is inhibited by the PKC inhibitor H7 , whereas <e1> tg - induced il - 2r alpha </e1> was inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "    'PROTEIN']]],\n",
       " [' pma - induced il - 2r alphais inhibited by the PKC inhibitor H7 , whereas TG - but not PMA - induced IL - 2R alpha was inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "  [[' <e1> pma - induced il - 2r alpha </e1> is inhibited by the PKC inhibitor H7 , whereas TG - but not PMA - induced IL - 2R alpha was inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "    'PROTEIN']]],\n",
       " ['PMA - but not TG - induced IL - 2R alpha is inhibited by the PKC inhibitor H7 , whereas tg - induced il - 2r alphawas inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "  [['PMA - but not TG - induced IL - 2R alpha is inhibited by the PKC inhibitor H7 , whereas <e1> tg - induced il - 2r alpha </e1> was inhibited by cholera toxin , forskolin and 1 , 9 - dideoxy forskolin .',\n",
       "    'PROTEIN']]],\n",
       " ['The TCL1 gene sequence , which , to our knowledge , shows no sequence homology with other human genes , is preferentially expressed early in t - lymphocytedifferentiation .',\n",
       "  [['The TCL1 gene sequence , which , to our knowledge , shows no sequence homology with other human genes , is preferentially expressed early in <e1> t - lymphocyte </e1> differentiation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These results indicate that the monocyte/B - cell - specific transcription factor PU.1 and the mono a protein complexact in concert to regulate monocyte - specific transcription of the CSF - 1 receptor .',\n",
       "  [['These results indicate that the monocyte/B - cell - specific transcription factor PU.1 and the <e1> mono a protein complex </e1> act in concert to regulate monocyte - specific transcription of the CSF - 1 receptor .',\n",
       "    'PROTEIN']]],\n",
       " ['These results indicate that the monocyte/B - cell - specific transcription factor PU.1 and the mono b protein complexact in concert to regulate monocyte - specific transcription of the CSF - 1 receptor .',\n",
       "  [['These results indicate that the monocyte/B - cell - specific transcription factor PU.1 and the <e1> mono b protein complex </e1> act in concert to regulate monocyte - specific transcription of the CSF - 1 receptor .',\n",
       "    'PROTEIN']]],\n",
       " ['Untreated NS - Meg cells expressed mRNA for the Epo receptor ( EpoR ) , for GATA - 1 , and for alpha 1 globin gene .',\n",
       "  [['Untreated NS - Meg cells expressed mRNA for the Epo receptor ( EpoR ) , for GATA - 1 , and for <e1> alpha 1 globin gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Untreated NS - Meg cells expressed mRNA for the Epo receptor ( EpoR ) , for GATA - 1 , and for alpha 2 globin gene .',\n",
       "  [['Untreated NS - Meg cells expressed mRNA for the Epo receptor ( EpoR ) , for GATA - 1 , and for <e1> alpha 2 globin gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['These results indicate that NS - Meg cells undergo terminal differentiation of both megakaryocytic lineage .',\n",
       "  [['These results indicate that NS - Meg cells undergo terminal differentiation of both <e1> megakaryocytic lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Previous studies have demonstrated that IL - 1 receptor ( IL - 1R ) - and TCR - initiated signals can interact synergistically to increase the rate of transcription of several lymphokine geneduring the competence phase of the activation program in T helper lymphocytes .',\n",
       "  [['Previous studies have demonstrated that IL - 1 receptor ( IL - 1R ) - and TCR - initiated signals can interact synergistically to increase the rate of transcription of several <e1> lymphokine gene </e1> during the competence phase of the activation program in T helper lymphocytes .',\n",
       "    'DNA']]],\n",
       " ['Previous studies have demonstrated that IL - 1 receptor ( IL - 1R ) - and TCR - initiated signals can interact synergistically to increase the rate of transcription of several lymphokine receptor geneduring the competence phase of the activation program in T helper lymphocytes .',\n",
       "  [['Previous studies have demonstrated that IL - 1 receptor ( IL - 1R ) - and TCR - initiated signals can interact synergistically to increase the rate of transcription of several <e1> lymphokine receptor gene </e1> during the competence phase of the activation program in T helper lymphocytes .',\n",
       "    'DNA']]],\n",
       " ['T cell hybridomas respond to activation signals by undergoing apoptotic cell death , and this is likely to represent comparable events related to tolerance induction in immature t cellin vivo .',\n",
       "  [['T cell hybridomas respond to activation signals by undergoing apoptotic cell death , and this is likely to represent comparable events related to tolerance induction in <e1> immature t cell </e1> in vivo .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Previously , an inducible enhancer between nucleotides - 299 and - 228 that contains nf - kappa b motifwas identified .',\n",
       "  [['Previously , an inducible enhancer between nucleotides - 299 and - 228 that contains <e1> nf - kappa b motif </e1> was identified .',\n",
       "    'DNA']]],\n",
       " ['Transcription from the IL - 2R alpha promoter was inhibited when either the elf - 1 binding sitewas mutated .',\n",
       "  [['Transcription from the IL - 2R alpha promoter was inhibited when either the <e1> elf - 1 binding site </e1> was mutated .',\n",
       "    'DNA']]],\n",
       " ['Elf - 1 physically associated with HMG - I and with NF - kappa B p50 and c - Rel in vitro , suggesting that protein - protein interactions might functionally coordinate the actions of the upstream positive regulatory element .',\n",
       "  [['Elf - 1 physically associated with HMG - I and with NF - kappa B p50 and c - Rel in vitro , suggesting that protein - protein interactions might functionally coordinate the actions of the <e1> upstream positive regulatory element </e1> .',\n",
       "    'DNA']]],\n",
       " ['Androgen receptor mRNA was translated in vitro , and androgen - bound receptor complexwere studied using limited proteolytic digestion by trypsin .',\n",
       "  [['Androgen receptor mRNA was translated in vitro , and <e1> androgen - bound receptor complex </e1> were studied using limited proteolytic digestion by trypsin .',\n",
       "    'PROTEIN']]],\n",
       " ['Cotransfection of nf - kappa b p50/p65 - expression vectorinto Jurkat cells with a luciferase reporter containing the GM - CSF promoter did not stimulate transcription from the GM - CSF promoter .',\n",
       "  [['Cotransfection of <e1> nf - kappa b p50/p65 - expression vector </e1> into Jurkat cells with a luciferase reporter containing the GM - CSF promoter did not stimulate transcription from the GM - CSF promoter .',\n",
       "    'DNA']]],\n",
       " ['Cotransfection of NF - kappa B ( p50/p65 ) - or ap - 1 c - jun/c - fos - expression vectorinto Jurkat cells with a luciferase reporter containing the GM - CSF promoter did not stimulate transcription from the GM - CSF promoter .',\n",
       "  [['Cotransfection of NF - kappa B ( p50/p65 ) - or <e1> ap - 1 c - jun/c - fos - expression vector </e1> into Jurkat cells with a luciferase reporter containing the GM - CSF promoter did not stimulate transcription from the GM - CSF promoter .',\n",
       "    'DNA']]],\n",
       " ['These results suggest that cooperation among nf - kappa b - binding sequenceis required for induction of the GM - CSF gene through PKC - and Ca2+ - signaling pathways downstream of T cell activation .',\n",
       "  [['These results suggest that cooperation among <e1> nf - kappa b - binding sequence </e1> is required for induction of the GM - CSF gene through PKC - and Ca2+ - signaling pathways downstream of T cell activation .',\n",
       "    'DNA']]],\n",
       " ['These results suggest that cooperation among NF - kappa B - , ap - 1 - binding sequenceis required for induction of the GM - CSF gene through PKC - and Ca2+ - signaling pathways downstream of T cell activation .',\n",
       "  [['These results suggest that cooperation among NF - kappa B - , <e1> ap - 1 - binding sequence </e1> is required for induction of the GM - CSF gene through PKC - and Ca2+ - signaling pathways downstream of T cell activation .',\n",
       "    'DNA']]],\n",
       " ['These results suggest that cooperation among nf - at - binding sequenceis required for induction of the GM - CSF gene through PKC - and Ca2+ - signaling pathways downstream of T cell activation .',\n",
       "  [['These results suggest that cooperation among <e1> nf - at - binding sequence </e1> is required for induction of the GM - CSF gene through PKC - and Ca2+ - signaling pathways downstream of T cell activation .',\n",
       "    'DNA']]],\n",
       " ['When we compared the activity of the transfected dPRL promoter in prl - secreting lymphoid cell, we found that the 3 kb 5 - flanking region of the dPRL promoter did not contain elements restricting expression to only those lymphocytes that produce PRL but allowed expression of fusion reporter genes irrespective of the status of the endogenous PRL gene .',\n",
       "  [['When we compared the activity of the transfected dPRL promoter in <e1> prl - secreting lymphoid cell </e1> , we found that the 3 kb 5 - flanking region of the dPRL promoter did not contain elements restricting expression to only those lymphocytes that produce PRL but allowed expression of fusion reporter genes irrespective of the status of the endogenous PRL gene .',\n",
       "    'CELL_TYPE']]],\n",
       " ['When we compared the activity of the transfected dPRL promoter in prl - nonsecreting lymphoid cell, we found that the 3 kb 5 - flanking region of the dPRL promoter did not contain elements restricting expression to only those lymphocytes that produce PRL but allowed expression of fusion reporter genes irrespective of the status of the endogenous PRL gene .',\n",
       "  [['When we compared the activity of the transfected dPRL promoter in <e1> prl - nonsecreting lymphoid cell </e1> , we found that the 3 kb 5 - flanking region of the dPRL promoter did not contain elements restricting expression to only those lymphocytes that produce PRL but allowed expression of fusion reporter genes irrespective of the status of the endogenous PRL gene .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Signals and nuclear factors that regulate the expression of interleukin - 4 genein helper T cells .',\n",
       "  [['Signals and nuclear factors that regulate the expression of <e1> interleukin - 4 gene </e1> in helper T cells .',\n",
       "    'DNA']]],\n",
       " ['Signals and nuclear factors that regulate the expression of interleukin - 5 genein helper T cells .',\n",
       "  [['Signals and nuclear factors that regulate the expression of <e1> interleukin - 5 gene </e1> in helper T cells .',\n",
       "    'DNA']]],\n",
       " ['The P sequence of the IL - 4 gene , defined as a responsive element for PMA and calcium ionophore ( A23187 ) , shares sequence similarity with the nf kappa b binding site .',\n",
       "  [['The P sequence of the IL - 4 gene , defined as a responsive element for PMA and calcium ionophore ( A23187 ) , shares sequence similarity with the <e1> nf kappa b binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['Taken together , these results suggest that NF - AT - like factors are involved in the regulation of il - 4 gene .',\n",
       "  [['Taken together , these results suggest that NF - AT - like factors are involved in the regulation of <e1> il - 4 gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Taken together , these results suggest that NF - AT - like factors are involved in the regulation of il - 5 gene .',\n",
       "  [['Taken together , these results suggest that NF - AT - like factors are involved in the regulation of <e1> il - 5 gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['A salient difference between solution structureis observed in the C - terminal segment of alpha - helix 3 ( the HTH recognition helix ) , which is not well ordered in solution .',\n",
       "  [['A salient difference between <e1> solution structure </e1> is observed in the C - terminal segment of alpha - helix 3 ( the HTH recognition helix ) , which is not well ordered in solution .',\n",
       "    'PROTEIN']]],\n",
       " ['Ii kappa B - 1 is a positive regulatory element in B - cell lines and in the Ii - expressing T - cell line , H9 , but acts as a negative regulatory element in myelomonocytic cell line .',\n",
       "  [['Ii kappa B - 1 is a positive regulatory element in B - cell lines and in the Ii - expressing T - cell line , H9 , but acts as a negative regulatory element in <e1> myelomonocytic cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In vivo protein - DNA contacts are detectable at Ii kappa B - 1 in cell lines in which this site is functional as either a positive regulator .',\n",
       "  [['In vivo protein - DNA contacts are detectable at Ii kappa B - 1 in cell lines in which this site is functional as either a <e1> positive regulator </e1> .',\n",
       "    'DNA']]],\n",
       " ['Ii kappa B - 2 is a site of positive regulation in B - cell lines and a site of negative regulation in H9 T cells , myelomonocytic cell line .',\n",
       "  [['Ii kappa B - 2 is a site of positive regulation in B - cell lines and a site of negative regulation in H9 T cells , <e1> myelomonocytic cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['PGE2 enhanced the complex formation with nf - at sequencewhen the cells were activated by either anti - CD3 mAb or PMA /A23187 stimulation .',\n",
       "  [['PGE2 enhanced the complex formation with <e1> nf - at sequence </e1> when the cells were activated by either anti - CD3 mAb or PMA /A23187 stimulation .',\n",
       "    'DNA']]],\n",
       " ['PGE2 enhanced the complex formation with NF - AT , ap - 1 sequencewhen the cells were activated by either anti - CD3 mAb or PMA /A23187 stimulation .',\n",
       "  [['PGE2 enhanced the complex formation with NF - AT , <e1> ap - 1 sequence </e1> when the cells were activated by either anti - CD3 mAb or PMA /A23187 stimulation .',\n",
       "    'DNA']]],\n",
       " ['Treatment of both U - 937 and TUR cells with okadaic acid , an inhibitor of serine/threonine protein phosphatase 2a, was associated with induction of monocytic differentiation and EGR - 1 transcription through the 5 - most CArG element .',\n",
       "  [['Treatment of both U - 937 and TUR cells with okadaic acid , an inhibitor of <e1> serine/threonine protein phosphatase 2a </e1> , was associated with induction of monocytic differentiation and EGR - 1 transcription through the 5 - most CArG element .',\n",
       "    'PROTEIN']]],\n",
       " ['In contrast , analysis of pp90rsk activity by phosphorylation of a peptide derived from S6 protein demonstrated stimulation of this kinase in tpa - treated u - 937 cell .',\n",
       "  [['In contrast , analysis of pp90rsk activity by phosphorylation of a peptide derived from S6 protein demonstrated stimulation of this kinase in <e1> tpa - treated u - 937 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast , analysis of pp90rsk activity by phosphorylation of a peptide derived from S6 protein demonstrated stimulation of this kinase in tpa - treated tur cell .',\n",
       "  [['In contrast , analysis of pp90rsk activity by phosphorylation of a peptide derived from S6 protein demonstrated stimulation of this kinase in <e1> tpa - treated tur cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['The activity of the immunoglobulin heavy - chain ( IgH ) enhancer is restricted to B cells , although it binds both b - cell - restricted transcription factor .',\n",
       "  [['The activity of the immunoglobulin heavy - chain ( IgH ) enhancer is restricted to B cells , although it binds both <e1> b - cell - restricted transcription factor </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The transcription factor nuclear factor - kappa B ( NF - kappa B ) is critical for the inducible expression of multiple cellular geneinvolved in inflammation and infection including interleukin - 1 ( IL - 1 ) , IL - 6 , and adhesion molecules .',\n",
       "  [['The transcription factor nuclear factor - kappa B ( NF - kappa B ) is critical for the inducible expression of multiple <e1> cellular gene </e1> involved in inflammation and infection including interleukin - 1 ( IL - 1 ) , IL - 6 , and adhesion molecules .',\n",
       "    'DNA']]],\n",
       " ['Activation of a novel serine /threonine kinase that phosphorylates c - Fos upon stimulation of t lymphocytevia antigen and cytokine receptors .',\n",
       "  [['Activation of a novel serine /threonine kinase that phosphorylates c - Fos upon stimulation of <e1> t lymphocyte </e1> via antigen and cytokine receptors .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Ligation of Ag receptors in t lymphocyteinitiates signal transduction cascades which alter the expression of genes that regulate cellular proliferation and differentiation .',\n",
       "  [['Ligation of Ag receptors in <e1> t lymphocyte </e1> initiates signal transduction cascades which alter the expression of genes that regulate cellular proliferation and differentiation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The transmission of signals from the membrane to the nucleus is mediated principally through the action of protein tyrosine kinase .',\n",
       "  [['The transmission of signals from the membrane to the nucleus is mediated principally through the action of <e1> protein tyrosine kinase </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The transmission of signals from the membrane to the nucleus is mediated principally through the action of protein serine/threonine kinase .',\n",
       "  [['The transmission of signals from the membrane to the nucleus is mediated principally through the action of <e1> protein serine/threonine kinase </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Fos kinase was rapidly activated after ligation of the cd3 receptorin Jurkat and normal human T lymphocytes and in response to IL - 6 and anti - IgM in the human B cell lines AF10 and Ramos , respectively .',\n",
       "  [['Fos kinase was rapidly activated after ligation of the <e1> cd3 receptor </e1> in Jurkat and normal human T lymphocytes and in response to IL - 6 and anti - IgM in the human B cell lines AF10 and Ramos , respectively .',\n",
       "    'PROTEIN']]],\n",
       " ['The gc2 - specific cd4+ clonehad cytotoxic activity .',\n",
       "  [['The <e1> gc2 - specific cd4+ clone </e1> had cytotoxic activity .',\n",
       "    'CELL_LINE']]],\n",
       " ['We conclude that the nf - il6 sitemediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "  [['We conclude that the <e1> nf - il6 site </e1> mediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "    'DNA']]],\n",
       " ['We conclude that the nf - kappa b sitemediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "  [['We conclude that the <e1> nf - kappa b site </e1> mediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "    'DNA']]],\n",
       " ['We conclude that the NF - IL6 and NF - kappa B sites mediate IL - 6 induction in response to both LPS and LAM , acting as bacterial response element .',\n",
       "  [['We conclude that the NF - IL6 and NF - kappa B sites mediate IL - 6 induction in response to both LPS and LAM , acting as <e1> bacterial response element </e1> .',\n",
       "    'DNA']]],\n",
       " ['We conclude that the nf - il6 sitemediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "  [['We conclude that the <e1> nf - il6 site </e1> mediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "    'DNA']]],\n",
       " ['We conclude that the nf - kappa b sitemediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "  [['We conclude that the <e1> nf - kappa b site </e1> mediate IL - 6 induction in response to both LPS and LAM , acting as bacterial or mycobacterial response elements .',\n",
       "    'DNA']]],\n",
       " ['We conclude that the NF - IL6 and NF - kappa B sites mediate IL - 6 induction in response to both LPS and LAM , acting as bacterial response element .',\n",
       "  [['We conclude that the NF - IL6 and NF - kappa B sites mediate IL - 6 induction in response to both LPS and LAM , acting as <e1> bacterial response element </e1> .',\n",
       "    'DNA']]],\n",
       " ['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid cellon reporter genes containing HLF or C/EBP consensus binding sites .',\n",
       "  [['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in <e1> lymphoid cell </e1> on reporter genes containing HLF or C/EBP consensus binding sites .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing hlf consensus binding site .',\n",
       "  [['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing <e1> hlf consensus binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid cellon reporter genes containing HLF or C/EBP consensus binding sites .',\n",
       "  [['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in <e1> lymphoid cell </e1> on reporter genes containing HLF or C/EBP consensus binding sites .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing hlf consensus binding site .',\n",
       "  [['Both wild - type and chimeric HLF proteins displayed transcriptional activator properties in lymphoid and nonlymphoid cells on reporter genes containing <e1> hlf consensus binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['The glutathione - depleting agent diethyl maleate ( DEM ) prevented the development of differentiated features in response to phorbol esters , including adherence of the cells to plastic surfaces and repression of the myeloperoxidase gene .',\n",
       "  [['The glutathione - depleting agent diethyl maleate ( DEM ) prevented the development of differentiated features in response to phorbol esters , including adherence of the cells to plastic surfaces and repression of the <e1> myeloperoxidase gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['In vitro binding studies demonstrated that the TF site bound translated c - rel homodimerbut not p50/p65 heterodimers or p50 homodimers .',\n",
       "  [['In vitro binding studies demonstrated that the TF site bound translated <e1> c - rel homodimer </e1> but not p50/p65 heterodimers or p50 homodimers .',\n",
       "    'PROTEIN']]],\n",
       " ['Recent findings suggest an involvement of reactive oxygen species in the pathway of TPA and protein kinase C leading to expression of c - fos mrna .',\n",
       "  [['Recent findings suggest an involvement of reactive oxygen species in the pathway of TPA and protein kinase C leading to expression of <e1> c - fos mrna </e1> .',\n",
       "    'RNA']]],\n",
       " ['Recent findings suggest an involvement of reactive oxygen species in the pathway of TPA and protein kinase C leading to expression of c - jun mrna .',\n",
       "  [['Recent findings suggest an involvement of reactive oxygen species in the pathway of TPA and protein kinase C leading to expression of <e1> c - jun mrna </e1> .',\n",
       "    'RNA']]],\n",
       " ['Our studies reveal that inactivation of the v - abl protein tyrosine kinase triggers high - frequency rearrangement of kappa light - chain gene .',\n",
       "  [['Our studies reveal that inactivation of the v - abl protein tyrosine kinase triggers high - frequency rearrangement of <e1> kappa light - chain gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes ( MDS ) in advanced stage were enriched for blasts and tested for ( 1 ) karyotype , ( 2 ) genomic configuration and ( 3 ) expression of il - 3 genewhich are all located on the long arm of chromosome 5 .',\n",
       "  [['Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes ( MDS ) in advanced stage were enriched for blasts and tested for ( 1 ) karyotype , ( 2 ) genomic configuration and ( 3 ) expression of <e1> il - 3 gene </e1> which are all located on the long arm of chromosome 5 .',\n",
       "    'DNA']]],\n",
       " ['Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes ( MDS ) in advanced stage were enriched for blasts and tested for ( 1 ) karyotype , ( 2 ) genomic configuration and ( 3 ) expression of IL - 3 , gm - csf genewhich are all located on the long arm of chromosome 5 .',\n",
       "  [['Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes ( MDS ) in advanced stage were enriched for blasts and tested for ( 1 ) karyotype , ( 2 ) genomic configuration and ( 3 ) expression of IL - 3 , <e1> gm - csf gene </e1> which are all located on the long arm of chromosome 5 .',\n",
       "    'DNA']]],\n",
       " ['Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes ( MDS ) in advanced stage were enriched for blasts and tested for ( 1 ) karyotype , ( 2 ) genomic configuration and ( 3 ) expression of IL - 3 , GM - CSF , fms genewhich are all located on the long arm of chromosome 5 .',\n",
       "  [['Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes ( MDS ) in advanced stage were enriched for blasts and tested for ( 1 ) karyotype , ( 2 ) genomic configuration and ( 3 ) expression of IL - 3 , GM - CSF , <e1> fms gene </e1> which are all located on the long arm of chromosome 5 .',\n",
       "    'DNA']]],\n",
       " ['An autocrine mechanism of growth could be hypothesized only for the 2 patients whose cells expressed both the m - csf gene .',\n",
       "  [['An autocrine mechanism of growth could be hypothesized only for the 2 patients whose cells expressed both the <e1> m - csf gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['The expression of the p50 nf - kappa b subunitwas also shown to be regulated differentially after exposures to 1.0 and 2.0 Gy .',\n",
       "  [['The expression of the <e1> p50 nf - kappa b subunit </e1> was also shown to be regulated differentially after exposures to 1.0 and 2.0 Gy .',\n",
       "    'PROTEIN']]],\n",
       " ['The human gata3 transcription unitstart at a major initiation site .',\n",
       "  [['The <e1> human gata3 transcription unit </e1> start at a major initiation site .',\n",
       "    'DNA']]],\n",
       " ['CD38 is a leukocyte differentiation antigen that has been thought to be a phenotypic marker of different subpopulations of t - lymphocyte .',\n",
       "  [['CD38 is a leukocyte differentiation antigen that has been thought to be a phenotypic marker of different subpopulations of <e1> t - lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Induction of CD38 in acute promyelocytic leukemia cellwas independent of ATRA - induced cytodifferentiation .',\n",
       "  [['Induction of CD38 in <e1> acute promyelocytic leukemia cell </e1> was independent of ATRA - induced cytodifferentiation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Induction of CD38 in acute myeloblastic leukemia cellwas independent of ATRA - induced cytodifferentiation .',\n",
       "  [['Induction of CD38 in <e1> acute myeloblastic leukemia cell </e1> was independent of ATRA - induced cytodifferentiation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Macrophages and t lymphocyteinfiltrated the tumor in moderate numbers with occasional lymphoid aggregate formation .',\n",
       "  [['Macrophages and <e1> t lymphocyte </e1> infiltrated the tumor in moderate numbers with occasional lymphoid aggregate formation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These parameters were examined in normal and Epstein - Barr virus - immortalized human B cells and compared with 1 alpha,25 - (OH)2D3 - responsive cells of the t lineage .',\n",
       "  [['These parameters were examined in normal and Epstein - Barr virus - immortalized human B cells and compared with 1 alpha,25 - (OH)2D3 - responsive cells of the <e1> t lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Finally , the ap - 1 - 186 to - 176 site( - 206 to - 195 ) respond to different cellular activation in EL4 cells .',\n",
       "  [['Finally , the <e1> ap - 1 - 186 to - 176 site </e1> ( - 206 to - 195 ) respond to different cellular activation in EL4 cells .',\n",
       "    'DNA']]],\n",
       " ['One major transcription start sitewere identified 101 and 130 base pairs ( bp ) upstream , respectively , from the protein translation start ATG .',\n",
       "  [['One <e1> major transcription start site </e1> were identified 101 and 130 base pairs ( bp ) upstream , respectively , from the protein translation start ATG .',\n",
       "    'DNA']]],\n",
       " ['The interleukin - 8 ap - 1 siteare genetic end targets of FK506 - sensitive pathway accompanied by calcium mobilization .',\n",
       "  [['The <e1> interleukin - 8 ap - 1 site </e1> are genetic end targets of FK506 - sensitive pathway accompanied by calcium mobilization .',\n",
       "    'DNA']]],\n",
       " ['Our results indicate that not only the reported il - 2 nf - at site, but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .',\n",
       "  [['Our results indicate that not only the reported <e1> il - 2 nf - at site </e1> , but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .',\n",
       "    'DNA']]],\n",
       " ['Our results indicate that not only the reported IL - 2 NF - AT and nfil - 2a site, but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .',\n",
       "  [['Our results indicate that not only the reported IL - 2 NF - AT and <e1> nfil - 2a site </e1> , but also the IL - 8 AP - 1 and kappa B - like sites are terminals of FK506 - sensitive pathway involving Ca2+ mobilization .',\n",
       "    'DNA']]],\n",
       " [' corticosteroid type i receptorare inversely correlated with age .',\n",
       "  [[' <e1> corticosteroid type i receptor </e1> are inversely correlated with age .',\n",
       "    'PROTEIN']]],\n",
       " [' corticosteroid type ii receptorare inversely correlated with age .',\n",
       "  [[' <e1> corticosteroid type ii receptor </e1> are inversely correlated with age .',\n",
       "    'PROTEIN']]],\n",
       " ['Priming with 10 nM RA , or subsequent treatment with D3 ( 5 nM ) , did not alter expression of mRNAs encoding receptors for D3 ( VDR ) , RA ( RAR alpha ) or 9 - CIS RA ( rxr beta, gamma ) .',\n",
       "  [['Priming with 10 nM RA , or subsequent treatment with D3 ( 5 nM ) , did not alter expression of mRNAs encoding receptors for D3 ( VDR ) , RA ( RAR alpha ) or 9 - CIS RA ( <e1> rxr beta </e1> , gamma ) .',\n",
       "    'PROTEIN']]],\n",
       " ['Priming with 10 nM RA , or subsequent treatment with D3 ( 5 nM ) , did not alter expression of mRNAs encoding receptors for D3 ( VDR ) , RA ( RAR alpha ) or 9 - CIS RA ( rxr gamma) .',\n",
       "  [['Priming with 10 nM RA , or subsequent treatment with D3 ( 5 nM ) , did not alter expression of mRNAs encoding receptors for D3 ( VDR ) , RA ( RAR alpha ) or 9 - CIS RA ( <e1> rxr gamma </e1> ) .',\n",
       "    'PROTEIN']]],\n",
       " ['Thrombin stimulated tyrosine phosphorylation of several proteins of molecular mass 40 kda .',\n",
       "  [['Thrombin stimulated tyrosine phosphorylation of several proteins of <e1> molecular mass 40 kda </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Thrombin stimulated tyrosine phosphorylation of several proteins of molecular mass 42 kda .',\n",
       "  [['Thrombin stimulated tyrosine phosphorylation of several proteins of <e1> molecular mass 42 kda </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Thrombin stimulated tyrosine phosphorylation of several proteins of molecular mass 70 kda .',\n",
       "  [['Thrombin stimulated tyrosine phosphorylation of several proteins of <e1> molecular mass 70 kda </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Thrombin stimulated tyrosine phosphorylation of several proteins of molecular mass 120 kda .',\n",
       "  [['Thrombin stimulated tyrosine phosphorylation of several proteins of <e1> molecular mass 120 kda </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Thrombin stimulated tyrosine phosphorylation of several proteins of molecular mass 130 kda .',\n",
       "  [['Thrombin stimulated tyrosine phosphorylation of several proteins of <e1> molecular mass 130 kda </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['We have identified and characterized a previously unrecognized form of acute leukemia that shares features of both myeloid cell .',\n",
       "  [['We have identified and characterized a previously unrecognized form of acute leukemia that shares features of both <e1> myeloid cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We have identified and characterized a previously unrecognized form of acute leukemia that shares features of both myeloid and natural killer nk cell .',\n",
       "  [['We have identified and characterized a previously unrecognized form of acute leukemia that shares features of both myeloid and <e1> natural killer nk cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Multicolor flow cytometric assays confirmed the coexpression of myeloid cd33 , cd13 , cd15 antigenin each case , whereas reverse transcription polymerase chain reaction ( RT - PCR ) assays confirmed the identity of CD56 ( neural cell adhesion molecule ) in leukemic blasts .',\n",
       "  [['Multicolor flow cytometric assays confirmed the coexpression of <e1> myeloid cd33 , cd13 , cd15 antigen </e1> in each case , whereas reverse transcription polymerase chain reaction ( RT - PCR ) assays confirmed the identity of CD56 ( neural cell adhesion molecule ) in leukemic blasts .',\n",
       "    'PROTEIN']]],\n",
       " ['Multicolor flow cytometric assays confirmed the coexpression of myeloid ( CD33 , CD13 , CD15 ) and nk cell - associated cd56 antigenin each case , whereas reverse transcription polymerase chain reaction ( RT - PCR ) assays confirmed the identity of CD56 ( neural cell adhesion molecule ) in leukemic blasts .',\n",
       "  [['Multicolor flow cytometric assays confirmed the coexpression of myeloid ( CD33 , CD13 , CD15 ) and <e1> nk cell - associated cd56 antigen </e1> in each case , whereas reverse transcription polymerase chain reaction ( RT - PCR ) assays confirmed the identity of CD56 ( neural cell adhesion molecule ) in leukemic blasts .',\n",
       "    'PROTEIN']]],\n",
       " ['Although two cases expressed CD4 , no case expressed CD2 , CD3 , or CD8 and no case showed clonal rearrangement of genes encoding the T - cell receptor ( tcr gamma, delta ) .',\n",
       "  [['Although two cases expressed CD4 , no case expressed CD2 , CD3 , or CD8 and no case showed clonal rearrangement of genes encoding the T - cell receptor ( <e1> tcr gamma </e1> , delta ) .',\n",
       "    'PROTEIN']]],\n",
       " ['Although two cases expressed CD4 , no case expressed CD2 , CD3 , or CD8 and no case showed clonal rearrangement of genes encoding the T - cell receptor ( tcr delta) .',\n",
       "  [['Although two cases expressed CD4 , no case expressed CD2 , CD3 , or CD8 and no case showed clonal rearrangement of genes encoding the T - cell receptor ( <e1> tcr delta </e1> ) .',\n",
       "    'PROTEIN']]],\n",
       " ['Our studies suggest that this form of acute leukemia may arise from transformation of a precursor cell common to both the myeloid cell lineage; thus we propose the designation myeloid/NK acute leukemia .',\n",
       "  [['Our studies suggest that this form of acute leukemia may arise from transformation of a precursor cell common to both the <e1> myeloid cell lineage </e1> ; thus we propose the designation myeloid/NK acute leukemia .',\n",
       "    'CELL_TYPE']]],\n",
       " ['IL - 4 , a product of the t - helper 0 th0 subset, was originally described as a B - cell stimulatory factor and has subsequently been found to suppress IL - 1 alpha , IL - 1 beta , IL - 6 , IL - 8 , and TNF - alpha gene expression in monocytes stimulated with LPS , and to upregulate IL - 1 receptor antagonist ( IL1 - RA ) gene expression .',\n",
       "  [['IL - 4 , a product of the <e1> t - helper 0 th0 subset </e1> , was originally described as a B - cell stimulatory factor and has subsequently been found to suppress IL - 1 alpha , IL - 1 beta , IL - 6 , IL - 8 , and TNF - alpha gene expression in monocytes stimulated with LPS , and to upregulate IL - 1 receptor antagonist ( IL1 - RA ) gene expression .',\n",
       "    'CELL_TYPE']]],\n",
       " ['IL - 4 , a product of the t - helper 2 th2 subset, was originally described as a B - cell stimulatory factor and has subsequently been found to suppress IL - 1 alpha , IL - 1 beta , IL - 6 , IL - 8 , and TNF - alpha gene expression in monocytes stimulated with LPS , and to upregulate IL - 1 receptor antagonist ( IL1 - RA ) gene expression .',\n",
       "  [['IL - 4 , a product of the <e1> t - helper 2 th2 subset </e1> , was originally described as a B - cell stimulatory factor and has subsequently been found to suppress IL - 1 alpha , IL - 1 beta , IL - 6 , IL - 8 , and TNF - alpha gene expression in monocytes stimulated with LPS , and to upregulate IL - 1 receptor antagonist ( IL1 - RA ) gene expression .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The induced expression of il - 1 beta mrnain the monocytic THP - 1 cell line increased as quickly as in primary cells .',\n",
       "  [['The induced expression of <e1> il - 1 beta mrna </e1> in the monocytic THP - 1 cell line increased as quickly as in primary cells .',\n",
       "    'RNA']]],\n",
       " ['IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements , the AP - 1 protein being composed of c - jun gene product .',\n",
       "  [['IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements , the AP - 1 protein being composed of <e1> c - jun gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements , the AP - 1 protein being composed of c - fos gene product .',\n",
       "  [['IL - 1 beta and IL - 6 genes contain AP - 1 binding sites as regulatory elements , the AP - 1 protein being composed of <e1> c - fos gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Protein tyrosine kinases transmit signals from cytokine receptor .',\n",
       "  [['Protein tyrosine kinases transmit signals from <e1> cytokine receptor </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Two new isoforms were found that generate novel amino - terminal sequence .',\n",
       "  [['Two new isoforms were found that generate novel <e1> amino - terminal sequence </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The zinc finger transcription factor GATA - 1 is a major regulator of gene expression in erythroid cell lineage .',\n",
       "  [['The zinc finger transcription factor GATA - 1 is a major regulator of gene expression in <e1> erythroid cell lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The zinc finger transcription factor GATA - 1 is a major regulator of gene expression in erythroid , megakaryocyte cell lineage .',\n",
       "  [['The zinc finger transcription factor GATA - 1 is a major regulator of gene expression in erythroid , <e1> megakaryocyte cell lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In clonogenetic fetal calf serum - supplemented fcs+ culturetreated with saturating levels of interleukin - 3 ( IL - 3 ) granulocyte - macrophage colony - stimulating factor ( GM - CSF ) and erythropoietin ( Ep ) ( combined with c - kit ligand in FCS( - ) - culture conditions ) , RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation , the latter colonies being essentially represented by granulocytic clones .',\n",
       "  [['In <e1> clonogenetic fetal calf serum - supplemented fcs+ culture </e1> treated with saturating levels of interleukin - 3 ( IL - 3 ) granulocyte - macrophage colony - stimulating factor ( GM - CSF ) and erythropoietin ( Ep ) ( combined with c - kit ligand in FCS( - ) - culture conditions ) , RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation , the latter colonies being essentially represented by granulocytic clones .',\n",
       "    'CELL_LINE']]],\n",
       " ['In clonogenetic fetal calf serum - nonsupplemented fcs - culturetreated with saturating levels of interleukin - 3 ( IL - 3 ) granulocyte - macrophage colony - stimulating factor ( GM - CSF ) and erythropoietin ( Ep ) ( combined with c - kit ligand in FCS( - ) - culture conditions ) , RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation , the latter colonies being essentially represented by granulocytic clones .',\n",
       "  [['In <e1> clonogenetic fetal calf serum - nonsupplemented fcs - culture </e1> treated with saturating levels of interleukin - 3 ( IL - 3 ) granulocyte - macrophage colony - stimulating factor ( GM - CSF ) and erythropoietin ( Ep ) ( combined with c - kit ligand in FCS( - ) - culture conditions ) , RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation , the latter colonies being essentially represented by granulocytic clones .',\n",
       "    'CELL_LINE']]],\n",
       " ['Both sIgM - and sIgD - crosslinking with antibodies induced elevation of cAMP levels , phosphatidylinositol turnover , PKC activation and expression of egr - 1 mrna, although sIgM - crosslinking was more effective than sIgD - crosslinking , presumably due to the higher expression of sIgM than of sIgD .',\n",
       "  [['Both sIgM - and sIgD - crosslinking with antibodies induced elevation of cAMP levels , phosphatidylinositol turnover , PKC activation and expression of <e1> egr - 1 mrna </e1> , although sIgM - crosslinking was more effective than sIgD - crosslinking , presumably due to the higher expression of sIgM than of sIgD .',\n",
       "    'RNA']]],\n",
       " ['Therefore , we compared the nucleotide sequences of the cd11a gene promoterto identify common elements that might contribute to inducible expression .',\n",
       "  [['Therefore , we compared the nucleotide sequences of the <e1> cd11a gene promoter </e1> to identify common elements that might contribute to inducible expression .',\n",
       "    'DNA']]],\n",
       " ['Therefore , we compared the nucleotide sequences of the CD11a , cd11b gene promoterto identify common elements that might contribute to inducible expression .',\n",
       "  [['Therefore , we compared the nucleotide sequences of the CD11a , <e1> cd11b gene promoter </e1> to identify common elements that might contribute to inducible expression .',\n",
       "    'DNA']]],\n",
       " ['PML appears to be transcriptionally regulated by class i interferon, which raises the possibility that interferons modulate the function and growth and differentiation potential of normal myeloid cells and precursors by activating PML - dependent pathways .',\n",
       "  [['PML appears to be transcriptionally regulated by <e1> class i interferon </e1> , which raises the possibility that interferons modulate the function and growth and differentiation potential of normal myeloid cells and precursors by activating PML - dependent pathways .',\n",
       "    'PROTEIN']]],\n",
       " ['PML appears to be transcriptionally regulated by class ii interferon, which raises the possibility that interferons modulate the function and growth and differentiation potential of normal myeloid cells and precursors by activating PML - dependent pathways .',\n",
       "  [['PML appears to be transcriptionally regulated by <e1> class ii interferon </e1> , which raises the possibility that interferons modulate the function and growth and differentiation potential of normal myeloid cells and precursors by activating PML - dependent pathways .',\n",
       "    'PROTEIN']]],\n",
       " ['We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes , lymphocytes , and polymorphonucleate cells , but is markedly induced by interferon ; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line , which carries the t(15; 17) , and in APL blasts from patients ; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA ; that interferons alone have minimal maturation effect on NB4 cells ; and , finally , that interferon alphaor beta , induces maturation and growth suppression of NB4 cells with de novo retinoid resistance , and partially restores RA response .',\n",
       "  [['We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes , lymphocytes , and polymorphonucleate cells , but is markedly induced by interferon ; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line , which carries the t(15; 17) , and in APL blasts from patients ; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA ; that interferons alone have minimal maturation effect on NB4 cells ; and , finally , that <e1> interferon alpha </e1> or beta , induces maturation and growth suppression of NB4 cells with de novo retinoid resistance , and partially restores RA response .',\n",
       "    'PROTEIN']]],\n",
       " ['We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes , lymphocytes , and polymorphonucleate cells , but is markedly induced by interferon ; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line , which carries the t(15; 17) , and in APL blasts from patients ; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA ; that interferons alone have minimal maturation effect on NB4 cells ; and , finally , that interferon beta, induces maturation and growth suppression of NB4 cells with de novo retinoid resistance , and partially restores RA response .',\n",
       "  [['We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes , lymphocytes , and polymorphonucleate cells , but is markedly induced by interferon ; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line , which carries the t(15; 17) , and in APL blasts from patients ; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA ; that interferons alone have minimal maturation effect on NB4 cells ; and , finally , that <e1> interferon beta </e1> , induces maturation and growth suppression of NB4 cells with de novo retinoid resistance , and partially restores RA response .',\n",
       "    'PROTEIN']]],\n",
       " ['Effects of Ara - C on neutral sphingomyelinase and mitogen - activated protein kinasein T - lymphocyte cell lines .',\n",
       "  [['Effects of Ara - C on neutral sphingomyelinase and <e1> mitogen - activated protein kinase </e1> in T - lymphocyte cell lines .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparative analysis identifies conserved tumor necrosis factor receptor - associated factor 3 binding sites in the human epstein - barr virus oncogene lmp1 .',\n",
       "  [['Comparative analysis identifies conserved tumor necrosis factor receptor - associated factor 3 binding sites in the <e1> human epstein - barr virus oncogene lmp1 </e1> .',\n",
       "    'DNA']]],\n",
       " ['Chromosome 1 abnormalities with loss of 1p36 have been investigated in 95 breast - cancer samples by means of a dual - target fluorescence in - situ hybridization ( FISH ) technique using the pUC 1.77 and p1 - 79 probes , specific for the 1q12 region, respectively .',\n",
       "  [['Chromosome 1 abnormalities with loss of 1p36 have been investigated in 95 breast - cancer samples by means of a dual - target fluorescence in - situ hybridization ( FISH ) technique using the pUC 1.77 and p1 - 79 probes , specific for the <e1> 1q12 region </e1> , respectively .',\n",
       "    'DNA']]],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal band 1p21 - 22, 3q21 - 24 , 8p12 , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "  [['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal band 1p21 - 22 </e1> , 3q21 - 24 , 8p12 , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "    'DNA']]],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal band 3q21 - 24, 8p12 , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "  [['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal band 3q21 - 24 </e1> , 8p12 , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "    'DNA']]],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal band 8p12, 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "  [['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal band 8p12 </e1> , 13q14 , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "    'DNA']]],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal band 13q14, 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "  [['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal band 13q14 </e1> , 19p13.3 and 11p14 - 15.1 , respectively .',\n",
       "    'DNA']]],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal band 19p13.3and 11p14 - 15.1 , respectively .',\n",
       "  [['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal band 19p13.3 </e1> and 11p14 - 15.1 , respectively .',\n",
       "    'DNA']]],\n",
       " ['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the human chromosomal band 11p14 - 15.1, respectively .',\n",
       "  [['Using fluorescence in situ hybridization ( FISH ) , we show here that the genes encoding the TATA - box binding protein ( TBP ) , TFIIB , TFIIE alpha , TFIIE beta , RAP30 , RAP74 and the 62 kDa subunit , of TFIIH are located at the <e1> human chromosomal band 11p14 - 15.1 </e1> , respectively .',\n",
       "    'DNA']]],\n",
       " ['Early buds are characterized by a branching morphogenesis of the ductal epithelium from which endocrine precursor cellbud to eventually form the two other compartments .',\n",
       "  [['Early buds are characterized by a branching morphogenesis of the ductal epithelium from which <e1> endocrine precursor cell </e1> bud to eventually form the two other compartments .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Deletion mutants containing 1.3 kb 5 - flanking dnawere incrementally less transcriptionally active , although 0.2 kb still mediated a 12 - fold induction by PRL .',\n",
       "  [['Deletion mutants containing <e1> 1.3 kb 5 - flanking dna </e1> were incrementally less transcriptionally active , although 0.2 kb still mediated a 12 - fold induction by PRL .',\n",
       "    'DNA']]],\n",
       " ['Deletion mutants containing 1.3 , 0.6 kb 5 - flanking dnawere incrementally less transcriptionally active , although 0.2 kb still mediated a 12 - fold induction by PRL .',\n",
       "  [['Deletion mutants containing 1.3 , <e1> 0.6 kb 5 - flanking dna </e1> were incrementally less transcriptionally active , although 0.2 kb still mediated a 12 - fold induction by PRL .',\n",
       "    'DNA']]],\n",
       " ['SCL protein was detected in erythroid cell line, as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements .',\n",
       "  [['SCL protein was detected in <e1> erythroid cell line </e1> , as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements .',\n",
       "    'CELL_LINE']]],\n",
       " ['SCL protein was detected in erythroid , megakaryocyte cell line, as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements .',\n",
       "  [['SCL protein was detected in erythroid , <e1> megakaryocyte cell line </e1> , as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements .',\n",
       "    'CELL_LINE']]],\n",
       " ['SCL protein was detected in erythroid , megakaryocyte , mast cell line, as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements .',\n",
       "  [['SCL protein was detected in erythroid , megakaryocyte , <e1> mast cell line </e1> , as well as in several lymphoid leukemia cell lines which are known to harbor SCL gene rearrangements .',\n",
       "    'CELL_LINE']]],\n",
       " ['Cytomegalovirus ( CMV ) infection is nonpermissive or persistent in many lymphoid cell typebut can be activated in differentiated macrophages .',\n",
       "  [['Cytomegalovirus ( CMV ) infection is nonpermissive or persistent in many <e1> lymphoid cell type </e1> but can be activated in differentiated macrophages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Two multicopy basal enhancer motifs within the SCMV MIE enhancer , namely , 11 copies of the 16 - bp cyclic AMP response element ( CRE ) and 3 copies of novel 17 - bp serum response factor ( SRF ) binding sites referred to as the SNE ( SRF/NFkappaB - like element ) , as well as four classical NFkappaB sites within the HCMV version , contribute to TPA responsiveness in transient assays in monocyte type .',\n",
       "  [['Two multicopy basal enhancer motifs within the SCMV MIE enhancer , namely , 11 copies of the 16 - bp cyclic AMP response element ( CRE ) and 3 copies of novel 17 - bp serum response factor ( SRF ) binding sites referred to as the SNE ( SRF/NFkappaB - like element ) , as well as four classical NFkappaB sites within the HCMV version , contribute to TPA responsiveness in transient assays in <e1> monocyte type </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The SCMV SNE sites contain potential overlapping core recognition binding motifs for SRF , Rel/NFkappaB , ETS , and YY1 class transcription factors but fail to respond to either serum necrosis factor alpha .',\n",
       "  [['The SCMV SNE sites contain potential overlapping core recognition binding motifs for SRF , Rel/NFkappaB , ETS , and YY1 class transcription factors but fail to respond to either <e1> serum necrosis factor alpha </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the hcmv mie enhancer, we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the <e1> hcmv mie enhancer </e1> , we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "    'DNA']]],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of multimerized wild - type elementadded upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of <e1> multimerized wild - type element </e1> added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "    'DNA']]],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of multimerized mutant elementadded upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of <e1> multimerized mutant element </e1> added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "    'DNA']]],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the hcmv mie enhancer, we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the <e1> hcmv mie enhancer </e1> , we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "    'DNA']]],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of multimerized wild - type elementadded upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of <e1> multimerized wild - type element </e1> added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "    'DNA']]],\n",
       " ['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of multimerized mutant elementadded upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "  [['Therefore , to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF/ ETS element ) motif found in the HCMV and chimpanzee CMV MIE enhancers , we have examined the functional responses and protein binding properties of <e1> multimerized mutant element </e1> added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937 , K - 562 , HL - 60 , THP - 1 , and Jurkat cell lines .',\n",
       "    'DNA']]],\n",
       " ['Slight differences in the sequence of the core SRF binding site compared with that of the classical c - Fos promoter serum response element , together with differences in the spacing between the srf motif, appear to account for the inability of the SCMV SNEs to respond to serum induction .',\n",
       "  [['Slight differences in the sequence of the core SRF binding site compared with that of the classical c - Fos promoter serum response element , together with differences in the spacing between the <e1> srf motif </e1> , appear to account for the inability of the SCMV SNEs to respond to serum induction .',\n",
       "    'DNA']]],\n",
       " ['Murine fra - 1 was highly homologous to rat fra - 1 .',\n",
       "  [['Murine fra - 1 was highly homologous to <e1> rat fra - 1 </e1> .',\n",
       "    'DNA']]],\n",
       " ['The PB1 sequence motif is highly conserved in both human gm - csf gene .',\n",
       "  [['The PB1 sequence motif is highly conserved in both <e1> human gm - csf gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['In vitro mutagenesis experiments demonstrated that both the ets siteare required for binding of the inducible PB1 nuclear protein complex and for the transcriptional activity of this element and the GM - CSF promoter in activated T cells .',\n",
       "  [['In vitro mutagenesis experiments demonstrated that both the <e1> ets site </e1> are required for binding of the inducible PB1 nuclear protein complex and for the transcriptional activity of this element and the GM - CSF promoter in activated T cells .',\n",
       "    'DNA']]],\n",
       " ['Surprisingly , traf - 2, or - 3 does not interact with the terminal LMP1 CT aa 333 to 386 which can independently mediate NF - kappaB activation .',\n",
       "  [['Surprisingly , <e1> traf - 2 </e1> , or - 3 does not interact with the terminal LMP1 CT aa 333 to 386 which can independently mediate NF - kappaB activation .',\n",
       "    'PROTEIN']]],\n",
       " ['Surprisingly , traf - 3does not interact with the terminal LMP1 CT aa 333 to 386 which can independently mediate NF - kappaB activation .',\n",
       "  [['Surprisingly , <e1> traf - 3 </e1> does not interact with the terminal LMP1 CT aa 333 to 386 which can independently mediate NF - kappaB activation .',\n",
       "    'PROTEIN']]],\n",
       " ['In this report we address the contribution of the regulatory domainof pp56(lck) to another function of this enzyme independent of CD4 : TCR - induced IL - 2 production .',\n",
       "  [['In this report we address the contribution of the <e1> regulatory domain </e1> of pp56(lck) to another function of this enzyme independent of CD4 : TCR - induced IL - 2 production .',\n",
       "    'PROTEIN']]],\n",
       " ['PRRI is an inducible proximal enhancer , located between nucleotides - 276 and - 244 , which contains nf - kappab motif .',\n",
       "  [['PRRI is an inducible proximal enhancer , located between nucleotides - 276 and - 244 , which contains <e1> nf - kappab motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['IL - 2 induced the binding of stat 5a proteinto the human GASd element .',\n",
       "  [['IL - 2 induced the binding of <e1> stat 5a protein </e1> to the human GASd element .',\n",
       "    'PROTEIN']]],\n",
       " ['IL - 2 induced the binding of stat 5b proteinto the human GASd element .',\n",
       "  [['IL - 2 induced the binding of <e1> stat 5b protein </e1> to the human GASd element .',\n",
       "    'PROTEIN']]],\n",
       " ['p52 and RelB were detected in the nuclei in both CD1a+ and CD68+ cells from the T cell area , whereas p50 was found only in cd68 - cell .',\n",
       "  [['p52 and RelB were detected in the nuclei in both CD1a+ and CD68+ cells from the T cell area , whereas p50 was found only in <e1> cd68 - cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['When the promoter region was linked with a heterologous reporter gene , we found that the promoter region is inducible by both interferons ( interferon - gamma) and interferon regulatory factor 1 .',\n",
       "  [['When the promoter region was linked with a heterologous reporter gene , we found that the promoter region is inducible by both interferons ( <e1> interferon - gamma </e1> ) and interferon regulatory factor 1 .',\n",
       "    'PROTEIN']]],\n",
       " ['Freshly isolated cells show high levels of fosb/g0s3 mrna, which decline rapidly during incubation in culture medium .',\n",
       "  [['Freshly isolated cells show high levels of <e1> fosb/g0s3 mrna </e1> , which decline rapidly during incubation in culture medium .',\n",
       "    'RNA']]],\n",
       " ['In freshly isolated cells , both fos mrnaincrease dramatically in response to the protein synthesis inhibitor cycloheximide .',\n",
       "  [['In freshly isolated cells , both <e1> fos mrna </e1> increase dramatically in response to the protein synthesis inhibitor cycloheximide .',\n",
       "    'RNA']]],\n",
       " ['In fetal liver of PU.1 - / - mice , which lack lymphoid cell, expression of Btk was reduced two - to threefold but not abolished .',\n",
       "  [['In fetal liver of PU.1 - / - mice , which lack <e1> lymphoid cell </e1> , expression of Btk was reduced two - to threefold but not abolished .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Collectively this study shows that expression of the Btk gene is regulated by the combined action of sp1 - family member .',\n",
       "  [['Collectively this study shows that expression of the Btk gene is regulated by the combined action of <e1> sp1 - family member </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Studies of cell lines representing endocrine lineageusing polyclonal antisera to detect E2A proteins have suggested that significant E2A protein expression is restricted to B - lymphocytes .',\n",
       "  [['Studies of cell lines representing <e1> endocrine lineage </e1> using polyclonal antisera to detect E2A proteins have suggested that significant E2A protein expression is restricted to B - lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Studies of cell lines representing endocrine , fibroblast lineageusing polyclonal antisera to detect E2A proteins have suggested that significant E2A protein expression is restricted to B - lymphocytes .',\n",
       "  [['Studies of cell lines representing endocrine , <e1> fibroblast lineage </e1> using polyclonal antisera to detect E2A proteins have suggested that significant E2A protein expression is restricted to B - lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We have developed a monoclonal antibody , Yae , which is specific for Pan/ E2A proteins , and have used the Yae antibody to examine a variety of endocrine cell lineagefor differences in Pan/ E2A protein expression , subcellular localization , and heteromeric complex formation .',\n",
       "  [['We have developed a monoclonal antibody , Yae , which is specific for Pan/ E2A proteins , and have used the Yae antibody to examine a variety of <e1> endocrine cell lineage </e1> for differences in Pan/ E2A protein expression , subcellular localization , and heteromeric complex formation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In contrast to previous results obtained using polyclonal antiseras to detect Pan/ E2A proteins , we report comparable levels of Pan proteins in gh/prl - producing lymphocyte cell .',\n",
       "  [['In contrast to previous results obtained using polyclonal antiseras to detect Pan/ E2A proteins , we report comparable levels of Pan proteins in <e1> gh/prl - producing lymphocyte cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast to previous results obtained using polyclonal antiseras to detect Pan/ E2A proteins , we report comparable levels of Pan proteins in GH/PRL - and insulin - producing lymphocyte cell .',\n",
       "  [['In contrast to previous results obtained using polyclonal antiseras to detect Pan/ E2A proteins , we report comparable levels of Pan proteins in GH/PRL - and <e1> insulin - producing lymphocyte cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast to previous results obtained using polyclonal antiseras to detect Pan/ E2A proteins , we report comparable levels of Pan proteins in GH/PRL - and insulin - producing , b - lymphocyte cell .',\n",
       "  [['In contrast to previous results obtained using polyclonal antiseras to detect Pan/ E2A proteins , we report comparable levels of Pan proteins in GH/PRL - and insulin - producing , <e1> b - lymphocyte cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " [' nasal nk - cell lymphomashare the same type of Epstein - Barr virus latency as nasopharyngeal carcinoma and Hodgkin s disease .',\n",
       "  [[' <e1> nasal nk - cell lymphoma </e1> share the same type of Epstein - Barr virus latency as nasopharyngeal carcinoma and Hodgkin s disease .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Both nk - cell subtypeare closely associated with Epstein - Barr virus ( EBV ) .',\n",
       "  [['Both <e1> nk - cell subtype </e1> are closely associated with Epstein - Barr virus ( EBV ) .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In addition , analysis of EBV protein expression by IH revealed a heterogeneous pattern of EBV gene expression at the single - cell level consisting of both lmp1+ tumour cell, suggesting a mixture of latency I and II .',\n",
       "  [['In addition , analysis of EBV protein expression by IH revealed a heterogeneous pattern of EBV gene expression at the single - cell level consisting of both <e1> lmp1+ tumour cell </e1> , suggesting a mixture of latency I and II .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Now we have examined whether naive t lymphocytediffer in their sensitivity to ROI - mediated signals .',\n",
       "  [['Now we have examined whether <e1> naive t lymphocyte </e1> differ in their sensitivity to ROI - mediated signals .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not jun family member, renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "  [['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not <e1> jun family member </e1> , renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "    'PROTEIN']]],\n",
       " ['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not Jun , fos family member, renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "  [['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not Jun , <e1> fos family member </e1> , renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "    'PROTEIN']]],\n",
       " ['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not Jun , Fos , nf - kappab family member, renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "  [['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not Jun , Fos , <e1> nf - kappab family member </e1> , renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "    'PROTEIN']]],\n",
       " ['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not Jun , Fos , NF - kappaB , oct family member, renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "  [['Furthermore , overexpression and constitutive nuclear localization of NF - AT , but not Jun , Fos , NF - kappaB , <e1> oct family member </e1> , renders the interleukin - 2 enhancer in Jurkat T lymphocytes resistant to FK506 and cyclosporin A .',\n",
       "    'PROTEIN']]],\n",
       " ['Subsequent studies have revealed that ( i ) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the nf - kappa b2 p100 genes; ( ii ) in contrast to RelA - I kappa B alpha , RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation ; ( iii ) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo ; ( iv ) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA , which is required for I kappa B alpha binding ; ( v ) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain , which mediates cytoplasmic retention of RelA ; and ( vi ) as observed with I kappa B alpha , nuclear RelA stimulates p100 mRNA and protein expression .',\n",
       "  [['Subsequent studies have revealed that ( i ) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the <e1> nf - kappa b2 p100 genes </e1> ; ( ii ) in contrast to RelA - I kappa B alpha , RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation ; ( iii ) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo ; ( iv ) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA , which is required for I kappa B alpha binding ; ( v ) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain , which mediates cytoplasmic retention of RelA ; and ( vi ) as observed with I kappa B alpha , nuclear RelA stimulates p100 mRNA and protein expression .',\n",
       "    'DNA']]],\n",
       " ['Subsequent studies have revealed that ( i ) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the nf - kappa b1 p105 genes; ( ii ) in contrast to RelA - I kappa B alpha , RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation ; ( iii ) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo ; ( iv ) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA , which is required for I kappa B alpha binding ; ( v ) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain , which mediates cytoplasmic retention of RelA ; and ( vi ) as observed with I kappa B alpha , nuclear RelA stimulates p100 mRNA and protein expression .',\n",
       "  [['Subsequent studies have revealed that ( i ) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the <e1> nf - kappa b1 p105 genes </e1> ; ( ii ) in contrast to RelA - I kappa B alpha , RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation ; ( iii ) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo ; ( iv ) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA , which is required for I kappa B alpha binding ; ( v ) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain , which mediates cytoplasmic retention of RelA ; and ( vi ) as observed with I kappa B alpha , nuclear RelA stimulates p100 mRNA and protein expression .',\n",
       "    'DNA']]],\n",
       " ['In this study , we obtained evidence that transfection of the cDNAs for cn a catalytic subunitalso augments transcription from the GM - CSF promoter and recovers the transcription inhibited by CsA .',\n",
       "  [['In this study , we obtained evidence that transfection of the cDNAs for <e1> cn a catalytic subunit </e1> also augments transcription from the GM - CSF promoter and recovers the transcription inhibited by CsA .',\n",
       "    'PROTEIN']]],\n",
       " ['In this study , we obtained evidence that transfection of the cDNAs for cn b regulatory subunitalso augments transcription from the GM - CSF promoter and recovers the transcription inhibited by CsA .',\n",
       "  [['In this study , we obtained evidence that transfection of the cDNAs for <e1> cn b regulatory subunit </e1> also augments transcription from the GM - CSF promoter and recovers the transcription inhibited by CsA .',\n",
       "    'PROTEIN']]],\n",
       " ['These results suggest that CN is involved in the coordinated induction of the gm - csf geneis a functional analogue of the NF - AT - binding site in the IL - 2 promoter , which mediates signals downstream of T cell activation .',\n",
       "  [['These results suggest that CN is involved in the coordinated induction of the <e1> gm - csf gene </e1> is a functional analogue of the NF - AT - binding site in the IL - 2 promoter , which mediates signals downstream of T cell activation .',\n",
       "    'DNA']]],\n",
       " ['These results suggest that CN is involved in the coordinated induction of the GM - CSF and il - 2 geneis a functional analogue of the NF - AT - binding site in the IL - 2 promoter , which mediates signals downstream of T cell activation .',\n",
       "  [['These results suggest that CN is involved in the coordinated induction of the GM - CSF and <e1> il - 2 gene </e1> is a functional analogue of the NF - AT - binding site in the IL - 2 promoter , which mediates signals downstream of T cell activation .',\n",
       "    'DNA']]],\n",
       " ['These results suggest that blasts in M7 and TMD may correspond to progenitors of both erythroid lineage .',\n",
       "  [['These results suggest that blasts in M7 and TMD may correspond to progenitors of both <e1> erythroid lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['E3 transcripts are present in the myeloid lineage, absent in nonhematopoietic cells , and encode a highly hydrophobic , potentially phosphorylated polypeptide of unknown function with significant homology to a putative protein expressed in myeloid cells .',\n",
       "  [['E3 transcripts are present in the <e1> myeloid lineage </e1> , absent in nonhematopoietic cells , and encode a highly hydrophobic , potentially phosphorylated polypeptide of unknown function with significant homology to a putative protein expressed in myeloid cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['E3 transcripts are present in the myeloid , b - lymphoid lineage, absent in nonhematopoietic cells , and encode a highly hydrophobic , potentially phosphorylated polypeptide of unknown function with significant homology to a putative protein expressed in myeloid cells .',\n",
       "  [['E3 transcripts are present in the myeloid , <e1> b - lymphoid lineage </e1> , absent in nonhematopoietic cells , and encode a highly hydrophobic , potentially phosphorylated polypeptide of unknown function with significant homology to a putative protein expressed in myeloid cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We have identified two new isoforms of the transcription factor NFAT1 ( previously termed NFATp ) that are the predominant isoforms expressed in murine t cell .',\n",
       "  [['We have identified two new isoforms of the transcription factor NFAT1 ( previously termed NFATp ) that are the predominant isoforms expressed in <e1> murine t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We previously characterized drosophila taf subunitthat make up the core TFIID complex found in all cells .',\n",
       "  [['We previously characterized <e1> drosophila taf subunit </e1> that make up the core TFIID complex found in all cells .',\n",
       "    'PROTEIN']]],\n",
       " ['No instance of microsatellite instability was observed in a total of 880 comparisons of granulocyte dna .',\n",
       "  [['No instance of microsatellite instability was observed in a total of 880 comparisons of <e1> granulocyte dna </e1> .',\n",
       "    'DNA']]],\n",
       " ['In t - cell line, the E ( gre ) motifs were of major importance for Akv MLV transcriptional activity , while the EA/S motif had some effect .',\n",
       "  [['In <e1> t - cell line </e1> , the E ( gre ) motifs were of major importance for Akv MLV transcriptional activity , while the EA/S motif had some effect .',\n",
       "    'CELL_LINE']]],\n",
       " ['The positive region can be divided into an upstream regulatory region .',\n",
       "  [['The positive region can be divided into an <e1> upstream regulatory region </e1> .',\n",
       "    'DNA']]],\n",
       " ['Northern analysis using a probe encompassing a common region of both isoforms showed two mRNA species of 2.7 kilobase pairmRNA which was preferentially expressed in the spleen .',\n",
       "  [['Northern analysis using a probe encompassing a common region of both isoforms showed two mRNA species of <e1> 2.7 kilobase pair </e1> mRNA which was preferentially expressed in the spleen .',\n",
       "    'RNA']]],\n",
       " ['Northern analysis using a probe encompassing a common region of both isoforms showed two mRNA species of 2.7 and 4.5 kilobase pairmRNA which was preferentially expressed in the spleen .',\n",
       "  [['Northern analysis using a probe encompassing a common region of both isoforms showed two mRNA species of 2.7 and <e1> 4.5 kilobase pair </e1> mRNA which was preferentially expressed in the spleen .',\n",
       "    'RNA']]],\n",
       " ['Latent membrane protein ( LMP ) 2A mRNA was detected in three of seven cases ; however , neither lmp1 mrnawas detected in any of the tumours tested .',\n",
       "  [['Latent membrane protein ( LMP ) 2A mRNA was detected in three of seven cases ; however , neither <e1> lmp1 mrna </e1> was detected in any of the tumours tested .',\n",
       "    'RNA']]],\n",
       " ['Both are located in the particulate fraction following platelet activation and are also able to bind to a GST - construct containing the sh2 domainof phospholipase C gamma 1 .',\n",
       "  [['Both are located in the particulate fraction following platelet activation and are also able to bind to a GST - construct containing the <e1> sh2 domain </e1> of phospholipase C gamma 1 .',\n",
       "    'PROTEIN']]],\n",
       " ['In this study , we characterize an essential upstream IL - 2 response element that contains both consensus gas motif, and a GATA motif , which overlaps the non - consensus GAS motif .',\n",
       "  [['In this study , we characterize an essential upstream IL - 2 response element that contains both <e1> consensus gas motif </e1> , and a GATA motif , which overlaps the non - consensus GAS motif .',\n",
       "    'DNA']]],\n",
       " ['In this study , we characterize an essential upstream IL - 2 response element that contains both consensus and non - consensus gas motif, and a GATA motif , which overlaps the non - consensus GAS motif .',\n",
       "  [['In this study , we characterize an essential upstream IL - 2 response element that contains both consensus and <e1> non - consensus gas motif </e1> , and a GATA motif , which overlaps the non - consensus GAS motif .',\n",
       "    'DNA']]],\n",
       " ['Thus , IL - 2 - induced IL - 2R alpha promoter activity requires a complex upstream element , which appears to contain binding sites for both positive regulatory factor .',\n",
       "  [['Thus , IL - 2 - induced IL - 2R alpha promoter activity requires a complex upstream element , which appears to contain binding sites for both <e1> positive regulatory factor </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Cloning and characterization of the beta subunit of human proximal sequence element - binding transcription factor and its involvement in transcription of small nuclear RNA genes by rna polymerase iii .',\n",
       "  [['Cloning and characterization of the beta subunit of human proximal sequence element - binding transcription factor and its involvement in transcription of small nuclear RNA genes by <e1> rna polymerase iii </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['We previously reported the purification of human PTF , a complex of four subunits , and the molecular cloning and characterization of ptf gamma subunit .',\n",
       "  [['We previously reported the purification of human PTF , a complex of four subunits , and the molecular cloning and characterization of <e1> ptf gamma subunit </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['We previously reported the purification of human PTF , a complex of four subunits , and the molecular cloning and characterization of ptf delta subunit .',\n",
       "  [['We previously reported the purification of human PTF , a complex of four subunits , and the molecular cloning and characterization of <e1> ptf delta subunit </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Abnormalities of p16 genein recurrent malignant astrocytomas .',\n",
       "  [['Abnormalities of <e1> p16 gene </e1> in recurrent malignant astrocytomas .',\n",
       "    'DNA']]],\n",
       " ['Abnormalities of p16 , p15 genein recurrent malignant astrocytomas .',\n",
       "  [['Abnormalities of p16 , <e1> p15 gene </e1> in recurrent malignant astrocytomas .',\n",
       "    'DNA']]],\n",
       " ['Abnormalities in the p16 genethat regulate transition through the G1 phase of the cell cycle have been implicated in the malignant progression of astrocytomas .',\n",
       "  [['Abnormalities in the <e1> p16 gene </e1> that regulate transition through the G1 phase of the cell cycle have been implicated in the malignant progression of astrocytomas .',\n",
       "    'DNA']]],\n",
       " ['Abnormalities in the p16 , p15 genethat regulate transition through the G1 phase of the cell cycle have been implicated in the malignant progression of astrocytomas .',\n",
       "  [['Abnormalities in the p16 , <e1> p15 gene </e1> that regulate transition through the G1 phase of the cell cycle have been implicated in the malignant progression of astrocytomas .',\n",
       "    'DNA']]],\n",
       " ['The primary and recurrent tumors in Group A did not show structural alterations in the p16 gene, whereas homozygous codeletion of p16 and p15 was observed in both primary and recurrent tumors in Group B .',\n",
       "  [['The primary and recurrent tumors in Group A did not show structural alterations in the <e1> p16 gene </e1> , whereas homozygous codeletion of p16 and p15 was observed in both primary and recurrent tumors in Group B .',\n",
       "    'DNA']]],\n",
       " ['The primary and recurrent tumors in Group A did not show structural alterations in the p16 , p15 gene, whereas homozygous codeletion of p16 and p15 was observed in both primary and recurrent tumors in Group B .',\n",
       "  [['The primary and recurrent tumors in Group A did not show structural alterations in the p16 , <e1> p15 gene </e1> , whereas homozygous codeletion of p16 and p15 was observed in both primary and recurrent tumors in Group B .',\n",
       "    'DNA']]],\n",
       " ['Signals leading to the activation of NF - kappa B transcription factor are stronger in neonatal t lymphocyte .',\n",
       "  [['Signals leading to the activation of NF - kappa B transcription factor are stronger in <e1> neonatal t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The data obtained demonstrate that phorbol dibutyrate/calcium ionophore A23187 ( PDBu/iono ) combination induced a clearly higher nuclear translocation of NF - kappa B in neonatal t cell .',\n",
       "  [['The data obtained demonstrate that phorbol dibutyrate/calcium ionophore A23187 ( PDBu/iono ) combination induced a clearly higher nuclear translocation of NF - kappa B in <e1> neonatal t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 protein, indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "  [['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the <e1> p50 protein </e1> , indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and rela p65 protein, indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "  [['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and <e1> rela p65 protein </e1> , indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and RelA ( p65 ) proteins , indicated that the composition of NF - kappa B was similar in neonatal cell .',\n",
       "  [['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and RelA ( p65 ) proteins , indicated that the composition of NF - kappa B was similar in <e1> neonatal cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 protein, indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "  [['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the <e1> p50 protein </e1> , indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and rela p65 protein, indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "  [['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and <e1> rela p65 protein </e1> , indicated that the composition of NF - kappa B was similar in neonatal and adult cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and RelA ( p65 ) proteins , indicated that the composition of NF - kappa B was similar in neonatal cell .',\n",
       "  [['Analysis of the nuclear extracts with antibodies directed against the major components of NF - kappa B the p50 and RelA ( p65 ) proteins , indicated that the composition of NF - kappa B was similar in <e1> neonatal cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Studies on unicellular daughter cell cultureunequivocally indicate that the shift is mediated by modulation of the HPC differentiation program to the granulopoietic pathway ( rather than RA - induced down - modulation of multipotent / erythroid /monocytic HPC growth coupled with recruitment of granulocytic HPCs ) .',\n",
       "  [['Studies on <e1> unicellular daughter cell culture </e1> unequivocally indicate that the shift is mediated by modulation of the HPC differentiation program to the granulopoietic pathway ( rather than RA - induced down - modulation of multipotent / erythroid /monocytic HPC growth coupled with recruitment of granulocytic HPCs ) .',\n",
       "    'CELL_LINE']]],\n",
       " ['In the present study , corticosteroid type i receptorin mononuclear leukocytes were measured in 10 elderly subjects and in 9 young adults , before and after overnight DST ( 1 mg ) .',\n",
       "  [['In the present study , <e1> corticosteroid type i receptor </e1> in mononuclear leukocytes were measured in 10 elderly subjects and in 9 young adults , before and after overnight DST ( 1 mg ) .',\n",
       "    'PROTEIN']]],\n",
       " ['In the present study , corticosteroid type ii receptorin mononuclear leukocytes were measured in 10 elderly subjects and in 9 young adults , before and after overnight DST ( 1 mg ) .',\n",
       "  [['In the present study , <e1> corticosteroid type ii receptor </e1> in mononuclear leukocytes were measured in 10 elderly subjects and in 9 young adults , before and after overnight DST ( 1 mg ) .',\n",
       "    'PROTEIN']]],\n",
       " ['The number of type i receptorbefore the test was lower in elderly subjects than in adults .',\n",
       "  [['The number of <e1> type i receptor </e1> before the test was lower in elderly subjects than in adults .',\n",
       "    'PROTEIN']]],\n",
       " ['The number of type ii receptorsbefore the test was lower in elderly subjects than in adults .',\n",
       "  [['The number of <e1> type ii receptors </e1> before the test was lower in elderly subjects than in adults .',\n",
       "    'PROTEIN']]],\n",
       " [' il4 receptorshare the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .',\n",
       "  [[' <e1> il4 receptor </e1> share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .',\n",
       "    'PROTEIN']]],\n",
       " ['IL4 and IL13 receptors share the gamma c chain and activate stat6 proteinin normal human B cells .',\n",
       "  [['IL4 and IL13 receptors share the gamma c chain and activate <e1> stat6 protein </e1> in normal human B cells .',\n",
       "    'PROTEIN']]],\n",
       " ['IL4 and IL13 receptors share the gamma c chain and activate STAT6 , stat3 proteinin normal human B cells .',\n",
       "  [['IL4 and IL13 receptors share the gamma c chain and activate STAT6 , <e1> stat3 protein </e1> in normal human B cells .',\n",
       "    'PROTEIN']]],\n",
       " [' il4 receptorshare the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .',\n",
       "  [[' <e1> il4 receptor </e1> share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .',\n",
       "    'PROTEIN']]],\n",
       " ['IL4 and IL13 receptors share the gamma c chain and activate stat6 proteinin normal human B cells .',\n",
       "  [['IL4 and IL13 receptors share the gamma c chain and activate <e1> stat6 protein </e1> in normal human B cells .',\n",
       "    'PROTEIN']]],\n",
       " ['IL4 and IL13 receptors share the gamma c chain and activate STAT6 , stat3 proteinin normal human B cells .',\n",
       "  [['IL4 and IL13 receptors share the gamma c chain and activate STAT6 , <e1> stat3 protein </e1> in normal human B cells .',\n",
       "    'PROTEIN']]],\n",
       " ['In previous studies , we identified calcineurin mutations that block binding by the cyclophilin a /csa complexand thereby render yeast cells resistant to the antifungal effects of CsA or FK506 .',\n",
       "  [['In previous studies , we identified calcineurin mutations that block binding by the <e1> cyclophilin a /csa complex </e1> and thereby render yeast cells resistant to the antifungal effects of CsA or FK506 .',\n",
       "    'PROTEIN']]],\n",
       " ['A critical role of sp1 - related transcription factorin maintaining CTL - specific expression of the mouse perforin gene .',\n",
       "  [['A critical role of <e1> sp1 - related transcription factor </e1> in maintaining CTL - specific expression of the mouse perforin gene .',\n",
       "    'PROTEIN']]],\n",
       " ['The previously defined minimal enhancer containing the mua siteis transactivated by a combination of the ETS - domain proteins PU.1 and Ets - 1 in nonlymphoid cells .',\n",
       "  [['The previously defined minimal enhancer containing the <e1> mua site </e1> is transactivated by a combination of the ETS - domain proteins PU.1 and Ets - 1 in nonlymphoid cells .',\n",
       "    'DNA']]],\n",
       " ['The previously defined minimal enhancer containing the muA , mue3 siteis transactivated by a combination of the ETS - domain proteins PU.1 and Ets - 1 in nonlymphoid cells .',\n",
       "  [['The previously defined minimal enhancer containing the muA , <e1> mue3 site </e1> is transactivated by a combination of the ETS - domain proteins PU.1 and Ets - 1 in nonlymphoid cells .',\n",
       "    'DNA']]],\n",
       " ['The core GGAAs of the mua siteare separated by 30 nucleotides , suggesting that ETS proteins bind to these sites from these same side of the DNA helix .',\n",
       "  [['The core GGAAs of the <e1> mua site </e1> are separated by 30 nucleotides , suggesting that ETS proteins bind to these sites from these same side of the DNA helix .',\n",
       "    'DNA']]],\n",
       " ['We propose that the requirement for precise spacing of the mua elementis due in part to a directed DNA bend induced by PU.1 .',\n",
       "  [['We propose that the requirement for precise spacing of the <e1> mua element </e1> is due in part to a directed DNA bend induced by PU.1 .',\n",
       "    'DNA']]],\n",
       " ['Our results , although limited , suggest that normal individuals can express both the wild - type and truncated version at the same time , whereas lupus patients only express either the wild - type er .',\n",
       "  [['Our results , although limited , suggest that normal individuals can express both the wild - type and truncated version at the same time , whereas lupus patients only express either the <e1> wild - type er </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Sialoadhesin is a macrophage - restricted member of the Ig superfamily that mediates adhesion with lymphoid cell .',\n",
       "  [['Sialoadhesin is a macrophage - restricted member of the Ig superfamily that mediates adhesion with <e1> lymphoid cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In addition , inhibition of mRNA synthesis with actinomycin D indicated that DOX induced an increased stability of pbgd mrna, whereas ACLA did not affect the half - lives of these mRNAs .',\n",
       "  [['In addition , inhibition of mRNA synthesis with actinomycin D indicated that DOX induced an increased stability of <e1> pbgd mrna </e1> , whereas ACLA did not affect the half - lives of these mRNAs .',\n",
       "    'RNA']]],\n",
       " ['Finally , GATA - 1 protein level was shown to be increased in acla - treated cell .',\n",
       "  [['Finally , GATA - 1 protein level was shown to be increased in <e1> acla - treated cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal b cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of <e1> normal b cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal t cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of <e1> normal t cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic b cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and <e1> leukemic b cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal t lymphocyte .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of <e1> normal t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic t lymphocyte .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and <e1> leukemic t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic b cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic <e1> b cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal b cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of <e1> normal b cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal t cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of <e1> normal t cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic b cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and <e1> leukemic b cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal t lymphocyte .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of <e1> normal t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic t lymphocyte .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and <e1> leukemic t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic b cell precursorand T lymphocytes .',\n",
       "  [['Interleukin - 7 ( IL - 7 ) stimulates the proliferation of normal and leukemic <e1> b cell precursor </e1> and T lymphocytes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To determine the contribution of the cytoplasmic domain of the IL - 7 receptor alpha chain ( IL - 7R alpha ) to activation of STAT proteins , transfectants of the murine pro - B cell line BAF3 were made that express chimeric receptors consisting of the extracellular domain of human granulocyte colony - stimulating factor receptor ( G - CSF - R ) and the transmembrane domainof human IL - 7R alpha .',\n",
       "  [['To determine the contribution of the cytoplasmic domain of the IL - 7 receptor alpha chain ( IL - 7R alpha ) to activation of STAT proteins , transfectants of the murine pro - B cell line BAF3 were made that express chimeric receptors consisting of the extracellular domain of human granulocyte colony - stimulating factor receptor ( G - CSF - R ) and the <e1> transmembrane domain </e1> of human IL - 7R alpha .',\n",
       "    'PROTEIN']]],\n",
       " ['The oligo sequence I stimulated proliferation of both t cell .',\n",
       "  [['The oligo sequence I stimulated proliferation of both <e1> t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The percentage of cells expressing CD40 in t cell co - cultureincreased from 4.2 % to 13.8 % after oligo stimulation in patients , while it increased form 4.7 % to 48.6 % in healthy controls .',\n",
       "  [['The percentage of cells expressing CD40 in <e1> t cell co - culture </e1> increased from 4.2 % to 13.8 % after oligo stimulation in patients , while it increased form 4.7 % to 48.6 % in healthy controls .',\n",
       "    'CELL_LINE']]],\n",
       " ['IL - 12 - induced activation of nk celloccurs in the absence of immediate - early activation gene expression .',\n",
       "  [['IL - 12 - induced activation of <e1> nk cell </e1> occurs in the absence of immediate - early activation gene expression .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Using reverse - transcription PCR differential display , we isolated an mRNA species expressed in il - 2 - stimulated nk cell .',\n",
       "  [['Using reverse - transcription PCR differential display , we isolated an mRNA species expressed in <e1> il - 2 - stimulated nk cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Using reverse - transcription PCR differential display , we isolated an mRNA species expressed in il - 12 - stimulated nk cell .',\n",
       "  [['Using reverse - transcription PCR differential display , we isolated an mRNA species expressed in <e1> il - 12 - stimulated nk cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['This was identified as the mRNA encoding the transcription factor egr - 1 , which is expressed with fast kinetics in t cellupon IL - 2 , but not IL - 12 , stimulation .',\n",
       "  [['This was identified as the mRNA encoding the transcription factor egr - 1 , which is expressed with fast kinetics in <e1> t cell </e1> upon IL - 2 , but not IL - 12 , stimulation .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Analysis of the accumulation of mRNA - encoding members of the AP - 1 transcription factor family demonstrated that c - fos and junB are also expressed upon stimulation of nk cellwith IL - 2 , but not IL - 12 , whereas expression of c - jun and junD is not modified by either cytokine .',\n",
       "  [['Analysis of the accumulation of mRNA - encoding members of the AP - 1 transcription factor family demonstrated that c - fos and junB are also expressed upon stimulation of <e1> nk cell </e1> with IL - 2 , but not IL - 12 , whereas expression of c - jun and junD is not modified by either cytokine .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Analysis of the expression of genes reported to regulate cytokine - induced proliferation demonstrated that both IL - 2 and IL - 12 induce c - myc mRNA accumulation in nk cell, whereas only IL - 2 induces bcl - 2 expression .',\n",
       "  [['Analysis of the expression of genes reported to regulate cytokine - induced proliferation demonstrated that both IL - 2 and IL - 12 induce c - myc mRNA accumulation in <e1> nk cell </e1> , whereas only IL - 2 induces bcl - 2 expression .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Our data provide the first demonstration that IL - 12 - mediated activation of t celldoes not involve expression of members of the immediate - early activation genes family ( egr - 1 , c - fos , and junB ) , AP - 1 transcriptional activity , or bcl - 2 expression .',\n",
       "  [['Our data provide the first demonstration that IL - 12 - mediated activation of <e1> t cell </e1> does not involve expression of members of the immediate - early activation genes family ( egr - 1 , c - fos , and junB ) , AP - 1 transcriptional activity , or bcl - 2 expression .',\n",
       "    'CELL_TYPE']]],\n",
       " ['This indicates that functional differences observed in il - 2 - stimulated cellmay depend , at least in part , on differential gene regulation .',\n",
       "  [['This indicates that functional differences observed in <e1> il - 2 - stimulated cell </e1> may depend , at least in part , on differential gene regulation .',\n",
       "    'CELL_LINE']]],\n",
       " ['This indicates that functional differences observed in il - 12 - stimulated cellmay depend , at least in part , on differential gene regulation .',\n",
       "  [['This indicates that functional differences observed in <e1> il - 12 - stimulated cell </e1> may depend , at least in part , on differential gene regulation .',\n",
       "    'CELL_LINE']]],\n",
       " ['Here we demonstrate that the human gm - csf enhanceralso encompass binding sites for core - binding factor ( CBF ) .',\n",
       "  [['Here we demonstrate that the <e1> human gm - csf enhancer </e1> also encompass binding sites for core - binding factor ( CBF ) .',\n",
       "    'DNA']]],\n",
       " ['The aml1 genethat encode CBF each have the ability to influence cell growth and differentiation and have been implicated as proto - oncogenes in acute myeloid leukemia .',\n",
       "  [['The <e1> aml1 gene </e1> that encode CBF each have the ability to influence cell growth and differentiation and have been implicated as proto - oncogenes in acute myeloid leukemia .',\n",
       "    'DNA']]],\n",
       " ['However , PHA/ PMA but not oxidative signals induced the coordinate activation of reporter constructs containing the ap - 1 - tre promoter regionalong with IL - 2 mRNA expression .',\n",
       "  [['However , PHA/ PMA but not oxidative signals induced the coordinate activation of reporter constructs containing the <e1> ap - 1 - tre promoter region </e1> along with IL - 2 mRNA expression .',\n",
       "    'DNA']]],\n",
       " ['However , PHA/ PMA but not oxidative signals induced the coordinate activation of reporter constructs containing the AP - 1 - TRE , nf - at promoter regionalong with IL - 2 mRNA expression .',\n",
       "  [['However , PHA/ PMA but not oxidative signals induced the coordinate activation of reporter constructs containing the AP - 1 - TRE , <e1> nf - at promoter region </e1> along with IL - 2 mRNA expression .',\n",
       "    'DNA']]],\n",
       " ['Activation of human monocytic cells by treponema pallidum lipoproteinand synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF - kappa B .',\n",
       "  [['Activation of human monocytic cells by <e1> treponema pallidum lipoprotein </e1> and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF - kappa B .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of GR chimeric receptors containing the potent vp16 viral transactivation domainin place of the GR N terminus revealed that even low level expression of these receptors resulted in both enhanced steroid sensitivity and MMTV induction , thus supporting a role for transactivation in apoptosis .',\n",
       "  [['Analysis of GR chimeric receptors containing the potent <e1> vp16 viral transactivation domain </e1> in place of the GR N terminus revealed that even low level expression of these receptors resulted in both enhanced steroid sensitivity and MMTV induction , thus supporting a role for transactivation in apoptosis .',\n",
       "    'DNA']]],\n",
       " ['Finally , IL - 2 induced tyrosine phosphorylation of JAK1 and JAK3 , while IL - 12 induced phosphorylation of JAK2 and TYK2 in both preactivated primary nk cell .',\n",
       "  [['Finally , IL - 2 induced tyrosine phosphorylation of JAK1 and JAK3 , while IL - 12 induced phosphorylation of JAK2 and TYK2 in both <e1> preactivated primary nk cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Finally , IL - 2 induced tyrosine phosphorylation of JAK1 and JAK3 , while IL - 12 induced phosphorylation of JAK2 and TYK2 in both preactivated primary nk3.3 cell .',\n",
       "  [['Finally , IL - 2 induced tyrosine phosphorylation of JAK1 and JAK3 , while IL - 12 induced phosphorylation of JAK2 and TYK2 in both <e1> preactivated primary nk3.3 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['The proliferative responses of purified cd4+ cellare suppressed more strongly by TPCK when anti - CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .',\n",
       "  [['The proliferative responses of <e1> purified cd4+ cell </e1> are suppressed more strongly by TPCK when anti - CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The proliferative responses of purified cd8+ t cellare suppressed more strongly by TPCK when anti - CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .',\n",
       "  [['The proliferative responses of <e1> purified cd8+ t cell </e1> are suppressed more strongly by TPCK when anti - CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Cytokine ( IL - 2 , IL - 6 , INF - gamma ) production is inhibited 95 - 100 % by concentrations of TPCK that totally suppress the mitogenesis of cd4+ cell .',\n",
       "  [['Cytokine ( IL - 2 , IL - 6 , INF - gamma ) production is inhibited 95 - 100 % by concentrations of TPCK that totally suppress the mitogenesis of <e1> cd4+ cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Cytokines that bind to the interleukin - 2 ( IL - 2 ) receptor common gamma chain ( gamma c ) , including IL - 2 , IL - 4 , IL - 7 , IL - 9 , and IL - 15 , are important for the growth and differentiation of t lymphocyte, natural killer cells , macrophages , and monoctyes .',\n",
       "  [['Cytokines that bind to the interleukin - 2 ( IL - 2 ) receptor common gamma chain ( gamma c ) , including IL - 2 , IL - 4 , IL - 7 , IL - 9 , and IL - 15 , are important for the growth and differentiation of <e1> t lymphocyte </e1> , natural killer cells , macrophages , and monoctyes .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Yet , little is known as to how the ra receptor networkoperates in hematopoietic cells , and whether receptor interactions can explain the interplay between the RA - and VitD3 - signaling pathways during differentiation .',\n",
       "  [['Yet , little is known as to how the <e1> ra receptor network </e1> operates in hematopoietic cells , and whether receptor interactions can explain the interplay between the RA - and VitD3 - signaling pathways during differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Although the band 14q11 is a locus of t - cell receptor alpha - chain( TCR alpha/delta ) , lymphoma cells expressed B - cell , IgGk phenotype .',\n",
       "  [['Although the band 14q11 is a locus of <e1> t - cell receptor alpha - chain </e1> ( TCR alpha/delta ) , lymphoma cells expressed B - cell , IgGk phenotype .',\n",
       "    'PROTEIN']]],\n",
       " ['Although the band 14q11 is a locus of t - cell receptor delta - chain( TCR alpha/delta ) , lymphoma cells expressed B - cell , IgGk phenotype .',\n",
       "  [['Although the band 14q11 is a locus of <e1> t - cell receptor delta - chain </e1> ( TCR alpha/delta ) , lymphoma cells expressed B - cell , IgGk phenotype .',\n",
       "    'PROTEIN']]],\n",
       " ['This is achieved in part through the positive activities of the ap - 1 sitein the IL - 3 promoter .',\n",
       "  [['This is achieved in part through the positive activities of the <e1> ap - 1 site </e1> in the IL - 3 promoter .',\n",
       "    'DNA']]],\n",
       " ['Transcription factors of t lymphocyte- - basic research and clinical perspectives for gastroenterology .',\n",
       "  [['Transcription factors of <e1> t lymphocyte </e1> - - basic research and clinical perspectives for gastroenterology .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Furthermore , the most important trans - acting factors of t lymphocyte( e.g. NF - kB , NF - AT and STAT families ) and their functional importance are described .',\n",
       "  [['Furthermore , the most important trans - acting factors of <e1> t lymphocyte </e1> ( e.g. NF - kB , NF - AT and STAT families ) and their functional importance are described .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Receptors for interleukin il - 10 - type cytokineuse similar signaling mechanisms for inducing transcription through IL - 6 response elements .',\n",
       "  [['Receptors for <e1> interleukin il - 10 - type cytokine </e1> use similar signaling mechanisms for inducing transcription through IL - 6 response elements .',\n",
       "    'PROTEIN']]],\n",
       " ['Receptors for interleukin ( il - 6 - type cytokineuse similar signaling mechanisms for inducing transcription through IL - 6 response elements .',\n",
       "  [['Receptors for interleukin ( <e1> il - 6 - type cytokine </e1> use similar signaling mechanisms for inducing transcription through IL - 6 response elements .',\n",
       "    'PROTEIN']]],\n",
       " ['To determine whether the IL - 10R has signaling functions similar to IL - 6R in cells normally expressing these receptors , leukocytes of the b - cell lineagewere treated with either cytokine .',\n",
       "  [['To determine whether the IL - 10R has signaling functions similar to IL - 6R in cells normally expressing these receptors , leukocytes of the <e1> b - cell lineage </e1> were treated with either cytokine .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To determine whether the IL - 10R has signaling functions similar to IL - 6R in cells normally expressing these receptors , leukocytes of the B - , t - cell lineagewere treated with either cytokine .',\n",
       "  [['To determine whether the IL - 10R has signaling functions similar to IL - 6R in cells normally expressing these receptors , leukocytes of the B - , <e1> t - cell lineage </e1> were treated with either cytokine .',\n",
       "    'CELL_TYPE']]],\n",
       " [' c - terminal activating domaindetermine the transactivation potential of BSAP ( Pax - 5 ) , Pax - 2 and Pax - 8 .',\n",
       "  [[' <e1> c - terminal activating domain </e1> determine the transactivation potential of BSAP ( Pax - 5 ) , Pax - 2 and Pax - 8 .',\n",
       "    'PROTEIN']]],\n",
       " [' c - terminal inhibitory domaindetermine the transactivation potential of BSAP ( Pax - 5 ) , Pax - 2 and Pax - 8 .',\n",
       "  [[' <e1> c - terminal inhibitory domain </e1> determine the transactivation potential of BSAP ( Pax - 5 ) , Pax - 2 and Pax - 8 .',\n",
       "    'PROTEIN']]],\n",
       " ['In vitro mutagenesis and transient transfection experiments indicate that the C - terminal serine / threonine / proline - rich region of BSAP contains a potent transactivation domain of 55 amino acids which is active from promoter position .',\n",
       "  [['In vitro mutagenesis and transient transfection experiments indicate that the C - terminal serine / threonine / proline - rich region of BSAP contains a potent transactivation domain of 55 amino acids which is active from <e1> promoter position </e1> .',\n",
       "    'DNA']]],\n",
       " ['The same arrangement of positively acting sequencehas been conserved in the mammalian Pax - 2 and Pax - 8 , the zebrafish Pax - b as well as the sea urchin Pax - 258 proteins .',\n",
       "  [['The same arrangement of <e1> positively acting sequence </e1> has been conserved in the mammalian Pax - 2 and Pax - 8 , the zebrafish Pax - b as well as the sea urchin Pax - 258 proteins .',\n",
       "    'DNA']]],\n",
       " ['These data demonstrate that the transcriptional competence of a subfamily of Pax proteins is determined by a C - terminal regulatory module composed of activating sequence .',\n",
       "  [['These data demonstrate that the transcriptional competence of a subfamily of Pax proteins is determined by a C - terminal regulatory module composed of <e1> activating sequence </e1> .',\n",
       "    'DNA']]],\n",
       " ['The ability to regulate AR gene transcription via the second messenger pathway is lost in the pc - 3 cell line .',\n",
       "  [['The ability to regulate AR gene transcription via the second messenger pathway is lost in the <e1> pc - 3 cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Absence of t - cell - specific transcription factorTCF - 1 , GATA - 3 , and BSAP in Hodgkin s Reed - Sternberg cells .',\n",
       "  [['Absence of <e1> t - cell - specific transcription factor </e1> TCF - 1 , GATA - 3 , and BSAP in Hodgkin s Reed - Sternberg cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in l428 celllines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "  [['Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in <e1> l428 cell </e1> lines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "    'CELL_LINE']]],\n",
       " ['Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in L428 and hdlm - 1 celllines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "  [['Based on the presence of T cell receptor - beta ( TcR - beta ) gene rearrangements in L428 and <e1> hdlm - 1 cell </e1> lines derived from patients with Hodgkin s disease are lymphoid in nature .',\n",
       "    'CELL_LINE']]],\n",
       " ['The sensitivity and specificity of this assay for determination of cell lineage have been established in a large number of cultured human cell line .',\n",
       "  [['The sensitivity and specificity of this assay for determination of cell lineage have been established in a large number of <e1> cultured human cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['The sensitivity and specificity of this assay for determination of cell lineage have been established in a large number of cultured murine cell line .',\n",
       "  [['The sensitivity and specificity of this assay for determination of cell lineage have been established in a large number of <e1> cultured murine cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Triplex formation by GM3 blocked recombinant nf - kappab proteinbinding to the GM - CSF element .',\n",
       "  [['Triplex formation by GM3 blocked <e1> recombinant nf - kappab protein </e1> binding to the GM - CSF element .',\n",
       "    'PROTEIN']]],\n",
       " ['Although p45 mRNA is transcribed from two different promoters , aNF - E2 promoter and fNF - E2 promoter , in erythroid lineage cell, p45 mRNA is transcribed only from aNF - E2 promoter .',\n",
       "  [['Although p45 mRNA is transcribed from two different promoters , aNF - E2 promoter and fNF - E2 promoter , in <e1> erythroid lineage cell </e1> , p45 mRNA is transcribed only from aNF - E2 promoter .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The binding activity of transcription factor AP - 1 , which consists of dimers of fos family protein, was also studied using a gel shift assay .',\n",
       "  [['The binding activity of transcription factor AP - 1 , which consists of dimers of <e1> fos family protein </e1> , was also studied using a gel shift assay .',\n",
       "    'PROTEIN']]],\n",
       " ['We demonstrated an uncoupling of AP - 1 binding activity from p62c - fos , and p39c - jun AP - 1 activity was expressed more strongly in the G1 - and G2/M - phase enriched samples than in the S - phase enriched samples of HL60 cells , while levels of nuclear p39c - junwere constant .',\n",
       "  [['We demonstrated an uncoupling of AP - 1 binding activity from p62c - fos , and p39c - jun AP - 1 activity was expressed more strongly in the G1 - and G2/M - phase enriched samples than in the S - phase enriched samples of HL60 cells , while levels of <e1> nuclear p39c - jun </e1> were constant .',\n",
       "    'PROTEIN']]],\n",
       " ['We also observed that cytoplasmic p39c - junwere present in HL60 cells and PHA - stimulated PBL .',\n",
       "  [['We also observed that <e1> cytoplasmic p39c - jun </e1> were present in HL60 cells and PHA - stimulated PBL .',\n",
       "    'PROTEIN']]],\n",
       " ['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid celland myeloid genes , and is critical for development of both of these lineages .',\n",
       "  [['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in <e1> myeloid cell </e1> and myeloid genes , and is critical for development of both of these lineages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and b celland myeloid genes , and is critical for development of both of these lineages .',\n",
       "  [['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and <e1> b cell </e1> and myeloid genes , and is critical for development of both of these lineages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and B cells , activates many b cell gene, and is critical for development of both of these lineages .',\n",
       "  [['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and B cells , activates many <e1> b cell gene </e1> , and is critical for development of both of these lineages .',\n",
       "    'DNA']]],\n",
       " ['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid celland myeloid genes , and is critical for development of both of these lineages .',\n",
       "  [['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in <e1> myeloid cell </e1> and myeloid genes , and is critical for development of both of these lineages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and b celland myeloid genes , and is critical for development of both of these lineages .',\n",
       "  [['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and <e1> b cell </e1> and myeloid genes , and is critical for development of both of these lineages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and B cells , activates many b cell gene, and is critical for development of both of these lineages .',\n",
       "  [['PU.1 ( spi - 1 ) , a member of the Ets transcription factor family , is predominantly expressed in myeloid and B cells , activates many <e1> b cell gene </e1> , and is critical for development of both of these lineages .',\n",
       "    'DNA']]],\n",
       " ['Both the 5 untranslated regionof the TNF gene were required to elicit maximal translational suppression by CNI - 1493 .',\n",
       "  [['Both the <e1> 5 untranslated region </e1> of the TNF gene were required to elicit maximal translational suppression by CNI - 1493 .',\n",
       "    'DNA']]],\n",
       " ['The human T - cell leukemia virus - encoded tax protein is a potent activator of many viral genetranscribed by RNA polymerase II .',\n",
       "  [['The human T - cell leukemia virus - encoded tax protein is a potent activator of many <e1> viral gene </e1> transcribed by RNA polymerase II .',\n",
       "    'DNA']]],\n",
       " ['1 alpha, 25 - Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal cell .',\n",
       "  [['1 alpha, 25 - Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both <e1> normal cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Alternative splicing generates type a transcriptthat potentially encode two entirely distinct proteins ; type A transcripts code for a small mitochondrial protein , p8MTCP1 , and type B transcripts , containing an additional open reading frame , may code for 107 amino - acid protein , p13MTCP1 .',\n",
       "  [['Alternative splicing generates <e1> type a transcript </e1> that potentially encode two entirely distinct proteins ; type A transcripts code for a small mitochondrial protein , p8MTCP1 , and type B transcripts , containing an additional open reading frame , may code for 107 amino - acid protein , p13MTCP1 .',\n",
       "    'RNA']]],\n",
       " ['Alternative splicing generates type b transcriptthat potentially encode two entirely distinct proteins ; type A transcripts code for a small mitochondrial protein , p8MTCP1 , and type B transcripts , containing an additional open reading frame , may code for 107 amino - acid protein , p13MTCP1 .',\n",
       "  [['Alternative splicing generates <e1> type b transcript </e1> that potentially encode two entirely distinct proteins ; type A transcripts code for a small mitochondrial protein , p8MTCP1 , and type B transcripts , containing an additional open reading frame , may code for 107 amino - acid protein , p13MTCP1 .',\n",
       "    'RNA']]],\n",
       " ['We have generated rabbit antisera against this putative p13MTCP1 protein and screened for expression of p13MTCP1 normal lymphoid tissues and 33 cases of immature lymphoid t - cell proliferationusing a sensitive Western blot assay .',\n",
       "  [['We have generated rabbit antisera against this putative p13MTCP1 protein and screened for expression of p13MTCP1 normal lymphoid tissues and 33 cases of <e1> immature lymphoid t - cell proliferation </e1> using a sensitive Western blot assay .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Priming of human monocytes with IFN - gamma resulted in the down regulation of c - fos mrnain response to stimulation with lipopolysaccharide ( LPS ) compared to the effects of LPS alone .',\n",
       "  [['Priming of human monocytes with IFN - gamma resulted in the down regulation of <e1> c - fos mrna </e1> in response to stimulation with lipopolysaccharide ( LPS ) compared to the effects of LPS alone .',\n",
       "    'RNA']]],\n",
       " ['Priming of human monocytes with IFN - gamma resulted in the down regulation of c - jun mrnain response to stimulation with lipopolysaccharide ( LPS ) compared to the effects of LPS alone .',\n",
       "  [['Priming of human monocytes with IFN - gamma resulted in the down regulation of <e1> c - jun mrna </e1> in response to stimulation with lipopolysaccharide ( LPS ) compared to the effects of LPS alone .',\n",
       "    'RNA']]],\n",
       " ['BCR - induced increases in CD44 mRNA expression and transcription levels are shown to occur in egr1 - expressing subcloneof the B - cell line WEHI - 231 .',\n",
       "  [['BCR - induced increases in CD44 mRNA expression and transcription levels are shown to occur in <e1> egr1 - expressing subclone </e1> of the B - cell line WEHI - 231 .',\n",
       "    'CELL_LINE']]],\n",
       " ['BCR - induced increases in CD44 mRNA expression and transcription levels are shown to occur in egr1 - nonexpressing subcloneof the B - cell line WEHI - 231 .',\n",
       "  [['BCR - induced increases in CD44 mRNA expression and transcription levels are shown to occur in <e1> egr1 - nonexpressing subclone </e1> of the B - cell line WEHI - 231 .',\n",
       "    'CELL_LINE']]],\n",
       " ['Transactivation of the interleukin - 1alpha promoter by human t - cell leukemia virus type i tax protein .',\n",
       "  [['Transactivation of the interleukin - 1alpha promoter by <e1> human t - cell leukemia virus type i tax protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Transactivation of the interleukin - 1alpha promoter by human t - cell leukemia virus type ii tax protein .',\n",
       "  [['Transactivation of the interleukin - 1alpha promoter by <e1> human t - cell leukemia virus type ii tax protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Moreover , deletion of either 5 nf - kappab sitereduced IL - 1alpha promoter activity in MT - 2 cells and transactivation of the IL - 1alpha promoter by exogenous NF - kappaB and Tax in Jurkat cells .',\n",
       "  [['Moreover , deletion of either <e1> 5 nf - kappab site </e1> reduced IL - 1alpha promoter activity in MT - 2 cells and transactivation of the IL - 1alpha promoter by exogenous NF - kappaB and Tax in Jurkat cells .',\n",
       "    'DNA']]],\n",
       " ['To develop a transformation system with a conditional Epstein - Barr virus nuclear antigen 2 ( EBNA2 ) gene , we fused the hormone binding domain of the oestrogen receptor to the n terminusof EBNA2 .',\n",
       "  [['To develop a transformation system with a conditional Epstein - Barr virus nuclear antigen 2 ( EBNA2 ) gene , we fused the hormone binding domain of the oestrogen receptor to the <e1> n terminus </e1> of EBNA2 .',\n",
       "    'PROTEIN']]],\n",
       " ['In order to better characterize the human gammac promoter and define the minimal tissue - specific promoter region , progressive 5 - deletion constructs of a segment extending 1053 base pairs upstream of the major transcription start site were generated and tested for promoter activity in various hematopoietic cell type .',\n",
       "  [['In order to better characterize the human gammac promoter and define the minimal tissue - specific promoter region , progressive 5 - deletion constructs of a segment extending 1053 base pairs upstream of the major transcription start site were generated and tested for promoter activity in various <e1> hematopoietic cell type </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Coexpression of the interleukin - 13 genecluster on human chromosome 5q23 - 31 .',\n",
       "  [['Coexpression of the <e1> interleukin - 13 gene </e1> cluster on human chromosome 5q23 - 31 .',\n",
       "    'DNA']]],\n",
       " ['Coexpression of the interleukin - 4 genecluster on human chromosome 5q23 - 31 .',\n",
       "  [['Coexpression of the <e1> interleukin - 4 gene </e1> cluster on human chromosome 5q23 - 31 .',\n",
       "    'DNA']]],\n",
       " ['Similar to IL - 4 , IL - 13 mRNA expression was highest in T - cell populations enriched for cells that had previously been primed in vivo or in vitro , indicating that priming increases the expression of the il - 13 genein a coordinate manner .',\n",
       "  [['Similar to IL - 4 , IL - 13 mRNA expression was highest in T - cell populations enriched for cells that had previously been primed in vivo or in vitro , indicating that priming increases the expression of the <e1> il - 13 gene </e1> in a coordinate manner .',\n",
       "    'DNA']]],\n",
       " ['Similar to IL - 4 , IL - 13 mRNA expression was highest in T - cell populations enriched for cells that had previously been primed in vivo or in vitro , indicating that priming increases the expression of the il - 4 genein a coordinate manner .',\n",
       "  [['Similar to IL - 4 , IL - 13 mRNA expression was highest in T - cell populations enriched for cells that had previously been primed in vivo or in vitro , indicating that priming increases the expression of the <e1> il - 4 gene </e1> in a coordinate manner .',\n",
       "    'DNA']]],\n",
       " ['Because the primed T cells contain higher levels of nuclear NF - ATp , capable of binding to P elements of the il - 4 promoter, than do freshly - isolated T cells , the NF - AT - binding P elements are attractive candidates to mediate the coordinate expression of these two cytokine genes .',\n",
       "  [['Because the primed T cells contain higher levels of nuclear NF - ATp , capable of binding to P elements of the <e1> il - 4 promoter </e1> , than do freshly - isolated T cells , the NF - AT - binding P elements are attractive candidates to mediate the coordinate expression of these two cytokine genes .',\n",
       "    'DNA']]],\n",
       " ['Because the primed T cells contain higher levels of nuclear NF - ATp , capable of binding to P elements of the il - 13 promoter, than do freshly - isolated T cells , the NF - AT - binding P elements are attractive candidates to mediate the coordinate expression of these two cytokine genes .',\n",
       "  [['Because the primed T cells contain higher levels of nuclear NF - ATp , capable of binding to P elements of the <e1> il - 13 promoter </e1> , than do freshly - isolated T cells , the NF - AT - binding P elements are attractive candidates to mediate the coordinate expression of these two cytokine genes .',\n",
       "    'DNA']]],\n",
       " ['Thus , the RAR - RXR response pathway can signal growth inhibition of normal bone marrow myeloid cell .',\n",
       "  [['Thus , the RAR - RXR response pathway can signal growth inhibition of <e1> normal bone marrow myeloid cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['After treatment of APL cells with AM580 either alone or in combination with granulocyte colony - stimulating factor ( G - CSF ) , the compound induces granulocytic maturation , as assessed by determination of the levels of leukocyte alkaline phosphatase mrna, at concentrations that are 10 - to 100 - fold lower than those of ATRA necessary to produce similar effects .',\n",
       "  [['After treatment of APL cells with AM580 either alone or in combination with granulocyte colony - stimulating factor ( G - CSF ) , the compound induces granulocytic maturation , as assessed by determination of the levels of <e1> leukocyte alkaline phosphatase mrna </e1> , at concentrations that are 10 - to 100 - fold lower than those of ATRA necessary to produce similar effects .',\n",
       "    'RNA']]],\n",
       " ['After treatment of APL cells with AM580 either alone or in combination with granulocyte colony - stimulating factor ( G - CSF ) , the compound induces granulocytic maturation , as assessed by determination of the levels of leukocyte alkaline phosphatase , cd11b mrna, at concentrations that are 10 - to 100 - fold lower than those of ATRA necessary to produce similar effects .',\n",
       "  [['After treatment of APL cells with AM580 either alone or in combination with granulocyte colony - stimulating factor ( G - CSF ) , the compound induces granulocytic maturation , as assessed by determination of the levels of leukocyte alkaline phosphatase , <e1> cd11b mrna </e1> , at concentrations that are 10 - to 100 - fold lower than those of ATRA necessary to produce similar effects .',\n",
       "    'RNA']]],\n",
       " ['After treatment of APL cells with AM580 either alone or in combination with granulocyte colony - stimulating factor ( G - CSF ) , the compound induces granulocytic maturation , as assessed by determination of the levels of leukocyte alkaline phosphatase , CD11b , cd33 mrna, at concentrations that are 10 - to 100 - fold lower than those of ATRA necessary to produce similar effects .',\n",
       "  [['After treatment of APL cells with AM580 either alone or in combination with granulocyte colony - stimulating factor ( G - CSF ) , the compound induces granulocytic maturation , as assessed by determination of the levels of leukocyte alkaline phosphatase , CD11b , <e1> cd33 mrna </e1> , at concentrations that are 10 - to 100 - fold lower than those of ATRA necessary to produce similar effects .',\n",
       "    'RNA']]],\n",
       " ['The extracts were compared for their ability to retard the migration of radiolabeled double stranded oligomers representative of the VDREs of the human osteocalcin gene promoter .',\n",
       "  [['The extracts were compared for their ability to retard the migration of radiolabeled double stranded oligomers representative of the VDREs of the <e1> human osteocalcin gene promoter </e1> .',\n",
       "    'DNA']]],\n",
       " [' resting b lymphocytecontain high levels of BCL - 6 mRNA .',\n",
       "  [[' <e1> resting b lymphocyte </e1> contain high levels of BCL - 6 mRNA .',\n",
       "    'CELL_TYPE']]],\n",
       " [' resting t lymphocytecontain high levels of BCL - 6 mRNA .',\n",
       "  [[' <e1> resting t lymphocyte </e1> contain high levels of BCL - 6 mRNA .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Stimulation of mouse B cells with anti - igm antibody, bacterial lipopolysaccharide , phorbol 12 - myristate 13 - acetate plus ionomycin , or CD40 ligand led to a five - fold to 35 - fold decrease in BCL - 6 mRNA levels .',\n",
       "  [['Stimulation of mouse B cells with <e1> anti - igm antibody </e1> , bacterial lipopolysaccharide , phorbol 12 - myristate 13 - acetate plus ionomycin , or CD40 ligand led to a five - fold to 35 - fold decrease in BCL - 6 mRNA levels .',\n",
       "    'PROTEIN']]],\n",
       " ['Stimulation of mouse B cells with anti - igd antibody, bacterial lipopolysaccharide , phorbol 12 - myristate 13 - acetate plus ionomycin , or CD40 ligand led to a five - fold to 35 - fold decrease in BCL - 6 mRNA levels .',\n",
       "  [['Stimulation of mouse B cells with <e1> anti - igd antibody </e1> , bacterial lipopolysaccharide , phorbol 12 - myristate 13 - acetate plus ionomycin , or CD40 ligand led to a five - fold to 35 - fold decrease in BCL - 6 mRNA levels .',\n",
       "    'PROTEIN']]],\n",
       " ['The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21 , which encodes p16 , the inhibitor of cyclin - dependent - kinase - 6, in tumorigenesis is not yet clear .',\n",
       "  [['The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21 , which encodes p16 , the inhibitor of <e1> cyclin - dependent - kinase - 6 </e1> , in tumorigenesis is not yet clear .',\n",
       "    'PROTEIN']]],\n",
       " ['Compared to normal lymphocytes , molt - 4 cellcycle regulation of thymidine kinase , a much higher intracellular activity of this enzyme , and higher thymidine kinase mRNA expression .',\n",
       "  [['Compared to normal lymphocytes , <e1> molt - 4 cell </e1> cycle regulation of thymidine kinase , a much higher intracellular activity of this enzyme , and higher thymidine kinase mRNA expression .',\n",
       "    'CELL_LINE']]],\n",
       " ['Compared to normal lymphocytes , MOLT - 4 and cem cellcycle regulation of thymidine kinase , a much higher intracellular activity of this enzyme , and higher thymidine kinase mRNA expression .',\n",
       "  [['Compared to normal lymphocytes , MOLT - 4 and <e1> cem cell </e1> cycle regulation of thymidine kinase , a much higher intracellular activity of this enzyme , and higher thymidine kinase mRNA expression .',\n",
       "    'CELL_LINE']]],\n",
       " ['Transient expression of p16 in normal human lymphocytes caused arrest in G1 , but was without effect on the cell growth of molt - 4 cell, although all of them express functional retinoblastoma protein .',\n",
       "  [['Transient expression of p16 in normal human lymphocytes caused arrest in G1 , but was without effect on the cell growth of <e1> molt - 4 cell </e1> , although all of them express functional retinoblastoma protein .',\n",
       "    'CELL_LINE']]],\n",
       " ['Authentic nfat targetdid not compete for the META(D+) binding factor ( s ) .',\n",
       "  [['Authentic <e1> nfat target </e1> did not compete for the META(D+) binding factor ( s ) .',\n",
       "    'DNA']]],\n",
       " ['Pretreatment with a protein kinase C activator , phorbol 12 - myristate 13 - acetate , caused almost complete inhibition of histamine - induced [ Ca2+ ]i rise , but did not do so by activators of camp - dependent protein kinase .',\n",
       "  [['Pretreatment with a protein kinase C activator , phorbol 12 - myristate 13 - acetate , caused almost complete inhibition of histamine - induced [ Ca2+ ]i rise , but did not do so by activators of <e1> camp - dependent protein kinase </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['We used oligonucleotide probes from the beta - casein gene promoterand the ISRE probe to detect STAT proteins in nuclear extracts from acute leukemia cells in bandshift assays .',\n",
       "  [['We used oligonucleotide probes from the <e1> beta - casein gene promoter </e1> and the ISRE probe to detect STAT proteins in nuclear extracts from acute leukemia cells in bandshift assays .',\n",
       "    'DNA']]],\n",
       " [' stat5 - related factorwere detected in ALL and STAT1 - , STAT3 - , and STAT5 - related proteins were present in nuclear cell extracts from AML .',\n",
       "  [[' <e1> stat5 - related factor </e1> were detected in ALL and STAT1 - , STAT3 - , and STAT5 - related proteins were present in nuclear cell extracts from AML .',\n",
       "    'PROTEIN']]],\n",
       " ['STAT5 - and STAT1 - related factors were detected in ALL and stat1 - related proteinswere present in nuclear cell extracts from AML .',\n",
       "  [['STAT5 - and STAT1 - related factors were detected in ALL and <e1> stat1 - related proteins </e1> were present in nuclear cell extracts from AML .',\n",
       "    'PROTEIN']]],\n",
       " ['STAT5 - and STAT1 - related factors were detected in ALL and STAT1 - , stat3 - related proteinswere present in nuclear cell extracts from AML .',\n",
       "  [['STAT5 - and STAT1 - related factors were detected in ALL and STAT1 - , <e1> stat3 - related proteins </e1> were present in nuclear cell extracts from AML .',\n",
       "    'PROTEIN']]],\n",
       " [' stat5 - related factorwere detected in ALL and STAT1 - , STAT3 - , and STAT5 - related proteins were present in nuclear cell extracts from AML .',\n",
       "  [[' <e1> stat5 - related factor </e1> were detected in ALL and STAT1 - , STAT3 - , and STAT5 - related proteins were present in nuclear cell extracts from AML .',\n",
       "    'PROTEIN']]],\n",
       " ['STAT5 - and STAT1 - related factors were detected in ALL and stat1 - related proteinswere present in nuclear cell extracts from AML .',\n",
       "  [['STAT5 - and STAT1 - related factors were detected in ALL and <e1> stat1 - related proteins </e1> were present in nuclear cell extracts from AML .',\n",
       "    'PROTEIN']]],\n",
       " ['STAT5 - and STAT1 - related factors were detected in ALL and STAT1 - , stat3 - related proteinswere present in nuclear cell extracts from AML .',\n",
       "  [['STAT5 - and STAT1 - related factors were detected in ALL and STAT1 - , <e1> stat3 - related proteins </e1> were present in nuclear cell extracts from AML .',\n",
       "    'PROTEIN']]],\n",
       " ['Here , we describe the effect of 383 - bp delta383 sequencecontaining the PYBF - binding site on transcription from various globin and non - globin promoters , using a transient assay with the cat reporter gene in murine erythroleukemia ( MEL ) cells , a cell line with abundant PYBF activity .',\n",
       "  [['Here , we describe the effect of <e1> 383 - bp delta383 sequence </e1> containing the PYBF - binding site on transcription from various globin and non - globin promoters , using a transient assay with the cat reporter gene in murine erythroleukemia ( MEL ) cells , a cell line with abundant PYBF activity .',\n",
       "    'DNA']]],\n",
       " ['Here , we describe the effect of 383 - bp ( delta383 ) and 99 - bp delta99 sequencecontaining the PYBF - binding site on transcription from various globin and non - globin promoters , using a transient assay with the cat reporter gene in murine erythroleukemia ( MEL ) cells , a cell line with abundant PYBF activity .',\n",
       "  [['Here , we describe the effect of 383 - bp ( delta383 ) and <e1> 99 - bp delta99 sequence </e1> containing the PYBF - binding site on transcription from various globin and non - globin promoters , using a transient assay with the cat reporter gene in murine erythroleukemia ( MEL ) cells , a cell line with abundant PYBF activity .',\n",
       "    'DNA']]],\n",
       " ['We show that both delta383 and delta99 specifically enhance expression of cat for plasmids containing a human adult globin ( HBB ) promoter , whereas expression of similar constructs using human fetal a gamma - globin hbg1 promoteris not enhanced .',\n",
       "  [['We show that both delta383 and delta99 specifically enhance expression of cat for plasmids containing a human adult globin ( HBB ) promoter , whereas expression of similar constructs using <e1> human fetal a gamma - globin hbg1 promoter </e1> is not enhanced .',\n",
       "    'DNA']]],\n",
       " ['We show that both delta383 and delta99 specifically enhance expression of cat for plasmids containing a human adult globin ( HBB ) promoter , whereas expression of similar constructs using human fetal ( A gamma - ) globin ( HBG1 ) or simian virus 40 sv40 promoteris not enhanced .',\n",
       "  [['We show that both delta383 and delta99 specifically enhance expression of cat for plasmids containing a human adult globin ( HBB ) promoter , whereas expression of similar constructs using human fetal ( A gamma - ) globin ( HBG1 ) or <e1> simian virus 40 sv40 promoter </e1> is not enhanced .',\n",
       "    'DNA']]],\n",
       " ['In B lymphoid cells , deltaspi - b mrnawere present simultaneously in a ratio of around 10 % .',\n",
       "  [['In B lymphoid cells , <e1> deltaspi - b mrna </e1> were present simultaneously in a ratio of around 10 % .',\n",
       "    'RNA']]],\n",
       " ['Efficient transcription and replication of simian immunodeficiency virus in the absence of nf - kappab binding element .',\n",
       "  [['Efficient transcription and replication of simian immunodeficiency virus in the absence of <e1> nf - kappab binding element </e1> .',\n",
       "    'DNA']]],\n",
       " ['All mutants , including one extensively mutagenized strain entirely missing the nf - kappab binding element, replicated with wild - type kinetics and to a wild - type level in peripheral blood mononuclear cell cultures in 50 to 100 % of the experiments .',\n",
       "  [['All mutants , including one extensively mutagenized strain entirely missing the <e1> nf - kappab binding element </e1> , replicated with wild - type kinetics and to a wild - type level in peripheral blood mononuclear cell cultures in 50 to 100 % of the experiments .',\n",
       "    'DNA']]],\n",
       " ['Reversions or additional mutations were not detected in the u3 regionof proviral DNA from CEMxl74 cells infected with the SIVmac239 mutants .',\n",
       "  [['Reversions or additional mutations were not detected in the <e1> u3 region </e1> of proviral DNA from CEMxl74 cells infected with the SIVmac239 mutants .',\n",
       "    'DNA']]],\n",
       " ['Analysis of long terminal repeat - driven secreted alkaline phosphatase activity in transient assays showed that , unlike human immunodeficiency virus type 1 , the SIV long terminal repeat possesses an enhancer region just upstream of the NF - kappaB element which maintains significant levels of basal transcription in the absence of nf - kappab site .',\n",
       "  [['Analysis of long terminal repeat - driven secreted alkaline phosphatase activity in transient assays showed that , unlike human immunodeficiency virus type 1 , the SIV long terminal repeat possesses an enhancer region just upstream of the NF - kappaB element which maintains significant levels of basal transcription in the absence of <e1> nf - kappab site </e1> .',\n",
       "    'DNA']]],\n",
       " ['Using human b - cell linetransfected with ZpCat reporter gene constructs , we demonstrate that a region designated the ZII domain of Zp is the target of HHV - 6 transactivation .',\n",
       "  [['Using <e1> human b - cell line </e1> transfected with ZpCat reporter gene constructs , we demonstrate that a region designated the ZII domain of Zp is the target of HHV - 6 transactivation .',\n",
       "    'CELL_LINE']]],\n",
       " ['Using human t - cell linetransfected with ZpCat reporter gene constructs , we demonstrate that a region designated the ZII domain of Zp is the target of HHV - 6 transactivation .',\n",
       "  [['Using <e1> human t - cell line </e1> transfected with ZpCat reporter gene constructs , we demonstrate that a region designated the ZII domain of Zp is the target of HHV - 6 transactivation .',\n",
       "    'CELL_LINE']]],\n",
       " ['Structure/function analysis of various Oct - 2a effector regions in the context of the GAL4 DNA - binding domain revealed that Oct - 2a contains two functionally different activation domains at the n termini .',\n",
       "  [['Structure/function analysis of various Oct - 2a effector regions in the context of the GAL4 DNA - binding domain revealed that Oct - 2a contains two functionally different activation domains at the <e1> n termini </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic granulocyte .',\n",
       "  [['Opposing effects of glucocorticoids on the rate of apoptosis in <e1> neutrophilic granulocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Mice lacking Rel are defective in mitogenic activation of b lymphocyteand display impaired humoral immunity .',\n",
       "  [['Mice lacking Rel are defective in mitogenic activation of <e1> b lymphocyte </e1> and display impaired humoral immunity .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Exogenous IL - 2 , which restitutes the proliferative response of the anti - cd3 - treated rel - / - t cell, restores production of IL - 5 , TNF - alpha , and IFN - gamma , but not IL - 3 and GM - CSF expression to approximately normal levels .',\n",
       "  [['Exogenous IL - 2 , which restitutes the proliferative response of the <e1> anti - cd3 - treated rel - / - t cell </e1> , restores production of IL - 5 , TNF - alpha , and IFN - gamma , but not IL - 3 and GM - CSF expression to approximately normal levels .',\n",
       "    'CELL_LINE']]],\n",
       " ['Exogenous IL - 2 , which restitutes the proliferative response of the anti - cd28 - treated rel - / - t cell, restores production of IL - 5 , TNF - alpha , and IFN - gamma , but not IL - 3 and GM - CSF expression to approximately normal levels .',\n",
       "  [['Exogenous IL - 2 , which restitutes the proliferative response of the <e1> anti - cd28 - treated rel - / - t cell </e1> , restores production of IL - 5 , TNF - alpha , and IFN - gamma , but not IL - 3 and GM - CSF expression to approximately normal levels .',\n",
       "    'CELL_LINE']]],\n",
       " ['Further , in normal and cd45 - deficient cell line, Fas stimulation results in activation of Jun kinase ( JNK ) , a proposed mediator of stress activation pathways .',\n",
       "  [['Further , in normal and <e1> cd45 - deficient cell line </e1> , Fas stimulation results in activation of Jun kinase ( JNK ) , a proposed mediator of stress activation pathways .',\n",
       "    'CELL_LINE']]],\n",
       " ['In promoter regions , the actively transcribed genes demonstrated extensive and consistent footprints over the canonical elements , such as caccc motif .',\n",
       "  [['In promoter regions , the actively transcribed genes demonstrated extensive and consistent footprints over the canonical elements , such as <e1> caccc motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['The adult globin expressing cells displayed more extensive footprints than the fetal globin expressing cells in the 3 regulatory sequences of both the agamma - globin geneexpression .',\n",
       "  [['The adult globin expressing cells displayed more extensive footprints than the fetal globin expressing cells in the 3 regulatory sequences of both the <e1> agamma - globin gene </e1> expression .',\n",
       "    'DNA']]],\n",
       " ['The adult globin expressing cells displayed more extensive footprints than the fetal globin expressing cells in the 3 regulatory sequences of both the Agamma - and the beta - globin geneexpression .',\n",
       "  [['The adult globin expressing cells displayed more extensive footprints than the fetal globin expressing cells in the 3 regulatory sequences of both the Agamma - and the <e1> beta - globin gene </e1> expression .',\n",
       "    'DNA']]],\n",
       " ['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the gamma - globin gene promoter, and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the fetal or the adult globin gene .',\n",
       "  [['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the <e1> gamma - globin gene promoter </e1> , and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the fetal or the adult globin gene .',\n",
       "    'DNA']]],\n",
       " ['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the gamma - and beta - globin gene promoters , and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the fetal globin gene .',\n",
       "  [['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the gamma - and beta - globin gene promoters , and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the <e1> fetal globin gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the gamma - globin gene promoter, and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the fetal or the adult globin gene .',\n",
       "  [['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the <e1> gamma - globin gene promoter </e1> , and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the fetal or the adult globin gene .',\n",
       "    'DNA']]],\n",
       " ['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the gamma - and beta - globin gene promoters , and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the fetal globin gene .',\n",
       "  [['Our results suggest that the bulk of protein - DNA interactions that underlies the developmental control of globin genes takes place in the gamma - and beta - globin gene promoters , and that GT motifs of the beta - globin locus LCR may play a role in the developmental regulation of human beta - globin gene expression , perhaps by increasing the probability of interaction of the LCR holocomplex with the <e1> fetal globin gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Galectin - 3 is widely distributed in various tissues and cell types and is expressed in many leukocytes , with the notable exception of b lymphocyte .',\n",
       "  [['Galectin - 3 is widely distributed in various tissues and cell types and is expressed in many leukocytes , with the notable exception of <e1> b lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The up - regulation of galectin - 3 expression appeared to correlate well with HTLV - I gene expression , as undetectable or very low levels of galectin - 3 were found in the s1t cell line, which are nonproductively infected with HTLV - I .',\n",
       "  [['The up - regulation of galectin - 3 expression appeared to correlate well with HTLV - I gene expression , as undetectable or very low levels of galectin - 3 were found in the <e1> s1t cell line </e1> , which are nonproductively infected with HTLV - I .',\n",
       "    'CELL_LINE']]],\n",
       " ['Interstitial collagenase ( MMP - 1 ) , a metalloproteinase produced by resident cellduring connective tissue turnover , cleaves type I collagen fibrils .',\n",
       "  [['Interstitial collagenase ( MMP - 1 ) , a metalloproteinase produced by <e1> resident cell </e1> during connective tissue turnover , cleaves type I collagen fibrils .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Since promoter elements controlling collagenase transcription in monocytic cells have not been previously defined , we sought to delineate responsive cis - acting elements of the collagenase promoter in transiently transfected human u937 monocytic cell line .',\n",
       "  [['Since promoter elements controlling collagenase transcription in monocytic cells have not been previously defined , we sought to delineate responsive cis - acting elements of the collagenase promoter in transiently transfected <e1> human u937 monocytic cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Since promoter elements controlling collagenase transcription in monocytic cells have not been previously defined , we sought to delineate responsive cis - acting elements of the collagenase promoter in transiently transfected human ( U937 ) and murine j774 monocytic cell line .',\n",
       "  [['Since promoter elements controlling collagenase transcription in monocytic cells have not been previously defined , we sought to delineate responsive cis - acting elements of the collagenase promoter in transiently transfected human ( U937 ) and <e1> murine j774 monocytic cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Nuclear extracts from LPS - and zymosan - treated cells showed strong AP - 1 activity by gel - shift analysis , and supershift analysis showed the AP - 1 complexes contained specific members of both the jun gene family .',\n",
       "  [['Nuclear extracts from LPS - and zymosan - treated cells showed strong AP - 1 activity by gel - shift analysis , and supershift analysis showed the AP - 1 complexes contained specific members of both the <e1> jun gene family </e1> .',\n",
       "    'DNA']]],\n",
       " ['LPS treatment of RAW 264.7 cells , murine bone marrow - derived macrophages , and the human monocyte cell line THP - 1 resulted in rapid activation of the p46 isoformof JNK .',\n",
       "  [['LPS treatment of RAW 264.7 cells , murine bone marrow - derived macrophages , and the human monocyte cell line THP - 1 resulted in rapid activation of the <e1> p46 isoform </e1> of JNK .',\n",
       "    'PROTEIN']]],\n",
       " [' truncated c - jun mutant proteinincluding wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "  [[' <e1> truncated c - jun mutant protein </e1> including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "    'PROTEIN']]],\n",
       " [' truncated c - fos mutant proteinincluding wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "  [[' <e1> truncated c - fos mutant protein </e1> including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "    'PROTEIN']]],\n",
       " ['Truncated c - Jun and c - Fos mutant proteins including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization domainof c - Jun and c - Fos .',\n",
       "  [['Truncated c - Jun and c - Fos mutant proteins including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the <e1> dimerization domain </e1> of c - Jun and c - Fos .',\n",
       "    'PROTEIN']]],\n",
       " [' truncated c - jun mutant proteinincluding wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "  [[' <e1> truncated c - jun mutant protein </e1> including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "    'PROTEIN']]],\n",
       " [' truncated c - fos mutant proteinincluding wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "  [[' <e1> truncated c - fos mutant protein </e1> including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos .',\n",
       "    'PROTEIN']]],\n",
       " ['Truncated c - Jun and c - Fos mutant proteins including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the dimerization domainof c - Jun and c - Fos .',\n",
       "  [['Truncated c - Jun and c - Fos mutant proteins including wbJun and wbFos were also ubiquitinylated under the same conditions , suggesting the sites of ubiquitinylation are located within the <e1> dimerization domain </e1> of c - Jun and c - Fos .',\n",
       "    'PROTEIN']]],\n",
       " ['IL - 10 cooperates with TNF - alpha to activate HIV - 1 from latently infected cellof monocyte/macrophage lineage .',\n",
       "  [['IL - 10 cooperates with TNF - alpha to activate HIV - 1 from <e1> latently infected cell </e1> of monocyte/macrophage lineage .',\n",
       "    'CELL_TYPE']]],\n",
       " ['MHC class II density on the APC was modified using dq2 homo zygous b - lclas APCs , however this variation of MHC concentration had no effect on T cell proliferation .',\n",
       "  [['MHC class II density on the APC was modified using <e1> dq2 homo zygous b - lcl </e1> as APCs , however this variation of MHC concentration had no effect on T cell proliferation .',\n",
       "    'CELL_LINE']]],\n",
       " ['MHC class II density on the APC was modified using dq2 hetero zygous b - lclas APCs , however this variation of MHC concentration had no effect on T cell proliferation .',\n",
       "  [['MHC class II density on the APC was modified using <e1> dq2 hetero zygous b - lcl </e1> as APCs , however this variation of MHC concentration had no effect on T cell proliferation .',\n",
       "    'CELL_LINE']]],\n",
       " ['One - hybrid assays in yeast isolated NF - ATp as an E1 binding protein , and transfection of NF - ATp into t cell linestrongly enhanced the activation - dependent SCM - 1 promoter activity .',\n",
       "  [['One - hybrid assays in yeast isolated NF - ATp as an E1 binding protein , and transfection of NF - ATp into <e1> t cell line </e1> strongly enhanced the activation - dependent SCM - 1 promoter activity .',\n",
       "    'CELL_LINE']]],\n",
       " ['The importance of NF - kappaB sites was confirmed by using vectors containing wild - type kappab sitein a heterologous promoter .',\n",
       "  [['The importance of NF - kappaB sites was confirmed by using vectors containing <e1> wild - type kappab site </e1> in a heterologous promoter .',\n",
       "    'DNA']]],\n",
       " ['In this study , we analyzed the binding activity of il - 10 - activated stat moleculeto two kinds of GAS - motif sequences .',\n",
       "  [['In this study , we analyzed the binding activity of <e1> il - 10 - activated stat molecule </e1> to two kinds of GAS - motif sequences .',\n",
       "    'PROTEIN']]],\n",
       " [' mouse cellthat were rendered cytolytic susceptible by E1A were also sensitized to CL - induced and chemically induced apoptosis .',\n",
       "  [[' <e1> mouse cell </e1> that were rendered cytolytic susceptible by E1A were also sensitized to CL - induced and chemically induced apoptosis .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Mouse , rat cellthat were rendered cytolytic susceptible by E1A were also sensitized to CL - induced and chemically induced apoptosis .',\n",
       "  [['Mouse , <e1> rat cell </e1> that were rendered cytolytic susceptible by E1A were also sensitized to CL - induced and chemically induced apoptosis .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Mouse , rat , hamster cellthat were rendered cytolytic susceptible by E1A were also sensitized to CL - induced and chemically induced apoptosis .',\n",
       "  [['Mouse , rat , <e1> hamster cell </e1> that were rendered cytolytic susceptible by E1A were also sensitized to CL - induced and chemically induced apoptosis .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Consecutive il - 1beta - mrnawere elevated ( up to 1.9 +/ - 0.58 - fold ) .',\n",
       "  [['Consecutive <e1> il - 1beta - mrna </e1> were elevated ( up to 1.9 +/ - 0.58 - fold ) .',\n",
       "    'RNA']]],\n",
       " ['Consecutive il - 6 - mrnawere elevated ( up to 1.9 +/ - 0.58 - fold ) .',\n",
       "  [['Consecutive <e1> il - 6 - mrna </e1> were elevated ( up to 1.9 +/ - 0.58 - fold ) .',\n",
       "    'RNA']]],\n",
       " ['Mutagenesis of nf kappa b elementwithin the LTR resulted in no change in the ability of CD8+ T cell supernatants to inhibit Tat - or mitogen - mediated LTR transcription .',\n",
       "  [['Mutagenesis of <e1> nf kappa b element </e1> within the LTR resulted in no change in the ability of CD8+ T cell supernatants to inhibit Tat - or mitogen - mediated LTR transcription .',\n",
       "    'DNA']]],\n",
       " ['The resulting diminished phosphorylation of c - Jun and JunD at their NH(2) - termini decreases the ability of these nuclear proteins to autostimulate the expression of the c - jun gene, thus leading to lower production of c - Jun and JunD .',\n",
       "  [['The resulting diminished phosphorylation of c - Jun and JunD at their NH(2) - termini decreases the ability of these nuclear proteins to autostimulate the expression of the <e1> c - jun gene </e1> , thus leading to lower production of c - Jun and JunD .',\n",
       "    'DNA']]],\n",
       " ['Consistent with these data , CD40 signals up - regulate c - jun mrnaand alter the transcription factor ATF2 but not the Raf - 1 protein .',\n",
       "  [['Consistent with these data , CD40 signals up - regulate <e1> c - jun mrna </e1> and alter the transcription factor ATF2 but not the Raf - 1 protein .',\n",
       "    'RNA']]],\n",
       " ['Consistent with these data , CD40 signals up - regulate c - fos mrnaand alter the transcription factor ATF2 but not the Raf - 1 protein .',\n",
       "  [['Consistent with these data , CD40 signals up - regulate <e1> c - fos mrna </e1> and alter the transcription factor ATF2 but not the Raf - 1 protein .',\n",
       "    'RNA']]],\n",
       " ['Using cd45 - negative variantof the Jurkat leukemic T - cell line we show that the different biochemical events induced by pervanadate appeared to be dependent on the presence at the cell surface of either CD45 or CD3 .',\n",
       "  [['Using <e1> cd45 - negative variant </e1> of the Jurkat leukemic T - cell line we show that the different biochemical events induced by pervanadate appeared to be dependent on the presence at the cell surface of either CD45 or CD3 .',\n",
       "    'CELL_LINE']]],\n",
       " ['We also show that expression of the B1 transcript from a second gene , MTCP1 , occurred at a relatively high level only in two T - PLL tumours from A - T patients with t(X;14) translocations whereas the MTCP1 /A1 transcript is much more widely expressed in both tumour cellof A - T and non - A - T individuals .',\n",
       "  [['We also show that expression of the B1 transcript from a second gene , MTCP1 , occurred at a relatively high level only in two T - PLL tumours from A - T patients with t(X;14) translocations whereas the MTCP1 /A1 transcript is much more widely expressed in both <e1> tumour cell </e1> of A - T and non - A - T individuals .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Sequencing of BRCA1 amplified from genomic DNA of lymphocytes and microdissected ovarian tumor cells of a familial ovarian cancer patient revealed three , rare heterozygous DNA variations ( 2418delA , 233G - - > A , and IVS1 - 10T - - > C ) in both tumor dna .',\n",
       "  [['Sequencing of BRCA1 amplified from genomic DNA of lymphocytes and microdissected ovarian tumor cells of a familial ovarian cancer patient revealed three , rare heterozygous DNA variations ( 2418delA , 233G - - > A , and IVS1 - 10T - - > C ) in both <e1> tumor dna </e1> .',\n",
       "    'DNA']]],\n",
       " ['Sequencing of BRCA1 amplified from genomic DNA of lymphocytes and microdissected ovarian tumor cells of a familial ovarian cancer patient revealed three , rare heterozygous DNA variations ( 2418delA , 233G - - > A , and IVS1 - 10T - - > C ) in both tumor and constitutional lymphocyte dna .',\n",
       "  [['Sequencing of BRCA1 amplified from genomic DNA of lymphocytes and microdissected ovarian tumor cells of a familial ovarian cancer patient revealed three , rare heterozygous DNA variations ( 2418delA , 233G - - > A , and IVS1 - 10T - - > C ) in both tumor and <e1> constitutional lymphocyte dna </e1> .',\n",
       "    'DNA']]],\n",
       " ['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal protein, whereas the DC - specific cDNAs are homologous to signaling , chemokine , and IFN - gamma - inducible genes .',\n",
       "  [['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding <e1> cytoskeletal protein </e1> , whereas the DC - specific cDNAs are homologous to signaling , chemokine , and IFN - gamma - inducible genes .',\n",
       "    'PROTEIN']]],\n",
       " ['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to signaling gene .',\n",
       "  [['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to <e1> signaling gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to signaling , chemokine gene .',\n",
       "  [['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to signaling , <e1> chemokine gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal protein, whereas the DC - specific cDNAs are homologous to signaling , chemokine , and IFN - gamma - inducible genes .',\n",
       "  [['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding <e1> cytoskeletal protein </e1> , whereas the DC - specific cDNAs are homologous to signaling , chemokine , and IFN - gamma - inducible genes .',\n",
       "    'PROTEIN']]],\n",
       " ['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to signaling gene .',\n",
       "  [['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to <e1> signaling gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to signaling , chemokine gene .',\n",
       "  [['A distinctive pattern of differentially expressed cDNAs is evident where macrophage - specific cDNAs are homologous to genes encoding cytoskeletal and cell - surface proteins , whereas the DC - specific cDNAs are homologous to signaling , <e1> chemokine gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Although the mutant strain was able to kill hl - 60 - derived macrophage, it could not replicate within a protozoan host , Acanthamoeba castellanii .',\n",
       "  [['Although the mutant strain was able to kill <e1> hl - 60 - derived macrophage </e1> , it could not replicate within a protozoan host , Acanthamoeba castellanii .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Pax5 is predominantly transcribed from only one of its two alleles in early B - lymphoid progenitors and mature B cells , while it transiently switches to a biallelic mode of transcription in pre - b cell .',\n",
       "  [['Pax5 is predominantly transcribed from only one of its two alleles in early B - lymphoid progenitors and mature B cells , while it transiently switches to a biallelic mode of transcription in <e1> pre - b cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These data suggest the potential utility of agents that disrupt calcineurin - mediated signal transduction pathways by blocking formation of the catalytically active dimer of calcineurin a subunit .',\n",
       "  [['These data suggest the potential utility of agents that disrupt calcineurin - mediated signal transduction pathways by blocking formation of the catalytically active dimer of <e1> calcineurin a subunit </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['These data suggest the potential utility of agents that disrupt calcineurin - mediated signal transduction pathways by blocking formation of the catalytically active dimer of calcineurin b subunit .',\n",
       "  [['These data suggest the potential utility of agents that disrupt calcineurin - mediated signal transduction pathways by blocking formation of the catalytically active dimer of <e1> calcineurin b subunit </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The hematopoietic cell - specific pattern of MNDA expression was elucidated through a comprehensive analysis of normal and neoplastic tissues , and the results provide further evidence of the coexpression of b - cell markerin neoplastic B cells and identify a normal B cell population that might be related to the cell of origin of a subset of B cell neoplasms .',\n",
       "  [['The hematopoietic cell - specific pattern of MNDA expression was elucidated through a comprehensive analysis of normal and neoplastic tissues , and the results provide further evidence of the coexpression of <e1> b - cell marker </e1> in neoplastic B cells and identify a normal B cell population that might be related to the cell of origin of a subset of B cell neoplasms .',\n",
       "    'PROTEIN']]],\n",
       " ['To determine the functionality of both the c/ebp - binding site, we analyzed whether C/EBPbeta and GATA - 1 can stimulate the MBP promoter in the C/EBPbeta and GATA - 1 negative Jurkat T - cell line .',\n",
       "  [['To determine the functionality of both the <e1> c/ebp - binding site </e1> , we analyzed whether C/EBPbeta and GATA - 1 can stimulate the MBP promoter in the C/EBPbeta and GATA - 1 negative Jurkat T - cell line .',\n",
       "    'DNA']]],\n",
       " ['Cotransfection with c/ebpbeta expression vectorproduced a 5 - fold increase compared with cotransfection with the C/EBPbeta or GATA - 1 expression vectors individually .',\n",
       "  [['Cotransfection with <e1> c/ebpbeta expression vector </e1> produced a 5 - fold increase compared with cotransfection with the C/EBPbeta or GATA - 1 expression vectors individually .',\n",
       "    'DNA']]],\n",
       " ['Our results provide the first evidence that both GATA - 1 and C/EBPbeta synergistically transactivate the promoter of an eosinophil - specific granule protein gene and that FOG may act as a negative cofactor for the eosinophil lineage , unlike its positively regulatory function for the erythroid lineage .',\n",
       "  [['Our results provide the first evidence that both GATA - 1 and C/EBPbeta synergistically transactivate the promoter of an eosinophil - specific granule protein gene and that FOG may act as a negative cofactor for the eosinophil lineage , unlike its positively regulatory function for the <e1> erythroid lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['DNase I footprinting identified several protected areas including sp1 binding siteswithin the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including <e1> sp1 binding sites </e1> within the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , sp1/ap - 2 binding siteswithin the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , <e1> sp1/ap - 2 binding sites </e1> within the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and camp response element cre binding siteswithin the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and <e1> camp response element cre binding sites </e1> within the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and sp1 binding sitein the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and <e1> sp1 binding site </e1> in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , nre - 2a binding sitein the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , <e1> nre - 2a binding site </e1> in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , NRE - 2a , tcf - 1/lef - 1 binding sitein the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , NRE - 2a , <e1> tcf - 1/lef - 1 binding site </e1> in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including sp1 binding siteswithin the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including <e1> sp1 binding sites </e1> within the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , sp1/ap - 2 binding siteswithin the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , <e1> sp1/ap - 2 binding sites </e1> within the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and camp response element cre binding siteswithin the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and <e1> camp response element cre binding sites </e1> within the 201 - bp core promoter region and Sp1 , NRE - 2a , TCF - 1/LEF - 1 , and Sp1/NF - AT binding sites in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and sp1 binding sitein the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and <e1> sp1 binding site </e1> in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , nre - 2a binding sitein the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , <e1> nre - 2a binding site </e1> in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , NRE - 2a , tcf - 1/lef - 1 binding sitein the upstream regulatory region .',\n",
       "  [['DNase I footprinting identified several protected areas including Sp1 , Sp1/AP - 2 , and cAMP response element ( CRE ) binding sites within the 201 - bp core promoter region and Sp1 , NRE - 2a , <e1> tcf - 1/lef - 1 binding site </e1> in the upstream regulatory region .',\n",
       "    'DNA']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 1 gene product .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 1 gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 2 gene product .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 2 gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 2or GATA - 1 and - 3 gene products .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 2 </e1> or GATA - 1 and - 3 gene products .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing GATA - 1 and - 2 or gata - 3gene products .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing GATA - 1 and - 2 or <e1> gata - 3 </e1> gene products .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 1 gene product .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 1 gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 2 gene product .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 2 gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 2or GATA - 1 and - 3 gene products .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 2 </e1> or GATA - 1 and - 3 gene products .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing GATA - 1 and - 2 or gata - 3gene products .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing GATA - 1 and - 2 or <e1> gata - 3 </e1> gene products .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 1 gene product .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 1 gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 2 gene product .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 2 gene product </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing gata - 2or GATA - 1 and - 3 gene products .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing <e1> gata - 2 </e1> or GATA - 1 and - 3 gene products .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing GATA - 1 and - 2 or gata - 3gene products .',\n",
       "  [['Interestingly , GATA - 2 and GATA - 3 proteins also localized to the same nuclear bodies in cell lines co - expressing GATA - 1 and - 2 or <e1> gata - 3 </e1> gene products .',\n",
       "    'PROTEIN']]],\n",
       " ['After incubation of purified mbp - hbdwith rabbit reticulocyte lysate , known to be rich in heat shock proteins , we obtained saturable binding of [3H]aldosterone .',\n",
       "  [['After incubation of purified <e1> mbp - hbd </e1> with rabbit reticulocyte lysate , known to be rich in heat shock proteins , we obtained saturable binding of [3H]aldosterone .',\n",
       "    'PROTEIN']]],\n",
       " ['Estrogen receptors are found on vascular endothelial cell; their expression is influenced by exposure to the hormone .',\n",
       "  [['Estrogen receptors are found on <e1> vascular endothelial cell </e1> ; their expression is influenced by exposure to the hormone .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Overexpression of dominant negative forms of ikk - betademonstrates that only IKKbeta is the target for PKC and calcineurin .',\n",
       "  [['Overexpression of dominant negative forms of <e1> ikk - beta </e1> demonstrates that only IKKbeta is the target for PKC and calcineurin .',\n",
       "    'PROTEIN']]],\n",
       " ['The product of the B - cell - specific B29 gene ( B29 , Ig beta , CD79b ) is essential for Ig - mediated B - cell activation via the B - cell antigen receptor complex ( BCR ) on human b lymphocyte .',\n",
       "  [['The product of the B - cell - specific B29 gene ( B29 , Ig beta , CD79b ) is essential for Ig - mediated B - cell activation via the B - cell antigen receptor complex ( BCR ) on <e1> human b lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The human B29 gene lacks either a tata boxand transcription is initiated at multiple sites .',\n",
       "  [['The human B29 gene lacks either a <e1> tata box </e1> and transcription is initiated at multiple sites .',\n",
       "    'DNA']]],\n",
       " ['This minimal promoter exhibits B - cell - specific activity and contains sp1 transcription factor motif .',\n",
       "  [['This minimal promoter exhibits B - cell - specific activity and contains <e1> sp1 transcription factor motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['This minimal promoter exhibits B - cell - specific activity and contains SP1 , ets transcription factor motif .',\n",
       "  [['This minimal promoter exhibits B - cell - specific activity and contains SP1 , <e1> ets transcription factor motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['This minimal promoter exhibits B - cell - specific activity and contains SP1 , ETS , oct transcription factor motif .',\n",
       "  [['This minimal promoter exhibits B - cell - specific activity and contains SP1 , ETS , <e1> oct transcription factor motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['The transcriptional mechanisms that drive colony - forming unit granulocyte - macrophage ( CFU - GM ) myeloid progenitors to differentiate into cells of either the granulocytic lineageare not fully understood .',\n",
       "  [['The transcriptional mechanisms that drive colony - forming unit granulocyte - macrophage ( CFU - GM ) myeloid progenitors to differentiate into cells of either the <e1> granulocytic lineage </e1> are not fully understood .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We have recently demonstrated that hydrocortisone and other glucocorticoids inhibit reactive oxygen species ( ROS ) generation by mononuclear mnc leucocyte( PMNL ) .',\n",
       "  [['We have recently demonstrated that hydrocortisone and other glucocorticoids inhibit reactive oxygen species ( ROS ) generation by <e1> mononuclear mnc leucocyte </e1> ( PMNL ) .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Finally , we investigated whether the modulation of corticosensitivity in tnfalpha - pretreated u937 cellwas related to a change of the glucocorticoid receptor concentration and affinity .',\n",
       "  [['Finally , we investigated whether the modulation of corticosensitivity in <e1> tnfalpha - pretreated u937 cell </e1> was related to a change of the glucocorticoid receptor concentration and affinity .',\n",
       "    'CELL_LINE']]],\n",
       " ['The intensity of C/EBP beta staining was greater ( P < 0.001 ) in synovial fluid monocytes than in those from normal peripheral blood .',\n",
       "  [['The intensity of C/EBP beta staining was greater ( P < 0.001 ) in synovial fluid monocytes than in those from <e1> normal peripheral blood </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Direct interaction of hematopoietic transcription factor gata - 1: functional antagonism in erythroid cells .',\n",
       "  [['Direct interaction of <e1> hematopoietic transcription factor gata - 1 </e1> : functional antagonism in erythroid cells .',\n",
       "    'PROTEIN']]],\n",
       " ['PU.1 is a hematopoietic - specific Ets family transcription factor that is required for development of some lymphoid lineage .',\n",
       "  [['PU.1 is a hematopoietic - specific Ets family transcription factor that is required for development of some <e1> lymphoid lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To determine whether it is possible to artificially enhance the opening of the chromatin structure of a minimal beta - globin promoter , we placed a 101bp , erythroid - specific DNase 1 hypersensitive site - forming element ( HSFE ) immediately upstream of the beta - globin gene .',\n",
       "  [['To determine whether it is possible to artificially enhance the opening of the chromatin structure of a minimal beta - globin promoter , we placed a 101bp , erythroid - specific DNase 1 hypersensitive site - forming element ( HSFE ) immediately upstream of the <e1> beta - globin gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Despite constitutive association with TRADD or RIP , LMP1 does not induce apoptosis in ebv - negative burkitt lymphoma cell .',\n",
       "  [['Despite constitutive association with TRADD or RIP , LMP1 does not induce apoptosis in <e1> ebv - negative burkitt lymphoma cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Inhibition of NF - kappa B activity in human T lymphocytes induces caspase - dependent apoptosis without detectable activation of caspase - 3 .',\n",
       "  [['Inhibition of NF - kappa B activity in human T lymphocytes induces caspase - dependent apoptosis without detectable activation of <e1> caspase - 3 </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['We identified this 92 - kDa protein as STAT5 , but not as stats 3, and 6 nor c - fes and vav protooncogene products , and demonstrated its translocation to the nucleus , enhancement of specific DNA binding capacity , and potentiation of trancriptional activity by GM - CSF .',\n",
       "  [['We identified this 92 - kDa protein as STAT5 , but not as <e1> stats 3 </e1> , and 6 nor c - fes and vav protooncogene products , and demonstrated its translocation to the nucleus , enhancement of specific DNA binding capacity , and potentiation of trancriptional activity by GM - CSF .',\n",
       "    'PROTEIN']]],\n",
       " ['We identified this 92 - kDa protein as STAT5 , but not as stats 6nor c - fes and vav protooncogene products , and demonstrated its translocation to the nucleus , enhancement of specific DNA binding capacity , and potentiation of trancriptional activity by GM - CSF .',\n",
       "  [['We identified this 92 - kDa protein as STAT5 , but not as <e1> stats 6 </e1> nor c - fes and vav protooncogene products , and demonstrated its translocation to the nucleus , enhancement of specific DNA binding capacity , and potentiation of trancriptional activity by GM - CSF .',\n",
       "    'PROTEIN']]],\n",
       " ['N - formyl - methionyl - leucyl - phenylalanine ( FMLP ) and phorbol myristate acetate ( PMA ) induced tyrosine phosphorylation of 42 - kda protein, which were identified as extracellular signal - regulated kinase ( ERK ) , in human monocytes .',\n",
       "  [['N - formyl - methionyl - leucyl - phenylalanine ( FMLP ) and phorbol myristate acetate ( PMA ) induced tyrosine phosphorylation of <e1> 42 - kda protein </e1> , which were identified as extracellular signal - regulated kinase ( ERK ) , in human monocytes .',\n",
       "    'PROTEIN']]],\n",
       " ['We searched for proteins that interact with Ras in interleukin il - 2 - stimulated cell, and found that the transcription factor Aiolos interacts with Ras .',\n",
       "  [['We searched for proteins that interact with Ras in <e1> interleukin il - 2 - stimulated cell </e1> , and found that the transcription factor Aiolos interacts with Ras .',\n",
       "    'CELL_LINE']]],\n",
       " ['We searched for proteins that interact with Ras in interleukin ( il - 2 - deprived cell, and found that the transcription factor Aiolos interacts with Ras .',\n",
       "  [['We searched for proteins that interact with Ras in interleukin ( <e1> il - 2 - deprived cell </e1> , and found that the transcription factor Aiolos interacts with Ras .',\n",
       "    'CELL_LINE']]],\n",
       " ['In addition , we show that PNU156804 does not block significantly the induction of either IL - 2 or il - 2r alpha - chainbut inhibits IL - 2 - dependent T cell proliferation .',\n",
       "  [['In addition , we show that PNU156804 does not block significantly the induction of either IL - 2 or <e1> il - 2r alpha - chain </e1> but inhibits IL - 2 - dependent T cell proliferation .',\n",
       "    'PROTEIN']]],\n",
       " ['In addition , we show that PNU156804 does not block significantly the induction of either IL - 2 or il - 2r gamma - chainbut inhibits IL - 2 - dependent T cell proliferation .',\n",
       "  [['In addition , we show that PNU156804 does not block significantly the induction of either IL - 2 or <e1> il - 2r gamma - chain </e1> but inhibits IL - 2 - dependent T cell proliferation .',\n",
       "    'PROTEIN']]],\n",
       " ['Human T - cell leukemia virus type 1 Tax protein induces the expression of stat1 genein T - cells .',\n",
       "  [['Human T - cell leukemia virus type 1 Tax protein induces the expression of <e1> stat1 gene </e1> in T - cells .',\n",
       "    'DNA']]],\n",
       " ['HTLV - 1 - transformed T - cell lines expressed higher amounts of stat1 rnaand proteins than virus - negative T cells .',\n",
       "  [['HTLV - 1 - transformed T - cell lines expressed higher amounts of <e1> stat1 rna </e1> and proteins than virus - negative T cells .',\n",
       "    'RNA']]],\n",
       " ['HTLV - 1 - transformed T - cell lines expressed higher amounts of STAT1 , stat3 rnaand proteins than virus - negative T cells .',\n",
       "  [['HTLV - 1 - transformed T - cell lines expressed higher amounts of STAT1 , <e1> stat3 rna </e1> and proteins than virus - negative T cells .',\n",
       "    'RNA']]],\n",
       " ['The expression of stat1 mrnawere also induced by a T - cell mitogen in normal human peripheral blood mononuclear cells .',\n",
       "  [['The expression of <e1> stat1 mrna </e1> were also induced by a T - cell mitogen in normal human peripheral blood mononuclear cells .',\n",
       "    'RNA']]],\n",
       " ['The expression of STAT1 , stat3 mrnawere also induced by a T - cell mitogen in normal human peripheral blood mononuclear cells .',\n",
       "  [['The expression of STAT1 , <e1> stat3 mrna </e1> were also induced by a T - cell mitogen in normal human peripheral blood mononuclear cells .',\n",
       "    'RNA']]],\n",
       " ['A unique transcriptional mechanism distinct from those regulating the il - 2 gene .',\n",
       "  [['A unique transcriptional mechanism distinct from those regulating the <e1> il - 2 gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['A unique transcriptional mechanism distinct from those regulating the il - 4 gene .',\n",
       "  [['A unique transcriptional mechanism distinct from those regulating the <e1> il - 4 gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['We found that the spontaneous production of tumor necrosis factor alpha and other pro - inflammatory cytokines is NF - kappaB - dependent in rheumatoid synovial tissue , in contrast to the main anti - inflammatory mediators , like il - 11, and the IL - 1 receptor antagonist .',\n",
       "  [['We found that the spontaneous production of tumor necrosis factor alpha and other pro - inflammatory cytokines is NF - kappaB - dependent in rheumatoid synovial tissue , in contrast to the main anti - inflammatory mediators , like <e1> il - 11 </e1> , and the IL - 1 receptor antagonist .',\n",
       "    'PROTEIN']]],\n",
       " ['Of even more interest , IkappaBalpha overexpression inhibited the production of matrix metalloproteinase 3while not affecting their tissue inhibitor .',\n",
       "  [['Of even more interest , IkappaBalpha overexpression inhibited the production of <e1> matrix metalloproteinase 3 </e1> while not affecting their tissue inhibitor .',\n",
       "    'PROTEIN']]],\n",
       " ['To find out if the induction by UV light is caused by the formation of an Ah receptor ligand , hepa - 1 wild - type cell linewere applied .',\n",
       "  [['To find out if the induction by UV light is caused by the formation of an Ah receptor ligand , <e1> hepa - 1 wild - type cell line </e1> were applied .',\n",
       "    'CELL_LINE']]],\n",
       " ['Enforced expression of Id3 , which has the capacity to inhibit many basic helix - loop - helix ( bHLH ) transcription factors , in human CD34(+) hematopoietic progenitor cells that have not undergone T cell receptor ( TCR ) gene rearrangements inhibits development of the transduced cells into tcr alpha beta cellin a fetal thymic organ culture ( FTOC ) .',\n",
       "  [['Enforced expression of Id3 , which has the capacity to inhibit many basic helix - loop - helix ( bHLH ) transcription factors , in human CD34(+) hematopoietic progenitor cells that have not undergone T cell receptor ( TCR ) gene rearrangements inhibits development of the transduced cells into <e1> tcr alpha beta cell </e1> in a fetal thymic organ culture ( FTOC ) .',\n",
       "    'CELL_LINE']]],\n",
       " ['Thus , cosignaling via the lt - beta receptoris probably involved in the modulation of HIV - 1 replication and the subsequent determination of HIV - 1 viral burden in monocytes .',\n",
       "  [['Thus , cosignaling via the <e1> lt - beta receptor </e1> is probably involved in the modulation of HIV - 1 replication and the subsequent determination of HIV - 1 viral burden in monocytes .',\n",
       "    'PROTEIN']]],\n",
       " ['However NF - ATs appear in the nuclei of il - 4 - stimulated eosinophil .',\n",
       "  [['However NF - ATs appear in the nuclei of <e1> il - 4 - stimulated eosinophil </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['However NF - ATs appear in the nuclei of il - 5 - stimulated eosinophil .',\n",
       "  [['However NF - ATs appear in the nuclei of <e1> il - 5 - stimulated eosinophil </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Only NF - AT1 and NF - AT4 , but not NF - AT2 and NF - AT3 , have translocated into the nuclei in il - 4 - stimulated eosinophil .',\n",
       "  [['Only NF - AT1 and NF - AT4 , but not NF - AT2 and NF - AT3 , have translocated into the nuclei in <e1> il - 4 - stimulated eosinophil </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Only NF - AT1 and NF - AT4 , but not NF - AT2 and NF - AT3 , have translocated into the nuclei in il - 5 - stimulated eosinophil .',\n",
       "  [['Only NF - AT1 and NF - AT4 , but not NF - AT2 and NF - AT3 , have translocated into the nuclei in <e1> il - 5 - stimulated eosinophil </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['A well - studied example is nuclear factors of activated T - cell ( NFAT ) sites which are composite elements of a nfatp/c binding site .',\n",
       "  [['A well - studied example is nuclear factors of activated T - cell ( NFAT ) sites which are composite elements of a <e1> nfatp/c binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['A well - studied example is nuclear factors of activated T - cell ( NFAT ) sites which are composite elements of a NFATp/c and an activating protein 1 ap - 1 binding site .',\n",
       "  [['A well - studied example is nuclear factors of activated T - cell ( NFAT ) sites which are composite elements of a NFATp/c and <e1> an activating protein 1 ap - 1 binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['All three steps progressively helpX?ed to discriminate T - cell - specific promoter sequences against other functional regions ( coding sequence) of the same genes , against promoters of muscle - specific genes or against random sequences .',\n",
       "  [['All three steps progressively helpX?ed to discriminate T - cell - specific promoter sequences against other functional regions ( <e1> coding sequence </e1> ) of the same genes , against promoters of muscle - specific genes or against random sequences .',\n",
       "    'DNA']]],\n",
       " ['A silent mutation in codon 10 of exon 1 , detected in er - negative human breast cancer cell line, in breast tumors and blood DNA from breast cancer patients , has been recognized as a polymorphic site .',\n",
       "  [['A silent mutation in codon 10 of exon 1 , detected in <e1> er - negative human breast cancer cell line </e1> , in breast tumors and blood DNA from breast cancer patients , has been recognized as a polymorphic site .',\n",
       "    'CELL_LINE']]],\n",
       " ['A silent mutation in codon 10 of exon 1 , detected in er - positive human breast cancer cell line, in breast tumors and blood DNA from breast cancer patients , has been recognized as a polymorphic site .',\n",
       "  [['A silent mutation in codon 10 of exon 1 , detected in <e1> er - positive human breast cancer cell line </e1> , in breast tumors and blood DNA from breast cancer patients , has been recognized as a polymorphic site .',\n",
       "    'CELL_LINE']]],\n",
       " ['The c - Myc oncoprotein is important in control of cellular proliferation and differentiation , while Yin - Yang 1 ( YY1 ) has been shown to control the expression of a number of cellular gene .',\n",
       "  [['The c - Myc oncoprotein is important in control of cellular proliferation and differentiation , while Yin - Yang 1 ( YY1 ) has been shown to control the expression of a number of <e1> cellular gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Expression and role of PML gene in normal adult hematopoiesis : functional interaction between pml proteinin erythropoiesis .',\n",
       "  [['Expression and role of PML gene in normal adult hematopoiesis : functional interaction between <e1> pml protein </e1> in erythropoiesis .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , early treatment ( day 0 HPCs ) with alpha - PML reduced the number of both erythroid colony, whereas late treatment ( day 5 culture ) reduced erythroid , but not granulocytic , clonogenesis .',\n",
       "  [['Interestingly , early treatment ( day 0 HPCs ) with alpha - PML reduced the number of both <e1> erythroid colony </e1> , whereas late treatment ( day 5 culture ) reduced erythroid , but not granulocytic , clonogenesis .',\n",
       "    'CELL_LINE']]],\n",
       " ['Different sequence requirements for expression in erythroid cellwithin a regulatory element upstream of the GATA - 1 gene .',\n",
       "  [['Different sequence requirements for expression in <e1> erythroid cell </e1> within a regulatory element upstream of the GATA - 1 gene .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The lineage - restricted transcription factor GATA - 1 is required for differentiation of erythroid cell .',\n",
       "  [['The lineage - restricted transcription factor GATA - 1 is required for differentiation of <e1> erythroid cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['HS I directs high - level expression of reporter GATA - 1/lacZ genes to primitive erythroid celland megakaryocytes in transgenic mice .',\n",
       "  [['HS I directs high - level expression of reporter GATA - 1/lacZ genes to <e1> primitive erythroid cell </e1> and megakaryocytes in transgenic mice .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Immortalization of cd4+ t lymphocyteby human T - cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone .',\n",
       "  [['Immortalization of <e1> cd4+ t lymphocyte </e1> by human T - cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In contrast , dominant negative rac proteindid not affect monocyte adhesion or spreading .',\n",
       "  [['In contrast , <e1> dominant negative rac protein </e1> did not affect monocyte adhesion or spreading .',\n",
       "    'PROTEIN']]],\n",
       " ['In contrast , dominant negative cdc42 proteindid not affect monocyte adhesion or spreading .',\n",
       "  [['In contrast , <e1> dominant negative cdc42 protein </e1> did not affect monocyte adhesion or spreading .',\n",
       "    'PROTEIN']]],\n",
       " ['Finally , receptor clusters colocalized with ezrin protein .',\n",
       "  [['Finally , receptor clusters colocalized with <e1> ezrin protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Finally , receptor clusters colocalized with ezrin / moesin protein .',\n",
       "  [['Finally , receptor clusters colocalized with ezrin / <e1> moesin protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Expression of th1 type cytokineresponding to HBsAg and HBxAg in chronic hepatitis B patients .',\n",
       "  [['Expression of <e1> th1 type cytokine </e1> responding to HBsAg and HBxAg in chronic hepatitis B patients .',\n",
       "    'PROTEIN']]],\n",
       " ['METHODS : Eight malignant lymphocytic cell lines and primary cultures of lymphocytic leukemia cellwere treated with As2O3 , with or without dithiothreitol ( DTT ) or buthionine sulfoximine ( BSO ) ( an inhibitor of glutathione synthesis ) .',\n",
       "  [['METHODS : Eight malignant lymphocytic cell lines and primary cultures of <e1> lymphocytic leukemia cell </e1> were treated with As2O3 , with or without dithiothreitol ( DTT ) or buthionine sulfoximine ( BSO ) ( an inhibitor of glutathione synthesis ) .',\n",
       "    'CELL_TYPE']]],\n",
       " ['NF - kappaB functions as both a proapoptotic regulatory factorwithin a single cell type .',\n",
       "  [['NF - kappaB functions as both a <e1> proapoptotic regulatory factor </e1> within a single cell type .',\n",
       "    'PROTEIN']]],\n",
       " ['To determine why alveolar macrophages do not express AP - 1 DNA binding activity , we first showed that there was not a decrease in expression of the fos proteinthat make up the AP - 1 complex .',\n",
       "  [['To determine why alveolar macrophages do not express AP - 1 DNA binding activity , we first showed that there was not a decrease in expression of the <e1> fos protein </e1> that make up the AP - 1 complex .',\n",
       "    'PROTEIN']]],\n",
       " ['The secondary lymphoid tissues are located at strategic sites where foreign antigens can be efficiently brought together with immune system regulatory cell .',\n",
       "  [['The secondary lymphoid tissues are located at strategic sites where foreign antigens can be efficiently brought together with <e1> immune system regulatory cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The secondary lymphoid tissues are located at strategic sites where foreign antigens can be efficiently brought together with immune system effector cell .',\n",
       "  [['The secondary lymphoid tissues are located at strategic sites where foreign antigens can be efficiently brought together with <e1> immune system effector cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['This correlates with changes of nuclear protein - binding activities to two motifs , site beta, within the CD28 minimal promoter .',\n",
       "  [['This correlates with changes of nuclear protein - binding activities to two motifs , <e1> site beta </e1> , within the CD28 minimal promoter .',\n",
       "    'PROTEIN']]],\n",
       " ['In vivo expanded cd4+cd28null t celluniformly lack alpha - and beta - bound complexes , resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "  [['In vivo expanded <e1> cd4+cd28null t cell </e1> uniformly lack alpha - and beta - bound complexes , resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack alpha - bound complex, resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "  [['In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack <e1> alpha - bound complex </e1> , resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "    'PROTEIN']]],\n",
       " ['In vivo expanded cd4+cd28null t celluniformly lack alpha - and beta - bound complexes , resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "  [['In vivo expanded <e1> cd4+cd28null t cell </e1> uniformly lack alpha - and beta - bound complexes , resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack alpha - bound complex, resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "  [['In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack <e1> alpha - bound complex </e1> , resembling the pattern seen in chronically activated cells and not of senescent cells .',\n",
       "    'PROTEIN']]],\n",
       " ['The contact of natural killer ( NK ) cells with foreign cells and with certain virus - infected celltriggers the cytolytic machinery of NK cells .',\n",
       "  [['The contact of natural killer ( NK ) cells with foreign cells and with certain <e1> virus - infected cell </e1> triggers the cytolytic machinery of NK cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Differences in phosphorylation of the IL - 2R associated JAK/STAT proteins between htlv - i+ cell lineand uncultured leukemic cells from patients with adult T - cell lymphoma/leukemia .',\n",
       "  [['Differences in phosphorylation of the IL - 2R associated JAK/STAT proteins between <e1> htlv - i+ cell line </e1> and uncultured leukemic cells from patients with adult T - cell lymphoma/leukemia .',\n",
       "    'CELL_LINE']]],\n",
       " ['Differences in phosphorylation of the IL - 2R associated JAK/STAT proteins between HTLV - I(+) , il - 2 - independent cell lineand uncultured leukemic cells from patients with adult T - cell lymphoma/leukemia .',\n",
       "  [['Differences in phosphorylation of the IL - 2R associated JAK/STAT proteins between HTLV - I(+) , <e1> il - 2 - independent cell line </e1> and uncultured leukemic cells from patients with adult T - cell lymphoma/leukemia .',\n",
       "    'CELL_LINE']]],\n",
       " ['Differences in phosphorylation of the IL - 2R associated JAK/STAT proteins between HTLV - I(+) , il - 2 - dependent cell lineand uncultured leukemic cells from patients with adult T - cell lymphoma/leukemia .',\n",
       "  [['Differences in phosphorylation of the IL - 2R associated JAK/STAT proteins between HTLV - I(+) , <e1> il - 2 - dependent cell line </e1> and uncultured leukemic cells from patients with adult T - cell lymphoma/leukemia .',\n",
       "    'CELL_LINE']]],\n",
       " ['IL - 10 is a well - known immunosuppressive cytokine .',\n",
       "  [['IL - 10 is a well - known <e1> immunosuppressive cytokine </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Cell growth - regulated expression of mammalian mcm5 genemediated by the transcription factor E2F .',\n",
       "  [['Cell growth - regulated expression of <e1> mammalian mcm5 gene </e1> mediated by the transcription factor E2F .',\n",
       "    'DNA']]],\n",
       " ['Cell growth - regulated expression of mammalian mcm6 genemediated by the transcription factor E2F .',\n",
       "  [['Cell growth - regulated expression of <e1> mammalian mcm6 gene </e1> mediated by the transcription factor E2F .',\n",
       "    'DNA']]],\n",
       " [' human mcm5 promoterregulation following serum stimulation and exogenous E2F expression .',\n",
       "  [[' <e1> human mcm5 promoter </e1> regulation following serum stimulation and exogenous E2F expression .',\n",
       "    'DNA']]],\n",
       " [' human mcm6 promoterregulation following serum stimulation and exogenous E2F expression .',\n",
       "  [[' <e1> human mcm6 promoter </e1> regulation following serum stimulation and exogenous E2F expression .',\n",
       "    'DNA']]],\n",
       " ['Our results demonstrated that the growth - regulated expression of mammalian mcm5 gene, and presumably other MCM members , is primarily regulated by E2F through binding to multiple E2F sites in the promoters .',\n",
       "  [['Our results demonstrated that the growth - regulated expression of <e1> mammalian mcm5 gene </e1> , and presumably other MCM members , is primarily regulated by E2F through binding to multiple E2F sites in the promoters .',\n",
       "    'DNA']]],\n",
       " ['Our results demonstrated that the growth - regulated expression of mammalian mcm6 gene, and presumably other MCM members , is primarily regulated by E2F through binding to multiple E2F sites in the promoters .',\n",
       "  [['Our results demonstrated that the growth - regulated expression of <e1> mammalian mcm6 gene </e1> , and presumably other MCM members , is primarily regulated by E2F through binding to multiple E2F sites in the promoters .',\n",
       "    'DNA']]],\n",
       " ['These results offer insight into a new role for NF - kappaB in maintaining survival and function in hematopoietic stem celland suggest that proposed strategies involving inhibition of NF - kappaB activation as an adjunct to cancer chemotherapy should be approached with caution .',\n",
       "  [['These results offer insight into a new role for NF - kappaB in maintaining survival and function in <e1> hematopoietic stem cell </e1> and suggest that proposed strategies involving inhibition of NF - kappaB activation as an adjunct to cancer chemotherapy should be approached with caution .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These results offer insight into a new role for NF - kappaB in maintaining survival and function in hematopoietic progenitor celland suggest that proposed strategies involving inhibition of NF - kappaB activation as an adjunct to cancer chemotherapy should be approached with caution .',\n",
       "  [['These results offer insight into a new role for NF - kappaB in maintaining survival and function in <e1> hematopoietic progenitor cell </e1> and suggest that proposed strategies involving inhibition of NF - kappaB activation as an adjunct to cancer chemotherapy should be approached with caution .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The effects of GDSP on pancreatic weight , serum lipase, morphologic changes in the pancreas , neutrophil infiltration , and nuclear factor KB ( NF - KB ) activation were measured in rats infused with supramaximal dose of cerulein ( 5 ( g/kg/h ) for 6 h .',\n",
       "  [['The effects of GDSP on pancreatic weight , <e1> serum lipase </e1> , morphologic changes in the pancreas , neutrophil infiltration , and nuclear factor KB ( NF - KB ) activation were measured in rats infused with supramaximal dose of cerulein ( 5 ( g/kg/h ) for 6 h .',\n",
       "    'PROTEIN']]],\n",
       " ['Capacitance would simply involve expression of il - 12r beta 1 subunit, regulated by TCR , IL - 4 and IFNs .',\n",
       "  [['Capacitance would simply involve expression of <e1> il - 12r beta 1 subunit </e1> , regulated by TCR , IL - 4 and IFNs .',\n",
       "    'PROTEIN']]],\n",
       " ['Capacitance would simply involve expression of il - 12r beta 2 subunit, regulated by TCR , IL - 4 and IFNs .',\n",
       "  [['Capacitance would simply involve expression of <e1> il - 12r beta 2 subunit </e1> , regulated by TCR , IL - 4 and IFNs .',\n",
       "    'PROTEIN']]],\n",
       " ['This effect can be associated with the activation of specific hormone receptors , since we observed the expression of the estrogen receptor alpha er - alpha mrna; the ER - alpha protein expression was confirmed by immunocytochemical analysis .',\n",
       "  [['This effect can be associated with the activation of specific hormone receptors , since we observed the expression of the <e1> estrogen receptor alpha er - alpha mrna </e1> ; the ER - alpha protein expression was confirmed by immunocytochemical analysis .',\n",
       "    'RNA']]],\n",
       " ['This effect can be associated with the activation of specific hormone receptors , since we observed the expression of the estrogen receptor alpha ( er - beta mrna; the ER - alpha protein expression was confirmed by immunocytochemical analysis .',\n",
       "  [['This effect can be associated with the activation of specific hormone receptors , since we observed the expression of the estrogen receptor alpha ( <e1> er - beta mrna </e1> ; the ER - alpha protein expression was confirmed by immunocytochemical analysis .',\n",
       "    'RNA']]],\n",
       " ['This effect can be associated with the activation of specific hormone receptors , since we observed the expression of the estrogen receptor alpha ( ER - alpha ) , ER - beta , and progesterone receptor pr mrna; the ER - alpha protein expression was confirmed by immunocytochemical analysis .',\n",
       "  [['This effect can be associated with the activation of specific hormone receptors , since we observed the expression of the estrogen receptor alpha ( ER - alpha ) , ER - beta , and <e1> progesterone receptor pr mrna </e1> ; the ER - alpha protein expression was confirmed by immunocytochemical analysis .',\n",
       "    'RNA']]],\n",
       " ['Efforts to pinpoint the exact site of action and specificity of HePTP in the signaling cascade revealed that HePTP acts directly on the mitogen - activated protein ( MAP ) kinases erk 2and consequently reduces the magnitude and duration of their catalytic activation in intact T cells .',\n",
       "  [['Efforts to pinpoint the exact site of action and specificity of HePTP in the signaling cascade revealed that HePTP acts directly on the mitogen - activated protein ( MAP ) kinases <e1> erk 2 </e1> and consequently reduces the magnitude and duration of their catalytic activation in intact T cells .',\n",
       "    'PROTEIN']]],\n",
       " ['T cell proliferation and production of IL - 2 , IL - 4 , and IFN - gamma induced by both CD3 and CD3 /CD28 ligation and the nuclear expression of the c - jun proteinare each blocked by the p38 MAPK inhibitor SB203580 .',\n",
       "  [['T cell proliferation and production of IL - 2 , IL - 4 , and IFN - gamma induced by both CD3 and CD3 /CD28 ligation and the nuclear expression of the <e1> c - jun protein </e1> are each blocked by the p38 MAPK inhibitor SB203580 .',\n",
       "    'PROTEIN']]],\n",
       " ['Epo caused an increase in the proportion of cells expressing cell surface glycophorin A ( GPA ) and up - regulated beta - globinby several fold .',\n",
       "  [['Epo caused an increase in the proportion of cells expressing cell surface glycophorin A ( GPA ) and up - regulated <e1> beta - globin </e1> by several fold .',\n",
       "    'PROTEIN']]],\n",
       " [' interferon - betapromote the reversion of blast Tcells to a resting G0/G1 configuration with all the characteristic features of stromal cell rescue ; such as high Bcl - XL expression and low Bcl - 2 .',\n",
       "  [[' <e1> interferon - beta </e1> promote the reversion of blast Tcells to a resting G0/G1 configuration with all the characteristic features of stromal cell rescue ; such as high Bcl - XL expression and low Bcl - 2 .',\n",
       "    'PROTEIN']]],\n",
       " ['Here we show that both a fasl - reporter constructare inefficiently induced in these cells compared to wild - type cells .',\n",
       "  [['Here we show that both a <e1> fasl - reporter construct </e1> are inefficiently induced in these cells compared to wild - type cells .',\n",
       "    'DNA']]],\n",
       " ['Inhibition of IL - 4 - inducible gene expression in human monocytes by type i interferon .',\n",
       "  [['Inhibition of IL - 4 - inducible gene expression in human monocytes by <e1> type i interferon </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Inhibition of IL - 4 - inducible gene expression in human monocytes by type ii interferon .',\n",
       "  [['Inhibition of IL - 4 - inducible gene expression in human monocytes by <e1> type ii interferon </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The Th2 - type cytokines , interleukin - 4 ( IL - 4 ) and interleukin - 13 ( IL - 13 ) , induce expression of a distinct subset of genes in human monocytes , including FcepsilonRIIb ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and type i il - 1 receptor( IL - 1R ) .',\n",
       "  [['The Th2 - type cytokines , interleukin - 4 ( IL - 4 ) and interleukin - 13 ( IL - 13 ) , induce expression of a distinct subset of genes in human monocytes , including FcepsilonRIIb ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and <e1> type i il - 1 receptor </e1> ( IL - 1R ) .',\n",
       "    'PROTEIN']]],\n",
       " ['The Th2 - type cytokines , interleukin - 4 ( IL - 4 ) and interleukin - 13 ( IL - 13 ) , induce expression of a distinct subset of genes in human monocytes , including FcepsilonRIIb ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and type ii il - 1 receptor( IL - 1R ) .',\n",
       "  [['The Th2 - type cytokines , interleukin - 4 ( IL - 4 ) and interleukin - 13 ( IL - 13 ) , induce expression of a distinct subset of genes in human monocytes , including FcepsilonRIIb ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and <e1> type ii il - 1 receptor </e1> ( IL - 1R ) .',\n",
       "    'PROTEIN']]],\n",
       " ['We also discuss our recent findings that type i ifnsuppress IL - 4 / IL - 13 - inducible gene expression by inhibiting tyrosine phosphorylation and nuclear translocation of STAT6 .',\n",
       "  [['We also discuss our recent findings that <e1> type i ifn </e1> suppress IL - 4 / IL - 13 - inducible gene expression by inhibiting tyrosine phosphorylation and nuclear translocation of STAT6 .',\n",
       "    'PROTEIN']]],\n",
       " ['We also discuss our recent findings that type ii ifnsuppress IL - 4 / IL - 13 - inducible gene expression by inhibiting tyrosine phosphorylation and nuclear translocation of STAT6 .',\n",
       "  [['We also discuss our recent findings that <e1> type ii ifn </e1> suppress IL - 4 / IL - 13 - inducible gene expression by inhibiting tyrosine phosphorylation and nuclear translocation of STAT6 .',\n",
       "    'PROTEIN']]],\n",
       " ['The ability of type i ifnto inhibit IL - 4 / IL - 13 - induced STAT6 activity is dose - and time - dependent , and is not unique to monocytes because IFNs induce the same effects in fibroblasts .',\n",
       "  [['The ability of <e1> type i ifn </e1> to inhibit IL - 4 / IL - 13 - induced STAT6 activity is dose - and time - dependent , and is not unique to monocytes because IFNs induce the same effects in fibroblasts .',\n",
       "    'PROTEIN']]],\n",
       " ['The ability of type ii ifnto inhibit IL - 4 / IL - 13 - induced STAT6 activity is dose - and time - dependent , and is not unique to monocytes because IFNs induce the same effects in fibroblasts .',\n",
       "  [['The ability of <e1> type ii ifn </e1> to inhibit IL - 4 / IL - 13 - induced STAT6 activity is dose - and time - dependent , and is not unique to monocytes because IFNs induce the same effects in fibroblasts .',\n",
       "    'PROTEIN']]],\n",
       " ['A cdk2 inhibitor , Olomoucine , as well as a dominant - negative cdk2 construct prevented HLA class I - mediated inactivation of Rb ; in contrast , dominant - negative cdk4 constructhad no effect .',\n",
       "  [['A cdk2 inhibitor , Olomoucine , as well as a dominant - negative cdk2 construct prevented HLA class I - mediated inactivation of Rb ; in contrast , <e1> dominant - negative cdk4 construct </e1> had no effect .',\n",
       "    'DNA']]],\n",
       " ['A cdk2 inhibitor , Olomoucine , as well as a dominant - negative cdk2 construct prevented HLA class I - mediated inactivation of Rb ; in contrast , dominant - negative cdk6 constructhad no effect .',\n",
       "  [['A cdk2 inhibitor , Olomoucine , as well as a dominant - negative cdk2 construct prevented HLA class I - mediated inactivation of Rb ; in contrast , <e1> dominant - negative cdk6 construct </e1> had no effect .',\n",
       "    'DNA']]],\n",
       " ['PG490 can completely inhibit transcriptional activation at the purine - box/arre/nf - at target dna sequencetriggered by all stimuli examined ( PMA , PMA /Iono , tumor necrosis factor - alpha ) .',\n",
       "  [['PG490 can completely inhibit transcriptional activation at the <e1> purine - box/arre/nf - at target dna sequence </e1> triggered by all stimuli examined ( PMA , PMA /Iono , tumor necrosis factor - alpha ) .',\n",
       "    'DNA']]],\n",
       " ['Most erythroleukemic cell lines established in vitro coexpress erythrocytic markerthat often are associated with expression of Spi - 1 and/or Fli - 1 transcription factors known as transactivators of megakaryocyte - specific promoters .',\n",
       "  [['Most erythroleukemic cell lines established in vitro coexpress <e1> erythrocytic marker </e1> that often are associated with expression of Spi - 1 and/or Fli - 1 transcription factors known as transactivators of megakaryocyte - specific promoters .',\n",
       "    'PROTEIN']]],\n",
       " ['Despite this drastic effect in vivo , the in vitro immortalization of erythropoietin - dependent erythroid progenitors unexpectedly occurred at low frequency , and all four cell lines established expressed both erythrocytic globins marker( glycoprotein IIb , platelet factor 4 ) as well as Spi - 1 and Fli - 1 transcripts at permissive temperature .',\n",
       "  [['Despite this drastic effect in vivo , the in vitro immortalization of erythropoietin - dependent erythroid progenitors unexpectedly occurred at low frequency , and all four cell lines established expressed both <e1> erythrocytic globins marker </e1> ( glycoprotein IIb , platelet factor 4 ) as well as Spi - 1 and Fli - 1 transcripts at permissive temperature .',\n",
       "    'PROTEIN']]],\n",
       " ['Interestingly , enhanced expression of spi - 1 genealready was detected in the Ter 119 positive cell population of transgenic mice spleen in vivo .',\n",
       "  [['Interestingly , enhanced expression of <e1> spi - 1 gene </e1> already was detected in the Ter 119 positive cell population of transgenic mice spleen in vivo .',\n",
       "    'DNA']]],\n",
       " ['Taken together , these data indicate that the unexpected expression of megakaryocytic genes is a specific property of immortalized cells that can not be explained only by enhanced expression of spi - 1 gene .',\n",
       "  [['Taken together , these data indicate that the unexpected expression of megakaryocytic genes is a specific property of immortalized cells that can not be explained only by enhanced expression of <e1> spi - 1 gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Here we show that fludarabine , but not the immunosuppressant cyclosporine A , inhibits the cytokine - induced activation of STAT1 and STAT1 - dependent gene transcription in normal resting lymphocyte .',\n",
       "  [['Here we show that fludarabine , but not the immunosuppressant cyclosporine A , inhibits the cytokine - induced activation of STAT1 and STAT1 - dependent gene transcription in <e1> normal resting lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Furthermore , pre - b cell linewere Spi - C - negative , suggesting that Spi - C might be a regulatory molecule during a specific phase of B lymphoid development .',\n",
       "  [['Furthermore , <e1> pre - b cell line </e1> were Spi - C - negative , suggesting that Spi - C might be a regulatory molecule during a specific phase of B lymphoid development .',\n",
       "    'CELL_LINE']]],\n",
       " ['Whereas the NF - kappaB binding activity in Tax - expressing T - cell lines consisted mostly of p50/c - Rel , fresh ATL samples contained p50/p50 heterodimer .',\n",
       "  [['Whereas the NF - kappaB binding activity in Tax - expressing T - cell lines consisted mostly of p50/c - Rel , fresh ATL samples contained <e1> p50/p50 heterodimer </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Interferon - alpha induction of stats 3DNA binding and growth arrest is independent of Lck and active mitogen - activated kinase in T cells .',\n",
       "  [['Interferon - alpha induction of <e1> stats 3 </e1> DNA binding and growth arrest is independent of Lck and active mitogen - activated kinase in T cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Furthermore , stats 3are effectively phosphorylated and activated to bind DNA in the absence of Lck expression in IFN - alpha - treated cells .',\n",
       "  [['Furthermore , <e1> stats 3 </e1> are effectively phosphorylated and activated to bind DNA in the absence of Lck expression in IFN - alpha - treated cells .',\n",
       "    'PROTEIN']]],\n",
       " ['The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter : synergistic activation by CD40 ligand and IL - 4 via cooperative nf - kappa b binding site .',\n",
       "  [['The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter : synergistic activation by CD40 ligand and IL - 4 via cooperative <e1> nf - kappa b binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['These partially overlapping cd40l responsive elementare functionally cooperative as the disruption of one of them prevents synergistic promoter activation .',\n",
       "  [['These partially overlapping <e1> cd40l responsive element </e1> are functionally cooperative as the disruption of one of them prevents synergistic promoter activation .',\n",
       "    'DNA']]],\n",
       " ['The STP oncoproteins of the herpesvirus saimiri ( HVS ) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with tumor necrosis factor receptor - associated factor traf 1, 2 , or 3 .',\n",
       "  [['The STP oncoproteins of the herpesvirus saimiri ( HVS ) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with <e1> tumor necrosis factor receptor - associated factor traf 1 </e1> , 2 , or 3 .',\n",
       "    'PROTEIN']]],\n",
       " ['The STP oncoproteins of the herpesvirus saimiri ( HVS ) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with tumor necrosis factor receptor - associated factor traf 2, or 3 .',\n",
       "  [['The STP oncoproteins of the herpesvirus saimiri ( HVS ) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with <e1> tumor necrosis factor receptor - associated factor traf 2 </e1> , or 3 .',\n",
       "    'PROTEIN']]],\n",
       " ['The STP oncoproteins of the herpesvirus saimiri ( HVS ) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with tumor necrosis factor receptor - associated factor traf 3 .',\n",
       "  [['The STP oncoproteins of the herpesvirus saimiri ( HVS ) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with <e1> tumor necrosis factor receptor - associated factor traf 3 </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['CD40 ligation on MM by CD40L - transfected murine L - cells or by a soluble CD40L fusion protein up - regulated their expression of intercellular adhesion molecule - 1 and mhc class i moleculeand their secretion of IL - 6 , IL - 8 , tumor necrosis factor - a , and granulocyte macrophage colony - stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB .',\n",
       "  [['CD40 ligation on MM by CD40L - transfected murine L - cells or by a soluble CD40L fusion protein up - regulated their expression of intercellular adhesion molecule - 1 and <e1> mhc class i molecule </e1> and their secretion of IL - 6 , IL - 8 , tumor necrosis factor - a , and granulocyte macrophage colony - stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB .',\n",
       "    'PROTEIN']]],\n",
       " ['CD40 ligation on MM by CD40L - transfected murine L - cells or by a soluble CD40L fusion protein up - regulated their expression of intercellular adhesion molecule - 1 and mhc class ii moleculeand their secretion of IL - 6 , IL - 8 , tumor necrosis factor - a , and granulocyte macrophage colony - stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB .',\n",
       "  [['CD40 ligation on MM by CD40L - transfected murine L - cells or by a soluble CD40L fusion protein up - regulated their expression of intercellular adhesion molecule - 1 and <e1> mhc class ii molecule </e1> and their secretion of IL - 6 , IL - 8 , tumor necrosis factor - a , and granulocyte macrophage colony - stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB .',\n",
       "    'PROTEIN']]],\n",
       " ['We evaluated the immunoreactivity of the regulatory subunitof cAMP - dependent protein kinase ( protein kinase A ) and 1 of its substrates , Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .',\n",
       "  [['We evaluated the immunoreactivity of the <e1> regulatory subunit </e1> of cAMP - dependent protein kinase ( protein kinase A ) and 1 of its substrates , Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .',\n",
       "    'PROTEIN']]],\n",
       " ['Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL - 6 protein , which coincided with enhanced binding activity of NF - kappa B as well as with phosphorylation and activation of the erk1/2 protein .',\n",
       "  [['Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL - 6 protein , which coincided with enhanced binding activity of NF - kappa B as well as with phosphorylation and activation of the <e1> erk1/2 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as bcl - 2+ cell, and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  [['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as <e1> bcl - 2+ cell </e1> , and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , cd56+ cell, and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  [['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , <e1> cd56+ cell </e1> , and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , cd3+ cell, and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  [['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , <e1> cd3+ cell </e1> , and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , CD3+ , cd8+ cell, and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "  [['Tissues from women undergoing elective termination of uterine pregnancy and from women with ectopic pregnancy were used to detect the presence of cells important for the maintenance of pregnancy , such as BCL - 2+ , CD56+ , CD3+ , <e1> cd8+ cell </e1> , and the presence of oestrogen ( ER ) and progesterone receptors ( PR ) by immunohistochemistry .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These effects were blocked by mAbs against endothelial adhesion molecule( beta1 and beta2 integrins ) .',\n",
       "  [['These effects were blocked by mAbs against <e1> endothelial adhesion molecule </e1> ( beta1 and beta2 integrins ) .',\n",
       "    'PROTEIN']]],\n",
       " ['These effects were blocked by mAbs against endothelial and/or leukocyte adhesion molecules ( beta1 integrin) .',\n",
       "  [['These effects were blocked by mAbs against endothelial and/or leukocyte adhesion molecules ( <e1> beta1 integrin </e1> ) .',\n",
       "    'PROTEIN']]],\n",
       " ['These effects were blocked by mAbs against endothelial adhesion molecule( beta1 and beta2 integrins ) .',\n",
       "  [['These effects were blocked by mAbs against <e1> endothelial adhesion molecule </e1> ( beta1 and beta2 integrins ) .',\n",
       "    'PROTEIN']]],\n",
       " ['These effects were blocked by mAbs against endothelial and/or leukocyte adhesion molecules ( beta1 integrin) .',\n",
       "  [['These effects were blocked by mAbs against endothelial and/or leukocyte adhesion molecules ( <e1> beta1 integrin </e1> ) .',\n",
       "    'PROTEIN']]],\n",
       " ['The E2A - HLF fusion gene , generated by t(17;19)(q22;p13) in acute lymphoblastic leukemia ( ALL ) , encodes a chimeric transcription factor in which the trans - activating domains of E2A are fused to the dna - binding domainof hepatic leukemic factor ( HLF ) .',\n",
       "  [['The E2A - HLF fusion gene , generated by t(17;19)(q22;p13) in acute lymphoblastic leukemia ( ALL ) , encodes a chimeric transcription factor in which the trans - activating domains of E2A are fused to the <e1> dna - binding domain </e1> of hepatic leukemic factor ( HLF ) .',\n",
       "    'PROTEIN']]],\n",
       " ['The E2A - HLF fusion gene , generated by t(17;19)(q22;p13) in acute lymphoblastic leukemia ( ALL ) , encodes a chimeric transcription factor in which the trans - activating domains of E2A are fused to the dna - dimerization domainof hepatic leukemic factor ( HLF ) .',\n",
       "  [['The E2A - HLF fusion gene , generated by t(17;19)(q22;p13) in acute lymphoblastic leukemia ( ALL ) , encodes a chimeric transcription factor in which the trans - activating domains of E2A are fused to the <e1> dna - dimerization domain </e1> of hepatic leukemic factor ( HLF ) .',\n",
       "    'PROTEIN']]],\n",
       " ['To investigate its biological role , we generated transgenic mice expressing E2A - HLF using ig promoter, which direct transgene expression in cells committed to the lymphoid lineage .',\n",
       "  [['To investigate its biological role , we generated transgenic mice expressing E2A - HLF using <e1> ig promoter </e1> , which direct transgene expression in cells committed to the lymphoid lineage .',\n",
       "    'DNA']]],\n",
       " ['IL - 12 and IL - 2 can stimulate mitogen - activated t cellto proliferate , produce IFN - gamma , and kill tumor cells .',\n",
       "  [['IL - 12 and IL - 2 can stimulate <e1> mitogen - activated t cell </e1> to proliferate , produce IFN - gamma , and kill tumor cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Consistent with previous data from human fibroblastand T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas E2F 1 and - 3 are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "  [['Consistent with previous data from <e1> human fibroblast </e1> and T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas E2F 1 and - 3 are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Consistent with previous data from human and mouse fibroblasts and T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas e2f - 3are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "  [['Consistent with previous data from human and mouse fibroblasts and T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas <e1> e2f - 3 </e1> are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "    'PROTEIN']]],\n",
       " ['Consistent with previous data from human fibroblastand T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas E2F 1 and - 3 are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "  [['Consistent with previous data from <e1> human fibroblast </e1> and T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas E2F 1 and - 3 are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Consistent with previous data from human and mouse fibroblasts and T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas e2f - 3are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "  [['Consistent with previous data from human and mouse fibroblasts and T - lymphocytes , E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B - lymphocyte cell cycle , whereas <e1> e2f - 3 </e1> are first detected in late G1 , and their expression levels increase towards S phase .',\n",
       "    'PROTEIN']]],\n",
       " ['Though the levels of dp - 2increase when cells progress from G0 to S , the proportion of DP1 to DP2 remains relatively constant during the cell cycle .',\n",
       "  [['Though the levels of <e1> dp - 2 </e1> increase when cells progress from G0 to S , the proportion of DP1 to DP2 remains relatively constant during the cell cycle .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of tnf receptor 2; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of <e1> tnf receptor 2 </e1> ; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; pkc isoform beta i, beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> pkc isoform beta i </e1> , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; pkc isoform beta ii, and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> pkc isoform beta ii </e1> , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; pkc isoform mu; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> pkc isoform mu </e1> ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of tnf receptor 2; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of <e1> tnf receptor 2 </e1> ; PKC isoforms alpha , beta I , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; pkc isoform beta i, beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> pkc isoform beta i </e1> , beta II , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; pkc isoform beta ii, and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> pkc isoform beta ii </e1> , and mu ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; pkc isoform mu; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "  [['Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2 ; <e1> pkc isoform mu </e1> ; and RelB , suggesting that these components/pathways are important for DC differentiation .',\n",
       "    'PROTEIN']]],\n",
       " ['NF - ATc isoforms are differentially expressed and regulated in murine t cell .',\n",
       "  [['NF - ATc isoforms are differentially expressed and regulated in <e1> murine t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['NF - ATc isoforms are differentially expressed and regulated in murine mast cell .',\n",
       "  [['NF - ATc isoforms are differentially expressed and regulated in <e1> murine mast cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Detection of NF - ATc.alpha mRNA is strictly dependent on cell activation signals in both t cell line .',\n",
       "  [['Detection of NF - ATc.alpha mRNA is strictly dependent on cell activation signals in both <e1> t cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " [' aml proteinregulate the I alpha1 germ - line promoter .',\n",
       "  [[' <e1> aml protein </e1> regulate the I alpha1 germ - line promoter .',\n",
       "    'PROTEIN']]],\n",
       " ['Here we show that the I alpha1 promoter contains several binding sites for the AML /PEBP2/CBF family of transcription factors and that aml proteinare major regulators of the basal and TGF - beta - inducible promoter activity .',\n",
       "  [['Here we show that the I alpha1 promoter contains several binding sites for the AML /PEBP2/CBF family of transcription factors and that <e1> aml protein </e1> are major regulators of the basal and TGF - beta - inducible promoter activity .',\n",
       "    'PROTEIN']]],\n",
       " ['Role of Egr - 2 in up - regulation of Fas ligand in normal T cells and aberrant double - negative lpr t cell .',\n",
       "  [['Role of Egr - 2 in up - regulation of Fas ligand in normal T cells and <e1> aberrant double - negative lpr t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Role of Egr - 2 in up - regulation of Fas ligand in normal T cells and aberrant double - negative gld t cell .',\n",
       "  [['Role of Egr - 2 in up - regulation of Fas ligand in normal T cells and <e1> aberrant double - negative gld t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Unstimulated mrl - lpr/lpr t cellconstitutively contained high levels of two proteins that bound to the FLRE .',\n",
       "  [['Unstimulated <e1> mrl - lpr/lpr t cell </e1> constitutively contained high levels of two proteins that bound to the FLRE .',\n",
       "    'CELL_LINE']]],\n",
       " ['Unstimulated MRL - lpr/lpr and c3h - gld/gld cd4 - cd8 - t cellconstitutively contained high levels of two proteins that bound to the FLRE .',\n",
       "  [['Unstimulated MRL - lpr/lpr and <e1> c3h - gld/gld cd4 - cd8 - t cell </e1> constitutively contained high levels of two proteins that bound to the FLRE .',\n",
       "    'CELL_LINE']]],\n",
       " ['Activation of normal lymph node cells resulted in increased expression of egr - 2, and - 3 .',\n",
       "  [['Activation of normal lymph node cells resulted in increased expression of <e1> egr - 2 </e1> , and - 3 .',\n",
       "    'PROTEIN']]],\n",
       " ['Activation of normal lymph node cells resulted in increased expression of egr - 3 .',\n",
       "  [['Activation of normal lymph node cells resulted in increased expression of <e1> egr - 3 </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['FasL - dependent reporter constructs in mrl - lpr/lpr t cellwere constitutively active , and this activity was largely prevented by mutation of the critical Egr family binding element .',\n",
       "  [['FasL - dependent reporter constructs in <e1> mrl - lpr/lpr t cell </e1> were constitutively active , and this activity was largely prevented by mutation of the critical Egr family binding element .',\n",
       "    'CELL_LINE']]],\n",
       " ['FasL - dependent reporter constructs in MRL - lpr/lpr and c3h - gld/gld cd4 - cd8 - t cellwere constitutively active , and this activity was largely prevented by mutation of the critical Egr family binding element .',\n",
       "  [['FasL - dependent reporter constructs in MRL - lpr/lpr and <e1> c3h - gld/gld cd4 - cd8 - t cell </e1> were constitutively active , and this activity was largely prevented by mutation of the critical Egr family binding element .',\n",
       "    'CELL_LINE']]],\n",
       " ['Thus , Egr - 2 , in addition to Egr - 3 , regulates FasL expression in activated normal T cells , and Egr - 2 is likely to play a direct role in aberrant fasL up - regulation in lpr/lpr t cell .',\n",
       "  [['Thus , Egr - 2 , in addition to Egr - 3 , regulates FasL expression in activated normal T cells , and Egr - 2 is likely to play a direct role in aberrant fasL up - regulation in <e1> lpr/lpr t cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Thus , Egr - 2 , in addition to Egr - 3 , regulates FasL expression in activated normal T cells , and Egr - 2 is likely to play a direct role in aberrant fasL up - regulation in lpr/lpr and gld/gld cd4 - cd8 - t cell .',\n",
       "  [['Thus , Egr - 2 , in addition to Egr - 3 , regulates FasL expression in activated normal T cells , and Egr - 2 is likely to play a direct role in aberrant fasL up - regulation in lpr/lpr and <e1> gld/gld cd4 - cd8 - t cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Recent molecular evidence points to transient and/or stage - specific expression of delta - opioid receptorby thymic and peripheral T lymphocytes .',\n",
       "  [['Recent molecular evidence points to transient and/or stage - specific expression of <e1> delta - opioid receptor </e1> by thymic and peripheral T lymphocytes .',\n",
       "    'PROTEIN']]],\n",
       " ['Recent molecular evidence points to transient and/or stage - specific expression of delta - and kappa - opioid receptors by thymic t lymphocyte .',\n",
       "  [['Recent molecular evidence points to transient and/or stage - specific expression of delta - and kappa - opioid receptors by <e1> thymic t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Recent molecular evidence points to transient and/or stage - specific expression of delta - opioid receptorby thymic and peripheral T lymphocytes .',\n",
       "  [['Recent molecular evidence points to transient and/or stage - specific expression of <e1> delta - opioid receptor </e1> by thymic and peripheral T lymphocytes .',\n",
       "    'PROTEIN']]],\n",
       " ['Recent molecular evidence points to transient and/or stage - specific expression of delta - and kappa - opioid receptors by thymic t lymphocyte .',\n",
       "  [['Recent molecular evidence points to transient and/or stage - specific expression of delta - and kappa - opioid receptors by <e1> thymic t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Reporter gene constructs were used to map this effect of deltorphin to the ap - 1 - binding siteof the IL - 2 promoter .',\n",
       "  [['Reporter gene constructs were used to map this effect of deltorphin to the <e1> ap - 1 - binding site </e1> of the IL - 2 promoter .',\n",
       "    'DNA']]],\n",
       " ['Electrophoretic mobility shift assay revealed that the potential NF - kappaB binding sequence which is located around 120 bp upstream of the transcription initiation site in murine p40 geneformed an NF - kappaB complex with nuclear extract from Daudi cells stimulated by CD40 ligation .',\n",
       "  [['Electrophoretic mobility shift assay revealed that the potential NF - kappaB binding sequence which is located around 120 bp upstream of the transcription initiation site in <e1> murine p40 gene </e1> formed an NF - kappaB complex with nuclear extract from Daudi cells stimulated by CD40 ligation .',\n",
       "    'DNA']]],\n",
       " ['These results suggest that the NF - kappaB binding site located around 120 bp upstream of the transcription initiation site in murine p40 promoter regioncould be important for the p40 induction by CD40 ligation via activation of NF - kappaB .',\n",
       "  [['These results suggest that the NF - kappaB binding site located around 120 bp upstream of the transcription initiation site in <e1> murine p40 promoter region </e1> could be important for the p40 induction by CD40 ligation via activation of NF - kappaB .',\n",
       "    'DNA']]],\n",
       " ['HS I - III , located 5 from the transcriptional initiation site , were found in hematopoietic cell, whereas HS IV - VII , located 3 from the transcriptional start site , were exclusively observed in T - cells .',\n",
       "  [['HS I - III , located 5 from the transcriptional initiation site , were found in <e1> hematopoietic cell </e1> , whereas HS IV - VII , located 3 from the transcriptional start site , were exclusively observed in T - cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Two CAGGTG E - boxes , located at the 5 - endof the silencer , were necessary for this silencer activity .',\n",
       "  [['Two CAGGTG E - boxes , located at the <e1> 5 - end </e1> of the silencer , were necessary for this silencer activity .',\n",
       "    'DNA']]],\n",
       " ['5 - LOX and 5 - LOX activating protein ( FLAP ) are coexpressed in lymphoid cells but not in monocytic cell .',\n",
       "  [['5 - LOX and 5 - LOX activating protein ( FLAP ) are coexpressed in lymphoid cells but not in <e1> monocytic cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The molecular basis for restricted cytokine expression by t helper 1 th1 cellis unclear .',\n",
       "  [['The molecular basis for restricted cytokine expression by <e1> t helper 1 th1 cell </e1> is unclear .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The molecular basis for restricted cytokine expression by t helper 2 th2 cellis unclear .',\n",
       "  [['The molecular basis for restricted cytokine expression by <e1> t helper 2 th2 cell </e1> is unclear .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Here we demonstrate that fusion of HeLa cells with either diploid b cell- encoded genes that are expressed in a B cell - specific manner .',\n",
       "  [['Here we demonstrate that fusion of HeLa cells with either <e1> diploid b cell </e1> - encoded genes that are expressed in a B cell - specific manner .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid b cell- encoded genes that are expressed in a B cell - specific manner .',\n",
       "  [['Here we demonstrate that fusion of HeLa cells with either diploid or <e1> tetraploid b cell </e1> - encoded genes that are expressed in a B cell - specific manner .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In contrast , both in th1 cloneNFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between Th1 and Th2 clones .',\n",
       "  [['In contrast , both in <e1> th1 clone </e1> NFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between Th1 and Th2 clones .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast , both in Th1 and Th2 clones NFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between th1 clone .',\n",
       "  [['In contrast , both in Th1 and Th2 clones NFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between <e1> th1 clone </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast , both in th1 cloneNFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between Th1 and Th2 clones .',\n",
       "  [['In contrast , both in <e1> th1 clone </e1> NFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between Th1 and Th2 clones .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast , both in Th1 and Th2 clones NFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between th1 clone .',\n",
       "  [['In contrast , both in Th1 and Th2 clones NFAT - containing complexes were strongly inducible at the P1 site , consisting of NFAT2 and a P0 - compatible NFAT activity , without apparent differences between <e1> th1 clone </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['To characterize the human elk - 1 promoter , we mapped the transcriptional start site and isolated elk - 1 - specific genomic phage clones that contained extensive upstream sequence .',\n",
       "  [['To characterize the human elk - 1 promoter , we mapped the transcriptional start site and isolated elk - 1 - specific genomic phage clones that contained extensive <e1> upstream sequence </e1> .',\n",
       "    'DNA']]],\n",
       " ['Anti - rheumatic compound aurothioglucose inhibits tumor necrosis factor - alpha - induced HIV - 1 replication in latently infected om10.1 cell .',\n",
       "  [['Anti - rheumatic compound aurothioglucose inhibits tumor necrosis factor - alpha - induced HIV - 1 replication in latently infected <e1> om10.1 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['In this report we have examined the efficacy of the gold compound AuTG as an inhibitor of HIV replication in latently infected om10.1 cell .',\n",
       "  [['In this report we have examined the efficacy of the gold compound AuTG as an inhibitor of HIV replication in latently infected <e1> om10.1 cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Methylation of hpaii sitenear the polymorphic trinucleotide repeat of the human androgen receptor gene ( HUMARA ) has been shown to correlate with X - inactivation .',\n",
       "  [['Methylation of <e1> hpaii site </e1> near the polymorphic trinucleotide repeat of the human androgen receptor gene ( HUMARA ) has been shown to correlate with X - inactivation .',\n",
       "    'DNA']]],\n",
       " ['Its effects are exerted by interaction with the vitamin D receptor , which is present on human monocytes and activated t lymphocyte .',\n",
       "  [['Its effects are exerted by interaction with the vitamin D receptor , which is present on human monocytes and <e1> activated t lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Its effects are exerted by interaction with the vitamin D receptor , which is present on human monocytes and activated b lymphocyte .',\n",
       "  [['Its effects are exerted by interaction with the vitamin D receptor , which is present on human monocytes and <e1> activated b lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and bp - 14 kd) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and <e1> bp - 14 kd </e1> ) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "    'PROTEIN']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and bp - 18 kd) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and <e1> bp - 18 kd </e1> ) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "    'PROTEIN']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and bp - 19 kd) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and <e1> bp - 19 kd </e1> ) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "    'PROTEIN']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and BP - 14 , 18 , 19 kDs ) isolated from splenic cellof immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and BP - 14 , 18 , 19 kDs ) isolated from <e1> splenic cell </e1> of immunized rats were studied .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and bp - 14 kd) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and <e1> bp - 14 kd </e1> ) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "    'PROTEIN']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and bp - 18 kd) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and <e1> bp - 18 kd </e1> ) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "    'PROTEIN']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and bp - 19 kd) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and <e1> bp - 19 kd </e1> ) isolated from splenic and brain cells of immunized rats were studied .',\n",
       "    'PROTEIN']]],\n",
       " ['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and BP - 14 , 18 , 19 kDs ) isolated from splenic cellof immunized rats were studied .',\n",
       "  [['The physico - chemical and functional parameters of the low molecular nuclear proteins ( SP and BP - 14 , 18 , 19 kDs ) isolated from <e1> splenic cell </e1> of immunized rats were studied .',\n",
       "    'CELL_TYPE']]],\n",
       " ['When we analyzed the nature of STAT proteins capable of binding to IL - 2Ralpha , pim - 1 elementafter cytokine stimulation , we observed IFN - alpha - induced binding of STAT1 , STAT3 , and STAT4 , but not STAT5 to all of these elements .',\n",
       "  [['When we analyzed the nature of STAT proteins capable of binding to IL - 2Ralpha , <e1> pim - 1 element </e1> after cytokine stimulation , we observed IFN - alpha - induced binding of STAT1 , STAT3 , and STAT4 , but not STAT5 to all of these elements .',\n",
       "    'DNA']]],\n",
       " ['Binding sites for testosterone on the surface of both cd4+ subsetof T cells are directly revealed with the impeded ligand testosterone - BSA - FITC by confocal laser scanning microscopy ( CLSM ) and flow cytometry , respectively .',\n",
       "  [['Binding sites for testosterone on the surface of both <e1> cd4+ subset </e1> of T cells are directly revealed with the impeded ligand testosterone - BSA - FITC by confocal laser scanning microscopy ( CLSM ) and flow cytometry , respectively .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Using the wild - type human retinoic acid receptor alphaas a model , kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .',\n",
       "  [['Using the <e1> wild - type human retinoic acid receptor alpha </e1> as a model , kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .',\n",
       "    'PROTEIN']]],\n",
       " ['Interleukin - 10 inhibits expression of both interferon alpha - induced geneby suppressing tyrosine phosphorylation of STAT1 .',\n",
       "  [['Interleukin - 10 inhibits expression of both <e1> interferon alpha - induced gene </e1> by suppressing tyrosine phosphorylation of STAT1 .',\n",
       "    'DNA']]],\n",
       " ['Interleukin - 10 inhibits expression of both interferon gamma - induced geneby suppressing tyrosine phosphorylation of STAT1 .',\n",
       "  [['Interleukin - 10 inhibits expression of both <e1> interferon gamma - induced gene </e1> by suppressing tyrosine phosphorylation of STAT1 .',\n",
       "    'DNA']]],\n",
       " ['The reduction in gene expression resulted from the ability of IL - 10 to suppress IFN - induced assembly of signal transducer and activator of transcription ( STAT ) factors to specific promoter motifs on ifnalpha - inducible gene .',\n",
       "  [['The reduction in gene expression resulted from the ability of IL - 10 to suppress IFN - induced assembly of signal transducer and activator of transcription ( STAT ) factors to specific promoter motifs on <e1> ifnalpha - inducible gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['This was accomplished by preventing the IFN - induced tyrosine phosphorylation of STAT1 , a component of both ifnalpha - induced dna binding complex .',\n",
       "  [['This was accomplished by preventing the IFN - induced tyrosine phosphorylation of STAT1 , a component of both <e1> ifnalpha - induced dna binding complex </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['These include Fc epsilonRII ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and type i il - 1 receptor( IL - 1R ) .',\n",
       "  [['These include Fc epsilonRII ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and <e1> type i il - 1 receptor </e1> ( IL - 1R ) .',\n",
       "    'PROTEIN']]],\n",
       " ['These include Fc epsilonRII ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and type ii il - 1 receptor( IL - 1R ) .',\n",
       "  [['These include Fc epsilonRII ( CD23 ) , 15 - lipoxygenase , IL - 1 receptor antagonist ( IL - 1ra ) , and <e1> type ii il - 1 receptor </e1> ( IL - 1R ) .',\n",
       "    'PROTEIN']]],\n",
       " ['In both cell types , the cytokine that inhibits the induction of IkappaBalpha by DEX , also rescues these cells from DEX - induced apoptosis , although the rescue cytokine is different in th1 cell .',\n",
       "  [['In both cell types , the cytokine that inhibits the induction of IkappaBalpha by DEX , also rescues these cells from DEX - induced apoptosis , although the rescue cytokine is different in <e1> th1 cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['We identified a cell - type - specific differential response : creb genewere strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "  [['We identified a cell - type - specific differential response : <e1> creb gene </e1> were strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "    'DNA']]],\n",
       " ['We identified a cell - type - specific differential response : CREB , ctf genewere strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "  [['We identified a cell - type - specific differential response : CREB , <e1> ctf gene </e1> were strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "    'DNA']]],\n",
       " ['We identified a cell - type - specific differential response : CREB , CTF , otf - 1 genewere strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "  [['We identified a cell - type - specific differential response : CREB , CTF , <e1> otf - 1 gene </e1> were strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "    'DNA']]],\n",
       " ['We identified a cell - type - specific differential response : CREB , CTF , OTF - 1 , oft - 2 genewere strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "  [['We identified a cell - type - specific differential response : CREB , CTF , OTF - 1 , <e1> oft - 2 gene </e1> were strongly induced 1 to 4 hours after influenza A virus infection in the monocytic cell line Mono Mac 6 , while in freshly prepared human monocytes no significant changes were detected .',\n",
       "    'DNA']]],\n",
       " ['Late gene expression from the Epstein - Barr virus bclf1 promoterdoes not require DNA replication in cis .',\n",
       "  [['Late gene expression from the Epstein - Barr virus <e1> bclf1 promoter </e1> does not require DNA replication in cis .',\n",
       "    'DNA']]],\n",
       " ['LPS core - specific mabinhibited mCD14 - mediated LPS uptake by both cell types in the presence of serum .',\n",
       "  [['LPS <e1> core - specific mab </e1> inhibited mCD14 - mediated LPS uptake by both cell types in the presence of serum .',\n",
       "    'PROTEIN']]],\n",
       " ['Cross - competition assays among the P - like elements revealed element - specific complex .',\n",
       "  [['Cross - competition assays among the P - like elements revealed <e1> element - specific complex </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Constitutive expression c - fos mrnais in nucleated fetal blood cells and up - regulation of c - fos and c - jun with anti - CD3 stimulation .',\n",
       "  [['Constitutive expression <e1> c - fos mrna </e1> is in nucleated fetal blood cells and up - regulation of c - fos and c - jun with anti - CD3 stimulation .',\n",
       "    'RNA']]],\n",
       " ['Constitutive expression c - jun mrnais in nucleated fetal blood cells and up - regulation of c - fos and c - jun with anti - CD3 stimulation .',\n",
       "  [['Constitutive expression <e1> c - jun mrna </e1> is in nucleated fetal blood cells and up - regulation of c - fos and c - jun with anti - CD3 stimulation .',\n",
       "    'RNA']]],\n",
       " [' fetal lymphocyteare relatively resistant to activation and cytokine production when stimulated either via their T - cell antigen receptors or lectins .',\n",
       "  [[' <e1> fetal lymphocyte </e1> are relatively resistant to activation and cytokine production when stimulated either via their T - cell antigen receptors or lectins .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Furthermore , PDTC differentially targeted both nfatp family member, inhibiting the transactivation functions of NFATp and mRNA induction of NFATc .',\n",
       "  [['Furthermore , PDTC differentially targeted both <e1> nfatp family member </e1> , inhibiting the transactivation functions of NFATp and mRNA induction of NFATc .',\n",
       "    'PROTEIN']]],\n",
       " ['The A - myb transcription factor in neoplastic b cell .',\n",
       "  [['The A - myb transcription factor in <e1> neoplastic b cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In previous experiments , the - 70 to - 65 regionof the CD11b promoter were shown to be essential for Sp1 - mediated activation of these genes .',\n",
       "  [['In previous experiments , the <e1> - 70 to - 65 region </e1> of the CD11b promoter were shown to be essential for Sp1 - mediated activation of these genes .',\n",
       "    'DNA']]],\n",
       " ['In previous experiments , the - 121 to - 103 regionof the CD11b promoter were shown to be essential for Sp1 - mediated activation of these genes .',\n",
       "  [['In previous experiments , the <e1> - 121 to - 103 region </e1> of the CD11b promoter were shown to be essential for Sp1 - mediated activation of these genes .',\n",
       "    'DNA']]],\n",
       " ['Deletion of both the - 70 to - 65 regionof the CD11c promoter resulted in the loss of activation by Sp3 .',\n",
       "  [['Deletion of both the <e1> - 70 to - 65 region </e1> of the CD11c promoter resulted in the loss of activation by Sp3 .',\n",
       "    'DNA']]],\n",
       " ['Deletion of both the - 121 to - 103 regionof the CD11c promoter resulted in the loss of activation by Sp3 .',\n",
       "  [['Deletion of both the <e1> - 121 to - 103 region </e1> of the CD11c promoter resulted in the loss of activation by Sp3 .',\n",
       "    'DNA']]],\n",
       " ['Antisense experiments that knocked out endogenous Sp3 expression in the myelomocytic cell line , HL60 , revealed that Sp3 participates in activation of the cd11c promoterin vivo .',\n",
       "  [['Antisense experiments that knocked out endogenous Sp3 expression in the myelomocytic cell line , HL60 , revealed that Sp3 participates in activation of the <e1> cd11c promoter </e1> in vivo .',\n",
       "    'DNA']]],\n",
       " ['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to gata sitein the H5 promoter and enhancer .',\n",
       "  [['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to <e1> gata site </e1> in the H5 promoter and enhancer .',\n",
       "    'DNA']]],\n",
       " ['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to GATA and CACCC sites in the h5 enhancer .',\n",
       "  [['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to GATA and CACCC sites in the <e1> h5 enhancer </e1> .',\n",
       "    'DNA']]],\n",
       " ['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to gata sitein the H5 promoter and enhancer .',\n",
       "  [['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to <e1> gata site </e1> in the H5 promoter and enhancer .',\n",
       "    'DNA']]],\n",
       " ['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to GATA and CACCC sites in the h5 enhancer .',\n",
       "  [['Using electrophoretic mobility shift assays , we found that in the presence of rabbit reticulocyte lysate , human ER reduced the binding activities of chicken immature erythrocyte nuclear extracted proteins to GATA and CACCC sites in the <e1> h5 enhancer </e1> .',\n",
       "    'DNA']]],\n",
       " ['Since the DSE and TRE sites can not bind CREB/ATF homodimers , we propose a mechanism in which the HIV - 1 DSE bind heterodimers composed of both ap - 1 protein .',\n",
       "  [['Since the DSE and TRE sites can not bind CREB/ATF homodimers , we propose a mechanism in which the HIV - 1 DSE bind heterodimers composed of both <e1> ap - 1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " [' c - rel subunitbind to an upstream NF - kappaB site in human granulocyte macrophage - colony stimulating factor promoter involved in phorbol ester response in 5637 cells .',\n",
       "  [[' <e1> c - rel subunit </e1> bind to an upstream NF - kappaB site in human granulocyte macrophage - colony stimulating factor promoter involved in phorbol ester response in 5637 cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Of these , the xpb geneencode proteins that are subunits of a general transcription factor , TFIIH , involved in both nucleotide excision repair ( NER ) and initiation of mRNA transcription by RNA polymerase II .',\n",
       "  [['Of these , the <e1> xpb gene </e1> encode proteins that are subunits of a general transcription factor , TFIIH , involved in both nucleotide excision repair ( NER ) and initiation of mRNA transcription by RNA polymerase II .',\n",
       "    'DNA']]],\n",
       " ['In humans , mutation of the xpb geneimpairs NER , resulting in hyper - sensitivity to sunlight and greatly increased skin tumor formation .',\n",
       "  [['In humans , mutation of the <e1> xpb gene </e1> impairs NER , resulting in hyper - sensitivity to sunlight and greatly increased skin tumor formation .',\n",
       "    'DNA']]],\n",
       " ['Although the growth rate was normal , the xp - b cellcontained reduced amounts of TFIIH .',\n",
       "  [['Although the growth rate was normal , the <e1> xp - b cell </e1> contained reduced amounts of TFIIH .',\n",
       "    'CELL_LINE']]],\n",
       " ['Although the growth rate was normal , the xp - d cellcontained reduced amounts of TFIIH .',\n",
       "  [['Although the growth rate was normal , the <e1> xp - d cell </e1> contained reduced amounts of TFIIH .',\n",
       "    'CELL_LINE']]],\n",
       " ['Extracts prepared from xp - b lymphoblastoid cellexhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells .',\n",
       "  [['Extracts prepared from <e1> xp - b lymphoblastoid cell </e1> exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['Extracts prepared from xp - d lymphoblastoid cellexhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells .',\n",
       "  [['Extracts prepared from <e1> xp - d lymphoblastoid cell </e1> exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells .',\n",
       "    'CELL_LINE']]],\n",
       " ['Thus , we conclude that the xp - b lymphoblastoid celldo not have impaired RNA transcription activity .',\n",
       "  [['Thus , we conclude that the <e1> xp - b lymphoblastoid cell </e1> do not have impaired RNA transcription activity .',\n",
       "    'CELL_LINE']]],\n",
       " ['Thus , we conclude that the xp - d lymphoblastoid celldo not have impaired RNA transcription activity .',\n",
       "  [['Thus , we conclude that the <e1> xp - d lymphoblastoid cell </e1> do not have impaired RNA transcription activity .',\n",
       "    'CELL_LINE']]],\n",
       " ['RESULTS : Here , we have isolated the murine cdnawhich encode a novel form of MZF protein ( MZF - 2 ) .',\n",
       "  [['RESULTS : Here , we have isolated the <e1> murine cdna </e1> which encode a novel form of MZF protein ( MZF - 2 ) .',\n",
       "    'DNA']]],\n",
       " [' murine mzf - 2 proteinconsisted of 814 and 775 amino acids , respectively , and have identity of 75.3 % between them .',\n",
       "  [[' <e1> murine mzf - 2 protein </e1> consisted of 814 and 775 amino acids , respectively , and have identity of 75.3 % between them .',\n",
       "    'PROTEIN']]],\n",
       " ['CONCLUSIONS : mzf - 1 mrnaseem to be produced by the alternative use of two different transcription initiation sites .',\n",
       "  [['CONCLUSIONS : <e1> mzf - 1 mrna </e1> seem to be produced by the alternative use of two different transcription initiation sites .',\n",
       "    'RNA']]],\n",
       " ['CONCLUSIONS : mzf - 2 mrnaseem to be produced by the alternative use of two different transcription initiation sites .',\n",
       "  [['CONCLUSIONS : <e1> mzf - 2 mrna </e1> seem to be produced by the alternative use of two different transcription initiation sites .',\n",
       "    'RNA']]],\n",
       " ['In mammalian cells , I kappa B alpha and I kappa B beta proteins have been purified and shown to be the inhibitors of NF - kappa B through their association with the p65 subunit .',\n",
       "  [['In mammalian cells , I kappa B alpha and I kappa B beta proteins have been purified and shown to be the inhibitors of NF - kappa B through their association with the <e1> p65 subunit </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Aberrant splicing of the tsg101 geneoccurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours .',\n",
       "  [['Aberrant splicing of the <e1> tsg101 gene </e1> occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours .',\n",
       "    'DNA']]],\n",
       " ['Our findings demonstrate that truncated tsg101 transcriptare commonly detected in both normal and malignant tissues and that a significant fraction of these are likely to be the result of aberrant splicing .',\n",
       "  [['Our findings demonstrate that <e1> truncated tsg101 transcript </e1> are commonly detected in both normal and malignant tissues and that a significant fraction of these are likely to be the result of aberrant splicing .',\n",
       "    'RNA']]],\n",
       " ['Our findings demonstrate that truncated fhit transcriptare commonly detected in both normal and malignant tissues and that a significant fraction of these are likely to be the result of aberrant splicing .',\n",
       "  [['Our findings demonstrate that <e1> truncated fhit transcript </e1> are commonly detected in both normal and malignant tissues and that a significant fraction of these are likely to be the result of aberrant splicing .',\n",
       "    'RNA']]],\n",
       " ['Inhibition of proliferation and apoptosis of human t lymphocyteby curcumin , a curry pigment .',\n",
       "  [['Inhibition of proliferation and apoptosis of <e1> human t lymphocyte </e1> by curcumin , a curry pigment .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Since AP - 1 is part of the NFAT complex , we conclude that the IL - 7 - signaling pathway is involved in the activation of the fos proteinof which AP - 1 consists .',\n",
       "  [['Since AP - 1 is part of the NFAT complex , we conclude that the IL - 7 - signaling pathway is involved in the activation of the <e1> fos protein </e1> of which AP - 1 consists .',\n",
       "    'PROTEIN']]],\n",
       " ['The visualization of heavy chain genein B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the gamma and lambda genes consistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "  [['The visualization of <e1> heavy chain gene </e1> in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the gamma and lambda genes consistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "    'DNA']]],\n",
       " ['The visualization of heavy and light chain genes in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the gamma geneconsistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "  [['The visualization of heavy and light chain genes in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the <e1> gamma gene </e1> consistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "    'DNA']]],\n",
       " ['The visualization of heavy chain genein B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the gamma and lambda genes consistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "  [['The visualization of <e1> heavy chain gene </e1> in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the gamma and lambda genes consistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "    'DNA']]],\n",
       " ['The visualization of heavy and light chain genes in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the gamma geneconsistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "  [['The visualization of heavy and light chain genes in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes : the kappa genes were found to be preferentially confined to an outer nuclear volume , whereas the <e1> gamma gene </e1> consistently occupied more central positions within the nucleus , the lambda genes being more interior when compared with the gamma genes .',\n",
       "    'DNA']]],\n",
       " ['The activity of A - MYB in b cellwas observed when either an artificial construct or the c - MYC promoter was used as a reporter .',\n",
       "  [['The activity of A - MYB in <e1> b cell </e1> was observed when either an artificial construct or the c - MYC promoter was used as a reporter .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Finally , a 110 - kDa protein has been identified in the nuclei of all the b cell linethat specifically binds to this A - MYB N - terminal domain .',\n",
       "  [['Finally , a 110 - kDa protein has been identified in the nuclei of all the <e1> b cell line </e1> that specifically binds to this A - MYB N - terminal domain .',\n",
       "    'CELL_LINE']]],\n",
       " ['Finally , a 110 - kDa protein has been identified in the nuclei of all the B , but not t cell linethat specifically binds to this A - MYB N - terminal domain .',\n",
       "  [['Finally , a 110 - kDa protein has been identified in the nuclei of all the B , but not <e1> t cell line </e1> that specifically binds to this A - MYB N - terminal domain .',\n",
       "    'CELL_LINE']]],\n",
       " [' polyclonal ctlthat were generated by stimulating peripheral blood mononuclear cells with an HLA B8+ homozygous LCL lysed T cell blasts pulsed with the peptide , RAKFKQLLQ ; lysis of certain HLA B8+ LCL targets was associated with the abundance of BZLF1 transcripts .',\n",
       "  [[' <e1> polyclonal ctl </e1> that were generated by stimulating peripheral blood mononuclear cells with an HLA B8+ homozygous LCL lysed T cell blasts pulsed with the peptide , RAKFKQLLQ ; lysis of certain HLA B8+ LCL targets was associated with the abundance of BZLF1 transcripts .',\n",
       "    'CELL_LINE']]],\n",
       " ['To define the CD40 signaling components upstream of NF - kappa B activation and the functional consequences downstream of NF - kappa B activation , we examined mouse B cell transfectants expressing wild - type cd40 .',\n",
       "  [['To define the CD40 signaling components upstream of NF - kappa B activation and the functional consequences downstream of NF - kappa B activation , we examined mouse B cell transfectants expressing <e1> wild - type cd40 </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and tumor necrosis factor tnf receptor i p55) and II ( p75 ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "  [['Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and <e1> tumor necrosis factor tnf receptor i p55 </e1> ) and II ( p75 ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and tumor necrosis factor tnf receptor ii p75) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "  [['Messenger RNA ( mRNA ) levels for the granulocyte - colony stimulating factor ( G - CSF ) receptor , granulocyte - macrophage ( GM ) - CSF receptor alpha subunit and <e1> tumor necrosis factor tnf receptor ii p75 </e1> ) were also detected in this subset in addition to c - kit and flt - 3 , receptors known to be expressed on progenitor cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon - gamma activation sequence ( GAS ) , and these complexes rapidly translocated ( within 1 min ) into the nucleus of il - 2 - treated cell .',\n",
       "  [['Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon - gamma activation sequence ( GAS ) , and these complexes rapidly translocated ( within 1 min ) into the nucleus of <e1> il - 2 - treated cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon - gamma activation sequence ( GAS ) , and these complexes rapidly translocated ( within 1 min ) into the nucleus of il - 7 - treated cell .',\n",
       "  [['Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon - gamma activation sequence ( GAS ) , and these complexes rapidly translocated ( within 1 min ) into the nucleus of <e1> il - 7 - treated cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Thus , our data establish that ATF/CREB factors functionally modulate histone H4 gene transcription at distal promoter element .',\n",
       "  [['Thus , our data establish that ATF/CREB factors functionally modulate histone H4 gene transcription at <e1> distal promoter element </e1> .',\n",
       "    'DNA']]],\n",
       " ['Finally , we speculate that molecular mimicry between one or more gliadin peptides and some , as yet unidentified , bacterial superantigenplays a role in disease pathogenesis .',\n",
       "  [['Finally , we speculate that molecular mimicry between one or more gliadin peptides and some , as yet unidentified , <e1> bacterial superantigen </e1> plays a role in disease pathogenesis .',\n",
       "    'PROTEIN']]],\n",
       " ['SR 31747A , defined as a sigma ligand , is a novel immunosuppressive agent that blocks proliferation of human lymphocyte .',\n",
       "  [['SR 31747A , defined as a sigma ligand , is a novel immunosuppressive agent that blocks proliferation of <e1> human lymphocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['In this study , we used a RT - PCR based approach to compare the stability of the big t allelein normal heterozygous lymphocytes and the heterozygous cell lines NB4 ( myeloid leukemia ) and PC - 3 and DU 145 ( prostate cancers ) .',\n",
       "  [['In this study , we used a RT - PCR based approach to compare the stability of the <e1> big t allele </e1> in normal heterozygous lymphocytes and the heterozygous cell lines NB4 ( myeloid leukemia ) and PC - 3 and DU 145 ( prostate cancers ) .',\n",
       "    'DNA']]],\n",
       " ['Differanisole A and 9 - cis retinoic acid ( 9cisRA ) synergistically inhibited the growth and induced functional and morphologic differentiation of hl - 60 cell, whereas the combined treatment with differanisole A and all - trans retinoic acid or 1alpha,25 - dihydroxyvitamin D3 was less effective .',\n",
       "  [['Differanisole A and 9 - cis retinoic acid ( 9cisRA ) synergistically inhibited the growth and induced functional and morphologic differentiation of <e1> hl - 60 cell </e1> , whereas the combined treatment with differanisole A and all - trans retinoic acid or 1alpha,25 - dihydroxyvitamin D3 was less effective .',\n",
       "    'CELL_LINE']]],\n",
       " ['In contrast , long - term treatment with oxLDL prevented the lipopolysaccharide - induced depletion of I kappa B - alpha , accompanied by an inhibition of both NF - kappa B activation and the expression of tumor necrosis factor - alpha gene .',\n",
       "  [['In contrast , long - term treatment with oxLDL prevented the lipopolysaccharide - induced depletion of I kappa B - alpha , accompanied by an inhibition of both NF - kappa B activation and the expression of <e1> tumor necrosis factor - alpha gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Among the regulatory promoter elements potentially regulating eotaxin gene expression and/or mediating the effects of anti - inflammatory drugs we identified consensus sequences known to interact with nuclear factors like NF - IL6 , AP - 1 , a NF - kappa - B like consensus sequence and gamma - interferon - response element .',\n",
       "  [['Among the regulatory promoter elements potentially regulating eotaxin gene expression and/or mediating the effects of anti - inflammatory drugs we identified consensus sequences known to interact with nuclear factors like NF - IL6 , AP - 1 , a NF - kappa - B like consensus sequence and <e1> gamma - interferon - response element </e1> .',\n",
       "    'DNA']]],\n",
       " ['Differential interaction of nuclear factors with the leukocyte - specific pp52 promoter in b cell .',\n",
       "  [['Differential interaction of nuclear factors with the leukocyte - specific pp52 promoter in <e1> b cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The leukocyte - specific , cytoskeleton - binding pp52 ( LSP - 1 , WP - 34 ) protein is widely expressed in multiple leukocyte lineages , including b lymphocyte, granulocytes , and macrophages .',\n",
       "  [['The leukocyte - specific , cytoskeleton - binding pp52 ( LSP - 1 , WP - 34 ) protein is widely expressed in multiple leukocyte lineages , including <e1> b lymphocyte </e1> , granulocytes , and macrophages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Here we describe the functional characterization of this promoter and identification of the factors in b cellthat regulate its activity .',\n",
       "  [['Here we describe the functional characterization of this promoter and identification of the factors in <e1> b cell </e1> that regulate its activity .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The pp52 promoter contains an initiator specifying the unique 5 terminus of pp52 mRNA , tandem pairs of ets motif .',\n",
       "  [['The pp52 promoter contains an initiator specifying the unique 5 terminus of pp52 mRNA , tandem pairs of <e1> ets motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['The pp52 promoter contains an initiator specifying the unique 5 terminus of pp52 mRNA , tandem pairs of Ets and sp1 motif .',\n",
       "  [['The pp52 promoter contains an initiator specifying the unique 5 terminus of pp52 mRNA , tandem pairs of Ets and <e1> sp1 motif </e1> .',\n",
       "    'DNA']]],\n",
       " ['These findings reveal the features controlling the pp52 promoter in b celland provide the foundation for determining the regulation of this promoter in other leukocyte lineages .',\n",
       "  [['These findings reveal the features controlling the pp52 promoter in <e1> b cell </e1> and provide the foundation for determining the regulation of this promoter in other leukocyte lineages .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The immediate - early gene product Egr - 1 regulates the human interleukin - 2 receptor beta - chain promoter through noncanonical egr binding site .',\n",
       "  [['The immediate - early gene product Egr - 1 regulates the human interleukin - 2 receptor beta - chain promoter through <e1> noncanonical egr binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['The immediate - early gene product Egr - 1 regulates the human interleukin - 2 receptor beta - chain promoter through noncanonical sp1 binding site .',\n",
       "  [['The immediate - early gene product Egr - 1 regulates the human interleukin - 2 receptor beta - chain promoter through <e1> noncanonical sp1 binding site </e1> .',\n",
       "    'DNA']]],\n",
       " ['The tcr alpha beta chainbind the peptide ligand , whereas the associated CD3 delta epsilon gamma and TCR zeta subunits couple the TCR to intracellular signal transduction components .',\n",
       "  [['The <e1> tcr alpha beta chain </e1> bind the peptide ligand , whereas the associated CD3 delta epsilon gamma and TCR zeta subunits couple the TCR to intracellular signal transduction components .',\n",
       "    'PROTEIN']]],\n",
       " ['The tcr gamma delta chainbind the peptide ligand , whereas the associated CD3 delta epsilon gamma and TCR zeta subunits couple the TCR to intracellular signal transduction components .',\n",
       "  [['The <e1> tcr gamma delta chain </e1> bind the peptide ligand , whereas the associated CD3 delta epsilon gamma and TCR zeta subunits couple the TCR to intracellular signal transduction components .',\n",
       "    'PROTEIN']]],\n",
       " ['In addition , in vivo footprint analysis showed the putative x boxto be occupied by transcription factors in wild - type B cells , but not in RFX - deficient B cells .',\n",
       "  [['In addition , in vivo footprint analysis showed the putative <e1> x box </e1> to be occupied by transcription factors in wild - type B cells , but not in RFX - deficient B cells .',\n",
       "    'DNA']]],\n",
       " ['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor - 3beta, - 3gamma , - 4gamma , and - 6 .',\n",
       "  [['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding <e1> hepatocyte nuclear factor - 3beta </e1> , - 3gamma , - 4gamma , and - 6 .',\n",
       "    'PROTEIN']]],\n",
       " ['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor - 3gamma, - 4gamma , and - 6 .',\n",
       "  [['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding <e1> hepatocyte nuclear factor - 3gamma </e1> , - 4gamma , and - 6 .',\n",
       "    'PROTEIN']]],\n",
       " ['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor - 4gamma, and - 6 .',\n",
       "  [['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding <e1> hepatocyte nuclear factor - 4gamma </e1> , and - 6 .',\n",
       "    'PROTEIN']]],\n",
       " ['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor - 6 .',\n",
       "  [['Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding <e1> hepatocyte nuclear factor - 6 </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['In this study , we show that hnf - 3beta, - 3gamma , - 4gamma , and - 6 are expressed in pancreatic beta - cells .',\n",
       "  [['In this study , we show that <e1> hnf - 3beta </e1> , - 3gamma , - 4gamma , and - 6 are expressed in pancreatic beta - cells .',\n",
       "    'PROTEIN']]],\n",
       " ['In this study , we show that hnf - 3gamma, - 4gamma , and - 6 are expressed in pancreatic beta - cells .',\n",
       "  [['In this study , we show that <e1> hnf - 3gamma </e1> , - 4gamma , and - 6 are expressed in pancreatic beta - cells .',\n",
       "    'PROTEIN']]],\n",
       " ['In this study , we show that hnf - 4gamma, and - 6 are expressed in pancreatic beta - cells .',\n",
       "  [['In this study , we show that <e1> hnf - 4gamma </e1> , and - 6 are expressed in pancreatic beta - cells .',\n",
       "    'PROTEIN']]],\n",
       " ['In this study , we show that hnf - 6are expressed in pancreatic beta - cells .',\n",
       "  [['In this study , we show that <e1> hnf - 6 </e1> are expressed in pancreatic beta - cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Our previous studies showed that the exposure of human monocytes to E. chaffeensis induces the expression of interleukin - 1beta ( IL - 1beta ) , IL - 8 , and IL - 10 genes in vitro but not the expression of tumor necrosis factor alpha tnf - alpha mrna .',\n",
       "  [['Our previous studies showed that the exposure of human monocytes to E. chaffeensis induces the expression of interleukin - 1beta ( IL - 1beta ) , IL - 8 , and IL - 10 genes in vitro but not the expression of <e1> tumor necrosis factor alpha tnf - alpha mrna </e1> .',\n",
       "    'RNA']]],\n",
       " ['The expression of tnf - alpha mrnawas also induced .',\n",
       "  [['The expression of <e1> tnf - alpha mrna </e1> was also induced .',\n",
       "    'RNA']]],\n",
       " ['During myelopoiesis , which includes the development of granulocytic lineage, transcription factors from several families are active , including AML1/CBF beta , C/EBP , Ets , c - Myb , HOX , and MZF - 1 .',\n",
       "  [['During myelopoiesis , which includes the development of <e1> granulocytic lineage </e1> , transcription factors from several families are active , including AML1/CBF beta , C/EBP , Ets , c - Myb , HOX , and MZF - 1 .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Stat ( signal transducers and activators of transcription ) and Jak ( Janus kinases ) proteins are central components in the signal transduction events in hematopoietic cell .',\n",
       "  [['Stat ( signal transducers and activators of transcription ) and Jak ( Janus kinases ) proteins are central components in the signal transduction events in <e1> hematopoietic cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Cis - acting elements with nfkappab - like binding motifhave been identified in the promoter region of the GM - CSF gene , and are important or essential for transcriptional activity following T cell activation .',\n",
       "  [['Cis - acting elements with <e1> nfkappab - like binding motif </e1> have been identified in the promoter region of the GM - CSF gene , and are important or essential for transcriptional activity following T cell activation .',\n",
       "    'DNA']]],\n",
       " ['Cis - acting elements with NFkappaB , ap1 - like binding motifhave been identified in the promoter region of the GM - CSF gene , and are important or essential for transcriptional activity following T cell activation .',\n",
       "  [['Cis - acting elements with NFkappaB , <e1> ap1 - like binding motif </e1> have been identified in the promoter region of the GM - CSF gene , and are important or essential for transcriptional activity following T cell activation .',\n",
       "    'DNA']]],\n",
       " ['The tandem cre siteare of major functional importance as judged by mutational and electrophoretic mobility shift analyses .',\n",
       "  [['The tandem <e1> cre site </e1> are of major functional importance as judged by mutational and electrophoretic mobility shift analyses .',\n",
       "    'DNA']]],\n",
       " ['NAC had no effect on the half - life of e - selectin mrna .',\n",
       "  [['NAC had no effect on the half - life of <e1> e - selectin mrna </e1> .',\n",
       "    'RNA']]],\n",
       " ['Human cytomegalovirus induces interleukin - 8 production by a human monocytic cell line , THP - 1 , through acting concurrently on ap - 1 - binding siteof the interleukin - 8 gene .',\n",
       "  [['Human cytomegalovirus induces interleukin - 8 production by a human monocytic cell line , THP - 1 , through acting concurrently on <e1> ap - 1 - binding site </e1> of the interleukin - 8 gene .',\n",
       "    'DNA']]],\n",
       " ['The functional analysis of the IL - 8 gene revealed that both ap - 1 - binding elementwere involved in conferring the responsiveness to CMV .',\n",
       "  [['The functional analysis of the IL - 8 gene revealed that both <e1> ap - 1 - binding element </e1> were involved in conferring the responsiveness to CMV .',\n",
       "    'DNA']]],\n",
       " ['By transfecting tumor cells with both il - 12 cdna, it may be possible to use these modified targets as vaccines .',\n",
       "  [['By transfecting tumor cells with both <e1> il - 12 cdna </e1> , it may be possible to use these modified targets as vaccines .',\n",
       "    'DNA']]],\n",
       " ['The chimeric oncoprotein E2a - Pbx1 results from fusion of the e2a genefollowing t(1;19) chromosomal translocations in B cell precursor acute leukemias .',\n",
       "  [['The chimeric oncoprotein E2a - Pbx1 results from fusion of the <e1> e2a gene </e1> following t(1;19) chromosomal translocations in B cell precursor acute leukemias .',\n",
       "    'DNA']]],\n",
       " ['In DNA - protein binding studies , we detected the binding of transcription factors gabp - betato a dyad symmetry element ( DSE ) of the distal enhancer , which is formed by palindromic binding sites of Ets - like factors .',\n",
       "  [['In DNA - protein binding studies , we detected the binding of transcription factors <e1> gabp - beta </e1> to a dyad symmetry element ( DSE ) of the distal enhancer , which is formed by palindromic binding sites of Ets - like factors .',\n",
       "    'PROTEIN']]],\n",
       " ['In addition , LPS stimulation induced the binding of cognate nuclear factors to the egr - 1 site, which were identified as Egr - 1 and p50/p65 , respectively .',\n",
       "  [['In addition , LPS stimulation induced the binding of cognate nuclear factors to the <e1> egr - 1 site </e1> , which were identified as Egr - 1 and p50/p65 , respectively .',\n",
       "    'DNA']]],\n",
       " ['The cre sitein region II together conferred strong LPS responsiveness to a heterologous promoter , whereas individually they failed to provide transcriptional activation .',\n",
       "  [['The <e1> cre site </e1> in region II together conferred strong LPS responsiveness to a heterologous promoter , whereas individually they failed to provide transcriptional activation .',\n",
       "    'DNA']]],\n",
       " ['We found that IL - 2 , interferon - alpha ( IFN - alpha ) , and IFN - beta inhibited IL - 2 deprivation apoptosis in th0 clone .',\n",
       "  [['We found that IL - 2 , interferon - alpha ( IFN - alpha ) , and IFN - beta inhibited IL - 2 deprivation apoptosis in <e1> th0 clone </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['We found that IL - 2 , interferon - alpha ( IFN - alpha ) , and IFN - beta inhibited IL - 2 deprivation apoptosis in Th0 , th1 clone .',\n",
       "  [['We found that IL - 2 , interferon - alpha ( IFN - alpha ) , and IFN - beta inhibited IL - 2 deprivation apoptosis in Th0 , <e1> th1 clone </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Our present study shows that ifn - betamediate anti - apoptotic effect through other pathways than that of IL - 2 in growth factor deprivation apoptosis .',\n",
       "  [['Our present study shows that <e1> ifn - beta </e1> mediate anti - apoptotic effect through other pathways than that of IL - 2 in growth factor deprivation apoptosis .',\n",
       "    'PROTEIN']]],\n",
       " ['Analysis of phosphotyrosine - containing proteins bound to truncated p85 constructs revealed cooperative binding of the two SH2 domains but no apparent differences between the n - terminal sh2 domain .',\n",
       "  [['Analysis of phosphotyrosine - containing proteins bound to truncated p85 constructs revealed cooperative binding of the two SH2 domains but no apparent differences between the <e1> n - terminal sh2 domain </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Constitutive and inducible protein/DNA interactions of the interferon - gamma promoter in vivo in [ corrected ] cd45ra t helper subset[ published erratum appears in Eur J Immunol 1997 Jul ; 27 ( 7 ) : 1830 .',\n",
       "  [['Constitutive and inducible protein/DNA interactions of the interferon - gamma promoter in vivo in [ corrected ] <e1> cd45ra t helper subset </e1> [ published erratum appears in Eur J Immunol 1997 Jul ; 27 ( 7 ) : 1830 .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Accordingly , Jurkat T cells and primary cd45ra cd4+ t cell subsetisolated from peripheral blood using immunomagnetic beads were cultured and analyzed by LM - PCR .',\n",
       "  [['Accordingly , Jurkat T cells and <e1> primary cd45ra cd4+ t cell subset </e1> isolated from peripheral blood using immunomagnetic beads were cultured and analyzed by LM - PCR .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Accordingly , Jurkat T cells and primary cd45r0 cd4+ t cell subsetisolated from peripheral blood using immunomagnetic beads were cultured and analyzed by LM - PCR .',\n",
       "  [['Accordingly , Jurkat T cells and <e1> primary cd45r0 cd4+ t cell subset </e1> isolated from peripheral blood using immunomagnetic beads were cultured and analyzed by LM - PCR .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Interestingly , an inducible footprint between - 183 and - 196 was consistently observed in Jurkat T cells and cd45ra t helper subsetupon stimulation with phorbol 12 - myristate 13 - acetate + phytohemagglutinin ( PMA + PHA ) that was highly sensitive to treatment with corticosteroids .',\n",
       "  [['Interestingly , an inducible footprint between - 183 and - 196 was consistently observed in Jurkat T cells and <e1> cd45ra t helper subset </e1> upon stimulation with phorbol 12 - myristate 13 - acetate + phytohemagglutinin ( PMA + PHA ) that was highly sensitive to treatment with corticosteroids .',\n",
       "    'CELL_TYPE']]],\n",
       " ['ZEBRA activation can be replaced by a heterologous acidic activation domain .',\n",
       "  [['ZEBRA activation can be replaced by a <e1> heterologous acidic activation domain </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['ZEBRA activation can be replaced by a heterologous proline - rich activation domain .',\n",
       "  [['ZEBRA activation can be replaced by a <e1> heterologous proline - rich activation domain </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['ZEBRA activation can be replaced by a heterologous glutamine - rich activation domain .',\n",
       "  [['ZEBRA activation can be replaced by a <e1> heterologous glutamine - rich activation domain </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['To better understand the AP - 1 - dependent luciferase expression in Jurkat T cells , we tested two specific inhibitors of serine/threonine phosphatase - 2a: okadaic acid and calyculin A .',\n",
       "  [['To better understand the AP - 1 - dependent luciferase expression in Jurkat T cells , we tested two specific inhibitors of <e1> serine/threonine phosphatase - 2a </e1> : okadaic acid and calyculin A .',\n",
       "    'PROTEIN']]],\n",
       " ['Moderate ubiquitous activation is further induced by creb/atf factorthrough proximal upstream elements .',\n",
       "  [['Moderate ubiquitous activation is further induced by <e1> creb/atf factor </e1> through proximal upstream elements .',\n",
       "    'PROTEIN']]],\n",
       " ['The biologic actions of GM - CSF are mediated by binding to a specific receptor consisting of two chains designated as alpha subunit .',\n",
       "  [['The biologic actions of GM - CSF are mediated by binding to a specific receptor consisting of two chains designated as <e1> alpha subunit </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the human gm - csf receptor alpha subunit( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "  [['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the <e1> human gm - csf receptor alpha subunit </e1> ( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "    'PROTEIN']]],\n",
       " ['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the human gm - csf receptor beta subunit( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "  [['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the <e1> human gm - csf receptor beta subunit </e1> ( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "    'PROTEIN']]],\n",
       " ['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the human gm - csf receptor alpha subunit( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "  [['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the <e1> human gm - csf receptor alpha subunit </e1> ( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "    'PROTEIN']]],\n",
       " ['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the human gm - csf receptor beta subunit( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "  [['We have demonstrated that the murine FDC - P1 - derived cell line WT - 19 transfected with the <e1> human gm - csf receptor beta subunit </e1> ( GM - CSFR alpha and beta ) can be induced to differentiate by the addition of human GM - CSF ( hGM - CSF ) .',\n",
       "    'PROTEIN']]],\n",
       " ['An enhancer - blocking element between alpha gene segmentwithin the human T cell receptor alpha/delta locus .',\n",
       "  [['An enhancer - blocking element between <e1> alpha gene segment </e1> within the human T cell receptor alpha/delta locus .',\n",
       "    'DNA']]],\n",
       " ['Involvement of rel proteinin binding activity to the IL - 2 promoter CD28 response element/ AP - 1 sequence in human T cells .',\n",
       "  [['Involvement of <e1> rel protein </e1> in binding activity to the IL - 2 promoter CD28 response element/ AP - 1 sequence in human T cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Involvement of Rel , fos proteinin binding activity to the IL - 2 promoter CD28 response element/ AP - 1 sequence in human T cells .',\n",
       "  [['Involvement of Rel , <e1> fos protein </e1> in binding activity to the IL - 2 promoter CD28 response element/ AP - 1 sequence in human T cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Patients with one type of major histocompatibility complex class II combined immunodeficiency have mutations in a gene termed class II transactivator ( CIITA ) , which coordinately controls the transcription of the three major human class II genes , hla - dq, and - DP .',\n",
       "  [['Patients with one type of major histocompatibility complex class II combined immunodeficiency have mutations in a gene termed class II transactivator ( CIITA ) , which coordinately controls the transcription of the three major human class II genes , <e1> hla - dq </e1> , and - DP .',\n",
       "    'DNA']]],\n",
       " ['Patients with one type of major histocompatibility complex class II combined immunodeficiency have mutations in a gene termed class II transactivator ( CIITA ) , which coordinately controls the transcription of the three major human class II genes , hla - dp .',\n",
       "  [['Patients with one type of major histocompatibility complex class II combined immunodeficiency have mutations in a gene termed class II transactivator ( CIITA ) , which coordinately controls the transcription of the three major human class II genes , <e1> hla - dp </e1> .',\n",
       "    'DNA']]],\n",
       " ['We show that ligand - induced homodimerization of chimeric surface receptors consisting of the extracellular domainof IL - 4Ralpha induces Janus kinase 1 ( Jak1 ) activation , STAT6 activation , and Cepsilon germline transcripts in human B cell line BJAB .',\n",
       "  [['We show that ligand - induced homodimerization of chimeric surface receptors consisting of the <e1> extracellular domain </e1> of IL - 4Ralpha induces Janus kinase 1 ( Jak1 ) activation , STAT6 activation , and Cepsilon germline transcripts in human B cell line BJAB .',\n",
       "    'PROTEIN']]],\n",
       " ['We show that ligand - induced homodimerization of chimeric surface receptors consisting of the extracellular and transmembrane domainof IL - 4Ralpha induces Janus kinase 1 ( Jak1 ) activation , STAT6 activation , and Cepsilon germline transcripts in human B cell line BJAB .',\n",
       "  [['We show that ligand - induced homodimerization of chimeric surface receptors consisting of the extracellular and <e1> transmembrane domain </e1> of IL - 4Ralpha induces Janus kinase 1 ( Jak1 ) activation , STAT6 activation , and Cepsilon germline transcripts in human B cell line BJAB .',\n",
       "    'PROTEIN']]],\n",
       " ['Gel shift assays demonstrated SP1 and Egr - 1 binding to the CD19 GC box , while unknown nuclear proteins bound the pyg box .',\n",
       "  [['Gel shift assays demonstrated SP1 and Egr - 1 binding to the CD19 GC box , while unknown nuclear proteins bound the <e1> pyg box </e1> .',\n",
       "    'DNA']]],\n",
       " ['BSAP failed to trans - activate CD19 promoter constructs in B cells or non - B cells , suggesting that cis elements such as the pyg boxare also necessary for high level CD19 promoter expression .',\n",
       "  [['BSAP failed to trans - activate CD19 promoter constructs in B cells or non - B cells , suggesting that cis elements such as the <e1> pyg box </e1> are also necessary for high level CD19 promoter expression .',\n",
       "    'DNA']]],\n",
       " ['Multiple functionally important ebf binding sitewere identified in the lambda5 promoter/enhancer region , indicating that lambda5 is a direct genetic target for these transcription factors .',\n",
       "  [['Multiple functionally important <e1> ebf binding site </e1> were identified in the lambda5 promoter/enhancer region , indicating that lambda5 is a direct genetic target for these transcription factors .',\n",
       "    'DNA']]],\n",
       " ['That the signal transduction pathways used by the cytokines IL - 2 and IL - 15 are identical would suggest that these cytokines have redundant roles in lymphoid development ; instead , IL - 2 is the guardian of thymus - derived T - cell homeostasis , while interleukin - 15 promotes extrathymic development of t cell .',\n",
       "  [['That the signal transduction pathways used by the cytokines IL - 2 and IL - 15 are identical would suggest that these cytokines have redundant roles in lymphoid development ; instead , IL - 2 is the guardian of thymus - derived T - cell homeostasis , while interleukin - 15 promotes extrathymic development of <e1> t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To test this latter possibility , a chimeric receptor containing the extracellular domain of c - kit ( the stem cell factor ( SCF ) receptor ) and the cytoplasmic domainof the IL - 4R alpha chain was generated .',\n",
       "  [['To test this latter possibility , a chimeric receptor containing the extracellular domain of c - kit ( the stem cell factor ( SCF ) receptor ) and the <e1> cytoplasmic domain </e1> of the IL - 4R alpha chain was generated .',\n",
       "    'PROTEIN']]],\n",
       " ['We examined the effects of histamine and its agonists on the expression of the c - fos proto - oncogeneat the transcriptional and translational levels in the human promonocytic U937 cell line .',\n",
       "  [['We examined the effects of histamine and its agonists on the expression of the <e1> c - fos proto - oncogene </e1> at the transcriptional and translational levels in the human promonocytic U937 cell line .',\n",
       "    'DNA']]],\n",
       " ['We examined the effects of histamine and its agonists on the expression of the c - myc proto - oncogeneat the transcriptional and translational levels in the human promonocytic U937 cell line .',\n",
       "  [['We examined the effects of histamine and its agonists on the expression of the <e1> c - myc proto - oncogene </e1> at the transcriptional and translational levels in the human promonocytic U937 cell line .',\n",
       "    'DNA']]],\n",
       " ['The work strongly suggests that EBV - replicative lesions are subject to direct CTL control in vivo and that immediate early proteinare frequently the immunodominant targets .',\n",
       "  [['The work strongly suggests that EBV - replicative lesions are subject to direct CTL control in vivo and that <e1> immediate early protein </e1> are frequently the immunodominant targets .',\n",
       "    'PROTEIN']]],\n",
       " ['The work strongly suggests that EBV - replicative lesions are subject to direct CTL control in vivo and that immediate early proteinare frequently the immunodominant targets .',\n",
       "  [['The work strongly suggests that EBV - replicative lesions are subject to direct CTL control in vivo and that immediate <e1> early protein </e1> are frequently the immunodominant targets .',\n",
       "    'PROTEIN']]],\n",
       " ['This contrasts with findings in alpha - and beta - herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen - processing pathway during lytic infection renders immediate early proteinmuch less immunogenic .',\n",
       "  [['This contrasts with findings in alpha - and beta - herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen - processing pathway during lytic infection renders <e1> immediate early protein </e1> much less immunogenic .',\n",
       "    'PROTEIN']]],\n",
       " ['This contrasts with findings in alpha - and beta - herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen - processing pathway during lytic infection renders immediate early proteinmuch less immunogenic .',\n",
       "  [['This contrasts with findings in alpha - and beta - herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen - processing pathway during lytic infection renders immediate <e1> early protein </e1> much less immunogenic .',\n",
       "    'PROTEIN']]],\n",
       " ['Transcription factor GATA - 3 is differentially expressed in murine th1 celland controls Th2 - specific expression of the interleukin - 5 gene .',\n",
       "  [['Transcription factor GATA - 3 is differentially expressed in <e1> murine th1 cell </e1> and controls Th2 - specific expression of the interleukin - 5 gene .',\n",
       "    'CELL_LINE']]],\n",
       " ['Transcription factor GATA - 3 is differentially expressed in murine th2 celland controls Th2 - specific expression of the interleukin - 5 gene .',\n",
       "  [['Transcription factor GATA - 3 is differentially expressed in <e1> murine th2 cell </e1> and controls Th2 - specific expression of the interleukin - 5 gene .',\n",
       "    'CELL_LINE']]],\n",
       " ['We previously established a critical role for the transcription factor GATA - 3 in IL - 5 promoter activation in EL - 4 cells , which express both th1 - type cytokine .',\n",
       "  [['We previously established a critical role for the transcription factor GATA - 3 in IL - 5 promoter activation in EL - 4 cells , which express both <e1> th1 - type cytokine </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Cross - linking of the cd3 moleculeon T lymphocytes represents one of the most effective signals for T lymphocyte activation and triggering of their cytotoxic effector function .',\n",
       "  [['Cross - linking of the <e1> cd3 molecule </e1> on T lymphocytes represents one of the most effective signals for T lymphocyte activation and triggering of their cytotoxic effector function .',\n",
       "    'PROTEIN']]],\n",
       " ['We show for human Jurkat T leukemia cells , as well as human primary t lymphocyte, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c - Rel , RelA/p65 and NF - kappa B1/p50 , whereas the nuclear appearance of RelB remains unaffected .',\n",
       "  [['We show for human Jurkat T leukemia cells , as well as <e1> human primary t lymphocyte </e1> , that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c - Rel , RelA/p65 and NF - kappa B1/p50 , whereas the nuclear appearance of RelB remains unaffected .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Administration of dexamethasone to temporal artery - SCID chimeras for 1 wk induced a partial suppression of T cell and macrophage function as indicated by the reduced tissue concentrations of il - 2 mrna, and by the diminished expression of inducible NO synthase .',\n",
       "  [['Administration of dexamethasone to temporal artery - SCID chimeras for 1 wk induced a partial suppression of T cell and macrophage function as indicated by the reduced tissue concentrations of <e1> il - 2 mrna </e1> , and by the diminished expression of inducible NO synthase .',\n",
       "    'RNA']]],\n",
       " ['Administration of dexamethasone to temporal artery - SCID chimeras for 1 wk induced a partial suppression of T cell and macrophage function as indicated by the reduced tissue concentrations of il - 1beta mrna, and by the diminished expression of inducible NO synthase .',\n",
       "  [['Administration of dexamethasone to temporal artery - SCID chimeras for 1 wk induced a partial suppression of T cell and macrophage function as indicated by the reduced tissue concentrations of <e1> il - 1beta mrna </e1> , and by the diminished expression of inducible NO synthase .',\n",
       "    'RNA']]],\n",
       " ['Administration of dexamethasone to temporal artery - SCID chimeras for 1 wk induced a partial suppression of T cell and macrophage function as indicated by the reduced tissue concentrations of il - 6 mrna, and by the diminished expression of inducible NO synthase .',\n",
       "  [['Administration of dexamethasone to temporal artery - SCID chimeras for 1 wk induced a partial suppression of T cell and macrophage function as indicated by the reduced tissue concentrations of <e1> il - 6 mrna </e1> , and by the diminished expression of inducible NO synthase .',\n",
       "    'RNA']]],\n",
       " ['Western and supershift analyses indicated that functional jun proteinwere present in nuclear extracts of PMA - differentiated U937 cells .',\n",
       "  [['Western and supershift analyses indicated that <e1> functional jun protein </e1> were present in nuclear extracts of PMA - differentiated U937 cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Western and supershift analyses indicated that functional fos proteinwere present in nuclear extracts of PMA - differentiated U937 cells .',\n",
       "  [['Western and supershift analyses indicated that <e1> functional fos protein </e1> were present in nuclear extracts of PMA - differentiated U937 cells .',\n",
       "    'PROTEIN']]],\n",
       " ['Both truncated forms also bound to the transcription factor RBP - Jkappa in extracts prepared from human t - all cell line .',\n",
       "  [['Both truncated forms also bound to the transcription factor RBP - Jkappa in extracts prepared from <e1> human t - all cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Biochemical analysis by Western blotting of fetal hematopoietic populationshows several runt isoforms .',\n",
       "  [['Biochemical analysis by Western blotting of <e1> fetal hematopoietic population </e1> shows several runt isoforms .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Upregulation of c - Fos in activated t lymphoid cellby human immunodeficiency virus - 1 Tat protein .',\n",
       "  [['Upregulation of c - Fos in <e1> activated t lymphoid cell </e1> by human immunodeficiency virus - 1 Tat protein .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Upregulation of c - Fos in activated monocytic cellby human immunodeficiency virus - 1 Tat protein .',\n",
       "  [['Upregulation of c - Fos in <e1> activated monocytic cell </e1> by human immunodeficiency virus - 1 Tat protein .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To get further insights into the molecular mechanisms underlying the biological activity of Tat , we investigated the effect of endogenous and exogenous Tat protein on c - fos gene expression in t lymphoblastoid jurkat cell line, as well as in primary peripheral blood mononuclear cells ( PBMC ) .',\n",
       "  [['To get further insights into the molecular mechanisms underlying the biological activity of Tat , we investigated the effect of endogenous and exogenous Tat protein on c - fos gene expression in <e1> t lymphoblastoid jurkat cell line </e1> , as well as in primary peripheral blood mononuclear cells ( PBMC ) .',\n",
       "    'CELL_LINE']]],\n",
       " ['To get further insights into the molecular mechanisms underlying the biological activity of Tat , we investigated the effect of endogenous and exogenous Tat protein on c - fos gene expression in T lymphoblastoid ( Jurkat ) and monocytic u937 cell line, as well as in primary peripheral blood mononuclear cells ( PBMC ) .',\n",
       "  [['To get further insights into the molecular mechanisms underlying the biological activity of Tat , we investigated the effect of endogenous and exogenous Tat protein on c - fos gene expression in T lymphoblastoid ( Jurkat ) and <e1> monocytic u937 cell line </e1> , as well as in primary peripheral blood mononuclear cells ( PBMC ) .',\n",
       "    'CELL_LINE']]],\n",
       " ['Cytokines control growth , differentiation , death , and function of cells of lymphocytic system, and together with nerve cells provide a pertinent model to study intercellular communications and intercellular signal networks .',\n",
       "  [['Cytokines control growth , differentiation , death , and function of cells of <e1> lymphocytic system </e1> , and together with nerve cells provide a pertinent model to study intercellular communications and intercellular signal networks .',\n",
       "    'CELL_TYPE']]],\n",
       " ['NF - kappa B/Rel proteins have been shown to physically interact with both ap - 1 protein .',\n",
       "  [['NF - kappa B/Rel proteins have been shown to physically interact with both <e1> ap - 1 protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The two AP - 1 sites bound c - Fos /c - Jun heterodimers in both unstimulated cell .',\n",
       "  [['The two AP - 1 sites bound c - Fos /c - Jun heterodimers in both <e1> unstimulated cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Electrophoretic mobility shift ( EMS ) analyses utilizing oligonucleotides homologous to each of the 21 bp repeat elements reacted with nuclear extracts derived from cell lines of lymphocytic cell originhave demonstrated differential binding of cellular factors to the three 21 bp repeats ( 1 - 4 ) .',\n",
       "  [['Electrophoretic mobility shift ( EMS ) analyses utilizing oligonucleotides homologous to each of the 21 bp repeat elements reacted with nuclear extracts derived from cell lines of <e1> lymphocytic cell origin </e1> have demonstrated differential binding of cellular factors to the three 21 bp repeats ( 1 - 4 ) .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Electrophoretic mobility shift ( EMS ) analyses utilizing oligonucleotides homologous to each of the 21 bp repeat elements reacted with nuclear extracts derived from cell lines of lymphocytic , monocytic cell originhave demonstrated differential binding of cellular factors to the three 21 bp repeats ( 1 - 4 ) .',\n",
       "  [['Electrophoretic mobility shift ( EMS ) analyses utilizing oligonucleotides homologous to each of the 21 bp repeat elements reacted with nuclear extracts derived from cell lines of lymphocytic , <e1> monocytic cell origin </e1> have demonstrated differential binding of cellular factors to the three 21 bp repeats ( 1 - 4 ) .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Electrophoretic mobility shift ( EMS ) analyses utilizing oligonucleotides homologous to each of the 21 bp repeat elements reacted with nuclear extracts derived from cell lines of lymphocytic , monocytic , neuronal cell originhave demonstrated differential binding of cellular factors to the three 21 bp repeats ( 1 - 4 ) .',\n",
       "  [['Electrophoretic mobility shift ( EMS ) analyses utilizing oligonucleotides homologous to each of the 21 bp repeat elements reacted with nuclear extracts derived from cell lines of lymphocytic , monocytic , <e1> neuronal cell origin </e1> have demonstrated differential binding of cellular factors to the three 21 bp repeats ( 1 - 4 ) .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Unlike this physiologically relevant stimulation , PHA stimulates productive LAI replication in both naive t cell .',\n",
       "  [['Unlike this physiologically relevant stimulation , PHA stimulates productive LAI replication in both <e1> naive t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Transcription factor E2F binds to cellular promoters of certain growth - controlling geneand forms distinct heteromeric complexes with other nuclear proteins .',\n",
       "  [['Transcription factor E2F binds to cellular promoters of certain <e1> growth - controlling gene </e1> and forms distinct heteromeric complexes with other nuclear proteins .',\n",
       "    'DNA']]],\n",
       " ['In addition , RNase protection assays revealed that anti - CD3/ PMA - stimulated T cells from a substantial proportion of elderly subjects exhibited decreased levels of c - fos mrnacompared to T cells from young subjects .',\n",
       "  [['In addition , RNase protection assays revealed that anti - CD3/ PMA - stimulated T cells from a substantial proportion of elderly subjects exhibited decreased levels of <e1> c - fos mrna </e1> compared to T cells from young subjects .',\n",
       "    'RNA']]],\n",
       " ['In addition , RNase protection assays revealed that anti - CD3/ PMA - stimulated T cells from a substantial proportion of elderly subjects exhibited decreased levels of c - jun mrnacompared to T cells from young subjects .',\n",
       "  [['In addition , RNase protection assays revealed that anti - CD3/ PMA - stimulated T cells from a substantial proportion of elderly subjects exhibited decreased levels of <e1> c - jun mrna </e1> compared to T cells from young subjects .',\n",
       "    'RNA']]],\n",
       " ['Using electrophoretic mobility shift assays , the levels of nuclear regulatory proteins recognizing the AP - 1 consensus TRE motif , the proximal c - jun TRE - like promoter element , and the c - fos serum response element ( SRE ) were determined in resting t cell .',\n",
       "  [['Using electrophoretic mobility shift assays , the levels of nuclear regulatory proteins recognizing the AP - 1 consensus TRE motif , the proximal c - jun TRE - like promoter element , and the c - fos serum response element ( SRE ) were determined in <e1> resting t cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Although the stimulation of T cells from young subjects resulted in coordinated increases of nuclear protein complexes binding the AP - 1 TRE , c - jun TRE , and c - fos SRE DNA sequence motifs , age - related reductions in the activation of AP - 1 were accompanied by decreased levels of c - jun tre binding complex .',\n",
       "  [['Although the stimulation of T cells from young subjects resulted in coordinated increases of nuclear protein complexes binding the AP - 1 TRE , c - jun TRE , and c - fos SRE DNA sequence motifs , age - related reductions in the activation of AP - 1 were accompanied by decreased levels of <e1> c - jun tre binding complex </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Although the stimulation of T cells from young subjects resulted in coordinated increases of nuclear protein complexes binding the AP - 1 TRE , c - jun TRE , and c - fos SRE DNA sequence motifs , age - related reductions in the activation of AP - 1 were accompanied by decreased levels of c - fos sre binding complex .',\n",
       "  [['Although the stimulation of T cells from young subjects resulted in coordinated increases of nuclear protein complexes binding the AP - 1 TRE , c - jun TRE , and c - fos SRE DNA sequence motifs , age - related reductions in the activation of AP - 1 were accompanied by decreased levels of <e1> c - fos sre binding complex </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['BACKGROUND : The immediate early genes ( IE ) of human cytomegalovirus ( CMV ) can be expressed in monocytic cells and are known to regulate viral gene .',\n",
       "  [['BACKGROUND : The immediate early genes ( IE ) of human cytomegalovirus ( CMV ) can be expressed in monocytic cells and are known to regulate <e1> viral gene </e1> .',\n",
       "    'DNA']]],\n",
       " ['Cotransfection of CMV IE genes and il - 6 chloramphenicol acetyl transferase cat constructwere used to study IL - 6 promoter activity .',\n",
       "  [['Cotransfection of CMV IE genes and <e1> il - 6 chloramphenicol acetyl transferase cat construct </e1> were used to study IL - 6 promoter activity .',\n",
       "    'DNA']]],\n",
       " ['Cotransfection of CMV IE genes and il - 6 luciferase constructwere used to study IL - 6 promoter activity .',\n",
       "  [['Cotransfection of CMV IE genes and <e1> il - 6 luciferase construct </e1> were used to study IL - 6 promoter activity .',\n",
       "    'DNA']]],\n",
       " [' nuclear rel - a protein complexare differentially distributed within human thymocytes .',\n",
       "  [[' <e1> nuclear rel - a protein complex </e1> are differentially distributed within human thymocytes .',\n",
       "    'PROTEIN']]],\n",
       " [' nuclear c - rel protein complexare differentially distributed within human thymocytes .',\n",
       "  [[' <e1> nuclear c - rel protein complex </e1> are differentially distributed within human thymocytes .',\n",
       "    'PROTEIN']]],\n",
       " ['In the present report , we identified NF - kappa B proteins extracted from human thymocyte nuclei as being p50/p65 complex .',\n",
       "  [['In the present report , we identified NF - kappa B proteins extracted from human thymocyte nuclei as being <e1> p50/p65 complex </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['p65 , p50 , and c - Rel activities were found in both cd4 - positive thymocyte .',\n",
       "  [['p65 , p50 , and c - Rel activities were found in both <e1> cd4 - positive thymocyte </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These observations suggest that p65 complexplay distinct roles in gene expression and that both forms of NF - kappa B play critical roles during late stages of the intrathymic maturation of T cells .',\n",
       "  [['These observations suggest that <e1> p65 complex </e1> play distinct roles in gene expression and that both forms of NF - kappa B play critical roles during late stages of the intrathymic maturation of T cells .',\n",
       "    'PROTEIN']]],\n",
       " ['AML1 may play a role in growth and differentiation of cells along erythroid lineage, because a significant level of the AML1 gene is expressed in these cells .',\n",
       "  [['AML1 may play a role in growth and differentiation of cells along <e1> erythroid lineage </e1> , because a significant level of the AML1 gene is expressed in these cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['The influence of the anti - allergy agent azelastine hydrochloride ( Azeptin ) on NF - kappa B activation associated with the generation of cytokines and nitric oxide ( NO ) was investigated in various kinds of human cell .',\n",
       "  [['The influence of the anti - allergy agent azelastine hydrochloride ( Azeptin ) on NF - kappa B activation associated with the generation of cytokines and nitric oxide ( NO ) was investigated in various kinds of <e1> human cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['To investigate the mechanisms responsible for tissue - specific expression of the IL - 4 gene , we analyzed nuclear factors binding to the PRE - I site and compared the binding activities of these factors to the IL - 4 promoter of th1 cell .',\n",
       "  [['To investigate the mechanisms responsible for tissue - specific expression of the IL - 4 gene , we analyzed nuclear factors binding to the PRE - I site and compared the binding activities of these factors to the IL - 4 promoter of <e1> th1 cell </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Gene inactivation studies on the pu.1 genehave revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "  [['Gene inactivation studies on the <e1> pu.1 gene </e1> have revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "    'DNA']]],\n",
       " ['Gene inactivation studies on the PU.1 , ikaros genehave revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "  [['Gene inactivation studies on the PU.1 , <e1> ikaros gene </e1> have revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "    'DNA']]],\n",
       " ['Gene inactivation studies on the PU.1 , Ikaros and GATA - 3 genes have revealed that their encoded factors are essential for the earliest commitment step into the b lymphoid lineage .',\n",
       "  [['Gene inactivation studies on the PU.1 , Ikaros and GATA - 3 genes have revealed that their encoded factors are essential for the earliest commitment step into the <e1> b lymphoid lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['Gene inactivation studies on the pu.1 genehave revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "  [['Gene inactivation studies on the <e1> pu.1 gene </e1> have revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "    'DNA']]],\n",
       " ['Gene inactivation studies on the PU.1 , ikaros genehave revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "  [['Gene inactivation studies on the PU.1 , <e1> ikaros gene </e1> have revealed that their encoded factors are essential for the earliest commitment step into the B and T lymphoid lineages .',\n",
       "    'DNA']]],\n",
       " ['Gene inactivation studies on the PU.1 , Ikaros and GATA - 3 genes have revealed that their encoded factors are essential for the earliest commitment step into the b lymphoid lineage .',\n",
       "  [['Gene inactivation studies on the PU.1 , Ikaros and GATA - 3 genes have revealed that their encoded factors are essential for the earliest commitment step into the <e1> b lymphoid lineage </e1> .',\n",
       "    'CELL_TYPE']]],\n",
       " ['HIV - 1 LTR transcription is controlled by a complex array of virus - encoded protein .',\n",
       "  [['HIV - 1 LTR transcription is controlled by a complex array of <e1> virus - encoded protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Under these conditions , etoposide produced a biphasic activation of protein kinase C , which consisted in an early transient activation ( from hours 1 to 6 ) of the membrane - bound enzyme followed by a later activation ( hour 48 ) of the total , membrane - bound enzyme .',\n",
       "  [['Under these conditions , etoposide produced a biphasic activation of protein kinase C , which consisted in an early transient activation ( from hours 1 to 6 ) of the membrane - bound enzyme followed by a later activation ( hour 48 ) of the total , <e1> membrane - bound enzyme </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['The jak1 tyrosine kinasehave been demonstrated to undergo tyrosine phosphorylation in response to interleukin ( IL ) - 4 stimulation in different cell systems .',\n",
       "  [['The <e1> jak1 tyrosine kinase </e1> have been demonstrated to undergo tyrosine phosphorylation in response to interleukin ( IL ) - 4 stimulation in different cell systems .',\n",
       "    'PROTEIN']]],\n",
       " ['The Jak1 , jak2 tyrosine kinasehave been demonstrated to undergo tyrosine phosphorylation in response to interleukin ( IL ) - 4 stimulation in different cell systems .',\n",
       "  [['The Jak1 , <e1> jak2 tyrosine kinase </e1> have been demonstrated to undergo tyrosine phosphorylation in response to interleukin ( IL ) - 4 stimulation in different cell systems .',\n",
       "    'PROTEIN']]],\n",
       " ['The Jak1 , Jak2 , jak3 tyrosine kinasehave been demonstrated to undergo tyrosine phosphorylation in response to interleukin ( IL ) - 4 stimulation in different cell systems .',\n",
       "  [['The Jak1 , Jak2 , <e1> jak3 tyrosine kinase </e1> have been demonstrated to undergo tyrosine phosphorylation in response to interleukin ( IL ) - 4 stimulation in different cell systems .',\n",
       "    'PROTEIN']]],\n",
       " ['Infection of human peripheral blood lymphocytes with HIV - 1 in vitro resulted in increased interleukin - 2 ( IL - 2 ) secretion in response to T cell activation via the cd3 receptor .',\n",
       "  [['Infection of human peripheral blood lymphocytes with HIV - 1 in vitro resulted in increased interleukin - 2 ( IL - 2 ) secretion in response to T cell activation via the <e1> cd3 receptor </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Freshly isolated monocytes constitutively expressed high levels of transcriptionally inactive p50 homodimer which decreased with time in culture in favor of the transcriptionally active p50/p65 heterodimer .',\n",
       "  [['Freshly isolated monocytes constitutively expressed high levels of transcriptionally inactive p50 homodimer which decreased with time in culture in favor of the transcriptionally active <e1> p50/p65 heterodimer </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['A T cell - specific enhancer in the interleukin - 3 locus is activated cooperatively by oct elementwithin a DNase I - hypersensitive site .',\n",
       "  [['A T cell - specific enhancer in the interleukin - 3 locus is activated cooperatively by <e1> oct element </e1> within a DNase I - hypersensitive site .',\n",
       "    'DNA']]],\n",
       " ['One of these NFAT - like elements encompassed overlapping oct - binding site, which functioned in a highly synergistic manner .',\n",
       "  [['One of these NFAT - like elements encompassed overlapping <e1> oct - binding site </e1> , which functioned in a highly synergistic manner .',\n",
       "    'DNA']]],\n",
       " ['We suggest that the T cell - specific expression of the IL - 3 gene is partly controlled through the enhancer by cooperation between oct family protein .',\n",
       "  [['We suggest that the T cell - specific expression of the IL - 3 gene is partly controlled through the enhancer by cooperation between <e1> oct family protein </e1> .',\n",
       "    'PROTEIN']]],\n",
       " ['Early viral RNA splicing patterns also differ between wild - type cell .',\n",
       "  [['Early viral RNA splicing patterns also differ between <e1> wild - type cell </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p4, P6 , P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p4 </e1> , P6 , P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p6, P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p6 </e1> , P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p7, and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p7 </e1> , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p9) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p9 </e1> ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p4, P6 , P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p4 </e1> , P6 , P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p6, P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p6 </e1> , P7 , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p7, and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p7 </e1> , and P9 ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Residues 432 , 435 , 437 , 438 , and 440 ( position p9) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "  [['Residues 432 , 435 , 437 , 438 , and 440 ( <e1> position p9 </e1> ) contributed to DQ2 binding , whereas residues 431 , 433 , 434 , and 436 ( positions P 1 , P2 , P3 , and P5 ) contributed to TCR contact .',\n",
       "    'DNA']]],\n",
       " ['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding componentof the IL - 12R , is expressed on human Th1 but not Th2 clones and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "  [['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned <e1> binding component </e1> of the IL - 12R , is expressed on human Th1 but not Th2 clones and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "    'PROTEIN']]],\n",
       " ['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on human th1 cloneand is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "  [['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on <e1> human th1 clone </e1> and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "    'CELL_LINE']]],\n",
       " ['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on human th2 cloneand is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "  [['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on <e1> human th2 clone </e1> and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "    'CELL_LINE']]],\n",
       " ['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding componentof the IL - 12R , is expressed on human Th1 but not Th2 clones and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "  [['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned <e1> binding component </e1> of the IL - 12R , is expressed on human Th1 but not Th2 clones and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "    'PROTEIN']]],\n",
       " ['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on human th1 cloneand is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "  [['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on <e1> human th1 clone </e1> and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "    'CELL_LINE']]],\n",
       " ['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on human th2 cloneand is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "  [['Here we show that the IL - 12 receptor ( IL - 12R ) beta 2 subunit , a recently cloned binding and signal transducing component of the IL - 12R , is expressed on <e1> human th2 clone </e1> and is induced during differentiation of human naive cells along the Th1 but not the Th2 pathway .',\n",
       "    'CELL_LINE']]],\n",
       " ['IL - 12 and type i interferoninduce expression of the IL - 12R beta 2 chain during in vitro T cell differentiation after antigen receptor triggering .',\n",
       "  [['IL - 12 and <e1> type i interferon </e1> induce expression of the IL - 12R beta 2 chain during in vitro T cell differentiation after antigen receptor triggering .',\n",
       "    'PROTEIN']]],\n",
       " ['IL - 12 and type ii interferoninduce expression of the IL - 12R beta 2 chain during in vitro T cell differentiation after antigen receptor triggering .',\n",
       "  [['IL - 12 and <e1> type ii interferon </e1> induce expression of the IL - 12R beta 2 chain during in vitro T cell differentiation after antigen receptor triggering .',\n",
       "    'PROTEIN']]],\n",
       " ['No degradation of p105 inhibitorwas observed under these conditions .',\n",
       "  [['No degradation of <e1> p105 inhibitor </e1> was observed under these conditions .',\n",
       "    'PROTEIN']]],\n",
       " ['Pax - 5a was detectable in pro - b - cell line, but not in pro - B - cell or T - cell lines .',\n",
       "  [['Pax - 5a was detectable in <e1> pro - b - cell line </e1> , but not in pro - B - cell or T - cell lines .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - , pre - b - cell line, but not in pro - B - cell or T - cell lines .',\n",
       "  [['Pax - 5a was detectable in pro - , <e1> pre - b - cell line </e1> , but not in pro - B - cell or T - cell lines .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - , pre - , and mature b - cell line, but not in pro - B - cell or T - cell lines .',\n",
       "  [['Pax - 5a was detectable in pro - , pre - , and <e1> mature b - cell line </e1> , but not in pro - B - cell or T - cell lines .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - , pre - , and mature B - cell lines , but not in two plasmacytomas ; Pax - 5b was shown to be present at low levels in mature B - cell lines and , unexpectedly , in one plasma cell line , but not in pro - b - cell line .',\n",
       "  [['Pax - 5a was detectable in pro - , pre - , and mature B - cell lines , but not in two plasmacytomas ; Pax - 5b was shown to be present at low levels in mature B - cell lines and , unexpectedly , in one plasma cell line , but not in <e1> pro - b - cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - b - cell line, but not in pro - B - cell or T - cell lines .',\n",
       "  [['Pax - 5a was detectable in <e1> pro - b - cell line </e1> , but not in pro - B - cell or T - cell lines .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - , pre - b - cell line, but not in pro - B - cell or T - cell lines .',\n",
       "  [['Pax - 5a was detectable in pro - , <e1> pre - b - cell line </e1> , but not in pro - B - cell or T - cell lines .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - , pre - , and mature b - cell line, but not in pro - B - cell or T - cell lines .',\n",
       "  [['Pax - 5a was detectable in pro - , pre - , and <e1> mature b - cell line </e1> , but not in pro - B - cell or T - cell lines .',\n",
       "    'CELL_LINE']]],\n",
       " ['Pax - 5a was detectable in pro - , pre - , and mature B - cell lines , but not in two plasmacytomas ; Pax - 5b was shown to be present at low levels in mature B - cell lines and , unexpectedly , in one plasma cell line , but not in pro - b - cell line .',\n",
       "  [['Pax - 5a was detectable in pro - , pre - , and mature B - cell lines , but not in two plasmacytomas ; Pax - 5b was shown to be present at low levels in mature B - cell lines and , unexpectedly , in one plasma cell line , but not in <e1> pro - b - cell line </e1> .',\n",
       "    'CELL_LINE']]],\n",
       " ['Constitutive dephosphorylation and activation of a member of the nuclear factor of activated T cells , NF - AT1 , in tax - expressing human t cellleukemia virus - infected human T cells .',\n",
       "  [['Constitutive dephosphorylation and activation of a member of the nuclear factor of activated T cells , NF - AT1 , in <e1> tax - expressing human t cell </e1> leukemia virus - infected human T cells .',\n",
       "    'CELL_TYPE']]],\n",
       " ['These results suggest that activation of NF - AT1 in tax - expressing t cellresults from its dephosphorylation , which in turn may be due to deregulation of .',\n",
       "  [['These results suggest that activation of NF - AT1 in <e1> tax - expressing t cell </e1> results from its dephosphorylation , which in turn may be due to deregulation of .',\n",
       "    'CELL_LINE']]],\n",
       " ['Physical interactions between ets proteinplay an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells .',\n",
       "  [['Physical interactions between <e1> ets protein </e1> play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells .',\n",
       "    'PROTEIN']]],\n",
       " ['The transcriptional regulatory elements of many inducible T - cell genes contain adjacent or overlapping binding sites for the ets familyof transcription factors .',\n",
       "  [['The transcriptional regulatory elements of many inducible T - cell genes contain adjacent or overlapping binding sites for the <e1> ets family </e1> of transcription factors .',\n",
       "    'PROTEIN']]],\n",
       " ...]"
      ]
     },
     "execution_count": 836,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combinacaoEntidades_desc = list()\n",
    "combinacaoEntidadesAll_desc = list()\n",
    "palavrasDescontinua=['AND NOT', 'AND/OR', 'AS WELL AS', 'AND', 'OR', 'BUT NOT', 'NEITHER NOR', 'THAN']\n",
    "pulando_termos_postagger=[]\n",
    "# agora, tratar descontinuas\n",
    "for key in frasesComDescontinuas:\n",
    "    entidades = dicSentencesComLabel[key][1].copy()\n",
    "    for entidade in entidades:\n",
    "        indices = entidade[1]\n",
    "        if not areConsecutive(indices): # é descontinua\n",
    "            tipo_entidade = entidade[2]\n",
    "            texto_entidade = ' '.join(entidade[0])\n",
    "            #print(texto_entidade)\n",
    "            inicio=indices[0]\n",
    "            fim=indices[-1]\n",
    "            tokens = dicSentencesComLabel[key][0].copy()\n",
    "            so_tokens = [t[0] for t in tokens]\n",
    "            #print('so_tokens:', so_tokens)\n",
    "            inicio_frase = so_tokens[:inicio]\n",
    "            fim_frase = so_tokens[fim+1:-1] \n",
    "            #print('inicio_frase:', inicio_frase)\n",
    "            #print('fim_frase:', fim_frase)\n",
    "            meio_frase = '<e1> '+texto_entidade + ' </e1> '\n",
    "            frase_final = ' '.join(inicio_frase)+' '+meio_frase+' '.join(fim_frase)+' .'\n",
    "            frase_final_texto = ' '.join(inicio_frase)+' '+texto_entidade+' '.join(fim_frase)+' .'\n",
    "            frase_final = replaceWhiteSpaces(frase_final)\n",
    "            frase_final_texto = replaceWhiteSpaces(frase_final_texto)\n",
    "            #print('frase_final_texto:', frase_final_texto)\n",
    "            #print('frase_final:', frase_final)\n",
    "            combinacaoEntidades_desc.append([frase_final, tipo_entidade])\n",
    "            if len(combinacaoEntidades_desc)>0:\n",
    "                combinacaoEntidadesAll_desc.append([frase_final_texto, combinacaoEntidades_desc])\n",
    "            combinacaoEntidades_desc = list()\n",
    "            '''\n",
    "            #agora, as combinações possiveis\n",
    "            # primeiro, gerar o termo todo\n",
    "            menorIndice = entidade[1][0]\n",
    "            maiorIndice = entidade[1][-1]\n",
    "            novoIndice=[n for n in range(menorIndice, maiorIndice+1)]\n",
    "            print(menorIndice)\n",
    "            print(maiorIndice)\n",
    "            print('novoIndice:', novoIndice)\n",
    "            novoTexto=[]\n",
    "            for token in tokens:\n",
    "                for indice in novoIndice:\n",
    "                    if token[1] == indice:\n",
    "                        novoTexto.append(token[0]) # novo termo com o CC\n",
    "                        \n",
    "            novoTextoCC = ' '.join(novoTexto).lower()\n",
    "            novoTextoCC = novoTextoCC.replace('and not', \"and_not\").replace('as well as', \"as_well_as\").replace('neither nor', \"neither_no\")\n",
    "            #indices_cc = [palavra.lower() in novoTexto.split() for palavra in palavrasDescontinua]\n",
    "            #indices2 = [txt.lower().split().index(palavra.lower()) for palavra in palavrasDescontinua]\n",
    "\n",
    "            # segundo, ver onde está o CC (AND, OR, etc)\n",
    "            indice_cc=0\n",
    "            len_cc=0\n",
    "            for cc in palavrasDescontinua:\n",
    "                try:\n",
    "                    indice_cc = novoTextoCC.split().index(cc.lower()) # pega o primero indice da primeira palavra CC\n",
    "                    len_cc = len(cc.split())\n",
    "                    break\n",
    "                except:\n",
    "                    continue\n",
    "            \n",
    "            # terceiro, fazer a combinação com as descontinuas:\n",
    "            # tudo antes do CC + <pula um token> + tokens (a partir daqui, combinar)\n",
    "            print('novoTexto[0:-2]:', novoTexto[0:len(novoTexto)])\n",
    "            termos_antes_cc = novoTexto[:indice_cc]\n",
    "            #termos_apos_cc = novoTexto[len_cc+3:-1] # nao pega o primeiro apos\n",
    "            termos_apos_cc = novoTexto[len_cc+3:len(novoTexto)] # nao pega o primeiro apos\n",
    "            #termos_ultimo_cc = novoTexto[-1] # nao pega o primeiro apos\n",
    "            print('termos_antes_cc:', termos_antes_cc)\n",
    "            print('termos_apos_cc:', termos_apos_cc)\n",
    "            #print('termos_ultimo_cc:', termos_ultimo_cc)\n",
    "            \n",
    "            # concatena o termo antes, com os termos apos, mais a ultima palavra          \n",
    "            # a primeira e ultima palavra tbm é um termo\n",
    "            #nova_entidade = termos_antes_cc\n",
    "            nova_entidade = []\n",
    "            #for i, termo_apos in enumerate(termos_apos_cc):\n",
    "            for i in range(len(termos_apos_cc), 0, -1):\n",
    "                #nova_entidade = termos_antes_cc\n",
    "                #for j in range(i, len(termos_apos_cc)):\n",
    "                #nova_entidade = nova_entidade +[termos_apos_cc[j]]\n",
    "                nova_entidade = [termos_apos_cc[i-1]]+nova_entidade\n",
    "                #for j in range(i, 0, -1):\n",
    "                    #print('j:',j)\n",
    "                #    print('add ',termos_apos_cc[j-1])\n",
    "                #    nova_entidade = [termos_apos_cc[j-1]]+nova_entidade\n",
    "                #nova_entidade = nova_entidade\n",
    "                #print('nova_entidade:', termos_antes_cc+nova_entidade)\n",
    "                #nova_entidade=[]\n",
    "                frase_final = ' '.join(inicio_frase)+' '+' '.join(termos_antes_cc+nova_entidade)+' '.join(fim_frase)\n",
    "                frase_final_texto = ' '.join(inicio_frase)+' <e1> '+' '.join(termos_antes_cc+nova_entidade)+' </e1>'+' '.join(fim_frase)\n",
    "                print('frase_final:', frase_final)\n",
    "                print('frase_final_texto:', frase_final_texto)\n",
    "                # só salva se nao tem ainda\n",
    "                # e ver se está no padrão para salvar\n",
    "                devePular = 0\n",
    "                if '. </e1>' in frase_final_texto or ', </e1>' in frase_final_texto  or '; </e1>' in frase_final_texto or '- </e1>' in frase_final_texto  or ': </e1>' in frase_final_texto  or '= </e1>' in frase_final_texto  or '/ </e1>' in frase_final_texto  or '( </e1>' in frase_final_texto  or ') </e1>' in frase_final_texto  or '[ </e1>' in frase_final_texto  or '] </e1>' in frase_final_texto  or ': </e1>' in frase_final_texto or 'and </e1>' in frase_final_texto or 'or </e1>' in frase_final_texto:\n",
    "                    devePular=1\n",
    "                print('devePular:', devePular)\n",
    "                if '<e1> .' in frase_final_texto or '<e1> ,' in frase_final_texto  or '<e1> ;' in frase_final_texto or '<e1> -' in frase_final_texto  or '<e1> :' in frase_final_texto  or '<e1> =' in frase_final_texto  or '<e1> /' in frase_final_texto  or '<e1> (' in frase_final_texto  or '<e1> )' in frase_final_texto  or '<e1> [' in frase_final_texto  or '<e1> ]' in frase_final_texto  or '<e1> :' in frase_final_texto  or '<e1> and' in frase_final_texto  or '<e1> or' in frase_final_texto:\n",
    "                    devePular=1\n",
    "                print('devePular:', devePular)\n",
    "                if re.search(\"<e1> [0-9]* </e1>\", frase_final_texto):\n",
    "                    devePular=1\n",
    "                print('devePular:', devePular)\n",
    "                pos_tagger_termo = tipoPostaggerTokens(termo, dicPosTagger)\n",
    "                if pos_tagger_termo not in lista_postaggers_entidades:\n",
    "                    pulando_termos_postagger.append([termo, pos_tagger_termo])\n",
    "                    devePular=1\n",
    "\n",
    "                tem_frase = 0\n",
    "                for frase in combinacaoEntidades:\n",
    "                    if frase[0] == frase_string:\n",
    "                        tem_frase=''\n",
    "                        break\n",
    "                print('tem_frase:', tem_frase)\n",
    "                print('devePular:', devePular)\n",
    "                if tem_frase==0 and devePular==0:\n",
    "                    combinacaoEntidades_desc.append([frase_final, 'O'])\n",
    "                    combinacaoEntidadesAll_desc.append([frase_final_texto, combinacaoEntidades_desc])\n",
    "                combinacaoEntidades_desc= list()\n",
    "            '''\n",
    "            \n",
    "    #break\n",
    "    \n",
    "combinacaoEntidadesAll_desc\n",
    "#pulando_termos_postagger"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 837,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1568"
      ]
     },
     "execution_count": 837,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(combinacaoEntidadesAll_desc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 838,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "16614"
      ]
     },
     "execution_count": 838,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(combinacaoEntidadesAll)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 840,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "numTreinamento: 13291\n",
      "numTeste: 1661\n",
      "numTotalEntidades: 165571\n",
      "numTotalEntidadesTrain: 131376\n",
      "numTotalEntidadesDev: 16986\n",
      "numTotalEntidadesTest: 17209\n"
     ]
    }
   ],
   "source": [
    "# já ir gravando arquivos treinamento, test e dev...\n",
    "# pra fazer um teste sem descontinuas\n",
    "numTreinamento = len(combinacaoEntidadesAll)*0.8\n",
    "numTreinamento = int(numTreinamento)\n",
    "numTeste = (len(combinacaoEntidadesAll) - numTreinamento)/2\n",
    "numTeste = int(numTeste)\n",
    "numTotalEntidades=0\n",
    "numTotalEntidadesTrain=0\n",
    "numTotalEntidadesDev=0\n",
    "numTotalEntidadesTest=0\n",
    "\n",
    "print('numTreinamento:', numTreinamento)\n",
    "print('numTeste:', numTeste)\n",
    "\n",
    "f_train = open('genia.train', 'w')\n",
    "f_dev = open('genia.dev', 'w')\n",
    "f_test = open('genia.test', 'w')\n",
    "f_dev_entidades = open('genia_entidades.dev', 'w')\n",
    "f_test_entidades = open('genia_entidades.test', 'w')\n",
    "\n",
    "for i, combinacaoEntidades in enumerate(combinacaoEntidadesAll):\n",
    "    #print(dicSentences[i])\n",
    "    frase = combinacaoEntidades[0]\n",
    "    frases_entidade = combinacaoEntidades[1]\n",
    "    if i<=numTreinamento:\n",
    "        f_train.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_train.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesTrain=numTotalEntidadesTrain+1\n",
    "    elif i <= numTreinamento + numTeste:\n",
    "        f_dev.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_dev.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            f_dev_entidades.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesDev=numTotalEntidadesDev+1\n",
    "    else:\n",
    "        f_test.write(frase+'\\n')\n",
    "        for frase_entidade in frases_entidade:\n",
    "            f_test.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            f_test_entidades.write(frase_entidade[1]+'\\t'+frase_entidade[0]+'\\n')\n",
    "            numTotalEntidades=numTotalEntidades+1\n",
    "            numTotalEntidadesTest=numTotalEntidadesTest+1\n",
    "\n",
    "f_train.close()\n",
    "f_test.close()\n",
    "f_dev.close()\n",
    "f_test_entidades.close()\n",
    "f_dev_entidades.close()\n",
    "\n",
    "print('numTotalEntidades:', numTotalEntidades)\n",
    "print('numTotalEntidadesTrain:', numTotalEntidadesTrain)\n",
    "print('numTotalEntidadesDev:', numTotalEntidadesDev)\n",
    "print('numTotalEntidadesTest:', numTotalEntidadesTest)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''\n",
    "combinacaoEntidades_desc = list()\n",
    "combinacaoEntidadesAll_desc = list()\n",
    "palavrasDescontinua=['AND NOT', 'AND/OR', 'AS WELL AS', 'AND', 'OR', 'BUT NOT', 'NEITHER NOR', 'THAN']\n",
    "\n",
    "# agora, tratar descontinuas\n",
    "for key in frasesComDescontinuas:\n",
    "    entidades = dicSentencesComLabel[key][1].copy()\n",
    "    for entidade in entidades:\n",
    "        indices = entidade[1]\n",
    "        if not areConsecutive(indices): # é descontinua\n",
    "            tipo_entidade = entidade[2]\n",
    "            inicio=indices[0]\n",
    "            fim=indices[-1]\n",
    "            tokens = dicSentencesComLabel[key][0].copy()\n",
    "            so_tokens = [t[0] for t in tokens]\n",
    "            inicio_frase = so_tokens[:inicio]\n",
    "            fim_frase = so_tokens[fim+2:-1] # TODO - mais 2 ou 3?\n",
    "            print('inicio_frase:', inicio_frase)\n",
    "            print('fim_frase:', fim_frase)\n",
    "            texto_entidade = ' '.join(entidade[0])\n",
    "            meio_frase = '<e1> '+texto_entidade + ' </e1>'\n",
    "            frase_final = inicio_frase+meio_frase+fim_frase\n",
    "            frase_final_texto = inicio_frase+texto_entidade+fim_frase\n",
    "            print('frase_final_texto:', frase_final_texto)\n",
    "            print('frase_final:', frase_final)\n",
    "            combinacaoEntidades_desc.append([frase_final, tipo_entidade])\n",
    "            combinacaoEntidadesAll_desc.append([frase_final_texto, combinacaoEntidades_desc])\n",
    "            #agora, as combinações possiveis\n",
    "            # primeiro, gerar o termo todo\n",
    "            menorIndice = entidade[1][0]\n",
    "            maiorIndice = entidade[1][-1]\n",
    "            novoIndice=[n for n in range(menorIndice, maiorIndice+1)]\n",
    "            #print(menorIndice)\n",
    "            #print(maiorIndice)\n",
    "            #print('novoIndice:', novoIndice)\n",
    "            novoTexto=[]\n",
    "            for token in tokens:\n",
    "                for indice in novoIndice:\n",
    "                    if token[1] == indice:\n",
    "                        novoTexto.append(token[0]) # novo termo com o CC\n",
    "                        \n",
    "            novoTextoCC = ' '.join(novoTexto).lower()\n",
    "            novoTextoCC = novoTexto.replace('and not', \"and_not\").replace('as well as', \"as_well_as\").replace('neither nor', \"neither_no\")\n",
    "            #indices_cc = [palavra.lower() in novoTexto.split() for palavra in palavrasDescontinua]\n",
    "            #indices2 = [txt.lower().split().index(palavra.lower()) for palavra in palavrasDescontinua]\n",
    "\n",
    "            # segundo, ver onde está o CC (AND, OR, etc)\n",
    "            indice_cc=0\n",
    "            len_cc=0\n",
    "            for cc in palavrasDescontinua:\n",
    "                try:\n",
    "                    indice_cc = novoTextoCC.split().index(cc.lower()) # pega o primero indice da primeira palavra CC\n",
    "                    len_cc = len(cc.split())\n",
    "                    break\n",
    "                except:\n",
    "                    continue\n",
    "            \n",
    "            # terceiro, fazer a combinação com as descontinuas:\n",
    "            # tudo antes do CC + <pula um token> + tokens (a partir daqui, combinar)\n",
    "            termos_antes_cc = novoTexto[:indice_cc]\n",
    "            termos_apos_cc = novoTexto[len_cc+1:-1]# nao pega o primeiro apos\n",
    "            print('termos_antes_cc:', termos_antes_cc)\n",
    "            print('termos_apos_cc:', termos_apos_cc)\n",
    "            for i, termo_apos in enumerate(termos_apos_cc):\n",
    "                nova_entidade = termos_antes_cc\n",
    "                for j in range(i, len(termos_apos_cc)):                \n",
    "                    nova_entidade += nova_entidade +' ' + termos_apos_cc[j]\n",
    "                    print('nova_entidade:', nova_entidade)\n",
    "            # só salva se nao tem ainda\n",
    "            \n",
    "            # quarto: gerar nova frase com a nova combinação (replace das tags especiaid)\n",
    "\n",
    "    \n",
    "'''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''\n",
    "#dicSentencesComLabel_tratandoDesc = {}\n",
    "\n",
    "# soma as descontinuas numa entidade só\n",
    "# ex: alfa and beta globina -> ENT, ENT, ENT, ENT (o 'AND' vira ENT)\n",
    "# de 17 a 22\n",
    "for fraseDescontinua in frasesComDescontinuas:\n",
    "    entidades = dicSentencesComLabel[fraseDescontinua][1]\n",
    "    tokens = dicSentencesComLabel[fraseDescontinua][0]\n",
    "    #print(entidades)\n",
    "    novasEnt = []\n",
    "    for entidade in entidades:\n",
    "        #print('entidade:', entidade)\n",
    "        menorIndice = entidade[1][0]\n",
    "        maiorIndice = entidade[1][-1]\n",
    "        novoIndice=[n for n in range(menorIndice, maiorIndice+1)]\n",
    "        #print(menorIndice)\n",
    "        #print(maiorIndice)\n",
    "        #print('novoIndice:', novoIndice)\n",
    "        novoTexto=[]\n",
    "        for token in tokens:\n",
    "            for indice in novoIndice:\n",
    "                if token[1] == indice:\n",
    "                    novoTexto.append(token[0])\n",
    "        #novoTexto = [token[0] for token in tokens where token[1] in novoIndice]\n",
    "        #print('novoTexto:', novoTexto)\n",
    "        novaEnt = [novoTexto, novoIndice]\n",
    "        novasEnt.append(novaEnt)\n",
    "    dicSentencesComLabel[fraseDescontinua][1] = novasEnt\n",
    "'''"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
